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Chapter 1 
 
INTRODUCTION 
 
The present volume presents new 2018 findings from the U.S. national Monitoring the Future 
(MTF) follow-up study concerning substance use among the nation’s college students and adults 
from ages 19 through 60. We report 2018 prevalence estimates on numerous illicit and licit 
substances, examine how substance use differs across this age span, and show how substance use 
and related behaviors and attitudes have changed over the past four decades. MTF, now in its 45th 
year, is a research program conducted at the University of Michigan’s Institute for Social Research 
under a series of investigator-initiated, competing research grants from the National Institute on 
Drug Abuse – one of the National Institutes of Health. The integrated MTF study comprises several 
ongoing series of annual surveys of nationally representative samples of 8th and 10th grade students 
(begun in 1991), 12th grade students (begun in 1975), and high school graduates followed into 
adulthood (begun in 1976).  
 
We report the results of the repeated cross-sectional surveys of all high school graduating classes 
since 1976 as we follow them into their adult years (as discussed in Chapter 3, these cross-sections 
come from longitudinal data). Segments of the general adult population represented in these 
follow-up surveys include: 
 
 U.S. college students, 
 their age-peers who also are graduates from high school but not attending college, 
sometimes called the “forgotten half,”1 
 all young adult high school graduates of modal ages 19 to 30 (or 19-28 for trend estimates), 
to whom we refer as the “young adult” sample, and  
 high school graduates at the specific later modal ages of 35, 40, 45, 50, 55, and 60. 
 
This volume emphasizes historical and developmental changes in substance use and related 
attitudes and beliefs occurring at these age strata.  
 
The follow-up surveys have been conducted by mail and web2 on representative subsamples of the 
previous participants from each high school senior class. This volume presents data from the 1977 
through 2018 follow-up surveys of the graduating high school classes of 1976 through 2017, as 
these respondents have progressed into adulthood. The oldest MTF respondents, from the classes 
of 1976, have been surveyed through age 60 in 2018, 42 years after their graduation.  
 
                                                 
1 Halperin S. The forgotten half revisited: American youth and young families, 1988-2008. Washington DC: American Youth Policy Forum; 1998. 
2 For 2018 data collections of 19-30 year olds, MTF began the transition from our typical mail-based surveys to web-based surveys. To test for 
survey mode differences, we randomly assigned half of the young adult respondents to the typical mail survey condition and half to the new web-
push condition. In general, prevalence estimates did not vary significantly between the two conditions and thus the two are combined in a weighted 
average in this volume. Exceptions (that is, when estimates differ significantly between conditions) are noted. This is discussed in more detail in 
Chapter 3. 
1
Other monographs in this series include the Overview of Key Findings,3 which presents early 
results from the secondary school surveys; Volume I,4 which provides an in-depth look at the 
secondary school survey results; and the HIV/AIDS monograph,5 drawn from the follow-up 
surveys of 21- to 40-year-olds, which focuses on risk and protective behaviors related to the 
transmission of HIV/AIDS. This year's Overview and Volume I are currently available on the MTF 
website6; the next HIV/AIDS monograph will be published in mid-October, 2019. 
 
In this volume, we first set the stage by providing a summary (in Chapter 2) of key findings from 
the integrated MTF study, including 8th , 10th, and 12th graders, college students, and young adults. 
Chapter 3 (which also is similar to Chapter 3 in Volume I) outlines the integrated study’s design 
and procedures. Chapter 4 provides prevalence estimates, and Chapter 5 provides historical trends, 
for drug use for a number of age bands from age 18 through age 60. Chapter 6 concerns prevalence 
and trends in attitudes and beliefs about drug use for young adults. Chapter 7 covers the social 
context of drug use in terms of peer norms and use, as well as perceived availability of drugs. 
Chapters 8 and 9 provide prevalence estimates and historical trends, respectively, for college 
students and their same age peers. Chapter 10 (which also is Chapter 10 in Volume I) provides a 
summary of recent publications from the integrated MTF study. 
 
SURVEYS OF YOUNG ADULTS AND ADULTS AGES 35, 40, 45, 50, 55, AND 60 
The current young adult sample consists of representative samples from each graduating class from 
2006 to 2017, all surveyed in 2018 and corresponding to modal ages 19 through 30. College 
students are included as part of this young adult sample. The MTF study design calls for annual 
follow-up surveys of each high school class cohort through modal age 30, based on high school 
seniors being assumed to be modal age 18. Each individual participates in a follow-up survey only 
every two years, but a representative sample of people in each individual’s graduating class is 
obtained every year because each cohort’s follow-up sample is split into two random samples that 
are surveyed in alternate years. Thus, participants at modal ages 19-30 are surveyed biennially. 
Subsequent surveys are conducted at five-year intervals starting at age 35. In 2018 the graduating 
classes of 2006-2017 received biennial young adult surveys, and the classes of 1976, 1981, 1986, 
1991, 1996, and 2001 were sent the age-60, age-55, age-50, age-45, age-40, and age-35 
questionnaires, respectively. 
 
In this volume, we reweight respondent data to adjust for the effects of panel attrition on measures 
such as drug use, using post-stratification procedures described in Chapter 3 in the section on panel 
retention. We are less able to adjust for the absence of students who drop out of high school and 
who are not included in the original 12th grade sample. Because nearly all college students have 
completed high school, the omission of high school dropouts should have almost no effect on 
                                                 
3 Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Overview, key findings on adolescent drug use. Ann Arbor, MI: Institute for Social Research, The University 
of Michigan. 
4 Miech, R. A., Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975–2018: Volume I, Secondary school students. Ann Arbor, MI: Institute for Social Research, The University of 
Michigan.  
5 Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., Patrick, M. E. & Miech R. A. (2018). HIV/AIDS: Risk & protective behaviors 
among adults ages 21 to 40 in the U.S., 2004–2017. Ann Arbor, MI: Institute for Social Research, The University of Michigan.  
6 Please visit http://monitoringthefuture.org/pubs.html#monographs to access the full text of these monographs. 
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population estimates for the college students, but this omission does affect the estimates for entire 
age groups. Therefore, the reader is advised that the omission of about 7% to 15% of each cohort 
who have dropped out of high school likely means that drug use estimates given here for the 
various age bands are somewhat low for the age group as a whole. Fortunately, high school dropout 
rates continue to decline. US Census data indicate that dropout comprised approximately 15% of 
the class/age cohort through most of the life of the study, until about 2002. Since then, there has 
been a gradual decline, dropping to about 6% in 2018.7 The proportional effect of missing dropouts 
may be greatest for use of dangerous drugs such as heroin, crack, and methamphetamine, as well 
as cigarettes – the latter being highly correlated with educational aspirations and attainment. 
Nevertheless, even with some underreporting of usage rates, the year-to-year trends observed 
should be little affected by the limitations in sample coverage. 
 
For purposes beyond this volume, we note that studies on substance use and related factors that 
follow young people into middle adulthood are rare in the field. Monitoring the Future (MTF) 
provides for exceptionally useful analyses of adult substance use as well as many other behaviors 
and attitudes. These national data make possible (1) analyses aimed at differentiating period-, age- 
and cohort-related change; (2) analyses demonstrating long-term connections between use of 
various substances at various stages in life and many important potential outcomes (including 
eventual substance use disorders, adverse health outcomes, and functioning in work and family 
roles); (3) tracking substance use involvement and how such involvement is affected by transitions 
into and out of social roles and social contexts across the life course; and (4) identifying the 
individual and contextual factors in adolescence and early adulthood that are predictive of later 
substance use and substance use disorders. These and other topics are or will be covered in other 
publications by MTF. 
 
SURVEYS OF COLLEGE STUDENTS AND NONCOLLEGE PEERS 
As defined here, the college student population comprises all full-time students enrolled in a two- 
or four-year college one to four years after high school in March during the year of the survey. 
More is said about this sample definition in Chapter 3 on study design. Results on the prevalence 
of drug use in 2018 among college students and also among their noncollege peers are reported in 
Chapter 8, and results on trends in substance use among college students and their noncollege 
peers are reported in Chapter 9, covering the 38-year interval since 1980.  
 
The MTF follow-up samples have provided excellent coverage of the U.S. college student 
population for more than three and a half decades (1980–2018). College students tend to be a 
difficult population to study at the national level for a variety of reasons. In the past, they were 
generally not well covered in household surveys, which tended to exclude dormitories, fraternities, 
and sororities. Further, institution-based samples of college students must be quite large in order 
to attain accurate national representation because of the great heterogeneity in universities, 
colleges, and community colleges, and in the types of student populations they serve. Obtaining 
good samples within many institutions also poses difficulties, because the cooperation of each 
institution must be obtained, as well as reasonable samples of the student body.  
 
                                                 
7 U.S. Child Trends Databank. (2018). High school dropout rates. Bethesda, MD. 
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In contrast, MTF draws the college sample prospectively in the senior year of high school, so it 
has considerable advantages for generating a broadly representative sample of college students 
who emerge from each graduating cohort; moreover, it does so at very low cost. In addition, the 
“before, during, and after college” design permits examination of the many changes associated 
with the college experience. Finally, the MTF design also generates comparable panel data on high 
school graduates who are not attending college, an important segment of the young adult 
population not only in its own right, but also as a comparison group for college students. This is a 
particularly valuable and rare feature of this research design. 
 
GENERAL PURPOSES OF THE RESEARCH 
MTF’s research purposes are extensive and are outlined here only briefly.8 One major purpose is 
to serve an epidemiological social indicator function to accurately characterize the levels and 
trends in selected behaviors, attitudes, beliefs, and relevant social context conditions in the various 
populations covered. Social indicators can have important agenda-setting functions for society, 
drawing attention to new threats to public health and estimating the extent of those threats as well 
as determining where they are concentrated in the population. They are especially useful for 
gauging progress toward national goals and indicating the impacts of major historical events, 
including social trends and policy changes. Another purpose of the study is to develop knowledge 
that increases our understanding of how and why historical changes in these behaviors, attitudes, 
beliefs, and environmental conditions are taking place. Such work is usually considered to be 
social epidemiology. These two broad purposes are addressed in the current series of volumes. 
 
Additional etiologic purposes of MTF include helping to discover risk and protective factors for, 
and consequences of, drug use; indicating what types of young people are at greatest risk for 
developing various patterns of drug abuse; gaining a better understanding of the belief and attitude 
orientations associated with various patterns of drug use; and monitoring how all of these are 
shifting over historical time and across the life course. MTF data permit the investigation of the 
immediate and more general aspects of the social environment that are associated with drug use 
and abuse, and permit the assessment of how drug use is affected by major transitions into and out 
of social roles and contexts (such as military service, civilian employment, college, 
unemployment, marriage, pregnancy, parenthood, divorce, remarriage). MTF examines the life 
course of various drug-using behaviors during the transition to adulthood and through middle 
adulthood, including progression to substance use disorder. This knowledge allows MTF to 
distinguish such age effects from cohort and period effects that influence drug use and associated 
attitudes, to discover the effects of legislation and changing regulations on various types of 
substance use, and to understand consequences of the changing connotations of drug use and 
changing patterns of multiple drug use among youth. 
 
We believe that differentiating among age, period, and cohort effects on use of various types of 
substances and associated attitudes and beliefs has been a particularly important contribution of 
the project. The MTF cohort-sequential research design is well suited to discern changes with age 
                                                 
8 Johnston, L. D., O'Malley, P. M., Schulenberg, J. E., Bachman, J. G., Miech, R. A., & Patrick, M. E. (2016). The objectives and theoretical 
foundation of the Monitoring the Future Study (Monitoring the Future Occasional Paper No. 84). Ann Arbor, MI: Institute for Social Research, 
University of Michigan. See also Bachman, J. G., Johnston, L. D., O'Malley, P. M., Schulenberg, J. E., & Miech, R. A. (2015). The Monitoring the 
Future project after four decades: Design and procedures (Monitoring the Future Occasional Paper No. 82). Ann Arbor, MI: Institute for Social 
Research, University of Michigan.  
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common to all cohorts (age effects), differences among cohorts that tend to persist across time 
(cohort effects), and changes common to most or all ages in a given historical period (period 
effects).  
 
Knowing which type of change is occurring is important for at least three reasons. First, it can help 
to discover what types of causes account for the change. For example, age effects are often 
explained by maturation as well as by social role and context transitions associated with age, as 
this study has demonstrated through several books, articles, and book chapters (as listed on MTF 
website). Such age effects, as we have shown, can vary historically, indicating the historical 
embeddedness of developmental course.9,10 Second, the type of change can indicate when in the 
life course the causes may have had their impact; in the case of cohort effects, it may well have 
been in an earlier point in the life course than the age at which the change is actually documented. 
For example, we know from historical context and MTF data on age of initiation that the decline 
in cigarette smoking observed among 12th graders in the late 1970s actually reflected a cohort 
effect that emerged when those teens were younger, in the early 1970s, which was shortly after 
cigarette advertising was removed from radio and television. So, although we documented a cohort 
effect at 12th grade, its origins were most likely due to earlier changes in social context. The third 
reason that knowing the type of change is important is that it can help in predicting future change 
more accurately. For example, the study has shown that perceived risk often is a leading indicator 
of change and also that cohort effects help to predict forthcoming changes at later ages. Of course, 
predicting change is extremely valuable to the policy, prevention, and treatment communities. This 
volume documents some well-established age effects, some important cohort differences that 
emerged at various points across the past four decades, and past and recent period effects. 
 
Another important purpose of MTF, related to but distinct from the ones described so far, is to 
study risk and risk-reducing behaviors associated with HIV/AIDS. This purpose is addressed in 
the monograph HIV/AIDS: Risk & protective behaviors among adults ages 21 to 40 in the U.S., 
2004-201711 Beginning in 2004, MTF panel surveys have included questions on the prevalence 
and interconnectedness of risk and risk-reduction behaviors related to the spread of the human 
immunodeficiency virus (HIV) which causes acquired immunodeficiency syndrome (AIDS). The 
questions include drug involvement in general, injection drug use, needle sharing, number of 
sexual partners, gender(s) of those partners, use of condoms, getting tested for HIV/AIDS, and 
obtaining the results of such HIV tests.  
 
Readers interested in publications dealing with any of topics mentioned above are invited to visit 
the MTF website at www.monitoringthefuture.org. 
                                                 
9 Jager, J., Schulenberg, J. E., O'Malley, P. M., & Bachman, J. G. (2013). Historical variation in drug use trajectories across the transition to 
adulthood: The trend toward lower intercepts and steeper, ascending slopes. Development and Psychopathology, 25(2), 527-543.  
10 Jager, J., Keyes, K. M., & Schulenberg, J. E. (2015). Historical variation in young adult binge drinking trajectories and its link to historical 
variation in social roles and minimum legal drinking age. Developmental Psychology, 51(7): 962-974. 
11 Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., Patrick, M. E., & Miech, R. A. (2018). HIV/AIDS: Risk & protective 
behaviors among adults ages 21 to 40 in the U.S., 2004–2017. Ann Arbor, MI: Institute for Social Research, The University of Michigan. 
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Chapter 2 
 
KEY FINDINGS 
AN OVERVIEW AND INTEGRATION 
ACROSS FIVE POPULATIONS 
 
Monitoring the Future, having completed its 45th year of data collection, has become one of the 
nation’s most relied-upon scientific sources of valid information on trends in use of licit and illicit 
psychoactive drugs by U.S. adolescents, college students, young adults, and adults up to age 60. 
For over four decades, the study has tracked and reported on the use of an ever-growing array of 
such substances in these populations of adolescents and adults. 
 
The annual series of monographs, of which this is Volume II, is a primary mechanism through 
which the epidemiological findings from MTF are reported. Findings from the inception of the 
study in 1975 through 2018 are included – the results of 44 national in-school surveys and 42 
national follow-up surveys. 
 
MTF has conducted in-school surveys of nationally representative samples of (a) 12th grade 
students each year since 1975 and (b) 8th and 10th grade students each year since 1991. Annual 
findings for 8th, 10th, and 12th graders through 2018 are presented in Volume I (also see the 2019 
Overview volume). Beginning with the class of 1976, the study has conducted follow-up mail 
surveys on representative subsamples of the respondents from each previously participating 12th 
grade class. These follow-up surveys now continue well into adulthood, currently up to age 60. 
Annual findings from these follow-up surveys are presented in this volume. 
 
In this chapter, we summarize a number of important findings to provide the reader with an 
overview of the epidemiological results from the integrated MTF study that span modal ages 14 
through 28, a key developmental period for the onset, peak use, and decline in the use of most 
substances. Because so many populations, drugs, and prevalence intervals are discussed here, a 
single integrative set of tables (Tables 2-1 through 2-4) shows the 1991–2018 trends for all drugs 
on five populations: 1) 8th grade students (modal age 14), 2) 10th grade students (modal age 16), 
3) 12th grade students (modal age 18), 4) full-time college students modal ages 19–22, and 5) all 
young adults modal ages 19–28 who are high school graduates. (Note that the young adult group 
includes the college student population.)  
 
Chapter 3 in this volume provides a summary of methods and procedures for secondary students, 
college students, and adults. As noted in that chapter (and discussed throughout this volume), for 
2018 data collections of 19-30 year olds, MTF randomly assigned half to receive the typical mail 
survey protocol and half to be pushed to web-based surveys. In comparing the prevalence estimates 
between the two conditions reported in this current chapter for college students and for all young 
adults ages 19-28, there were very few significant differences between the two conditions (about 
6% of the over 250 comparisons) and thus we combined estimates as a weighted average for 2018. 
Exceptions (i.e., when there are significant differences between the two conditions in 2018) are 
noted in Tables 2-1 through 2-4. 
 
6
Volume I and the Overview volume provide more emphasis on the in-school epidemiological 
findings. In this current volume, we provide more emphasis on the epidemiological findings from 
young adults and college students, as well as from those at modal ages 35, 40, 45, 50, 55, and 60. 
 
TRENDS IN DRUG USE – SUB-GROUP DIFFERENCES AND COHORT EFFECTS  
Before considering the trends in specific drugs across the five sub-groups presented in Table 2-1, 
we first provide a brief summary of the rises and falls of substance use during the past quarter-
century to illustrate the impact of attitudes in historical trends of use and how cohort effects work 
to sometimes shift developmental trends. We introduce terms that are used throughout this volume. 
Early in the 1990s, MTF reported an increase in use of several illicit drugs among secondary school 
students, and some important changes among the students in terms of certain key attitudes and 
beliefs related to drug use. In the volume reporting 1992 survey results, we noted the beginning of 
such reversals in both use and attitudes among 8th graders, the youngest respondents surveyed in 
this study, and also a reversal in attitudes among 12th graders. Specifically, the proportions seeing 
great risk in using drugs began to decline, as did the proportions saying they disapproved of use. 
As we suggested then, those reversals indeed presaged “an end to the improvements in the drug 
situation that the nation may be taking for granted.”1 The use of illicit drugs rose sharply in all 
three grade levels after 1992, in what we refer to as the “relapse phase” in the larger epidemic of 
illicit drug use, as negative attitudes and beliefs about drug use continued to erode. Likewise, the 
use of illicit drugs among college students and young adults overall (ages 19-28) began to increase 
in the early 1990s. This pattern continued into the mid-1990s for the five age groups, and beyond 
that for some drugs, especially prescription-type psychotherapeutics like narcotics, amphetamines, 
tranquilizers, and sedatives. 
 
Then in 1997, for the first time in six years, the overall level of illicit drug use finally showed a 
decline among 8th graders. Although marijuana use continued to rise that year among 10th and 12th 
graders, their use of several other drugs leveled off, and relevant attitudes and beliefs also began 
to reverse in many cases. In 1998, illicit drug use continued a gradual decline among 8th graders 
and also started to decline at 10th and 12th grades. In 1999 and 2000, the decline continued for 8th 
graders, while use held fairly level among 10th and 12th graders. In 2002 and 2003, use by 8th and 
10th graders decreased significantly, and use by 12th graders finally began to drop; declines then 
continued for all three grades in 2004 and for several years thereafter. But in 2008, illicit drug use 
increased once again among 8th and 12th graders, followed by some increase in 8th and 10th grades 
in 2009, signaling an end to the immediately preceding period of decline. In 2010, the overall level 
of illicit drug use increased for all grades, although the increase was significant only among 8th 
graders. In 2011, the increase continued among 10th and 12th graders and declined some at 8th 
grade. Among college students, use continued to rise until 1998, leveled through about 2004, and 
showed uneven change through about 2010; among young adults overall, it continued to rise 
gradually until about 2004, and then leveled through about 2010. Publicity around legalizing 
medical marijuana, and in some cases recreational use for adults, may have served to normalize 
use of marijuana, the most widely used of all illicit substances. 
 
                                                 
1 Johnston, L. D., O'Malley, P. M., & Bachman, J. G. (1993). National survey results on drug use from the Monitoring the Future study, 1975-
1992. Volume I: Secondary school students. (NIH Publication No. 93-3597). Rockville, MD: National Institute on Drug Abuse. 
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As shown in Figure 2-1, levels of overall illicit drug use among teens have shown a slight 
downward trend for several years through 2016. (2013 is an exception and shows a slight increase 
that resulted from an expansion of the question on amphetamines to include more current examples 
of these drugs.) During this time period, marijuana prevalence decreased at a slower rate than it 
has for other substances such as cigarettes and alcohol, perhaps due in part to the ongoing changes 
in state laws on medical and recreational marijuana use. In 2017 and 2018, we see some 
nonsignificant increases in overall illicit drug use among teens (especially 8th and 10th graders), 
due in part to increases in marijuana use and inhalants (as summarized below and described in 
detail in Volume I), suggesting a leveling of use if not a turnaround. Among college students and 
young adults overall (aged 19-28), there has been a slow but steady rise since 2010 in overall illicit 
drug use (see Figure 2-1), with consistent increases in marijuana use across this time period. 
Whether marijuana use (or other drug use) will continue to increase in coming years among young 
adults, as more states legalize recreational marijuana use, is a matter to be clarified with continued 
monitoring. 
 
As will be illustrated below in the discussion of specific drugs, the increase in use of many drugs 
during the 1990s among secondary school students, combined with fairly level use among college 
students and young adults, resulted in some unusual reversals in prevalence levels by age (see 
Figure 2-1 and Table 2-2). In the early 1990s (the early years of what we have called the relapse 
phase of the epidemic), illicit drug use levels were higher in the college-age group than they were 
among secondary school students (especially 8th and 10th graders). This reflects a normative 
developmental trend showing that prevalence increases with age through adolescence into the early 
20s. But by the late 1990s, the highest levels of active use (i.e., use within the prior year or prior 
30 days) were found in the late secondary school years. In fact, in 1996 and 1997 both 10th and 
12th graders actually had higher annual prevalence levels for illicit drug use (i.e., higher 
percentages reporting any use within the prior year) than either college students or all young adults. 
This changed somewhat after 2001 (with 10th graders annual prevalence becoming lower than that 
for college students), as the earlier, heavier-using cohorts of adolescents began to comprise the 
college student and young adult populations, while at the same time use among the incoming 
secondary school students was declining. In the past few years, a more typical normative 
developmental trend has returned, with annual prevalence increasing with age across adolescence 
and the early 20s. 
 
As can be seen by the divergence of trends for the different age groups in what follows, something 
other than simple developmental or secular trends in drug use were taking place; important cohort 
differences were emerging such that all ages were not changing simultaneously and age differences 
were not constant across historical time. (A cohort refers to a group of people who were born in 
the same year [a birth cohort] or, in this case, are in the same graduating class [a class cohort]. A 
birth cohort and class cohort obviously are quite close but not identical. Developmental trends 
pertain to changes with age that tend to be constant across multiple cohorts. A secular trend is a 
trend across historical time that occurs simultaneously across multiple cohorts and multiple age 
groups.) 
 
Regarding 2018 prevalence levels, we note that the typical developmental trend of substance use 
increasing with age through the early twenties remains in place. In 2018, the rank order by age 
group for annual prevalence of using any illicit drug was college students (45%), all 19- to 28 year 
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old young adults (43%), 12th graders (39%), 10th graders (30%), and 8th graders (13%) (see Figure 
2-1 and Table 2-2). With respect to using any illicit drug other than marijuana in the past 12 
months, prevalence rank-ordering was 19% for all 19- to 28 year olds, 18% for college students 
specifically, 12% for 12th graders, 10% for 10th graders, and 6% for 8th graders (see Table 2-2). 
 
We turn now to summarize historical and developmental trends in the use of individual substances 
across the past quarter-century. 
 
 From the early 1990s until 1997, marijuana use rose sharply among secondary school 
students, as did their use of a number of other illicit drugs, though more gradually. As 
previously stated, we have called this period a “relapse phase” in the longer-term epidemic. 
An increase in marijuana use also began to occur among college students, largely reflecting 
“generational replacement” (i.e., a cohort effect), wherein earlier class cohorts were 
replaced in the college population by more recent ones who were more drug-experienced 
before they left high school. This resurgence in illicit drug use spread up the age spectrum 
in a reversal of the way the epidemic spread several decades earlier. In the 1960s, the 
epidemic began on the nation’s college campuses, and then diffused downward in age to 
high school students and eventually to middle school students. This time the increases 
began in middle schools and radiated up the age spectrum. The graduating class cohorts in 
the middle and late 1990s carried with them the pattern of heavier drug use that emerged 
while they were in secondary school in the early 1990s. 
 
Increases during the 1990s in use of any illicit drug (including use of marijuana and use 
of other illicit drugs treated as a class) were substantially larger, in both proportional and 
absolute terms, in the three secondary school grades than in either the college or young 
adult populations. Among college students and young adults, the annual prevalence of use 
of any illicit drug held remarkably stable from 1991 through 1997, at the same time use 
rose appreciably among adolescents (see Figure 2-1). We predicted that, as generational 
replacement continued to occur, we would likely see some increase in use of illicit drugs 
by the young adults. As would be expected given their younger age range (19–22), the 
increase happened sooner and more sharply among the college students than among the 
young adults in general (age range 19–28). Peak levels (since 1990) in annual prevalence 
of any illicit drug were reached in 1996 among 8th graders (24%), in 1997 among 10th and 
12th graders (39% and 42%, respectively), in 2001 among college students (38% before 
leveling for some years and increasing in recent years to a new peak of 45% in 2018), and 
in 2004 in the entire young adult segment (34% before leveling and increasing in recent 
years to a new peak of 43% in 2018). More recently, a different, more complex pattern of 
cohort effects has been operating. Specifically, since about 2010, there has been some 
divergence in the annual prevalence of any illicit drug across the five age groups, with 
declines among 8th and 10th graders, slight decline and leveling among 12th graders, and 
increases among college students and young adults (see Figure 2-1). However, in 2017 and 
2018, we see what may be a leveling or turnaround in annual prevalence among secondary 
school students (with nonsignificant increases to 13% and 30% in 2018 for 8th and 10th 
graders, respectively, and a leveling for 12th graders to 39% in 2018); among college 
students, there has been some uneven continued increases to 45% in 2018 and a continued 
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increase among young adults to 43% in 2018. Divergences among the five age groups 
continue to expand, with college students continuing to have the highest annual prevalence.  
 
Again, the earlier diverging trends across the different age strata clearly show that changes 
during the 1990s reflected the emergence of some important cohort effects rather than 
broad secular trends that would have appeared simultaneously in all of the age groups. 
From 1980 through 1992, the use of most drugs moved in parallel across most age groups, 
indicating that secular change was prevailing then, and in general use was declining. 
 
 During the 1990s, in the “relapse period” in the drug epidemic, the annual prevalence of 
marijuana use tripled among 8th graders (from 6% in 1991 to 18% in 1996), more than 
doubled among 10th graders (from 15% in 1992 to 35% in 1997), and nearly doubled among 
12th graders (from 22% in 1992 to 39% in 1997). Among college students and young adults 
overall, however, the increase in marijuana use was much more gradual, presumably due 
to a generational replacement effect. Annual prevalence of use rose by about one third for 
college students, from 27% in 1991 to 36% in 1998 and from 24% in 1991 to 28% in 1999 
for young adults overall. Marijuana use began to decline for 8th graders after 1996 (18%) 
through 2007 (10%) and then did the same after 1997 among 10th and 12th graders (when 
it was 35% and 39%, respectively) through 2008 (24% and 32%, respectively); it was fairly 
level for college students from 1998 through 2003 (when it was between 34% and 36%) 
and then dropped and leveled through 2011 (between 30% and 33%); and for young adults 
overall, it remained level from 2000 through 2010 (between 28% and 29%). Then, after 
the mid-2000s, the secondary school students showed some increases, followed by 
decreases or leveling through 2018: 8th graders increased from 10% in 2007 to 14% in 
2010, and then declined to 11% in 2018; 10th graders increased from 24% in 2008 to 30% 
in 2013, and then declined to 28% in 2018; and 12th graders increased from 32% in 2008 
to 36% in 2011 and then was fairly level through 2018 (36%). College students increased 
from 33% in 2011 to 43% in 2018, and young adults increased from 29% in 2010 to 39% 
in 2018.  
 
 Current daily marijuana use (defined as use on 20 or more occasions in the prior 30 days) 
rose substantially after 1992 in all five populations, reaching peak levels in a somewhat 
staggered fashion as that just described (see Table 2-4). Daily use began a slow decline 
after 1999 among 8th graders until 2007, after 2001 until 2009 among 10th graders, and after 
2003 until 2010 among 12th graders, consistent with a cohort effect pattern. Use at all three 
grade levels was fairly level after 2004. In 2010, daily use at all three grade levels increased 
significantly and it increased further in grades 10 and 12 in 2011 and 2012, while holding 
steady in 8th grade. In 2014, the prevalence of daily marijuana use declined in all three 
grades, with a significant decline in 10th grade; these levels remained essentially unchanged 
through 2018. The 2018 daily prevalence levels in grades 8, 10, and 12, respectively, were 
0.7%, 3.4%, and 5.8%. In other words, in 2018 about one in every seventeen high school 
seniors was a daily or near-daily marijuana user. College student and young adult 
prevalence of daily use showed an overall increase from 3.5% in 2007 to 5.8% in 2018 
among college students and from 5.0% to 8.0% over that same interval among all young 
adults. That is, in 2018 about one in every thirteen young adults aged 19-28 was a daily or 
near daily marijuana user. The role of the many debates on legalizing marijuana for 
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medical use, the actual legalization for recreational use by adults in some states, and the 
experiences those states have with the new laws may well have an impact on present and 
future secular trends and possibly cohort effects in use. 
 
 Synthetic marijuana contains synthetic versions of some of the cannabinoids found in 
marijuana sprayed onto herbal materials that are then sold in small packets under such 
brand names as Spice and K-2. They have been readily available as over-the-counter drugs 
on the Internet and in venues like head shops and gas stations. While many of the most 
widely used chemicals were scheduled by the Drug Enforcement Administration in March 
of 2011, making their sale no longer legal, purveyors of these products have skirted the 
restrictions by making small changes in the chemical composition of the cannabinoids 
used. Use of these products was first measured in MTF in 2011 (see Table 2-2). Annual 
prevalence was found to be 11.4%, 8.5%, and 7.4%, respectively, among 12th graders, 
college students, and young adults (8th and 10th graders were first asked about use of these 
drugs in 2012, and their annual prevalence levels were 4.4% and 8.8%, respectively). These 
relatively high prevalence levels made synthetic marijuana among the most widely used 
illicit drugs in 2011 and 2012. Use declined appreciably in 2013 and 2014 among all five 
populations, with most of the 1-year declines being significant. Efforts by the DEA and 
various states to make their sale illegal may well have had an impact. In 2018, prevalence 
was 1.6%, 2.9%, 3.5%, 1.6%, and 1.6%, respectively, across the five age groups from 
youngest to oldest, reflecting a leveling at a relatively low level for all age groups. 
 
 Among 12th graders, the proportions using any illicit drug other than marijuana in the 
past twelve months rose from a low of 15% in 1992 to a high of 21% in 1999 (see Table 
2-2); these levels were substantially below the 34% peak level reached two decades earlier, 
in 1981. All of the younger groups showed significant increases between 1992 and 1997, 
with use beginning to increase in 1992 among 8th graders, in 1993 among 10th and 12th 
graders, and in 1995 among college students – reflecting strong evidence of a cohort effect. 
Use peaked in 1996 among 8th and 10th graders, in 1997 among 12th graders, around 2004 
for college students, and in 2008 for all young adults. Since 1996, the 8th graders have 
shown a gradual but considerable decline of more than one-half in their use of illicit drugs 
other than marijuana, treated as a class (13% annual prevalence in 1996 to 6.1% in 2018). 
The decline among 10th graders paused from 1998 to 2001 with a net decline of about a 
third in annual prevalence from 18% in 1996 to 11% in 2008; use leveled again for several 
years and then declined further in 2011. It stood at 9.6% in 2018. Twelfth-grade use also 
showed some decline beginning after 2001 (22%), dropping to 12% in 2018. College 
students so far have shown little change over the course of the survey and have hovered 
between 18% and 21% since 2013 (when the questions were last updated); annual 
prevalence in 2018 was 18%. Use among all young adults varied between 17% and 21% 
from 2003 to 2018; 2018 annual prevalence was 19%. 
 
 Between 1989 and 1992, we noted an increase among 12th graders, college students, and 
young adults in their use of LSD, a drug quite popular in the late 1960s and early 1970s. 
In 1992, the newly added populations (8th and 10th graders) were also showing an increase 
in LSD use; for several more years, modest increases persisted in all five populations. Use 
of LSD peaked in 1995 among college students and young adults and in 1996 among 8th, 
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10th, and 12th graders, after which LSD use gradually declined in all five populations until 
about 2005 (the relatively large declines for all age groups in 2001 corresponded to the 
closing of a major LSD lab that year by the Drug Enforcement Administration). Since 2006 
through 2018, annual prevalence has remained at about 1% for 8th graders, ranged from 
1.7% to 2.1% for 10th graders, and increased slightly but steadily for the three older age 
groups from 1.7% to 3.2% for 12th graders, from 1.4% to 4.1% among college students, 
and from 1.2% to 3.9% for young adults. Overall, the pattern for LSD use seems more 
consistent with secular change than a cohort effect. The different age groups moved in 
parallel for the most part, likely in response to historical events in the environment, 
including a sharp reduction in LSD availability after 2001. 
 Questions about the use of MDMA, which goes by the street names “ecstasy” and more
recently “Molly,” have been included in the follow-up surveys of college students and
young adults since 1989; however, because of our concern about stimulating interest in an
attractive-sounding and little-known drug, these questions were not added to the secondary
school surveys until 1996. From 1989 to 1994, the annual prevalence levels tended to be
quite low in the older age groups for which we had data, but in 1995, these levels increased
– from 0.5% in 1994 to 2.4% in 1995 among college students, and from 0.7% to 1.6% over
the same time span among young adults generally.
When usage data were first gathered on secondary school students in 1996, the 10th and 
12th graders actually showed higher levels of annual use (both 4.6%) than the college 
students (2.8%). MDMA use then fell steadily in all three grades between 1996 and 1998, 
though it did not fall in the older age groups (see Table 2-2). But between 1998 and 2001, 
use rose sharply in all five populations. In fact, annual prevalence more than doubled in 
that three-year period among 12th graders, college students, and young adults, and nearly 
doubled in the lower grades. In 2000, even the 8th graders showed a significant increase in 
use. Since the peak highs in 2001, annual MDMA use has declined overall, with a slight 
increase around 2010 that proved fleeting. 
In 2018, annual prevalence of MDMA (ecstasy, Molly) was 1.1%, 1.4%, 2.2%, 4.3%, and 
3.9% among the five age groups, respectively. This annual prevalence remained level in 
2017 among 8th, 10th, and 12th graders (after declining significantly in 2016), and declined 
significantly among college students and young adults. In 2018, there were no significant 
changes. These recent declines are based on measures that included “Molly” as an example 
street name of MDMA, measures that were introduced in the survey in 2014. (Molly is 
supposed to be a stronger form of MDMA than ecstasy.) Per our custom when introducing 
new question wording, in 2014 we included the newly worded question to a random half 
of the respondents and the other half served as a control with the old version of the MDMA 
question. All 2016 through 2018 MDMA questions include the “Molly” street name, and 
are compared to the 2014 and 2015 measures that also include the “Molly” wording. The 
declines in annual prevalence from 2014 through 2018 suggest that any new popularity to 
MDMA brought by its new branding as Molly appears to have been transitory. 
Use of MDMA (ecstasy and more recently Molly) has been moving fairly synchronously 
among all five populations since 1999 until recent years, which suggests there was a secular 
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trend (likely due to some changes in the social environment that affected everyone). An 
important change during this period was the increasing availability of information on the 
adverse effects of ecstasy use via stories in the popular media, dissemination of scientific 
evidence by the National Institute on Drug Abuse, and an anti-ecstasy media campaign by 
the Partnership for a Drug-Free America and the Office of National Drug Control Policy, 
initiated in 2002. 
 
 Between 1982 and 1992, among 12th graders levels of amphetamine use in the past 12 
months (other than use that was ordered by a physician) fell by nearly two thirds, from 
20.3% to 7.1%. Levels among college students fell even more over the same interval, from 
21.1% to 3.6%. During the relapse phase in the drug epidemic in the 1990s, annual 
amphetamine use increased by about half among 8th and 10th graders between 1991 and 
1996, and also increased among 12th graders and college students between 1992 and 1996. 
After 1996, the age groups diverged. Among 8th and 10th graders, use dropped by over half 
from a high in 1996 (9.1% and 12.4%, respectively) through 2018 (3.7% and 5.7%). 
Annual use among 12th graders peaked in 2002 (11.1%) and dropped unevenly by half 
through 2018 (5.5%). In contrast, among college students levels of amphetamine use 
gradually increased from 1991 (3.9%) through 2012 (11.1%) and then showed uneven 
modest decline through 2018 (8.3%). It is possible more college students are using 
amphetamines to help their academic work. All young adults, who include the college 
students, showed less of an increase over the same interval, from 4.3% in 1991 to 7.5% in 
2018. Since the late 1990s, there has been a greater difference between use among 8th 
graders and use by older students, suggesting that an age effect has emerged, possibly due 
to the older students becoming more likely to use amphetamines to aid their academic 
performance. (“To help me study” was the reason most endorsed by 12th graders for 
amphetamine use in 2018.) 
 
 Use of the stimulant drug Ritalin outside of medical supervision showed a distinct increase 
around 1997 – with annual prevalence among 12th graders going from 0.1% in 1992 to 
2.8% in 1997 – and then stayed level for a few years (see Appendix C, Table C-22 in 
Volume I). Because of its increasing importance, a differently structured question was 
introduced for Ritalin use in 2001 for grades 8, 10, and 12, and in 2002 for college students 
and young adults. This new question, which we prefer to the original, does not use a prior 
branching question and produced somewhat higher prevalence levels. Results from the new 
question suggest an ongoing decline in Ritalin use, with prevalence levels in 2018 being 
half or less than they were in 2001-2002 for all five population groups; annual prevalence 
rates in 2018 were 0.5%, 0.9%, 0.9%, 1.3%, and 1.5%, respectively. 
 
 Another stimulant used in the treatment of the symptoms of attention deficit hyperactivity 
disorder (ADHD) is the amphetamine drug Adderall. A new question on its nonmedical 
use was introduced in 2009; annual prevalence levels in 2009 through 2018 were higher 
than those for Ritalin in all five populations. This suggests that Adderall to some degree 
                                                 
2 As discussed in Appendix C of Volume I, the absolute prevalence rates for Ritalin are probably higher than the statistics indicate, but the trend 
story is likely quite accurate. See Table 2-2 for more accurate estimates of the absolute annual prevalence rates in recent years; these estimates are 
based on a new question that does not require the respondent to indicate some amphetamine use before being branched to a question about Ritalin 
use. 
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replaced the use of Ritalin and may help to account for the declines [[that we have been 
observing]] for Ritalin. Since the drug was first tracked in 2009, annual prevalence of 
nonmedical use of Adderall has not shown much systematic change through 2018; it ranged 
between 9% and 11% for college students and 6% and 9% among young adults, which are 
fairly high levels. Among secondary students prevalence was 1-2% for 8th graders, 4-6% 
for 10th graders, and 5-8% for 12th graders. 
 
 Methamphetamine questions were introduced in 1999 because of rising concern about use 
of this drug; but an overall decline in use has been observed among all five populations in 
the years since then. In 2018, annual use in all five populations was very low – below 2%. 
These substantial declines occurred during a period in which there were many media 
reports suggesting that methamphetamine use was a growing problem – an example of the 
importance of having accurate epidemiological data. 
 
 Measures on the use of crystal methamphetamine or ice (a crystallized form of 
methamphetamine that can be smoked, much like crack) have been included in MTF since 
1990. The use of crystal methamphetamine increased between the early and late 1990s 
among the three populations asked about their use: 12th graders, college students, and 
young adults. However, use never reached very high levels. The estimates are less stable 
than usual due to the relatively small samples asked about this drug, but it appears that 
among 12th graders crystal methamphetamine use held fairly steady from 1999 through 
2005 (when it was 2.3%); since then it has declined by roughly three-fourths, to 0.6% in 
2018. Use rose somewhat among college students and all young adults until 2005, before 
dropping substantially since then. After their peak levels were reached in 2005, college 
students and young adults generally showed substantial drops in annual prevalence to 1% 
or less by 2018 (see Table 2-2). 
 
 Inhalants are defined as fumes or gases that are inhaled to get high, and they include 
common household substances such as glues, aerosols, butane, and solvents of various 
types. Among 12th graders, there was a long-term gradual increase in the use of inhalants 
(unadjusted for nitrite inhalants) from 1976 to 1987, followed by a leveling for a few years 
and then a further increase in the early 1990s. This troublesome increase in inhalant use 
also occurred among students in the lower grades, and was followed by a reversal in all 
three grades after 1995. After reaching a low point by 2002 or 2003 in grades 8, 10, and 
12, use of inhalants increased some in all grades, but then declined in all grades. Inhalant 
use has been much lower among college students and young adults over the years, and it 
has declined steadily over the past two decades. In 2018, annual prevalence was at or near 
the lowest point in the history of the study for all five groups at 4.6%, 2.4%, 1.6%, 1.3%, 
and 0.8%, respectively (see Table 2-2). Note that this is the only substance class that 
consistently declines in use with age. 
 
 Crack cocaine use spread rapidly from the early to mid-1980s. Still, among 12th graders, 
the use of crack remained relatively low during this period (3.9% annual prevalence in 
1987). Clearly, crack had quickly attained a reputation as a dangerous drug, and by the 
time of our first measurement of perceived risk in 1987, it was seen as the most dangerous 
of all drugs. Annual prevalence dropped sharply in the next few years, reaching 1.5% by 
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1991, where it remained through 1993. Perceived risk began a long and substantial decline 
after 1990 – again serving as a driver and leading indicator of use. (The decline in perceived 
risk in this period may well reflect generational forgetting of the dangers of this drug.) 
Annual prevalence among 12th graders rose gradually after 1993, from 1.5% to 2.7% by 
1999. It finally declined slightly in 2000 and then held level through 2007. Since then, 
some additional decline has occurred. In 2018, annual prevalence for crack cocaine among 
12th graders was at 0.9%. 
 
Among 8th and 10th graders, crack use rose gradually in the 1990s: from 0.7% in 1991 to 
2.1% by 1998 among 8th graders, and from 0.9% in 1992 to 2.5% in 1998 among 10th 
graders. And, as just discussed, use among 12th graders peaked in 1999 at 2.7% and among 
young adults at 1.4%. Since those peak years, crack use has declined appreciably— by 
more than half among 8th, 10th, and 12th graders – yet it held fairly steady among college 
students and young adults, at least until 2007, when use among college students finally 
began to decline. The 2018 prevalence levels for this drug were relatively low – 1% or less 
in all five groups. Twelfth graders have typically had the highest prevalence. Annual crack 
prevalence among the college-bound has generally been considerably lower than among 
those not bound for college. Among 12th graders, the levels of use in 2018 were 0.6% for 
college-bound and 1.9% for noncollege-bound. 
 
 Use of cocaine3 in general began to decline a year earlier than crack, probably because 
crack was still in the process of diffusing to new parts of the country, being still quite new. 
Between 1986 and 1987 the annual prevalence for cocaine dropped dramatically, by about 
one fifth in all three populations being studied at that time – 12th graders, college students, 
and young adults. The decline occurred when young people finally began to view 
experimental and occasional use – the type of use in which they thought they would be 
most likely to engage – as more dangerous. This change was probably influenced by the 
extensive media campaigns that began in the preceding year, but also almost surely by the 
highly publicized cocaine-related deaths in 1986 of sports stars Len Bias and Don Rogers. 
By 1992, the annual prevalence of cocaine use had fallen by about two thirds among the 
three populations for which long-term data are available (12th graders, college students, 
and young adults). 
 
During the resurgence of illicit drug use in the 1990s, however, cocaine use in all five 
populations increased once again, both beginning and ending in a staggered pattern by age, 
consistent with a cohort effect. Use rose among 8th graders from 1991 to 1998, among 10th 
and 12th graders from 1992 to 1999, among college students from 1994 to 2004, and among 
all young adults from 1996 through 2004. As with crack, all five populations showed some 
decline in cocaine use in 2008 through 2011 and a levelling over the next two years. Since 
then through 2018, cocaine use showed a slight decline among secondary students. For 
college students and young adults, annual prevalence has trended slightly upward since 
2011.Annual prevalence levels in 2018 were 0.8%, 1.5%, 2.3%, 5.2%, and 6.0% for the 
five populations, respectively. For a few years (1996–1999), 12th graders had higher 
prevalence than did the young adults; but because of the staggered declines in use, young 
adults have had the highest prevalence in all years since then (see Table 2-2). 
                                                 
3 Unless otherwise specified, all references to cocaine concern the use of cocaine in any form, including crack. 
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  Use of PCP (phencyclidine, also known as angel dust) is measured and reported only for 
12th graders and young adults. Its use fell sharply among 12th graders between 1979 and 
1982, from an annual prevalence of 7.0% to 2.2%. It reached a low point of 1.2% in 1988, 
rose some in the 1990s during the relapse period in the drug epidemic, reaching 2.6% by 
1996, and since 2002 has hovered at about 1%. For young adults, annual prevalence has 
fluctuated between 0.1% and 0.7%. 
 
 The annual prevalence of heroin use among 12th graders fell by half between 1975 (1.0%) 
and 1979 (0.5%), then stabilized for 15 years, through 1994. Heroin use was also stable in 
the early 1990s among the other four populations covered here (see Table 2-2). Then, in 
1994 for 8th graders and in 1995 for all other groups, use suddenly increased, with 
prevalence doubling or tripling in one or two years for 12th graders, college students, and 
young adults, and then remaining at the new higher levels among all five populations for 
the rest of the decade. After the period 1999 to 2001, heroin use fell back to lower levels 
than were observed in the mid- to late-1990s. Most of that decline was in heroin use without 
a needle, which we believe was largely responsible for the increase in use in the first half 
of the 1990s. In sum, all age groups except for the young adults had annual levels of heroin 
use in 2018 that were well below recent peaks (by roughly one half to two thirds). Young 
adults have remained at high levels (0.3–0.6% in 2008–2017). Twelfth graders did show a 
significant increase to 0.7% annual prevalence in 2010 for heroin use with a needle, though 
there was no evidence of such an increase in any of the other four populations, which left 
us cautious about that finding. However, the 2011 prevalence provided some confirmation 
that an increase did occur – annual prevalence was at 0.6%, which, except for 2010, was 
higher than any level reported since 1995 when this question was first asked. There is little 
evidence of any ongoing trend at present – indeed, the 12th graders’ annual prevalence for 
heroin use with a needle was 0.3% in 2018, suggesting that if there was an increase in use, 
it was short-lived. All five populations showed annual prevalence levels at 0.4% or less in 
2018. 
 
Two factors very likely contributed to the upturn in heroin use in the 1990s. One is a long-
term decline in the perceived risk of harm, probably due to generational forgetting, because 
it had been a long time since the country had experienced a heroin epidemic along with 
accompanying publicity about its casualties. The second factor, not unrelated to the first, 
is that in the 1990s the greatly increased purity of heroin allowed it to be used by means 
other than injection. This may have lowered an important psychological barrier for some 
potential users, making heroin use less aversive and risky in general, because avoiding 
injection reduces the likelihood of transmission of HIV, hepatitis, or other serious blood-
borne diseases. The introduction of additional questions on heroin use in 1995 showed that 
significant proportions of past-year users in all five populations were indeed taking heroin 
by means other than injection at that point (see Table 2-2, and Chapter 4 here and in Volume 
I for details). 
 
 The use of narcotics other than heroin outside of medical supervision is reported only for 
12th graders and older populations because we believe that younger students are not 
accurately discriminating among the drugs that should be included or excluded from this 
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general class. Use declined gradually over most of the first half of the study in these three 
older groups. Twelfth graders had an annual prevalence in 1977 of 6.4%, which fell to 
3.3% by 1992. But, after about 1992 or 1993, all of the older age groups showed continuing 
increases for a decade or more, through 2003 or 2004, before stabilizing. Updating the list 
of examples given in the question stem in 2002 (to include Vicodin and OxyContin) led to 
an increase in reported prevalence. After a considerable increase in use from 1992 through 
2001, during the relapse phase of the general drug epidemic and going beyond it, the use 
of narcotics other than heroin remained relatively constant at high levels through 2010. 
Since 2012, levels of use have declined overall among 12th graders, college students, and 
young adults. In 2018, annual prevalence was 3.4%, 2.7%, and 3.4% among 12th graders, 
college students, and young adults, respectively; these levels reflect decreases from 2017, 
with the decrease being significant for 12th graders. 
 
 In 2002, specific questions were added for the specific narcotic drugs Vicodin and 
OxyContin. The observed prevalence levels suggest that these two drugs likely help to 
account for the upturn and declines in use of the general class of narcotics other than heroin. 
In 2003, Vicodin had attained surprisingly high prevalence levels in the five populations 
under study here – annual levels of 2.8% in 8th grade, 7.2% in 10th grade, 10.5% in 12th 
grade, 7.5% among college students, and 8.6% among young adults. In 2018, prevalence 
levels were down for all age groups and stood at 0.6%, 1.1%, 1.7%, 1.5%, and 2.4%, 
respectively.  
 
OxyContin started with lower annual prevalence levels than Vicodin across all age groups 
in 2002. Annual prevalence for OxyContin increased in 2003 with slight further increases 
and leveling through 2011. Since then its use has declined overall, although the decline has 
not been smooth. Prevalence levels in 2018 were 0.8%, 2.2%, 2.3%, 1.6%, and 1.9% for 
8th, 10th, and 12th grades, college students, and young adults; given the highly addictive 
nature of this narcotic drug, these levels are not inconsequential.  
 
 Annual prevalence of tranquilizer use among 12th graders saw a long and very substantial 
decline from 11% in 1977 to 2.8% in 1992. After 1992, use increased significantly among 
12th graders as did most drugs, reaching 7.7% in 2002 (but the question was revised slightly 
in 2001 to include Xanax as an example of a tranquilizer, so a small portion of the increase 
may be an artifact). Since then, annual prevalence has dropped to 3.9% in 2018. Reported 
tranquilizer use also increased modestly among 8th graders, from 1.8% in 1991 to 3.3% in 
1996, before declining to 2.6% in 1998. It remained between 2.4% and 2.8% until 2011, 
when it began a decline; it was at 2.0% in 2018. As with a number of other drugs, the 
downturn in use began considerably earlier among 8th graders compared to their older 
counterparts. Among 10th graders, annual prevalence remained stable between 1991 and 
1994 at around 3.3%, and then increased significantly to 7.3% by 2001 (possibly including 
some artifact, as noted above). Since 2001, tranquilizer use has declined very gradually in 
all three grades. After a period of stability, college student use showed an increase between 
1994 and 2003 (to 6.9%), more than tripling in that period. Since then there has been a 
gradual decline there as well, to 3.5% by 2018. For the entire young adult sample, after a 
long period of decline, annual prevalence more than doubled between 1997 and 2002 to 
7.0%, with some overall decline thereafter to 4.0% in 2018. Thus, while there was a 
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considerable increase in use in all five populations, which reflected in part a cohort effect 
that first began in the early 1990s among 8th graders, that increase is clearly over and there 
has been some downward correction in recent years. Most of the reported tranquilizer use 
in recent years has involved Valium, Xanax, and more recently Klonopin (see Table C3 in 
Appendix C in Volume I). 
 
 The long-term gradual decline in sedative (barbiturate) use among 12th graders, which had 
been observed since the start of the study in 1975, halted in 1992. (Data are not included 
here for 8th and 10th graders, again because we believe that these students have more 
problems with proper classification of the relevant drugs.) Use among 12th graders then 
rose considerably during the relapse phase in the drug epidemic, from 2.8% in 1992 to 
6.7% by 2002 – but still well below the peak level of 10.7% in 1975; use has declined since 
2005 (7.2%) through 2018 (2.7%). The 2018 annual prevalence of this class of drugs was 
highest among 12th graders (2.7%) as compared to young adults (2.5%) and college 
students (1.5%). Use among college students began to rise a few years later than it did 
among 12th graders, reaching a peak of 4.2% in 2004, again likely reflecting a cohort effect, 
and has declined since 2004 to 1.5% in 2018. Among young adults, sedative (barbiturate) 
use increased since the early 1990s, rising from 1.6% in 1992 to 4.4% in 2004. It stood at 
2.5% in 2018, after declining some in recent years. 
 
 In this summary of the illicit drugs just discussed, it is clear that use of most of the classes 
of psychotherapeutic drugs – sedatives (barbiturates), tranquilizers, and narcotics other 
than heroin – became a larger part of the nation’s drug abuse problem over the years. While 
the rise in use appears to have halted, most prevalence levels remain relatively high. During 
much of the 1990s and into the 2000s, we saw a virtually uninterrupted increase among 
12th graders, college students, and young adults in the use of all of these drugs, which had 
fallen from favor from the mid-1970s through the early 1990s. These drugs continued to 
rise, even after the increase in use of most illegal drugs ended in the late 1990s and began 
to reverse. All three of these classes of psychotherapeutic drugs have shown gradual 
declines since about 2008 among 12th graders, college students, and young adults 
 
 To continue the summary of illicit drugs discussed above, four classes of illicitly used drugs 
– marijuana, amphetamines, cocaine, and LSD – have an impact on appreciable 
proportions of young Americans in their late teens and 20s. In 2018, 12th graders showed 
annual prevalence levels for these drugs of 35.9%, 5.5%, 2.3%, and 3.2% respectively, 
reflecting declines in most of them, especially cocaine and LSD. Among college students 
in 2018, the comparable annual prevalence levels were 42.6%, 8.3%, 5.2%, and 4.1%; for 
all young adults the levels were 39.1%, 7.5%, 6.0%, and 3.9%. Narcotics other than 
heroin became quite important due to the long-term rise in use that began in the 1990s 
(followed by declines in recent years). These narcotics now have annual prevalence levels 
of only 2–3% among 12th graders, college students, and young adults. Tranquilizers also 
became more important due to a similar rise in use (followed by recent declines), with 
prevalence levels in 2018 of about 3–4% across the same three populations, as have 
sedatives (barbiturates), with levels of 2.7%, 1.5%, and 2.5%, respectively.  
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 Several drugs have been added to MTF’s coverage over the years, including ketamine,
GHB, and Rohypnol, which are so-called “club drugs” (in addition to LSD and MDMA
[ecstasy, Molly]). In general, these drugs have low prevalence levels that have declined
over the past several years among the five age groups. For that reason, GHB and ketamine
were dropped from the 8th and 10th grade surveys in 2012 and GHB and Rohypnol from
the young adult surveys in 2016. For 12th graders, the 2018 annual prevalence was 0.7%
for ketamine and 0.3% for GHB. Annual prevalence of Rohypnol was 0.3% for 8th graders,
0.3% for 10th graders and 0.7% for 12th graders in 2018. Annual prevalence of ketamine
was 0.7%, 0.9%, and 0.9%, respectively, among 12th graders, college students, and young
adults.
 Bath salts, so-called because they are sold over the counter as apparently innocuous
products like real bath salts but contain strong synthetic stimulants, were first included in
the 2012 MTF survey, which we believe provided the first national survey data on their
use. Fortunately, we found the annual prevalence in 2012 to be very low, at 0.8%, 0.6%,
1.3%, 0.3%, and 0.5%, respectively, among the five age groups. In 2018, the prevalence
levels remain less than 1% in all five age groups.
 Salvia divinorum is a psychoactive plant that is legally available in most states; questions
on salvia were added to the 12th grade and follow-up questionnaires in 2009 and were added
to the 8th and 10th grade questionnaires in 2010. In 2011, the prevalence levels were 1.6%
among 8th graders, 3.9% among 10th graders, 5.9% among 12th graders, 3.1% for college
students, and 2.2% for all young adults (see Table 2-2). But by 2018, levels of salvia use
had declined in all five populations, suggesting that the popularity of this drug has peaked.
As of 2018, annual prevalence was less than 1% among all five age groups.
 Anabolic steroid use tends to be more common for males than females among secondary
school students. In 2018, the annual prevalence levels for males in 8th, 10th, and 12th grades
were 0.6%, 0.6%, and 1.5%, compared with 0.7%, 0.6%, and 0.4% for females (it may be
that younger females are over-reporting steroid use due confusing corticosteroids, often
prescribed for asthma and other common conditions, with anabolic steroids). Between 1991
and 1998, the overall annual prevalence levels were fairly stable among 8th and 10th graders,
ranging between 0.9% and 1.2%. In 1999, however, use jumped from 1.2% to 1.7% in both
grades. Almost all of that increase occurred among males, from 1.6% in 1998 to 2.5% in
1999 in 8th grade and from 1.9% to 2.8% in 10th grade. Thus, levels among males increased
by about half in a single year, which corresponded in time to stories in the news media
about the use of androstenedione, a steroid precursor, by baseball home-run king Mark
McGwire. Since then, among all 8th graders, anabolic steroid use has declined by more than
two thirds to 0.6% in 2018. Among 10th graders, use continued to increase, reaching 2.2%
in 2002, suggesting a cohort effect, but then declined by more than two thirds to 0.6% by
2018. Among 12th graders, annual prevalence rose significantly to 2.4% in 2001, but then
decreased to 1.1% by 2018. Use generally has been much lower among college students
and young adults, with annual prevalence being below 1% between 1991 and 2018.
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TRENDS IN ALCOHOL USE      
 Several findings about alcohol use in these five sub-groups are noteworthy. First, despite 
the fact that it is illegal for virtually all secondary school students and many college 
students and young adults to purchase alcoholic beverages, they have had a substantial 
amount of experience with alcohol. As of 2018, alcohol has been tried by 24% of 8th 
graders, 43% of 10th graders, 59% of 12th graders, 77% of college students, and 85% of 
young adults (19 to 28 years old) (Table 2-1). Current use (use in past 30 days) is also 
widespread. Of particular importance, is the prevalence of five or more drinks in a row at 
least once in the prior two-week period (binge drinking), which in 2018 was reported by 
4% of 8th graders, 9% of 10th graders, 14% of 12th graders, 28% of college students, and 
31% of all young adults. 
 
 As use of other illicit drugs decreased among 12th graders from the late 1970s to the early 
1990s, alcohol use did not increase, although it was common to hear such a “displacement 
hypothesis” asserted. MTF findings demonstrate that the opposite seems to be true. After 
1980, when illicit drug use was declining, the monthly prevalence of alcohol use among 
12th graders also declined gradually, but substantially, from 72% in 1980 to 51% in 1992. 
Daily alcohol use declined by half over the same interval, from a peak of 6.9% in 1979 to 
3.4% in 1992; the prevalence of drinking five or more drinks in a row during the prior 
two-week interval fell from 41% in 1983 to 28% in 1993 – nearly a one-third decline. When 
illicit drug use rose again in the 1990s relapse, alcohol use (particularly binge drinking of 
five more drinks in a row) rose as well – albeit not as sharply as marijuana use. In the late 
1990s, as illicit drug use leveled in secondary schools and began a gradual decline, similar 
trends were observed for alcohol. Therefore, long-term evidence indicates that alcohol use 
moves much more in concert with illicit drug use than counter to it, at least up to the year 
2007. 
 
However, since 2007 a new trend has emerged that is more consistent with the 
“displacement” hypothesis. From 2007 through 2018 alcohol use continued its long-term 
decline, reaching historic lows in the life of the study. Meanwhile, for most of this time 
period, marijuana use has stayed steady or increased for all age groups, consistent with the 
possibility that marijuana use has increasingly displaced alcohol use. For the past decade 
or so, trends in alcohol and marijuana use have been substantially diverging, suggesting 
that the historical relationship between these two drugs may be changing. 
 
 Given that the physiological impacts of five drinks are greater for the typical young female 
versus the typical young male, it is not surprising that we have found substantial gender 
differences in the prevalence of five or more drinks in a row; however, these differences 
have diminished somewhat in recent years. Among 12th graders, the levels of prevalence 
in 2018 were 12% for females versus 16% for males. This difference has diminished 
substantially since MTF began; in 1975 there was a 23-percentage-point difference, versus 
the 4-point difference in 2018. The proportions indicating in 2018 that they have been 
drunk in the prior 30 days were somewhat higher at 16% and 19% for females and males, 
respectively. As discussed in Chapters 4 and 5, the general pattern of heavy alcohol use 
being more common among men than women continues into young and middle adulthood; 
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likewise, the reduction of gender differences over the past few decades is evident among 
adults. 
 
TRENDS IN CIGARETTE SMOKING  
A number of very important findings about cigarette smoking among American adolescents and 
young adults have emerged during the life of the study, and we believe that one of the study’s more 
important contributions to the long-term health of the nation has been to document and call public 
attention to these trends, particularly the upsurge in adolescent smoking in the early 1990s. Despite 
the demonstrated health risks associated with smoking, young people have continued to establish 
regular cigarette habits during late adolescence in sizable proportions, and, during the first half of 
the 1990s, in rapidly growing proportions. Even as cigarette smoking among adolescents reaches 
historic lows today, it remains at or near the top of all psychoactive substances used on a daily 
basis. 
 
We note that, similar to the use patterns for illicit drugs, the trend for cigarette smoking evidenced 
a generational replacement effect during the 1990s in that college students showed a sharp increase 
in smoking beginning in 1995, as the heavier smoking cohorts of secondary school students from 
the early to mid-1990s entered college. This has been a more typical pattern of change for 
cigarettes, however, since differences in cigarette smoking levels among class cohorts tend to 
remain through the life course and also tend to account for much of the overall change in use 
observed at any given age. 
 
 During most of the 1980s, when smoking levels were falling steadily among adults, we 
reported that smoking among adolescents was not declining. Then the situation went from 
bad to worse. Among 8th and 10th graders, levels of current (past 30-day) smoking 
increased by about half between 1991 (when their use was first measured) and 1996; among 
12th graders, current smoking rose by nearly one third between 1992 and 1997. MTF played 
an important role in bringing these disturbing increases in adolescent smoking to public 
attention during those years, which was the historical period in which major social action 
was initiated in the White House, the Food & Drug Administration, the Congress, and 
eventually the state attorneys general, culminating in the 1998 Tobacco Master Settlement 
agreement between the tobacco industry and the states. 
 
 Fortunately, there have been some important declines in current smoking since 1996 among 
8th and 10th graders, and since 1997 among 12th graders. In fact, the declines have more 
than offset the increases observed earlier in the 1990s. In 2018, 2% of 8th graders (down 
from 14% in 1991 and 21% in 1996) reported smoking one or more cigarettes in the prior 
30 days – a decline of nine-tenths from the 1996 peak level. Some 4% of 10th graders were 
current smokers in 2018 (down from 21% in 1991 and 30% in 1996), representing a drop 
of three quarters from the 1996 peak level. And among 2018 12th grade students 8% were 
current smokers (versus 28% in 1991 and 37% in 1997), representing a drop of more than 
two thirds from the 1997 peak. Monthly prevalence of use for all three grades is now at or 
near the lowest point in the history of the study, and significantly declined in 2018 for 12th 
grade students. 
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 Several of the important attitudinal changes that accompanied these declines in use ended 
some years ago (around 2007), leading us to conclude that further reductions in smoking 
levels will likely have to come from changes in the environment – for example, enacting 
such policies as tobacco tax increases, further reducing the places in which smoking is 
permitted, and providing effective quit-smoking programs. In 2009, federal taxes on 
tobacco products were in fact raised, which may well have contributed to the resumption 
of declines in use starting in 2011. Despite these very important improvements in the past 
decade and a half, about one in twelve (8%) young Americans are current smokers by the 
time they complete high school. Other research consistently shows that smoking levels are 
substantially higher among those who drop out before graduating, so the estimates here, 
based on high school seniors, are low for the age cohort as a whole (see Appendix A in 
Volume I for household comparison data from NSDUH).4 
 
 Among college students, the peak level in current smoking (31%) was not reached until 
1999, reflecting a cohort effect, after which it has declined to 7% in 2018, a decline of 
almost three-quarters. All young adults 19 to 28 years old have also shown a decline 
between 2001 (30%) and 2018 (12%), a decline of nearly two thirds and also indicative of 
a cohort effect working its way up the age range. 
 
 There have been important gender differences in the trends in smoking. In the 1970s, 12th 
grade females caught up to and passed 12th grade males in levels of current smoking. Both 
genders then showed a decline in use followed by a long, fairly level period, with use by 
females consistently higher, but with the gender difference diminishing. In the early 1990s, 
another crossover occurred among the 12th graders when levels rose more among males 
than females; thereafter, males have had consistently slightly higher levels of current 
smoking. In the lower grades, the genders have generally had similar smoking levels since 
their use was first measured in 1991. 
 
 Among college students, females had a slightly higher probability of being daily smokers 
from 1980 through 1994 – although this long-standing gender difference was not seen 
among their age peers who were not in college. However, a crossover occurred between 
1994 and 2001, with college males exceeding college females in daily smoking – an echo 
of the crossover among 12th graders in 1991. Between about 2001 and 2005 there was little 
consistent gender difference in smoking among college students, but since 2006, college 
males have usually had higher levels of daily smoking than college females (see Chapter 
9). 
 
NEW TRENDS IN VAPING  
 MTF asked about e-cigarette use in 2014 and electronic vaporizer use in 2015 and 2016. 
We found that overall vaporizer use had higher 30-day prevalence than all types of tobacco 
products, including regular cigarettes, among 8th, 10th, and 12th graders; among college 
                                                 
4 For comparison of recent household data from NDSUH, see Appendix A in Volume 1. For an analysis showing much higher smoking rates among 
8th graders who later dropped out before completing high school, see Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., 
Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use connection: How successes and failures in school relate to adolescent 
smoking, drug use, and delinquency. New York: Lawrence Erlbaum Associates/Taylor & Francis. See also Table A-1 in Appendix A of this volume. 
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students and young adults, vaporizer use was lower compared to use among 10th and 12th 
graders, as well as lower compared to cigarette use.  
 
 In 2017, we expanded the vaping questions to get at specific substances being vaped 
including nicotine, marijuana, and just flavoring. Between 2017 and 2018, the 30-day 
prevalence of vaping nicotine increased dramatically for all five age groups: from 3.5% to 
6.1% for 8th graders, from 8.2% to 16.1% for 10th graders, from 11.0% to 20.9% for 12th 
graders, from 6.1% to 15.5% for college students, and from 6.5% to 10.6% for all young 
adults. Each of the one-year increases was significant, with the increase for college students 
being greatest among the five age groups. In fact, this one-year increase for college 
students in 30-day prevalence of vaping nicotine (from 6.1% in 2017 to 15.5% in 2018) is 
among the greatest one-year increases we have seen for any substance since MTF began 
over 40 years ago. The 2018 levels are higher than 30-day prevalence for cigarette use 
among 8th, 10th, and 12th graders, and now among college students, but not and young adults 
(Table 2-3). Part of the reason for the popularity of vaporizers among teens is their low 
perceived risk: for the specific vaporizer device of an e-cigarette, less than 23% of students 
in all grades see a “great risk” in regular vaporizer use, one of the lowest levels of perceived 
risk measured in the survey. . 
 
 The 30-day prevalence of vaping marijuana also increased between 2017 and 2018 for all 
age groups. It increased from 1.6% to 2.6% among 8th graders, from 4.3% to 7.0% among 
10th graders, from 4.9% to 7.5% among 12th graders, from 5.2% to 10.9% among college 
students, and from 6.6% to 9.3% among young adults (Table 2-3). Each of these one-year 
increases was significant, and as with vaping nicotine the rise of vaping marijuana among 
college students is especially notable. In fact, the doubling from 5.2% in 2017 to 10.9% in 
2018 of 30-day prevalence of vaping marijuana among college students is among the 
largest one-year proportion increases for any substance since MTF began over 40 years 
ago.  
 
SUMMARY AND CONCLUSIONS  
Over the past four decades, MTF has documented some good news, along with the worrisome 
news. From the late 1970s to the early 1990s – and again in the late 1990s – the use of a number 
of illicit drugs declined appreciably among 12th grade students, and declined even more among 
college students and young adults in the U.S. These substantial improvements – which seem 
largely explainable in terms of changes in attitudes about drug use, beliefs about the risks of drug 
use, and peer norms against drug use – have some extremely important policy implications. One 
clear implication is that these various substance-using behaviors among American young people 
are malleable – they can be changed. It has been done before. The second is that demand-side 
(rather than supply-side) factors appear to have been pivotal in bringing about most of those 
changes. The levels of marijuana availability, as reported by 12th graders, have held fairly steady 
at high levels throughout the life of the study. (Moreover, among students who abstained from 
marijuana use, as well as among those who quit, availability and price rank very low on their lists 
of reasons for not using marijuana.) And, in fact, the perceived availability of cocaine was actually 
rising during the beginning of the sharp decline in cocaine and crack use in the mid- to late-1980s, 
which occurred when the perceived risk associated with that drug rose sharply. (See Chapter 9 in 
Volume I for more examples and further discussion of this point.) However, improvements should 
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not be taken for granted. Relapse is always possible; indeed, just such a relapse in the longer-term 
epidemic occurred during the early to mid-1990s, as the country let down its guard on many fronts. 
(See Chapter 8 in Volume I for a more detailed discussion.) 
 
Over the years, MTF has demonstrated that changes in perceived risk and disapproval have been 
important causes of change in the use of a number of drugs. These beliefs and attitudes are almost 
certainly influenced by the amount and nature of public attention paid to the drug issue in the 
historical period during which young people are growing up. A substantial decline in attention to 
this issue in the early 1990s very likely explains why the increases in perceived risk and 
disapproval among students ceased and began to backslide. News coverage of the drug issue 
plummeted between 1989 and 1993 (although it made a considerable comeback as surveys – 
including MTF – began to document that the nation’s drug problem was worsening again), and the 
media’s pro bono placement of ads from the Partnership for a Drug-Free America also fell 
considerably. (During that period, MTF 12th graders showed a steady decline in their recalled 
exposure to such ads, and in the judged impact of such ads on their own drug-taking behavior.5) 
 
Also, the deterioration in the drug abuse situation first began among our youngest cohorts – 
perhaps because as they were growing up they had not had the same opportunities for vicarious 
learning from the adverse drug experiences of people around them and people portrayed in the 
media – those we have called the “unfortunate role models.” Clearly, there was a danger that, as 
the drug epidemic subsided in the 1980s and early 1990s, newer cohorts would have far less 
opportunity to learn through informal means about the dangers of drugs – that what we have called 
a generational forgetting of those risks would occur through a process of generational replacement 
of older, more drug-savvy cohorts with newer, more naive ones. This suggests that as drug use 
subsides, as it did by the early 1990s, the nation must redouble its efforts to ensure that such naive 
cohorts learn these lessons about the dangers of drugs through more formal means – from schools, 
parents, and focused messages in the media, including social media for example – and that this 
more formalized prevention effort be institutionalized so that it will endure for the long term. 
 
Clearly, for the foreseeable future, American young people will be aware of the psychoactive 
potential of a host of drugs and will continue to have access to them – a situation quite different 
from the one that preceded the late 1960s. (Awareness and access are two necessary conditions for 
an epidemic.6) That means that each new generation of young people must learn the reasons that 
they should not use drugs. Otherwise, their natural curiosity and desire for new experiences will 
lead a great many to use. 
 
One lesson evident from the changes of the past two decades is that the types of drugs most in 
favor can change substantially over time. The illegal drugs began to decline in use in the late 1990s, 
while prescription drugs, and even over-the-counter drugs, began to gain favor. Today a good 
many of the drugs having the highest prevalence levels among teens and young adults are of this 
type, including narcotic drugs other than heroin, despite their declines in use in the past few years. 
 
                                                 
5 Johnston, L. D. (2002, June 19). Written and oral testimony presented at hearings on the National Youth Anti-Drug Media Campaign, held by the 
Treasury and General Government Subcommittee on Appropriations of the U.S. Senate Appropriations Committee. Published in The Congressional 
Record. 
6 Johnston, L. D. (1991). Toward a theory of drug epidemics. In L. Donohew, H. E. Sypher, and W. J. Bukoski (Eds.), Persuasive communication 
and drug abuse prevention (pp.93-131). Hillsdale, NJ, Earlbaum.  
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Unfortunately, current conditions are well suited for a second relapse phase in drug use among 
youth and young adults in the U.S. Perceived risk for marijuana has fallen substantially in recent 
years as the recent string of states that have legalized recreational marijuana use for adults may 
have led some youth to believe the drug is safe and state-sanctioned. 
 
Another lesson that derives from the MTF epidemiological data is that social influences that tend 
to reduce the initiation of substance use also have the potential to deter continuation by those who 
have already begun to use, particularly if they are not yet habitual users. Chapter 5 of Volume I 
shows how increased quitting rates have contributed importantly to downturns in the use of a 
number of drugs at different historical periods. The lesson is that primary prevention should not 
be the only goal of intervention programs; early-stage users may be persuaded to quit when their 
beliefs and attitudes regarding drugs are changed. 
 
The following facts help to put into perspective the magnitude and variety of substance use 
problems that presently remain among young people in the U.S.: 
 
 Nearly one fourth (23%) of today’s 8th graders have tried an illicit drug (if inhalants are 
included as an illicit drug), and half (49%) of 12th graders have done so. 
 
 By their late 20s, almost two in three (64%) of today’s young adults have tried an illicit 
drug, and more than one in three (36%) have tried some illicit drug other than marijuana, 
usually in addition to marijuana. (These figures do not include inhalants.) 
 
 Marijuana use has shown an important change in terms of a widening of age-group 
differences, with annual and 30-day prevalence generally leveling during the past several 
years for secondary school students but increasing for college students and young adults. 
 
 One in every 17 12th graders (5.8%) in 2018 smoked marijuana daily. Among young adults 
ages 19 to 28, the percentage is a little higher at one in every 13 (8.0%). Also among 12th 
graders in 2018, one in every eight (12%) has been a daily marijuana smoker at some time 
in their life for at least a month. 
 
 About one in seven 12th graders (14%) had five or more drinks in a row (called binge 
drinking) on at least one occasion in just the two weeks prior to the survey, and we know 
that such behavior tends to increase among young adults one to four years past high school 
– that is, in the peak college years. Indeed, 28% of college students report such binge 
drinking. The study also has documented evidence of extreme binge drinking (also called 
high-intensity drinking) with 4.6% of 12th graders in 2018 indicating having had 10 or more 
drinks in a row, and 2.5% indicating 15 or more drinks in a row, in the prior two weeks 
(see Chapter 5 in Volume I). Among college students, about one in twenty report having 
10 or more drinks in a row, and one in 33 report having 15 or more at least once in just the 
prior two weeks (further detail is provided in Chapter 9). 
 
 Even with considerable declines in smoking among U.S. adolescents since the late 1990s, 
about one in twelve (8%) of 12th graders in 2018 currently smoke cigarettes, and one in 
twenty-five (4%) is already a daily smoker. In addition, we know from studying previous 
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cohorts that many smokers increase their levels of smoking within a year or so after they 
leave high school. 
 
 American secondary school students and young adults show a level of involvement with 
illicit drugs that is among the highest in the world’s industrialized nations.7 Even by longer-
term historical standards in the U.S., these levels remain extremely high, though in general 
they are not as high as in the peak years of the epidemic in the late 1970s. Binge drinking 
also remains widespread and troublesome, though it has been declining gradually over a 
long period and now is at or near historical lows among both teens and young adults. Of 
course, the continuing initiation to cigarette smoking of a fair-sized, albeit dramatically 
decreased, proportion of young people remains a matter of great public health concern. 
 
 Vaping presents a new challenge. MTF first asked about vaping in 2015 with an expansion 
of questions in 2017. Between 2017 and 2018, vaping nicotine increased dramatically, 
with 30-day prevalence nearly doubling for all age groups, reaching 6.1%, 16.1%, 20.9%, 
15.5%, and 10.6% across the five age groups, respectively. The increase was most dramatic 
for college students, increasing two-and-a-half times from 6.1% to 15.5% in the one-year 
period, among the greatest one-year increases evident for any substance over the past 40 
years. The 2018 prevalence levels are greater than those for any other tobacco product 
including cigarettes among secondary and college students. This increasing trend in 
nicotine vaping, especially for secondary school students, has the potential for a resurgence 
of teen and young nicotine addiction, especially given that vaping among youth who have 
never smoked significantly predicts future smoking.8  
 
 There were also significant increases between 2017 and 2018 for all five age groups in 30-
day prevalence of vaping marijuana, with the increase again being most dramatic for 
college students, doubling from 5.2% to 10.9%, among the highest proportional increases 
evident for any substance over the past 40 years. 
 
 Of particular note, abuse of prescription drugs by teens and young adults has declined in 
recent years, a welcome development after prevalence had stayed stubbornly high 
throughout the first decade of the 2000s. Among 12th grade students annual prevalence of 
narcotics other than heroin has declined for seven years in a row and is now at the lowest 
levels since the late 1990s among college students. Annual use of sedatives (barbiturates) 
among 12th graders, college students, and young adults declined or leveled in 2018 to the 
lowest levels in 20 years, with annual prevalence now about half or less what it was in 
2004-05 when it peaked for all three age groups. Annual use of tranquilizers is at or near 
the lowest levels since 2001 (when the question was last updated) in all five age groups. 
                                                 
7 A published report from a series of international collaborative studies, modeled largely after MTF, provides comparative data from national school 
surveys of 15- to 16 year olds, conducted every four years beginning in 1995. The most recent reported survey was published in in 2016, covering 
surveys in 35 European countries. (The report also includes 2015 MTF data from 10th graders in the United States.) See Kraus, L., Guttormsson, 
U., Leifman, H., Arpa, S. et al. (2016). The 2015 ESPAD report: Results from the European School Survey Project on Alcohol and Other Drugs. 
The European Monitoring Centre for Drugs and Drug Addiction. .See also, Johnston, L. D. (2016, September 23). National press release, "Compared 
with Europe, American teens have high rates of illicit drug use." University of Michigan News Service, Ann Arbor. University of Michigan News 
Service, September 23, 2016.    
8 Miech, R. A., Patrick, M. E., O'Malley, P. M., & Johnston, L. D. (2017). E-cigarette use as a predictor of cigarette smoking: Results from a 1-
year follow-up of a national sample of 12th grade students. Tobacco Control, 26(e2), e106-e111.  
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The update to the question on amphetamines in 2013 makes long-term trends difficult to 
discern, although there is evidence of leveling and declines in all five age groups since 
then. Perceived risk tends to be relatively low for these prescription-type drugs, which we 
believe is a major reason why their use had been relatively high. 
 We note the seemingly unending capacity of pharmacological experts and amateurs to
discover new substances with abuse potential that can be used to alter mood and
consciousness (e.g., bath salts and synthetic marijuana), and of young people to discover
the abuse potential of existing products (such as Robitussin and plants like salvia) and to
rediscover older drugs (such as LSD and heroin). While as a society we have made
significant progress on a number of fronts in the fight against drug abuse, we must remain
vigilant against the opening of new fronts, as well as the reemergence of trouble on older
ones. In particular, we must guard against generational forgetting in our newest cohorts of
adolescents due to a lack of public attention to the issue during the time that they are
growing up.
 One of the dynamics that keeps the drug epidemic rolling is the emergence of new drugs
whose hazards are little known. In 1999, we saw this happen with the drug ecstasy
(MDMA). Other drugs like Rohypnol, ketamine, GHB, and OxyContin appeared in the
1990s and were added to the list of drugs under study. Questions on use of salvia, Adderall,
and Provigil were then added to the questionnaires. In 2011, we added synthetic
marijuana, which turned out to be the second most used illicit drug after natural marijuana,
and in 2012 we added bath salts. In 2014, we added questions on e-cigarettes, and in 2015
we added questions on the more general category of “vaping,” which we discovered has
made rapid inroads among today’s adolescents and young adults, leading us to ask new
more detailed questions on vaping starting in 2017. The spread of such new drugs and drug
devices (e.g. Juuls for vaping) appears to be facilitated and hastened today by young
people’s widespread use of web-based social networks. We expect to see a continuous flow
of such new substances onto the national scene, and believe that the task of rapidly
documenting their emergence, establishing any adverse consequences, and quickly
demystifying them will remain an important means by which policymakers, researchers,
and educators deal with the continuing threats posed by such drugs. We also anticipate that
there will be rediscoveries of older substances, as occurred in recent years with respect to
the various psychotherapeutic prescription drugs, including tranquilizers, sedatives
(barbiturates), and narcotic drugs.
Substance abuse is a public health concern that recurs, reinvents itself, and goes through relapse 
phases. We cannot eradicate it but we can contain it to the extent possible on an ongoing basis. 
Therefore, it is a problem that requires an ongoing, dynamic response – one that takes into account 
the continuing generational replacement of our youth, the generational forgetting of the dangers of 
drugs that can occur with that replacement, and the perpetual stream of new health-compromising 
substances that may appeal to teens, college students, and young adults in general. 
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 18.7 20.6 22.5 25.7 28.5 31.2 29.4 29.0 28.3 26.8 26.8 24.5 22.8 21.5 21.4 20.9 19.0 19.6 19.9 21.4 20.1 18.5‡ 21.1 20.3 20.5 17.2 18.2 18.7 +0.6  
      10th Grade 30.6 29.8 32.8 37.4 40.9 45.4 47.3 44.9 46.2 45.6 45.6 44.6 41.4 39.8 38.2 36.1 35.6 34.1 36.0 37.0 37.7 36.8‡ 39.1 37.4 34.7 33.7 34.3 36.3 +2.0  
      12th Grade 44.1 40.7 42.9 45.6 48.4 50.8 54.3 54.1 54.7 54.0 53.9 53.0 51.1 51.1 50.4 48.2 46.8 47.4 46.7 48.2 49.9 49.1‡ 49.8 49.1 48.9 48.3 48.9 47.8 -1.1  
      College Students 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2 53.7 53.6 51.8 53.9 52.2 52.3 50.6 50.5 49.5 51.4 49.1 49.2 50.5‡ 53.3 52.4 53.4 54.4 55.4 55.5 +0.1
      Young Adults 62.2 60.2 59.6 57.5 57.4 56.4 56.7 57.0 57.4 58.2 58.1 59.0 60.2 60.5 60.4 59.7 59.8 59.3 59.3 58.4 59.1 58.9‡ 60.0 62.2 62.9 62.8 64.0 63.8 -0.2
      8th Grade 14.3 15.6 16.8 17.5 18.8 19.2 17.7 16.9 16.3 15.8‡ 17.0 13.7 13.6 12.2 12.1 12.2 11.1 11.2 10.4 10.6 9.8 8.7‡ 10.4 10.0 10.3 8.9 9.3 9.8 +0.5  
      10th Grade 19.1 19.2 20.9 21.7 24.3 25.5 25.0 23.6 24.0 23.1‡ 23.6 22.1 19.7 18.8 18.0 17.5 18.2 15.9 16.7 16.8 15.6 14.9‡ 16.4 15.9 14.6 14.0 13.7 14.2 +0.5  
      12th Grade 26.9 25.1 26.7 27.6 28.1 28.5 30.0 29.4 29.4 29.0‡ 30.7 29.5 27.7 28.7 27.4 26.9 25.5 24.9 24.0 24.7 24.9 24.1‡ 24.8 22.6 21.1 20.7 19.5 18.9 -0.6  
      College Students 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5 25.8‡ 26.3 26.9 27.6 28.0 26.5 26.3 25.3 22.6 25.6 24.8 24.3 23.8‡ 28.3 29.0 26.4 26.5 26.1 27.1 +1.0
      Young Adults 37.8 37.0 34.6 33.4 32.8 31.0 30.5 29.9 30.2 31.3‡ 31.6 32.8 33.9 35.2 34.0 34.8 34.2 34.7 32.8 33.3 33.2 32.8‡ 34.0 37.3 36.8 36.2 36.8 36.3 -0.5
  including 
  Inhalants a,c,d
      8th Grade 28.5 29.6 32.3 35.1 38.1 39.4 38.1 37.8 37.2 35.1 34.5 31.6 30.3 30.2 30.0 29.2 27.7 28.3 27.9 28.6 26.4 40.0‡ 25.9 25.2 24.9 20.6 23.3 23.2 -0.1  
      10th Grade 36.1 36.2 38.7 42.7 45.9 49.8 50.9 49.3 49.9 49.3 48.8 47.7 44.9 43.1 42.1 40.1 39.8 38.7 40.0 40.6 40.8 25.1‡ 41.6 40.4 37.2 35.9 37.0 38.7 +1.7  
      12th Grade 47.6 44.4 46.6 49.1 51.5 53.5 56.3 56.1 56.3 57.0 56.0 54.6 52.8 53.0 53.5 51.2 49.1 49.3 48.4 49.9 51.8 50.3‡ 52.3 49.9 51.4 49.3 50.3 49.0 -1.3  
      College Students 52.0 50.3 49.1 47.0 47.0 49.1 50.7 55.4 54.4 54.6 53.1 52.3 54.1 52.9 53.9 53.3 52.5 51.0 51.1 50.0 49.7 52.0‡ 53.3 51.8 52.0 52.6 53.3 55.5 +2.2
      Young Adults 63.4 61.2 61.2 58.5 59.0 58.2 58.4 58.5 58.5 59.5 59.0 59.6 60.6 62.5 61.4 61.2 61.2 60.2 59.3 59.3 59.5 59.5‡ 62.2 60.6 61.0 61.4 61.7 63.5 +1.8
      8th Grade 10.2 11.2 12.6 16.7 19.9 23.1 22.6 22.2 22.0 20.3 20.4 19.2 17.5 16.3 16.5 15.7 14.2 14.6 15.7 17.3 16.4 15.2 16.5 15.6 15.5 12.8 13.5 13.9 +0.4  
      10th Grade 23.4 21.4 24.4 30.4 34.1 39.8 42.3 39.6 40.9 40.3 40.1 38.7 36.4 35.1 34.1 31.8 31.0 29.9 32.3 33.4 34.5 33.8 35.8 33.7 31.1 29.7 30.7 32.6 +1.8  
      12th Grade 36.7 32.6 35.3 38.2 41.7 44.9 49.6 49.1 49.7 48.8 49.0 47.8 46.1 45.7 44.8 42.3 41.8 42.6 42.0 43.8 45.5 45.2 45.5 44.4 44.7 44.5 45.0 43.6 -1.4  
      College Students 46.3 44.1 42.0 42.2 41.7 45.1 46.1 49.9 50.8 51.2 51.0 49.5 50.7 49.1 49.1 46.9 47.5 46.8 47.5 46.8 46.6 49.1 47.7 48.5 50.4 51.0 50.5 52.4 +1.9
      Young Adults 58.6 56.4 55.9 53.7 53.6 53.4 53.8 54.4 54.6 55.1 55.7 56.8 57.2 57.4 57.0 56.7 56.7 55.9 56.0 55.9 56.3 56.5 57.1 57.5 58.5 58.7 60.1 60.1 0.0
      8th Grade 17.6 17.4 19.4 19.9 21.6 21.2 21.0 20.5 19.7 17.9 17.1 15.2 15.8 17.3 17.1 16.1 15.6 15.7 14.9 14.5 13.1 11.8 10.8 10.8 9.4 7.7 8.9 8.7 -0.2  
      10th Grade 15.7 16.6 17.5 18.0 19.0 19.3 18.3 18.3 17.0 16.6 15.2 13.5 12.7 12.4 13.1 13.3 13.6 12.8 12.3 12.0 10.1 9.9 8.7 8.7 7.2 6.6 6.1 6.5 +0.4  
      12th Grade 17.6 16.6 17.4 17.7 17.4 16.6 16.1 15.2 15.4 14.2 13.0 11.7 11.2 10.9 11.4 11.1 10.5 9.9 9.5 9.0 8.1 7.9 6.9 6.5 5.7 5.0 4.9 4.4 -0.5  
      College Students 14.4 14.2 14.8 12.0 13.8 11.4 12.4 12.8 12.4 12.9 9.6 7.7 9.7 8.5 7.1 7.4 6.3 4.9 6.9 5.5 3.7 5.7 4.3 3.5 3.1 3.2 3.4 3.0 -0.4
      Young Adults 13.4 13.5 14.1 13.2 14.5 14.1 14.1 14.2 14.2 14.3 12.8 12.4 12.2 11.6 10.3 10.9 9.1 9.5 8.9 7.9 7.2 7.2 6.5 6.7 6.4 6.3 5.2 5.6 +0.4
TABLE 2-1
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28)
2017–
(Entries are percentages.)
2018
change
Any Illicit Drug a
Any Illicit Drug other
  than Marijuana a,b
Any Illicit Drug
Marijuana/Hashish
(Table continued on next page.)
Inhalants c,d
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 3.2 3.8 3.9 4.3 5.2 5.9 5.4 4.9 4.8 4.6‡ 5.2 4.1 4.0 3.5 3.8 3.4 3.1 3.3 3.0 3.4 3.3 2.8 2.5 2.0 2.0 1.9 1.9 2.2 +0.3
      10th Grade 6.1 6.4 6.8 8.1 9.3 10.5 10.5 9.8 9.7 8.9‡ 8.9 7.8 6.9 6.4 5.8 6.1 6.4 5.5 6.1 6.1 6.0 5.2 5.4 5.0 4.6 4.4 4.2 3.9 -0.3
      12th Grade 9.6 9.2 10.9 11.4 12.7 14.0 15.1 14.1 13.7 13.0‡ 14.7 12.0 10.6 9.7 8.8 8.3 8.4 8.7 7.4 8.6 8.3 7.5 7.6 6.3 6.4 6.7 6.7 6.6 -0.1
      College Students 11.3 12.0 11.8 10.0 13.0 12.6 13.8 15.2 14.8 14.4‡ 14.8 13.6 14.5 12.0 11.0 10.6 9.1 8.5 8.0 7.8 7.4 7.6 7.8 7.6 6.5 7.7 7.2 8.5 +1.3
      Young Adults 15.7 15.7 15.4 15.4 16.1 16.4 16.8 17.4 18.0 18.4‡ 18.3 19.6 19.7 19.3 17.6 17.2 16.0 14.8 14.2 13.9 13.0 12.2 12.4 11.9 11.7 12.2 12.9 14.3 +1.4
      8th Grade 2.7 3.2 3.5 3.7 4.4 5.1 4.7 4.1 4.1 3.9 3.4 2.5 2.1 1.8 1.9 1.6 1.6 1.9 1.7 1.8 1.7 1.3 1.4 1.1 1.3 1.2 1.3 1.4 +0.1
      10th Grade 5.6 5.8 6.2 7.2 8.4 9.4 9.5 8.5 8.5 7.6 6.3 5.0 3.5 2.8 2.5 2.7 3.0 2.6 3.0 3.0 2.8 2.6 2.7 2.6 3.0 3.2 3.0 2.8 -0.2
      12th Grade 8.8 8.6 10.3 10.5 11.7 12.6 13.6 12.6 12.2 11.1 10.9 8.4 5.9 4.6 3.5 3.3 3.4 4.0 3.1 4.0 4.0 3.8 3.9 3.7 4.3 4.9 5.0 5.1 +0.1
      College Students 9.6 10.6 10.6 9.2 11.5 10.8 11.7 13.1 12.7 11.8 12.2 8.6 8.7 5.6 3.7 3.5 3.3 4.3 3.3 4.0 3.7 3.1 4.4 4.5 4.8 5.1 5.3 6.9 +1.7
      Young Adults 13.5 13.8 13.6 13.8 14.5 15.0 15.0 15.7 16.2 16.4 16.0 15.1 14.6 13.4 11.2 10.1 9.6 8.1 7.3 7.2 6.1 6.2 6.3 6.6 7.0 8.0 8.8 10.3 +1.5 s
      8th Grade 1.4 1.7 1.7 2.2 2.5 3.0 2.6 2.5 2.4 2.3‡ 3.9 3.3 3.2 3.0 3.3 2.8 2.6 2.5 2.4 2.7 2.8 2.3 1.9 1.5 1.2 1.3 1.2 1.5 +0.3
      10th Grade 2.2 2.5 2.8 3.8 3.9 4.7 4.8 5.0 4.7 4.8‡ 6.6 6.3 5.9 5.8 5.2 5.5 5.7 4.8 5.4 5.3 5.2 4.5 4.4 4.1 3.3 3.1 2.9 2.7 -0.2
      12th Grade 3.7 3.3 3.9 4.9 5.4 6.8 7.5 7.1 6.7 6.9‡ 10.4 9.2 9.0 8.7 8.1 7.8 7.7 7.8 6.8 7.7 7.3 6.6 6.4 5.1 4.8 4.7 4.8 4.5 -0.3
      College Students 6.0 5.7 5.4 4.4 6.5 6.5 7.5 8.7 8.8 8.2‡ 10.7 11.0 12.8 10.1 10.6 10.1 8.5 8.2 7.8 7.1 6.9 7.2 6.8 6.8 5.1 6.6 5.0 5.0 0.0
      Young Adults 8.4 8.0 7.6 7.4 7.8 7.9 8.5 9.4 9.3 9.9‡ 12.0 15.0 16.4 15.6 15.4 14.9 14.1 13.0 13.0 12.6 12.1 11.1 11.4 10.8 10.4 10.6 10.6 11.1 +0.5
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 2.9 2.4 2.9 2.8 2.7 4.0 3.9 3.9 3.4 3.4 3.5 3.1 2.5 1.6 2.4 2.2 2.1 1.8 1.7 1.8 2.3 1.6 1.3 — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 3.1 2.0 1.9 2.0 2.2 1.9 2.4 2.7 2.3 2.3 3.1 2.5 3.0 2.7 2.0 2.4 2.1 2.2 1.6 1.6 1.7 1.1 1.4 0.6 1.2 1.9 0.3 1.3 +1.0 ~
      8th Grade, original — — — — — 3.4 3.2 2.7 2.7 4.3 5.2 4.3 3.2 2.8 2.8 2.5 2.3 2.4 2.2 3.3 2.6 2.0 1.8 1.4 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 2.4 2.3 1.7 1.5 1.6 +0.1
      10th Grade, original — — — — — 5.6 5.7 5.1 6.0 7.3 8.0 6.6 5.4 4.3 4.0 4.5 5.2 4.3 5.5 6.4 6.6 5.0 5.7 3.7 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 5.2 3.8 2.8 2.8 2.4 -0.3
      12th Grade, original — — — — — 6.1 6.9 5.8 8.0 11.0 11.7 10.5 8.3 7.5 5.4 6.5 6.5 6.2 6.5 7.3 8.0 7.2 7.1 5.6 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 7.9 5.9 4.9 4.9 4.1
      College Students
Original 2.0 2.9 2.3 2.1 3.1 4.3 4.7 6.8 8.4 13.1 14.7 12.7 12.9 10.2 8.3 6.9 5.4 6.2 6.5 6.2 6.8 8.7 8.1 8.2 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 8.1 8.9 8.4 5.3 7.6 +2.3
      Young Adults
Original 3.2 3.9 3.8 3.8 4.5 5.2 5.1 7.2 7.1 11.6 13.0 14.6 15.3 16.0 14.9 14.4 13.1 13.1 11.5 12.3 11.3 11.4 11.6 11.4 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 12.5 12.9 12.5 12.6 12.2 -0.4
  Hallucinogens
    other than LSD b
  Ecstasy (MDMA) h
(Table continued on next page.)
change
  PCP g
and 12th Graders, College Students, and Young Adults (Ages 19–28)
2017–
2018
(Entries are percentages.)
TABLE 2-1 (cont.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
Hallucinogens b,f
  LSD b
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 2.3 2.9 2.9 3.6 4.2 4.5 4.4 4.6 4.7 4.5 4.3 3.6 3.6 3.4 3.7 3.4 3.1 3.0 2.6 2.6 2.2 1.9 1.7 1.8 1.6 1.4 1.3 1.4 +0.2  
      10th Grade 4.1 3.3 3.6 4.3 5.0 6.5 7.1 7.2 7.7 6.9 5.7 6.1 5.1 5.4 5.2 4.8 5.3 4.5 4.6 3.7 3.3 3.3 3.3 2.6 2.7 2.1 2.1 2.6 +0.5  
      12th Grade 7.8 6.1 6.1 5.9 6.0 7.1 8.7 9.3 9.8 8.6 8.2 7.8 7.7 8.1 8.0 8.5 7.8 7.2 6.0 5.5 5.2 4.9 4.5 4.6 4.0 3.7 4.2 3.9 -0.3  
      College Students 9.4 7.9 6.3 5.0 5.5 5.0 5.6 8.1 8.4 9.1 8.6 8.2 9.2 9.5 8.8 7.7 8.5 7.2 8.1 6.6 5.5 5.2 5.1 6.2 6.1 5.3 6.5 7.5 +1.0
      Young Adults 21.0 19.5 16.9 15.2 13.7 12.9 12.1 12.3 12.8 12.7 13.1 13.5 14.7 15.2 14.3 15.2 14.7 14.8 13.9 13.6 12.5 11.9 12.2 11.7 12.1 10.4 11.2 11.4 +0.2
      8th Grade 1.3 1.6 1.7 2.4 2.7 2.9 2.7 3.2 3.1 3.1 3.0 2.5 2.5 2.4 2.4 2.3 2.1 2.0 1.7 1.5 1.5 1.0 1.2 1.2 1.0 0.9 0.8 0.9 +0.1  
      10th Grade 1.7 1.5 1.8 2.1 2.8 3.3 3.6 3.9 4.0 3.7 3.1 3.6 2.7 2.6 2.5 2.2 2.3 2.0 2.1 1.8 1.6 1.4 1.5 1.0 1.1 0.8 0.8 1.0 +0.1  
      12th Grade 3.1 2.6 2.6 3.0 3.0 3.3 3.9 4.4 4.6 3.9 3.7 3.8 3.6 3.9 3.5 3.5 3.2 2.8 2.4 2.4 1.9 2.1 1.8 1.8 1.7 1.4 1.7 1.5 -0.1  
      College Students 1.5 1.7 1.3 1.0 1.8 1.2 1.4 2.2 2.4 2.5 2.0 1.9 3.1 2.0 1.7 2.3 1.3 1.4 1.0 1.2 0.8 0.7 0.7 1.4 0.5 0.4 0.6 0.6 0.0
      Young Adults 4.8 5.1 4.3 4.4 3.8 3.9 3.6 3.8 4.3 4.6 4.7 4.3 4.7 4.2 4.1 4.4 3.9 4.3 3.3 3.6 2.9 2.7 2.6 2.1 1.8 1.2 1.2 1.5 +0.3
    than Crack j
      8th Grade 2.0 2.4 2.4 3.0 3.4 3.8 3.5 3.7 3.8 3.5 3.3 2.8 2.7 2.6 2.9 2.7 2.6 2.4 2.1 2.1 1.8 1.6 1.4 1.4 1.3 1.1 1.0 1.2 +0.1  
      10th Grade 3.8 3.0 3.3 3.8 4.4 5.5 6.1 6.4 6.8 6.0 5.0 5.2 4.5 4.8 4.6 4.3 4.8 4.0 4.1 3.4 3.0 3.0 2.9 2.2 2.3 1.9 1.9 2.4 +0.5  
      12th Grade 7.0 5.3 5.4 5.2 5.1 6.4 8.2 8.4 8.8 7.7 7.4 7.0 6.7 7.3 7.1 7.9 6.8 6.5 5.3 5.1 4.9 4.4 4.2 4.1 3.4 3.3 3.5 3.3 -0.2  
      College Students 9.0 7.6 6.3 4.6 5.2 4.6 5.0 7.4 7.8 8.1 8.3 8.6 8.5 9.3 8.1 6.2 8.0 7.1 7.9 6.7 5.4 5.1 5.2 6.2 6.4 6.5 6.1 6.7 +0.6
      Young Adults 19.8 18.4 15.1 13.9 12.4 11.9 11.3 11.5 11.8 11.7 12.1 12.8 13.5 14.4 13.3 14.4 14.0 13.9 13.5 13.1 12.2 11.8 11.8 11.6 11.8 11.9 12.6 12.2 -0.4
      8th Grade 1.2 1.4 1.4 2.0 2.3 2.4 2.1 2.3 2.3 1.9 1.7 1.6 1.6 1.6 1.5 1.4 1.3 1.4 1.3 1.3 1.2 0.8 1.0 0.9 0.5 0.5 0.7 0.6 -0.1  
      10th Grade 1.2 1.2 1.3 1.5 1.7 2.1 2.1 2.3 2.3 2.2 1.7 1.8 1.5 1.5 1.5 1.4 1.5 1.2 1.5 1.3 1.2 1.1 1.0 0.9 0.7 0.6 0.4 0.4 -0.1  
      12th Grade 0.9 1.2 1.1 1.2 1.6 1.8 2.1 2.0 2.0 2.4 1.8 1.7 1.5 1.5 1.5 1.4 1.5 1.3 1.2 1.6 1.4 1.1 1.0 1.0 0.8 0.7 0.7 0.8 +0.1  
      College Students 0.5 0.5 0.6 0.1 0.6 0.7 0.9 1.7 0.9 1.7 1.2 1.0 1.0 0.9 0.5 0.7 0.5 0.7 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.5 0.1 0.1 +0.1
      Young Adults 0.9 0.9 0.9 0.8 1.1 1.3 1.3 1.6 1.7 1.8 2.0 1.8 1.9 1.9 1.7 1.9 1.6 1.9 1.6 1.8 1.7 1.6 1.6 1.4 1.6 1.6 1.4 1.4 0.0
      8th Grade —  — — — 1.5 1.6 1.3 1.4 1.6 1.1 1.2 1.0 1.0 1.1 1.0 1.0 0.9 0.9 0.9 0.9 0.8 0.6 0.6 0.8 0.3 0.3 0.4 0.4 0.0  
      10th Grade — — — — 1.0 1.1 1.1 1.2 1.3 1.0 0.8 1.0 0.9 0.8 0.8 0.9 0.9 0.7 0.9 0.8 0.8 0.7 0.7 0.6 0.5 0.5 0.3 0.2 -0.1  
      12th Grade — — — — 0.7 0.8 0.9 0.8 0.9 0.8 0.7 0.8 0.7 0.7 0.9 0.8 0.7 0.7 0.6 1.1 0.9 0.7 0.7 0.8 0.6 0.5 0.4 0.5 0.0  
      College Students — — — — 0.4 0.1 0.2 0.5 0.8 0.7 0.2 0.3 0.1 0.1 0.3 0.3 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.3 0.0 0.0 0.2 +0.2  
      Young Adults — — — — 0.4 0.4 0.3 0.4 0.6 0.4 0.6 0.4 0.5 0.4 0.6 0.6 0.5 0.5 0.5 0.8 0.7 0.5 1.0 0.7 0.7 0.7 0.8 0.4 -0.4
      8th Grade —  — — — 1.5 1.6 1.4 1.5 1.4 1.3 1.1 1.0 1.1 1.0 0.9 0.9 0.7 0.9 0.8 0.7 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 -0.1  
      10th Grade — — — — 1.1 1.7 1.7 1.7 1.6 1.7 1.3 1.3 1.0 1.1 1.1 1.0 1.1 0.8 1.0 0.9 0.8 0.8 0.7 0.5 0.4 0.3 0.3 0.2 -0.1  
      12th Grade — — — — 1.4 1.7 2.1 1.6 1.8 2.4 1.5 1.6 1.8 1.4 1.3 1.1 1.4 1.1 0.9 1.4 1.3 0.8 0.9 0.7 0.7 0.6 0.4 0.6 +0.1  
      College Students — — — — 0.5 1.0 1.2 2.1 1.0 2.5 1.3 1.2 1.1 1.0 0.3 0.8 0.4 0.7 0.4 0.4 0.4 0.5 0.8 0.1 0.4 0.2 0.1 0.2 0.0
      Young Adults — — — — 0.9 1.3 1.5 1.7 1.9 2.1 2.1 1.8 2.2 2.1 1.8 2.4 1.9 2.1 1.9 1.8 1.6 1.7 1.8 1.2 1.8 1.5 1.5 1.3 -0.1
Heroin k,l
2018
  Cocaine other 
Cocaine
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
  than Heroin m,n,ll  
      8th Grade —  — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 6.6 6.1 6.4 6.6 7.2 8.2 9.7 9.8 10.2 10.6 9.9‡ 13.5 13.2 13.5 12.8 13.4 13.1 13.2 13.2 13.0 13.0 12.2 11.1 9.5 8.4 7.8 6.8 6.0 -0.8  
      College Students 7.3 7.3 6.2 5.1 7.2 5.7 8.2 8.7 8.7 8.9 11.0‡ 12.2 14.2 13.8 14.4 14.6 14.1 12.4 14.0 12.2 12.4 10.3 10.8 9.9 6.6 7.4 6.8 6.6 -0.2
      Young Adults 9.3 8.9 8.1 8.2 9.0 8.3 9.2 9.1 9.5 10.0 11.5‡ 13.9 16.8 17.6 17.8 18.7 18.8 19.5 18.5 19.0 18.2 17.6 17.4 16.3 15.0 14.3 13.4 12.3 -1.2
      8th Grade 10.5 10.8 11.8 12.3 13.1 13.5 12.3 11.3 10.7 9.9 10.2 8.7 8.4 7.5 7.4 7.3 6.5 6.8 6.0 5.7 5.2 4.5‡ 6.9 6.7 6.8 5.7 5.7 5.9 +0.3  
      10th Grade 13.2 13.1 14.9 15.1 17.4 17.7 17.0 16.0 15.7 15.7 16.0 14.9 13.1 11.9 11.1 11.2 11.1 9.0 10.3 10.6 9.0 8.9‡ 11.2 10.6 9.7 8.8 8.2 8.6 +0.4  
      12th Grade 15.4 13.9 15.1 15.7 15.3 15.3 16.5 16.4 16.3 15.6 16.2 16.8 14.4 15.0 13.1 12.4 11.4 10.5 9.9 11.1 12.2 12.0‡ 13.8 12.1 10.8 10.0 9.2 8.6 -0.6  
      College Students 13.0 10.5 10.1 9.2 10.7 9.5 10.6 10.6 11.9 12.3 12.4 11.9 12.3 12.7 12.3 10.7 11.2 9.1 11.8 12.1 13.4 14.4‡ 16.1 15.0 13.9 13.6 12.6 13.2 +0.5
      Young Adults 22.4 20.2 18.7 17.1 16.6 15.3 14.6 14.3 14.1 15.0 15.0 14.8 15.2 15.9 14.6 15.6 15.3 14.6 14.9 16.1 16.5 17.4‡ 18.8 18.7 18.8 18.7 18.2 18.4 +0.3
  Methamphetamine p,q
      8th Grade —  — — — — — — — 4.5 4.2 4.4 3.5 3.9 2.5 3.1 2.7 1.8 2.3 1.6 1.8 1.3 1.3 1.4 1.0 0.8 0.6 0.7 0.7 0.0  
      10th Grade —  — — — — — — — 7.3 6.9 6.4 6.1 5.2 5.3 4.1 3.2 2.8 2.4 2.8 2.5 2.1 1.8 1.6 1.4 1.3 0.7 0.9 0.8 -0.1  
      12th Grade — — — — — — — — 8.2 7.9 6.9 6.7 6.2 6.2 4.5 4.4 3.0 2.8 2.4 2.3 2.1 1.7 1.5 1.9 1.0 1.2 1.1 0.7 -0.4  
      College Students —  — — — — — — — 7.1 5.1 5.3 5.0 5.8 5.2 4.1 2.9 1.9 1.9 1.0 1.1 0.6 0.3 0.9 0.7 0.8 0.6 0.6 1.0 +0.4
      Young Adults — — — — — — — — 8.8 9.3 9.0 9.1 8.9 9.0 8.3 7.3 6.7 6.3 4.7 4.3 3.2 3.5 3.1 2.3 2.4 2.2 2.6 2.7 +0.1
  Crystal Methamphetamine (Ice) q
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 3.3 2.9 3.1 3.4 3.9 4.4 4.4 5.3 4.8 4.0 4.1 4.7 3.9 4.0 4.0 3.4 3.4 2.8 2.1 1.8 2.1 1.7 2.0 1.3 1.2 1.4 1.5 1.1 -0.3  
      College Students 1.3 0.6 1.6 1.3 1.0 0.8 1.6 2.2 2.8 1.3 2.3 2.0 2.9 2.2 2.4 1.7 1.3 1.1 0.7 0.8 0.2 0.6 0.0 0.3 0.3 0.6 0.4 0.8 +0.4
      Young Adults 2.9 2.2 2.7 2.5 2.1 3.1 2.5 3.4 3.3 3.9 4.0 4.1 4.7 4.7 4.4 4.7 3.7 3.6 3.4 2.8 3.1 2.6 2.8 1.7 2.2 1.8 1.8 1.3 -0.5
  (Barbiturates) m,r
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 6.2 5.5 6.3 7.0 7.4 7.6 8.1 8.7 8.9 9.2 8.7 9.5  8.8‡ 9.9 10.5 10.2 9.3 8.5 8.2 7.5 7.0 6.9 7.5 6.8 5.9 5.2 4.5 4.2 -0.3  
      College Students 3.5 3.8 3.5 3.2 4.0 4.6 5.2 5.7 6.7 6.9 6.0 5.9 5.7 7.2 8.5 6.3 5.9 6.4 6.0 5.3 3.6 3.5‡ 5.4 5.9 4.4 3.3 3.9 3.3 -0.6
      Young Adults 8.2 7.4 6.5 6.4 6.7 6.6 6.5 6.9 7.4 8.1 7.8 8.0 8.7 9.7 10.0 9.5 9.8 10.6 9.5 8.6 7.9 7.2‡ 9.5 9.0 8.3 7.4 6.4 7.3 +0.8
2017–
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 3.8 4.1 4.4 4.6 4.5 5.3 4.8 4.6 4.4 4.4‡ 5.0 4.3 4.4 4.0 4.1 4.3 3.9 3.9 3.9 4.4 3.4 3.0 2.9 2.9 3.0 3.0 3.4 3.5 +0.1  
      10th Grade 5.8 5.9 5.7 5.4 6.0 7.1 7.3 7.8 7.9 8.0‡ 9.2 8.8 7.8 7.3 7.1 7.2 7.4 6.8 7.0 7.3 6.8 6.3 5.5 5.8 5.8 6.1 6.0 6.0 0.0  
      12th Grade 7.2 6.0 6.4 6.6 7.1 7.2 7.8 8.5 9.3 8.9‡ 10.3 11.4 10.2 10.6 9.9 10.3 9.5 8.9 9.3 8.5 8.7 8.5 7.7 7.4 6.9 7.6 7.5 6.6 -0.9  
      College Students 6.8 6.9 6.3 4.4 5.4 5.3 6.9 7.7 8.2 8.8‡ 9.7 10.7 11.0 10.6 11.9 10.0 9.1 8.6 9.2 8.1 7.1 6.4 7.8 6.9 7.8 6.5 6.7 7.4 +0.7
      Young Adults 11.8 11.3 10.5 9.9 9.7 9.3 8.6 9.6 9.6 10.5‡ 11.9 13.4 13.8 14.9 14.5 15.0 14.5 15.8 13.8 14.3 13.8 13.3 13.2 12.5 12.8 12.4 12.4 11.4 -1.0
Any Prescription Drug o,t
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — 24.0 23.9 22.2 21.5 20.9 21.6 21.7 21.2‡ 22.2 19.9 18.3 18.0 16.5 15.5 -0.9  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — 1.5 1.1 1.4 1.3 1.0 1.1 0.8 1.0 1.0 1.1 1.0 1.0 0.7 0.7 0.9 2.0 1.0 0.7 0.6 0.8 0.9 0.6 0.7 +0.1  
      10th Grade — — — — — 1.5 1.7 2.0 1.8 1.3 1.5 1.3 1.0 1.2 1.0 0.8 1.3 0.9 0.7 1.4 1.2 0.8 1.1 1.0 0.5 1.0 0.7 0.5 -0.2  
      12th Grade — — — — — 1.2 1.8 3.0 2.0 1.5 1.7 — — — — — — — — — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
  Any Use
      8th Grade 70.1 69.3‡ 55.7 55.8 54.5 55.3 53.8 52.5 52.1 51.7 50.5 47.0 45.6 43.9 41.0 40.5 38.9 38.9 36.6 35.8 33.1 29.5 27.8 26.8 26.1 22.8 23.1 23.5 +0.4  
      10th Grade 83.8 82.3‡ 71.6 71.1 70.5 71.8 72.0 69.8 70.6 71.4 70.1 66.9 66.0 64.2 63.2 61.5 61.7 58.3 59.1 58.2 56.0 54.0 52.1 49.3 47.1 43.4 42.2 43.0 +0.8  
      12th Grade 88.0 87.5‡ 80.0 80.4 80.7 79.2 81.7 81.4 80.0 80.3 79.7 78.4 76.6 76.8 75.1 72.7 72.2 71.9 72.3 71.0 70.0 69.4 68.2 66.0 64.0 61.2 61.5 58.5 -3.0 s
      College Students 93.6 91.8 89.3 88.2 88.5 88.4 87.3 88.5 88.0 86.6 86.1 86.0 86.2 84.6 86.6 84.7 83.1 85.3 82.6 82.3 80.5 81.0 78.0 79.4 81.4 81.3 79.1 77.4 -1.7
      Young Adults 94.1 93.4 92.1 91.2 91.6 91.2 90.7 90.6 90.2 90.7 89.9 90.2 89.3 89.4 89.1 88.9 87.9 88.4 87.9 87.5 87.4 86.5 86.2 86.3 85.7 85.9 85.2 85.0 -0.2
      8th Grade 26.7 26.8 26.4 25.9 25.3 26.8 25.2 24.8 24.8 25.1 23.4 21.3 20.3 19.9 19.5 19.5 17.9 18.0 17.4 16.3 14.8 12.8 12.2 10.8 10.9 8.6 9.2 9.2 0.0  
      10th Grade 50.0 47.7 47.9 47.2 46.9 48.5 49.4 46.7 48.9 49.3 48.2 44.0 42.4 42.3 42.1 41.4 41.2 37.2 38.6 36.9 35.9 34.6 33.5 30.2 28.6 26.0 25.1 26.2 +1.2  
      12th Grade 65.4 63.4 62.5 62.9 63.2 61.8 64.2 62.4 62.3 62.3 63.9 61.6 58.1 60.3 57.5 56.4 55.1 54.7 56.5 54.1 51.0 54.2 52.3 49.8 46.7 46.3 45.3 42.9 -2.4  
      College Students 79.6 76.8 76.4 74.4 76.6 76.2 77.0 76.8 75.1 74.7 76.1 75.1 74.9 73.4 72.9 73.1 71.6 72.5 69.1 70.5 67.9 70.0 66.5 68.8 68.6 66.7 64.8 66.8 +2.0
      Young Adults 82.9 81.1 81.4 80.7 82.1 80.7 81.4 79.8 81.6 80.4 81.1 81.2 80.9 80.1 79.9 80.9 80.1 80.1 78.2 79.0 78.9 78.9 77.4 78.3 76.4 75.2 75.4 76.2 +0.8
Tranquilizers b,m
(Entries are percentages.)
2017–
2018
change
Rohypnol u
Alcohol v
  Been Drunk w
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
  Flavored Alcoholic
    Beverages g,p,mm
      8th Grade — — — — — — — — — — — — — 37.9 35.5 35.5 34.0 32.8 29.4 30.0 27.0 23.5 21.9 19.2 19.3 16.3 16.0 18.0 +2.0  
      10th Grade — — — — — — — — — — — — — 58.6 58.8 58.1 55.7 53.5 51.4 51.3 48.4 46.7 44.9 42.3 38.7 33.3 34.8 35.9 +1.1  
      12th Grade — — — — — — — — — — — — — 71.0 73.6 69.9 68.4 65.5 67.4 62.6 62.4 60.5 58.9 57.5 55.6 53.6 51.2 50.4 -0.9  
      College Students — — — — — — — — — — — — — 79.0 84.5 80.9 80.6 78.6 78.1 77.4 76.7 76.6 67.5 72.7 74.8 76.1 72.4 71.0 -1.4
      Young Adults — — — — — — — — — — — — — 83.2 84.6 84.4 84.0 82.6 83.5 81.4 82.2 82.4 80.9 80.6 81.0 79.9 79.2 80.9 +1.7
  Any Use
      8th Grade 44.0 45.2 45.3 46.1 46.4 49.2 47.3 45.7 44.1 40.5 36.6 31.4 28.4 27.9 25.9 24.6 22.1 20.5 20.1 20.0 18.4 15.5 14.8 13.5 13.3 9.8 9.4 9.1 -0.3  
      10th Grade 55.1 53.5 56.3 56.9 57.6 61.2 60.2 57.7 57.6 55.1 52.8 47.4 43.0 40.7 38.9 36.1 34.6 31.7 32.7 33.0 30.4 27.7 25.7 22.6 19.9 17.5 15.9 16.0 0.0  
      12th Grade 63.1 61.8 61.9 62.0 64.2 63.5 65.4 65.3 64.6 62.5 61.0 57.2 53.7 52.8 50.0 47.1 46.2 44.7 43.6 42.2 40.0 39.5 38.1 34.4 31.1 28.3 26.6 23.8 -2.8 s
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade 22.2 20.7 18.7 19.9 20.0 20.4 16.8 15.0 14.4 12.8 11.7 11.2 11.3 11.0 10.1 10.2 9.1 9.8 9.6 9.9 9.7 8.1 7.9 8.0 8.6 6.9 6.2 6.4 +0.1  
      10th Grade 28.2 26.6 28.1 29.2 27.6 27.4 26.3 22.7 20.4 19.1 19.5 16.9 14.6 13.8 14.5 15.0 15.1 12.2 15.2 16.8 15.6 15.4 14.0 13.6 12.3 10.2 9.1 10.0 +0.9  
      12th Grade — 32.4 31.0 30.7 30.9 29.8 25.3 26.2 23.4 23.1 19.7 18.3 17.0 16.7 17.5 15.2 15.1 15.6 16.3 17.6 16.9 17.4 17.2 15.1 13.2 14.2 11.0 10.1 -0.9  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Any Vaping jj,kk,nn
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — 21.7 17.5‡ 18.5 21.5 +3.0 s
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — 32.8 29.0‡ 30.9 36.9 +6.0 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — 35.5 33.8‡ 35.8 42.5 +6.7 ss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — 26.0 26.8‡ 36.0 39.9 3.9
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — 30.3 26.9‡ 34.3 37.0 2.7
Vaping Nicotine jj,oo
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 10.6 13.5 +2.9 ss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 21.4 28.6 +7.2 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 25.0 34.0 +9.0 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 22.5 32.4 +9.9 ss
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 24.8 27.5 +2.7
(Entries are percentages.)
Cigarettes 
Smokeless Tobacco x
(Table continued on next page.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
TABLE 2-1 (cont.)
and 12th Graders, College Students, and Young Adults (Ages 19–28)
2017–
2018
change
33
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Vaping Marijuana jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 4.0 5.5 +1.5 s
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.8 14.2 +4.4 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 11.9 15.6 +3.8 ss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 14.4 23.8 9.5 ss
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 17.2 21.6 4.4 ss
Vaping Just Flavoring  jj,pp
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 17.0 19.4 +2.4  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 27.5 31.7 +4.3 ss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 30.7 34.1 +3.4  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 26.7 27.1 0.4
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 21.4 22.1 0.7
      8th Grade 1.9 1.7 1.6 2.0 2.0 1.8 1.8 2.3 2.7 3.0 2.8 2.5 2.5 1.9 1.7 1.6 1.5 1.4 1.3 1.1 1.2 1.2 1.1 1.0 1.0 0.9 1.1 1.1 0.0  
      10th Grade 1.8 1.7 1.7 1.8 2.0 1.8 2.0 2.0 2.7 3.5 3.5 3.5 3.0 2.4 2.0 1.8 1.8 1.4 1.3 1.6 1.4 1.3 1.3 1.4 1.2 1.3 1.1 1.2 +0.1  
      12th Grade 2.1 2.1 2.0 2.4 2.3 1.9 2.4 2.7 2.9 2.5 3.7 4.0 3.5 3.4 2.6 2.7 2.2 2.2 2.2 2.0 1.8 1.8 2.1 1.9 2.3 1.6 1.6 1.6 -0.1  
      College Students 1.4 1.7 1.9 0.5 0.8 0.6 1.6 0.9 1.3 0.6 1.5 1.2 1.2 1.6 1.0 1.9 0.6 1.6 1.3 0.7 1.1 0.4 0.8 0.9 0.6 0.8 1.2 0.3 -0.9
      Young Adults 1.7 1.9 1.5 1.3 1.5 1.5 1.4 1.4 1.9 1.4 1.4 1.6 1.8 1.9 1.8 1.8 1.7 1.8 1.8 1.7 1.3 1.7 1.2 1.7 1.6 1.4 1.4 1.0 -0.4
Previously surveyed drugs that have been dropped
— — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.6 1.5 1.4 1.7 1.5 1.8 2.0 2.7 1.7 0.8 1.9 1.5 1.6 1.3 1.1 1.2 1.2 0.6 1.1 — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 1.4 1.2 1.3 1.0 — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.3 1.6 0.8 1.4 1.2 2.0 1.7 1.6 1.8 0.8 1.1 1.5 1.0 1.3 1.3 1.2 1.0 0.8 0.7 0.4 0.6 0.8 — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.  The Monitoring the Future study, the University of Michigan.  
See footnotes following Table 2-4
  Methaqualone m,s
TABLE 2-1 (cont.)
Trends in Lifetime Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28)
(Entries are percentages.)
2017–
Nitrites e
      8th Grade
2018
change
Steroids y,z
34
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 11.3 12.9 15.1 18.5 21.4 23.6 22.1 21.0 20.5 19.5 19.5 17.7 16.1 15.2 15.5 14.8 13.2 14.1 14.5 16.0 14.7 13.4‡ 15.2 14.6 14.8 12.0 12.9 13.4 +0.5  
      10th Grade 21.4 20.4 24.7 30.0 33.3 37.5 38.5 35.0 35.9 36.4 37.2 34.8 32.0 31.1 29.8 28.7 28.1 26.9 29.4 30.2 31.1 30.1‡ 32.1 29.9 27.9 26.8 27.8 29.9 +2.1  
      12th Grade 29.4 27.1 31.0 35.8 39.0 40.2 42.4 41.4 42.1 40.9 41.4 41.0 39.3 38.8 38.4 36.5 35.9 36.6 36.5 38.3 40.0 39.7‡ 40.1 38.7 38.6 38.3 39.9 38.8 -1.1  
      College Students 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9 36.1 37.9 37.0 36.5 36.2 36.6 33.9 35.0 35.2 36.0 35.0 36.3 37.3‡ 40.5 38.6 41.4 42.8 42.4 45.2 +2.7
      Young Adults 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 32.1 32.5 33.8 33.3 33.2 34.7 34.0‡ 36.7 37.5 39.2 39.7 41.2 42.8 +1.6
      8th Grade 8.4 9.3 10.4 11.3 12.6 13.1 11.8 11.0 10.5 10.2‡ 10.8 8.8 8.8 7.9 8.1 7.7 7.0 7.4 7.0 7.1 6.4 5.5‡ 6.3 6.4 6.3 5.4 5.8 6.1 +0.3  
      10th Grade 12.2 12.3 13.9 15.2 17.5 18.4 18.2 16.6 16.7 16.7‡ 17.9 15.7 13.8 13.5 12.9 12.7 13.1 11.3 12.2 12.1 11.2 10.8‡ 11.2 11.2 10.5 9.8 9.4 9.6 +0.2  
      12th Grade 16.2 14.9 17.1 18.0 19.4 19.8 20.7 20.2 20.7 20.4‡ 21.6 20.9 19.8 20.5 19.7 19.2 18.5 18.3 17.0 17.3 17.6 17.0‡ 17.8 15.9 15.2 14.3 13.3 12.4 -0.9  
      College Students 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4 15.6‡ 16.4 16.6 17.9 18.6 18.5 18.1 17.3 15.3 16.9 17.1 16.8 17.1‡ 19.3 20.8 18.5 19.7 18.1 18.0 -0.1
      Young Adults 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9‡ 15.4 16.3 18.1 18.8 18.5 18.4 18.1 18.9 17.4 18.5 17.6 17.2‡ 18.1 21.2 19.5 19.9 20.1 19.0 -1.1
  including
  Inhalants a,c,d
      8th Grade 16.7 18.2 21.1 24.2 27.1 28.7 27.2 26.2 25.3 24.0 23.9 21.4 20.4 20.2 20.4 19.7 18.0 19.0 18.8 20.3 18.2 17.0‡ 17.6 16.8 17.0 13.5 15.8 16.0 +0.2  
      10th Grade 23.9 23.5 27.4 32.5 35.6 39.6 40.3 37.1 37.7 38.0 38.7 36.1 33.5 32.9 31.7 30.7 30.2 28.8 31.2 31.8 32.5 31.5‡ 33.2 31.0 28.9 27.7 29.1 31.0 +2.0  
      12th Grade 31.2 28.8 32.5 37.6 40.2 41.9 43.3 42.4 42.8 42.5 42.6 42.1 40.5 39.1 40.3 38.0 37.0 37.3 37.6 39.2 41.5 40.2‡ 42.3 39.2 40.2 38.7 41.2 40.2 -1.0  
      College Students 29.8 31.1 31.7 31.9 33.7 35.1 35.5 39.1 37.4 37.0 38.2 37.7 36.0 35.9 37.9 35.5 36.8 35.7 35.0 34.5 36.5 36.9‡ 40.1 36.3 40.7 40.3 42.4 46.1 +3.7
      Young Adults 27.8 29.2 28.9 29.2 30.4 30.2 30.1 30.6 30.6 31.2 33.2 32.4 32.7 34.9 32.8 32.6 33.2 33.5 33.1 33.3 34.2 34.2‡ 38.3 35.3 37.3 38.2 40.7 42.4 +1.7
      8th Grade 6.2 7.2 9.2 13.0 15.8 18.3 17.7 16.9 16.5 15.6 15.4 14.6 12.8 11.8 12.2 11.7 10.3 10.9 11.8 13.7 12.5 11.4 12.7 11.7 11.8 9.4 10.1 10.5 +0.3  
      10th Grade 16.5 15.2 19.2 25.2 28.7 33.6 34.8 31.1 32.1 32.2 32.7 30.3 28.2 27.5 26.6 25.2 24.6 23.9 26.7 27.5 28.8 28.0 29.8 27.3 25.4 23.9 25.5 27.5 +2.0  
      12th Grade 23.9 21.9 26.0 30.7 34.7 35.8 38.5 37.5 37.8 36.5 37.0 36.2 34.9 34.3 33.6 31.5 31.7 32.4 32.8 34.8 36.4 36.4 36.4 35.1 34.9 35.6 37.1 35.9 -1.2  
      College Students 26.5 27.7 27.9 29.3 31.2 33.1 31.6 35.9 35.2 34.0 35.6 34.7 33.7 33.3 33.3 30.2 31.8 32.3 32.8 32.7 33.2 34.9 35.5 34.4 37.9 39.3 38.3 42.6 +4.3
      Young Adults 23.8 25.2 25.1 25.5 26.5 27.0 26.8 27.4 27.6 27.9 29.2 29.3 29.0 29.2 28.2 27.7 28.5 28.6 29.3 28.7 31.0 30.2 32.2 31.6 34.0 35.3 37.5 39.1 +1.6
      8th Grade — — — — — — — — — — — — — — — — — — — — — 4.4 4.0 3.3 3.1 2.7 2.0 1.6 -0.5  
      10th Grade — — — — — — — — — — — — — — — — — — — — — 8.8 7.4 5.4 4.3 3.3 2.7 2.9 +0.3  
      12th Grade — — — — — — — — — — — — — — — — — — — — 11.4 11.3 7.9 5.8 5.2 3.5 3.7 3.5 -0.2  
      College Students — — — — — — — — — — — — — — — — — — — — 8.5 5.3 2.3 0.9 1.5 1.3 0.5 1.6 +1.1
      Young Adults — — — — — — — — — — — — — — — — — — — — 7.4 5.3 3.2 1.3 1.5 1.0 0.9 1.6 +0.6
Marijuana/Hashish
2018
(Table continued on next page.)
TABLE 2-2
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2017–
(Entries are percentages.)
change
Any Illicit Drug a
Any Illicit Drug other
  than Marijuana a,b
Any Illicit Drug
Synthetic Marijuana p,q
35
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 9.0 9.5 11.0 11.7 12.8 12.2 11.8 11.1 10.3 9.4 9.1 7.7 8.7 9.6 9.5 9.1 8.3 8.9 8.1 8.1 7.0 6.2 5.2 5.3 4.6 3.8 4.7 4.6 -0.1  
      10th Grade 7.1 7.5 8.4 9.1 9.6 9.5 8.7 8.0 7.2 7.3 6.6 5.8 5.4 5.9 6.0 6.5 6.6 5.9 6.1 5.7 4.5 4.1 3.5 3.3 2.9 2.4 2.3 2.4 +0.1  
      12th Grade 6.6 6.2 7.0 7.7 8.0 7.6 6.7 6.2 5.6 5.9 4.5 4.5 3.9 4.2 5.0 4.5 3.7 3.8 3.4 3.6 3.2 2.9 2.5 1.9 1.9 1.7 1.5 1.6 +0.1  
      College Students 3.5 3.1 3.8 3.0 3.9 3.6 4.1 3.0 3.2 2.9 2.8 2.0 1.8 2.7 1.8 1.5 1.5 1.1 1.2 1.7 0.9 1.5 0.5 1.3 0.6 0.2 1.7 1.3 -0.5
      Young Adults 2.0 1.9 2.1 2.1 2.4 2.2 2.3 2.1 2.3 2.1 1.7 1.6 1.4 1.7 1.3 1.3 0.8 1.4 0.9 1.2 0.8 1.1 0.5 1.1 0.9 0.9 0.7 0.8 0.0
      8th Grade 1.9 2.5 2.6 2.7 3.6 4.1 3.7 3.4 2.9 2.8‡ 3.4 2.6 2.6 2.2 2.4 2.1 1.9 2.1 1.9 2.2 2.2 1.6 1.6 1.3 1.3 1.2 1.1 1.4 +0.2  
      10th Grade 4.0 4.3 4.7 5.8 7.2 7.8 7.6 6.9 6.9 6.1‡ 6.2 4.7 4.1 4.1 4.0 4.1 4.4 3.9 4.1 4.2 4.1 3.5 3.4 3.3 3.1 2.9 2.8 2.7 -0.1  
      12th Grade 5.8 5.9 7.4 7.6 9.3 10.1 9.8 9.0 9.4 8.1‡ 9.1 6.6 5.9 6.2 5.5 4.9 5.4 5.9 4.7 5.5 5.2 4.8 4.5 4.0 4.2 4.3 4.4 4.3 -0.2  
      College Students 6.3 6.8 6.0 6.2 8.2 6.9 7.7 7.2 7.8 6.7‡ 7.5 6.3 7.4 5.9 5.0 5.6 4.9 5.1 4.7 4.9 4.1 4.5 4.5 4.0 4.3 4.5 4.1 5.1 +1.1
      Young Adults 4.5 5.0 4.5 4.8 5.6 5.6 5.9 5.2 5.4 5.4‡ 5.4 4.7 5.2 4.7 4.5 4.1 3.8 3.8 3.9 4.2 3.7 3.6 3.9 4.1 4.2 4.6 4.8 5.6 +0.8
      8th Grade 1.7 2.1 2.3 2.4 3.2 3.5 3.2 2.8 2.4 2.4 2.2 1.5 1.3 1.1 1.2 0.9 1.1 1.3 1.1 1.2 1.1 0.8 1.0 0.7 0.9 0.8 0.9 0.9 +0.1  
      10th Grade 3.7 4.0 4.2 5.2 6.5 6.9 6.7 5.9 6.0 5.1 4.1 2.6 1.7 1.6 1.5 1.7 1.9 1.8 1.9 1.9 1.8 1.7 1.7 1.9 2.0 2.1 2.1 2.0 -0.1  
      12th Grade 5.2 5.6 6.8 6.9 8.4 8.8 8.4 7.6 8.1 6.6 6.6 3.5 1.9 2.2 1.8 1.7 2.1 2.7 1.9 2.6 2.7 2.4 2.2 2.5 2.9 3.0 3.3 3.2 -0.2  
      College Students 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4 4.3 4.0 2.1 1.4 1.2 0.7 1.4 1.3 2.6 2.0 2.1 2.0 1.9 2.6 2.2 3.0 3.1 2.8 4.1 +1.3
      Young Adults 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 1.2 0.9 0.8 1.2 1.1 1.4 1.7 1.5 1.7 1.6 2.0 2.2 2.6 3.1 3.4 3.9 +0.6
      8th Grade 0.7 1.1 1.0 1.3 1.7 2.0 1.8 1.6 1.5 1.4‡ 2.4 2.1 2.1 1.9 2.0 1.8 1.6 1.6 1.5 1.8 1.8 1.3 1.2 1.0 0.8 0.8 0.7 0.9 +0.2  
      10th Grade 1.3 1.4 1.9 2.4 2.8 3.3 3.3 3.4 3.2 3.1‡ 4.3 4.0 3.6 3.7 3.5 3.7 3.8 3.3 3.5 3.5 3.5 3.0 2.7 2.6 1.9 2.0 1.8 1.7 -0.1  
      12th Grade 2.0 1.7 2.2 3.1 3.8 4.4 4.6 4.6 4.3 4.4‡ 5.9 5.4 5.4 5.6 5.0 4.6 4.8 5.0 4.2 4.8 4.3 4.0 3.7 3.0 2.9 2.7 2.9 2.7 -0.2  
      College Students 3.1 2.6 2.7 2.8 4.0 4.1 4.9 4.4 4.5 4.4‡ 5.5 5.8 7.1 5.6 5.0 5.4 4.7 4.4 4.1 4.4 3.4 3.9 3.7 3.2 3.0 3.4 2.5 2.4 -0.1
      Young Adults 1.7 1.9 1.9 2.0 2.5 2.8 3.1 3.0 3.0 3.4‡ 3.5 4.0 4.9 4.5 4.2 3.8 3.6 3.4 3.3 3.7 3.2 2.9 3.2 3.1 3.0 3.0 3.0 3.3 +0.3
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.4 1.4 1.6 1.8 2.6 2.3 2.1 1.8 2.3 1.8 1.1 1.3 0.7 1.3 0.7 0.9 1.1 1.0 1.0 1.3 0.9 0.7 0.8 1.4 1.3 1.0 1.1 +0.1  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 0.3 0.3 0.2 0.3 0.3 0.2 0.5 0.6 0.6 0.3 0.6 0.3 0.3 0.1 0.6 0.2 0.3 0.4 0.1 0.2 0.3 * 0.2 0.1 0.0 0.4 0.1 0.7 +0.6
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
  PCP g
2017–
(Table continued on next page.)
Inhalants c,d
    other than LSD b
2018
change
  Hallucinogens
Hallucinogens b,f
  LSD b
36
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade, original — — — — — 2.3 2.3 1.8 1.7 3.1 3.5 2.9 2.1 1.7 1.7 1.4 1.5 1.7 1.3 2.4 1.7 1.1 1.1 0.9 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.5 1.4 1.0 0.9 1.1 +0.2
      10th Grade, original — — — — — 4.6 3.9 3.3 4.4 5.4 6.2 4.9 3.0 2.4 2.6 2.8 3.5 2.9 3.7 4.7 4.5 3.0 3.6 2.3 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 3.8 2.4 1.8 1.7 1.4 -0.3
      12th Grade, original — — — — — 4.6 4.0 3.6 5.6 8.2 9.2 7.4 4.5 4.0 3.0 4.1 4.5 4.3 4.3 4.5 5.3 3.8 4.0 3.6 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 5.0 3.6 2.7 2.6 2.2 -0.4
      College Students
Original 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5 9.1 9.2 6.8 4.4 2.2 2.9 2.6 2.2 3.7 3.1 4.3 4.2 5.8 5.3 5.0 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 4.9 4.2 4.7 2.5 4.3 +1.8
      Young Adults
Original 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 4.5 3.5 3.0 3.0 2.5 3.3 3.1 3.5 3.6 4.1 4.2 4.8 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 5.1 4.4 5.1 3.6 3.9 +0.3
      8th Grade — — — — — — — — — — — — — — — — — — — 1.7 1.6 1.4 1.2 0.6 0.7 0.9 0.4 0.6 +0.2
      10th Grade — — — — — — — — — — — — — — — — — — — 3.7 3.9 2.5 2.3 1.8 1.2 0.9 0.9 0.7 -0.2
      12th Grade — — — — — — — — — — — — — — — — — — 5.7 5.5 5.9 4.4 3.4 1.8 1.9 1.8 1.5 0.9 -0.6
      College Students — — — — — — — — — — — — — — — — — — 5.8 3.5 3.1 1.5 1.0 1.1 0.4 0.7 0.3 0.9 +0.5
      Young Adults — — — — — — — — — — — — — — — — — — 3.5 3.6 2.2 1.4 0.9 1.2 0.6 0.8 0.5 0.7 +0.1
      8th Grade 1.1 1.5 1.7 2.1 2.6 3.0 2.8 3.1 2.7 2.6 2.5 2.3 2.2 2.0 2.2 2.0 2.0 1.8 1.6 1.6 1.4 1.2 1.0 1.0 0.9 0.8 0.8 0.8 0.0
      10th Grade 2.2 1.9 2.1 2.8 3.5 4.2 4.7 4.7 4.9 4.4 3.6 4.0 3.3 3.7 3.5 3.2 3.4 3.0 2.7 2.2 1.9 2.0 1.9 1.5 1.8 1.3 1.4 1.5 +0.2
      12th Grade 3.5 3.1 3.3 3.6 4.0 4.9 5.5 5.7 6.2 5.0 4.8 5.0 4.8 5.3 5.1 5.7 5.2 4.4 3.4 2.9 2.9 2.7 2.6 2.6 2.5 2.3 2.7 2.3 -0.4
      College Students 3.6 3.0 2.7 2.0 3.6 2.9 3.4 4.6 4.6 4.8 4.7 4.8 5.4 6.6 5.7 5.1 5.4 4.4 4.2 3.5 3.3 3.1 2.7 4.4 4.3 4.0 4.8 5.2 +0.5
      Young Adults 6.2 5.7 4.7 4.3 4.4 4.1 4.7 4.9 5.4 5.4 5.8 5.8 6.6 7.1 6.9 6.6 6.2 6.0 5.2 4.7 4.7 4.1 3.9 5.0 5.7 4.9 5.3 6.0 +0.8
      8th Grade 0.7 0.9 1.0 1.3 1.6 1.8 1.7 2.1 1.8 1.8 1.7 1.6 1.6 1.3 1.4 1.3 1.3 1.1 1.1 1.0 0.9 0.6 0.6 0.7 0.5 0.5 0.5 0.4 -0.1
      10th Grade 0.9 0.9 1.1 1.4 1.8 2.1 2.2 2.5 2.4 2.2 1.8 2.3 1.6 1.7 1.7 1.3 1.3 1.3 1.2 1.0 0.9 0.8 0.8 0.5 0.7 0.4 0.6 0.6 0.0
      12th Grade 1.5 1.5 1.5 1.9 2.1 2.1 2.4 2.5 2.7 2.2 2.1 2.3 2.2 2.3 1.9 2.1 1.9 1.6 1.3 1.4 1.0 1.2 1.1 1.1 1.1 0.8 1.0 0.9 -0.1
      College Students 0.5 0.4 0.6 0.5 1.1 0.6 0.4 1.0 0.9 0.9 0.9 0.4 1.3 1.3 0.8 1.0 0.6 0.5 0.3 0.4 0.3 0.3 0.3 0.8 0.2 0.0 0.2 0.4 +0.2
      Young Adults 1.2 1.4 1.3 1.1 1.1 1.1 1.0 1.1 1.4 1.2 1.3 1.0 1.0 1.3 1.2 1.1 1.0 0.9 0.7 0.5 0.6 0.5 0.3 0.4 0.4 0.0 0.2 0.2 0.0
  Ecstasy (MDMA ) h
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
change
Cocaine
  Crack i
Salvia p,q
(Table continued on next page.)
(Entries are percentages.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
    than Crack j
      8th Grade 1.0 1.2 1.3 1.7 2.1 2.5 2.2 2.4 2.3 1.9 1.9 1.8 1.6 1.6 1.7 1.6 1.5 1.4 1.3 1.3 1.1 1.0 0.8 0.8 0.8 0.6 0.6 0.7 0.0  
      10th Grade 2.1 1.7 1.8 2.4 3.0 3.5 4.1 4.0 4.4 3.8 3.0 3.4 2.8 3.3 3.0 2.9 3.1 2.6 2.3 1.9 1.7 1.8 1.6 1.3 1.5 1.1 1.2 1.4 +0.2  
      12th Grade 3.2 2.6 2.9 3.0 3.4 4.2 5.0 4.9 5.8 4.5 4.4 4.4 4.2 4.7 4.5 5.2 4.5 4.0 3.0 2.6 2.6 2.4 2.4 2.4 2.1 2.0 2.3 2.0 -0.4  
      College Students 3.2 2.4 2.5 1.8 3.3 2.3 3.0 4.2 4.2 4.1 4.1 5.0 5.1 6.3 5.0 3.8 5.3 4.2 4.2 4.0 3.0 3.0 2.8 4.1 4.2 4.7 4.4 4.6 +0.2
      Young Adults 5.4 5.1 3.9 3.6 3.9 3.8 4.3 4.5 4.8 4.8 5.3 5.6 6.1 6.4 6.3 5.9 5.6 5.5 5.0 4.8 4.3 4.0 3.7 4.8 5.4 5.9 5.9 6.2 +0.3
      8th Grade 0.7 0.7 0.7 1.2 1.4 1.6 1.3 1.3 1.4 1.1 1.0 0.9 0.9 1.0 0.8 0.8 0.8 0.9 0.7 0.8 0.7 0.5 0.5 0.5 0.3 0.3 0.3 0.3 0.0  
      10th Grade 0.5 0.6 0.7 0.9 1.1 1.2 1.4 1.4 1.4 1.4 0.9 1.1 0.7 0.9 0.9 0.9 0.8 0.8 0.9 0.8 0.8 0.6 0.6 0.5 0.5 0.3 0.2 0.2 -0.1  
      12th Grade 0.4 0.6 0.5 0.6 1.1 1.0 1.2 1.0 1.1 1.5 0.9 1.0 0.8 0.9 0.8 0.8 0.9 0.7 0.7 0.9 0.8 0.6 0.6 0.6 0.5 0.3 0.4 0.4 0.0  
      College Students 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.2 0.5 0.4 0.1 0.2 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.1 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0
      Young Adults 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.3 0.4 0.4 0.3 0.5 0.6 0.5 0.5 0.5 0.6 0.4 0.5 0.4 0.4 0.3 -0.1
      8th Grade —  — — — 0.9 1.0 0.8 0.8 0.9 0.6 0.7 0.6 0.6 0.7 0.6 0.5 0.6 0.5 0.5 0.6 0.5 0.4 0.3 0.4 0.2 0.2 0.2 0.2 0.0  
      10th Grade — — — — 0.6 0.7 0.7 0.8 0.6 0.5 0.4 0.6 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.5 0.5 0.4 0.5 0.4 0.2 0.3 0.2 0.1 -0.1  
      12th Grade — — — — 0.5 0.5 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.5 0.4 0.4 0.3 0.7 0.6 0.4 0.4 0.5 0.3 0.3 0.2 0.3 +0.1  
      College Students — — — — 0.1  * 0.1 0.2 0.1 0.1 0.1  * 0.1 0.1 0.3 0.3 * 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.2 0.1 -0.2
      Young Adults — — — — 0.1 0.1 0.1 0.1 0.1  * 0.3  *  * 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.4 0.3 0.3 0.2 0.2 0.3 0.2 0.1 -0.2
      8th Grade —  — — — 0.8 1.0 0.8 0.8 0.9 0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.6 0.4 0.5 0.4 0.3 0.3 0.2 0.2 0.2 0.3 0.2 0.0  
      10th Grade — — — — 0.8 0.9 1.1 1.0 1.1 1.1 0.7 0.8 0.5 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.5 0.4 0.4 0.3 0.3 0.2 0.1 0.1 0.0  
      12th Grade — — — — 1.0 1.0 1.2 0.8 1.0 1.6 0.8 0.8 0.8 0.7 0.8 0.6 1.0 0.5 0.6 0.8 0.7 0.4 0.4 0.5 0.4 0.3 0.2 0.2 0.0  
      College Students — — — — 0.0 0.8 0.4 0.9 0.3 0.8 0.6 0.2 0.1 0.6 0.2 0.3 0.2 0.3 0.1 0.3 0.2 0.1 0.5 0.1 0.0 0.0 0.3 0.1 -0.2
      Young Adults — — — — 0.3 0.4 0.4 0.7 0.6 0.5 0.9 0.2 0.4 0.3 0.4 0.5 0.3 0.4 0.6 0.4 0.2 0.4 0.7 0.3 0.5 0.4 0.3 0.1 -0.2
  than Heroin m,n
      8th Grade —  — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 3.5 3.3 3.6 3.8 4.7 5.4 6.2 6.3 6.7 7.0 6.7‡ 9.4 9.3 9.5 9.0 9.0 9.2 9.1 9.2 8.7 8.7 7.9 7.1 6.1 5.4 4.8 4.2 3.4 -0.8 s
      College Students 2.7 2.7 2.5 2.4 3.8 3.1 4.2 4.2 4.3 4.5 5.7‡ 7.4 8.7 8.2 8.4 8.8 7.7 6.5 7.6 7.2 6.2 5.4 5.4 4.8 3.3 3.8 3.1 2.7 -0.4
      Young Adults 2.5 2.5 2.2 2.5 3.0 2.9 3.3 3.4 3.8 4.1 5.0‡ 7.1 8.5 9.0 8.7 9.1 8.7 9.1 8.4 9.0 7.9 7.3 7.0 6.3 5.2 5.2 4.0 3.4 -0.7
  Cocaine other 
TABLE 2-2 (cont.)
(Table continued on next page.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2017–
2018
change
Heroin k,l
Narcotics other
  With a Needle l
  Without a Needle l
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — — — — 1.3 1.7 1.7 1.8 2.6 1.8 2.1 2.0 2.1 1.8 1.6 2.0 1.0 0.8 0.9 0.8 0.8 -0.1  
      10th Grade — — — — — — — — — — — 3.0 3.6 3.5 3.2 3.8 3.9 3.6 5.1 4.6 3.9 3.0 3.4 3.0 2.6 2.1 2.2 2.2 0.0  
      12th Grade — — — — — — — — — — — 4.0 4.5 5.0 5.5 4.3 5.2 4.7 4.9 5.1 4.9 4.3 3.6 3.3 3.7 3.4 2.7 2.3 -0.4  
      College Students — — — — — — — — — — — 1.5 2.2 2.5 2.1 3.0 2.8 3.6 5.0 2.3 2.4 1.2 2.3 1.3 1.5 1.9 1.7 1.6 -0.2
      Young Adults — — — — — — — — — — — 1.9 2.6 3.1 3.1 3.1 2.9 3.9 5.2 3.2 2.8 2.3 2.8 2.5 2.5 2.1 1.9 1.9 -0.1
      8th Grade — — — — — — — — — — — 2.5 2.8 2.5 2.6 3.0 2.7 2.9 2.5 2.7 2.1 1.3 1.4 1.0 0.9 0.8 0.7 0.6 -0.1  
      10th Grade — — — — — — — — — — — 6.9 7.2 6.2 5.9 7.0 7.2 6.7 8.1 7.7 5.9 4.4 4.6 3.4 2.5 1.7 1.5 1.1 -0.3  
      12th Grade — — — — — — — — — — — 9.6 10.5 9.3 9.5 9.7 9.6 9.7 9.7 8.0 8.1 7.5 5.3 4.8 4.4 2.9 2.0 1.7 -0.2  
      College Students — — — — — — — — — — — 6.9 7.5 7.4 9.6 7.6 6.7 6.7 8.4 4.9 5.8 3.8 4.4 2.8 1.6 1.3 1.1 1.5 +0.4
      Young Adults — — — — — — — — — — — 8.2 8.6 8.9 9.3 9.1 8.9 9.1 8.9 7.8 7.1 6.3 6.2 4.8 3.8 2.7 2.7 2.4 -0.2
      8th Grade 6.2 6.5 7.2 7.9 8.7 9.1 8.1 7.2 6.9 6.5 6.7 5.5 5.5 4.9 4.9 4.7 4.2 4.5 4.1 3.9 3.5 2.9‡ 4.2 4.3 4.1 3.5 3.5 3.7 +0.2  
      10th Grade 8.2 8.2 9.6 10.2 11.9 12.4 12.1 10.7 10.4 11.1 11.7 10.7 9.0 8.5 7.8 7.9 8.0 6.4 7.1 7.6 6.6 6.5‡ 7.9 7.6 6.8 6.1 5.6 5.7 0.0  
      12th Grade 8.2 7.1 8.4 9.4 9.3 9.5 10.2 10.1 10.2 10.5 10.9 11.1 9.9 10.0 8.6 8.1 7.5 6.8 6.6 7.4 8.2 7.9‡ 9.2 8.1 7.7 6.7 5.9 5.5 -0.4  
      College Students 3.9 3.6 4.2 4.2 5.4 4.2 5.7 5.1 5.8 6.6 7.2 7.0 7.1 7.0 6.7 6.0 6.9 5.7 7.5 9.0 9.3 11.1‡ 9.6 10.1 9.7 9.8 8.6 8.3 -0.2
      Young Adults 4.3 4.1 4.0 4.5 4.6 4.2 4.6 4.5 4.7 5.4 5.8 5.9 5.8 6.2 5.1 5.6 5.6 5.3 6.0 7.1 7.2 7.8‡ 7.5 8.0 7.9 7.2 7.8 7.5 -0.3
      8th Grade — — — — — — — — — — 2.9 2.8 2.6 2.5 2.4 2.6 2.1 1.6 1.8 1.5 1.3 0.7 1.1 0.9 0.6 0.8 0.4 0.5 +0.1  
      10th Grade — — — — — — — — — — 4.8 4.8 4.1 3.4 3.4 3.6 2.8 2.9 3.6 2.7 2.6 1.9 1.8 1.8 1.6 1.2 0.8 0.9 +0.1  
      12th Grade — — — — — — — — — — 5.1 4.0 4.0 5.1 4.4 4.4 3.8 3.4 2.1 2.7 2.6 2.6 2.3 1.8 2.0 1.2 1.3 0.9 -0.4  
      College Students — — — — — — — — — — — 5.7 4.7 4.7 4.2 3.9 3.7 3.2 1.7 1.9 2.3 1.8 3.6 1.6 2.0 2.4 1.4 1.3 -0.2
      Young Adults — — — — — — — — — — — 2.9 2.9 2.7 2.5 2.6 2.4 2.4 1.7 1.7 1.5 1.6 2.0 1.6 1.8 1.2 1.2 1.5 +0.3
      8th Grade — — — — — — — — — — — — — — — — — — 2.0 2.3 1.7 1.7 1.8 1.3 1.0 1.5 1.3 1.8 +0.5  
      10th Grade — — — — — — — — — — — — — — — — — — 5.7 5.3 4.6 4.5 4.4 4.6 5.2 4.2 4.0 4.1 +0.1  
      12th Grade — — — — — — — — — — — — — — — — — — 5.4 6.5 6.5 7.6 7.4 6.8 7.5 6.2 5.5 4.6 -1.0  
      College Students — — — — — — — — — — — — — — — — — — 10.2 9.0 9.8 9.0 10.7 9.6 10.7 9.9 9.4 11.0 +1.6
      Young Adults — — — — — — — — — — — — — — — — — — 5.8 7.0 6.6 7.4 7.0 7.8 7.7 7.2 8.3 9.1 +0.7
  Vicodin m,p,aa,bb
Amphetamines m,o
Adderall m,p,q,bb
  Ritalin m,p,q,bb
  OxyContin m,p,aa,bb
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — 3.2 2.5 2.8 2.2 2.5 1.5 1.8 1.8 1.1 1.2 1.0 1.2 0.8 1.0 1.0 0.6 0.5 0.4 0.5 0.4 -0.1  
      10th Grade — — — — — — — — 4.6 4.0 3.7 3.9 3.3 3.0 2.9 1.8 1.6 1.5 1.6 1.6 1.4 1.0 1.0 0.8 0.8 0.4 0.4 0.4 0.0  
      12th Grade — — — — — — — — 4.7 4.3 3.9 3.6 3.2 3.4 2.5 2.5 1.7 1.2 1.2 1.0 1.4 1.1 0.9 1.0 0.6 0.6 0.6 0.5 -0.1  
      College Students — — — — — — — — 3.3 1.6 2.4 1.2 2.6 2.9 1.7 1.2 0.4 0.5 0.3 0.4 0.2 0.0 0.4 0.1 0.5 0.0 0.4 0.4 -0.1
      Young Adults — — — — — — — — 2.8 2.5 2.8 2.5 2.7 2.8 2.4 1.9 1.5 1.0 0.9 0.7 0.5 1.0 0.6 0.5 0.7 0.4 0.6 1.2 +0.5
Crystal Methamphetamine (Ice) q
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.3 1.7 1.8 2.4 2.8 2.3 3.0 1.9 2.2 2.5 3.0 2.0 2.1 2.3 1.9 1.6 1.1 0.9 0.9 1.2 0.8 1.1 0.8 0.5 0.8 0.8 0.6 -0.2  
      College Students 0.1 0.2 0.7 0.8 1.1 0.3 0.8 1.0 0.5 0.5 0.6 0.8 0.9 1.1 1.4 0.6 0.7 0.1 0.1 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 -0.4
      Young Adults 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 1.3 1.5 1.6 1.1 1.1 0.8 0.8 0.5 0.5 0.6 0.8 0.3 0.5 0.1 0.7 0.4 -0.3
      8th Grade — — — — — — — — — — — — — — — — — — — — — 0.8 1.0 0.5 0.4 0.9 0.5 0.9 +0.3  
      10th Grade — — — — — — — — — — — — — — — — — — — — — 0.6 0.9 0.9 0.7 0.8 0.4 0.5 +0.1  
      12th Grade — — — — — — — — — — — — — — — — — — — — — 1.3 0.9 0.9 1.0 0.8 0.6 0.6 0.0  
      College Students — — — — — — — — — — — — — — — — — — — — — 0.3 0.1 0.2 0.1 0.0 0.2 0.0 -0.2
      Young Adults — — — — — — — — — — — — — — — — — — — — — 0.5 0.4 0.4 0.3 0.3 0.4 0.3 -0.1
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 3.4 2.8 3.4 4.1 4.7 4.9 5.1 5.5 5.8 6.2 5.7 6.7 6.0‡ 6.5 7.2 6.6 6.2 5.8 5.2 4.8 4.3 4.5 4.8 4.3 3.6 3.0 2.9 2.7 -0.3  
      College Students 1.2 1.4 1.5 1.2 2.0 2.3 3.0 2.5 3.2 3.7 3.8 3.7 4.1 4.2 3.9 3.4 3.6 3.7 3.1 2.5 1.7 2.2‡ 2.7 3.1 2.3 2.1 1.9 1.5 -0.4
      Young Adults 1.8 1.6 1.9 1.8 2.1 2.2 2.4 2.5 2.8 3.4 3.7 3.9 3.9 4.4 4.2 3.9 4.2 4.7 3.8 3.3 3.2 2.7‡ 3.4 3.2 2.7 2.6 2.2 2.5 +0.3
      8th Grade 1.8 2.0 2.1 2.4 2.7 3.3 2.9 2.6 2.5 2.6‡ 2.8 2.6 2.7 2.5 2.8 2.6 2.4 2.4 2.6 2.8 2.0 1.8 1.8 1.7 1.7 1.7 2.0 2.0 +0.1  
      10th Grade 3.2 3.5 3.3 3.3 4.0 4.6 4.9 5.1 5.4 5.6‡ 7.3 6.3 5.3 5.1 4.8 5.2 5.3 4.6 5.0 5.1 4.5 4.3 3.7 3.9 3.9 4.1 4.1 3.9 -0.2  
      12th Grade 3.6 2.8 3.5 3.7 4.4 4.6 4.7 5.5 5.8 5.7‡ 6.9 7.7 6.7 7.3 6.8 6.6 6.2 6.2 6.3 5.6 5.6 5.3 4.6 4.7 4.7 4.9 4.7 3.9 -0.8 s
      College Students 2.4 2.9 2.4 1.8 2.9 2.8 3.8 3.9 3.8 4.2‡ 5.1 6.7 6.9 6.7 6.4 5.8 5.5 5.0 5.4 4.9 4.2 3.4 4.4 3.5 4.3 4.9 3.6 3.5 -0.1
      Young Adults 3.5 3.4 3.1 2.9 3.4 3.2 3.1 3.8 3.7 4.6‡ 5.5 7.0 6.8 7.4 6.7 6.5 7.1 6.8 6.4 6.3 5.9 5.3 5.4 4.8 5.0 5.0 4.7 4.0 -0.7
Tranquilizers b,m
(Table continued on next page.)
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  Methamphetamine p,q
Sedatives
  (Barbiturates) m,r
Bath Salts (Synthetic stimulants) p,q,qq
40
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — 17.1 16.8 15.8 15.4 14.4 15.0 15.2 14.8‡ 15.9 13.9 12.9 12.0 10.9 9.9 -1.1  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Over-the-counter Cough/Cold
      8th Grade — — — — — — — — — — — — — — — 4.2 4.0 3.6 3.8 3.2 2.7 3.0 2.9 2.0 1.6 2.6 2.1 2.8 +0.7  
      10th Grade — — — — — — — — — — — — — — — 5.3 5.4 5.3 6.0 5.1 5.5 4.7 4.3 3.7 3.3 3.0 3.6 3.3 -0.3  
      12th Grade — — — — — — — — — — — — — — — 6.9 5.8 5.5 5.9 6.6 5.3 5.6 5.0 4.1 4.6 4.0 3.2 3.4 +0.2  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — 1.0 0.8 0.8 0.5 0.5 0.7 0.3 0.5 0.6 0.7 0.5 0.7 0.5 0.4 0.5 0.8 0.4 0.4 0.3 0.3 0.5 0.4 0.3 -0.1  
      10th Grade — — — — — 1.1 1.3 1.2 1.0 0.8 1.0 0.7 0.6 0.7 0.5 0.5 0.7 0.4 0.4 0.6 0.6 0.5 0.6 0.5 0.2 0.5 0.3 0.3 0.0  
      12th Grade — — — — — 1.1 1.2 1.4 1.0 0.8 0.9‡ 1.6 1.3 1.6 1.2 1.1 1.0 1.3 1.0 1.5 1.3 1.5 0.9 0.7 1.0 1.1 0.8 0.7 0.0  
      College Students — — — — — — — — — — — 0.7 0.4 0.3 0.1 0.2 0.1 0.3 0.0 — — — — — — — — — —
      Young Adults — — — — — — — — — — — 0.3 0.5 0.1 0.1 0.2 0.3 0.2 0.1 — — — — — — — — — —
GHB p,cc
      8th Grade — — — — — — — — — 1.2 1.1 0.8 0.9 0.7 0.5 0.8 0.7 1.1 0.7 0.6 0.6 — — — — — — — —
      10th Grade — — — — — — — — — 1.1 1.0 1.4 1.4 0.8 0.8 0.7 0.6 0.5 1.0 0.6 0.5 — — — — — — — —
      12th Grade — — — — — — — — — 1.9 1.6 1.5 1.4 2.0 1.1 1.1 0.9 1.2 1.1 1.4 1.4 1.4 1.0 1.0 0.7 0.9 0.4 0.3 -0.1  
      College Students — — — — — — — — — — — 0.6 0.3 0.7 0.4  * 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 — — — —
      Young Adults — — — — — — — — — — — 0.8 0.6 0.5 0.3 0.2 0.4 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.2 — — — —
Ketamine p,dd,rr
      8th Grade — — — — — — — — — 1.6 1.3 1.3 1.1 0.9 0.6 0.9 1.0 1.2 1.0 1.0 0.8 — — — — — — — —
      10th Grade — — — — — — — — — 2.1 2.1 2.2 1.9 1.3 1.0 1.0 0.8 1.0 1.3 1.1 1.2 — — — — — — — —
      12th Grade — — — — — — — — — 2.5 2.5 2.6 2.1 1.9 1.6 1.4 1.3 1.5 1.7 1.6 1.7 1.5 1.4 1.5 1.4 1.2 1.2 0.7 -0.4  
      College Students — — — — — — — — — — — 1.3 1.0 1.5 0.5 0.9 0.2 0.4 0.1 0.7 0.6 0.4 0.9 0.1 0.6 0.5 0.3 0.9 +0.6
      Young Adults — — — — — — — — — — — 1.2 0.9 0.6 0.5 0.5 0.3 0.4 0.5 0.8 0.5 0.8 0.5 0.4 0.7 0.7 0.5 0.9 +0.4
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2017–
2018
  Medicines p,q
Rohypnol u
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
change
(Table continued on next page.)
Any Prescription Drug o,t
41
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
  Any Use
      8th Grade 54.0 53.7‡ 45.4 46.8 45.3 46.5 45.5 43.7 43.5 43.1 41.9 38.7 37.2 36.7 33.9 33.6 31.8 32.1 30.3 29.3 26.9 23.6 22.1 20.8 21.0 17.6 18.2 18.7 +0.5  
      10th Grade 72.3 70.2‡ 63.4 63.9 63.5 65.0 65.2 62.7 63.7 65.3 63.5 60.0 59.3 58.2 56.7 55.8 56.3 52.5 52.8 52.1 49.8 48.5 47.1 44.0 41.9 38.3 37.7 37.8 +0.1  
      12th Grade 77.7 76.8‡ 72.7 73.0 73.7 72.5 74.8 74.3 73.8 73.2 73.3 71.5 70.1 70.6 68.6 66.5 66.4 65.5 66.2 65.2 63.5 63.5 62.0 60.2 58.2 55.6 55.7 53.3 -2.4  
      College Students 88.3 86.9 85.1 82.7 83.2 82.9 82.4 84.6 83.6 83.2 83.0 82.9 81.7 81.2 83.0 82.1 80.9 82.1 79.4 78.6 77.4 79.2 75.6 76.1 79.0 78.9 75.8 74.6 -1.2
      Young Adults 86.9 86.2 85.3 83.7 84.7 84.0 84.3 84.0 84.1 84.0 84.3 84.9 83.3 84.4 83.8 84.4 84.0 83.6 83.8 82.7 83.5 82.5 82.5 82.3 81.2 82.1 81.2 81.6 +0.4
      8th Grade 17.5 18.3 18.2 18.2 18.4 19.8 18.4 17.9 18.5 18.5 16.6 15.0 14.5 14.5 14.1 13.9 12.6 12.7 12.2 11.5 10.5 8.6 8.4 7.3 7.7 5.7 6.4 6.5 +0.1  
      10th Grade 40.1 37.0 37.8 38.0 38.5 40.1 40.7 38.3 40.9 41.6 39.9 35.4 34.7 35.1 34.2 34.5 34.4 30.0 31.2 29.9 28.8 28.2 27.1 24.6 23.4 20.5 20.4 20.9 +0.5  
      12th Grade 52.7 50.3 49.6 51.7 52.5 51.9 53.2 52.0 53.2 51.8 53.2 50.4 48.0 51.8 47.7 47.9 46.1 45.6 47.0 44.0 42.2 45.0 43.5 41.4 37.7 37.3 35.6 33.9 -1.7  
      College Students 69.1 67.3 65.6 63.1 62.1 64.2 66.8 67.0 65.4 64.7 68.8 66.0 64.7 67.1 64.2 66.2 64.8 66.8 61.5 63.8 60.1 61.5 57.9 60.5 61.6 60.7 58.0 59.2 +1.2
      Young Adults 62.0 60.9 61.1 58.8 61.6 59.9 63.2 59.6 63.2 60.6 63.1 61.8 62.9 63.8 63.5 65.7 65.8 66.0 65.5 64.8 64.0 64.6 63.1 63.5 61.2 61.0 60.9 62.6 +1.7
      8th Grade — — — — — — — — — — — — — 30.4 27.9 26.8 26.0 25.0 22.2 21.9 19.2 17.0 15.7 13.4 13.4 11.2 10.8 12.1 +1.3  
      10th Grade — — — — — — — — — — — — — 49.7 48.5 48.8 45.9 43.4 41.5 41.0 38.3 37.8 35.6 33.2 31.4 26.1 28.3 28.8 +0.5  
      12th Grade — — — — — — — — — — — — 55.2 55.8 58.4 54.7 53.6 51.8 53.4 47.9 47.0 44.4 44.2 43.6 42.8 40.0 39.6 38.4 -1.2  
      College Students — — — — — — — — — — — — — 63.2 67.0 63.5 62.6 65.0 66.1 60.3 63.0 58.1 57.6 64.2 64.5 68.5 60.3 58.4 -1.9
      Young Adults — — — — — — — — — — — — — 62.7 58.4 58.5 58.9 58.3 57.0 52.0 56.3 54.8 54.1 55.4 57.3 57.8 54.8 57.1 +2.3
    containing Caffeine p,w,ss
      8th Grade — — — — — — — — — — — — — — — — — — — — 11.8‡ 10.9 10.2 9.5 8.4 6.5 5.6 6.0 +0.4  
      10th Grade — — — — — — — — — — — — — — — — — — — — 22.5‡ 19.7 16.9 14.3 12.8 10.6 9.9 9.8 -0.1  
      12th Grade — — — — — — — — — — — — — — — — — — — — 26.4‡ 26.4 23.5 20.0 18.3 17.0 16.9 14.7 -2.2  
      College Students — — — — — — — — — — — — — — — — — — — — 33.6‡ 33.8 39.1 32.8 34.1 29.4 31.3 27.4 -3.9
      Young Adults — — — — — — — — — — — — — — — — — — — — 28.1‡ 36.7 36.9 35.0 33.5 29.6 31.8 29.9 -1.9
  Any Use
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      College Students 35.6 37.3 38.8 37.6 39.3 41.4 43.6 44.3 44.5 41.3 39.0 38.3 35.2 36.7 36.0 30.9 30.7 30.0 29.9 28.1 25.8 23.4 23.2 22.6 20.1 18.7 16.7 15.5 -1.3
      Young Adults 37.7 37.9 37.8 38.3 38.8 40.3 41.8 41.6 41.1 40.9 41.1 39.1 38.6 39.0 39.1 36.9 36.2 35.0 33.9 33.0 31.5 29.8 29.8 27.0 26.2 23.4 23.9 22.5 -1.4
Alcohol v
change
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2017–
2018
(Entries are percentages.)
    Beverages g,p,ee
Cigarettes
  Been Drunk w
  Flavored Alcoholic
  Alcoholic Beverages
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — — 17.1 18.5 18.3 21.4 22.9 19.8 13.0 10.1 7.8 -2.2  
      College Students — — — — — — — — — — — — — — — — — — — — 27.9 25.7 26.1 32.7 23.4 16.9 10.0 11.4 +1.4
      Young Adults — — — — — — — — — — — — — — — — — — — — 20.1 19.1 20.4 23.3 19.2 14.8 12.2 13.3 +1.2
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — — 23.1 19.5 19.9 20.4 18.9 15.9 15.6 13.3 9.2 -4.1 ss
      College Students — — — — — — — — — — — — — — — — — — — — 23.6 20.3 19.0 24.2 19.6 17.6 14.0 15.6 +1.6
      Young Adults — — — — — — — — — — — — — — — — — — — — 19.2 18.0 18.4 18.6 17.9 15.5 16.0 15.9 -0.1
      8th Grade — — — — — — — — — — — — — — — — — — — — — 1.0 1.1 1.1 0.9 0.7 0.6 0.6 -0.1  
      10th Grade — — — — — — — — — — — — — — — — — — — — — 1.6 1.2 1.3 1.1 0.9 0.6 1.1 +0.4  
      12th Grade — — — — — — — — — — — — — — — — — — — — 1.5 1.6 1.9 1.1 1.4 1.1 1.4 1.3 -0.1  
      College Students — — — — — — — — — — — — — — — — — — — — 0.0 0.3 0.2 0.5 1.1 0.3 0.7 0.0 -0.7
      Young Adults — — — — — — — — — — — — — — — — — — — — 0.3 0.6 0.3 0.5 0.4 0.5 0.8 0.4 -0.4
Snus p,s
      8th Grade — — — — — — — — — — — — — — — — — — — — — 2.4 2.0 2.2 1.9 2.2 1.1 1.3 +0.2  
      10th Grade — — — — — — — — — — — — — — — — — — — — — 6.9 5.2 4.5 4.0 3.0 2.6 3.1 +0.5  
      12th Grade — — — — — — — — — — — — — — — — — — — — 7.9 7.9 7.7 5.8 5.8 5.8 4.2 4.7 +0.6  
      College Students — — — — — — — — — — — — — — — — — — — — 6.5 4.7 4.8 5.0 5.8 3.3 4.3 1.0 -3.3
      Young Adults — — — — — — — — — — — — — — — — — — — — 6.1 5.7 4.8 4.8 4.8 3.6 4.6 3.8 -0.8
Any Vaping jj,uu,vv
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 13.3 17.6 +4.3 sss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 23.9 32.3 +8.5 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 27.8 37.3 +9.4 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 23.5 32.4 +8.9 s
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 23.0 27.3 +4.3 s
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
Dissolvable Tobacco p,s
TABLE 2-2 (cont.)
Small Cigars s
Tobacco using a Hookah s,ss,tt
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2017–
2018
change
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Vaping Nicotine jj,ww,xx
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 7.5 10.9 +3.4 sss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 15.8 24.7 +8.9 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 18.8 29.7 +10.9 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 13.0 25.6 +12.6 sss
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 14.4 18.2 +3.8 s
Vaping Marijuana jj,yy
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 3.0 4.4 +1.3 ss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 8.1 12.4 +4.2 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.5 13.1 +3.6 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 10.7 20.2 +9.4 ss
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 12.6 15.6 +3.1 s
Vaping Just Flavoring jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 11.8 15.1 +3.2 ss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 19.3 24.7 +5.4 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 20.6 25.7 +5.2 ss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 13.1 14.0 +0.9
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 9.9 9.9 0.0
      8th Grade 1.0 1.1 0.9 1.2 1.0 0.9 1.0 1.2 1.7 1.7 1.6 1.5 1.4 1.1 1.1 0.9 0.8 0.9 0.8 0.5 0.7 0.6 0.6 0.6 0.5 0.5 0.6 0.6 0.0  
      10th Grade 1.1 1.1 1.0 1.1 1.2 1.2 1.2 1.2 1.7 2.2 2.1 2.2 1.7 1.5 1.3 1.2 1.1 0.9 0.8 1.0 0.9 0.8 0.8 0.8 0.7 0.7 0.7 0.6 -0.1  
      12th Grade 1.4 1.1 1.2 1.3 1.5 1.4 1.4 1.7 1.8 1.7 2.4 2.5 2.1 2.5 1.5 1.8 1.4 1.5 1.5 1.5 1.2 1.3 1.5 1.5 1.7 1.0 1.1 1.1 +0.1  
      College Students 0.6 0.2 0.9 0.2 0.4 0.2 0.7 0.2 0.9 0.1 0.6 0.5 0.3 0.6 0.5 0.8 0.6 0.1 0.7 0.3 0.2 0.3 0.8 0.5 0.3 0.0 0.6 0.0 -0.6
      Young Adults 0.5 0.4 0.3 0.4 0.5 0.3 0.5 0.4 0.6 0.4 0.4 0.4 0.5 0.5 0.5 0.3 0.7 0.4 0.7 0.8 0.2 0.4 0.5 0.7 0.5 0.4 0.3 0.4 +0.1
Previously surveyed drugs that have been dropped
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.9 0.5 0.9 1.1 1.1 1.6 1.2 1.4 0.9 0.6 0.6 1.1 0.9 0.8 0.6 0.5 0.8 0.6 0.9 — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 0.2 0.1 0.4 0.3 — — — — — — — — — — — — — — — — — — — — — — — — —
(Entries are percentages.)
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2018
Nitrites e
Steroids y,z
change
2017–
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — — — — 1.8 1.3 1.5 — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — 0.2 0.0 0.2 — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — 0.5 0.5 0.3 — — — — — — — —
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.5 0.6 0.2 0.8 0.7 1.1 1.0 1.1 1.1 0.3 0.8 0.9 0.6 0.8 0.9 0.8 0.5 0.5 0.6 0.3 0.3 0.4 — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — 3.9 2.7 2.7 2.0 1.7 1.6 — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — 6.4 4.9 3.1 2.8 2.1 1.6 — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — 9.2 7.0 5.9 4.0 3.6 3.3 2.3 1.7 1.9 1.5 1.4 — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Kreteks p,ff
      8th Grade — — — — — — — — — — 2.6 2.6 2.0 1.9 1.4 — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — 6.0 4.9 3.8 3.7 2.8 — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — 10.1 8.4 6.7 6.5 7.1 6.2 6.8 6.8 5.5 4.6 2.9 3.0 1.6 1.6 — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.  The Monitoring the Future study, the University of Michigan.  
See footnotes following Table 2-4.
(Entries are percentages.)
2017–
2018
change
Methaqualone m,s
Provigil m,q
Bidis p,ff
TABLE 2-2 (cont.)
Trends in Annual Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
45
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 5.7 6.8 8.4 10.9 12.4 14.6 12.9 12.1 12.2 11.9 11.7 10.4 9.7 8.4 8.5 8.1 7.4 7.6 8.1 9.5 8.5 7.7‡ 8.7 8.3 8.1 6.9 7.0 7.3 +0.3  
      10th Grade 11.6 11.0 14.0 18.5 20.2 23.2 23.0 21.5 22.1 22.5 22.7 20.8 19.5 18.3 17.3 16.8 16.9 15.8 17.8 18.5 19.2 18.6‡ 19.2 18.5 16.5 15.9 17.2 18.3 +1.0  
      12th Grade 16.4 14.4 18.3 21.9 23.8 24.6 26.2 25.6 25.9 24.9 25.7 25.4 24.1 23.4 23.1 21.5 21.9 22.3 23.3 23.8 25.2 25.2‡ 25.2 23.7 23.6 24.4 24.9 24.0 -0.9  
      College Students 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6 21.5 21.9 21.5 21.4 21.2 19.5 19.2 19.3 18.9 20.7 19.2 21.4 22.3‡ 22.8 22.7 23.4 24.3 23.3 26.3 +3.0
      Young Adults 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 18.5 18.9 19.3 19.8 18.9 20.6 19.9‡ 21.6 22.3 23.2 23.5 24.7 25.9 +1.1
      8th Grade 3.8 4.7 5.3 5.6 6.5 6.9 6.0 5.5 5.5 5.6‡ 5.5 4.7 4.7 4.1 4.1 3.8 3.6 3.8 3.5 3.5 3.4 2.6‡ 3.6 3.3 3.1 2.7 2.7 3.0 +0.3  
      10th Grade 5.5 5.7 6.5 7.1 8.9 8.9 8.8 8.6 8.6 8.5‡ 8.7 8.1 6.9 6.9 6.4 6.3 6.9 5.3 5.7 5.8 5.4 5.0‡ 4.9 5.6 4.9 4.4 4.5 4.2 -0.3  
      12th Grade 7.1 6.3 7.9 8.8 10.0 9.5 10.7 10.7 10.4 10.4‡ 11.0 11.3 10.4 10.8 10.3 9.8 9.5 9.3 8.6 8.6 8.9 8.4‡ 8.2 7.7 7.6 6.9 6.3 6.0 -0.3  
      College Students 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4 6.9‡ 7.5 7.8 8.2 9.1 8.2 8.2 8.1 7.3 8.4 8.1 8.2 7.8‡ 8.8 10.0 9.2 8.4 7.0 7.6 +0.6
      Young Adults 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4‡ 7.0 7.7 8.3 8.5 8.2 8.1 8.6 8.9 8.5 8.6 8.4 7.8‡ 8.3 9.9 8.7 9.2 8.7 8.0 -0.6
      8th Grade 8.8 10.0 12.0 14.3 16.1 17.5 16.0 14.9 15.1 14.4 14.0 12.6 12.1 11.2 11.2 10.9 10.1 10.4 10.6 11.7 10.5 9.5‡ 10.0 9.5 9.3 7.9 8.6 8.3 -0.4  
      10th Grade 13.1 12.6 15.5 20.0 21.6 24.5 24.1 22.5 23.1 23.6 23.6 21.7 20.5 19.3 18.4 17.7 18.1 16.8 18.8 19.4 20.1 19.3‡ 20.0 19.1 17.1 16.4 18.0 18.7 +0.8  
      12th Grade 17.8 15.5 19.3 23.0 24.8 25.5 26.9 26.6 26.4 26.4 26.5 25.9 24.6 23.3 24.2 22.1 22.8 22.8 24.1 24.5 26.2 25.2‡ 26.5 24.3 24.7 24.6 25.7 25.0 -0.6  
      College Students 15.1 16.5 15.7 16.4 19.6 18.0 19.6 21.0 21.8 22.6 21.9 21.9 21.6 21.7 19.0 19.7 18.1 18.9 21.3 20.5 20.6 20.0‡ 23.5 21.1 23.3 24.1 23.4 26.9 +3.6
      Young Adults 15.4 15.3 15.1 16.1 16.1 16.4 16.9 16.7 17.4 18.8 19.2 19.5 20.1 19.6 18.0 18.4 19.1 19.3 20.3 19.6 20.3 19.1‡ 23.5 20.9 22.7 23.2 24.4 25.9 +1.5
      8th Grade 3.2 3.7 5.1 7.8 9.1 11.3 10.2 9.7 9.7 9.1 9.2 8.3 7.5 6.4 6.6 6.5 5.7 5.8 6.5 8.0 7.2 6.5 7.0 6.5 6.5 5.4 5.5 5.6 +0.1  
      10th Grade 8.7 8.1 10.9 15.8 17.2 20.4 20.5 18.7 19.4 19.7 19.8 17.8 17.0 15.9 15.2 14.2 14.2 13.8 15.9 16.7 17.6 17.0 18.0 16.6 14.8 14.0 15.7 16.7 +0.9  
      12th Grade 13.8 11.9 15.5 19.0 21.2 21.9 23.7 22.8 23.1 21.6 22.4 21.5 21.2 19.9 19.8 18.3 18.8 19.4 20.6 21.4 22.6 22.9 22.7 21.2 21.3 22.5 22.9 22.2 -0.7  
      College Students 14.1 14.6 14.2 15.1 18.6 17.5 17.7 18.6 20.7 20.0 20.2 19.7 19.3 18.9 17.1 16.7 16.8 17.0 18.5 17.5 19.4 20.5 20.6 20.8 21.1 22.2 21.2 24.7 +3.5
      Young Adults 13.5 13.3 13.4 14.1 14.0 15.1 15.0 14.9 15.6 16.1 16.7 16.9 17.3 16.5 15.8 15.7 16.0 16.0 17.0 16.1 18.3 17.7 19.0 19.2 20.1 21.6 23.0 24.1 +1.1
      8th Grade 4.4 4.7 5.4 5.6 6.1 5.8 5.6 4.8 5.0 4.5 4.0 3.8 4.1 4.5 4.2 4.1 3.9 4.1 3.8 3.6 3.2 2.7 2.3 2.2 2.0 1.8 2.1 1.8 -0.4  
      10th Grade 2.7 2.7 3.3 3.6 3.5 3.3 3.0 2.9 2.6 2.6 2.4 2.4 2.2 2.4 2.2 2.3 2.5 2.1 2.2 2.0 1.7 1.4 1.3 1.1 1.2 1.0 1.1 1.0 -0.1  
      12th Grade 2.4 2.3 2.5 2.7 3.2 2.5 2.5 2.3 2.0 2.2 1.7 1.5 1.5 1.5 2.0 1.5 1.2 1.4 1.2 1.4 1.0 0.9 1.0 0.7 0.7 0.8 0.8 0.7 -0.2  
      College Students 0.9 1.1 1.3 0.6 1.6 0.8 0.8 0.6 1.5 0.9 0.4 0.7 0.4 0.4 0.3 0.4 0.1 0.4 0.1 0.5 0.3 0.2 0.1 0.3 0.2 0.0 0.9 0.2 -0.7
      Young Adults 0.5 0.6 0.7 0.5 0.7 0.5 0.5 0.7 0.8 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.4 0.2 0.1 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.3 -0.1
2018
TABLE 2-3
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2017–
(Entries are percentages.)
change
Any Illicit Drug a
Any Illicit Drug other
  than Marijuana a,b
Any Illicit Drug
  including
  Inhalants a,c,d
Marijuana/Hashish zz
Inhalants c,d
(Table continued on next page.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 0.8 1.1 1.2 1.3 1.7 1.9 1.8 1.4 1.3 1.2‡ 1.6 1.2 1.2 1.0 1.1 0.9 1.0 0.9 0.9 1.0 1.0 0.6 0.8 0.5 0.6 0.6 0.5 0.6 +0.1
      10th Grade 1.6 1.8 1.9 2.4 3.3 2.8 3.3 3.2 2.9 2.3‡ 2.1 1.6 1.5 1.6 1.5 1.5 1.7 1.3 1.4 1.6 1.4 1.2 1.1 1.2 0.9 0.9 1.1 0.8 -0.3
      12th Grade 2.2 2.1 2.7 3.1 4.4 3.5 3.9 3.8 3.5 2.6‡ 3.3 2.3 1.8 1.9 1.9 1.5 1.7 2.2 1.6 1.9 1.6 1.6 1.4 1.5 1.6 1.4 1.6 1.4 -0.1
      College Students 1.2 2.3 2.5 2.1 3.3 1.9 2.1 2.1 2.0 1.4‡ 1.8 1.2 1.8 1.3 1.2 0.9 1.3 1.7 1.0 1.4 1.2 1.1 1.0 1.0 1.4 0.8 1.2 1.1 -0.1
      Young Adults 1.1 1.5 1.2 1.4 1.7 1.2 1.5 1.4 1.3 1.2‡ 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 1.0 0.9 0.6 1.0 0.9 1.1 0.8 0.9 1.2 +0.3
      8th Grade 0.6 0.9 1.0 1.1 1.4 1.5 1.5 1.1 1.1 1.0 1.0 0.7 0.6 0.5 0.5 0.4 0.5 0.5 0.5 0.6 0.5 0.3 0.5 0.3 0.4 0.4 0.3 0.4 +0.1
      10th Grade 1.5 1.6 1.6 2.0 3.0 2.4 2.8 2.7 2.3 1.6 1.5 0.7 0.6 0.6 0.6 0.7 0.7 0.7 0.5 0.7 0.7 0.5 0.6 0.6 0.6 0.7 0.8 0.5 -0.3 s
      12th Grade 1.9 2.0 2.4 2.6 4.0 2.5 3.1 3.2 2.7 1.6 2.3 0.7 0.6 0.7 0.7 0.6 0.6 1.1 0.5 0.8 0.8 0.8 0.8 1.0 1.1 1.0 1.2 1.0 -0.2
      College Students 0.8 1.8 1.6 1.8 2.5 0.9 1.1 1.5 1.2 0.9 1.0 0.2 0.2 0.2 0.1 0.3 0.3 0.8 0.3 0.7 0.5 0.4 0.4 0.5 0.7 0.4 0.8 1.0 +0.1
      Young Adults 0.8 1.1 0.8 1.1 1.3 0.7 0.9 1.0 0.8 0.8 0.7 0.3 0.2 0.1 0.1 0.2 0.2 0.4 0.2 0.4 0.3 0.3 0.4 0.4 0.7 0.6 0.6 0.8 +0.2
      8th Grade 0.3 0.4 0.5 0.7 0.8 0.9 0.7 0.7 0.6 0.6‡ 1.1 1.0 1.0 0.8 0.9 0.7 0.7 0.7 0.7 0.8 0.7 0.5 0.5 0.4 0.3 0.3 0.3 0.4 +0.1
      10th Grade 0.4 0.5 0.7 1.0 1.0 1.0 1.2 1.4 1.2 1.2‡ 1.4 1.4 1.2 1.4 1.3 1.3 1.4 1.0 1.1 1.2 1.1 0.9 0.8 0.8 0.6 0.5 0.6 0.5 -0.1
      12th Grade 0.7 0.5 0.8 1.2 1.3 1.6 1.7 1.6 1.6 1.7‡ 1.9 2.0 1.5 1.7 1.6 1.3 1.4 1.6 1.4 1.5 1.2 1.3 1.0 1.0 0.9 0.7 1.0 0.9 -0.1
      College Students 0.6 0.7 1.1 0.8 1.6 1.2 1.2 0.7 1.2 0.8‡ 0.8 1.1 1.7 1.2 1.1 0.7 1.1 1.3 0.8 1.2 0.8 0.7 0.8 0.7 0.9 0.5 0.6 0.4 -0.2
      Young Adults 0.3 0.5 0.6 0.6 0.6 0.6 0.7 0.5 0.6 0.7‡ 0.6 0.8 1.2 0.9 0.8 0.6 0.8 0.7 0.7 0.8 0.6 0.4 0.7 0.6 0.5 0.3 0.6 0.6 +0.1
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.5 0.6 1.0 0.7 0.6 1.3 0.7 1.0 0.8 0.9 0.5 0.4 0.6 0.4 0.7 0.4 0.5 0.6 0.5 0.8 0.8 0.5 0.4 — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults 0.1 0.2 0.2 0.1 * 0.1 0.1 0.2 0.2 * * 0.1 0.1 0.1 * * * 0.1 * 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.4 +0.3
      8th Grade, original — — — — — 1.0 1.0 0.9 0.8 1.4 1.8 1.4 0.7 0.8 0.6 0.7 0.6 0.8 0.6 1.1 0.6 0.5 0.5 0.4 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 0.7 0.5 0.3 0.4 0.4 +0.1
      10th Grade, original — — — — — 1.8 1.3 1.3 1.8 2.6 2.6 1.8 1.1 0.8 1.0 1.2 1.2 1.1 1.3 1.9 1.6 1.0 1.2 0.8 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.1 0.9 0.5 0.5 0.4 -0.1
      12th Grade, original — — — — — 2.0 1.6 1.5 2.5 3.6 2.8 2.4 1.3 1.2 1.0 1.3 1.6 1.8 1.8 1.4 2.3 0.9 1.5 1.4 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.5 1.1 0.9 0.9 0.5 -0.4 s
      College Students
Original 0.2 0.4 0.3 0.2 0.7 0.7 0.8 0.8 2.1 2.5 1.5 0.7 1.0 0.7 0.8 0.6 0.4 0.6 0.5 1.0 0.7 1.4 0.8 1.4 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.0 0.7 1.0 0.5 1.3 +0.8
      Young Adults
Original 0.1 0.3 0.3 0.2 0.4 0.3 0.6 0.8 1.3 1.9 1.8 1.3 0.8 0.6 0.6 0.7 0.5 0.6 0.6 0.8 0.7 1.0 1.1 1.3 — — — — —
Revised — — — — — — — — — — — — — — — — — — — — — — — 1.4 0.8 1.3 0.8 1.1 +0.3
Hallucinogens b,f
  LSD b
(Table continued on next page.)
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
2017–
 Hallucinogens
2018
change
    other than LSD b
  PCP g
  Ecstasy (MDMA) h
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 0.5 0.7 0.7 1.0 1.2 1.3 1.1 1.4 1.3 1.2 1.2 1.1 0.9 0.9 1.0 1.0 0.9 0.8 0.8 0.6 0.8 0.5 0.5 0.5 0.5 0.3 0.4 0.3 -0.1  
      10th Grade 0.7 0.7 0.9 1.2 1.7 1.7 2.0 2.1 1.8 1.8 1.3 1.6 1.3 1.7 1.5 1.5 1.3 1.2 0.9 0.9 0.7 0.8 0.8 0.6 0.8 0.4 0.5 0.6 +0.1  
      12th Grade 1.4 1.3 1.3 1.5 1.8 2.0 2.3 2.4 2.6 2.1 2.1 2.3 2.1 2.3 2.3 2.5 2.0 1.9 1.3 1.3 1.1 1.1 1.1 1.0 1.1 0.9 1.2 1.1 0.0  
      College Students 1.0 1.0 0.7 0.6 0.7 0.8 1.6 1.6 1.2 1.4 1.9 1.6 1.9 2.4 1.8 1.8 1.7 1.2 1.3 1.0 1.2 1.1 0.9 1.8 1.5 1.4 1.3 2.2 +0.9
      Young Adults 2.0 1.8 1.4 1.3 1.5 1.2 1.6 1.7 1.9 1.7 2.2 2.2 2.4 2.2 2.2 2.3 2.1 1.9 1.8 1.4 1.5 1.3 1.5 1.8 1.7 1.8 1.9 2.1 +0.2
      8th Grade 0.3 0.5 0.4 0.7 0.7 0.8 0.7 0.9 0.8 0.8 0.8 0.8 0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.4 0.5 0.3 0.3 0.3 0.3 0.2 0.3 0.2 -0.1  
      10th Grade 0.3 0.4 0.5 0.6 0.9 0.8 0.9 1.1 0.8 0.9 0.7 1.0 0.7 0.8 0.7 0.7 0.5 0.5 0.4 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.3 0.3 -0.1  
      12th Grade 0.7 0.6 0.7 0.8 1.0 1.0 0.9 1.0 1.1 1.0 1.1 1.2 0.9 1.0 1.0 0.9 0.9 0.8 0.6 0.7 0.5 0.6 0.6 0.7 0.6 0.5 0.6 0.5 -0.1  
      College Students 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.1 0.3 0.4 0.4 0.1 * 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.2 +0.2  
      Young Adults 0.4 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.2 +0.1
    than Crack j
      8th Grade 0.5 0.5 0.6 0.9 1.0 1.0 0.8 1.0 1.1 0.9 0.9 0.8 0.7 0.7 0.7 0.7 0.6 0.6 0.7 0.5 0.6 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.0  
      10th Grade 0.6 0.6 0.7 1.0 1.4 1.3 1.6 1.8 1.6 1.6 1.2 1.3 1.1 1.5 1.3 1.3 1.1 1.0 0.8 0.7 0.6 0.7 0.7 0.5 0.7 0.3 0.4 0.5 +0.2  
      12th Grade 1.2 1.0 1.2 1.3 1.3 1.6 2.0 2.0 2.5 1.7 1.8 1.9 1.8 2.2 2.0 2.4 1.7 1.7 1.1 1.1 1.0 1.0 0.9 0.9 1.1 0.6 1.1 1.0 -0.1  
      College Students 1.0 0.9 0.6 0.3 0.8 0.6 1.3 1.5 1.0 0.9 1.5 1.4 1.9 2.2 1.8 1.3 1.6 1.1 1.2 1.0 1.2 1.3 0.9 1.8 1.4 1.7 1.1 1.9 +0.9
      Young Adults 1.8 1.7 1.1 1.0 1.3 1.1 1.5 1.5 1.6 1.5 1.8 2.0 2.1 2.1 1.9 1.9 2.0 1.7 1.6 1.5 1.4 1.3 1.3 1.8 1.6 2.0 1.9 2.3 +0.4
      8th Grade 0.3 0.4 0.4 0.6 0.6 0.7 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.4 0.4 0.2 0.3 0.3 0.1 0.2 0.2 0.1 -0.1  
      10th Grade 0.2 0.2 0.3 0.4 0.6 0.5 0.6 0.7 0.7 0.5 0.3 0.5 0.3 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.2 0.2 0.1 0.1 0.0  
      12th Grade 0.2 0.3 0.2 0.3 0.6 0.5 0.5 0.5 0.5 0.7 0.4 0.5 0.4 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.2 0.3 0.2 -0.1  
      College Students 0.1 * * * 0.1 * 0.2 0.1 0.1 0.2 0.1 *  * 0.1 0.1 0.2 0.1  * 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0
      Young Adults * 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 * 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.3 0.2 0.2 -0.1
      8th Grade —  — — — 0.4 0.5 0.4 0.5 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 -0.1  
      10th Grade — — — — 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.1 0.0  
      12th Grade — — — — 0.3 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.4 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 +0.0  
      College Students — — — — * * 0.1 * 0.1 0.1 * * 0.1 0.1 0.1 0.1 * 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0
      Young Adults — — — — * * 0.1 * 0.1 * 0.2 *  * 0.1 0.1 0.1 *  * 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.3 0.1 0.1 0.0
change
(Table continued on next page.)
2017–
2018
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
(Entries are percentages.)
TABLE 2-3 (cont.)
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
Cocaine
  Crack i
  Cocaine other 
Heroin k,l
  With a Needle l
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade —  — — — 0.3 0.4 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 -0.1  
      10th Grade — — — — 0.3 0.3 0.4 0.5 0.5 0.4 0.2 0.4 0.2 0.3 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0  
      12th Grade — — — — 0.6 0.4 0.6 0.4 0.4 0.7 0.3 0.5 0.4 0.3 0.5 0.3 0.4 0.2 0.3 0.4 0.4 0.2 0.2 0.4 0.3 0.1 0.2 0.1 0.0  
      College Students — — — — * 0.1 0.2 0.2 0.3 0.4 0.3 * * 0.3 * 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 -0.1
      Young Adults — — — — 0.1 * 0.1 0.2 0.2 0.2 0.4 * 0.1 0.1 0.1 0.3 0.2  * 0.3 0.1 0.1 0.1 0.4 0.1 0.2 0.3 0.2 0.0 -0.1
  than Heroin m,n
      8th Grade —  — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.1 1.2 1.3 1.5 1.8 2.0 2.3 2.4 2.6 2.9 3.0‡ 4.0 4.1 4.3 3.9 3.8 3.8 3.8 4.1 3.6 3.6 3.0 2.8 2.2 2.1 1.7 1.6 1.1 -0.5 ss
      College Students 0.6 1.0 0.7 0.4 1.2 0.7 1.3 1.1 1.0 1.7 1.7‡ 3.2 2.3 3.0 3.1 3.1 2.2 2.3 2.7 2.3 2.1 2.2 1.5 1.2 1.3 1.1 0.7 1.0 +0.3
      Young Adults 0.6 0.7 0.7 0.6 0.9 0.7 0.9 0.9 1.2 1.4 1.7‡ 2.9 2.9 3.0 3.5 3.2 3.4 3.6 3.2 3.4 2.9 2.7 2.6 2.1 1.8 1.9 1.1 0.9 -0.2
      8th Grade 2.6 3.3 3.6 3.6 4.2 4.6 3.8 3.3 3.4 3.4 3.2 2.8 2.7 2.3 2.3 2.1 2.0 2.2 1.9 1.8 1.8 1.3‡ 2.3 2.1 1.9 1.7 1.7 1.8 +0.1  
      10th Grade 3.3 3.6 4.3 4.5 5.3 5.5 5.1 5.1 5.0 5.4 5.6 5.2 4.3 4.0 3.7 3.5 4.0 2.8 3.3 3.3 3.1 2.8‡ 3.3 3.7 3.1 2.7 2.5 2.4 0.0  
      12th Grade 3.2 2.8 3.7 4.0 4.0 4.1 4.8 4.6 4.5 5.0 5.6 5.5 5.0 4.6 3.9 3.7 3.7 2.9 3.0 3.3 3.7 3.3‡ 4.2 3.8 3.2 3.0 2.6 2.4 -0.2  
      College Students 1.0 1.1 1.5 1.5 2.2 0.9 2.1 1.7 2.3 2.9 3.3 3.0 3.1 3.2 2.9 2.5 3.1 2.8 3.4 4.1 4.5 4.6‡ 5.0 4.8 4.2 3.8 3.6 2.9 -0.8
      Young Adults 1.5 1.5 1.5 1.7 1.7 1.5 1.7 1.7 1.9 2.3 2.4 2.5 2.5 2.4 2.1 2.2 2.3 2.2 2.5 2.9 3.0 3.2‡ 3.0 3.5 3.1 2.9 3.1 2.7 -0.4
      8th Grade — — — — — — — — 1.1 0.8 1.3 1.1 1.2 0.6 0.7 0.6 0.6 0.7 0.5 0.7 0.4 0.5 0.4 0.2 0.3 0.3 0.2 0.1 -0.1  
      10th Grade — — — — — — — — 1.8 2.0 1.5 1.8 1.4 1.3 1.1 0.7 0.4 0.7 0.6 0.7 0.5 0.6 0.4 0.3 0.3 0.2 0.1 0.1 0.0  
      12th Grade — — — — — — — — 1.7 1.9 1.5 1.7 1.7 1.4 0.9 0.9 0.6 0.6 0.5 0.5 0.6 0.5 0.4 0.5 0.4 0.3 0.3 0.3 0.0  
      College Students — — — — — — — — 1.2 0.2 0.5 0.2 0.6 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 +0.4
      Young Adults — — — — — — — — 0.8 0.7 1.0 1.0 0.7 0.6 0.7 0.5 0.6 0.3 0.3 0.2 0.3 0.4 0.2 0.3 0.0 0.2 0.2 0.0 -0.2
Crystal Methamphetamine (Ice) q
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.6 0.5 0.6 0.7 1.1 1.1 0.8 1.2 0.8 1.0 1.1 1.2 0.8 0.8 0.9 0.7 0.6 0.6 0.5 0.6 0.6 0.4 0.8 0.4 0.3 0.4 0.5 0.4 -0.1  
      College Students * * 0.3 0.5 0.3 0.1 0.2 0.3 * * 0.1 * 0.3 0.1 0.2 * 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 -0.4
      Young Adults * 0.1 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.4 0.1 0.3 0.1 0.4 0.3 -0.1
Amphetamines m,o
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
2017–
2018
change
  Methamphetamine p,q
  Without a Needle l
Narcotics other
(Table continued on next page.)
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.1 1.3 1.7 2.2 2.1 2.1 2.6 2.6 3.0 2.8 3.2 2.9‡ 2.9 3.3 3.0 2.7 2.8 2.5 2.2 1.8 2.0 2.2 2.0 1.7 1.5 1.4 1.2 -0.2  
      College Students 0.3 0.7 0.4 0.4 0.5 0.8 1.2 1.1 1.1 1.1 1.5 1.7 1.7 1.5 1.3 1.3 1.4 1.4 1.2 0.6 0.8 0.8‡ 0.9 0.7 1.0 0.9 0.5 0.5 0.0
      Young Adults 0.5 0.5 0.6 0.6 0.8 0.8 0.9 0.9 1.1 1.3 1.7 1.5 1.5 1.8 1.7 1.5 1.6 1.9 1.2 1.1 1.1 1.1‡ 1.2 1.0 0.9 1.1 0.6 0.9 +0.3
      8th Grade 0.8 0.8 0.9 1.1 1.2 1.5 1.2 1.2 1.1 1.4‡ 1.2 1.2 1.4 1.2 1.3 1.3 1.1 1.2 1.2 1.2 1.0 0.8 0.9 0.8 0.8 0.8 0.7 0.9 +0.1  
      10th Grade 1.2 1.5 1.1 1.5 1.7 1.7 2.2 2.2 2.2 2.5‡ 2.9 2.9 2.4 2.3 2.3 2.4 2.6 1.9 2.0 2.2 1.9 1.7 1.6 1.6 1.7 1.5 1.5 1.3 -0.2  
      12th Grade 1.4 1.0 1.2 1.4 1.8 2.0 1.8 2.4 2.5 2.6‡ 2.9 3.3 2.8 3.1 2.9 2.7 2.6 2.6 2.7 2.5 2.3 2.1 2.0 2.1 2.0 1.9 2.0 1.3 -0.7 ss
      College Students 0.6 0.6 0.4 0.4 0.5 0.7 1.2 1.3 1.1 2.0‡ 1.5 3.0 2.8 2.7 2.2 2.1 1.8 1.6 2.2 1.3 1.6 1.1 1.2 1.7 1.6 1.8 0.9 1.1 +0.2
      Young Adults 0.9 1.0 1.0 0.8 1.1 0.7 1.1 1.2 1.3 1.8‡ 2.1 2.8 2.4 2.7 2.6 2.3 2.8 2.7 2.8 2.2 2.3 1.9 1.9 1.9 1.7 1.9 1.4 1.3 -0.1
Any Prescription Drug o,t
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — 8.6 8.1 7.8 7.2 7.3 6.9 7.2 7.0‡ 7.1 6.4 5.9 5.4 4.9 4.2 -0.6  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — 0.5 0.3 0.4 0.3 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.6 0.1 0.1 0.2 0.1 0.2 0.1 0.3 +0.1  
      10th Grade — — — — — 0.5 0.5 0.4 0.5 0.4 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.1 0.3 0.0 0.1 0.0  
      12th Grade — — — — — 0.5 0.3 0.3 0.3 0.4 0.3 — — — — — — — — — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
  Any Use
      8th Grade 25.1 26.1‡ 24.3 25.5 24.6 26.2 24.5 23.0 24.0 22.4 21.5 19.6 19.7 18.6 17.1 17.2 15.9 15.9 14.9 13.8 12.7 11.0 10.2 9.0 9.7 7.3 8.0 8.2 +0.2  
      10th Grade 42.8 39.9‡ 38.2 39.2 38.8 40.4 40.1 38.8 40.0 41.0 39.0 35.4 35.4 35.2 33.2 33.8 33.4 28.8 30.4 28.9 27.2 27.6 25.7 23.5 21.5 19.9 19.7 18.6 -1.1  
      12th Grade 54.0 51.3‡ 48.6 50.1 51.3 50.8 52.7 52.0 51.0 50.0 49.8 48.6 47.5 48.0 47.0 45.3 44.4 43.1 43.5 41.2 40.0 41.5 39.2 37.4 35.3 33.2 33.2 30.2 -3.0 s
      College Students 74.7 71.4 70.1 67.8 67.5 67.0 65.8 68.1 69.6 67.4 67.0 68.9 66.2 67.7 67.9 65.4 66.6 69.0 65.8 65.0 63.5 67.7 63.1 63.1 63.2 63.2 62.0 59.6 -2.4
      Young Adults 70.6 69.0 68.3 67.7 68.1 66.7 67.5 66.9 68.2 66.8 67.0 68.3 67.0 68.4 68.6 68.7 69.5 68.9 69.4 68.4 68.8 69.5 68.7 68.4 66.9 68.4 67.1 66.0 -1.2
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
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(Table continued on next page.)
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2018
change
50
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade 7.6 7.5 7.8 8.7 8.3 9.6 8.2 8.4 9.4 8.3 7.7 6.7 6.7 6.2 6.0 6.2 5.5 5.4 5.4 5.0 4.4 3.6 3.5 2.7 3.1 1.8 2.2 2.1 -0.2  
      10th Grade 20.5 18.1 19.8 20.3 20.8 21.3 22.4 21.1 22.5 23.5 21.9 18.3 18.2 18.5 17.6 18.8 18.1 14.4 15.5 14.7 13.7 14.5 12.8 11.2 10.3 9.0 8.9 8.4 -0.5  
      12th Grade 31.6 29.9 28.9 30.8 33.2 31.3 34.2 32.9 32.9 32.3 32.7 30.3 30.9 32.5 30.2 30.0 28.7 27.6 27.4 26.8 25.0 28.1 26.0 23.5 20.6 20.4 19.1 17.5 -1.6  
      College Students 45.0 45.0 43.8 42.8 37.9 40.3 46.4 44.3 44.6 43.9 44.7 44.4 40.4 47.4 43.1 47.6 46.8 45.3 42.4 43.6 39.9 40.1 40.2 42.6 38.4 40.8 34.8 37.8 +3.0
      Young Adults 35.4 35.6 34.2 34.3 33.0 33.2 35.6 34.2 37.7 35.7 36.8 37.1 37.8 39.0 39.0 42.1 41.4 40.7 40.5 39.4 39.5 39.1 37.7 39.3 34.2 36.6 36.1 35.9 -0.1
  Flavored Alcoholic
    Beverages g,p
      8th Grade — — — — — — — — — — — — — 14.6 12.9 13.1 12.2 10.2 9.5 9.4 8.6 7.6 6.3 5.7 5.5 4.0 4.4 4.9 +0.5  
      10th Grade — — — — — — — — — — — — — 25.1 23.1 24.7 21.8 20.2 19.0 19.4 15.8 16.3 15.5 14.0 12.8 11.0 12.9 11.8 -1.1  
      12th Grade — — — — — — — — — — — — — 31.1 30.5 29.3 29.1 27.4 27.4 24.1 23.1 21.8 21.0 19.9 20.8 18.3 20.2 18.1 -2.2  
      College Students — — — — — — — — — — — — — 34.1 30.9 26.2 27.5 35.8 32.3 31.5 29.5 31.3 29.1 32.9 30.5 33.5 36.7 30.9 -5.8
      Young Adults — — — — — — — — — — — — — 29.5 27.6 24.9 25.9 26.7 24.4 24.5 23.8 26.1 25.4 26.9 24.7 28.8 27.6 29.4 +1.8
  Any Use
      8th Grade 14.3 15.5 16.7 18.6 19.1 21.0 19.4 19.1 17.5 14.6 12.2 10.7 10.2 9.2 9.3 8.7 7.1 6.8 6.5 7.1 6.1 4.9 4.5 4.0 3.6 2.6 1.9 2.2 +0.3  
      10th Grade 20.8 21.5 24.7 25.4 27.9 30.4 29.8 27.6 25.7 23.9 21.3 17.7 16.7 16.0 14.9 14.5 14.0 12.3 13.1 13.6 11.8 10.8 9.1 7.2 6.3 4.9 5.0 4.2 -0.8  
      12th Grade 28.3 27.8 29.9 31.2 33.5 34.0 36.5 35.1 34.6 31.4 29.5 26.7 24.4 25.0 23.2 21.6 21.6 20.4 20.1 19.2 18.7 17.1 16.3 13.6 11.4 10.5 9.7 7.6 -2.0 ss
      College Students 23.2 23.5 24.5 23.5 26.8 27.9 28.3 30.0 30.6 28.2 25.7 26.7 22.5 24.3 23.8 19.2 19.9 17.9 17.9 16.4 15.2 12.5 14.0 12.9 11.3 8.9 8.0 6.8 -1.2
      Young Adults 28.2 28.3 28.0 28.0 29.2 30.1 29.9 30.9 30.3 30.1 30.2 29.2 28.4 29.2 28.6 27.0 26.2 24.6 23.3 22.4 21.3 19.7 20.0 17.5 16.6 14.2 15.3 12.3 -3.0 sss
      8th Grade 6.9 7.0 6.6 7.7 7.1 7.1 5.5 4.8 4.5 4.2 4.0 3.3 4.1 4.1 3.3 3.7 3.2 3.5 3.7 4.1 3.5 2.8 2.8 3.0 3.2 2.5 1.7 2.1 +0.3  
      10th Grade 10.0 9.6 10.4 10.5 9.7 8.6 8.9 7.5 6.5 6.1 6.9 6.1 5.3 4.9 5.6 5.7 6.1 5.0 6.5 7.5 6.6 6.4 6.4 5.3 4.9 3.5 3.8 3.9 +0.1  
      12th Grade — 11.4 10.7 11.1 12.2 9.8 9.7 8.8 8.4 7.6 7.8 6.5 6.7 6.7 7.6 6.1 6.6 6.5 8.4 8.5 8.3 7.9 8.1 8.4 6.1 6.6 4.9 4.2 -0.8  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Any Vaping jj,kk
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — 8.0 6.2‡ 6.6 10.4 +3.7 sss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — 14.2 11.0‡ 13.1 21.7 +8.5 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — 16.3 12.5‡ 16.6 26.7 +9.9 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — 8.8 6.9‡ 11.3 21.3 +10.0 sss
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — 9.2 6.0‡ 11.9 17.1 +5.2 sss
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2017–
2018
change
(Entries are percentages.)
(Table continued on next page.)
  Been Drunk w,aaa
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Smokeless Tobacco x
51
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Vaping Nicotine jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 3.5 6.1 +2.6 sss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 8.2 16.1 +7.9 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 11.0 20.9 +10.0 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 6.1 15.5 +9.4 sss
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 6.5 10.6 +4.0 sss
Vaping Marijuana jj,bbb
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 1.6 2.6 +1.0 ss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 4.3 7.0 +2.7 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 4.9 7.5 +2.5 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 5.2 10.9 +5.7 s
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 6.6 9.3 +2.7 s
Vaping Just Flavoring jj
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 5.3 8.1 +2.8 sss
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.2 13.1 +4.0 sss
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — 9.7 13.5 +3.8 sss
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — 4.3 4.8 +0.6
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — 3.3 4.2 +0.9
Tobacco using a Hookah s,hh
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — 2.8 2.5 1.6 -0.9 s
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — 4.0 3.0 2.4 -0.7  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — — — 6.1 5.0 4.4 -0.6  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — 5.2 4.6 6.2 +1.7
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — 3.5 4.2 4.5 +0.3
Large Cigars ii
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — 1.9 2.4 1.5 1.5 1.7 +0.2  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — 3.9 3.4 2.3 2.6 2.8 +0.1  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — 6.4 7.0 6.5 5.6 5.2 -0.3  
      College Students — — — — — — — — — — — — — — — — — — — — — — — 8.4 4.9 4.4 1.7 3.7 +2.1
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — 6.6 5.9 3.9 3.5 3.3 -0.2
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — 4.1 4.1 2.8 2.6 2.6 0.0  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — 6.9 6.1 4.9 4.0 5.3 +1.4  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — 11.9 11.4 9.5 10.1 8.9 -1.2  
      College Students — — — — — — — — — — — — — — — — — — — — — — — 9.8 5.6 5.6 4.9 5.6 +0.7
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — 6.9 6.9 4.8 5.5 5.9 0.4
Flavored Little Cigars ii
(Entries are percentages.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — 2.5 3.3 1.9 1.6 1.6 0.0  
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — 4.4 3.8 3.0 3.0 3.1 +0.1  
      12th Grade — — — — — — — — — — — — — — — — — — — — — — — 7.0 7.8 6.1 6.6 5.8 -0.7  
      College Students — — — — — — — — — — — — — — — — — — — — — — — 8.6 4.1 3.6 1.7 1.4 -0.3
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — 5.8 3.8 3.6 2.8 3.7 +0.9
      8th Grade 0.4 0.5 0.5 0.5 0.6 0.4 0.5 0.5 0.7 0.8 0.7 0.8 0.7 0.5 0.5 0.5 0.4 0.5 0.4 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0  
      10th Grade 0.6 0.6 0.5 0.6 0.6 0.5 0.7 0.6 0.9 1.0 0.9 1.0 0.8 0.8 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.3 0.3 0.4 +0.1  
      12th Grade 0.8 0.6 0.7 0.9 0.7 0.7 1.0 1.1 0.9 0.8 1.3 1.4 1.3 1.6 0.9 1.1 1.0 1.0 1.0 1.1 0.7 0.9 1.0 0.9 1.0 0.7 0.8 0.8 +0.0  
      College Students 0.3 0.2 0.2 0.2 0.1 * 0.2 0.2 0.4 * 0.3 * 0.1 * * * 0.1 * 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 -0.3
      Young Adults 0.2 0.1 * 0.1 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.3 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.3 +0.1
Previously surveyed drugs that have been dropped
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.4 0.3 0.6 0.4 0.4 0.7 0.7 1.0 0.4 0.3 0.5 0.6 0.7 0.7 0.5 0.3 0.5 0.3 0.6 — — — — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults * 0.1 0.2 0.1 — — — — — — — — — — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      12th Grade 0.2 0.4 0.1 0.4 0.4 0.6 0.3 0.6 0.4 0.2 0.5 0.3 0.4 0.5 0.5 0.4 0.4 0.2 0.3 0.2 0.2 0.3 — — — — — — —
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.  The Monitoring the Future study, the University of Michigan.  
See footnotes following Table 2-4.
Regular Little Cigars ii
  Methaqualone m,s
Nitrites e
Steroids y,z
2018
change
TABLE 2-3 (cont.)
Trends in 30-Day Prevalence of Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Marijuana/Hashish
  Daily gg
      8th Grade 0.2 0.2 0.4 0.7 0.8 1.5 1.1 1.1 1.4 1.3 1.3 1.2 1.0 0.8 1.0 1.0 0.8 0.9 1.0 1.2 1.3 1.1 1.1 1.0 1.1 0.7 0.8 0.7 0.0  
      10th Grade 0.8 0.8 1.0 2.2 2.8 3.5 3.7 3.6 3.8 3.8 4.5 3.9 3.6 3.2 3.1 2.8 2.8 2.7 2.8 3.3 3.6 3.5 4.0 3.4 3.0 2.5 2.9 3.4 +0.5  
      12th Grade 2.0 1.9 2.4 3.6 4.6 4.9 5.8 5.6 6.0 6.0 5.8 6.0 6.0 5.6 5.0 5.0 5.1 5.4 5.2 6.1 6.6 6.5 6.5 5.8 6.0 6.0 5.9 5.8 -0.2  
      College Students 1.8 1.6 1.9 1.8 3.7 2.8 3.7 4.0 4.0 4.6 4.5 4.1 4.7 4.5 4.0 4.3 3.5 3.9 4.9 4.4 4.7 4.8 5.1 5.9 4.6 4.9 4.4 5.8 +1.4
      Young Adults 2.3 2.3 2.4 2.8 3.3 3.3 3.8 3.7 4.4 4.2 5.0 4.5 5.3 5.0 4.9 5.0 5.0 5.1 5.4 5.3 6.1 5.6 6.2 6.9 6.8 7.6 7.8 8.0 +0.1
  Any Daily Use
      8th Grade 0.5 0.6‡ 1.0 1.0 0.7 1.0 0.8 0.9 1.0 0.8 0.9 0.7 0.8 0.6 0.5 0.5 0.6 0.7 0.5 0.5 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.0  
      10th Grade 1.3 1.2‡ 1.8 1.7 1.7 1.6 1.7 1.9 1.9 1.8 1.9 1.8 1.5 1.3 1.3 1.4 1.4 1.0 1.1 1.1 0.8 1.0 0.9 0.8 0.5 0.5 0.6 0.5 -0.1  
      12th Grade 3.6 3.4‡ 3.4 2.9 3.5 3.7 3.9 3.9 3.4 2.9 3.6 3.5 3.2 2.8 3.1 3.0 3.1 2.8 2.5 2.7 2.1 2.5 2.2 1.9 1.9 1.3 1.6 1.2 -0.4 s
      College Students 4.1 3.7 3.9 3.7 3.0 3.2 4.5 3.9 4.5 3.6 4.7 5.0 4.3 3.7 4.6 4.8 4.3 4.0 4.3 3.6 3.8 3.9 3.6 4.3 3.1 4.3 2.2 2.3 +0.2
      Young Adults 4.9 4.5 4.5 3.9 3.9 4.0 4.6 4.0 4.8 4.1 4.4 4.7 5.1 4.5 5.2 5.4 5.6 5.3 5.3 4.6 5.2 5.5 5.1 5.0 4.7 5.4 5.0 4.3 -0.7
      8th Grade 0.1 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0  
      10th Grade 0.2 0.3 0.4 0.4 0.6 0.4 0.6 0.6 0.7 0.5 0.6 0.5 0.5 0.4 0.4 0.5 0.5 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.2 0.2 0.0  
      12th Grade 0.9 0.8 0.9 1.2 1.3 1.6 2.0 1.5 1.9 1.7 1.4 1.2 1.6 1.8 1.5 1.6 1.3 1.4 1.1 1.6 1.3 1.5 1.3 1.1 0.8 0.8 1.1 0.7 -0.4  
      College Students 0.5 0.2 0.3 0.8 0.5 0.1 1.3 0.8 1.0 0.7 0.5 0.8 1.1 0.8 0.5 0.6 0.7 0.5 0.7 0.3 1.3 0.4 0.5 0.4 0.7 0.4 0.0 0.6 +0.6
      Young Adults 0.5 0.4 0.4 0.5 0.3 0.4 0.9 0.5 0.9 0.5 0.4 0.6 0.8 0.7 0.5 0.6 0.6 0.5 1.0 0.7 0.7 0.4 0.5 0.6 0.4 0.3 0.3 0.5 +0.1
  5+ Drinks in a Row
      8th Grade 10.9 11.3 11.3 12.1 12.3 13.3 12.3 11.5 13.1 11.7 11.0 10.3 9.8 9.4 8.4 8.7 8.3 8.1 7.8 7.2 6.4 5.1 5.1 4.1 4.6 3.4 3.7 3.7 0.0  
      10th Grade 21.0 19.1 21.0 21.9 22.0 22.8 23.1 22.4 23.5 24.1 22.8 20.3 20.0 19.9 19.0 19.9 19.6 16.0 17.5 16.3 14.7 15.6 13.7 12.6 10.9 9.7 9.8 8.7 -1.1  
      12th Grade 29.8 27.9 27.5 28.2 29.8 30.2 31.3 31.5 30.8 30.0 29.7 28.6 27.9 29.2 27.1 25.4 25.9 24.6 25.2 23.2 21.6 23.7 22.1 19.4 17.2 15.5 16.6 13.8 -2.8 ss
      College Students 42.8 41.4 40.2 40.2 38.6 38.3 40.7 38.9 40.0 39.3 40.9 40.1 38.5 41.7 40.1 40.2 41.1 40.0 36.9 37.0 36.1 37.4 35.2 35.4 31.9 32.4 32.7 28.4 -4.3 s
      Young Adults 34.7 34.2 34.4 33.7 32.6 33.6 34.4 34.1 35.8 34.7 35.9 35.9 35.8 37.1 37.0 37.6 37.8 37.9 36.7 35.9 36.5 35.5 35.1 33.5 31.9 32.3 31.8 31.2 -0.6
Cigarettes
  Any Daily Use
      8th Grade 7.2 7.0 8.3 8.8 9.3 10.4 9.0 8.8 8.1 7.4 5.5 5.1 4.5 4.4 4.0 4.0 3.0 3.1 2.7 2.9 2.4 1.9 1.8 1.4 1.3 0.9 0.6 0.8 +0.3  
      10th Grade 12.6 12.3 14.2 14.6 16.3 18.3 18.0 15.8 15.9 14.0 12.2 10.1 8.9 8.3 7.5 7.6 7.2 5.9 6.3 6.6 5.5 5.0 4.4 3.2 3.0 1.9 2.2 1.8 -0.4  
      12th Grade 18.5 17.2 19.0 19.4 21.6 22.2 24.6 22.4 23.1 20.6 19.0 16.9 15.8 15.6 13.6 12.2 12.3 11.4 11.2 10.7 10.3 9.3 8.5 6.7 5.5 4.8 4.2 3.6 -0.6  
      College Students 13.8 14.1 15.2 13.2 15.8 15.9 15.2 18.0 19.3 17.8 15.0 15.9 13.8 13.8 12.4 9.2 9.3 9.2 8.0 7.6 7.3 5.2 5.6 5.2 4.2 2.6 2.0 1.9 -0.1
      Young Adults 21.7 20.9 20.8 20.7 21.2 21.8 20.6 21.9 21.5 21.8 21.2 21.2 20.3 20.8 19.6 18.6 17.3 16.7 15.0 14.8 13.8 12.8 12.1 10.7 9.7 8.2 8.8 7.0 -1.8 ss
TABLE 2-4
Trends in 30-Day Prevalence of Daily Use of Various Drugs for 8th, 10th,
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
2017–
    in Last 2 Weeks
(Entries are percentages.)
2018
change
Alcohol v,gg
  Been Drunk
    Daily w,gg
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
  1/2 Pack+/Day
      8th Grade 3.1 2.9 3.5 3.6 3.4 4.3 3.5 3.6 3.3 2.8 2.3 2.1 1.8 1.7 1.7 1.5 1.1 1.2 1.0 0.9 0.7 0.6 0.7 0.5 0.4 0.3 0.2 0.3 +0.1  
      10th Grade 6.5 6.0 7.0 7.6 8.3 9.4 8.6 7.9 7.6 6.2 5.5 4.4 4.1 3.3 3.1 3.3 2.7 2.0 2.4 2.4 1.9 1.5 1.5 1.2 1.0 0.6 0.7 0.7 0.0  
      12th Grade 10.7 10.0 10.9 11.2 12.4 13.0 14.3 12.6 13.2 11.3 10.3 9.1 8.4 8.0 6.9 5.9 5.7 5.4 5.0 4.7 4.3 4.0 3.4 2.6 2.1 1.8 1.7 1.5 -0.2  
      College Students 8.0 8.9 8.9 8.0 10.2 8.4 9.1 11.3 11.0 10.1 7.8 7.9 7.6 6.8 6.7 4.9 4.3 4.3 3.8 3.9 2.5 2.4 2.4 2.4 1.4 1.7 0.2 0.5 +0.3
      Young Adults 16.0 15.7 15.5 15.3 15.7 15.3 14.6 15.6 15.1 15.1 14.6 14.2 13.9 13.5 12.5 11.9 11.1 10.2 9.3 9.3 7.5 7.6 7.0 6.6 5.7 4.9 4.7 3.8 -0.9
  Daily x
      8th Grade 1.6 1.8 1.5 1.9 1.2 1.5 1.0 1.0 0.9 0.9 1.2 0.8 0.8 1.0 0.7 0.7 0.8 0.8 0.8 0.9 0.8 0.5 0.5 0.5 0.8 0.6 0.4 0.3 -0.1  
      10th Grade 3.3 3.0 3.3 3.0 2.7 2.2 2.2 2.2 1.5 1.9 2.2 1.7 1.8 1.6 1.9 1.7 1.6 1.4 1.9 2.5 1.7 2.0 1.9 1.8 1.6 1.0 0.6 1.0 +0.4  
      12th Grade — 4.3 3.3 3.9 3.6 3.3 4.4 3.2 2.9 3.2 2.8 2.0 2.2 2.8 2.5 2.2 2.8 2.7 2.9 3.1 3.1 3.2 3.0 3.4 2.9 2.7 2.0 1.6 -0.4  
      College Students — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — — — — — — — — — — — — — — —
Source.   The Monitoring the Future study, the University of Michigan.
See footnotes on the next page.
Smokeless Tobacco
and 12th Graders, College Students, and Young Adults (Ages 19–28) 
(Entries are percentages.)
TABLE 2-4 (cont.)
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Notes.  Level of significance of difference between the two most recent classes: s = .05, ss = .01, sss = .001. ' — ' indicates data not available.'' * ' indicates less 
than 0.05% but greater than  0%. ' ‡ ' indicates that the question changed the following year. See relevant footnote for that drug. See relevant figure to 
assess the impact of the wording changes. Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent
years is due to rounding.
             Approximate 
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
8th Graders 17,500 18,600 18,300 17,300 17,500 17,800 18,600 18,100 16,700 16,700 16,200 15,100 16,500 17,000
10th Graders 14,800 14,800 15,300 15,800 17,000 15,600 15,500 15,000 13,600 14,300 14,000 14,300 15,800 16,400
12th Graders 15,000 15,800 16,300 15,400 15,400 14,300 15,400 15,200 13,600 12,800 12,800 12,900 14,600 14,600
College Students 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440 1,350 1,340 1,260 1,270 1,400
Young Adults 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700
Approximate
Weighted  N s 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
8th Graders 16,800 16,500 16,100 15,700 15,000 15,300 16,000 14,600 14,600 14,600 14,400 16,900 15,300 14,000
10th Graders 16,200 16,200 16,100 15,100 15,900 15,200 14,900 12,900 12,900 13,000 15,600 14,700 13,500 14,300
12th Graders 14,700 14,200 14,500 14,000 13,700 14,400 14,100 12,600 12,600 12,400 12,900 11,800 12,600 13,300
College Students 1,400 1,300 1,300 1,300 1,300 1,300 1,200 1,200 1,100 1,000 1,000 900 900 900
Young Adults 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
aFor 12th graders, college students, and young adults only: Use of any illicit drug includes any use of marijuana, LSD, other hallucinogens, crack, cocaine other than crack,
or heroin; or any use of narcotics other than heroin, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders. For 8th and 10th graders only:
The use of narcotics other than heroin and sedatives (barbiturates) has been excluded because these younger respondents appear to overreport use (perhaps 
because they include the use of nonprescription drugs in their answers).  Due to changes in the amphetamines questions 2013 data for any illicit drug and any illicit 
drug other than marijuana are based on half the N  indicated.  For any illicit drug including inhalants, 8th and 10th grades, college students, and young adults are 
based on one half the N indicated for 2013; 12th graders are based on one sixth of N  indicated in 2013.
bIn 2001 the question text was changed on half of the questionnaire forms for each age group. Other psychedelics was changed to other hallucinogens and shrooms  
was added to the list of examples. For the tranquilizer list of examples, Miltown was replaced with Xanax. For 8th, 10th, and 12th graders only: The 2001 data  
presented here are based on the changed forms only;  N  is one half of N  indicated. In 2002 the remaining forms were changed to the new wording. The data are 
based on all forms beginning in 2002. Data for any illicit drug other than marijuana and data for hallucinogens are also affected by these changes and have been 
handled in a parallel manner. Beginning in 2014 LSD and hallucinogens other than LSD based on five of six forms; N  is five sixths of N  indicated. Hallucinogens 
was also effected by this change.
cFor 12th graders, college students, and young adults only: Data based on five of six forms in 1991–1998;  N  is five sixths of N  indicated. Data based on three of 
six forms beginning in 1999; N  is three sixths of N  indicated.
dInhalants are unadjusted for underreporting of amyl and butyl nitrites.
eFor 12th graders and young adults only: Data based on one of six forms;  N  is one sixth of N  indicated. Questions about nitrite use were dropped from the young 
adult questionnaires in 1995 and from the 12th-grade questionnaires in 2010.
fHallucinogens are unadjusted for underreporting of PCP.
gFor 12th graders, college students, and young adults only: Data based on one of six forms;  N  is one sixth of N  indicated. For 12th graders only: In 2011 the flavored  
alcoholic beverage question text was changed. Skyy Blue and Zima were removed from the list of examples. An examination of the data did not show any effect from 
the wording change. In 2014 the PCP triplet was dropped from one form and replaced with a single annual use question in a different form.
Footnotes for Tables 2-1 through 2-4
Weighted  N s
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hFor 8th and 10th graders only: Data based on one of two forms in 1996;  N  is one half of N  indicated. Data based on one third of N  indicated in 1997–2001 due to   
changes in the questionnaire forms. Data based on two of four forms beginning in 2002;  N  is one half of N  indicated. For 12th graders only: Data based on one of 
six forms in 1996–2001;  N  is one sixth of N  indicated. Data based on two of six forms beginning in 2002;  N  is two sixths of N  indicated. For college students and 
young adults only: Data based on two of six forms in 1991–2001;  N  is two sixths of N  indicated. Data based on three of six forms beginning in 2002; N  is three 
sixths of N  indicated. For all levels: In 2014 a revised question on use of ecstasy (MDMA) including "Molly" was added to one form at each level. The 2013 and 
2014 "Original wording" data reported here are for only the questionnaires using the original question wording. The 2014 and 2015 data reported here are for only
the questionnaires using the "Revised wording" which includes "Molly." For 8th and 10th grades the "Original wording" data are based on two of four forms in 2013 
and 2014, N  is one half of N  indicated; the "Revised wording" data are based on one of four forms in 2014, N  is one third of N  indicated and based on three of 
four forms beginning in 2015, N  is five sixths of N  indicated. For 12th grade the "Original wording" data are based on two of six forms in 2013 and 2014, N  is two 
sixths of N  indicated; the "Revised wording" data are based on one of four forms in 2014, N  is one sixth of N  indicated and based on three of six forms beginning 
in 2015, N  is three sixths of N  indicated. For college students and young adults the "Original wording" data are based on three of six forms in 2013 and 2014, N  is 
three sixths of N  indicated; the "Revised wording" data are based on one of six forms in 2014, N  is one sixth of N  indicated and based on four of six forms beginning  
in 2015, N  is four sixths of N  indicated.
iFor college students and young adults only: Data based on five of six forms beginning in 2002;  N  is five sixths of N  indicated.
jFor 12th graders only: Data based on four of six forms; N  is four sixths of N  indicated. For college students and young adults only: Data based on four of six forms; 
N  is four sixths of N  indicated.
kIn 1995, the heroin question was changed in one of two forms for 8th and 10th graders, in three of six forms for 12th graders, and in two of six forms for college  
students and young adults. Separate questions were asked for use with and without injection. In 1996, the heroin question was changed in all remaining 8th- and  
10th-grade forms. Data presented here represent the combined data from all forms. For 8th and 10th graders only: Beginning in 2015 data based on three of four 
four forms; N  is two thirds of N  indicated.
lFor 8th and 10th graders only: Data based on one of two forms in 1995;  N  is one half of N  indicated. Data based on all forms beginning in 1996. For 12th graders   
only: Data based on three of six forms; N  is three sixths of N  indicated. For college students and young adults only: Data based on two of six forms;  N  is two sixths 
of N  indicated.
mOnly drug use not under a doctor’s orders is included here.
narcotics other than heroin was updated: Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—were replaced with Vicodin, OxyContin, 
and Percocet. The 2002 data presented here are based on the changed forms only;  N  is one half of N  indicated. In 2003, the remaining forms were changed to the 
new wording. The data are based on all forms beginning in 2003. In 2013 the list of examples was changed on one form: MS Contin, Roxycodone, Hydrocodone 
(Lortab, Lorcet, Norco), Suboxone, Tylox, and Tramadol were added to the list. An examination of the data did not show any affect from the wording change.
oFor 8th, 10th, and 12th graders: In 2009, the question text was changed slightly in half of the forms. An examination of the data did not show any effect from the
wording change. In 2010 the remaining forms were changed in a like manner. In 2011 the question text was changed slightly in one form; bennies, Benzedrine and 
Methadrine were dropped from the list of examples. An examination of the data did not show any effect from the wording change. In 2013 the question wording was
changed slightly in two of the 8th and 10th grade questionnaires and in three of the 12th grade questionnaires. The new wording in 2013 asked "On how many 
occasions (if any) have taken amphetamines or other prescription stimulant drugs…" In contrast, the old wording did not include the text highlighted in red. Results 
in 2013 indicated higher prevalence in questionnaires with the new wording as compared to the old wording; it was proportionally 61% higher in 8th grade, 34%  
higher in 10th grade, and 21% higher in 12th grade.  2013 data are based on the changed forms only; for 8th, 10th, and 12th graders N  is one half of N  indicated. 
In 2014 all questionnaires included the new, updated wording.
pFor 8th and 10th graders only: Data based on one of four forms;  N  is one third of N  indicated. In 2011 the flavored alcoholic beverage question text was changed.  
Skyy Blue and Zima were removed from the list of examples. An examination of the data did not show any effect from the wording change.
qFor 12th graders only: Data based on two of six forms;  N  is two sixths of N  indicated. Provigil was dropped from the study in 2012. For college students and  
young adults only: Beginning in 2009 Salvia data based on one of six forms;  N  is one sixth of N  indicated. Data based on two of six forms in 2010, 2011, and from
2017 forward; N is two sixths of N  indicated. Data based on three of six forms from 2012-2016; N  is three sixths of N  indicated. For Synthetic Marijuana data 
based on two of six forms in 2011; N  is two sixths of N  indicated. Data based on three of six forms beginning in 2012; N  is three sixths of N  indicated. For Bath 
Salts data based on three of six forms; N  is three sixths of N  indicated. 
nFor 12th graders, college students, and young adults only: In 2002 the question text was changed in half of the questionnaire forms. The list of examples of 
(Footnotes continued on next page.)
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rFor 12th graders only: In 2004 the question text was changed in half of the questionnaire forms. Barbiturates was changed to sedatives, including barbiturates. 
Goofballs, yellows, reds, blues, and rainbows were deleted from the list of examples; Phenobarbital, Tuinal, Nembutal, and Seconal were added. An examination of 
the data did not show any effect from the wording change. In 2005 the remaining forms were changed in a like manner. In 2013 the question text was changed in 
all forms: Tuinal, Nembutal, and Seconal were replaced with Ambien, Lunesta, and Sonata. In one form the list of examples was also changed: Tuinal was dropped
from the list and Dalmane, Restoril, Halcion, Intermezzo, and Zolpimist were added. An examination of the data did not show any effect from the wording change. 
In 2013 the college student and young adult questionnaires were changed in a like manner. An examination of the data showed an affect from the wording change. 
For this reason 2012 and 2013 data are not comparable.
sFor 12th graders only: Data based on one of six forms;  N  is one sixth of N  indicated. Methaqualone was dropped from the study in 2013. For college students 
and young adults only: Data based on three of six forms from 2011-2013. N  is three sixths of N  indicated.  Beginning in 2014, data based on 2 of 6 forms. N  is two    
sixths of N  indicated.
tThe use of any prescription drug includes use of any of the following: amphetamines, sedatives (barbiturates), narcotics other than heroin, or tranquilizers…
without a doctor telling you to use them.
uFor 8th and 10th graders only: Data based on one of two forms in 1996;  N  is one half of N  indicated. Data based on three of four forms in 1997–1998; N  is two 
thirds of N  indicated. Data based on two of four forms in 1999–2001;  N  is one third of N  indicated. Data based on one of four forms beginning in 2002; N  is one
sixth of N  indicated. For 12th graders only: Data based on one of six forms in 1996–2001;  N  is one sixth of N  indicated. Data based on two of six forms in 2002–
2009; N  is two sixths of N  indicated. Data for 2001 and 2002 are not comparable due to changes in the questionnaire forms. Data based on one of six forms   
beginning in 2010; N  is one sixth of N  indicated. For college students and young adults only: Data based on two of six forms; N  is two sixths of N indicated.
vFor 8th, 10th, and 12th graders only: In 1993, the question text was changed slightly in half of the forms to indicate that a drink meant more than just a few sips.  
The 1993 data are based on the changed forms only;  N  is one half of N  indicated for these groups. In 1994 the remaining forms were changed to the new wording. 
The data are based on all forms beginning in 1994. In 2004, the question text was changed slightly in half of the forms. An examination of the data did not show any 
effect from the wording change. The remaining forms were changed in 2005. For college students and young adults: The revision of the question text resulted in
rather little change in the reported prevalence of use. The data for all forms are used to provide the most reliable estimate of change.
wFor all grades: In 2012 the alcoholic beverage containing caffeine (like Four Loko or Joose) question text was changed to alcoholic beverage mixed with an energy 
drink (like Red Bull). The data in 2011 and 2012 are not comparable due to this question change. For 12th graders only: Data based on two of six forms; N  is two
sixths of N  indicated. For college students and young adults only: been drunk data based on three of six forms; N  is three sixths of N  indicated. Alcoholic beverages 
containing caffeine data based on two of six forms;  N  is two sixths of N  indicated.
xFor 8th and 10th graders only: Data based on one of two forms for 1991–1996 and on two of four forms beginning in 1997;  N  is one half of N  indicated. For 12th 
graders only: Data based on one of six forms;  N  is one sixth of N  indicated. For 8th, 10th, and 12th graders only: Snus and dissolvable tobacco were added to the 
list of examples in 2011. An examination of the data did not show any effect from the wording change. For college students and young adults only: Questions about 
smokeless tobacco use were dropped from the analyses in 1989.
yFor 8th and 10th graders only: In 2006, the question text was changed slightly in half of the questionnaire forms. An examination of the data did not show any effect 
from the wording change. In 2007 the remaining forms were changed in a like manner. In 2008 the question text was changed slightly in half of the questionnaire forms 
An examination of the data did not show any effect from the wording change. In 2009 the remaining forms were changed in a like manner. For 12th graders only: Data
based on two of six forms in 1991–2005;  N  is two sixths of N  indicated. In 2006 a slightly altered version of the question was added to a third form. An examination  
of the data did not show any effect from the wording change. Data based on three of six forms beginning in 2006;  N  is three sixths of N  indicated. In 2007 the 
remaining forms were changed in a like manner. In 2008 the question text was changed slightly in two of the questionnaire forms. An examination of the data did not
show any effect from the wording change. In 2009 the remaining form was changed in a like manner. 
zFor college students and young adults only: Data based on two of six forms in 1990–2009;  N  is two sixths of N  indicated. In 2008, the question text was 
changed slightly. 
aaFor 12th graders only: Data based on two of six forms in 2002–2005;  N  is two sixths of N  indicated. Data based on three of six forms beginning in 2006; N  is three   
sixths of N  indicated.
bbFor college students and young adults only: Data based on two of six forms through 2009;  N  is two sixths of N  indicated. Data based on three of six forms 
beginning in 2010; N  is three sixths of N  indicated.
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ccFor 12th graders only: Data based on two of six forms in 2000;  N  is two sixths of N  indicated. Data based on three of six forms in 2001;  N  is three sixths of N   
indicated. Data based on one of six forms beginning in 2002;  N  is one sixth of N  indicated. For college students and young adults only: Data based on two of six 
forms; N  is two sixths of N  indicated. Data based on three of six forms beginning in 2010;  N  is three sixths of N  indicated. Data based on two of six forms beginning
in 2012; N  is two sixths of N  indicated.
ddFor 12th graders only: Data based on two of six forms in 2000;  N  is two sixths of N  indicated. Data based on three of six forms in 2001–2009;  N  is three sixths  
of N  indicated. Data based on two of six forms beginning in 2010;  N  is two sixths of N  indicated. For college students and young adults only: Data based on two of
six forms;  N  is two sixths of N  indicated. Data based on three of six forms beginning in 2010;  N  is three sixths of N  indicated. 
eeFor 12th graders only: The 2003 flavored alcoholic beverage data were created by adjusting the 2004 data to reflect the observed 2003 to 2004 change in a slightly 
different version of the flavored alcoholic beverage question. In 2004 the original question was revised to include wine coolers among the examples―a change that had 
very little effect on the observed prevalence-of-use rate.
ffFor 12th graders only: Data based on two of six forms in 2000–2008;  N  is two sixths of N  indicated. Beginning in 2009 data based on one of six forms; N  is one 
sixth of N  indicated.
ggDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes and smokeless tobacco, for which actual daily use is measured, and
for 5+ drinks, for which the prevalence of having five or more drinks in a row in the last two weeks is measured.
hhFor 8th and 10th graders only: Data based on two of four forms.  N  is one third of N  indicated.  For 12th graders only: Data based on four of six forms; N  is four
sixths of N  indicated.  For college students and young adults only: Data based on one of six forms; N  is one sixth of N  indicated.
iiFor 8th and 10th graders only: Data based on two of four forms; N  is one third of N  indicated.  For 12th graders only: Data based on two of six forms; N  is two 
sixths of N  indicated.  For college students and young adults only: Data based on one of six forms; N  is one sixth of N  indicated.
jjFor 8th and 10th graders only: Data based on one of four forms; N  is one third of N  indicated.  For 12th graders only: Data based on two of six forms.  N  is two
sixths of N  indicated.  For college students and young adults only: Data based on one of six forms;N  is one sixth of N  indicated.
kkIn 2017, the surveys switched from asking about vaping in general to asking separately about vaping nicotine, marijuana, and just flavoring. 
Beginning in 2017, data presented for any vaping are based on these new questions
llFor the estimate of lifetime Narcotics other than Heroin for young adults in 2018, there was a significant difference (p<.01) between the typical mail mode (13.9%) and new
web-push mode (10.9%) of administration.
mmFor the estimate of lifetime Flavored Alcoholic Beverages for young adults in 2018, there was a significant difference (p<.01) between the typical mail mode (76.4%) and new
web-push mode (85.5%) of administration.
nnFor the estimate of lifetime Any Vaping for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (33.4%) and new
web-push mode (40.4%) of administration.
ooFor the estimate of lifetime Vaping Nicotine for young adults in 2018, there was a significant difference (p<.01) between the typical mail mode (23.8%) and new
web-push mode (30.9%) of administration.
ppFor the estimate of lifetime Vaping Just Flavoring for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (19.4%) and new
web-push mode (24.5%) of administration.
qqFor the estimate of annual Bath Salts for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (0.6%) and new
web-push mode (0.0%) of administration.
rrFor the estimate of annual Ketamine for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (1.6%) and new
web-push mode (0.4%) of administration.
ssFor the estimate of annual Alcoholic Bverages Containing Caffeine for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (34.6%) and new
web-push mode (25.9%) of administration.
ttFor the estimate of annual Tobacco with a Hookah for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (11.6%) and new
web-push mode (14.9%) of administration.
uuFor the estimate of annual Any Vaping for college students in 2018, there was a significant difference (p<.05) between the typical mail mode (26.9%) and new
web-push mode (37.8%) of administration.
vvFor the estimate of annual Any Vaping for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (24.3%) and new
web-push mode (29.9%) of administration.
wwFor the estimate of annual Vaping Nicotine for college students in 2018, there was a significant difference (p<.05) between the typical mail mode (19.0%) and new
web-push mode (32.0%) of administration.
xxFor the estimate of annual Any Vaping for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (15.6%) and new
web-push mode (20.6%) of administration.
(Footnotes continued on next page.)
Footnotes for Tables 2-1 through 2-4 (cont.)
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yyFor the estimate of annual Any Marijuana for college students in 2018, there was a significant difference (p<.05) between the typical mail mode (15.2%) and new
web-push mode (25.1%) of administration.
zzFor the estimate of 30-day Marijuana for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (22.5%) and new
web-push mode (25.5%) of administration.
aaaFor the estimate of 30-day Been Drunk for young adults in 2018, there was a significant difference (p<.05) between the typical mail mode (38.8%) and new
web-push mode (33.5%) of administration.
bbbFor the estimate of 30-day Vaping Marijuana for college students in 2018, there was a significant difference (p<.05) between the typical mail mode (7.3%) and new
web-push mode (14.5%) of administration.
Footnotes for Tables 2-1 through 2-4 (cont.)
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Illicit drug use index includes any use of marijuana, LSD, other hallucinogens, crack, cocaine other than crack, or heroin; 
or any use of narcotics other than heroin which is not under a doctor’s orders, stimulants, sedatives 
(barbiturates), methaqualone (excluded since 1990), or tranquilizers. Beginning in 1982, the question 
about stimulant use (i.e., amphetamines) was revised to get respondents to exclude the inappropriate 
reporting of nonprescription stimulants. The prevalence rate dropped slightly as a result of this 
methodological change.  In 2013, the question on use of amphetamines was changed such that  "Amphetamines" was replaced
with "Amphetamines and other stimulant drugs."  Data for any illicit drug were affected by this change.
            FIGURE 2-1
            Trends in Annual Prevalence of an Illicit Drug Use Index
            across 5 Populations
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Chapter 3 
 
STUDY DESIGN AND PROCEDURES 
 
Monitoring the Future (MTF) incorporates several survey designs into one study, yielding analytic 
power beyond the sum of those component parts. The components include cross-sectional studies, 
repeated cross-sectional studies, and panel studies of individual cohorts and sets of cohorts. The 
annual cross-sectional surveys provide point estimates of various behaviors and conditions in any 
given year for a number of subpopulations (e.g., 8th graders, 10th graders, 12th graders, college 
students, all young adult high school graduates ages 19–30, 35-year-olds, 40-year-olds, etc.), as 
well as point estimates for various subgroups within these different populations. Repeating these 
annual cross-sectional surveys over time allows an assessment of change across history in 
consistent age segments of the population, as well as among subgroups. The panel study feature 
permits the examination of developmental change in the same individuals as they assume adult 
responsibilities, enter and leave various adult roles and environments, and continue further into 
adulthood. It also permits an assessment of a number of outcomes later in life that MTF has shown 
to be linked to substance use in adolescence and beyond.1 
 
Finally, with a series of panel studies of sequential graduating class cohorts we are able to offer 
distinctions among, and explanations for, three fundamentally different types of change: age, 
period, and cohort. It is this feature that creates a synergistic effect in terms of analytic and 
explanatory power.2,3 
 
RESEARCH DESIGN AND PROCEDURES FOR THE 12th GRADE SURVEYS 
Twelfth graders have been surveyed in the spring of each year since 1975. Each year’s data 
collection has taken place in 120-140 public and private high schools selected to provide an 
accurate representative cross-section of 12th graders throughout the coterminous United States (see 
Figure 3-1). The participating 12th graders serve as the sampling frame for the MTF panels. In 
addition, 12th grade prevalence and trends are included as a comparison to the older age groups 
throughout this volume.  
 
The Population under Study 
Senior year of high school is a strategic point at which to monitor drug use and related attitudes of 
youth. First, completion of high school represents the end of an important developmental period 
in this society, demarcating both the end of universal education and, for many, the end of living 
                                                 
1 Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008) The Education–Drug Use 
Connection: How Successes and Failures in School Relate to Adolescent Smoking, Drinking, Drug Use, and Delinquency. New York: Lawrence 
Erlbaum Associates/Taylor & Francis; Bachman, J. G., O'Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002) 
The Decline of Substance Use in Young Adulthood: Changes in Social Activities, Roles, and Beliefs. Mahwah, New Jersey: Lawrence Erlbaum; 
Bachman, J. G., Wadsworth, K. N., O'Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, Drinking, and Drug Use in Young 
Adulthood: The Impacts of New Freedoms and New Responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
2 Bachman, J. G., Johnston, L. D., O'Malley, P. M., Schulenberg, J. E., & Miech, R. A. (2015). The Monitoring the Future project after four 
decades: Design and procedures (Monitoring the Future Occasional Paper No. 82). Ann Arbor, MI: Institute for Social Research, University of 
Michigan.  
3 For a more detailed description of the full range of research objectives of Monitoring the Future, see Johnston, L. D., O’Malley, P. M., Schulenberg, 
J. E., Bachman, J. G., Miech, R. A., & Patrick, M. E. (2016). The objectives and theoretical foundation of the Monitoring the Future study 
(Monitoring the Future Occasional Paper No. 84). Ann Arbor, MI: Institute for Social Research.  
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full-time in the parental home. Therefore, it is a logical point at which to take stock of cumulated 
influences. Further, completion of high school represents a jumping-off point, a point from which 
young people diverge into widely differing social environments and experiences. Thus senior year 
is a good time to take a “before” measure, allowing for the subsequent calculation of changes that 
may be attributable to the environmental transitions occurring in young adulthood, including 
college attendance, civilian employment, military service, and role transitions such as marriage, 
parenthood, and divorce. Finally, there are some important practical advantages built into the 
original system of data collections with samples of 12th graders. The need for systematically 
repeated, large-scale samples from which to make reliable estimates of change requires that 
considerable emphasis be put on cost efficiency as well as feasibility. The last year of high school 
constitutes the final point at which a reasonably good national sample of an age-specific cohort 
can be drawn and studied economically. 
 
The Omission of Dropouts 
One limitation in the MTF study design is the exclusion of individuals who drop out of high school 
before graduation – approximately 6–15% of each age cohort nationally, according to U.S. Census 
statistics. The dropout rate has been declining in recent years; 6% is the most recent estimate.4 
Clearly, the omission of high school dropouts introduces biases in the estimation of certain 
characteristics of the entire age group; however, for most purposes, the small proportion of 
students who drop out sets outer limits on the bias. Further, since the bias from missing dropouts 
should remain relatively constant from year to year, their omission should introduce little or no 
bias in year-to-year change estimates. Indeed, we believe the changes observed over time for those 
who are surveyed in the 12th grade are likely to parallel the changes for dropouts in most instances. 
Appendix A in Volume I5 addresses in detail the likely effects of the exclusion of dropouts (as well 
as absentees from school on the day of the survey administration) on estimates of drug use 
prevalence and trends for the entire age cohort. 
 
Sampling Procedures and Sample Weights 
A multistage random sampling procedure is used to secure the nationwide sample of 12th graders 
each year. Stage 1 is the selection of particular geographic areas, Stage 2 is the selection of one or 
more high schools in each area (with probability proportionate to the student enrollment size for 
the grade in question), and Stage 3 is the selection of 12th graders within each high school. Up to 
350 12th graders in each school may be included. In schools with more than 350 12th graders 
classrooms are typically randomly sampled. In schools with fewer 12th graders, the usual procedure 
is to include all of them in the data collection, though a smaller sample is sometimes taken to 
accommodate the needs of the school (either by randomly sampling entire classrooms or by some 
other unbiased, random method). Weights are assigned to compensate for differential probabilities 
of selection at each stage of sampling. Final weights are normalized to average 1.0, so that the 
weighted number of cases equals the unweighted number of cases overall. In order to be able to 
check observed trends in any given one-year interval, schools participate in the study for two 
consecutive years on a staggered schedule, with one half being replaced with a new random half-
sample of schools each year. Therefore, in any given year about half of the schools in the sample 
are participating for the first time and the other half are participating for their second and final 
                                                 
4 U.S. Child Trends Databank. (2018). High school dropout rates. Bethesda, MD. 
5 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan.  
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year. This three-stage sampling procedure, with annual replacement of half of the sample of 
schools each year, has yielded the numbers of participating schools and students shown in Table 
3-1. 
 
Questionnaire Administration 
About two weeks prior to the questionnaire administration date, parents of the target respondents 
are sent a letter by first-class mail, usually from the principal, announcing and describing the MTF 
study and providing parents with an opportunity to decline participation by their student if they 
wish. A flyer outlining the study in more detail is enclosed with the letter. Copies of the flyers are 
also given to the students by teachers in the target classrooms in advance of the date of 
administration. The flyers make clear that participation is entirely voluntary. Local Institute for 
Social Research representatives and their assistants conduct the actual questionnaire 
administrations following standardized procedures detailed in an instruction manual. The 
questionnaires are administered in classrooms during a normal class period whenever possible; 
however, circumstances in some schools require the use of larger group administrations. Teachers 
are asked to remain present in the classroom to help maintain order, but to remain at their desks so 
that they cannot see students’ answers. 
 
Questionnaire Format   
Because many questions are needed to cover all of the many topic areas in the MTF study, much 
of the questionnaire content for 12th graders is divided into six different questionnaire forms 
distributed to participants in an ordered sequence that ensures six virtually identical random 
subsamples. (Five questionnaire forms were used between 1975 and 1988.) About one third of 
each form consists of key, or “core,” variables common to all forms. All demographic and key 
drug variables are contained in this core set of measures. Many of the specific drugs that have been 
added over time are in one or more forms but not in the core set. Many questions on attitudes, 
beliefs, and perceptions of relevant features of the social environment are in fewer forms, and data 
are thus based on fewer cases – a single form would have one fifth of the total number of cases in 
1975–1988 (approximately 3,300 per year) and one sixth of the total beginning in 1989 
(approximately 2,500 per year). All tables in this report list the sample sizes upon which the 
statistics are based, stated in terms of the weighted number of cases which, as explained above, is 
roughly equivalent to the actual number of cases. 
 
RESEARCH DESIGN AND PROCEDURES FOR THE 8th AND 10th GRADE SURVEYS   
In 1991, MTF was expanded to include nationally representative samples of 8th and 10th grade 
students surveyed on an annual basis. The 8th and 10th grade samples are not followed up and thus 
not included in the MTF Panel. Their information is provided here because we cover 8th , 10th, and 
12th graders in Chapter 2 when comparing key findings across teens, college students, and young 
adults. Separate samples of schools and students are drawn at each grade level. In general, the 
procedures used for the annual in-school surveys of 8th and 10th grade students closely parallel 
those used for 12th graders, including the selection of schools and students, questionnaire 
administration, and questionnaire format. A major exception is that only two different 
questionnaire forms were used in 8th and 10th grade from 1991 to 1996, expanded to four forms 
beginning in 1997. The same four questionnaire forms are used for both 8th and 10th graders; most 
of the content is drawn from the 12th grade surveys, including the core section. Thus, key 
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demographic variables and measures of drug use and related attitudes and beliefs are generally 
identical for all three grades. Fewer values and attitudes are covered in the 8th and 10th grade forms, 
in part because they are likely to be more fully formed by 12th grade and best monitored there. 
 
About 15,000 8th grade students in approximately 130 schools (mostly middle schools) and about 
15,000 10th grade students in approximately 130 schools are surveyed each year (see Table 3-1). 
 
Mode of Administration  
Since 1999, all surveys for 8th and 10th graders have been fully anonymous. In previous years, 
MTF collected confidential, personal identification information from these respondents, and from 
1991 to 1993 this information was used to follow up with 8th and 10th graders in a manner similar 
to follow-ups of 12th graders (see “Research Design and Procedures for the 12th Grade Follow-Up 
Surveys” below).6 Follow-up of 8th and 10th graders was discontinued after 1993, precluding the 
need for further collection of confidential, personal identification information. Considerations 
supporting a switch to fully anonymous surveys in 8th and 10th grade included the following: (a) 
school cooperation might be easier to obtain; and (b) to the extent that collecting contact 
information had any effect on survey responses such an effect would be removed from the national 
data, which are widely compared with results of state and local surveys (nearly all of which use 
anonymous questionnaires), thus making those comparisons more valid.  
 
MTF considered in detail the effects of an anonymous survey as compared to a confidential survey 
that collected personal identification information. In 1998 the half-sample of 8th and 10th grade 
schools beginning their two-year participation in MTF received fully anonymous questionnaires, 
while the half-sample participating for their second and final year continued to get the confidential 
questionnaires that had been previously in use by MTF since 1991.  
 
Examination of the 1998 results, based on the two equivalent half-samples at grades 8 and 10, 
revealed that there was no effect of anonymous as compared to confidential surveys among 10th 
graders and only a very modest effect, if any, in self-reported substance use rates among 8th 
graders, with prevalence levels slightly higher in the anonymous condition.7 All tables and figures 
in this volume combine data from both half-samples of 8th graders surveyed in a given year. This 
is also true for 10th graders, for whom we found no methodological effect, and 12th graders, for 
whom we assumed no such effect since none was found for 10th graders. (This chapter’s later 
section “Representativeness and Sample Accuracy” provides further discussion of half samples in 
the three grades surveyed.) 
 
Questionnaire Forms and Sample Proportions 
Beginning in 1997, in order to increase the measurement content in the study of 8th and 10th graders, 
the number of forms was expanded from two to four, although they are not distributed in equal 
numbers. Forms 1, 2, 3, and 4 are assigned to one third, one third, one sixth, and one sixth of the 
                                                 
6 A book reporting results from analyses of these younger panels was published in 2008. See Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., 
Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use connection: How successes and failures in school relate 
to adolescent smoking, drinking, drug use, and delinquency. New York: Lawrence Erlbaum Associates/Taylor & Francis. 
7 We have examined in detail the effects of administration mode using multivariable controls to assess the effects of the change on 8th-grade self-
report data. Our findings generally show even less effect than is to be found without such controls. See O’Malley, P. M., Johnston, L. D., Bachman, 
J. G., & Schulenberg, J. E. (2000). A comparison of confidential versus anonymous survey procedures: Effects on reporting of drug use and related 
attitudes and beliefs in a national study of students. Journal of Drug Issues, 30, 35–54.  
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students, respectively. Thus, if a question appears on only one form, it is administered to either 
one third or one sixth of the sample. A question in two forms may be assigned to one third of the 
sample (one sixth plus one sixth), one half of the sample (one third plus one sixth), or two thirds 
of the sample (one third plus one third). A question in three forms may be assigned to two thirds 
(one third plus one sixth plus one sixth), or five sixths of the sample (one third plus one third plus 
one sixth). Footnotes to the tables throughout this volume indicate what proportion of all 
respondents in each grade was asked the question, if that proportion is other than the entire sample. 
All of the samples, whether based on one or more forms, are random samples. 
 
RESEARCH DESIGN AND PROCEDURES FOR THE 12th GRADE FOLLOW-UP 
SURVEYS 
Beginning with the graduating class of 1976, a subset of each 12th grade class has been selected to 
be surveyed by mail after high school. From the 12,000–19,000 12th graders originally surveyed 
in a given senior class, a representative sample of 2,450 is randomly chosen for follow-up.  
 
Survey mode. Up through 2017, all follow-up surveys were conducted by mail. As described in 
detail below, beginning in 2018, one random half of the 19-30 year old respondents receive the 
typical mail surveys and the other random half are encouraged to complete web-based surveys; 
content is the same across the two modes.  
 
Oversampling of substance users. In order to ensure that drug-using populations are adequately 
represented in the follow-up surveys, 12th graders reporting 20 or more occasions of marijuana use 
in the previous 30 days (i.e., daily or near daily users), or any use of the other illicit drugs in the 
previous 30 days are selected with higher probability (by a factor of 3.0) than the remaining 12th 
graders. Differential weighting is then used in all follow-up analyses to compensate for these 
differential sampling probabilities. Because those in the drug-using stratum receive a weight of 
only 0.33 in the calculation of all statistics to correct for their overrepresentation at the selection 
stage, there are actually more follow-up respondents than are reported in the weighted numbers 
given in the tables; in recent years actual numbers average about 20% higher than the weighted 
numbers.  
 
Follow-ups through young-, middle, and older-adulthood. The 2,450 participants selected from 
each 12th grade class are randomly split into two groups of 1,225 each – one group to be surveyed 
on even-numbered calendar years in a series of biannual follow-up surveys, and the other group to 
be surveyed on odd-numbered years also in a series of biannual follow-up surveys. By alternating 
the two half-samples through young adulthood, MTF collects data from every graduating class 
each year (through age 30), even though any given respondent participates only every other year. 
 
Until 2002, each respondent was surveyed biennially up to seven times; at the seventh follow-up, 
which would occur either 13 or 14 years after graduation, the respondents had reached modal age 
31 or 32. In 2002, as a cost-saving measure, the seventh biennial follow-up was discontinued, and 
since then each respondent is surveyed every other year until modal age 29 or 30. Additional 
middle- and older-adult follow-ups then occur at modal ages 35, 40, 45, 50, 55, and beginning in 
2018, age 60. Starting at age 35, both of the half-samples from each graduating high school class 
are surveyed simultaneously. These data, gathered on national samples over such a large portion 
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of the life span, are extremely rare and can provide needed insight into the etiology and life-course 
history of substance use and relevant behaviors. 
 
Mail Follow-Up Procedures  
Using information provided by 12th grade respondents on a confidential tear-off card (requesting 
the respondent’s name, address, phone numbers, and more recently, email address and cell phone 
numbers with consent to use text messaging), contact is maintained with the subset of people 
selected for inclusion in the follow up panels. Newsletters are sent to them each year, providing a 
short summary of results on a variety of survey topics. Name and address corrections are requested 
from both the U.S. Postal Service and the individual. Questionnaires are sent in the spring to each 
individual biennially through age 30, then at 5-year intervals. A check (for $25 in recent years8), 
made payable to the respondent, is attached to the front of each questionnaire. Reminder letters 
and postcards are sent at fixed intervals thereafter; telephone callers attempt to gather up-to-date 
location information for those respondents with whom we are trying to make contact; and, finally, 
those whom we can contact but who have not responded receive a prompting phone call from the 
Survey Research Center’s phone interviewing facility in Ann Arbor, Michigan. If requested by the 
respondent, a second copy of the questionnaire is sent. No questionnaire content is administered 
by phone. If a respondent asks not to be contacted further, that request is honored. 
 
Web-Based Follow-Up Procedures 
The 2018 data collections among young adults (19-30) mark the first use of web-based surveys 
with our panel participants. In 2018, one random half of the sample received our typical mail 
surveys and the other half received the “web-push” condition (i.e., first pushed toward web-based 
surveys and then given the opportunity to complete paper surveys). This splitting of the sample 
(which is replicated in 2019 data collections) allows us to calibrate our historical and 
developmental trends. In 2020, we plan to use web-push data collection with all young adults, and 
to offer paper surveys only on request and to non-respondents. Because it is possible that the data 
collection procedures can affect responses, we have been deliberate in this process of moving to 
web-based data collections. For the past several years, we have been conducting experiments with 
extra panel samples of young adults, examining feasibility and comparing our typical mail-only 
surveys to other designs pushing web-based surveys. Findings suggest that there are some 
condition and mode differences in responses, as detailed in our recent peer-reviewed publications.9 
In the 2018 data presented in this volume, there are only a few significant differences between 
those randomly assigned to mail-only and web-push conditions in the prevalence estimates of the 
many substances we cover. Thus, in this volume, we combine the estimates across the two 
conditions (using a weighted average to take into account sample size of each condition due to 
differential response rates as noted below) and note when there are significant differences. 
 
With the web-push condition, we have kept the procedures as similar as possible to our typical 
mail-based procedures, following many of the same steps summarized above for the mail-based 
                                                 
8 Until 1991, the follow-up checks were for $5. After an experiment indicated that an increase was warranted, the check amount was raised to $10 
beginning with the class of 1992. The check amount was raised to $20 in 2006, and to $25 beginning in 2008. 
9 Patrick, M. E., Couper, M. P., Laetz, V. B., Schulenberg, J. E., O'Malley, P. M., Johnston, L. D., & Miech, R. A. (2018). A sequential mixed 
mode experiment in the U.S. National Monitoring the Future study. Journal of Survey Statistics and Methodology, 6(1), 72-97. Patrick, M. E., 
Couper, M. P., Jang, B., Laetz, V. B., Schulenberg, J., Johnston, L. D., Bachman, J., O’Malley, P. M. (2019). Two-year follow-up of the 
sequential mixed-mode experiment in the U.S. National monitoring the future study. Survey Practice, 12(1). 
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procedures, including initial contact, incentives, mailing of newsletters, and follow-up contact with 
non-respondents. There are important differences to note. In the web-push procedures, respondents 
were provided information to respond online (i.e., they were each given a link and PIN to access 
their survey) and then they were later offered a paper survey if they did not respond to the web 
survey. In addition to initial mail contact, respondents were also contacted by email and text 
message (for those who provided email and cellphone contact information in the 12th grade 
surveys, along with their permission to contact them by text). We ensure confidentiality of web-
based responses, with data being immediately encrypted. By design, respondents can pause their 
web surveys and then easily get back into them; we send email reminders to non-respondents and 
respondents who have only partially completed the survey. The web-based surveys are optimized 
for a variety of operating systems and devices, including computers, tablets and smart phones.  
 
As is typical in web-push procedures, respondents randomly assigned to this condition were also 
provided access to paper surveys; those who did not respond within a month of initial contact were 
automatically sent paper surveys. In the process of telephoning non-respondents, paper surveys 
were offered in addition to the survey login information. We found that 20% of respondents in the 
web-push condition completed paper surveys instead of web-based surveys; these respondents 
were included in the web-push condition in our tests for differences by assigned survey condition 
reported in this Volume, as appropriate given the definition of web-push procedures as well as 
differences in respondent contact between the two conditions. In supplemental analyses not shown 
in this Volume, we also tested for differences by response mode (rather than assigned condition). 
Findings were similar to what we report in this Volume; in general, there are very few significant 
differences in prevalence estimates based on survey procedures. A more detailed comparison by 
assigned and completed survey mode among 2018 young adults is being conducted for an 
empirical article. 
 
Follow-Up Questionnaire Format 
The questionnaires used in the follow-up surveys of 19- to 30-year-olds parallel those used in 12th 
grade. Many of the questions are the same, including the core section dealing with drug use. 
Respondents are consistently sent the same form of the questionnaire that they first received in 
12th grade so that changes over time in their behaviors, attitudes, experiences, and so forth can be 
measured directly. Questions specific to high school status and experiences are dropped in the 
follow-ups, and questions relevant to post–high school status and experiences are added (mostly 
in the core section). The post-high school questions deal with issues such as college attendance, 
military service, civilian employment, marriage, and parenthood. In the study’s early follow-ups 
(through 1988), the sample size for a question appearing on a single form was one fifth of the total 
sample. A sixth form was introduced in 12th grade beginning with the class of 1989 and extended 
a year later beginning with the follow-up surveys of that same class. Therefore, since 1990, a 
question appearing on a single form has been administered to one sixth of the total sample in the 
19-30 young adult age band. Single-form data from a single cohort are typically too small to make 
reliable estimates; therefore, in most cases where they are reported, single-form data from several 
adjacent cohorts are combined. The content and ordering of items are identical between the typical 
mail surveys and the new web-based surveys for the 19-30 year olds, although the web-based 
surveys have more efficient skip patterns. The web-surveys have been optimized for use on 
multiple platforms, including smart phones and other devices. 
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For the five-year interval surveys beginning at age 35, both half-samples from a class cohort are 
surveyed simultaneously and only one questionnaire form is used (on paper only). Much of the 
questionnaire content is maintained but streamlined with a focus on the major family and work 
issues relevant to respondents ages 35, 40, 45, ,50, 55, and 60; we have also added measures of 
substance use disorders and a number of health outcomes. 
 
REPRESENTATIVENESS AND SAMPLE ACCURACY OF INITIAL SCHOOL-BASED 
DATA 
School Participation 
Schools are invited to participate in the MTF study for a two-year period. For each school that 
declines to participate, a similar school (in terms of size, geographic area, urbanicity, etc.) is 
recruited as a replacement. In 2018, either an original school or a replacement school was obtained 
in 90% of the sample units. With very few exceptions, each school participating in the first year 
has agreed to participate in the second year as well. Figure 3-2 provides the year-specific school 
participation rates and the percentage of units filled since 1977. As shown in the figure, 
replacements for schools that decline participation are obtained in the vast majority of cases. 
 
Two questions are sometimes raised with respect to school participation rates: (a) Are participation 
rates sufficient to ensure the representativeness of the sample? (b) Does variation in participation 
rates over time contribute to changes in estimates of drug use?  
 
With respect to participation rates ensuring that the sample is representative, the selection of a 
comparable replacement school that is demographically close to the original school occurs in 
practically all instances in which an original school does not participate. This should almost 
entirely remove problems of bias in region, urbanicity, and the like that might result from certain 
schools declining to participate.  
 
Among participating schools, there is very little difference in substance use levels between the 
sample of participating schools that were original selections, taken as a set, and the schools that 
were replacements. Averaged over the years 2003 through 2015 for grades 8, 10, and 12 combined, 
the difference between original schools and replacement schools averaged 0.26 percentage points 
in the observed prevalence averaged across a number of drug use measures: two indices of annual 
illicit drug use, the annual prevalence of each of the major illicit drug classes, and several measures 
of alcohol and cigarette use. For half of the measures prevalence was higher in the replacement 
selections and in the remaining half it was higher in the original selections; specifically, out of 39 
comparisons (13 drugs and drug indexes for each grade), prevalence was higher in 20 of the 
original selections and in 19 of the replacement selections.  
 
Potential biases could be subtle, however. If, for example, it turned out that most schools with 
“drug problems” refused to participate, the sample would be seriously biased. And if any other 
single factor were dominant in most refusals, that reason for refusal might also suggest a source of 
serious bias. However, the reasons schools fail to participate tend to be varied and are often a 
function of happenstance events specific to that particular year, such as a weather-related event 
that reduced the number of school days or the fact that the school already committed to participate 
in a number of other surveys that year; only very few schools object specifically to the drug-related 
survey content. 
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 If it were the case that schools differed substantially in drug use, then which particular schools 
participated could have a greater effect on estimates of drug use. However, the great majority of 
variance in drug use lies within schools, not between schools.10 For example, from 2003 to 2015 
for schools with 8th, 10th, or 12th grade students, about 2% to 8% of the variance in smoking 
cigarettes or drinking alcohol in the past 30 days was between schools. Among the illicit drugs, 
marijuana showed the largest amount of between-school variation, averaging between slightly less 
than 4% up to 5% for annual use, and 3% to 4% for 30-day use. Annual prevalence of cocaine use 
averaged between less than 1% and 1.5%, while prevalence of annual heroin use averaged less 
than 0.5%. Further, some, if not most, of the between-schools variance is due to differences related 
to factors such as region and urbanicity, which remain well controlled in the present sampling 
design. 
 
With respect to participation rates and changes in estimates of drug use, it is extremely unlikely 
that results have been significantly affected by changes in school participation rates. If changes in 
participation rates seriously affected prevalence estimates, there would be noticeable bumps up or 
down in concert with the changing rates. But this series of surveys produces results that are very 
smooth and generally change in an orderly fashion from one year to the next. Moreover, different 
substances trend in distinctly different ways. We have observed, for example, marijuana use 
decreasing while cocaine use was stable (in the early 1980s), alcohol use declining while cigarette 
use held steady (in the mid- to late 1980s), ecstasy use rising sharply while cocaine use showed 
some decline (late 1990s, early 2000s); and marijuana use continuing to rise while alcohol use hit 
historic lows (since 2011). Moreover, attitudes and perceptions about drugs have changed 
variously, but generally in ways quite consistent with the changes in actual use. All of these 
patterns are explainable in terms of psychological, social, and cultural factors; they cannot be 
explained by the common factor of changes in school participation rates.  
 
Of course, there could be some sort of constant bias across the years, but even in the unlikely event 
that there is, it seems highly improbable that it would be of much consequence for policy purposes, 
given that it would not affect trends and likely would have a very modest effect on levels of 
prevalence. Thus, we have a high degree of confidence that school refusal rates have not seriously 
biased the survey results. 
 
Nevertheless, securing the cooperation of schools has become increasingly difficult. This is a 
problem common to the field, not specific to MTF. Therefore, beginning with the 2003 survey, we 
have provided payment directly to schools as a means of increasing their incentive to participate. 
(By that time, several other ongoing school-based survey studies already were using payments to 
schools.) 
 
At each grade level, half of each year’s sample comprises schools that started their participation 
the previous year, and half comprises schools that began participating in the current year. (Both 
samples are national replicates, meaning that each is drawn to be nationally representative by 
itself.) This staggered half sample design is used to check on possible fluctuations in the year-to-
year trend estimates due to school turnover. For example, separate sets of one-year trend estimates 
                                                 
10 O’Malley, P. M., Johnston, L. D., Bachman, J. G., Schulenberg, J. E., & Kumar, R. (2006). How substance use differs among American secondary 
schools. Prevention Science, 7, 409–420.  
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are computed based on students in the half-sample of schools that participated in both 2017 and 
2018, then based on the students in the half-sample that participated in both 2016 and 2017, and 
so on. Thus, each one-year matched half-sample trend estimate derived in this way is based on a 
constant set of schools (about 65 in 12th grade, for example, over a given one-year interval). When 
the trend data derived from the matched half-sample (examined separately for each class of drugs) 
are compared with trends based on the total sample of schools surveyed each year, the results are 
usually highly similar, indicating that the trend estimates are affected little by school turnover or 
shifting participation rates. As would be expected, levels of absolute prevalence for a given year 
are not as precisely estimated using just the half sample because the sample size is only half as 
large. 
 
Student Participation 
In 2018, completed questionnaires were obtained from 89% of all sampled students in 8th grade, 
86% in 10th grade, and 81% in 12th grade (see Table 3-1 for student response rates in all years). In 
the large majority of cases, students are missed due to absence from school and/or class at the time 
of data collection; for reasons of cost efficiency, we typically do not schedule special follow up 
data collections for absent students. Because students with fairly high rates of absenteeism also 
report above-average rates of drug use, some degree of bias is introduced into the prevalence 
estimates by missing the absentees. Much of that bias could be corrected through the use of special 
weighting based on the self-reported absentee rates of the students who did respond; however, we 
decided not to use such a weighting procedure because the bias in overall drug use estimates was 
determined to be quite small and the necessary weighting procedures would have introduced 
greater sampling variance in the estimates. Appendix A in Volume I11 illustrates the changes in 
trend and prevalence estimates that would result if corrections for absentees had been included. Of 
course, some students simply refuse, when asked, to complete a questionnaire. However, the 
proportion of explicit refusals amounts to less than 1.8% of the target sample for each grade. 
 
Sampling Accuracy of the Estimates 
Confidence intervals (95%) are provided in Tables 4-1a through 4-1d in Volume I11 for lifetime, 
annual, 30-day, and daily prevalence of use for 8th, 10th, and 12th grade students. Confidence 
intervals for lifetime prevalence for 12th graders average less than ±1.4% across a variety of drug 
classes. That is, if we took a large number of samples of this size from the universe of all schools 
containing 12th graders in the coterminous United States, 95 times out of 100 the sample would 
yield a result that would be less than 1.4 percentage points divergent from the result we would get 
from a comparable massive survey of all 12th graders in all schools. This is a high level of sampling 
accuracy, permitting detection of fairly small changes from one year to the next. Confidence 
intervals for the other prevalence periods (last 12 months, last 30 days, and current daily use) are 
generally smaller than those for lifetime use. In general, confidence intervals for 8th and 10th 
graders are very similar to those observed for 12th graders. Some drugs (smokeless tobacco, PCP, 
and others, as indicated in the footnotes to the tables) are measured on only one or two 
questionnaire forms; these drugs will have somewhat larger confidence intervals because they are 
based on smaller sample sizes. 
 
                                                 
11 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan.  
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The Appendix C of Volume I published in years 2017 and earlier reported information on how to 
calculate confidence intervals for point estimates and how to calculate statistics that test the 
significance of changes over time or of differences between subgroups. This appendix is no longer 
necessary with the opening of MTF’s remote portal at the National Addiction and HIV Data 
Archive Program, which now allows researchers to compute such statistics directly using MTF 
weights and clustering variables. Interested readers may refer to Appendix C of earlier volumes 
for the information it provides about design effects and how their computational influence varies 
by substance. 
 
PANEL ATTRITION AND RETENTION   
 
We discuss here the nature of the panel attrition problem generally, the response rates for MTF 
panel surveys in recent years, and evidence relevant to assessing the impact of attrition on the 
study’s research results. 
 
The Problem of Panel Attrition 
Virtually all longitudinal studies – including MTF – experience attrition, which is often differential 
with respect to health risks including substance use.12 In addition, survey response rates in general 
have been declining in recent decades,13 highlighting an important challenge in the conduct of all 
population-based research. 
 
A vital feature of the MTF panel studies is the very low cost per respondent. There are many 
advantages to collecting panel data through low-cost surveys. Indeed, given the number of MTF 
follow-up questionnaires sent each year (roughly 19,000) across the entire coterminous U.S., we 
have viewed low-cost mail and web surveys as our best cost-effective options. One disadvantage 
of data collection by surveys is that attrition rates tend to be higher than for data obtained with 
much more expensive methods, such as intensive personal tracking and face-to-face interviewing. 
There are a few large epidemiological/etiological surveys that have better retention rates, but their 
procedures are extremely expensive and not realistic for an ongoing large-scale effort like MTF. 
Our retention rates compare favorably with those of most longitudinal studies reported in the field, 
including interview studies. We are working to increase response rates (or at least stem the general 
response rate erosion mentioned above and below), and the results of our experiments with web-
                                                 
12 Booker, C.L., Harding, S., & Benzeval, M. (2011). A systematic review of the effect of retention methods in population-based cohort studies. 
BMC Public Health, 11, 249; Brook, J.S., Saar, N.S., Zhang, C., & Brook, D.W. (2009). Psychosocial antecedents and adverse health 
consequences related to substance use. American Journal of Public Health, 99(3), 563-568; Galea, S., & Tracy, M. (2007). Participation rates in 
epidemiologic studies. Annals of Epidemiology, 17(9), 643-653; McCabe, S.E., & West, B.T. (2016). Selective nonresponse bias in population-
based survey estimates of drug use behaviors in the United States. Social Psychiatry & Psychiatric Epidemiology, 51(1), 141-153; McGuigan, K. 
A., Ellickson, P. L., Hays, R. D., & Bell, R. M. (1997). Adjusting for attrition in school-based samples: Bias, precision, and cost trade-off of three 
methods. Evaluation Review, 21, 554–567. 
13Dillman, D.A., Smyth, J.D., & Christian, L.M. (2009). Internet, mail, and mixed mode surveys: The tailored design method (3rd ed.). Hoboken, 
NJ: John Wiley & Sons; Groves, R. (2006). Nonresponse rates and nonresponse bias in household surveys. Public Opinion Quarterly, 70, 646–75; 
Groves, R.M., Dillman, D.A., Eltinge, J.L., & Little, R.J.A. (Eds.) (2002). Survey nonresponse. New York: Wiley. Kim, J., Gershenson, C., Glaser, 
P., & Smith, T.W. (2011). The polls – trends: Trends in surveys on surveys. Public Opinion Quarterly, 75(1), 165-191; Groves, R.M. (2006). 
Nonresponse rates and nonresponse bias in household surveys. Public Opinion Quarterly, 70(5), 646-675; Massey, D.S., & Tourangeau, R. (2013). 
The nonresponse challenge to surveys and statistics. Annals of the American Academy of Political and Social Science, 645, 1-236; Pew Research 
Center. (2012). Assessing the representativeness of public opinion surveys; Wechsler, H., Lee, J.E., Kuo, M., Seibring, M., Nelson, T.F., & Lee, 
H. (2002). Trends in college binge drinking during a period of increased prevention efforts: Findings from 4 Harvard School of Public Health 
College Alcohol Study surveys: 1993–2001. Journal of American College Health, 50, 203–217. 
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based data collections appear promising in terms of response rates and cost per respondent.14 As 
mentioned above, starting in 2018, we are using web-based survey procedures with a random half 
of young adults, and our plan for the future is to move all follow-up data collections to push web-
based surveys (and providing paper surveys as needed).  
 
Retention Rates 
The MTF survey data on American college students – an important subgroup in the panel surveys 
– now encompass 39 years. We know about our respondents’ actual college attendance only from 
those who are invited to and do complete follow-up questionnaires; however, we can use 12th grade 
questionnaire answers (i.e., college intentions/expectations and program of study) to predict 
college attendance with a high degree of accuracy. MTF’s retention of 12th graders who identified 
themselves as “college-bound” remains reasonably good. Among those participants in high school 
who were targeted for follow-up from the classes of 2012-2017, and who reported planning to 
attend college and being enrolled in a college-prep curriculum in 2018, the follow-up retention 
rates were: 40% in the first follow-up, one to two years past high school (based on the classes of 
2016-2017); 43% in the second follow-up, three to four years past high school (based on the classes 
of 2014-2015); and 44% in the third follow-up, five to six years past high school (based on the 
classes of 2012-2013).  
 
Retention rates in the biennial follow-ups of all panel members modal ages 19–30 (corresponding 
to the first six follow-ups) decline with the length of the follow-up interval, of course. For the five 
surveys from 2014 to 2018, the response rate in the first follow-up (corresponding to one to two 
years past high school) averaged 38%; and for the second through sixth follow-ups (corresponding 
to 3-12 years past high school) response rates averaged 39%. We found a significant difference (p 
<.001) in response rates by survey condition combining across 19-30 year olds in 2018: For typical 
mail condition, the response rate was 42.4%, and for web-push condition, the response rate was 
47.3% (note that these response rates are higher than the retention rates listed above for this age 
group because those young adults already lost to follow-up were not assigned to either condition 
and thus the denominator in these response rates are somewhat lower than those in retention rates 
indicated above). 
 
Among long-term respondents – those 35, 40, 45, 50, 55, and 60 years old – the retention rates are 
quite good, apparently due to cohort differences in their propensity to respond. Among respondents 
surveyed from 2014-2018, the average response rates for those age 35 (17 years past high school), 
age 40 (22 years past high school), age 45 (27 years past high school), age 50 (32 years past high 
school), and age 55 (37 years past high school) were 38%, 40%, 40%, 45%, and 53%, respectively. 
And for 60-year-olds, an age group surveyed for the first time in 2018, the response rate was 53%. 
In sum, the response rates attained under the current design range from respectable to good, 
especially when the low-cost nature of the procedures, the very long time intervals involved, and 
the substantial length of the questionnaires are taken into account. More importantly, the evidence 
leaves us confident that the data resulting from these follow-up panels are reasonably accurate. 
                                                 
14 Patrick, M. E., Couper, M. P., Laetz, V. B., Schulenberg, J. E., O'Malley, P. M., Johnston, L. D., & Miech, R. A. (2018). A sequential mixed 
mode experiment in the U.S. National Monitoring the Future study. Journal of Survey Statistics and Methodology, 6(1), 72-97. Patrick, M. E., 
Couper, M. P., Jang, B., Laetz, V. B., Schulenberg, J., Johnston, L. D., Bachman, J., O’Malley, P. M. (2019). Two-year follow-up of the sequential 
mixed-mode experiment in the U.S. National monitoring the future study. Survey Practice, 12(1). 
73
The Impact of Panel Attrition on Research Results 
An important purpose of the MTF panel study is to allow estimation of drug prevalence levels 
among U.S. high school graduates at various ages. Thus, we have always been concerned about 
making the appropriate adjustments to account for panel attrition. In essence, our standard 
adjustment process is a post-stratification procedure in which we reweight the data obtained from 
the follow-up samples in such a way that, when reweighted, the distribution of their 12th grade 
answers on a given drug matches the original distribution of use observed for that drug based on 
all participating high school seniors in their graduating class. This procedure is carried out 
separately for cigarettes, alcohol, and marijuana, as well as other illicit drugs (combined). As 
expected, it produces prevalence estimates in the follow-up data that are somewhat higher than 
those uncorrected for attrition, indicating a positive association between drug use and panel 
attrition. However, the adjustments are relatively modest. 
 
Attrition rates by levels of 12th grade substance use differ some, but less than one might expect. 
For example, based on analyses conducted some years ago for the classes of 1978–2008, among 
all respondents who had never used marijuana by 12th grade, an average of 74% participated in the 
first follow-up. The proportion responding was somewhat lower among those who had used 
marijuana once or twice in the last 12 months (67%). This proportion decreased gradually with 
increasing levels of marijuana use in 12th grade; but even among those who used marijuana on 20 
or more occasions in the last 30 days in 12th grade, 60% participated in the first follow-up. The 
corresponding participation rates for the same drug use strata at the fourth follow-up (i.e., at modal 
ages 25/26) were 64%, 57%, and 51%, respectively.15  
 
Thus, even among those who were active heavy users of marijuana in high school, response rates 
at the fourth follow-up were 13 percentage points lower than among those who had never used 
marijuana by 12th grade. That is not to say that we assume all types of drug users remain in the 
panels at comparably high rates. We believe that people who become dependent on or addicted to 
illicit drugs such as heroin, cocaine, or methamphetamine are less likely to be retained in 
reasonable proportions. That is why we are careful not to quantify or characterize these special 
segments of the population; but we note that they constitute very low proportions of the adult 
population. 
 
As a validation of our panel data on drug use, we compared MTF prevalence estimates with those 
from the National Survey on Drug Use and Health (NSDUH); this survey provides the best 
available comparison data because it is also based on national samples and uses cross-sectional 
surveys that do not have panel attrition. Using the NSDUH data from 2013 (Substance Abuse and 
Mental Health Administration, 201416), we compared the prevalence rates on a set of drugs – 
cigarettes, alcohol, marijuana, and cocaine – for which there was reasonable similarity in question 
wording across the two studies. As shown in Table 3-2, these comparisons showed a high degree 
of comparability in the prevalence estimates of the two studies,15 particularly with the post-
stratification procedure applied to the MTF data, as presented in this volume. 
 
                                                 
15 For more detail on these comparisons, see Chapter 3 in: Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Miech, R. A. 
(2015). Monitoring the Future national survey results on drug use, 1975-2014: Volume II, college students and adults ages 19-55. Ann Arbor: 
Institute for Social Research, The University of Michigan, 416 pp. 
16 Substance Abuse and Mental Health Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of 
National Findings and Detailed Tables. 
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In addition, attrition in the MTF panel is not necessarily as great a problem as nonresponse is in a 
cross-sectional study. In the MTF panel we know a great deal about each of the follow-up non-
respondents, including their prior substance use, based on a detailed questionnaire administered in 
12th grade (and, for many, in subsequent years as well). Thus, adjustments can be made utilizing 
data that are highly informative about the missing individuals. 
 
Finally, as is evident in the prevalence estimates and trends presented in this volume, substantial 
proportions of drug users remain in the MTF panels. Nonetheless, as mentioned above, we are 
unlikely to maintain large numbers of heavy drug users in our panels, suggesting that our estimates 
are conservative with respect to the adult population of U.S. high school graduates, even with post-
stratification weighting. 
 
Effects on Relational Analyses 
While differential attrition (uncorrected) may contribute to some bias in point estimates and other 
univariate statistics, a considerable amount of empirical research has shown that such attrition 
tends to have less influence on associations among variables.17 With MTF samples, we have found 
that correlations among variables at base year are very similar across groups who remain in the 
longitudinal study and those who do not.18 Thus, differential attrition may be of less concern in 
multivariable panel analyses focused on understanding the course, causes, and consequences of 
substance use. Still, as we summarized above, correcting for attrition can be important, and we 
continue to do so using these and other correction procedures (e.g., attrition weighting, data 
imputation, FIML) in our scientific publications. 
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on prevalence estimates and associations. Annals of Epidemiology, 13(2), 105–110. 
18 Bryant, A. L., Schulenberg, J. E., Bachman, J. G., O’Malley, P. M., & Johnston, L. D. (2000). Understanding the links among school misbehavior, 
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VALIDITY OF MEASURES OF SELF-REPORTED DRUG USE 
Are sensitive behaviors such as drug use honestly reported? Like most studies dealing with 
sensitive behaviors, we have no direct, totally objective validation of the present measures; 
however, the considerable amount of existing inferential evidence strongly suggests that the MTF 
self-report questions produce largely valid data. Here we briefly summarize this evidence.19  
 
First, using a three-wave panel design, we established that the various measures of self-reported 
drug use have a high degree of reliability – a necessary condition for validity.20 In essence, 
respondents were highly consistent in their self-reported behaviors over a three- to four-year time 
interval. Second, we found a high degree of consistency among logically related measures of use 
within the same questionnaire administration. Third, the proportion of 12th graders reporting some 
illicit drug use has reached two thirds of all respondents in peak years and over 80% in some follow 
up years, constituting prima facie evidence that the degree of underreporting must be very limited. 
Fourth, 12th graders’ reports of use by their unnamed friends – about whom they would presumably 
have considerably less reason to conceal information concerning use – have been highly consistent 
with self-reported use in the aggregate, both in terms of prevalence and trends in prevalence, as 
discussed in Chapter 7. Fifth, we have found self-reported drug use to relate in consistent and 
expected ways based on theory to a number of other attitudes, behaviors, beliefs, and social 
situations – strong evidence of “construct validity.” Sixth, the missing data levels for the self-
reported use questions are only very slightly higher than for the preceding nonsensitive questions, 
in spite of explicit instructions to respondents immediately preceding the drug section to leave 
blank those questions they feel they cannot answer honestly. Seventh, an examination of 
consistency in reporting of lifetime use conducted on the long-term panels of graduating seniors 
found quite low levels of recanting of earlier reported use of the illegal drugs.21 There was a higher 
level of recanting for the psychotherapeutic drugs, suggesting that adolescents may actually 
overestimate their use of some drugs because of misinformation about definitions, and this 
knowledge improves as they get older. Finally, the great majority of respondents, when asked, say 
they would answer such questions honestly if they are or were users.22  
 
As an additional step to assure the validity of the data, we check for logical inconsistencies in the 
answers to the triplet of questions about use of each drug (i.e., lifetime, annual, and 30-day use), 
and if a respondent exceeds a maximum number of inconsistencies across the set of drug use 
questions, his or her record is deleted from the data set. Similarly, we check for improbably high 
                                                 
19 A more complete discussion may be found in: Johnston, L. D. & O’Malley, P. M. (1985). Issues of validity and population coverage in student 
surveys of drug use. In B. A. Rouse, N. J. Kozel, & L. G. Richards (Eds.), Self-report methods of estimating drug use: Meeting current challenges 
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20 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. International Journal of the 
Addictions, 18, 805–824. 
21 Johnston, L. D. & O’Malley, P. M. (1997). The recanting of earlier reported drug use by young adults. In L. Harrison (Ed.), The validity of self-
reported drug use: Improving the accuracy of survey estimates (NIDA Research Monograph No. 167, pp. 59–80). Rockville, MD: National Institute 
on Drug Abuse. 
22 For a discussion of reliability and validity of student self-report measures of drug use like those used in MTF across varied cultural settings, see 
Johnston, L. D., Driessen, F. M. H. M., & Kokkevi, A. (1994). Surveying student drug misuse: A six-country pilot study. Strasbourg, France: 
Council of Europe.  
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rates of use of multiple drugs and delete such cases, assuming that the respondents are not taking 
the task seriously. Fortunately, very few cases (<3%) have to be eliminated for these reasons. 
 
This is not to argue that self-reported measures of drug use are necessarily valid in all studies. In 
MTF we have gone to great lengths to create a situation and set of procedures in which respondents 
recognize that their confidentiality will be protected. We have also tried to present a convincing 
case as to why such research is needed. The evidence suggests that a high level of validity has been 
obtained. Nevertheless, insofar as any remaining reporting bias exists, we believe it to be in the 
direction of underreporting. Thus, with the possible exception of the psychotherapeutic drugs, we 
believe our estimates to be lower than their true values, even for the obtained samples, but not 
substantially so. 
 
Consistency and Measurement of Trends 
MTF is designed to be sensitive to changes from one time period to another. A great strength of 
this study is that the measures and procedures have been standardized and applied consistently 
across many years. To the extent that any biases remain because of limits in school participation 
and/or respondent retention, and to the extent that there are distortions (lack of validity) in the 
responses of some students, it seems very likely that such problems will exist in much the same 
proportions from one year to the next. In other words, biases in the survey estimates will tend to 
be consistent from one year to another, meaning that they should have very little effect on our 
measurement of trends. Even as panel retention rates decline, our ability to adjust for differential 
attrition based on what we know about those lost to attrition allows for us to maintain consistency 
in the panel samples over time. The smooth and consistent nature of most trend curves reported 
for the various drugs provides rather compelling empirical support for this assertion. 
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Grade: 8th 10th 12th 8th 10th 12th 8th 10th 12th Total 8th 10th 12th Total 8th 10th 12th
1975 — — 111 — — 14 — — 125 — — — 15,791 — — — 78
1976 — — 108 — — 15 — — 123 — — — 16,678 — — — 77
1977 — — 108 — — 16 — — 124 — — — 18,436 — — — 79
1978 — — 111 — — 20 — — 131 — — — 18,924 — — — 83
1979 — — 111 — — 20 — — 131 — — — 16,662 — — — 82
1980 — — 107 — — 20 — — 127 — — — 16,524 — — — 82
1981 — — 109 — — 19 — — 128 — — — 18,267 — — — 81
1982 — — 116 — — 21 — — 137 — — — 18,348 — — — 83
1983 — — 112 — — 22 — — 134 — — — 16,947 — — — 84
1984 — — 117 — — 17 — — 134 — — — 16,499 — — — 83
1985 — — 115 — — 17 — — 132 — — — 16,502 — — — 84
1986 — — 113 — — 16 — — 129 — — — 15,713 — — — 83
1987 — — 117 — — 18 — — 135 — — — 16,843 — — — 84
1988 — — 113 — — 19 — — 132 — — — 16,795 — — — 83
1989 — — 111 — — 22 — — 133 — — — 17,142 — — — 86
1990 — — 114 — — 23 — — 137 — — — 15,676 — — — 86
1991 131 107 117 31 14 19 162 121 136 419 17,844 14,996 15,483 48,323 90 87 83
1992 133 106 120 26 19 18 159 125 138 422 19,015 14,997 16,251 50,263 90 88 84
1993 126 111 121 30 17 18 156 128 139 423 18,820 15,516 16,763 51,099 90 86 84
1994 116 116 119 34 14 20 150 130 139 419 17,708 16,080 15,929 49,717 89 88 84
1995 118 117 120 34 22 24 152 139 144 435 17,929 17,285 15,876 51,090 89 87 84
1996 122 113 118 30 20 21 152 133 139 424 18,368 15,873 14,824 49,065 91 87 83
1997 125 113 125 27 18 21 152 131 146 429 19,066 15,778 15,963 50,807 89 86 83
1998 122 110 124 27 19 20 149 129 144 422 18,667 15,419 15,780 49,866 88 87 82
1999 120 117 124 30 23 19 150 140 143 433 17,287 13,885 14,056 45,228 87 85 83
2000 125 121 116 31 24 18 156 145 134 435 17,311 14,576 13,286 45,173 89 86 83
2001 125 117 117 28 20 17 153 137 134 424 16,756 14,286 13,304 44,346 90 88 82
2002 115 113 102 26 20 18 141 133 120 394 15,489 14,683 13,544 43,716 91 85 83
2003 117 109 103 24 20 19 141 129 122 392 17,023 16,244 15,200 48,467 89 88 83
2004 120 111 109 27 20 19 147 131 128 406 17,413 16,839 15,222 49,474 89 88 82
2005 119 107 108 27 20 21 146 127 129 402 17,258 16,711 15,378 49,347 90 88 82
2006 122 105 116 29 18 20 151 123 136 410 17,026 16,620 14,814 48,460 91 88 83
2007 119 103 111 32 17 21 151 120 132 403 16,495 16,398 15,132 48,025 91 88 81
2008 116 103 103 28 19 17 144 122 120 386 16,253 15,518 14,577 46,348 90 88 79
2009 119 102 106 26 17 19 145 119 125 389 15,509 16,320 14,268 46,097 88 89 82
2010 120 105 104 27 18 22 147 123 126 396 15,769 15,586 15,127 46,482 88 87 85
2011 117 105 110 28 21 19 145 126 129 400 16,496 15,382 14,855 46,733 91 86 83
2012 115 107 107 27 19 20 142 126 127 395 15,678 15,428 14,343 45,449 91 87 83
2013 116 103 106 27 17 20 143 120 126 389 15,233 13,262 13,180 41,675 90 88 82
2014 111 98 105 30 16 17 141 114 122 377 15,195 13,341 13,015 41,551 90 88 82
2015 111 102 101 30 18 20 141 120 121 382 15,015 16,147 13,730 44,892 89 87 83
2016 117 92 100 25 18 20 142 110 120 372 17,643 15,230 12,600 45,473 90 88 80
2017 109 89 105 22 17 18 131 106 123 360 16,010 14,171 13,522 43,703 87 85 79
2018 110 106 106 28 20 22 138 126 128 392 14,836 15,144 14,502 44,482 89 86 81
Source.   The Monitoring the Future study, the University of Michigan.  
Public Schools Private Schools Number of Schools Number of Students Rate (%)
TABLE 3-1
Sample Sizes and Response Rates
Number of Number of Total Total Student Response
78
MTF MTF
NSDUH (Selection Weight Only) (Post‐Stratification Weight)
17.9 16.9 19.1
4.7 3.5 3.9
65.0 67.7 68.7
32.1 17.5 20.0
Source.   The Monitoring the Future study, the University of Michigan and the National Survey on Drug Use and Health.
                 
TABLE 3-2
Marijuana (use in past month)
Cocaine (use in past year)
Alcohol (use in past month)
Cigarettes (use in past month)
Substance Use Among Ages 19-28, Based on 2013 Data from
Monitoring the Future and The National Survey on Drug Use and Health
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Schools Included in One Year's Data Collection
Eighth, Tenth, and Twelfth Grades
FIGURE 3-1
One dot equals one school.
Source: The Monitoring the Future Study, the University of Michigan.
Note:
FIGURE 3-1
 Schools included in 1 Year’s Data Collection
8th, 10th, and 12th Grades
Source. The Monitoring the Future study, the University of Michigan.
Note. One dot equals one school.
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81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98
Percent of slots 
filled by... ’77 ’78 ’79 ’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07
Original 59 63 62 63 71 71 66 72 67 66 72 71 68 70 59 55 60 53 52 53 51 51 57 62 56 49 53 62 63 59 58
Replacements 39 36 35 32 25 26 32 26 29 33 26 26 30 29 39 43 39 44 44 43 47 48 42 35 42 48 45 37 34 40 39
Total 98 99 97 95 96 97 99 98 96 99 99 98 99 99 98 98 99 97 96 96 98 99 99 97 98 97 98 99 97 99 97
filled by... ’08 ’09 ’10 ’11 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17 ’18
Original 53 54 58 56 53 54 58 56 53 54 51 44 44 41 40
Replacements 43 44 39 40 43 44 39 40 43 41 41 49 47 49 50
Total 96 98 97 96 96 98 97 96 96 95 92 93 91 90 90
Source:  The Monitoring the Future study, the University of Michigan.
FIGURE 3-2
School Participation Rates
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Chapter 4 
 
PREVALENCE OF DRUG USE  
IN EARLY, MIDDLE, AND LATER ADULTHOOD 
 
Longitudinal panel studies that track the same individuals across several years are typically used 
to examine developmental changes with age, as is evident in many of our publications. At the same 
time, the multiple cohort feature of the MTF design provides a useful snapshot of each age group 
in a given year, showing the prevalence of use of various substances for each age group in that 
year, thus enabling us to compare these prevalence estimates with those of the same age in earlier 
years. This chapter highlights such prevalence data for the adult age groups covered by MTF, 
starting right after high school and moving through middle and into older adulthood. Each age 
group is defined by the modal age for its graduating high school class cohort.1 We will see that 
recent use tends to be higher in the early post-high school age groups, corresponding to the new 
freedoms associated with leaving high school and often moving away from the parental home.2,3 
But sometimes there are also strong cohort effects that underlie differences among age groups at a 
given point in time; in this chapter we will see evidence of both age-related differences and cohort 
effects. 
 
Estimates of drug use in the adult population are most often generated through household survey 
interviews of cross-sections of the general population. In the present study, our estimates come 
from self-reported questionnaires from respondents in the follow-up surveys. These are 
representative samples of previous classes of high school students who started their participation 
in MTF in their senior year. As described in more detail in Chapter 3, MTF has conducted ongoing 
panel studies on representative samples from each graduating high school senior class beginning 
with the class of 1976. From each class, two matched nationally representative subpanels of 
roughly 1,200 students each are randomly selected to comprise the follow-up panels through young 
adulthood; one subpanel is surveyed one year after graduation and every two years after that up 
through age 29/30. Beginning at modal age 35, data collection occurs at the same time for both 
subpanels at five-year intervals. So, while each cohort participates every year up through age 30, 
each individual respondent participates only every other year until age 29/30. This alternating 
panel design was chosen to reduce the burden and repetitiveness of participating in the panel study 
every year while still allowing for full age coverage between 19 and 30. Thus, in a given year, the 
study includes respondents ages 19-30 from one of the two subpanels from each of the last 12 
senior classes previously participating in MTF.4  
 
In 2018, representative samples of the classes of 2006 through 2017—modal ages 19 to 30—were 
surveyed using the same set of standard young adult survey instruments at each age. (There are six 
                                                 
1 High school seniors have a modal age (the most common age) of 18; therefore, in a follow-up conducted 12 years later they would have a modal 
age of 30. 
2 Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
3 Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in 
young adulthood: Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates. 
4 Through 2001, the follow-ups also included modal ages 31 and 32. This seventh follow-up was dropped in 2002 because we believed that the 
costs were no longer justified by the marginal benefits of having these follow-up data, given that an age-35 survey was being conducted.  
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different questionnaire forms and each individual receives the form corresponding to the form he 
or she completed in 12th grade.) For brevity, we refer to this 19-30 year old age range as “young 
adults” in this chapter. 
 
As discussed in Chapter 3, for 2018 data collections of 19-30 year olds, MTF began the transition 
from our typical mail-based surveys to web-based surveys. To test for survey mode differences, 
we randomly assigned half of the young adult respondents in 2018 to the typical mail survey 
condition and half to the new web-push condition (as described in Chapter 3). We found few 
significant differences in prevalence estimates between the two conditions, and thus combined the 
two in a weighted average in this chapter. We note exceptions when estimates differed significantly 
between conditions in the text and tables. At the end of the first section below on prevalence of 
substance use, we summarize the few significant differences in prevalence estimates across the 
two conditions. 
 
To build on the national panels of young adults, we extend the surveys into and beyond middle 
adulthood. The middle adulthood surveys are conducted beginning at modal age 35 (that is, 17 
years after high school graduation) and at five-year intervals thereafter through age 60. In each of 
these later follow-ups, the two sub-panels from the relevant graduating class are both surveyed in 
the same year, using a single questionnaire form instead of the six forms that were used from age 
19 to 30. The content of the questionnaires is revised to some degree across age to be more relevant 
to the different developmental periods, although key substance use and other measures remain the 
same. The results of the 2018 follow-up surveys characterize the population of high school 
graduates of modal ages 19-30, 35, 40, 45, 50, 55, and 60. In 2018, we conducted our first age 60 
follow-up survey (senior class of 1976); this volume provides the first examination of age 60 data. 
As discussed in Chapter 1, the high school dropout segment, between 6% and 15% across survey 
years, is missing from the senior year surveys and all of the follow-up surveys as well (as noted in 
Chapter 1, the high school dropout rate has declined for the younger cohorts). Thus, the results 
presented here are not necessarily generalizable to the entire population of each age, but are 
generalizable to the great majority of young and middle-aged adults—those who completed high 
school. 
 
Figures 4-1 through 4-21 contain 2018 prevalence data by age, corresponding to respondents ages 
19-30 (for total and in two-year age groups), as well as 35, 40, 45, 50, 55, and 60 year olds. For 
comparison purposes, data are also included for the 2018 high school senior class, listed as 18 year 
olds. Figures provided in Chapter 5 contain the trend data for each of these age groups derived 
from the repeated cross-sectional surveys, including 12th graders and high school graduates 
through age 60. In the figures in Chapters 4 and 5, age groups spanning the young adult years have 
been paired into two-year intervals in order to increase the number of cases, and thus the precision, 
for each point estimate; the approximate weighted sample sizes are 4,400 for 19-30 year olds, and 
700-800 per two year age group (see Tables 4-1 through 4-5). The data for ages 35, 40, 45, 50, 55, 
and 60 are, of necessity, based on a single age in each case. As indicated above, both half-samples 
from a given class cohort are included in each year’s samples of 35, 40, 45, 50, 55, and 60 year 
olds. In 2018 the paired half-samples came from the high school graduating classes of 2001, 1996, 
1991, 1986, 1981, and 1976, respectively. The respective weighted numbers of cases were 692, 
752, 771, 737, 775, and 825. (Actual unweighted numbers are somewhat higher because those 
from the oversampled drug-using stratum in high school, drawn at three times the rate of the others 
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to assure a sufficient sample of drug users, are counted as only one third of a case in the weighted 
follow-up data. This is discussed more in Chapter 3.)  
 
The weighting procedures used to adjust the panel data for the effects of panel attrition are 
described in Chapter 3. 
 
REPLICABILITY OF FINDINGS 
It is worth noting that any pattern of age-related differences found in one year can be checked in 
an adjacent year (i.e., the previous or succeeding year’s volume) for replicability, because two 
non-overlapping half-samples of follow-up respondents in the 19-to-30 age band are surveyed on 
alternating years. In the case of the 35, 40, 45, 50, 55, and 60 year olds, two entirely different 
graduating classes make up the samples for any two adjacent, chronological years of the survey 
results. 
 
THE IMPORTANCE OF ADJUSTED LIFETIME PREVALENCE ESTIMATES 
In Figures 4-1 through 4-21, two different estimates of lifetime prevalence are provided. One 
estimate is based on the respondents’ most recent (i.e., 2018) responses about ever having used the 
drug in question (the blue bar). The other estimate takes into account each respondent’s answers 
regarding lifetime use gathered from all of the previous data collections in which he or she 
participated (the white bar). To be categorized as one who has used the drug based on all past 
answers regarding that drug, a respondent must have reported either lifetime use in the most 
recent data collection and/or reported some use in his or her lifetime on at least two earlier data 
collections. (Because respondents of ages 18 through 20 cannot have their responses adjusted on 
the basis of two earlier data collections, adjusted prevalence rates are reported only for ages 21 
and up; when considering the total age 19-30 sample, lifetime prevalence is also unadjusted.) Most 
other epidemiological studies can present only an unadjusted estimate because they have data from 
a single cross-sectional survey. An adjusted estimate of the type used here is possible only when 
panel data have been gathered so that a respondent can be classified as having used a drug at some 
time in his or her life, based on earlier answers, even though he or she no longer indicates lifetime 
use in the most recent survey. 
 
The divergence of these two estimates increases as time passes; consistent divergences within age 
across history suggest this is largely an age effect (rather than a period or cohort effect). Obviously, 
there is more opportunity for inconsistency within individuals as the number of data collections 
increases. Our judgment is that the truth lies somewhere between the two estimates: the lower 
estimate may be depressed by tendencies to forget, forgive, or conceal earlier use, whereas the 
upper estimate may include earlier response errors or incorrect definitions of drugs that 
respondents appropriately corrected in later surveys as they became more knowledgeable. It should 
be noted that a fair proportion of those giving inconsistent answers across time had earlier reported 
having used the given drug only once or twice in their lifetime. 
 
As we have reported in depth previously, the cross-time stability of self-reported usage measures, 
taking into account both prevalence and frequency of self-reported use, is very high.5 Note that the 
                                                 
5 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. International Journal of the 
Addictions, 18, 805–824. 
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divergence between the two lifetime prevalence estimates is greatest for the psychotherapeutic 
drugs (including amphetamines, sedatives (barbiturates), narcotics other than heroin, and 
tranquilizers) and for the derivative index of use of an illicit drug other than marijuana (Figure 
4-2), which is heavily affected by the estimates of use of these psychotherapeutic drugs (without 
a doctor’s orders). We believe this is due to respondents having greater difficulty accurately 
categorizing psychotherapeutic drugs (usually taken in pill form) with a high degree of certainty, 
especially if such a drug was used (without a doctor’s orders) only once or twice. We expect higher 
inconsistency across time when the event, and in many of these cases a single event, is reported 
with a relatively low degree of certainty at quite different points in time. Those who have gone 
beyond simple experimentation with one of these drugs would likely be able to categorize them 
with a higher degree of certainty. Also, those who have experimented more recently (i.e., in the 
past month or year) should have a higher probability of recall as well as fresher information for 
accurately categorizing the drug. 
 
We provide both estimates of lifetime use across the list of drugs to make clear that a full use of 
respondent information provides a possible range for lifetime prevalence estimates, not a single 
point. However, by far the most important use of the prevalence data is to track trends in annual 
and 30-day (as opposed to lifetime) use. Thus, we are much less concerned about the nature of the 
variability in the lifetime estimates than we might otherwise be. The lifetime prevalence estimates 
are of importance primarily in showing the degree to which a drug class has penetrated the general 
population overall as well as particular cohorts; we believe that the evidence from the lifetime 
estimates suggests that other cross-sectional surveys of adults are subject to underreporting and 
that to some degree such underreporting increases with age, because adolescence and early 
adulthood are the periods in the life course during which most drug use occurs.6 
 
PREVALENCE OF DRUG USE ACROSS AGE GROUPS  
Figures 4-1 through 4-21 provide 2018 prevalence rates for each class of drugs, covering 
respondents ages 18 to 60. Tables 4-1 through 4-5 provide 2018 prevalence estimates for 19-30 
year olds, for the total sample and by sociodemographic characteristics. 
 
This section discusses differences in 2018 as a function of age, but it should be noted that these 
age differences are confounded with cohort differences. Thus, although the discussion is accurate 
with respect to age differences, it is not necessarily the case that the age differences would be 
similar in other time periods. In fact, our recent evidence, including many findings provided in 
Chapter 5, suggests both similarities and differences by age across cohorts. 7 
 
To begin this summary, we note three general age-related trends in 2018 prevalence; these trends 
were evident as they have been in our previous annual findings. First, for nearly all illicit drugs 
considered across ages 18 to 60, lifetime prevalence was higher for the older age groups, as would 
be expected (because of both age effects and cohort effects, with the current older cohorts being 
                                                 
6 For a more detailed analysis and discussion, see Johnston, L. D., & O’Malley, P. M. (1997). The recanting of earlier-reported drug use by young 
adults. In L. Harrison & A. Hughes (Eds.), The validity of self-reported drug use: Improving the accuracy of survey estimates (NIDA Research 
Monograph No-167). Washington, DC: National Institute on Drug Abuse. Accessed at https://archives.drugabuse.gov/nida-research-monograph-
index 
7 See Jager, J., Schulenberg, J. E., O'Malley, P. M., & Bachman, J. G. (2013). Historical variation in drug use trajectories across the transition to 
adulthood: The trend toward lower intercepts and steeper, ascending slopes. Development and Psychopathology, 25(2), 527-543. 
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from the highest drug using cohorts in the life of the study). The high levels of lifetime use among 
adults at ages 55 and 60 in 2018 are especially noteworthy, with adjusted lifetime prevalence of 
ever using any illicit drug being almost nine out of ten for 2018 55 and 60 year olds. Second, 
annual and 30-day illicit drug use in 2018 are highest among those in their early 20s for nearly all 
drugs, and then lower in subsequent age groups through age 60. Regarding marijuana in particular, 
annual use (43-44%) and 30-day use (26-28%) were highest for 21-24 year olds, with both 
declining mostly linearly with age to 16% and 11%, respectively, at age 60. Third, these age trends 
of annual and 30-day use did not generally apply for alcohol and tobacco use in 2018, with most 
age patterns being either rather flat across age or showing increases with age. An important 
exception is binge drinking (five or more drinks in a row at least once in last two weeks), which 
was highest at age 23/24 in 2018 at 37% and then progressively lower across age groups to 16% 
among 60 year olds. Details of and exceptions to these general age-related trends are provided 
below. As we note, age-related trends likely reflect, to some extent, cohort effects and secular 
trends.8 
 
 The adjusted lifetime prevalence figures are most striking for today’s 55 and 60 year olds 
(the high school classes of 1981 and 1976), who were passing through adolescence near 
the peak of the 1970s drug epidemic. Nearly nine out of ten (89%) reported trying an illicit 
drug (lifetime prevalence, adjusted), leaving only 11% who reported never having done so 
(Figure 4-1). Staying with the adjusted lifetime figures, about four out of five 55 and 60 
year olds (82% and 79%, respectively) said they had tried marijuana (Figure 4-3), and 
about three quarters (75% and 77%, respectively) said they had tried some other illicit drug 
(Figure 4-2), including almost half (47% and 48%) who had tried cocaine specifically 
(Figure 4-7). The adjusted lifetime prevalence of any illicit drug for 2018 50 year olds 
(high school class of 1986) was somewhat lower than for the 55 and 60 year olds, but still 
notably high at 82%; moving down the age spectrum, prevalence for 35-45 year olds was 
74-78% in 2018. It is clear from Figure 4-1 (and many of the other figures in this chapter) 
that the parents and grandparents of today’s teenagers and young adults represent very 
drug-experienced generations; this may help to explain the acceptance of medical 
marijuana in a large number of states and legalization of recreational marijuana for adults 
in a growing number of states. 
 
 In 2018, almost half (48%) of the high school seniors reported trying at least one illicit 
drug in their lifetime, typically marijuana (44%) as summarized below. Lifetime 
prevalence figures tend to be higher for those in their 20s than at earlier ages, suggesting 
that initiation of some drugs continues for many youth through their 20s. Among 29 to 30 
year olds adjusted lifetime prevalence reached 77% for any illicit drug, 70% for 
marijuana, 55% for any illicit drug other than marijuana, and 20% for cocaine. The 29 
to 30 year olds graduated from high school in 2006 and 2007, long after the peak of the 
1970s drug epidemic and after the peak of the relapse phase in the epidemic during the  
1990s; even in these relatively low drug-using cohorts, only about one fourth (23%) report 
never having tried an illegal drug. 
 
                                                 
8 See for example: Patrick, M. E., Terry-McElrath, Y. M., Lanza, S. T., Jager, J., Schulenberg, J. E., & O’Malley, P. M. (2019). Shifting age of 
peak binge drinking prevalence: Historical changes in normative trajectories among young adults aged 18 to 30. Alcoholism: Clinical and 
Experimental Research, 43, 287-298. 
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 As summarized below, despite the higher lifetime prevalence rates of illicit drugs among 
older age groups, these older groups generally showed annual or 30-day prevalence rates 
that are typically considerably lower than those of today’s 12th graders and young adults, 
suggesting that desistence more than offsets the incidence of initiating use of most illicit 
drugs during the years after high school. 
 
In analyses published elsewhere, we looked closely at patterns of change in drug use with 
age and identified post-high school experiences that contribute to declining levels of annual 
or 30-day use of drugs as respondents grow older. For example, the likelihood of marriage 
increases with age, and we have found that marriage is consistently associated with 
declines in alcohol use, binge drinking, marijuana use, and cocaine use, and most likely 
just about all of the other illicit drugs as well.9 
 
 For use of any illicit drug, annual prevalence in 2018 was 42% among 19-30 year olds 
combined (Table 4-1), peaking among 21 to 24 year olds (47%); it was lowest among the 
older age groups, ranging between 19% and 30% among 35 to 60 year olds (Figure 4-1). 
Thirty-day prevalence was 26% among 19-30 year olds combined and highest among 21-
22 year olds (30%); it was lower among the older age groups (12% to 18%). Thus, the 
annual and 30-day use of any illicit drugs in 2018 was highest among those in their early 
20s.  
 
 Lifetime prevalence for marijuana (Figure 4-3) in 2018 generally increased with age 
through the 20s, with adjusted lifetime prevalence reaching 70% among those aged 29-30. 
But, against the general pattern of increasing lifetime prevalence with age, prevalence was 
level or even slightly lower among 45 year olds (68%). This pattern of lifetime use leveling 
or even being lower among 45 year olds was also true for some other illicit drugs (e.g., 
amphetamines, cocaine, sedatives (barbiturates). The 45 year olds graduated from high 
school in 1991 when prevalence of marijuana and other drugs was at or near historic lows 
across the past four decades, thus suggesting a cohort effect.   
 
 Annual prevalence for marijuana in 2018 was 38%10 for 19-30 year olds combined (Table 
4-1), and highest at ages 21-22 (44%); it generally declined through age 50 (13%) and then 
                                                 
9 See MTF website for examples including: a) Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). 
Smoking, drinking, and drug use in young adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum 
Associates; and Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of 
substance use in young adulthood: Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates; b) O’Malley, P. 
M., Bachman, J. G., Johnston, L. D., & Schulenberg, J. E. (2004). Studying the transition from youth to adulthood: Impacts on substance use and 
abuse. In J. S. House, F. T. Juster, R. L. Kahn, H. Schuman, & E. Singer (Eds.), A telescope on society: Survey research and social science at the 
University of Michigan and beyond (pp. 305–329). Ann Arbor, MI: The University of Michigan Press; c) Staff, J., Schulenberg, J. E., Maslowsky, 
J., Bachman, J. G., O’Malley, P. M., Maggs, J. L., & Johnston, L. D. (2010). Substance use changes and social role transitions: Proximal 
developmental effects on ongoing trajectories from late adolescence through early adulthood. Development and Psychopathology, 22 (Special issue: 
Developmental cascades: Part 2), 917-932; d) Maggs, J. L., Jager, J., Patrick, M. E., & Schulenberg, J. E. (2012). Social patterning in early adulthood 
in the USA: Adolescent predictors and concurrent wellbeing across four distinct configurations. Longitudinal and Life Course Studies (Special 
Section: Transition to Adulthood in the UK, the US and Finland; Guest Editors: J. E. Schulenberg and I. Schoon), 3(2), 190-210; e) McCabe, S. E., 
Kloska, D. D., Veliz, P., Jager, J., & Schulenberg, J. E. (2016). Developmental course of nonmedical use of prescription drugs from adolescence 
to adulthood in the United States: National longitudinal data. Addiction, 111(12), 2166-2176; f)  Jang, B., Patrick, M. E., & Schuler, M. S. (2018). 
Substance use behaviors and the timing of family formation during young adulthood. Journal of Family Issues, 39, 1396-1418; and Jang, B., 
Schuler, M. S., Evans-Polce, R. J., Patrick, M. E. (2018). Marital status as a partial mediator of the associations between young adult substance use 
and subsequent substance use disorder: Application of causal inference methods. Journal of Studies on Alcohol and Drugs, 79, 567-577. 
10 As noted in Table 4-1, for the 2018 estimate of annual marijuana use for 19-30 year olds combined, there was a significant difference (p<.05) 
between the typical mail condition of survey administration (36.5%) and the new web-push condition (39.5%) of survey administration. 
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increased somewhat at ages 55 and 60 (16%) (Figure 4-3). A similar age-group pattern held 
for 30-day prevalence. It was 24% for ages 19-30 combined and highest for 21-22 year 
olds (28%); it declined through age 50 (8%) and then increased somewhat at ages 55 and 
60 (10-11%). As is evident in Figure 4-3 comparing annual and 30-day prevalence with 
lifetime prevalence, greater proportions—usually much greater proportions—of the older 
cohorts have discontinued use. 
 
 Current daily marijuana use (defined as using on 20 or more occasions in the past 30 days) 
in 2018 was 8% among 19-30 year olds combined (Table 4-1). It showed some age 
differences (see Figure 4-3 in this chapter as well as in Figure 5-3c in Chapter 5), standing 
at 6% at age 18, 9% at ages 21-24, and then dropping with age to 3-4% at ages 45 to 60. 
This suggests that many respondents who were daily users at some point in their teenage 
and young adult years are no longer daily users in middle to later adulthood. 
 
 New questions about vaping marijuana were added to two forms of the young adult 
surveys in 2017 and 2018 (yielding sample sizes of about 1500 for 19-30 combined, and 
230-270 per age group). In 2018, lifetime prevalence was 21% among 19-30 year olds; 
across the age groups, it was 22% at ages 19-24, 23-24% at ages 25-28, and dropping to 
18% at ages 29-30 (Table 4-2). Annual prevalence was 15% among 19-30 year olds; for 
the young adult age groups, it was 17% at ages 19-24, 16% at ages 25-26, 12% at ages 27-
28, and 14% at ages 29-30 (Table 4-3). Thirty-day prevalence of vaping marijuana in 2018 
was 8.5% among 19-30 year olds; for the young adult age groups it was 10-11% for age 
groups between 19-20 and 25-26, dropping to 6% at ages 27-30 (Table 4-4). Thus, in 2018, 
vaping marijuana is more common among those in their early to mid-20s than later 20s. 
The recent rapid increase in vaping among adolescents11 may well have generated cohort 
differences that are reflected in these age groups and may also appear in later age groups 
in the future. Beginning in 2019, the vaping items will be on four of the six young adult 
survey forms, and will be in the age 35 and up forms, providing a better perspective on this 
rapidly growing phenomenon. Trends (2017-2018) in vaping marijuana among young 
adults are presented in Chapter 5. 
 
 Synthetic marijuana refers to a set of substances containing synthetic cannabinoids that 
are meant to mimic the effects of cannabinoids found in natural marijuana; synthetic 
cannabinoids are created artificially and typically sprayed on herbal and plant material, 
which is then smoked. These substances have been sold over the counter in head shops, 
gas stations, on the Internet, and in other venues under various brand names like “spice” 
and “K-2.” Only 1.4% of young adults ages 19 to 30 years reported using synthetic 
marijuana in the last 12 months in 2018 (Table 4-3). Use rates were highest among the 19-
20 year olds (2%), and then declined unevenly with age to 0.4% among 29-30 year olds 
(use is not asked of those over age 30). Clearly, synthetic marijuana is not a commonly 
used drug, especially beyond the early 20s.  
 
 Adjusted rates for lifetime use of any illicit drug other than marijuana (Figure 4-2) 
showed an appreciable rise across age groups in 2018, reaching 55% for the 29-30 year 
                                                 
11 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
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olds and 77% among 60 year olds (Figure 4-2). In other words, about three quarters of all 
60 year olds have tried some illicit drug other than marijuana, and over half of today’s 30 
year olds have done so.  
In 2018, both annual and past 30-day use were highest in the early to mid-20s (Figure 4-
2). Annual use was 19% among 19-30 year olds combined (Table 4-1). It rose with age 
from 12% among 12th graders to 22% among 21-24 year olds, and then was fairly level 
through age 29-30 (18-20%). Thirty-day use was 8% among 19-30 year olds combined 
(Table 4-4); it rose across age groups  from 6% at age 18 to 10% at ages 23-24, and was 7-
9% for ages 25-30. Among those age 35 and older, annual prevalence declined unevenly 
from 14% at age 35 to 7% at age 60; 30-day prevalence was fairly level from ages 35 to 60 
at 4% to 6%. As summarized below, a number of the individual drugs that comprise this 
general category show lower rates of use at higher ages for annual prevalence, usually with 
the highest rate observed at ages 18-24. This is particularly true for amphetamines, 
cocaine, hallucinogens, LSD specifically, hallucinogens other than LSD, inhalants, and 
MDMA (ecstasy, Molly). The falloff across age strata is not as great nor as consistent for 
crystal methamphetamine (ice), heroin, narcotics other than heroin, sedatives 
(barbiturates), and tranquilizers, though in general, usage rates are somewhat lower 
among those in their late-20s and older than among those in their early to mid-20s. Several 
of these classes of drugs are discussed individually next.  
 Hallucinogens (Figure 4-10) have been used by a fair proportion of adults. Adjusted
lifetime rates in 2018 were between 22% and 28% for the 35-50 year olds. (Hallucinogens
are not included in the age 55 or age 60 survey.) Adjusted lifetime prevalence was lower
at younger ages, and was at 13% at age 21-22. Annual prevalence in 2018 was 5% among
19-30 year olds combined (Table 4-3), ranging 4-6% in this age group; it was 2% or less
at the older ages (Figure 4-10).
 LSD (Figure 4-11) had a fairly limited adjusted lifetime prevalence among young adults in
2018, reaching a high of 14% among 23-24 and 29-30 year olds. Annual prevalence was
4% among 19-30 year olds combined (Table 4-3), and highest among 19-22 year olds at
5%, falling thereafter to 2-4% through age 29-30. LSD use was not asked of those over age
30.
 Hallucinogens other than LSD (Figure 4-12), which means psilocybin (“magic
mushrooms”) for the most part, had a higher adjusted lifetime prevalence among young
adults in 2018 than LSD, reaching 20% by age 29-30. Annual prevalence was level at 3-
4% across all age groups 19 to 30. Overall, among young adults aged 19-30, annual
prevalence was similar for hallucinogens other than LSD (3.3%) and for LSD (3.6%)
(Table 4-3). Use was not asked of those over age 30.
 Inhalants are not commonly used by adults. In 2018, adjusted lifetime prevalence
increased across age strata, peaking at 13% among 29-30 year olds (Figure 4-13). Annual
prevalence was highest at ages 18-20 (2%) and declined with age, while 30-day rates were
already quite low by age 18 and did not have much more room to decline. Clearly, 30-day
use of inhalants is almost absent beyond about age 18, and we know from data presented
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in Volume I that much of the decline in use with age has already occurred by 10th grade. 
Use was not asked of those over age 30. 
 
 For amphetamines used without a doctor’s orders, lifetime prevalence was much higher 
among the older age groups, with adjusted lifetime prevalence increasing from 16% at age 
21-22 to 29% at age 29-30 and to 53% at age 60 in 2018 (Figure 4-4). This increase with 
age reflects in part the addition of new users who initiate use in adulthood, but also 
reflecting some cohort differences carried over from high school. Those aged 45 in 2018 
had relatively lower lifetime amphetamine use, reflecting that these respondents graduated 
from high school in the early 1990s when prevalence was at or near historic lows across 
the past four decades. As is true for most psychotherapeutic drugs, corrected lifetime 
prevalence and contemporaneously reported lifetime prevalence diverge considerably 
especially among those age 35 and older. However, more recent use, as reflected in annual 
prevalence (Table 4-3 and Figure 4-4), was considerably lower among the older age groups. 
It was 7.5% for those age 19-30 combined, peaking at 10% at age 23-24 and declining to 
7% at age 29-30 and to 1% by age 60. Thirty-day prevalence was 2.8% for 19-30 year olds 
overall (Table 4-3), ranging from 2% to 4% in this age group; it was 0-1% among those 
aged 35-60. These age differences have not always been true; the present pattern reflects a 
sharper historic decline in use among older respondents than has occurred among 12th 
graders, as well as cohort differences in having ever used these drugs. These trends are 
discussed in the next chapter. 
 
 Ritalin, a stimulant widely prescribed for the treatment of attention deficit hyperactivity 
disorder or ADHD, shows a relatively low annual prevalence of nonmedical use, between 
0.8% and 1.8% for ages 19 to 30 in 2018 (Table 4-3). Use was not asked of those over age 
30. 
  
 Adderall, an amphetamine stimulant also used in the treatment of ADHD, showed a 
substantially higher annual prevalence of nonmedical use in 2018 compared to Ritalin. It 
was 8.7% among 19-30 year olds combined; it was highest at 12% among 21-24 year olds 
and was 6-7% among 25-30 year olds (Table 4-3). The higher rates of use among those in 
their early 20s are consistent with the interpretation that initially Ritalin and perhaps now 
Adderall are sometimes used by college students in an effort to enhance their academic 
performance. Use was not asked of those over age 30. 
  
 Questions on the use of methamphetamine are contained in only two of the six 
questionnaire forms for young adults, so estimates are less reliable than those based on all 
six forms. In 2018 adjusted lifetime use increased across age strata, from 2% for 21-22 year 
olds to 7% for 29-30 year olds. This suggests that much initiation of methamphetamine use 
occurs after high school, though more recent cohorts of high school graduates have been 
reporting considerably lower levels of use post high school. Annual prevalence did not vary 
much with age, however, remaining at 0.4-2.5% for ages 19-30 in this population of high 
school graduates (Table 4-3 and Figure 4-5.) Respondents over age 30 are not asked about 
methamphetamine use. 
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 Crystal methamphetamine (ice) is also included on only two questionnaire forms through 
age 30 and is not asked of older respondents. In 2018, adjusted lifetime prevalence was 
highest at 5% among those age 29-30. Among the 19-30 year old respondents combined, 
only 0.4% reported any use in the prior year, similar to the 0.6% reported by 12th graders 
(Table 4-3 and Figure 4-6). 
 
 Questions regarding bath salts were added to the MTF questionnaires for young adults in 
2012. Fortunately, the rates of use of these dangerous over-the-counter stimulants 
containing cathinones, which are intended to mimic the effects of amphetamines, are quite 
low at this point. In 2018, 12th graders had an annual prevalence of 0.6%; among young 
adults 19-30, prevalence in 2018 was 0.2%,12 with some minor variation by age (Table 4-
3). Use is not asked of those over age 30.  
 
 Nonmedical use of sedatives (barbiturates) showed adjusted lifetime prevalence rates in 
2018 that rose fairly linearly from age 21-22 (6%) through age 60 (36%), and showing a 
slight relative dip at age 45 (Figure 4-14). Annual use was 2.5% among 19-30 year olds 
combined (Table 4-1) and was quite level across all age groups from 18 to 60 at 2-3%. 
Thirty-day use was 0-1% across all age groups. It is noteworthy that because of the 
substantial long-term decline in sedative (barbiturate) use over the life of MTF, the 60 year 
olds had by far the highest adjusted lifetime prevalence (36%); but they were not any more 
likely to be currently using than the younger age groups.13  
 
 Nonmedical use of tranquilizers (Figure 4-16) shows a similar picture to that for sedatives 
(barbiturates), with a general increase across age-bands in adjusted lifetime prevalence 
through age 35 (29%), with a slight dip among those ages 40 and 45 (27%), reflecting a 
likely cohort effect in terms of the lower use among adolescents in the late 1980s and early 
1990s. Those aged 50, 55, and 60 again showed higher, indeed the highest, levels of 
adjusted lifetime prevalence (31%, 38%, and 46% respectively). Annual prevalence of 
nonmedical tranquilizer use was 4.2% among 19-30 year olds combined (Table 4-1) and 
was similar across all age groups, ranging between 3% and 5% from age 18 through age 
60. Thirty-day prevalence was 0-2% across all age groups.  
 
 Adjusted lifetime prevalence of nonmedical use of narcotics other than heroin (Figure 4-
15) varied considerably across the age groups in 2018 from 10% for those age 21-22 to 
29% for those age 29-30; it was 34% at age 35, 32% at age 40, 31% at age 45, 33% at age 
50, 33% at age 55, and 37% at age 60. 14These age differences in adjusted lifetime 
prevalence likely reflect cohort effects, with the oldest and more recent cohorts through 
age 35 showing higher prevalence. Annual prevalence of narcotics other than heroin was 
                                                 
12 As noted in Table 4-1, for the 2018 estimate of annual bath salt use for 19-30 year olds combined, there was a significant difference (p<.05) 
between the typical mail condition (0.4%) and new web-push condition (<0.05% - essentially 0.0%) of survey administration. 
13 Barbiturates were the dominant form of sedatives in use when these questions were first introduced. In the intervening years, a number of non-
barbiturate sedatives have entered the market and largely displaced barbiturates. We believe that a number of users of non-barbiturate sedatives are 
reporting them in answer to this question, which also defines them in terms of the conditions for which they are prescribed. In recognition of this 
fact, we now label them as “sedatives (barbiturates).” The rewording of the question was made in half of the questionnaire forms in 2004 and in 
the other half in 2005. 
14 As noted in Table 4-2, for the 2018 estimate of (unadjusted) lifetime narcotics other than heroin use for 19-30 year olds combined (14.0%), there 
was a significant difference (p<.01) between the typical mail condition (15.2%) and new web-push condition (12.7%) of survey administration. 
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3.6% among 19-30 year olds combined, and increased slightly across the 20s from 2.2% at 
age 19-20 to 4.5 at age 29-30 (Table 4-3). Among older adults, it was highest at age 35 
(5%) and level from ages 40 to 60 (3-4%). Thirty-day prevalence showed little difference 
across the age bands, with rates at 1-2% up through age 60.  
 Adjusted lifetime prevalence of cocaine in 2018 was lowest among 21-22 year olds (10%)
and generally increased through age 40 (23%); it then leveled through age 45 (22%),
continued to increase at age 50 (32%) and 55 (47%), and peaked at age 60 (48%) (Figure
4-7). This uneven age progression is indicative of a cohort effect, with the 40-45 year olds
being from lower drug using 12th grade cohorts (as discussed in Chapter 5, there have been
clear cohort effects in cocaine use over the years). Annual prevalence in 2018 was 5.9%
for ages 19-30 combined, peaking at 9.2% at ages 23-24, and was otherwise at 4-6% among
young adults; annual use was only 1-3% in the age groups beyond age 30. Thirty-day use
was 2.2% for ages 19-30 combined, ranging from 1.5% to 2.9% among young adults. Very
few (0-1%) of the 35-60 year olds today are past-30-day users of cocaine, despite the fact
that so many of them used it at least once in their lifetime. Among 55 and 60 year olds,
nearly half used cocaine at some time in their life but less than 1% reported using it in the
past 30 days. In other words, noncontinuation rates for cocaine are now extremely high
among adults, particularly older adults.
 In 2018, adjusted lifetime prevalence of crack use (Figure 4-8) was much lower than
general cocaine use. It was 2% among 23-24 year olds and then increased with age to 11%
among 60 year olds, peaking at 13% among 55 year olds. That it was highest among 50-60
year olds (10-13%) reflects something of a cohort effect due to the rather transient
popularity of crack in the early to mid-1980s and a brief resurgence in the mid-1990s.
Annual prevalence was highest among 18 year olds at 0.9%, and was between 0.0% and
0.4% for all other age groups. Thirty-day prevalence was less than 0.5% in each of these
age groups.
 MDMA (ecstasy and, more recently, Molly) is asked about in four of the six follow-up
questionnaire forms up through age 30. Molly was added as an example in half of the
questionnaire forms in 2014 and in all young adult forms in 2015 (use is not asked for those
over age 30). As Table 5-2 in the next chapter shows, the inclusion of Molly appears to
have only raised the annual prevalence estimate in 2014 (when the two versions could be
compared) by a little—from 4.8% to 5.1%. In 2018, among 19-30 year olds combined,
13% said they have tried MDMA (adjusted lifetime prevalence), compared to 4% of 12th
graders. Across the 20s, adjusted lifetime MDMA prevalence increased unevenly with age,
peaking at 20% among 29-30 year olds (Figure 4-17). Annual prevalence was 4.0% for
ages 19-30 combined, ranging from 3.1% to 4.5% (Table 4-3). Thirty-day MDMA use was
at 1% or lower for all age strata between 18 and 30 years in 2018. There clearly has been
a high degree of noncontinuation of the use of this drug in 18-30 year olds, and the large
differences across age groups likely reflect cohort effects. (Note in Figure 4-17 that there
is practically no difference between the current reporting of lifetime prevalence and the
adjusted figures.)
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 A question about the use of salvia was introduced into one questionnaire form in 2009 as 
a single tripwire question asking only the frequency of use in the past twelve months (Table 
4-3). Salvia has some mild hallucinogenic properties. It is not currently regulated by the 
federal government, but a number of states have restrictions on it, and other states are 
considering restrictions; previously, there had been considerable attention in the media paid 
to its potential for harm. Annual prevalence for ages 19 through 30 combined is very low; 
it stood at 0.6% in 2018 (Table 4-3). Thirty-day use was 1% or less across ages 18-30. 
Older respondents are not asked the question. 
 
 In 2018, all alcohol prevalence estimates were considerably higher among young adults 
than among 12th graders, and they generally increased after high school, through at least 
the mid-20s (Figures 4-20a and 4-20b). Adjusted lifetime prevalence was 86% among 21-
22 year olds and ranged from 93% to 94% among 23-30 year olds; it changed very little 
after age 30, due in large part to a “ceiling effect” (prevalence was 96% to 99% among 
those age 35 to 60). Annual use was 53% at age 18 and 83% at ages 19-30 combined (Table 
4-3); it rose sharply with age, peaking at 90% at age 23-34; it was level from age 25-26 
through age 40 (86-87%), and then declined to 78% among 60 year olds. Thirty-day use 
was 30% at age 18 and 67% at ages 19-30 combined (Table 4-3); it rose sharply with age, 
peaking at 75% among 23-24 year olds, was fairly level from age 25-26 to age 45 (70-
73%), and then declined unevenly through age 60 (61%). Current daily drinking (Figure 
4-20b) increased gradually and steadily across age strata, peaking at 12% at age 60.  
 
Binge drinking (i.e., having five or more drinks in a row on at least one occasion in the 
two weeks prior to the survey) was 31%15 for young adults age 19-30 combined (Table 4-
5) and showed considerable differences by age (Figure 4-20b). Prevalence was 14% at age 
18 and 21% among those ages 19-20. It was highest at age 23-24 at 37% and ranged from 
31% to 33% among 25-30 year olds; it was 27% at age 35 and declined with age to 16% at 
age 60. We have interpreted this increasing-then-decreasing relationship with age as 
reflecting an age effect, not a cohort effect, because it seems to replicate across different 
graduating class cohorts and also because it has been linked directly to age-related events 
such as leaving the parental home (which is linked to increases binge drinking) and 
marriage (which is linked to decreases).16 Clearly, binge drinking is most popular among 
people in their twenties and falls off after that. Still, among those age 50 and older, almost 
a fifth report current binge drinking.  
 
                                                 
15 As noted in Table 4-5, for the 2018 estimate of binge drinking for 19-30 year olds combined, there was a significant difference (p<.05) between 
the typical mail condition (29.4%) and new web-push condition (32.9%) of survey administration. 
16 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade 
of change, 1976–1986. American Journal of Public Health, 78(10), 1315–1321. See also a) Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., 
Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young adulthood: The impacts of new freedoms and new 
responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates; b) Schulenberg, J. E., & Maggs, J. L. (2002). A developmental perspective on alcohol 
use and heavy drinking during adolescence and the transition to young adulthood. Journal of Studies on Alcohol, Supplement, (14), 54-70; c) 
Patrick, M. E., Terry-McElrath, Y. M., Lanza, S. T., Jager, J., Schulenberg, J. E., & O’Malley, P. M. (2019). Shifting age of peak binge drinking 
prevalence: Historical changes in normative trajectories among young adults aged 18 to 30. Alcoholism: Clinical and Experimental Research, 43, 
287-298. 
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Questions regarding extreme binge drinking (also referred to as high-intensity 
drinking)17,18,19,20 were introduced into MTF surveys in 2005. Two measures are used: 
drinking 10 or more drinks on one or more occasions in the prior two weeks and drinking 
15 or more drinks on one or more occasions in the prior two weeks.21 Among all young 
adults 19-30 (Table 4-5), prevalence of having 10 or more drinks on at least one occasion 
in the two weeks prior to the survey was 8.4% in 2018 or roughly one in every twelve 
respondents; it was 5.7% at ages 19-20, 8-11% at ages 23-30, and highest at ages 23-24 
(11%). The combined age 19-30 prevalence for having 15 or more drinks on at least one 
occasion in the prior two weeks was 3.4% or about one in 30 respondents; it appeared 
highest among 21-22 year olds (5.5%). These questions are not asked of respondents over 
age 30.  
 
 Cigarette smoking showed an unusual pattern of age-related differences, influenced to 
some extent by cohort differences (Figure 4-21). In 2018 30-day (current) smoking 
prevalence was lowest among 12th graders (8%), highest among 23-24 and 29-30 year olds 
(15%) and was 10-13% among other young adults; among those age 35-60, it was level, 
ranging from 11% to 14%. Among 18-30 year olds, the prevalence of daily smoking 
generally was higher among the older age strata, peaking at ages 29-30 (10%); among those 
aged 35-60, it was 9-12%. At older ages, a rising proportion past-30-day smokers also 
reported daily smoking. Through age 30 a majority of those indicating any smoking in the 
prior year were not daily smokers; the proportion then declined with age so that among 
those age 60 only about one fifth of those who smoked in the prior year were not daily 
smokers.  
 
The prevalence of smoking half a pack or more of cigarettes per day was only 1% among 
those age 18 and increased with age across young adulthood to 6% at age 29-30; it was 6-
7% among 35-50 year olds, and highest among 55-60 year olds (9-10%). The proportions 
of current smokers who smoked a half-pack or more per day also were higher among older 
respondents in 2018: about one eighth among 18 year olds (1% smoking a half-pack or 
more divided by 8% who are 30-day smokers), about one third among 29-30 year olds (5% 
smoking a half-pack or more divided by 15% who are 30-day smokers), and nearly three 
fourths at age 60 (10% smoking a half-pack or more divided by 13% who are 30-day 
smokers).  
 
In essence, lighter smoking (in the past 12 months, but not in the past 30-days) falls off as 
one moves up the age bands beyond age 30, after which regular/heavy smoking accounts 
                                                 
 17 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O’Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence of 
binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41(7), 
1319-1328. 
18 Patrick, M. E. & Terry-McElrath, Y. M. (2017). High-intensity drinking by underage young adults in the United States. Addiction, 112, 82-93. 
19 Patrick, M. E., Terry-McElrath, Y. M., Kloska, D. D., & Schulenberg, J. E. (2016). High-intensity drinking among young adults in the United 
States: Prevalence, frequency, and developmental change. Alcoholism: Clinical and Experimental Research, 40, 1905-1912. 
20 Terry-McElrath, Y. M. & Patrick, M. E. (2016). Intoxication and binge and high-intensity drinking among US young adults in their mid-20s. 
Substance Abuse, 37, 597-605.  
21 Because these two measures reported here have been included in only one of the six questionnaire forms used with young adults (they are included 
on a second form, but those data are not included here due to inconsistent variations between the responses on the two forms), the numbers of cases 
are very limited, less than 200 weighted cases per year for each two-year age band from 19 to 30. Therefore, the estimates may be less reliable than 
those based on more cases.  
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for increasing proportions of all current smoking, as may be seen in Figure 4-21. It appears 
highly likely that cohort differences in ever initiating smoking drive this pattern of cross-
age smoking rates. 
 
 Past 30-day prevalence of smokeless tobacco use (asked in one of the six questionnaire 
forms, so estimates tend to vary unsystematically) stood at 7.2% among all young adults 
in 2018 (most of it by males, as will be discussed below). Daily prevalence was 3.6% 
among all young adults, with the highest rate observed among 23-24 year olds (9.5%) 
(Tables 4-4 and 4-5).  
 
 In 2017, we expanded the questions about vaping on two of the survey forms to get at 
specific substances being vaped, specifically for nicotine, marijuana, and “just flavoring.” 
In 2018, lifetime prevalence of vaping nicotine was 27%22 among 19-30 year olds, with it 
being highest for 19-20 year olds (35%) and declining across the age groups (Table 4-2). 
Annual prevalence was 17%23 among 19-30 year olds, with it also being highest among 
19-20 year olds (27%) and declining across age groups (Table 4-3). Thirty-day prevalence 
was 10%24 among 19-30 year olds, and again highest among 19-20 year olds (16%) and 
declining across age groups (Table 4-4). The recent rapid increase in vaping nicotine 
among adolescents25 may well have generated cohort differences that are reflected in these 
age groups and may also be related to future increases in later age groups. It remains an 
open question whether nicotine vaping will continue to fall off with advancing age or 
whether it will remain primarily at levels set in young adulthood, a pattern seen for cigarette 
use. Beginning in 2019, the vaping items will be on four of the six young adult survey 
forms, and will be in the age 35 and up forms, providing a better perspective on this rapidly 
growing phenomenon. Trends (2017-2018) in vaping nicotine among young adults are 
presented in Chapter 5. 
 
 Questions were added in 2011 on the consumption by young adults of tobacco in various 
specific forms other than cigarettes and vaping nicotine. Tripwire questions are used for 
these forms of tobacco use, providing only annual prevalence and frequency data (Table 4-
3). Past-year prevalence of use in 2018 among 19-30 year olds was 12%26 for using a 
hookah to smoke tobacco, 15% for smoking small cigars, 3.2% for using snus, and only 
0.2% for using dissolvable tobacco. Among young adults, hookah smoking was highest 
among 23-24 year olds at 17% and declined steadily to 8% at ages 29 to 30. (Rather than 
being an age effect, this could represent more of a cohort effect corresponding to the 
increased and then decreased popularity of this practice.) Annual prevalence of smoking 
small cigars was highest among 23-26 year olds at 17%, and 12-14% among other young 
adults. Annual prevalence of use of snus was highest among the 23-24 year olds at 7.7% 
                                                 
22 As noted in Table 4-2, for the 2018 estimate of lifetime vaping nicotine, there was a significant difference (p<.05) between the typical mail 
condition (23.6%) and new web-push condition (29.0%) of survey administration. 
23 As noted in Table 4-3, for the 2018 estimate of annual vaping nicotine, there was a significant difference (p<.05) between the typical mail 
condition (14.4%) and new web-push condition (18.8%) of survey administration. 
24 As noted in Table 4-4, for the 2018 estimate of 30-day vaping nicotine, there was a significant difference (p<.05) between the typical mail 
condition (8.1%) and new web-push condition (11.3%) of survey administration. 
25 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
26 As noted in Table 4-3, for the 2018 estimate of annual hookah smoking, there was a significant difference (p<.05) between the typical mail 
condition (11.3%) and new web-push condition (14.1%) of survey administration. 
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vs. 2-4% among the older age groups of young adults. Annual prevalence of dissolvable 
tobacco use was 0.8% or less among all young adult age groups. 
 
 Questions on anabolic steroid use (Figure 4-18) were added to one questionnaire form in 
1989 and to an additional form in 1990, making it difficult to determine age-related 
differences with much accuracy due to limited sample sizes. Overall, 1.3% of all 19-30 
year olds in 2018 reported having used anabolic steroids in their lifetime and 0.5% in the 
prior 12 months. Use did not vary greatly or systematically by age. Questions about steroid 
use are not asked of respondents over age 30. 
 
In sum, in 2018, annual and 30-day marijuana and the many forms of illicit drug use tended to be 
highest among those in their early to mid-20s. This is true as well regarding near-daily marijuana 
use and binge drinking. Annual and 30-day prevalence of vaping marijuana also tended to be 
highest in 2018 among those in their early to mid-20s, and vaping nicotine was highest among 19-
20 year olds. Lifetime prevalence in some of the older age groups (particularly those aged 55 and 
60), who passed through adolescence in the heyday of the drug epidemic, showed remarkably high 
lifetime rates of illicit drug use—particularly when lifetime prevalence was corrected for the 
recanting (or forgetting) of previously reported use. This highlights the importance of cohort 
effects when considering age-related changes (for example, for some drugs, including 
amphetamines, cocaine, sedatives [barbiturates], and tranquilizers, there  tended to be a lower 
lifetime prevalence in 2018 at age 45 compared to those younger and older, consistent with their 
lower prevalence as teens in the late 1980s and early 1990s). However, 30-day use of most illicit 
drugs was substantially lower among those over age 30 than among those in their late teens to 
early 20s. For the two licit drugs, alcohol and cigarettes, the picture is different; there is less falloff 
in active use with age, and there are higher levels of daily alcohol use and regular cigarette smoking 
in the older ages.  
 
When considering these various prevalence estimates, it is important to recall that our samples are 
based on high school graduates and thus exclude those who drop out of high school, a group that 
tends to show higher prevalence of most substances, especially cigarettes; in addition, we are less 
likely to maintain persistent heavy drug users, such as current heroin and crack cocaine users, in 
our sample. Thus, prevalence estimates are likely underestimates of the total population of adults, 
but on target for adults who are high school graduates. 
 
As discussed above and in Chapter 3, in 2018 we began our transition to web-based surveys among 
young adults, with half being randomly assigned to our typical mail-based condition and half to 
the new web-push condition in order to gauge any impact of survey condition on the prevalence 
estimates. As indicated above and in footnotes to Tables 4-1 through 4-5, there were very few 
significant differences in prevalence estimates between the two conditions, and thus we combined 
estimates across the two conditions into an average (weighted for sample size per condition) for 
young adults. About 10% of the comparisons reported in this chapter for young adults across all 
drugs and intensities of use yielded significant differences (and most all were at p<.05 level), and 
except for the vaping questions, there was little consistency in the significant differences across 
substances and drug use intensities. To summarize, significant differences were found for the 
following in 2018: lifetime prevalence of narcotics other than heroin (15% for typical mail 
condition, 13% for web-push condition) and flavored alcoholic beverages (77% for mail and 84% 
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for web-push); annual prevalence of bath salts (0.4% for mail and 0.05% for web-push), for 
ketamine (1.3% for mail, 0.3% for web-push), and hookah tobacco use (11% for mail, 14% for 
web-push); and of two-week binge drinking (29% for mail, 33% for web-push). For the vaping 
items, significant differences were found for six of the twelve items including for lifetime any 
vaping (34% for mail and 39% for web-push), annual any vaping (24% for mail and 28% for web-
push),  lifetime nicotine vaping (24% for mail and 29% for nicotine), annual nicotine vaping (14% 
and 19%), 30-day nicotine vaping (8% for mail and 11% for web-push), and annual vaping just 
flavoring (7% for mail and 10% for web-push). Thus, the vaping item differences between 
condition in 2018 appeared to be localized for nicotine, with the web-push condition showing 
higher prevalence than the typical mail condition for lifetime, annual, and 30-day prevalence. We 
note that the vaping items are included on only two of the six young adult survey forms, meaning 
relatively small sample sizes for these comparisons (which argue against finer-grained condition 
comparisons by sociodemographic characteristics); also, in the two-year comparisons between 
2017 (all typical mail condition) and 2018 (half typical mail and half web-push condition) 
summarized in Chapter 5, the increases in vaping generally held regardless of 2018 condition. We 
are repeating this condition comparison in 2019 for young adults (which is an independent sample 
from 2018 given the biennial assessments for young adults), and will consider the extent to which 
significant differences between conditions hold in 2019. For additional information, see our 
published articles for earlier experiments on mail and web conditions among young adults.27 
 
PREVALENCE COMPARISONS FOR SUBGROUPS OF YOUNG ADULTS 
Subgroup differences for 19-30 year olds are presented in Tables 4-1 through 4-5. While Table 4-
1 provides only gender differences, the remaining tables show prevalence estimates by gender, 
age, region of the country, and population density. Age-group differences were summarized above; 
below we summarize gender, region, and population density differences separately. Lifetime, 
annual, 30-day, and daily use prevalence are shown in Tables 4-2 through 4-5, respectively. 
 
Gender Differences 
In general, most of the gender differences in drug use that are observed among young adults (19-
30) were observed in high school students as well. See Tables 4-1 and 4-5 for the full set of gender 
comparisons.  
 
 Among the full young adult sample ages 19 to 30 in 2018, lifetime use of any illicit drug 
was similar for men (66%) and women (65%), and the same was true regarding lifetime 
marijuana use (62% vs. 61%); but lifetime use of any illicit drug other than marijuana 
was clearly higher among men (42%) than women (35%) (Table 4-3). Regarding annual 
prevalence, men were somewhat higher than women on reported annual use of any illicit 
drug (44% vs. 41%), marijuana (40% vs. 37%), and any illicit drug other than marijuana 
(22% vs. 17%). Similarly, slighty more men than women reported 30-day use of any illicit 
drug (27% vs. 25%), marijuana (25% vs. 23%), and any illicit drug other than marijuana 
(9.6% vs. 7.4%) (Table 4-1). 
 
                                                 
27 Patrick, M. E., Couper, M. P., Laetz, V. B., Schulenberg, J. E., O'Malley, P. M., Johnston, L. D., & Miech, R. A. (2018). A sequential mixed 
mode experiment in the U.S. National Monitoring the Future study. Journal of Survey Statistics and Methodology, 6(1), 72-97. Patrick, M. E., 
Couper, M. P., Jang, B., Laetz, V. B., Schulenberg, J., Johnston, L. D., Bachman, J., O’Malley, P. M. (2019). Two-year follow-up of the sequential 
mixed-mode experiment in the U.S. National monitoring the future study. Survey Practice, 12(1). 
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 Vaping marijuana (based on new questions included in two of the six forms of the young
adult surveys starting in 2017) was somewhat more common for young adult men than
women in 2018 (Table 4-1). The 2018 annual prevalence of vaping marijuana among 19-
30 year old men and women was 17% and 14%, respectively (this compares to 2017 annual
prevalence of 16% and 9%, respectively, indicating some increase over the one-year period
for both men and women). For 30-day prevalence of vaping marijuana, it was 10% for men
and 7% for women (this compares to 2017 30-day prevalence of 9% and 4%, respectively,
again reflecting increases for both men and women over the one-year period).
 Daily marijuana use (i.e., using on 20 or more occasions in the past 30 days) was more
common for men (10.3%) than women (6.3%) among 19-30 year olds in 2018 (Table 4-5).
 Annual prevalence of synthetic marijuana use in 2018 was low and about equivalent
among young adult men and women (1.4% vs. 1.3%) (Table 4-1).
 Among 19-30 year olds in 2018, men had higher annual prevalence levels than women for
nearly all illicit drugs, sometimes with ratios of two times greater or more among
infrequently used drugs (including crack, heroin, and bath salts.) (Table 4-3). We
summarize some of the gender differences in annual use of some specific illicit drugs next.
 Annual hallucinogen use was more common among men (6.9%) than women (4.1%) in
2018, and the same was true regarding LSD (4.9% vs. 2.8%) and hallucinogens other than
LSD (4.5% vs. 2.4%) (Table 4-1).
 Use of MDMA (ecstasy, Molly) was slightly higher among men than among women with
annual prevalence in 2018 of 4.6% and 3.6%, respectively.
 All measures of cocaine use were higher among men than women in 2018. Annual cocaine
use was reported by 7.4% of men and 5.0% of women, powder cocaine use by 7.3% of
men and 5.1% of women, and crack use by 0.4% of men and 0.1% of women (Table 4-1).
 Annual prevalence of use of narcotics other than heroin outside of medical supervision
was slightly higher in 2018 among men than women (4.3% vs. 3.1%) (Table 4-1). The use
of Vicodin, one of the most widely used drugs in the class, was similar for men (2.5%) and
women (2.4%); likewise, OxyContin use was similar for men (1.9%) and women (1.8%)
(Table 4-3).
 The use of amphetamines was higher among men than women, with 2018 annual
prevalence of 9.1% and 6.4%, respectively; the same was true regarding annual use of
Adderall (9.8% vs. 7.9%) (Table 4-3).
 Regarding 30-day alcohol use, prevalence was somewhat higher among men (69%) than
women (66%), as was true for 30-day prevalence of being drunk (37% vs. 34%). Women
(29%) were higher than men (24%) for 30-day prevalence of flavored alcoholic beverage
use (Table 4-4).
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 For more frequent use of alcohol, gender differences were greater. Among 19-30 year olds 
in 2018, daily alcohol use was more common for men than women (6.3% vs. 3.6%), as 
was true for binge drinking—having five or more drinks in a row at least once in the prior 
two weeks (37% vs. 27%). There was a particularly large gender difference in the measures 
of extreme binge drinking (also called high-intensity drinking) in 2018: prevalence of 
having 10 or more drinks at least once in the prior two weeks across ages was 14.9% for 
men vs. 4.0% for women; prevalence of having 15 or more drinks was 6.5% for men and 
1.2% for women28 (Table 4-5).  
 
 In 2018, 19-30 year old men were more likely than women to smoke cigarettes in the past 
year (26% vs. 20%) and past month (15% vs. 12%); but men and women were similar for 
smoking daily in the past month (7.5% vs. 7.7%), and for smoking half a pack or more per 
day in the past month (3.8% vs. 4.3%) (Table 4-1).  
 
 Based on new vaping questions added in 2017, annual prevalence of vaping nicotine in 
2018 was higher at ages 19-30 for men than women (20% vs. 14%) (Table 4-1); this 
compares to 2017 annual prevalence of 18% and 10%, respectively, indicating some 
increase for both men and women over the one-year period. Regarding 30-day prevalence 
in 2018, it was also higher for men than women (13% vs. 8%) (Table 4-1); this compares 
to 2017 30-day prevalence of 9% and 4%, respectively, again reflecting increases for both 
men and women over the one-year period.   
 
 Among young adults there was a very large gender difference in 2018 in the use of 
smokeless tobacco, with men much more likely than women to have used in their lifetime 
(37% vs. 13%) (Table 4-2) and in the past month (12.7% vs. 2.9%) (Table 4-1). Almost all 
past-year use of snus occurred among men (6.2% vs. 1.1% among women); and there was 
very little annual use of dissolvable tobacco for men (0.1%) or women (0.2%) (Table 4-3).  
 
 In 2018, men were much more likely to have smoked small cigars in the past year than 
women (23.2% vs. 8.7%). The same was true for past 30-day use of regular little cigars 
(6.0% vs. 2.2%) and of flavored little cigars (7.2% vs 4.7%). 
 
 There was less gender difference in the annual use of hookah pipes (13.1% for men vs. 
11.8% for women). 
 
 Steroid use among young adults is relatively rare, with adjusted lifetime prevalence being 
2.7% for men and 0.3% for women in 2018 among 19-30 year olds. Annual and 30-day 
prevalence was 1.1% or below for men and women.  
                                                 
28 For information on gender differences by age for these measures, see for example: Patrick, M. E., & Terry-McElrath, Y. M. (2019). Prevalence 
of high-intensity drinking from adolescence through young adulthood: National data from 2016-2017. Substance Abuse: Research and Treatment, 
13, 1-5. 
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Regional Differences 
Follow-up respondents are asked in what state they resided as of March of current year. States are 
then grouped into the same four regions used in the analysis of high school data.29 Tables 4-2 
through 4-5 present regional differences in lifetime, annual, 30-day, and current daily prevalence 
for 19-30 year olds combined. 
 There exist some regional differences in the annual prevalence of marijuana use, with
2018 rates being higher in the Northeast (43%) and West (43%) than the Midwest (37%)
and the South (34%). Likewise, regarding annual prevalence of any illicit drug use, which
is driven largely by marijuana use, rates were higher in the Northeast (47%) and West
(46%) than in the Midwest (40%) and South (39%) (Table 4-3).
 In 2018, the annual prevalence of any illicit drug other than marijuana (Table 4-3) was
highest in the West (21%) and lowest in the South (18%).
 Thirty-day prevalence of marijuana use was higher in the Northeast (28%) and West
(28%) and lower in the Midwest (21%) and South (21%) (Table 4-4). Daily use of
marijuana, however, was similar across regions (ranging from 7.5% to 8.6%) (Table 4-5).
 The annual prevalence for vaping marijuana in 2018 was higher in the West (23%) and
Northeast (18%) than in the Midwest (12%) and South (11%) (Table 4-3); this compares
to 2017 annual prevalence of 15%, 14%, 11%, and 6%, respectively, indicating the same
pattern of regional differences in the two years, and an increase for each over the one-year
period. The same regional pattern held for 30-day prevalence of vaping marijuana in 2018
(West at 14.6%, Northeast at 11.4%, Midwest at 6.4%, and South at 5.4%) (Table 4-4);
this compares to 2017 30-day prevalence of 10.4%, 6.8%, 5.5%, and 4.3%, respectively,
showing the same pattern of regional differences in the two years, and an increase for each
over the one-year period. Thus, regional ranking of vaping marijuana is similar to overall
marijuana use.
 The annual prevalence for synthetic marijuana in 2018 was quite low and did not differ
much by region (ranging from 1.0% to 1.9%) (Table 4-3).
 In 2018, the use of hallucinogens tended to be highest in the West and lowest in the South.
Annual prevalence of hallucinogen use was 7.7% and 4.2% in the West and South,
respectively; for LSD, it was 5.3% and 3.1%, respectively; and for hallucinogens other
than LSD, it was 5.3% and 2.4%, respectively (Table 4-3).
 For MDMA (ecstasy, Molly), annual 2018 prevalence was considerably higher in the West
(6.6%) than in the other regions of the country, with annual prevalence in the Northeast
(2.5%), the South (2.8%) and the Midwest (3.7%) (Table 4-3).
29 States are grouped into regions as follows: Northeast—Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, 
New Jersey, and Pennsylvania; Midwest—Ohio, Indiana, Illinois, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, 
Nebraska, and Kansas; South—Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, 
Florida, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and Texas; West—Montana, Idaho, Wyoming, Colorado, 
New Mexico, Arizona, Utah, Nevada, Washington, Oregon, and California. 
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 In 2018, annual prevalence of cocaine was higher in the West (8.2%) and Northeast (6.8%)
than in the South (4.2%) and Midwest (5.3%) (Table 4-3).
 The annual prevalence for narcotics other than heroin was similar across regions in 2018
(ranging from 3.2% to 4.4%) (Table 4-3).
 The annual prevalence of amphetamines was similar across regions in 2018 (ranging from
6.9% to 8.0%), and the same was true regarding Adderall (ranging from 7.8% to 9.9%)
(Table 4-3).
 Overall, regarding illicit drug use, it is noteworthy that the use of LSD, hallucinogens
other than LSD, MDMA (ecstasy, Molly), and cocaine tended to be higher in 2018 among
young adults in the West than the other regions. Across other illicit drugs, regional
differences in 2018 were not substantial (Tables 4-2 through 4-5).
 Prevalence rates for alcohol use are typically somewhat higher in the Northeast and
Midwest regions than in the South and West; this pattern still pertained in 2018 and was
generally true among 12th graders as well (as reported in Volume I30). For binge drinking
among 19-30 year olds, the Northeast and Midwest were at 35% and 34% respectively,
with the South at 28% and the West at 29% (Table 4-5). Regarding extreme binge drinking
(high intensity drinking) among 19-30 year olds, having 10 or more drinks in a row was
more common in the Midwest (12.3%) and Northeast (8.7%) than in the South and West
(6.2% and 7.1%, respectively). Thirty-day self-reported drunkenness showed a similar
pattern (Table 4-4), as would be expected.
 Cigarette smoking among young adults tended to be slightly higher in the Midwest and
Northeast and lowest in the West in 2018. Thirty-day prevalence was 14% in both the
Midwest and Northeast, 13% in the South, and 11% in the West (Table 4-4).
 In 2018, 30-day prevalence of vaping nicotine was higher for the West (12.6%) than for
the South (9.2%), Northeast (9.2%), and Midwest (9.6%) (Table 4-4); this compares to
2017 30-day prevalence of 6.1%, 6.4%, 7.7%, and 5.1%, respectively, indicating increases
for each region over the one-year period, especially for the West. Thus, regional differences
for vaping nicotine do not follow those for smoking cigarettes, although the Ns by region
for vaping nicotine are relatively small.
 Use of flavored little cigars (Table 4-4) showed some regional difference in 2018, with the
30-day prevalence ranging from 7.7% in the South to 3.8% in the West. Similarly, the 30-
day prevalence of regular little cigars (i.e., non-flavored) ranged from 4.9% in the South
to 1.4% in the West, and 30-day prevalence for the use of large cigars ranged from 7.3%
in the South to 1.5% in the West (Table 4-4).
 The 30-day prevalence of smokeless tobacco use in 2018 was higher in the Midwest
(15.5%) than the other regions (ranging from 0.8% to 5.8%) (Table 4-4).
30 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
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 The annual use of snus in 2018 was higher in the Midwest (5.4%) compared to the South
(3.2%), West (1.2%), and Northeast (3.4%) (Table 4-3).
 Annual use of a hookah to smoke tobacco was somewhat higher in Northeast (15.0%),
compared to the West (12.4%), Midwest (11.7%), and South (11.1%) (Table 4-3).
Population Density Differences 
Population density is measured by asking respondents to select the response category that best 
describes the size and nature of the community where they lived during March of the year in which 
they completed the follow-up questionnaire. The various categories are listed in Tables 4-2 through 
4-5; the population sizes given to the respondent to help define each level are provided in a footnote
to each table.31 See Tables 4-2 through 4-5 for the tabular results on 19-30 year olds combined.
 Most differences in illicit drug use by population density tend to be modest, perhaps more
modest than is commonly supposed. Among the general population, use of most illicit
drugs is broadly distributed among all areas from rural to urban. To the extent that there
are variations, almost all of the associations are positive with regard to density, with
rural/country areas having the lowest levels of use, and small towns having the next lowest.
Medium-sized cities, large cities, and very large cities tend to be appreciably higher. In
2018, positive associations with population density existed for annual prevalence of any
illicit drug (ranging from 31.1% for farm/country to 51.0% for very large city), any illicit
drug other than marijuana (ranging from 16.1% to 25.8%, respectively), and marijuana
(25.3% to 47.4%, respectively) (Table 4-3). The annual prevalence of vaping marijuana
showed the same pattern, ranging from 9.4% for farm/country to 22.8% for very large city
(the same pattern was found in 2017 for annual prevalence of vaping marijuana, ranging
from 7.0% to 18.6%, respectively, with each region showing some increase over the one-
year period). Most of the drugs that comprise the measure of any illicit drug other than
marijuana showed a similar pattern, with exceptions noted below.
 Annual prevalence of cocaine, MDMA (ecstasy, Molly), and hallucinogens other than
LSD tended to be twice as high in 2018 in very large cities (10.2%, 7.8%, and 5.0%,
respectively) than the other density strata, with little difference among them (Table 4-3).
 Annual prevalence was distinctly higher in the farm/country stratum compare to the other
four strata for some uncommonly used drugs including methamphetamine (2.0% vs. 0.6-
1.5%), synthetic marijuana (2.3% vs. 0.8-1.7%), and inhalants (2.4% vs. 0.2-0.9%).
 Differences among density strata were quite small in 2018 for annual prevalence of
narcotics other than heroin, ranging from 3.2% to 4.4% (and the same was true for
OxyContin and Vicodin specifically) (Table 4-3). Similarly, many of the illicit drugs with
relatively low annual prevalence did not show substantial variation by population density,
including use of PCP, salvia, crack, heroin, sedatives (barbiturates), Ketamine, and
steroids (Table 4-3).
31 An examination of the 1987 and 1988 drug use data for the two most urban strata revealed that the modest differences in prevalence rates between 
the suburbs and their corresponding cities were not worth the complexity of reporting them separately; accordingly, since then these categories 
have been merged to increase sample sizes. 
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 Among young adults age 19-30, the lifetime and annual alcohol use measures all showed 
a slight positive association with population density, while 30-day use had a somewhat 
stronger positive association, with 55% of the farm/country stratum reporting alcohol use 
in the prior 30 days versus 75% of those in very large cities.  
 
Prevalence of binge drinking among young adults was positively associated with 
population density as well (Table 4-5), with 24% of those in the farm/country stratum 
indicating having had five or more drinks in a row at least once in the prior two weeks 
compared to 37% of those in the very large cities. Daily alcohol use in the prior month 
varied little by population density in 2018 (ranging from 4.1% to 5.3%). For 10 or more 
drinks in a row in the past two weeks (extreme binge drinking), prevalence in 2018 was 
highest in farm/country (13.6%), next highest in very large cities (8.3%) and large cities 
(8.2%), and lowest in small towns (7.9%) and medium cities (7.7%) (Table 4-5). 
 
 Contrary to what we find for almost all other substances, there exists a negative association 
between population density and daily cigarette smoking, which was highest in the 
farm/country stratum (daily prevalence of 11%) and lowest in the large and very large cities 
(daily prevalence of 6% and 7%, respectively). Smoking at the half-pack-a-day level in the 
prior 30 days was more than twice as high in the farm/country stratum as in very large 
cities (7.2% vs. 2.8%, respectively; Table 4-5). 
 
 Annual prevalence of small cigars was lowest in the farm/country stratum (10%), and 
ranged from 13% to 17% in the other population density strata. (As noted in Table 4-3, Ns 
are relatively small for these and other forms of tobacco use summarized below.) 
 
 Thirty-day prevalence of flavored little cigars was highest in the farm/country stratum 
(9.3%) and lower in all other strata (1.0% to 6.4%). (Table 4-4). 
 
 Similarly, 30-day prevalence of smokeless tobacco use was highest in the farm/country 
stratum (12.9%) and lowest in cities (4.3-4.7%) (Table 4-4). 
 
 In contrast, the annual prevalence of hookah smoking (Table 4-3) was highest in very large 
cities (19.3%) and declined with population density, being smallest in the farm/country 
stratum (4.9%). 
 
 Finally, vaping nicotine varied somewhat by population density. Annual prevalence in 
2018 was 11% in the farm/country stratum and ranged from 16% to 20% in the other 
density strata (Table 4-3); in 2017, the annual prevalence ranged from 12% to 15%, with 
little variation by population density and showing one-year increases for most strata. The 
30-day prevalence in 2018 was also lowest in the farm/country stratum (5.3%) and ranged 
from 8.9% to 12.4% in the other strata (Table 4-4); in 2017, there was little variation by 
population density, ranging from 5.8% to 6.4%.  
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Men Women Total
Approximate Weighted N = 1,800 2,600 4,400
Annual 43.9 40.8 42.0
30-Day 27.0 24.9 25.7
Annual 22.0 17.4 19.2
30-Day  9.6 7.4 8.3
Annual j 40.0 36.9 38.1
30-Day 25.0 23.1 23.9
Daily b 10.3 6.3 8.0
Annual c  1.4  1.3  1.4
Annual 1.0 0.6 0.8
30-Day 0.3 0.2 0.2
Annual 6.9 4.1 5.3
30-Day 1.6 1.0 1.3
Annual 4.9 2.8 3.6
30-Day 1.0 0.8 0.9
Annual 4.5 2.4 3.3
30-Day 1.1 0.4 0.7
Annual * 0.9 0.6
30-Day * 0.5 0.3
Annual 4.6 3.6 4.0
30-Day 1.3 1.0 1.2
Annual 7.4 5.0 5.9
30-Day 3.0 1.7 2.2
Annual 0.4 0.1 0.2
30-Day 0.4 0.1 0.2
Annual 7.3 5.1 5.9
30-Day 3.1 1.6 2.2
Annual 0.5 0.1 0.3
30-Day 0.3 0.1 0.2
Annual * 0.1 *
30-Day * 0.1 *
Annual * 0.2 0.1
30-Day * 0.1 *
     PCP d
Cocaine
     MDMA (Ecstasy, Molly) f
     With a Needle g
     Without a Needle g
(Table continued on next page.)
Synthetic Marijuana 
Prevalence of Use of Various Types of Drugs by Gender
TABLE 4-1
Heroin
     Hallucinogens other than LSD e
(Entries are percentages.)
among Respondents of Modal Ages 19–30, 2018
Hallucinogens e
Inhalants c
Marijuana
Any Illicit Drug a
Any Illicit Drug other than Marijuana a 
     LSD e
     Other Cocaine f
     Crack e
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Men Women Total
Approximate Weighted N = 1,800 2,600 4,400
Annual 4.3 3.1 3.6
30-Day 0.9 0.9 0.9
Annual 9.1 6.4 7.5
30-Day 3.6 2.2 2.8
Annual 1.3 0.9 1.0
30-Day 0.5 0.3 0.4
Annual 0.5 0.3 0.4
30-Day 0.3 0.2 0.2
Annual k 0.3 0.1 0.2
Annual 2.9 2.3 2.5
30-Day 0.9 0.9 0.9
Annual 4.3 4.1 4.2
30-Day 1.5 1.3 1.4
Annual 81.5 83.2 82.5
30-Day 69.2 65.9 67.3
Daily b 6.3 3.6 4.7
5+ Drinks in a Row in Last 2 Weeks l 36.6 27.4 31.2
10+ Drinks in a Row in Last 2 Weeks d 14.9 4.0 8.4
15+ Drinks in a Row in Last 2 Weeks d 6.5 1.2 3.4
Annual 63.4 62.1 62.6
30-Day 37.4 33.8 35.2
Daily b 0.2 0.5 0.4
Annual 48.9 57.2 53.9
30-Day 24.2 29.0 27.1
Annual 25.9 20.2 22.5
30-Day 14.5 11.6 12.8
Daily 7.5 7.7 7.6
1/2 Pack+/Day 3.8 4.3 4.1
Annual m 27.6 23.1 24.9
30-Day 18.3 14.7 16.2
Annual 15.2 14.6 14.8
30-Day 9.6 8.2 8.8
Annual n 18.2 13.4 15.4
30-Day o 12.4 9.7 10.8
     Vaping Nicotine g
(Table  continued on next page.)
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
Amphetamines, Adjusted h,i
Crystal Methamphetamine (Ice) g
Methamphetamine g
Narcotics other than Heroin h
Any Vaping g
     Vaping Marijuana g
Cigarettes
Alcohol
Tranquilizers h
Sedatives (Barbiturates) h
     Flavored Alcoholic Beverages d
     Been Drunk c
TABLE 4-1 (cont.)
Prevalence of Use of Various Types of Drugs by Gender
Bath Salts (Synthetic Stimulants) c
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Men Women Total
Annual p 9.4 8.5 8.9
30-Day 4.1 3.2 3.6
Smokeless Tobacco d
30-Day 12.7 2.9 7.2
Daily 6.1 1.7 3.6
Steroids g
Annual 1.1 0.1 0.5
30-Day 0.6 0.0 0.2
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, 
sedatives (barbiturates), or tranquilizers  not under a doctor’s orders.
bDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, and 5+ drinks, 
measured as having five or more drinks in a row in the last two weeks.
cThis drug was asked about in three of the six questionnaire forms. Total  N  is approximately 2,200.
dThis drug was asked about in one of the six questionnaire forms. Total  N  is approximately 700. 
eThis drug was asked about in five of the six questionnaire forms. Total  N  is approximately 3,700. 
fThis drug was asked about in four of the six questionnaire forms. Total  N  is approximately 2,900. 
gThis drug was asked about in two of the six questionnaire forms. Total  N  is approximately 1,500. 
hOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
jFor the total estimate of annual Marijuana use in 2018, there was a significant difference (p<.05) between the typical mail condition (36.5%) and new 
web-push condition (39.5%) of survey administration.
kFor the total estimate of annual Bath Salt use in 2018, there was a significant difference (p<.05) between the typical mail condition (0.4%) and new 
web-push condition (0.0%) of survey administration.
lFor the total estimate of 5+ Drinks in a Row in Last 2 Weeks in 2018, there was a significant difference (p<.01) between the typical mail condition (29.4%) and new
 web-push condition (33.0%) of survey administration.
mFor the total estimate of annual Any Vaping in 2018, there was a significant difference (p<.05) between the typical mail condition (23.7%) and new 
web-push condition (28.4%) of survey administration.
nFor the total estimate of annual Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail condition (14.4%) and new 
web-push condition (18.8%) of survey administration.
oFor the total estimate of 30-day Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail condition (8.1%) and new 
web-push condition (11.3%) of survey administration.
pFor the total estimate of annual Vaping Just Flavoring in 2018, there was a significant difference (p<.05) between the typical mail condition (7.3%) and new 
web-push condition (10.4%) of survey administration.
     Vaping Just Flavoring g
among Respondents of Modal Ages 19–30, 2018
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Any Illicit Drug
Any Illicit other than Hallucinogens MDMA
Drug a Marijuana a Marijuana Inhalants b Hallucinogens d LSD d other than LSD d   PCP c (Ecstasy,Molly) f Cocaine Crack d
Total 4,400 65.3 38.3 61.3 6.4 14.9 10.5 11.9 1.3 13.4 12.7 1.7
Gender
    Men 1,800 65.7 41.7 62.0 7.0 18.9 14.2 15.7 0.5 15.2 14.9 1.9
    Women 2,600 65.0 35.9 60.9 6.0 12.2 8.0 9.5 1.8 12.2 11.1 1.6
Modal Age
     19–20 800 52.2 22.9 48.9 3.8 9.0 7.6 4.9 1.2 5.7 5.2 1.1
     21–22 700 62.0 34.3 58.6 5.1 12.4 10.1 8.5 0.8 10.5 9.7 0.4
     23–24 700 68.3 40.9 64.6 5.4 18.0 13.2 14.5 0.4 16.8 16.5 2.1
     25–26 700 68.9 41.3 65.8 6.2 15.0 9.6 12.7 1.6 13.0 13.1 0.8
     27–28 800 67.6 42.4 63.0 7.5 17.2 11.2 15.2 2.3 14.7 12.9 3.0
     29–30 800 72.2 46.1 67.0 9.7 17.8 11.5 15.6 1.1 18.7 17.7 2.6
Region
    Northeast 800 68.4 40.5 65.1 6.2 15.2 10.5 12.0 2.5 12.7 14.9 1.8
    Midwest 1,200 65.2 39.1 61.2 5.0 14.0 9.5 11.1 0.2 11.1 10.7 2.0
    South 1,400 62.8 36.7 57.8 6.1 13.3 9.8 10.2 0.6 12.0 11.3 1.6
    West 1,000 66.8 37.2 64.1 8.3 17.5 12.0 14.9 2.5 18.0 14.8 1.4
Population Density e
    Farm/Country 400 56.2 35.7 49.4 8.4 15.2 10.0 13.0 2.7 8.0 8.9 3.0
    Small Town 1,100 64.3 35.2 60.1 5.6 12.5 9.4 9.3 0.5 11.2 11.0 2.0
    Medium City 1,200 63.9 36.1 59.7 6.1 14.5 10.0 11.2 1.3 11.3 10.3 1.2
    Large City 1,000 66.4 38.2 64.0 7.2 14.0 9.5 11.3 1.4 14.3 13.2 0.8
    Very Large City 700 73.0 47.7 69.5 6.0 20.4 14.8 17.4 1.4 22.1 19.8 2.3
Approximate
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Crystal
Other Heroin with Heroin without Narcotics other Methamphetamine
Cocaine f Heroin a Needle g a Needle g than Heroin h,j Amphetamines h,i Methamphetamine g  (Ice) g
Total 4,400 13.4 1.6 0.6 1.5 14.0 19.7 3.2 1.9
Gender
    Men 1,800 15.9 2.1 0.6 2.2 16.0 22.3 3.9 2.0
    Women 2,600 11.7 1.3 0.6 1.0 12.6 17.9 2.7 1.8
Modal Age
     19–20 800 4.7 0.4 0.4 0.2 5.5 10.3 0.4 0.2
     21–22 700 9.6 0.6 0.2 0.4 9.0 15.5 1.8 1.2
     23–24 700 16.8 1.8 * 2.2 13.6 22.5 3.5 2.0
     25–26 700 13.9 1.8 0.7 2.1 15.8 21.3 3.2 1.6
     27–28 800 15.8 2.3 0.5 1.8 17.3 22.7 4.3 1.6
     29–30 800 18.3 2.6 1.4 2.2 21.4 24.7 5.4 4.1
Region
    Northeast 800 16.1 1.7 0.9 1.5 13.6 21.2 2.7 0.8
    Midwest 1,200 12.9 1.1 0.4 1.1 14.3 20.1 2.1 2.0
    South 1,400 10.8 1.5 0.2 1.0 13.7 18.9 4.1 2.3
    West 1,000 15.1 2.0 1.0 2.4 13.6 18.5 3.3 2.0
Population Density e
    Farm/Country 400 9.4 1.5 0.4 1.1 14.5 16.6 4.3 0.8
    Small Town 1,100 12.7 1.7 0.9 1.9 15.0 18.3 4.7 3.2
    Medium City 1,200 11.0 1.8 0.6 1.2 13.2 17.7 1.8 1.3
    Large City 1,000 12.3 1.1 0.5 1.5 12.4 19.5 2.2 1.4
    Very Large City 700 21.9 1.7 0.2 1.6 15.2 27.0 3.4 1.9
(Table continued on next page.)
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Flavored 
Sedatives Been Alcoholic Vaping Vaping
(Barbiturates) h Tranquilizers h Alcohol Drunk b Beverages c,k Cigarettes Any Vaping g,l Marijuana g Nicotine g,m
Total 4,400 8.3 12.6 86.2 78.1 80.6 — 36.1 21.2 26.5
Gender
    Men 1,800 9.4 12.8 84.3 75.6 76.0 — 38.6 23.4 30.2
    Women 2,600 7.6 12.4 87.5 79.8 83.7 — 34.4 19.6 23.9
Modal Age
     19–20 800 3.5 7.0 66.6 54.9 64.0 — 43.6 21.7 34.7
     21–22 700 5.0 9.9 85.8 73.1 80.2 — 37.8 21.6 26.1
     23–24 700 8.9 13.4 92.2 84.5 87.1 — 34.2 23.0 26.2
     25–26 700 10.1 13.4 91.0 85.2 86.2 — 36.5 24.1 26.9
     27–28 800 8.8 13.3 90.2 83.4 87.9 — 33.4 18.4 24.0
     29–30 800 12.9 18.0 91.1 85.2 78.9 — 33.0 19.6 21.8
Region
    Northeast 800 7.5 13.9 88.7 83.3 78.9 — 37.7 22.9 28.2
    Midwest 1,200 7.2 11.0 89.2 84.3 83.8 — 33.0 15.5 23.6
    South 1,400 8.5 13.1 85.0 73.6 79.3 — 33.1 17.4 25.8
    West 1,000 9.4 12.5 82.4 73.7 78.4 — 43.5 32.0 29.7
Population Density e
    Farm/Country 400 6.4 10.3 82.6 75.7 82.6 — 28.8 11.5 23.8
    Small Town 1,100 9.0 12.1 83.1 75.0 75.2 — 35.3 16.3 27.4
    Medium City 1,200 7.1 12.1 86.3 76.4 80.2 — 34.0 21.6 25.5
    Large City 1,000 7.5 12.3 89.3 82.1 85.9 — 38.9 23.8 28.4
    Very Large City 700 11.1 15.8 89.1 80.9 81.2 — 42.6 31.4 25.9
(Table continued on next page.)
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Vaping Smokeless
Just Flavoring g Tobacco c Steroids g
Total 4,400 20.6 23.5 1.3
Gender
    Men 1,800 20.7 37.3 2.7
    Women 2,600 20.5 12.8 0.3
Modal Age
     19–20 800 33.3 21.5 0.4
     21–22 700 24.6 15.2 0.4
     23–24 700 21.7 31.2 1.9
     25–26 700 16.7 * 1.4
     27–28 800 15.3 30.3 1.0
     29–30 800 15.0 35.3 2.3
Region
    Northeast 800 18.3 17.1 1.4
    Midwest 1,200 20.3 38.2 0.3
    South 1,400 20.3 23.9 1.8
    West 1,000 24.3 10.2 1.5
Population Density e
    Farm/Country 400 14.8 27.1 1.2
    Small Town 1,100 20.6 32.4 1.5
    Medium City 1,200 20.5 17.8 1.1
    Large City 1,000 25.2 19.1 0.4
    Very Large City 700 19.0 23.1 2.5
(Table continued on next page.)
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Source. The Monitoring the Future study, the University of Michigan.
Notes.  ' — ' indicates data not available.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders.
bThis drug was asked about in three of the six questionnaire forms. Total N is approximately 2,200.
cThis drug was asked about in one of the six questionnaire forms. Total N is approximately 700.
dThis drug was asked about in five of the six questionnaire forms. Total N  is approximately 3,700.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; and a very large city as having over 
500,000. Within each level of population density, suburban and urban respondents are combined.
fThis drug was asked about in four of the six questionnaire forms. Total N is approximately 3,900.
gThis drug was asked about in two of the six questionnaire forms. Total N  is approximately 1,900.
hOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
jFor the total estimate of lifetime Narcotics other than Heroin use in 2018, there was a significant difference (p<.01) between the typical mail condition (15.2%) and new 
web-push condition (12.7%) of survey administration.
kFor the total estimate of lifetime Flavored Alcoholic Beverages use in 2018, there was a significant difference (p<.05) between the typical mail condition (77.1%) and new 
web-push condition (84.2%) of survey administration.
lFor the total estimate of lifetime Any Vaping in 2018, there was a significant difference (p<.05) between the typical mail condition (33.7%) and new 
web-push condition (38.9%) of survey administration.
mFor the total estimate of lifetime Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail condition (23.6%) and new 
web-push condition (29.0%) of survey administration.
FOOTNOTES FOR TABLE 4-2
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Any Any Illicit Drug
Illicit other than Synthetic Hallucinogens MDMA
Drug a Marijuana a Marijuana j Marijuana c Inhalants c Hallucinogens e      LSD e other than LSD e   PCP d (Ecstasy,Molly) f Salvia c Cocaine Crack e
Total 4,400 42.0 19.2 38.1 1.4 0.8 5.3 3.6 3.3 0.6 4.0 0.6 5.9 0.2
Gender
     Men 1,800 43.9 22.0 40.0 1.4 1.0 6.9 4.9 4.5 * 4.6 0.7 7.4 0.4
     Women 2,600 40.8 17.4 36.9 1.3 0.6 4.1 2.8 2.4 0.9 3.6 0.6 5.0 0.1
Modal Age
     19–20 800 43.1 14.2 40.5 2.0 1.9 5.9 5.1 2.9 0.3 3.1 0.9 3.9 0.2
     21–22 700 47.2 22.1 44.3 1.7 0.5 5.9 4.6 3.5 0.8 4.5 0.4 5.9 0.2
     23–24 700 47.0 22.1 43.0 1.4 0.3 5.7 3.2 4.0 * 4.5 0.3 9.2 0.2
     25–26 700 40.2 17.8 36.4 0.9 0.6 4.1 2.4 2.8 0.8 3.9 * 6.0 *
     27–28 800 36.9 19.1 32.0 1.8 0.5 6.3 4.2 3.5 1.5 3.8 1.7 5.2 0.4
     29–30 800 39.2 19.9 34.3 0.4 0.9 3.8 2.4 2.9 * 4.1 0.4 5.5 0.2
Region
     Northeast 800 46.5 20.3 42.9 1.2 1.3 4.8 3.0 2.9 2.1 2.5 0.2 6.8 0.4
     Midwest 1,200 40.4 19.1 37.1 1.9 0.8 4.8 3.5 2.6 * 3.7 0.6 5.3 0.3
     South 1,400 38.6 17.6 33.6 1.3 0.6 4.2 3.1 2.4 0.2 2.8 0.6 4.2 0.1
     West 1,000 46.1 20.7 42.8 1.0 0.7 7.7 5.3 5.3 0.6 6.6 0.9 8.2 0.2
Population Density i
     Farm/Country 400 31.1 16.1 25.3 2.3 2.4 3.5 2.6 2.5 2.0 1.8 0.6 3.4 0.8
     Small Town 1,100 40.5 18.1 36.7 1.6 0.5 4.9 3.6 2.6 0.5 2.6 0.2 4.7 *
     Medium City 1,200 41.3 17.8 36.4 0.8 0.9 5.2 3.8 3.2 0.5 3.4 1.1 4.6 0.5
     Large City 1,000 42.8 18.2 40.7 1.7 0.8 4.7 3.3 2.7 0.5 3.9 0.8 6.3 *
     Very Large City 700 51.0 25.8 47.4 0.8 0.2 7.4 5.0 5.0 * 7.8 0.2 10.2 *
TABLE 4-3
Annual Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
Approximate
Weighted N
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Heroin Narcotics Crystal
Other Heroin with without a other than Methamphetamine
Cocaine f Heroin a Needle b Needle b Heroin g OxyContin c,g Vicodin c,g Amphetamines g,h Ritalin c,g Adderall c,g Methamphetamine b (Ice) b
Total 4,400 5.9 0.3 * 0.1 3.6 1.9 2.4 7.5 1.3 8.7 1.0 0.4
Gender
     Men 1,800 7.3 0.5 * * 4.3 1.9 2.5 9.1 1.2 9.8 1.3 0.5
     Women 2,600 5.1 0.1 0.1 0.2 3.1 1.8 2.4 6.4 1.4 7.9 0.9 0.3
Modal Age
     19–20 800 3.8 0.1 * * 2.2 1.7 2.0 5.5 1.1 8.3 0.4 0.2
     21–22 700 6.0 0.2 * * 3.6 1.4 1.3 8.8 1.7 11.7 0.9 0.2
     23–24 700 8.5 0.3 * 0.2 3.6 1.5 3.0 10.1 1.8 11.9 1.2 0.6
     25–26 700 6.9 0.3 0.3 0.2 3.1 2.1 2.9 6.6 1.3 7.0 0.9 0.6
     27–28 800 5.7 0.4 * 0.2 4.3 2.7 2.8 6.6 1.6 6.4 2.5 0.4
     29–30 800 4.9 0.3 * * 4.5 2.1 2.6 7.5 0.8 7.0 0.5 0.2
Region
     Northeast 800 6.8 0.2 0.2 * 3.2 2.2 1.4 7.4 1.9 9.9 1.2 *
     Midwest 1,200 5.8 0.1 * 0.1 3.2 1.7 3.4 7.6 0.9 8.6 0.8 0.6
     South 1,400 4.3 0.4 * 0.2 3.6 1.6 2.0 6.9 0.9 7.8 0.6 0.3
     West 1,000 7.6 0.2 * * 4.4 2.5 2.9 8.0 2.0 8.7 1.6 0.4
Population Density i
     Farm/Country 400 4.0 0.2 * * 4.2 1.8 2.0 6.4 1.6 6.0 2.0 *
     Small Town 1,100 5.4 0.2 0.2 0.1 4.3 2.2 2.7 6.4 1.2 8.4 1.5 0.4
     Medium City 1,200 4.8 0.4 * 0.1 3.3 1.8 2.0 7.0 1.7 8.7 0.6 0.4
     Large City 1,000 5.5 0.1 * * 2.8 1.3 2.6 7.7 1.1 8.9 0.6 0.5
     Very Large City 700 10.6 0.4 * 0.2 3.6 2.6 3.0 10.2 1.2 10.1 0.8 0.2
TABLE 4-3 (cont.)
Annual Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
Approximate
Weighted N
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Alcoholic  
Bath Salts Flavored Beverages Tobacco
(synthetic Sedatives Been Alcoholic containing  using a Small Vaping
stimulants) c,k (Barbiturates) g Tranquilizers g GHB b Ketamine b,l Alcohol Drunk c Beverages d Caffeine b Cigarettes Hookah c,m Cigars b Any Vaping b,n Marijuana b
Total 4,400 0.2 2.5 4.2 - 0.8 82.5 62.6 53.9 28.9 22.5 12.3 14.6 25.9 15.1
Gender
     Men 1,800 0.3 2.9 4.3 - 0.4 81.5 63.4 48.9 33.7 25.9 13.1 23.2 28.6 17.0
     Women 2,600 0.1 2.3 4.1 - 1.0 83.2 62.1 57.2 25.4 20.2 11.8 8.7 23.9 13.8
Modal Age
     19–20 800 0.4 2.1 3.5 - 1.2 63.0 47.0 51.5 20.5 18.4 11.3 14.1 35.5 16.6
     21–22 700 0.3 2.2 3.9 - 0.5 83.5 63.8 66.1 31.5 21.9 15.2 14.7 28.3 17.4
     23–24 700 * 3.1 4.7 - 0.9 89.7 70.5 67.0 40.8 27.2 17.2 16.9 27.7 16.9
     25–26 700 * 2.3 3.9 - 0.6 86.8 69.4 56.8 28.3 22.7 14.4 17.2 27.8 16.4
     27–28 800 0.8 2.8 4.0 - 1.3 85.7 62.6 44.5 27.0 22.4 8.6 14.1 18.5 11.6
     29–30 800 * 2.8 5.1 - * 86.1 61.3 39.0 25.2 22.6 7.9 11.6 20.5 13.6
Region
     Northeast 800 0.4 2.4 4.0 - 1.0 86.3 70.1 53.2 28.9 22.1 15.0 16.8 29.0 17.7
     Midwest 1,200 0.5 2.1 3.2 - 0.6 86.0 68.2 62.6 40.4 25.4 11.7 18.7 21.5 12.1
     South 1,400 0.1 2.6 4.9 - 0.4 80.2 56.0 49.3 22.9 21.4 11.1 10.9 23.1 11.4
     West 1,000 * 2.8 4.2 - 0.6 78.6 59.7 50.0 23.5 20.5 12.4 13.9 32.7 22.7
Population Density i
     Farm/Country 400 * 1.5 4.1 - 0.3 74.6 50.6 54.9 20.5 23.7 4.9 10.2 16.2 9.4
     Small Town 1,100 0.4 2.4 3.5 - 0.6 79.3 59.0 51.3 30.3 25.0 9.1 15.8 24.6 13.0
     Medium City 1,200 0.3 2.1 4.2 - 0.8 82.8 60.8 54.7 26.8 20.2 11.6 12.5 24.7 14.3
     Large City 1,000 0.3 2.1 3.7 - 0.5 86.3 68.2 60.8 33.2 21.4 15.4 16.1 29.6 16.4
     Very Large City 700 * 4.7 5.8 - 1.3 86.5 69.4 47.6 30.3 23.4 19.3 17.0 31.6 22.8
TABLE 4-3 (cont.)
Annual Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
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Vaping Vaping Dissolvable
Nicotine b,p Just Flavoring b Tobacco b Snus b Steroids g
Total 4,400 16.7 8.8 0.2 3.2 0.5
Gender
     Men 1,800 20.1 9.2 0.1 6.2 1.1
     Women 2,600 14.3 8.4 0.2 1.1 0.1
Modal Age
     19–20 800 27.1 20.5 0.8 2.8 *
     21–22 700 19.9 9.3 * 0.8 0.4
     23–24 700 17.8 9.6 0.3 7.7 0.8
     25–26 700 15.7 6.6 * 3.7 0.4
     27–28 800 11.5 4.3 0.7 3.2 0.6
     29–30 800 10.3 4.3 * 2.4 0.6
Region
     Northeast 800 17.5 8.8 0.7 3.4 0.5
     Midwest 1,200 15.4 7.7 0.4 5.4 0.2
     South 1,400 15.8 8.8 0.2 3.2 0.3
     West 1,000 19.6 10.8 * 1.2 0.8
Population Density i
     Farm/Country 400 11.0 4.0 0.5 1.7 0.6
     Small Town 1,100 16.1 11.4 * 6.3 1.0
     Medium City 1,200 17.7 8.2 0.4 2.3 0.3
     Large City 1,000 20.0 9.4 0.6 1.4 *
     Very Large City 700 15.8 8.0 0.0 5.6 0.6
Weighted N
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Source. The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives  (barbiturates), or tranquilizers not under a doctor’s orders.
bThis drug was asked about in two of the six questionnaire forms. Total N  is approximately 1,500.
cThis drug was asked about in three of the six questionnaire forms. Total  N  is approximately 2,200.
dThis drug was asked about in one of the six questionnaire forms. Total  N  is approximately 700.
eThis drug was asked about in five of the six questionnaire forms. Total  N  is approximately 3,700.
fThis drug was asked about in four of the six questionnaire forms. Total N  is approximately 2,900.
gOnly drug use that was not under a doctor’s orders is included here.
hBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
iA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; and a very large city as having over 500,000. 
Within each level of population density, suburban and urban respondents are combined.
jFor the total estimate of annual Marijuana use in 2018, there was a significant difference (p<.05) between the typical mail condition (36.5%) and new web-push condition (39.5%) of survey administration.
kFor the total estimate of annual Bath Salts use in 2018, there was a significant difference (p<.05) between the typical mail condition (0.4%) and new web-push condition (0.0%) of survey administration.
lFor the total estimate of annual Ketamine use in 2018, there was a significant difference (p<.05) between the typical mail condition (1.3%) and new web-push condition (0.3%) of survey administration.
mFor the total estimate of annual Tobacco Using a Hookah in 2018, there was a significant difference (p<.05) between the typical mail condition (11.3%) and new web-push condition (14.1%) of survey administration.
nFor the total estimate of annual Any Vaping in 2018, there was a significant difference (p<.05) between the typical mail condition (23.7%) and new web-push condition (28.4%) of survey administration.
oFor the total estimate of annual Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail condition (14.4%) and new web-push condition (18.8%) of survey administration.
pFor the total estimate  of annual Vaping Just Flavoring in 2018, there was a significant difference (p<.05) between the typical mail condition (7.3%) and new web-push condition (10.4%) of survey administration.
FOOTNOTES FOR TABLE 4-3
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Any Illicit Drug a Hallucinogens 
Any Illicit other than other than MDMA
Drug a Marijuana Marijuana Inhalants b Hallucinogens d     LSD d LSD d   PCP c (Ecstasy,Molly) f Cocaine Crack d
Total 4,400 25.7 8.3 23.9 0.2 1.3 0.9 0.7 0.3 1.2 2.2 0.2
Gender
     Men 1,800 27.0 9.6 25.0 0.3 1.6 1.0 1.1 * 1.3 3.0 0.4
     Women 2,600 24.9 7.4 23.1 0.2 1.0 0.8 0.4 0.5 1.0 1.7 0.1
Modal Age
     19–20 800 24.7 6.1 24.1 0.6 1.9 1.5 1.0 0.3 1.3 1.5 *
     21–22 700 29.8 9.3 27.5 0.2 0.9 0.6 0.3 * 0.9 2.4 0.2
     23–24 700 28.5 10.0 26.1 * 1.0 0.7 0.4 * 1.3 2.9 0.2
     25–26 700 23.1 6.7 21.7 0.6 1.0 0.8 0.4 0.8 0.7 2.4 *
     27–28 800 23.6 8.3 21.5 * 1.3 0.5 1.0 0.7 1.4 1.5 0.4
     29–30 800 25.2 9.0 22.7 * 1.4 1.0 0.9 * 1.2 2.7 0.2
Region
     Northeast 800 30.4 9.7 28.4 0.4 1.0 0.6 0.8 1.4 0.9 2.9 0.4
     Midwest 1,200 23.5 8.2 21.2 0.2 1.0 0.9 0.1 * 1.0 1.8 0.1
     South 1,400 22.8 7.3 20.7 0.3 1.3 0.7 0.7 0.2 1.2 1.6 0.1
     West 1,000 29.4 8.6 28.1 0.2 1.6 1.3 0.9 * 1.3 3.0 0.2
Population Density e
     Farm/Country 400 19.0 7.0 16.5 1.0 0.4 0.1 0.3 2.0 0.4 0.7 0.8
     Small Town 1,100 24.3 8.3 22.8 0.2 1.4 1.1 0.6 * 0.9 2.4 *
     Medium City 1,200 24.3 6.7 22.9 0.3 1.4 1.0 0.8 0.5 1.4 1.5 0.4
     Large City 1,000 26.4 7.5 24.8 0.1 0.9 0.8 0.2 * 0.5 1.8 *
     Very Large City 700 33.1 12.0 29.5 * 1.5 0.8 1.2 * 2.0 4.0 *
TABLE 4-4
Thirty-Day Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
Approximate
Weighted N
(Table continued on next page.)
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Narcotics Crystal
Other Heroin Heroin other than Methamphetamine 
Cocaine f Heroin With Needle g Without Needle g Heroin h Amphetamines h,i Methamphetamine g (Ice) g
Total 4,400 2.2 0.2 * * 0.9 2.8 0.4 0.2
Gender
     Men 1,800 3.1 0.3 * * 0.9 3.6 0.5 0.3
     Women 2,600 1.6 0.1 0.1 0.1 0.9 2.2 0.3 0.2
Modal Age
     19–20 800 1.4 0.1 * * 0.6 1.7 * *
     21–22 700 2.1 * * * 1.0 3.3 * *
     23–24 700 3.2 0.1 * * 1.1 3.7 0.8 0.6
     25–26 700 3.2 0.3 0.3 0.2 0.5 2.1 * 0.4
     27–28 800 1.7 0.3 * * 1.5 2.8 1.3 0.4
     29–30 800 1.7 0.3 * * 0.8 3.1 0.1 *
Region
     Northeast 800 3.1 0.2 0.2 * 1.4 3.5 0.4 *
     Midwest 1,200 2.1 0.0 * * 1.1 2.6 0.5 0.4
     South 1,400 1.4 0.3 * 0.1 0.8 2.7 0.1 0.2
     West 1,000 2.7 0.2 * * 0.5 2.6 0.6 0.3
Population Density e
     Farm/Country 400 1.7 0.2 * * 1.7 1.9 0.7 *
     Small Town 1,100 3.0 0.1 0.2 * 1.5 2.6 1.0 0.3
     Medium City 1,200 0.9 0.2 * * 0.6 2.4 0.2 0.4
     Large City 1,000 1.8 0.1 * * 0.3 3.0 * 0.3
     Very Large City 700 3.9 0.4 * 0.2 0.8 4.1 * *
Thirty-Day Prevalence of Use of Various Types of Drugs by Subgroups
TABLE 4-4 (cont.)
among Respondents of Modal Ages 19–30, 2018
Approximate
Weighted N
(Table continued on next page.)
(Entries are percentages.)
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Flavored
Sedatives Been  Alcoholic Large Flavored Little Regular Little
(Barbiturates) h Tranquilizers h Alcohol Drunk b Beverages c Cigarettes Cigars c Cigars c Cigars c
Total 4,400 0.9 1.4 67.3 35.2 27.1 12.8 3.5 5.7 3.7
Gender
     Men 1,800 0.9 1.5 69.2 37.4 24.2 14.5 7.7 7.2 6.0
     Women 2,600 0.9 1.3 65.9 33.8 29.0 11.6 0.7 4.7 2.2
Modal Age
     19–20 800 0.9 0.5 44.4 24.9 30.2 10.5 3.8 8.2 3.9
     21–22 700 0.6 1.8 68.8 40.5 31.3 10.9 1.7 3.3 2.5
     23–24 700 1.3 1.5 75.1 44.3 37.2 14.7 3.7 7.4 5.4
     25–26 700 0.7 0.8 73.0 39.3 24.8 13.0 4.0 3.8 3.1
     27–28 800 1.0 1.8 69.6 31.1 22.9 12.4 2.7 6.1 3.3
     29–30 800 1.0 1.9 72.1 31.1 16.1 14.6 4.9 4.5 3.6
Region
     Northeast 800 1.5 1.5 72.0 41.8 30.2 13.6 2.4 6.4 4.0
     Midwest 1,200 0.7 1.1 70.9 40.0 32.7 13.9 7.3 7.7 4.9
     South 1,400 0.8 1.8 63.6 28.8 21.8 12.8 2.2 4.9 3.3
     West 1,000 0.9 1.2 64.0 33.2 23.8 10.5 1.5 3.8 1.4
Population Density e
     Farm/Country 400 0.9 1.2 55.2 21.8 32.6 15.1 3.6 9.3 2.6
     Small Town 1,100 1.1 1.1 61.5 33.4 26.6 15.1 2.0 6.4 4.3
     Medium City 1,200 0.6 1.4 67.3 30.9 26.5 11.3 3.0 6.0 5.2
     Large City 1,000 0.7 1.0 73.0 41.1 32.2 10.5 5.7 5.3 2.3
     Very Large City 700 1.5 2.5 75.3 43.0 17.3 13.2 4.1 1.0 3.1
TABLE 4-4 (cont.)
Thirty-Day Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
Approximate
Weighted N
(Table continued on next page.)
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Vaping Vaping Vaping Smokeless
Any Vaping g Marijuana g Nicotine g,j Just Flavoring g Tobaccoc Steroids g
Total 4,400 16.1 8.5 9.9 3.6 7.2 0.2
Gender
     Men 1,800 18.8 10.3 12.8 4.1 12.7 0.6
     Women 2,600 14.2 7.2 7.9 3.3 2.9 *
Modal Age
     19–20 800 22.9 9.8 15.8 7.7 6.3 *
     21–22 700 19.4 10.1 13.1 4.2 2.1 0.4
     23–24 700 17.4 10.5 10.5 4.6 14.9 0.4
     25–26 700 16.0 10.0 8.2 2.7 * 0.4
     27–28 800 11.0 6.4 6.1 2.1 9.4 0.2
     29–30 800 12.3 5.7 7.2 1.4 7.5 *
Region
     Northeast 800 18.1 11.4 9.2 4.7 5.8 0.5
     Midwest 1,200 13.7 6.4 9.6 2.6 15.5 0.2
     South 1,400 13.0 5.4 9.2 2.9 5.0 *
     West 1,000 23.4 14.6 12.6 5.2 0.8 0.3
Population Density e
     Farm/Country 400 8.3 4.2 5.3 1.7 12.9 *
     Small Town 1,100 16.3 9.7 9.5 4.7 11.0 0.4
     Medium City 1,200 14.6 6.9 10.9 3.3 4.3 0.3
     Large City 1,000 19.6 10.2 12.4 4.2 4.4 *
     Very Large City 700 18.8 10.8 8.9 2.6 4.7 0.4
Source. The Monitoring the Future study, the University of Michigan.
Notes.    ' * ' indicates a prevalence rate of less than 0.05%.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders.
bThis drug was asked about in three of the six questionnaire forms. Total N  is approximately 2,200.
cThis drug was asked about in one of the six questionnaire forms. Total N  is approximately 700.
dThis drug was asked about in five of the six questionnaire forms. Total N  is approximately 3,700.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; and a very large city as having over 500,000.   
Within each level of population density, suburban and urban respondents are combined.
fThis drug was asked about in four of the six questionnaire forms. Total N is approximately 2,900.
gThis drug was asked about in two of the six questionnaire forms. Total N  is approximately 1,500.
hOnly drug use that was not under a doctor’s orders is included here.
iBased on data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
jFor the total estimate of 30-day Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail mode (8.1%) and new web-push mode (11.3%) of administration.
(Entries are percentages.)
TABLE 4-4 (cont.)
Thirty-Day Prevalence of Use of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
Approximate
Weighted N
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Alcohol: Alcohol: Alcohol:
5+ Drinks 10+ Drinks 15+ Drinks Cigarettes:
in a Row in in a Row in in a Row in 1/2 Pack+ Smokeless
Marijuana Daily Alcohol Daily Last 2 Weeks d Last 2 Weeks c Last 2 Weeks c Cigarettes Daily per Day Tobaccoc
Total 4,400 8.0 4.7 31.2 8.4 3.4 7.6 4.1 3.6
Gender
     Men 1,800 10.3 6.3 36.6 14.9 6.5 7.5 3.8 6.1
     Women 2,600 6.3 3.6 27.4 4.0 1.2 7.7 4.3 1.7
Modal Age:
     19–20 800 7.1 1.4 20.5 5.7 2.9 5.9 2.3 4.2
     21–22 700 8.6 3.5 34.3 6.9 5.5 4.4 2.3 0.7
     23–24 700 7.5 6.0 37.0 11.1 4.1 8.2 4.3 9.5
     25–26 700 8.3 5.0 33.5 9.1 2.9 7.6 4.2 0.0
     27–28 800 8.4 5.5 31.4 8.0 2.4 8.9 5.7 2.7
     29–30 800 8.0 6.4 30.6 9.8 2.9 10.3 5.7 3.7
Region
     Northeast 800 8.6 5.6 34.6 8.7 1.2 8.7 3.7 3.4
     Midwest 1,200 7.8 5.9 34.2 12.3 6.3 8.7 5.0 6.7
     South 1,400 7.5 3.3 27.9 6.2 3.0 7.9 4.7 3.3
     West 1,000 8.6 4.8 29.3 7.1 1.9 5.1 2.7 0.6
Population Density b
     Farm/Country 400 8.8 4.1 23.8 13.6 5.2 10.7 7.2 2.9
     Small Town 1,100 7.9 5.3 29.1 7.9 4.4 9.9 5.5 8.4
     Medium City 1,200 7.2 4.4 29.2 7.7 3.3 6.7 3.8 2.3
     Large City 1,000 7.9 4.3 34.9 8.2 2.2 5.5 2.5 1.4
     Very Large City 700 8.7 5.0 36.5 8.3 2.7 6.8 2.8 1.9
Source. The Monitoring the Future study, the University of Michigan.
aDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, 
and 5+ drinks, measured as having five or more drinks in a row in the last two weeks.
bA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000–100,000; a large city as 100,000–500,000; 
and a very large city as having over 500,000. Within each level of population density, suburban and urban respondents are combined.
cThis drug was asked about in one of the six questionnaire forms. Total N  is approximately 700.
dFor the total estimate of 5+ Drinks in a Row in Last 2 Weeks in 2018, there was a significant difference (p<.01) between the typical mail condition (29.4%) and new web-push condition (33.0%) of survey administration.
Approximate
Weighted N
TABLE 4-5
Thirty-Day Prevalence of Daily Use a of Various Types of Drugs by Subgroups
among Respondents of Modal Ages 19–30, 2018
(Entries are percentages.)
121
Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.  
aThe questions on hallucinogen use are not included in the age 55 or age 60 questionnaires.  Therefore, the data presented here include hallucinogens
for ages 18 to 50, but not for ages 55 and 60.
FIGURE 4-1
ANY ILLICIT DRUGa
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aThe questions on hallucinogen use are not included in the age 55 or age 60 questionnaires.  Therefore, the data presented here include hallucinogens
for ages 18 to 50, but not for ages 55 and 60.
FIGURE 4-2
ANY ILLICIT DRUG OTHER THAN MARIJUANAa
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding some bars with the same number may have uneven height.
FIGURE 4-3
MARIJUANA
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, 30-Day, and Daily Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-4
AMPHETAMINES
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of methamphetamines were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-5
METHAMPHETAMINE
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of crystal methamphetamine were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-6
CRYSTAL METHAMPHETAMINE (ICE)
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding some bars with the same number may have uneven height.
FIGURE 4-7
COCAINE
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-8
CRACK COCAINE
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-9
OTHER COCAINE
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens were not included in the questionnaires for 55-year-olds.
FIGURE 4-10
HALLUCINOGENS a 
among Respondents of Modal Ages 18 through 50b
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of LSD were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-11
LSD
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
10
14
10
12
14
5
8
10
13
10
11 11
3
5
5
3
2
4
2
1
2
1 1 1 0
1
0
5
10
15
20
25
30
18 19–20 21–22 23–24 25–26 27–28 29–30
P
E
R
C
E
N
T
AGE AT ADMINISTRATION
Lifetime, Adjusted
Lifetime
Annual
30-Day
132
Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens other than LSD were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-12
HALLUCINOGENS OTHER THAN LSD a 
among Respondents of Modal Ages 18 through 30 b
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding some, bars with the same number may have uneven height.
aUnadjusted for the possible underreporting of amyl and butyl nitrites. 
bQuestions about the use of inhalants were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-13
INHALANTS a 
among Respondents of Modal Ages 18 through 30 b
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-14
SEDATIVES (BARBITURATES)
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.    Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-15
NARCOTICS OTHER THAN HEROIN
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-16
TRANQUILIZERS
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of ecstasy were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-17
MDMA (Ecstasy, Molly)
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
aQuestions about the use of steroids were not included in the questionnaires for 35- to 60-year-olds.
FIGURE 4-18
STEROIDS
among Respondents of Modal Ages 18 through 30 a
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-19
HEROIN
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes.     Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time. See text for discussion.
Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-20a
ALCOHOL
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Lifetime, Annual, and 30-Day Prevalence
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Source. The Monitoring the Future study, the University of Michigan.
Notes. Due to rounding some bars with the same number may have uneven height.
FIGURE 4-20b
ALCOHOL
by Age Group, 2018
2-Week Prevalence of 5 or More Drinks in a Row and
30-Day Prevalence of Daily Use 
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Source. The Monitoring the Future study, the University of Michigan.
Notes. Due to rounding, some bars with the same number may have uneven height.
FIGURE 4-21
CIGARETTES
among Respondents of Modal Ages 18 through 60
by Age Group, 2018
Annual, 30-Day, Daily, and Half-Pack-a-Day Prevalence
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Chapter 5 
 
TRENDS IN DRUG USE 
IN EARLY AND MIDDLE ADULTHOOD 
 
In this chapter we examine historical trends through 2018 in substance use for various age bands 
from early to later adulthood, ages 19 through 60. We use MTF panel data from graduating high 
school seniors spanning more than four decades. Although such panel data are typically used to 
study stability and change in the same individuals over time, we use the data here cross-sectionally 
to consider how substance use has varied across the years for each age group, much as we use the 
repeated cross-sectional surveys of secondary school students to track changes in behaviors over 
time for particular grade levels (8, 10, and 12) in Volume I. In the early 1990s, we began to 
document large and important increases among secondary school students in the use of several 
substances, particularly marijuana and cigarettes. The increases continued among 12th graders 
through 1997, as discussed in Volume I. One of the important issues addressed in this chapter is 
whether such increases occurred only among adolescents or whether those higher-using graduating 
classes have carried their higher levels of drug use with them as they moved into young adulthood. 
In other words, are they exhibiting lasting differences across class cohorts, known as cohort 
effects? These would be indicated by the inflection points in the cross-time trends (turning either 
up or down) coming sequentially across the age strata as cohorts age with a time lag between 
adjacent strata. 
 
Figures 5-1 through 5-19c present separate trend lines for two-year age strata through age 30,1 that 
is, respondents who are one to two years beyond high school, three to four years beyond high 
school, and so on. These two-year age strata are used to reduce the random fluctuations that would 
be seen with one-year strata due to smaller sample size.2 Each data point through age 30 in these 
figures is based on approximately 680 to 900 weighted cases drawn from two adjacent high school 
classes; actual (unweighted) numbers of cases are somewhat higher than those shown in the tables.3 
Figures 5-1 through 5-19c also present trend data from respondents at modal ages 35, 40, 45, 50, 
55, and 60 based on follow-up data collected at those ages. Beginning at age 35, the age strata are 
constituted in a slightly different way, in that the two half-samples from a single graduating class 
(which up through age 30 had been surveyed in alternating years) are now both surveyed in the 
same year. In 2018, the 35 year olds are graduates from the high school class of 2001 (weighted N 
= 692, the 40 year olds from the high school class of 1996 (weighted N = 752), the 45 year olds 
from the high school class of 1991 (weighted N = 771), the 50 year olds are graduates from the 
high school class of 1986 (weighted N = 737), the 55 year olds are graduates from the high school 
class of 1981 (weighted N=775), and the 60 year olds are graduates from the high school class of 
                                                 
1 MTF collected age 31 and 32 data from 1990 through 2001, then stopped collecting data from this age group to put resources instead into longer 
term data collections at 5 year intervals after age 30. Thus, starting in 2002, we collected data from young adults biennially through age 30, and 
from middle adults every five years starting at age 35. We no longer present trends on the age 31-32 year band; for such trends, please see the 
previous editions of this volume. Schulenberg, J. E., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Miech, R. A., & Patrick, M. E. 
(2017). Monitoring the Future national survey results on drug use, 1975-2016: Volume II, college students and adults ages 19-55. Ann Arbor: 
Institute for Social Research, The University of Michigan.  
2 Strictly speaking, these two-year strata are not age strata, because they are based on all respondents in the given year from two adjacent high 
school classes, and they do not take into account the any differences in individual respondents’ ages within each graduating class; however, they 
are close approximations to age strata, and we characterize them by the modal age of the respondents as ages 19 to 20, 21 to 22, and so on.  
3 For example, in the 2016 data, the 19-20 year old stratum is composed of participating respondents from the high school graduating classes of 
2015 and 2014, respectively; the 21-22 year old stratum contains data from the classes of 2013 and 2012, respectively; and so on. 
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1976 (weighted N=825). The unweighted actual Ns are somewhat higher. Modal age 55 was first 
added to the survey in 2013, providing five-year trends in 2018; modal age 60 was just added this 
year, so we include 2018 estimates in the figures and will add in trend data for 60 year olds next 
year. The figures also include trend data for 18 year olds for comparison purposes. The page 
following the figure for each drug contains a table of values for each point in the trend lines 
separately for the various age strata. 
 
Tables 5-1 through 5-5 are derived from the same data but presented in tabular form for 19-28 year 
olds combined—who we call “young adults” —providing an overall view of the first decade after 
high school. Data are given for each year in which they are available for that full age band (i.e., 
from 1986 onward). The percentage point changes between 2017 and 2018 are listed in the second 
to last column, along with an indication about the statistical significance of this one-year change. 
We also include percentage point changes over the past five years (2013-2018) in the last column, 
indicating whether the five-year change is significant. Respondents ages 29 and over are omitted 
from the tables. However, the full data for those respondents are contained in Figures 5-1 through 
5-19c.  
 
As we discuss in Chapters 3 and 4, for the 2018 data collections of 19-30 year olds, MTF began 
the transition from our typical mail-based surveys to web-based surveys. To test for possible 
survey mode differences, we randomly assigned half of the young adult respondents 2018 to the 
typical mail survey condition and half to the new web-push condition (as described in Chapter 3). 
We discuss in Chapter 4 that there were few significant differences in 2018 prevalence estimates 
between the two conditions among 19-30 year olds, and thus combined the two in a weighted 
average in that chapter and noted the few significant differences. In the current chapter, we also 
combined the prevalence estimates from the two conditions in 2018, and in Tables 5-1 through 5-
4 concerning trends among 19-28 year olds combined, we note the few significant differences 
between the two conditions.  
 
RECENT TRENDS IN DRUG USE AMONG YOUNG ADULTS AGES 19-28 
In this section we focus on recent trends over the past year and past five years in substance use 
among young adults ages 19 to 28 combined (shown in Tables 5-1 through 5-4). Longer term 
trends for individual age groups of young adults and older adults are summarized in the next 
section. 
  
 The percent of young adults ages 19 to 28 indicating use of any illicit drug in the prior 12 
months continued to increase—up by a nonsignificant 1.6 percentage points over 2017 
prevalence to reach 42.8% in 2018. This is up from the most recent low of 32.1% in 2006 
(Table 5-2). As shown in the last column in Table 5-2, this prevalence increased a 
significant 6.2 percentage points over the past five years, that is, since 2013. 
Correspondingly, 30-day use of any illicit drug increased a significant 4.3 percentage 
points over the past five years, rising to 25.9% in 2018 (Table 5-3). These increases 
primarily have been due to the increases in marijuana use.  
 
 Marijuana use showed a one-year nonsignificant 1.6 percentage point rise in annual 
prevalence to 39.1% in 2018 for 19-28 year olds. This was up from 27.7 % in 2006—the 
most recent low point. Levels today for this age group are at the highest they have been in 
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over three decades, above the 36.5% prevalence in 1986 when we began tracking this age 
span (Table 5-2). The five-year change in annual marijuana use was a significant increase 
of 7.0 percentage points for 19-28 year olds. Likewise, 30-day use of marijuana has 
increased significantly by 5.1 percentage points across the past five years, rising to 24.1% 
in 2018, an all-time high for the study (Table 5-3). Thus, as of 2018 annual and 30-day 
marijuana use among young adults aged 19-28 are at the highest levels in the 33 years that 
MTF has been monitoring their use. As shown in Figure 5-3a (in table after the figure), the 
percentage point increases over the past five years (2013-2018) have been greater for those 
in their mid- to late-20s than for those in their early 20s (e.g., annual use increased across 
the five years by 5.0, 8.7, and 6.8 percentage points, respectively for the 19-20, 23-24, and 
27-28 age bands; 2018 prevalence for these three age groups was 41%, 43%, and 32%, 
respectively ). Although the trends for the 35-55 year olds are considered in the next 
section, it is worth noting here that their annual and 30-day marijuana use also increased 
in recent years through 2018 (e.g., between 2013 and 2018, annual use rose 7.6, 7.7, 7.4, 
1.0, and 4.1 percentage points, respectively, for 35, 40, 45, 50, and 55 year olds; 2018 
prevalence was 25%, 22%, 19%, 13%, and 16%, respectively). Thus, it is likely that the 
recent increases in marijuana across all age bands of adults 19-55 reflect both secular trends 
as well as cohort effects. 
 
 Daily or near daily marijuana use (defined as use of marijuana on 20 or more occasions 
in the past 30 days) among young adults increased nonsignificantly between 2017 and 2018 
to 8.0% , the highest level ever observed in this young adult population since tracking their 
use began over 30 years ago. It is over three times the level in 1992 (2.3%), the low point 
since 1986 (Table 5-4). Daily marijuana increased a significant 1.7 percentage points over 
the past five years. Thus, as of 2018, almost one-in-twelve young adults aged 19-28 is a 
daily marijuana user.  
 
 With regard to marijuana use, there has been a recent cross-over in terms of age differences, 
with those in their early 20s showing higher prevalence than 12th graders of annual use 
(since 2016), 30-day use (since 2015), and daily marijuana use (since 2014), with the gaps 
widening in the past few years. In recent years, up until this cross-over, 12th graders had 
higher or similar prevalence levels. This likely reflects somewhat of a cohort effect, with 
prevalence leveling for 12th graders after an increase through about 2012, and prevalence 
continuing to rise for those in their early-to-mid-20s. A similar pattern is found for annual 
prevalence of the index of any illicit drug other than marijuana (Figure 5-2). 
 
 New questions about vaping marijuana were added to two forms of the young adult 
surveys in 2017 and 2018. Annual prevalence of vaping marijuana in 2017 and 2018 was 
12.6% and 15.6%, respectively, among 19-28 year olds overall, showing a significant 3.1 
percentage point increase in 2018 (Table 5-2). For the individual young adult age groups 
in 2017 and 2018, annual prevalence was 12% and 17% for ages 19-20, 11% and 17% for 
ages 21-22, 17% and 17% for ages 23-24, 11% and 16% for ages 25-26, and 12% and 12% 
for ages 27-28. Thus, between 2017 and 2018, annual vaping of marijuana increased 
significantly for 19-28 year olds, with increases in most age strata; it was highest in both 
2017 and 2018 among 23-24 year olds at 17%. Thirty-day prevalence of vaping marijuana 
in 2017 and 2018 was 6.6% and 9.3%, respectively, among 19-28 year olds overall, 
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showing a significant 2.7 percentage point increase (Table 5-3). For the individual young 
adult age groups in 2017 and 2018, 30-day prevalence was 6% and 10% for ages 19-20, 
6% and 10% for ages 21-22, 8% and 11% for ages 23-24, 5% and 10% for ages 25-26, and 
7% and 6% for ages 27-28. Thus, 30-day prevalence of vaping marijuana also increased 
significantly between 2017 and 2018 for young adults, especially those in their early- to-
mid 20s, where use was highest in 2018 (Table 4-4). It is clear that vaping marijuana is 
increasing among young adults, and it appears more common in the early- and mid-20s 
than later-20s. The recent rapid increase in vaping among adolescents4 may well have 
generated cohort differences that are reflected in these age groups and that will appear in 
later age groups in the future.   
 
 Annual use of synthetic marijuana remained essentially unchanged in 2018 at 1.6% (Table 
5-2). This is down appreciably from the 7.4% annual prevalence observed in 2011, when 
use of this drug was first measured; the five-year decrease from 2013 was significant. This 
decline parallels a sharp decline in synthetic marijuana use among secondary school 
students.   
 
 Annual use of any illicit drug other than marijuana showed a one-year nonsignificant 
decrease of 1.1 percentage points to 19.0% in 2017, following a significant increase in 
2014 when it rose from 18.1% to 21.2%. This annual prevalence had been relatively stable 
from 2003 to 2013, at between 17% and 19%. The five-year increase between 2013 and 
2018 was a nonsignificant 0.9 percentage points. As summarized below, this lack of 
significant change over the past five years in this index of any illicit drug other than 
marijuana appears largely to be due a mix of some drugs increasing significantly over the 
past five years (annual use of hallucinogens, specifically LSD, and cocaine, specifically 
cocaine other than crack) and others decreasing significantly over the past five years 
(annual use of narcotics other than heroin, sedatives (barbiturates), and tranquilizers).  
 
 Hallucinogens and LSD specifically showed slight one-year increases in 2018, and 
significant five-year increases. Between 2013 and 2018, annual use of hallucinogens rose 
significantly from 3.9% to 5.6%, and LSD rose significantly from 2.0% to 3.9% (Table 5-
2).  
 
 The annual prevalence of cocaine (any type including crack and cocaine powder) among 
young adults showed a one-year nonsignificant increase in 2018 to 6.0%, up from an all-
time low of 3.9% in 2013. The increase of 2.1 percentage points over the past five years is 
significant (Table 5-2). Annual use of cocaine other than crack (typically in powdered 
form) remained fairly level across the past three years (6.2% in 2018), and showed a five-
year significant increase of 2.5 percentage points. Annual use of crack, however, declined 
unevenly and nonsignificantly over the past five years from 0.5% to 0.2%, indicating that 
this drug is now all but forgotten -- among young adult high school graduates, at least.  
 
 
                                                 
4 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
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 Annual nonmedical use of Adderall has increased in recent years, showing a significant
five-year increase of 2.1 percentage points to 9.1% in 2018, the highest level since it was
first measured in 2009. Amphetamine use in general, however, has been level in recent
years as mentioned below.
 A few specific illicit drugs showed recent declines. Most notably, annual use of narcotics
other than heroin by young adults showed a nonsignificant one-year decline in 2018 to
3.4%, as well as a significant five-year decline of 3.6 percentage points. Its peak was 9.1%
in 2006 and 2008 (Table 5-2). Correspondingly, annual use of Vicodin showed a significant
five-year decline of 3.7 percentage points to 2.4% in 2018; its peak was 9.3% in 2005.
OxyContin appears to have leveled at very low prevalence (1.9% in 2018), also showing a
significant decrease of 0.9 percentage points in the past five years. This is an important
class of substances, accounting for many overdose deaths5, so the fact that use is now in
decline among young adults is a very favorable development for the nation's health.
 Annual prevalence levels of both sedatives (barbiturates) and tranquilizers have been
declining somewhat in recent years among young adults, both now at or near all-time lows
for the past two decades. Although annual use of sedatives (barbiturates) has been fairly
level in the past few years (2.5% in 2018), it declined significantly by one percentage point
over the past five years. Annual use of tranquilizers declined nonsignificantly in 2018 (to
4.0% in 2018), with a significant five-year decline of 1.4 percentage points (Table 5-2).
 Annual use of MDMA (ecstasy, and more recently Molly) has also declined somewhat in
recent years, showing a leveling in 2018 (3.9%). In 2014, we added Molly as an example,
and since then, annual use has declined from 5.1% to 3.9% (Table 5-2).
 The annual use of several other illicit drugs have shown some leveling in recent years as
summarized in Table 5-2. In particular, the annual use of amphetamines has leveled
recently at a relatively high level, ranging between 7.2% and 8.0% over the past five years
(Table 5-2). As mentioned above in the summary of drugs that have increased recently,
annual nonmedical use of Adderall increased significantly over the past five years (to 9.1%
in 2018); annual nonmedical use of Ritalin leveled in recent years at 1.2% to 2.0% between
2013 and 2018.
 There have been some recent declines in alcohol use among young adults. Annual
prevalence both of use and of been drunk was fairly level over the past five years (82%
and 63%, respectively in 2018) (Table 5-2). The 30-day prevalence of alcohol use declined
slightly, but significantly, over the past five years from 68.7% in 2013 to 66.0% in 2018;
the 30-day prevalence of been drunk declined nonsignificantly from 37.7% in 2013 to
35.9% in 2018 (Table 5-3). The annual use of alcoholic beverages mixed with energy
drinks showed some uneven declines in recent years, with a net significant five-year
decline of 7.3 percentage points in 2018 to 29.9% (Table 5-2). The annual use of flavored
alcoholic beverages, however, showed some nonsignificant increase in the past five years
(to 57% in 2018).
5 National Institute on Drug Abuse (2019). Overdose death rates. Accessed July 30, 2019. 
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Binge drinking—having five or more drinks at least once in the prior two weeks—declined 
gradually from 2008 (when 37.9% of young adults indicated such use) through 2015 
(31.9%), about where it remained in 2018 (31.2%); the five-year decline of 3.9 percentage 
points was significant (Table 5-4). This decline among young adults follows a similar 
decline among high school seniors. Extreme binge drinking (also known as high intensity 
drinking) has shown some uneven change in recent years among young adults (due to some 
extent to the relatively small Ns that are asked these questions, only one-sixth of the 
sample). For having 10 or more drinks on one or more occasions in the past two weeks, 
prevalence ranged between 7.3% and 11.2% in the past five years (neither the one-year nor 
five-year change was significant); similarly, prevalence of having 15 or more drinks 
ranged between 2.4% and 3.7% in the past five years (neither the one-year nor five-year 
change was significant) (Table 5-4).  
 
 Cigarette smoking among young adults significantly declined over the past five years, a 
continuation of longer-term declines and reaching historic lows in 2018. Annual prevalence 
declined nonsignificantly to 22.5% in 2018, and the five-year decline of 7.3 percentage 
points was significant (Table 5-2). Thirty-day prevalence decreased a significant 3.0 
percentage points in 2018 to 12.3%; the five-year decline of 7.7 percentage points was also 
significant (Table 5-3). Daily smoking decreased a significant 1.8 percentage points in 
2018 to 7.0%; the five-year decline of 5.1 percentage points was significant (Table 5-4). 
Half-pack-a-day smoking by young adults declined by a nonsignificant 0.9 percentage 
points to 3.8% in 2018; the five-year decline of 3.2 percentage points was significant (Table 
5-4). On all of these measures of smoking, the 2018 levels were at historic lows. This 
pattern of significant decline follows appreciable declines to historic lows among high 
school seniors (Figures 5-19a, b, and c). 
 
 In 2017, we expanded the questions about vaping on two of the survey forms assess specific 
substances being vaped, specifically for nicotine, marijuana, and “just flavoring.” Annual 
prevalence of vaping nicotine in 2017 and 2018 was 12.6% and 15.6%, respectively, 
among 19-28 year olds, showing a significant 3.0 percentage point increase (Table 5-2). 
For the young adult age groups in 2017 and 2018, annual prevalence was 14% and 27% 
for ages 19-20, 17% and 20% for ages 21-22, 15% and 18% for ages 23-24, 12% and 16% 
for ages 25-26, and 14% and 12% for ages 27-28. Thus, annual prevalence of vaping 
nicotine significantly increased between 2017 and 2018 for young adults, with the increase 
being especially large at age 19-20, where use was highest in 2018 at 27%. Thirty-day 
prevalence of vaping nicotine in 2017 and 2018 was 6.5% and 10.6%, respectively, among 
19-28 year olds, showing a significant 4.0 percentage point increase (Table 5-3). For the 
young adult age groups in 2017 and 2018, 30-day prevalence was 7% and 16% for ages 
19-20, 6% and 13% for ages 21-22, 8% and 11% for ages 23-24, 4% and 8% for ages 25-
26, and 7% and 6% for ages 27-28; thus, between 2017 and 2018, 30-day vaping nicotine 
also increased significantly, with the increase being largest among 19-20 year olds, who 
had the highest level at 16% in 2018. It is clear that vaping nicotine is increasing among 
young adults, especially among 19-20 year olds, where it was most common in 2018 (for 
lifetime, annual, and 30-day use). The recent rapid increase in vaping nicotine among 
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adolescents6 may well have generated cohort differences that are reflected in these age 
groups and may also be related to increases in later age groups in the future. It remains an 
open question whether nicotine vaping will continue to decline with advancing age or 
whether it will remain primarily at levels set in young adulthood, a pattern seen for cigarette 
use. Beginning in 2019, the vaping items will be on four of the six young adult survey 
forms, and will be in the age 35 and older forms, providing more precise estimates on this 
rapidly growing phenomenon. 
In summary of the recent trends among young adults age 19-28, marijuana use has increased to 
all-time highs, which is true for annual use, 30-day use, and daily use; the five-year increases from 
2013 to 2018 for all three levels of marijuana use were significant. As of 2018, nearly four-in-ten 
young adults (39%) used marijuana at least once in the past year, nearly one-in-four (24%) used it 
at least once in the past month, and nearly one-in-twelve (8.0%) was a daily or near-daily marijuana 
user in the past month.  
Concerning the index of illicit drugs other than marijuana, annual use has been steady the last 
few years, with the five-year trend showing no significant change (19% in 2018). This level trend 
corresponds to a mix of five year increases in annual use of certain illicit drugs (including 
hallucinogens, specifically LSD, and cocaine other than crack, all three showing significant five-
year increases in 2018 to 5.6%, 3.9%, and 6.2%, respectively), and declines in annual use of other 
illicit drugs (including annual nonmedical use of narcotics other than heroin, sedatives 
[barbiturates], and tranquilizers showing a significant five-year declines in 2018 to 3.4%, 2.5%, 
and 4.0%, respectively). MDMA (ecstasy, and more recently Molly) has also been in decline, with 
annual use showing a significant decline from 2016 to 2017, and a leveling in 2018 (3.9%); it has 
declined from 5.1% since 2014 (when we first included Molly as an example). Nonmedical annual 
use of amphetamines has been fairly steady in recent years, showing no significant change across 
the past five years (7.5% in 2018); however, annual nonmedical use of Adderall showed a 
significant five-year increase of 2.1 percentage points to 9.1% in 2018, the highest level since it 
was first measured in 2009.    
There have been continued recent declines in alcohol use among young adults, with 30-day 
prevalence of alcohol use declining significantly over the past five years to 66.0% in 2018; binge 
drinking declined a significant 3.9 percentage points across the past five years to 31.2% in 2018.  
Cigarette use continued to decline through 2018, with annual, 30-day, daily, and half-pack a day 
prevalence declining significantly over the past five years.  
Finally, based on new vaping questions added to the young adult surveys in 2017 and 2018, annual 
and 30-day prevalence of vaping marijuana showed significant increases in 2018 for 19-28 year 
olds (to 15.6% and 9.3%, respectively, in 2018), with annual use in 2018 being highest among 23-
24 year olds (17%) and 30-day use being similar among 19-26 year olds (10-11%). Annual and 
30-day prevalence of vaping nicotine also showed significant increases in 2018 for 19-28 year
olds (to 18.2% and 10.6%, respectively), with annual and 30-day use being highest in 2018 among
19-20 year olds (27% and 16% respectively).
6 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
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LONGER-TERM TRENDS IN EARLY AND MIDDLE ADULTHOOD 
In this section we consider longer-term trends among 19-28 year olds overall (Tables 5-1 through 
5-4), as well as among all age groups individually (Figures 5-1 through 5-19), giving attention to 
how trends have varied by age and by cohort.  
 
 Longer-term declines among young adults in the annual prevalence of several drugs 
appeared to end in 1992 or 1993 (Table 5-2, Figure 5-1). Among the 19-28 year olds 
overall, this was true for the use of any illicit drug, marijuana, any illicit drug other than 
marijuana, hallucinogens, narcotics other than heroin, crack, amphetamines, sedatives 
(barbiturates), and tranquilizers. In 1994, annual prevalence for most drugs remained 
steady. Cocaine other than crack reached its low point in 1994 after a period of substantial 
decline that began in the late 1980s. In 1995 there again were modest increases (a 
percentage point or less) in the annual prevalence of almost all of the drug classes in Table 
5-2, some of which were statistically significant. 
 
Thus, it was clear that by 1992 or 1993 the downward secular trend (i.e., period effect) 
running back to the 1980s and observable in all of these age strata (as well as among 
adolescents) had ended. What has happened since then, however, is more of a cohort effect, 
reflecting an interaction between age and period such that only adolescents showed an 
increase in illicit drug use initially, and they then carried those new (higher) levels of drug 
use with them as they entered older age bands. Figure 5-1 shows the effects of generational 
replacement on the use of any illicit drug, as the teens of the early 1990s reached their 20s. 
While all age groups generally moved in parallel through about 1992, the youngest age 
bands first showed signs of increase in their overall level of illicit drug use. The 18 year 
olds shifted up first, followed by the 19-20 year olds in 1994, the 21-22 year olds in 1996, 
the 23-26 year olds in 1999, the 29-30 year olds in 2004, and the 35 year olds in 2008. So 
far, the 40, 45, 50 and 55 year olds have not shown much systematic increase in any illicit 
drug use through 2014. (It is noteworthy that 8th graders, who are not included in these 
graphs but are described in Volume I, actually began an increase in use a year earlier than 
the 12th graders, suggesting a cohort effect was already underway before use turned upward 
among 12th graders.)   
 
Then, from 2007 to 2013, use among 12th graders and several of the youngest young adult 
age bands increased, and a number of the older age bands followed suit in subsequent years 
including increases among 35 year olds starting in 2013, among 40 year olds starting in 
2015, and among 45 year olds in 2017, once again suggesting a cohort effect (see Figure 
5-1). 
 
To summarize, in the earlier decline phase of the drug epidemic, annual prevalence of use 
of any illicit drug moved in parallel for all age strata, as illustrated in Figure 5-1; this 
pattern reflects a secular trend, because a similar change is observed simultaneously across 
different age levels. After 1992—in what we have called the “relapse phase” of the popular 
drug epidemic that began in the 1960s—a quite different pattern emerged: 8th graders 
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increased their drug use first, followed by 10th and 12th graders7; then the next-oldest age 
group increased use, but with a little delay; the next-oldest then increased use, but with a 
longer delay; and so on. This pattern reflects a classic cohort effect, in which different age 
groups are not all moving in parallel; rather, different age groups show increases when the 
cohorts (i.e., high school classes) having heavier use at an earlier stage in development 
reach the relevant age level. In addition, note that the slopes of the age bands are 
successively less steep in the older age groups, suggesting that some of the cohort effect 
may be dissipating with maturation, quite likely indicating an age effect. But we think it 
unlikely that only cohort effects are occurring (in addition to the long-established age 
effects); period effects also likely play a role.  
 
 Use of marijuana shows an almost identical pattern to the illicit drug use index—not 
surprising given the fact that marijuana, by far the most prevalent of the illicit drugs, tends 
to drive the index (Figure 5-3a). After a long and steady decline from the late 1970s to the 
early 1990s, annual marijuana use leveled for a while among young adults before beginning 
a gradual increase. Virtually all of this increase was attributable to the two youngest age 
bands (18 and 19 to 20) until 1996, when the 21-22 year olds began to show a rise. The 
older age bands then tended to show increases fairly sequentially, with 29-30- and 35 year 
olds showing significant increases in 2008. The 18 year olds’ use of marijuana in the prior 
12 months declined after 1997 and, later, several of the succeeding age bands through age 
26 began to show declines in a pattern that again suggests lasting cohort differences. Since 
about 2006, however, use rose not only among the 18 year olds (through about 2011, 
leveling since then) but also among all age bands through 2018, including uneven increases 
for 35 to 45 year olds (and for 50 and 55 year olds since 2008 and 2013, respectively), thus 
indicating a secular trend. This strongly suggests an impact on use by culture-wide events 
to which all of the age bands are exposed and by which they all were affected during this 
historical period. Changing attitudes toward marijuana use, perhaps driven in part by the 
legalization of medical use in many states and more recently by legalization of recreational 
use for adults in some states, likely have played an important role in this secular trend.  
 
 A similar pattern emerged for current daily marijuana use (Figure 5-3c). In the mid- to 
late 1990s, daily marijuana use among 35 and 40 year olds was as high as or higher than 
use among some younger age groups, suggesting a lasting cohort effect on this behavior, 
because the cohorts comprising those older age strata grew up in a period of particularly 
high adolescent marijuana use. However, in more recent years through the mid-2000s, the 
35, 40, and 45 year olds were similar to respondents ages 27 to 30, who had among the 
lowest levels of daily use in adolescence. An important finding shown in Figure 5-3c is 
that, although the various age groups had been moving in parallel for many years at fairly 
similar levels of prevalence, the trends diverged considerably in the 1990s in a staggered 
fashion, such that the 18-30 year olds came to have distinctly higher levels of daily 
marijuana use than the older age groups, again reflecting stable cohort differences and 
perhaps some new age effects emerging in the middle-to-late adult ages (this is discussed 
further below when considering the strong cohort effects in cigarette use). In 2010 the 
upturn in daily marijuana use that had been occurring at younger ages (best seen in the 
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table accompanying Figure 5-3c) reached the age-35 stratum, with a significant increase 
from their 2009 prevalence rate putting the age 35 group back in company with the younger 
adults through 2015. Since about 2010, the increase has been greater for those in the mid- 
to late-20s through age 40, and these age groups had higher levels of daily use in 2018 than 
they did in 2010, reaching levels well above those observed in the early to mid-1990s 
(Figure 5-3c and associated table).  
 
 The index of using any illicit drug other than marijuana has shown a similar transition in 
the pattern of change. Period effects seemed to predominate in the 1980s until about 1992 
as all age groups moved in parallel, but a cohort-related pattern of change emerged 
thereafter (Figure 5-2). And, while the rise in annual use leveled by 1997 among 18 year 
olds, it began rising in 1999 among 19-20 year olds, in 2000 among 21-22 year olds, in 
2002 among 23-24 year olds, in 2005 among 29-30 year olds, and so on. The primary 
difference from the picture for marijuana is that the increases were not as sharp in the 1990s 
for most of the age groups. (Compare Figure 5-2 with Figure 5-1 to see the difference.) 
Between about 2000 and 2008, annual use remained fairly steady or dropped some for 12th 
graders and 19-22 year olds, and increased for the other age groups, particularly the 23-30 
year olds. Since about 2008 the levels of use of any illicit drug other than marijuana in 
nearly all age groups have remained fairly steady, except for 12th graders who have shown 
a decline.   
 
 With regard to inhalants, the large separation of trend lines for the younger age groups in 
Figure 5-4 shows that, across many cohorts, annual use has dropped consistently and 
sharply with age, particularly in the first few years after high school. In fact, of all the 
populations covered by MTF, the 8th graders (not shown in Figure 5-4) have had the highest 
rate of use, indicating that the decline in use with age starts at least as early as 8th or 9th 
grade.8 Like cocaine, inhalants have shown a strong age effect, but unlike cocaine, use of 
inhalants declines rather than increases with age and the age effect generally has been 
sustained throughout the life of the study. 
 
Figure 5-4 also shows that, until the mid-1990s, there was a long-term gradual increase in 
annual inhalant use (unadjusted for underreporting of nitrite inhalants), one which was 
greatest among 12th graders, next greatest among 19-20 year olds, and next greatest among 
21-22 year olds. Respondents more than six years past high school, who historically have 
had a negligible rate of use, did not exhibit the increases in use seen among the younger 
respondents, which began at least as early as 1977 among 12th graders and in 1983 among 
19-20 year olds. There was some subsequent increase among 21-22 year olds and, later 
still, an increase among 23-24 year olds. After 1995, this long-term trend, reflecting a 
cohort effect, began to reverse in the two youngest age strata (coincident with an anti-
inhalant media campaign by the Partnership for a Drug-Free America) as well as among 
several other age strata, suggesting a period effect due to some culture-wide influence, such 
as a media campaign. Subsequently, further declines among several age strata are 
suggestive of a cohort effect. Those in their mid- to late-20s have generally shown very 
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low rates of inhalant use throughout the course of the study (this question is not asked of 
the age 35 and above groups).   
 In the late 1980s and again in the first half of the 1990s, LSD use also increased among
those in their teens and early 20s much more than among the older strata, as Figure 5-6
illustrates. Over the interval 1985 to 1996, there was a gradual but considerable increase in
annual LSD use among respondents ages 18 to 24, which was sharpest among 12th graders
and 19-20 year olds. The increase did not seem to radiate up the age spectrum beyond age
26. A turnaround began among 12th graders after 1995 and then among the older age groups
in a somewhat staggered fashion, again indicative of a cohort effect. Declines through 2003
were greatest among 18-24 year olds, who had attained the highest rates of LSD use. Use
declined considerably from 2001 to 2003 in all age bands (including 8th and 10th graders),
and then leveled through 2007 at historically low rates, suggesting that an important secular
trend may have set in, which was quite possibly related to decreased availability of the
drug. Since 2007 there has been evidence of a very gradual increase in use in all age groups
18-30, particularly among those ages 18 to 28; in the past few years, use also has increased
unevenly among the 29-30 year olds. Among 35 year olds, use has been near-zero (this
question is not asked for those age 40 and older). It thus appears that LSD may be making
a gradual comeback among young adults since about 2007.
 The use of hallucinogens other than LSD showed a similar and fairly parallel decline in
use among all age bands through the 1980s, indicating a secular trend (Figure 5-7). During
the relapse phase for many drugs during the 1990s, there was a substantial increase in use
among the younger age bands, but not among those ages 27 or older. The increases in the
older age bands did not appear for some time, again indicating a cohort effect at work.
Since about 2003 through 2018, the prevalence of use of hallucinogens other than LSD has
continued to decline gradually among 18-20 year olds, declined gradually and leveled
among 21-24 year olds, increased unevenly for 25-35 year olds, and was fairly level for
those aged 40 and above; this resulted in a considerable convergence in use among the
various age strata.
 The annual prevalence for MDMA use (ecstasy and more recently Molly) among those
aged 19 to 28 was at about 1.5% in 1989 and 1990 (Table 5-2 and Figure 5-8). After 1991
it dropped to around 0.8% for several years before rising significantly in 1995. MDMA use
then rose sharply in all of the young adult age strata, most notably in the younger age bands
(19 through 26) through 2001. Use among 12th graders, which was not measured until 1996,
was by then the highest of any of the age groups at 4.6% annual prevalence. Twelfth
graders’ use declined by a full percentage point through 1998 before jumping
significantly—by two full percentage points—in 1999. (Use by 10th graders also jumped
significantly in 1999.9) Thus it appears that young people from their mid-teens to mid-20s
“discovered” MDMA after some years of low and relatively level use. In 2000 the sharp
increase in use continued among ages 15 to 16 (10th graders) through age 26—with highs
of over 10% among 19-22 year olds—and also showed up among 8th graders for the first
time. By 2001 the increase had slowed and even begun to reverse among those aged 18 to
9 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
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26. We attributed the deceleration in 2001 to a fairly sharp increase in perceived risk of
MDMA use in that year, and based on that, we predicted a turnaround in use in 2002. In
2002, and again in 2003, perceived risk increased sharply and, as Figure 5-8 illustrates, all
age bands showed a reversal with a sharp decrease in use. Clearly, the decrease has been
sharpest in the younger age bands, perhaps because a cohort effect is at work in the upper
ages, helping to offset a downward secular trend. From about 2005 through 2014 there was
some rebound in MDMA use in all age bands through age 30 (older respondents are not
asked about this drug), and the increase was staggered, suggesting that another cohort effect
was underway. Between 2014 (when the question was changed to include Molly as an
example) and 2018, there has been some uneven decrease or leveling for most of the age
groups in annual MDMA use; however, there was a continued uneven increase for those
aged 23-24, who had the highest prevalence among young adults in 2018 at 4.5% (it was
also 4.5% in 2018 among 21-22 year olds, but their trend since 2014 has been an uneven
decrease).
 Several drug classes exhibited a faster decline in use among the older age groups than
among 12th graders during the earlier period of decline in the 1980s (see Figures 5-1
through 5-19c). These included any illicit drug, any illicit drug other than marijuana,
amphetamines, hallucinogens (until 1987), LSD (through 1989), and methaqualone, but
not marijuana or cocaine.
 In fact, a crossover was evident for some drugs when 12th graders were compared to young
adults. In earlier years 12th graders had lower usage levels, but for some years after 1993
they tended to have higher levels than young adults for use of any illicit drug, marijuana,
hallucinogens, LSD specifically, crack cocaine, tranquilizers, and crystal
methamphetamine (ice). However, as summarized above regarding recent trends in
marijuana use, there has been another crossover for most of these drugs, with 12th graders
again having lower annual prevalence than those in their early to mid-20s.
 Cocaine (Figure 5-9) gives quite a dramatic picture of change. Unlike most other drugs,
annual use of cocaine has generally tended to rise with age after high school, usually
peaking three to four years past graduation from the mid-1970s through the mid-1990s.
This was a classic example of an age effect. Despite the large age differences in absolute
prevalence during that period, all age strata moved in a fairly parallel way through 1991,
indicating that a secular trend was taking place in addition to the age effect. All age strata
began a sharp and sustained decline in use after 1986—again reflecting a period effect. The
two youngest strata (12th graders and 19-20 year olds) leveled by 1992, whereas use
continued a decelerating decline for a few years beyond that in the older age groups,
signaling the continuation of a cohort effect that began earlier. From 1994 to 1999, annual
prevalence of cocaine use rose some in the five youngest strata (i.e., those younger than
27) on a somewhat staggered basis, with the three older groups still decreasing a bit more
over that same period. This, to some degree, reversed the age differences that were so
prominent in the 1970s and 1980s.
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Cohort-related change appears to have predominated in the 1990s, quite possibly as the 
result of “generational forgetting” of the cocaine-related casualties so evident in the early 
to mid-1980s. In other words, those in the older cohorts retained that learning experience, 
but those in the newer cohorts never had it. The fact that from 1994 to 1996 the 35 year 
olds had higher lifetime prevalence levels of cocaine use than some of the younger age 
groups also suggests some lasting cohort-related differences established during the peak 
years of the cocaine epidemic. From about 2005 or 2006 through 2013 there was a gradual 
decline in cocaine use in all age bands, but particularly among the younger ages who had 
earlier attained higher prevalence levels. Between 2013 and 2014, however, there was a 
significant increase in cocaine use among young adults ages 19 to 28 combined (but not 
for 12th graders and those over age 30), and the five-year increase between 2013 and 2018 
for 19-28 year olds was also significant as noted above. Between 2014 and 2018 use either 
leveled or declined for most age groups; however, for those aged 21-24, there was some 
continued uneven increase, reaching 5.9% to 9.2% annual use (Figure 5-9). This recent 
continued increase, at least for those in their early 20s, suggests a possible resurgence in 
cocaine use since the relapse that started in the early 1990s.  
 
Crack use was added to the 12th graders’ questionnaires in 1986 and to the follow-up 
questionnaires in 1987. The decline in annual crack use, which began right after the 
introduction of these questions, ended in 1991 among 12th graders, and by 1994 it had 
ended among young adults (Figure 5-10 and Table 5-2). Among 19-28 year olds, the annual 
prevalence rate held at about 1%, which was down from the peak levels of just over 3% in 
1986 through 1988. As was true for a number of other drugs, crack use began to rise after 
1993 among 12th graders, at the beginning of the relapse phase in the epidemic, but not in 
the older age strata until years later, when increases were observed in a somewhat staggered 
pattern going up the age scale. Again, a cohort effect due to generational replacement seems 
to have been occurring. Since 1994, 18 year olds have had the highest-reported rates of 
use, though they have shown considerable decline since 1999. Among all young adults 
ages 19-28, crack use had its lowest prevalence in 2016 through 2018 (0.2% or lower, 
compared with 3.2% in 1986).    
 
 Use of heroin increased appreciably in 1995 among 12th graders and young adults ages 19 
to 24, but not among the older age bands (Figure 5-11). It remained at this higher plateau 
in these younger age bands through 2000 or 2001, before falling off some, particularly 
among 12th graders. Among young adults aged 19-28 as a group, annual use had previously 
been quite stable from at least as far back as 1986 through 1994 at 0.2% (Table 5-2), and 
it stabilized again at a higher level of 0.4% from 1995 through 2018. Use among 12th 
graders has declined since 2000, among 19-20 year olds since 2001, and among the 21 to 
22 year olds since 2006, but it remains fairly stable (at a very low rate of use) among the 
older age groups.  
 
 Among 19-28 year olds, use of narcotics other than heroin leveled after 1991, following 
a long period of slow, fairly steady decline (Figure 5-12 and Table 5-2). After 1992 twelfth 
graders showed an appreciable increase in use, which continued for more than a decade 
into 2004, while 19-20 year olds showed some increase after 1994, 21-22 year olds after 
1996, 23-24 year olds after 1997, and the older age groups after 2000. Thus, cohort-related 
156
change appears to have been occurring during the 1990s and beyond for this class of drugs 
as well, following a long period of secular trends. In 2002, the question text was changed 
on three of the six questionnaire forms to update the list of examples of narcotic drugs other 
than heroin. Talwin, laudanum, and paregoric, each of which had negligible rates of use by 
2001, were replaced by Vicodin, OxyContin, and Percocet. As a consequence of this 
revision, reported use rates increased in 2002 as may be seen in Figure 5-12. Data presented 
for 2002 are from three of the six questionnaire forms with the new wording (which showed 
higher prevalence rates than the older question did). All six questionnaire forms contained 
the new wording beginning in 2003, so the data presented for 2003 onward are based on 
all forms. Although the older version of the question showed no significant changes 
occurring in 2002, there was a significant increase in narcotics use observed in 2003 (based 
on the new question in both 2002 and 2003). Among 19-28 year olds, annual prevalence 
reached a peak level of 9.1% in 2006; it has since fallen by more than half to 3.4% by 2018. 
Some turnaround was observed among 19-22 year olds after 2004 in the use of this 
important class of drugs, but use continued to rise in some of the older age bands through 
2007 to 2009, likely reflecting a cohort effect. Use of these drugs outside of medical 
supervision remained relatively high in all age groups studied here through about 2010, 
and has since declined for 12th graders and young adults (to between 2.2% and 4.5% in 
2018), and largely leveled for those aged 35-55 (to between 3.5% and 5.5% in 2018). 
Overall, in the past few years, use of this important class of drugs has decreased in younger 
age groups and leveled for those age 35 and older. 
 
 The annual prevalence rates for Vicodin and OxyContin, first measured in 2002 (separately 
from the general question about narcotics other than heroin), were appreciable (8.2% and 
1.9%, respectively) for 19-28 year olds. Increases were observed for these two drugs in 
subsequent years. Among 19-28 year olds (Table 5-2), the annual prevalence of OxyContin 
use rose from 1.9% in 2002 to 3.1% in 2004 through 2006—changes that were fairly 
parallel to those observed among 12th graders over the same interval (when their slightly 
higher annual prevalence rose from 4.0% in 2002 to 5.5% in 2005). The increases in 
OxyContin use between 2002 and 2005 were significant for both 12th graders and 19-28 
year olds. Annual prevalence was stable from 2004 to 2007 at about 3% for young adults, 
increased to 5.2% in 2009, but was down to 1.9% by 2018. Vicodin use (Table 5-2) rose 
by less, but started from a higher base, with annual prevalence increasing slightly among 
19-28 year olds, from 8.2% in 2002 to 8.9% in 2004; it remained at about 9% through 2009, 
followed by a decline to 2.4% by 2018. Thus, since 2009 the annual prevalence of both 
OxyContin and Vicodin among young adults has declined by over half. Given the 
widespread concern about these narcotic drugs, which are among those most cited in 
overdose deaths, this downturn is very good news. Further good news would be a cohort 
effect carrying these declines in use to later age bands.   
 
 In the late 1970s, amphetamine use outside of medical supervision rose some with age 
beyond high school, but after a long period of secular decline in use from 1981 to the early 
1990s, this relationship had reversed (see Figure 5-13). The declines were greatest in the 
older strata and least among 12th graders, even though use decreased substantially in all 
groups. As was true for many illicit drugs, amphetamine use began to rise among 12th 
graders after 1992, and eventually among the 19-24 year olds; but there was only a small 
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increase among 25-30 year old respondents. In other words, another cohort-related pattern 
of change was beginning to emerge in the 1990s for amphetamines, and the increase in use 
has really only developed since 2006 among the 25-30 year olds as can be seen in Figure 
5-13. While amphetamine use declined a fair amount among 12th graders between 2002 
and 2009 (from 11.1% to 6.6%), there was less proportional decline among 18-20 year olds 
and really no decline among the 21-55 year old age strata. After 2009 there was some 
resurgence in use, particularly among the younger age groups in 12th grade and college age. 
It may well be that the use of amphetamines for studying was what caused this resurgence. 
In recent years, use has leveled or begun to decline at most younger ages and increased 
somewhat among the 25-40 year olds, quite possibly as a result of a continuing cohort 
effect. Among those strata ages 45 and older, use has been very low, and there has been 
little change for more than a decade. For several years, the age differences in amphetamine 
use through age 55 have been of considerable magnitude and mostly ordinal; however, 
since about 2009, it has been curvilinear, with use being highest for 21-24 year olds. (See 
the table accompanying Figure 5-13.)  
 
 Since 1990, when it was first measured, use of crystal methamphetamine (ice) has 
remained at low rates in the young adult population (Figure 5-14). However, among 19-28 
year olds combined, annual prevalence rose from 0.4% in 1992 to 1.6% by 2005 (Table 5-
2). (Use had been rising among 12th graders and 19-20 year olds specifically between 2000 
and 2002, reaching peak levels, but since then their use has declined to low levels.) For 19-
28 year olds, use declined unevenly from 2005 through 2018, reaching 0.4%; in 2018, 
among the lowest levels for the past decade. General methamphetamine use was first 
measured in 1999; its use was stable until 2005 among 19-28 year olds, with annual 
prevalence fluctuating between 2.4% and 2.8%. Use has declined since to 0.4% by 2018 
(Table 5-2). (Use of these drugs is not asked of those over age 30.) 
 
 Sedative (barbiturate) use (Figure 5-15) outside of medical supervision showed a long-
term parallel decline in all age groups covered through the late 1970s and 1980s, leveling 
by about 1988. While use then remained low and quite level for most of the age bands for 
about five years, it began to rise by 1993 among 18 year olds, by 1995 among 19-20 year 
olds, by 1997 among 21-22 year olds, by 1998 among 23-24 year olds, by 2001 among 25-
28 year olds, and by 2005 among 29-30 year olds. The same cohort-related pattern of 
change seen during the 1990s for many other drugs also exists for sedatives (barbiturates); 
like most other drugs, this pattern was preceded by a long period of secular change during 
which all age groups moved in parallel. While use leveled off among most age groups by 
2005, the 35, 40, and 45 year olds all showed increases in sedative (barbiturate) use 
between 2006 and 2008. However, their usage rates leveled after 2008. In 2018 the annual 
usage rates for the 35-60 year olds were about 2-3%. Sedative use among 18 year olds 
declined steadily after 2005, among 19-20 year olds after 2008, and among 21-22 year olds 
after 2009, suggesting another cohort effect. From 2011 through 2018 the usage rates in 
most age strata leveled off or declined slightly. The 12th graders have consistently had the 
highest annual prevalence for sedative use without medical supervision, though their 
continued decline has resulted in relatively little differences among the age groups in 2016 
through 2018. 
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 Tranquilizers (Figure 5-16) follow a similar pattern to that just described for sedatives 
(barbiturates). One difference is that the 12th graders’ annual prevalence rate has not always 
been the highest among the various age groups, as was the case for sedatives (barbiturates), 
although it was highest between 1994 and 2000 as a result of a greater increase in 
tranquilizer use among the 12th graders than in the young adult strata. Since about 2004, 
however, as use rose and then leveled among those in their early 20s, the 12th graders no 
longer stood out as having the highest rate of tranquilizer use. In fact, the 21-22 year olds 
or 23-24 year olds had the highest rate in 2005 through 2009; in 2011, the 25-26 year olds 
had the highest rate; and in 2012 the 27-28 year olds had the highest rate of use. Use then 
increased among the 29-30 year olds, who had the highest rate in 2015. This was another 
clear example of a cohort-related pattern of change. Since about 2011 and 2012, use has 
declined somewhat for 18-28 year olds, and leveled for those aged 29 and older. 
 
 Use of anabolic steroids has been substantially lower after high school than during 12th 
grade (Figure 5-17), ever since measures were first introduced in 1991 (in two follow-up 
questionnaire forms). The age-related differences are not consistent; prevalence rates 
among the young adult strata are all quite low and do not appear to trend in any systematic 
way. (In general, as covered in Volume I, it seems that the rise in steroid use from 1999 to 
2003 among 8th and 10th graders and from 2001 to 2004 among 12th graders was largely 
specific to those age groups.) Annual prevalence rates are now very low for respondents in 
all young adult strata of ages 19-30 (ranging from less than 0.1% to 1.0%).  
 
 Alcohol trends for the older age groups (Figures 5-18a–d) have been somewhat different 
than for the younger age groups in some interesting ways. For annual and 30-day 
prevalence, the declines for the two youngest age strata (12th graders and those one to two 
years past high school) during the 1980s were greater than for the older age groups. These 
differential trends were due in part to the effects of changes in minimum drinking age laws 
in many states—changes that would be expected to affect primarily the age groups under 
age 21. However, because similar (though weaker) trends were evident among 12th graders 
in states that maintained a constant minimum drinking age of 21, the changed laws cannot 
account for all the downward trends, suggesting that there was also a more general 
downward trend in alcohol consumption during the 1980s.10 By 1994, the declines in 30-
day prevalence had slowed or discontinued for virtually all age groups until 1997, when 
they began to turn downward again for 12th graders, and 1999, when they began to decline 
among 19-20 year olds. The long term declines in the 30-day prevalence of alcohol use 
have been substantial—from 72% in 1980 to 30% in 2018 among 18 year olds, and from 
77% in 1981 to 44% in 2018 among 19-20 year olds. Since about 1997, as the declines 
continued in the under-21 groups (that is, those under the minimum legal drinking age), no 
such declines occurred among the 21 and older groups; in fact, there have been some 
modest increases in all these groups. These trends have resulted in substantial differences 
in 30-day drinking rates in 2018 between those 18 to 20 years of age (30% to 44%) versus 
those 21 through 30 (69% to 75%)—much larger differences than when we first looked at 
them in the 1980s. 
 
                                                 
10 O’Malley, P. M., & Wagenaar, A. C. (1991). Effects of minimum drinking age laws on alcohol use, related behaviors, and traffic crash 
involvement among American youth: 1976–1987. Journal of Studies on Alcohol, 52, 478–491. 
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 Binge drinking has continued an uneven but substantial decline for 18 and 19-20 year olds 
since the early 2000s through 2018, reaching the lowest levels ever in 2018 at 14% and 
21%, respectively, down from the all-time highs in 1981 of 41% and 43%, respectively 
(Figure 5-18d). Respondents three to four years past high school show the smallest 
downward trend since the early 1980s, but even this age group has shown declines in the 
past decade from 46% in 2007 to 34% in 2018. One important segment of that age stratum 
is composed of college students who have shown less decline in alcohol use over the past 
quarter century (see Chapter 9, which also shows prevalence of and trends in extreme binge 
drinking).  
 
Across the life of the study, declines in binge drinking have been modest among those aged 
23-30. Note that the binge drinking trend lines for different age groups (Figure 5-18d) are 
spread out on the vertical dimension, reflecting large and persisting age differentials (age 
effects) in this behavior. The relationship with age is curvilinear, however. In the past 
decade, the 21-26 year olds have consistently shown the highest rates of binge drinking. 
Binge drinking had been gradually increasing since the early 2000s through about 2008 
among 25-30 year olds, perhaps reflecting a cohort effect that emerged during the period 
of increasing adolescent binge drinking in the early 1990s, but this has turned around in 
recent years, with binge drinking among 25-30 year olds now being among the lowest it 
has been for several years. Among those aged 35 to 55, binge drinking has shown some 
uneven increases over the years, with recent leveling for most age groups.  
 
From the early 1980s through the mid-1990s, rates of daily drinking (Figure 5-18c) fell by 
considerable proportions in all age strata for which we have data, reflecting a secular trend 
and an important change in drinking patterns in the culture. Among 19-28 year olds 
combined, daily drinking declined from 1987 (6.6%) to 2000 (4.1%), but has since 
increased unevenly to 4.3% by 2018 (Table 5-4). Daily drinking rates now show a fairly 
linear age trend, and have generally been highest for the age 55 group in recent years, 
whereas daily drinking has declined substantially among 18 year olds and 19-20 year olds 
over the life of the study. In 2018 there was a considerable difference among the age strata 
in rates of daily drinking, ranging from 1% among 19-20 year olds to 10% to 12% among 
45, 50, 55, and 60 year olds. 
 
It is worth noting that the 35, 40, 45, 50, 55, and 60 year olds have had among the lowest 
rates of binge drinking but among the highest rates of daily drinking in recent years. These 
patterns—particularly the high rate of daily drinking—likely reflect age effects as well as 
perhaps some enduring cohort differences (because these cohorts had considerably higher 
rates of daily drinking when they were in high school). They may also have been influenced 
by the widely disseminated medical findings that suggest that one or two drinks per day 
for males and one per day for females have some benefits for heart health.11,12 That may be 
                                                 
11 Manttari, M., Tenkanen, L., Alikoski, T., & Manninen, V. (1997). Alcohol and coronary heart disease: The roles of HDL-cholesterol and smoking. 
Journal of Internal Medicine, 241, 157–63. 
12 Savolainen, M. J., & Kesaniemi, Y. A. (1995). Effects of alcohol on lipoproteins in relation to coronary heart disease. Current Opinions in 
Lipidology, 6, 243–50. 
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a more salient message for those who are in their forties or above than for younger people. 
Whether there really are such health effects has been questioned since.13,14  
 
 The prevalence levels for cigarette smoking show more complex trends than most other 
substances, due to the long-term presence of both cohort and age effects, plus slightly 
different patterns of such effects on the several different measures of smoking during the 
past 30 days (one or more cigarettes per month, one or more cigarettes per day, and a half 
pack or more of cigarettes per day). 
 
In the earlier years of MTF, the curves across time were of the same general shape for each 
age band (Figures 5-19a–c), but each of those curves tended to be displaced to the right of 
the immediately preceding age group, which was two years younger. The pattern is clearest 
in Figure 5-19c (half pack plus per day) during the late 1970s and 1980s. This pattern is 
very similar to the one described in Volume I for lifetime smoking rates for various grade 
levels below senior year; it is the classic pattern exhibited by a cohort effect,15 and we 
believe that the persisting cohort differences are due to the dependence-producing 
characteristics of cigarette smoking. 
 
The declining levels of cigarette smoking observed in the 12th grade classes of 1978 
through 1981 were later observable in the early-30s age band, as those same high school 
graduating classes grew older (Figures 5-19b and c). This was true at least through about 
1991. By then there had been a considerable convergence of rates across age groups, largely 
because there were few cohort differences among the senior classes who graduated from 
the early to mid-1980s through the early 1990s—a period of fairly level cigarette use in 
high school. 
 
In addition to these cohort differences, there are somewhat different age trends in which, 
as respondents grow older, the proportion smoking at all in the past 30 days declines some, 
while the proportion smoking a half pack per day actually increases. Put another way, many 
of the light smokers in high school either transition to heavier smoking or quit smoking.16-
18 
 
The picture was further complicated in the 1990s when it appears that a new cohort effect 
emerged, with smoking among adolescents rising sharply (beginning after 1991 for 8th and 
10th graders and after 1992 for 12th graders). The 19-20 year olds soon showed a rise at the 
beginning of the 1990s—perhaps responding to some of the same social forces as the 
                                                 
13 Keyes, K., & Miech, R. A. (2013). Commentary on Dawson et al. (2013): Drink to Your Health? Maybe Not. Addiction, 108(4), 723-724. 
14 Goulden, R. (2016). Moderate alcohol consumption is not associated with reduced all-cause mortality. The American Journal of Medicine 129, 
180-186. 
15 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade 
of change, 1976–1986. American Journal of Public Health, 78, 1315–1321. 
16 To illustrate, in the graduating class cohort of 1976, 39% were 30-day smokers in senior year, 39% by ages 19 to 20, but only 29% by ages 29-
30—a net drop of 11 percentage points over the entire interval. By way of contrast, 19% of that class was half-pack-a-day smokers in senior year, 
24% by ages 19 to 20, and 22% at ages 29-30—a net gain of five percentage points and three percentage points over the respective intervals.  
17 Bachman, J. G., Wadsworth, K. N., O'Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
18 Bachman, J. G., O'Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in 
young adulthood: Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates 
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adolescents (including the Joe Camel advertising campaign); but 21-24 year olds did not 
show an increase until about 1995, and 25-26 year olds until about 1996. Young adults 
over age 26 showed a modest increase from 1997 through 2004, but a decline in use since 
then; it is quite possible that an upward cohort effect was at least partially offset by a 
downward secular trend during this period.  
 
After about 1999, smoking rates among nearly all age groups leveled or declined, 
suggesting that societal forces may be affecting all age groups in a similar way, giving rise 
to a secular trend. Large increases in the price of cigarettes were important. The tobacco 
settlement between the state attorneys general and the major tobacco companies likely 
played a critical role, because the industry had to raise prices in order to recoup their 
substantial losses in the settlement. Price increases also were due at least in part to sales 
tax increases19 and later federal excise taxes. In addition, there was a great deal of adverse 
publicity for the tobacco industry along with the introduction of the national anti-smoking 
campaign of the American Legacy Foundation, an increase in state and national anti-
smoking advertising, the demise of the Joe Camel campaign and all billboard advertising, 
and the imposition of no-smoking regulations in many public and workplace settings by 
states and municipalities. From 2003 through 2018, thirty-day, daily, and half-pack 
smoking have all declined among 35, 40, and 45 year olds; recent trends among 50 and 55 
year olds have shown some modest declines (Figures 5-19a through 5-19c). In sum, there 
have been very substantial declines in smoking among all age groups. Since smoking is the 
leading cause of preventable death and disease in the country, these improvements are 
extremely important for population health and longevity. 
 
 Apart from cigarettes, none of the other drugs included in the study showed a clear long-
term pattern of enduring cohort differences in the earlier years of MTF (the 1970s and 
1980s), despite wide variations in their use by different cohorts at a given age. There was 
one exception for daily marijuana use (long-term trends are summarized above, but we 
give them more detail here by way of contrast with cigarette smoking trends). A modest 
cohort effect was observable for daily marijuana use (Figure 5-3c) during the late 1970s 
and early 1980s.20 But as subsequent classes leveled at lower rates of use, evidence for the 
cohort effect faded. The emergence in the 1990s of a new epidemic of marijuana use among 
teens once again yielded a strong pattern of cohort effects. As can be seen in Figure 5-3c, 
daily use rose sharply among 12th graders and 19-20 year olds after 1992, among 21-22 
year olds after 1993 with a sharp rise occurring in 1997, among 23-24 year olds after 1998, 
among 25-26 year olds after 2000, among 27-28 year olds in 2003, among 29-30 year olds 
in 2005, among 35 and 40 year olds in 2006, and among 45 year olds in 2007. This is not 
unlike the pattern of change for cigarette smoking that occurred in the 1990s (Figure 5-
19a). The cohort effect for daily marijuana use may be attributable, in part, to the very 
strong association between that behavior and regular cigarette smoking. The net effect of 
all of this is that a considerable age difference has emerged in current daily marijuana use 
since the early 1990s, when there was practically no difference. The cohort effect resulting 
                                                 
19 Huang, J., & Chaloupka, F. J. (2012). The impact of the 2009 federal tobacco excise tax increase on youth tobacco use. NBER Working Paper 
18026. National Bureau of Economic Research, Cambridge, MA. 
20 O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade 
of change, 1976–1986. American Journal of Public Health, 78, 1315–1321. 
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from the rise in use among 18 year olds in the latter half of the 1990s has been working its 
way up the age spectrum, and in 2010 was observable in the form of a significant increase 
among 35 year olds (more recent trends in daily marijuana use are discussed above).  
 
In sum of longer-term trends in reference to cohort effects, trends up until 1992 in illicit drug use 
were highly parallel across 12th graders and young adult age groups, indicating a secular trend. 
(Cigarettes and alcohol showed a different pattern.) Since 1992, however, there has been 
considerable divergence in the trends for different age bands on a number of drugs as use among 
adolescents rose sharply, followed by subsequent rises among 19-20 year olds, 21-22 year olds, 
and so on. This divergence indicated a new cohort effect, quite possibly reflecting a generational 
forgetting21 of the dangers of drugs by the cohorts who reached senior year in the early to mid-
1990s. Data discussed in Chapter 6, “Attitudes and Beliefs about Drugs among Young Adults,” 
provide additional evidence for this interpretation.  
                                                 
21 Johnston, L. D. (1991). Toward a theory of drug epidemics. In L. Donohew, H. E. Sypher, & W. J. Bukoski (Eds.), Persuasive communication 
and drug abuse prevention (pp. 93-131). Hillsdale, NJ: Lawrence Erlbaum. 
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TRENDS FOR IMPORTANT SUBGROUPS OF YOUNG ADULTS 
Four-year age bands are used here to examine subgroup trends in order to yield sufficiently large 
numbers of cases to permit reliable estimates for the various subgroups being examined. Subgroup 
data for young adult respondents of each gender and for respondents from communities of different 
sizes are available for 19-22 year olds since 1980, 23-26 year olds since 1984, and 27-30 year olds 
since 1988. (Subgroup data are not presented for the ages above 30.) A question about state of 
residence was added in 1987 to all follow-up questionnaires, permitting trend data to be calculated 
for the four regions of the country since then (MTF samples within these four regions, so each is 
represented by these data). These various subgroup data are not presented in tables or figures here 
because of the substantial amount of space they would require. However, for the reader interested 
in more detail, these are available in a separate MTF Occasional paper. Subgroup data on young 
adults through 2018 are available in MTF Occasional Paper 93. That document contains both 
tabular and graphic presentations of the data, with the graphs, which are by far the easier to read, 
showing each subgroup in a different color. A synopsis of trends through 2018 for young adults is 
presented below.  
 
Gender Differences in Trends 
 Over the long term, gender differences narrowed for some drugs among young adults in 
each of these three age bands (19-22, 23-26, 27-30), primarily when a steeper decline in 
use among men (who generally had higher rates of use) occurred in the 1980s. The overall 
picture, though, is one of parallel trends, with use among men remaining consistently and 
modestly higher for most drugs, including the indexes of annual use of any illicit drug 
and of any illicit drug other than marijuana (see Table 5-5, which lists prevalence for 
19-28 year olds separately by gender, for example, and Figures 1 and 4 in Occasional 
Paper 93). In general, the gender gap for 19-22 year olds annual prevalence of any illicit 
drug has been somewhat narrower than in the other age bands across the years through 
2018 (but note that the trends for the three age bands are not on the same scale in the 
figures). 
 
 The downward trend in marijuana use among 19-22 year olds between 1980 and 1989 
was also a bit sharper among men than women, narrowing the gap between the two groups. 
Annual prevalence fell by 22 percentage points (to 34%) among men, compared to a drop 
of 14 percentage points (to 31%) among women, leaving a difference of three percentage 
points (Figure 7 in Occasional Paper 93). From 1995 through 2018, the gender gap has 
averaged about 5 to 9 percentage points in all three age groups—that is, for 19-22 year 
olds, 23-26 year olds, and 27-30 year olds. However, between 2015 and 2017, the gender 
gap for 19-22  year olds diminished to 2 to 3 percentage points for annual marijuana use, 
and in 2018, for the first time ever, annual prevalence of marijuana use was higher for 
women (43%) than for men (41%). (Regarding vaping marijuana, the one-year changes 
in prevalence from 2017 to 2018 for men and women are presented in Chapter 4.) 
 
 Between 1980 and 1993, daily marijuana use for the 19–22 age group fell from 12.9% to 
2.9% among men, and 6.1% to 1.7% among women, narrowing the rather large gap that 
existed in the early 1980s (Figure 9 in Occasional Paper 93). As overall use rose after 
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1993, the gap widened again. Among 23-26 year olds, as daily use first began to increase 
in 1998 and 1999, the gap between the genders began to widen. In the oldest age group 
(ages 27–30), the difference had been fairly constant, with daily marijuana use among 
men generally being about two percentage points higher than among women through 
2005; from 2006 through 2018, the gender gap within the age groups widened somewhat 
to between three and four percentage points for most years. Consistent with what is true 
for overall trends, daily marijuana use in 2018 was at or near historic highs for both men 
and women across the three age groups, at 10.2% and 6.1% respectively for 19-22  year 
olds, 9.9% and 6.3% respectively for 23-26  year olds, and 10.8% and 6.6% respectively 
for 27-30  year olds. 
 
 In all three age bands, use of synthetic marijuana by men tended to be higher than use by 
women. In 2011, when use was first measured, it was highest among the 19-22 year olds 
with men higher than women; it has fallen sharply since 2011 for both genders and the 
gap between them has closed considerably (Figure 14 in Occasional Paper 93). Annual 
prevalence in 2018 for the 19-22 age group was 2.5% for men and 1.5% for women. The 
two older age bands started out with considerably lower rates in 2011, but also have shown 
some decline since then, narrowing the gender difference in both groups. 
 
 Inhalant use, while always quite low in these young adult age groups, was fairly 
consistently higher among men than women; however, this difference has disappeared in 
the past few years after a long period of decline in which prevalence declined to 2% or 
lower for all groups since 2011 (Figure 17 in Occasional Paper 93). 
 
 For LSD, men have consistently had higher rates of use than women (Figure 22 in 
Occasional Paper 93). Among 19-22 year olds, the male–female differences tended to 
diminish as use declined (from 1980 to 1985 and again from 1999 to 2004) and expand as 
use increased (1986–1995). Since 2011, the gender gap has widened again as use has 
increased somewhat, with men having about twice the level of women; annual prevalence 
in 2018 for men and women were at highest levels since 2001, at 6.6% and 3.7%, 
respectively. In the two older age bands there was less change in use, and differences had 
been relatively consistent (with men higher) since data have been available, beginning in 
1984 for 23-26 year olds and in 1988 for 27-30 year olds. After 1999 and 2001 for the two 
older groups, respectively, overall LSD use dropped, substantially narrowing the gender 
differences. Men began to show these declines first, and both genders moved to almost no 
use of LSD between 2003 and 2009. Beginning in 2009 among the 23-26 year olds, use 
increased for men especially in 2016 and 2017, widening the gender gap, with women 
showing some increase through 2016; in 2017, men increased to 6.4% (an all-time high) 
and women decreased to 1.9%. However, in 2018, use decreased significantly for men 
(3.4%) and leveled for women (2.4%). Similarly, the gender gap among 27-30  year olds 
in annual use of LSD began to widen again as use increased somewhat for men in 2011 
and especially 2016 through 2018; for women, it also increased in the past few years, 
significantly so in 2018. In 2018, levels were 4.7% and 2.4% respectively, at all-time 
highs. Overall, it appears that there has been some return of LSD use in the last few years 
among young adults. 
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 Use of hallucinogens other than LSD taken as a group has consistently been considerably
higher among men in all three age strata with the difference growing larger when use
increased some in the late 1990s and early 2000s (Figure 25, Occasional Paper 93). The
differences have been greatest in the youngest of the three age strata and least in the oldest
one. Use and gender differences have been relatively level for several years through 2016,
showing no increase at least through 2016. However, there has been some change in the
past two years in the two older age groups. Use increased among 23-26 year old men to
6.2% (an all-time high) in 2017 and then decreased in 2018 to 3.9% (consistent with the
pattern of increase and decrease in LSD for this age group of men); use also increased
nonsignificantly for 23-26 year old women in 2018 (to 3.0%, an all-time high). In addition,
use increased nonsignificantly in 2018 among 27-30 year old men to 4.9%, an all-time
high. Thus, as was true for LSD, there is some evidence of recent increased use of
hallucinogens other than LSD among young adults.
 MDMA (ecstasy and more recently Molly) exhibited little or no gender difference in any
of the three age bands before use began to grow in the late 1990s (Figure 28 in Occasional
Paper 93). Between then and 2009, there was little gender difference in MDMA use
among 19-22 year olds. From 2009 through 2016, use rose some for men, slightly
widening the gender differences; but in the past two years, use declined among men
reducing the gender difference (4.9% for men, 3.0% for women in 2018). In the older age
groups, a gender difference opened up after 1997, with men fairly consistently having
higher rates of use among both 23-26 year olds and 27-30 year olds. From about 2009 to
2016, use among 23-26 year olds rose unevenly for both genders with little consistent
difference between men and women. In 2017, use rose significantly for men 23 to 26 years
old to 7.1% and declined nonsignificantly to 2.7% for women; however, this pattern
reversed in 2018 (with a nonsignificant decrease for men to 4.4% and nonsignificant
increase for women to 4.1%), reducing the gender difference. Among 27-30 year olds
between 2010 and 2016, use increased more for men, widening the gender difference
(even though women increased some through 2016). In 2017, use declined significantly
for men to 2.3% and declined nonsignificantly for women to 2.8%; in 2018, use again
increased nonsignificantly for both men and women, to 4.4% and 3.6%, respectively.
 The annual prevalence of salvia use (Figure 31 in Occasional Paper 93) was much higher
among men in the 19-22 year olds when first measured in 2009, and somewhat higher
among men in the two older age groups. However, use by men has dropped dramatically
in the years since then such that use has become negligible (below 1% in 2018) among
the two younger age groups. Among the 27-30 year olds, there has been some
nonsignificant increase in the past two years for men and women, though use is still quite
low (1.4% and 0.8%, respectively, in 2018).
 Men have had higher rates of cocaine use than women since MTF began. During the
period of sharp decline from the peak levels in annual cocaine prevalence (1986–1993),
use dropped more among men than women, narrowing the gender differences that existed
(Figure 34 in Occasional Paper 93). In the 19-22 year old age band, by 1993 annual
prevalence for men had declined by 16 percentage points (to 4.5%) versus 13 percentage
points among women (to 2.8%). In the 23-26 year old age band, there was also a narrowing
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of the gender difference between 1986 and 1993, with annual prevalence down 19 
percentage points among men (to 6.9%) and 13 percentage points among women (to 
4.2%). Use in the 27-30 year old group also dropped faster among men between 1988 
(when data were first available) and 1997—down 13 percentage points versus 7 among 
women. In sum, during the period of sharp decline in overall cocaine use, the gender 
differences—which had been fairly large—narrowed considerably in all three of these age 
bands. During the resurgence in cocaine use of the 1990s and into the early 2000s, which 
occurred on a somewhat staggered basis over the years, the gap between genders expanded 
only slightly. In the past decade, overall use and gender differences have remained fairly 
level in all age groups, with the gender difference generally being less among the 19-22 
age group (6.0% for men and 4.2% for women in 2018). Among the two older age groups, 
there was some evidence of increases in 2018; for 23-26 year olds, it leveled for men at 
9.5% and increased significantly for women to 6.2%; and for 27-30 year olds, it increased 
nonsignificantly for men to 6.7% and for women to 4.5%.   
 
 Crack followed a similar pattern during the earlier period of decline, though the 
proportional difference between the two genders had been consistently higher than for 
cocaine overall in the first decade of measurement (Figure 37 in Occasional Paper 93). 
With crack, though, there was some gender convergence (between 1992 and 1998) among 
19-22 year olds, as use among men declined slightly and use among women rose 
gradually; the genders converged somewhat for the two older groups in the late 1990s. 
After 1999, there was no consistent change for some years in differences between men 
and women. In all three age bands, men consistently had slightly higher crack usage rates, 
at least until a greater decline among men in recent years has nearly eliminated the gender 
differences and brought all of the annual prevalence levels below 1%. 
 
 There have been modest gender differences in heroin use for all of the three age groups 
of young adults in recent years, with men generally having higher rates of use than women. 
There was very little gender difference when the project first reported results for young 
adults in the 1980s, and differences emerged only when heroin prevalence rose in the last 
half of the 1990s during the relapse phase of the drug epidemic (Figure 40 in Occasional 
Paper 93). As of 2018, prevalence ranged between 0.1% and 0.5% across both genders in 
the three age groups. 
 
 Among 19-22 year olds, both genders showed some decline in their nonmedical use of 
narcotics other than heroin between 1980 and 1991, with a near elimination of previous 
gender differences (males had been higher). (Figure 43 in Occasional Paper 93.) 
Beginning in 1994, use by men began to rise in this age group, while use by women began 
to rise a year later. Some gender differences developed as use increased, with use by men 
being higher; after 2006, as use declined, there was a smaller difference, with annual 
prevalence in 2018 at 3.3% for men and 2.6% for women. The picture for 23-26 year olds 
is very similar except that the increase in use occurred a few years later (in 1997 and 
1998). The gender difference (males higher) had been eliminated by 1988, but re-emerged 
after 1995 as use increased more among men. Since 2010, use has declined for both 
genders, with a consistent gender difference of about 2 percentage points (it was 4.2% for 
men and 2.8% for women in 2018). Among 27-30 year olds, there has been a smaller 
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gender difference and the least increase in use in the 2000s. Still, use increased for both 
genders after 1999 and leveled in the mid-2000s, with men emerging with modestly higher 
rates of use most years thereafter (it was 5.3% for men and 3.9% for women in 2018). 
 
 Since 2002, the first year in which the survey gathered data on nonmedical use of 
OxyContin, its use has generally been higher among men than women for all three age 
bands (Figure 46 in Occasional Paper 93). Both genders showed some increase in use 
between 2002 and 2009 or 2010, followed by some falloff since then in the two younger 
age bands. In the past few years, there have not been consistent gender differences in any 
of the age groups. In 2018, use was 2% or lower for men and women in all age groups, 
except it was 3.0% among the 27-30 year old men. 
 
 Nonmedical use of Vicodin, first measured in 2002, also has been higher among men in 
most years. There was a somewhat larger increase in use among men in all age bands 
initially, but the men began to trend down earlier than the women, reducing the disparities 
in use such that in 2015-2018 the gender difference was nearly eliminated in all three age 
bands; in 2018, use ranged from 1.2% to 3.4% among both genders in all age groups 
(Figure 49 in Occasional Paper 93).  
 
 In general, there have been no appreciable gender differences in amphetamine use for 
most years in any of these three young adult age bands, although there is some evidence 
of emerging gender differences in recent years in the two older age bands. Between 1981 
and 1991, rates of amphetamine use were similar for men and women and showed 
substantial and parallel downward trends for both genders (Figure 52 in Occasional Paper 
93). Among 19-22 year olds, annual prevalence of use dropped 22 percentage points for 
men (to 5.2% in 1991) and 21 percentage points for women (to 4.7% in 1991). There were 
small increases in annual prevalence for both genders in the 19-22 year old age group after 
1991, in the 23-26 year old age group after 1995, and in the 27-30 year old age band after 
2000, but the genders diverged only slightly (with men higher). At about 2008, annual 
amphetamine use began drifting up slowly in all three age bands, with men consistently a 
bit higher than women. Among 19-22 year olds, use has declined for men in the past few 
years (to 6.6% in 2018) and remained fairly level for women (at 7.3% in 2018). Among 
the 23-26 year olds and the 27-30 year olds, while use has been fairly level for women in 
recent years, it has increased some for men. In 2017, the increase was significant for men 
in both of these older age groups, rising to 10.4% and 9.3%, respectively (compared to 
6.1% and 4.7% for women in the two age groups, respectively); in 2018, it continued to 
rise nonsignificantly for 23-26 year old men to 12.1%, and declined nonsignificantly for 
27-30 year old men to 8.3% (compared to 5.6% and 6.3% for women in the two age 
groups, respectively).     
 
 Nonmedical use of Ritalin, a prescription stimulant used in the treatment of ADHD, was 
added to MTF questionnaires in 2002 (Figure 55 in Occasional Paper 93). Findings for 
the first decade show prevalence being somewhat higher for men than women, after which 
gender differences have tended to be small and inconsistent. Use in 2018 ranged from 
0.5% to 1.6% among both genders in all age groups. 
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 Like Ritalin, nonmedical use of Adderall (another prescription stimulant) has generally 
been slightly higher among men than women since 2009, when the question was added 
(Figure 58 in Occasional Paper 93). The largest gender difference in annual use was 
initially among 19-22 year olds, the age band that includes most of those in college, and 
this difference diminished since 2016 as use dropped for men (in 2018, it was 10.9% for 
men and 9.3% for women). Since 2011 a fair-sized gender difference emerged among the 
23-26 year olds that closed in 2016 as use dropped among men; however, use rose 
significantly for men in 2017 and 2018 and remained unchanged for women (in 2018, it 
was 12.1% for men and 7.5% for women). The gender differences generally have been 
small among those over age 26 (in 2018, it was 6.2% for men and 7.0% for women).  
 
 A question on methamphetamine use was introduced in 1999 (Figure 59 in Occasional 
Paper 93); by 2011, after many years of decline, annual prevalence was at or below 1% 
for both genders in all age groups, and has been 1.8% or less since then. Throughout, men 
generally showed slightly higher prevalence than women, particularly in the first years of 
measurement; however, in recent years, gender differences have been small or 
nonexistent. 
 
 Crystal methamphetamine (“ice”) was added to the study’s coverage in 1990 (Figure 62 
in Occasional Paper 93). In the early 1990s, use was low and very similar for both genders 
in all three young adult age bands. In the mid-1990s the younger two age bands showed a 
greater increase in annual use among men, opening a gender gap. The gap then narrowed, 
though men on average were slightly more likely to report use of crystal 
methamphetamine until 2005. From 2009 through 2018 the gender differences have been 
small and inconsistent. In 2018, annual prevalence was between 0.2% and 0.3% for 
women in the three age groups and between 0.2% and 0.9% for men. It should be noted 
that the estimates are less stable for this drug due to limited sample sizes.  
 
 Questions about the use of “bath salts”—stimulant designer drugs (synthetic cathinones) 
meant to mimic the effects of amphetamines—were first introduced in 2012, so there are 
as yet only limited data on trends in their use (Figure 65 in Occasional Paper 93). Among 
19-22 year olds in 2012 there was a large gender difference in use (annual prevalence of 
3.0% among men vs. 0.5% among women); however, there was virtually no gender 
difference in the two older age bands (0.7% vs. 0.6%, respectively, among 23-26 year olds 
and less than 0.5% for both genders among 27-30 year olds). In 2013 the large gap 
between the genders among the 19-22 year olds disappeared as men that age showed a 
significant 2.8 percentage point decline in use. This decline coincided with a dramatic 18 
percentage point increase in the perceived risk of trying bath salts (for men and women 
combined). A similar change in perceived risk occurred among both older groups, as well, 
no doubt serving to hold their usage rates very low. As of 2018, annual use was below 
0.5% among both men and women in all three age bands.  
 
 As sedative (barbiturate) use declined through the 1980s, the modest gender differences 
(males were higher) were virtually eliminated in all three age bands (Figure 68 in 
Occasional Paper 93). Beginning in the early 1990s, a staggered increase in use by both 
genders emerged across all three age groups, with men increasing more than women, 
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thereby again opening a small difference in the late 1990s and into the 2000s. From about 
2008 through 2018, use declined and generally leveled for men and women in the three 
age groups, essentially eliminating gender differences. In 2018, use ranged between 1.7% 
and 3.2% across both genders and all age groups. 
 
 For tranquilizers, both genders showed a long, gradual decline and very similar rates of 
use from 1980 through about 1993 in all three age bands (Figure 71 in Occasional Paper 
93). Beginning in 1995, use increased for both genders in the 19-22 year old group, 
followed by an increase beginning after 1997 among 23-26 year olds and after 1999 
among 27-30 year olds, again reflecting cohort effects driven by generational replacement. 
Some gender differences emerged during these periods of increase and remained during 
part of the subsequent decrease after 2002 and 2003 for the two younger age bands. Men 
generally reported somewhat higher usage rates, though the gender differences have 
narrowed in recent years as use has generally declined or leveled for all three age groups. 
In 2018, use ranged between 3.2% and 4.9% across both genders and all age groups.    
 
 Inhalant use has generally been quite a bit higher among men than women, particularly 
in the younger age groups (Figure 17 in Occasional Paper 93). The 19-22 year old group 
showed a gradual upward shift from 1980 to 1988, followed by a leveling for some years 
for both genders. In 1997, annual inhalant use began to decline among 19-22 year old 
women, followed by men in 2001; however, the gender gap did not diminish much with 
this decline until 2005, when there was a convergence that continued through 2016, with 
some divergence since then due to a slight increase for men (in 2018, it was 2.0% for men 
and 0.7% for women). Among 23-26 year olds the gender gap widened as use by men 
increased between 1992 and 1999, though a subsequent decline in use among men 
narrowed the gap, almost eliminating it by 2005 (use has been under 1.0% for both in the 
past few years). It then re-emerged between 2008 and 2012 and diminished since then. In 
the oldest age stratum, use among men has generally been slightly higher, though the 
prevalence of inhalant use has been very low in this age group (under 0.9% in 2018). 
 
 Use of three “club drugs”— Rohypnol, GHB, and ketamine—has tended to be more 
concentrated among men in all three age strata (Figures 74, 76, and 79 in Occasional 
Paper 93), but the estimates are not very stable because of the limited numbers of cases 
upon which they are based. By 2009, annual prevalence levels were very low for all three 
drugs, and gender differences were small; this has continued to be the case in the years 
since then. In 2018, annual ketamine prevalence was between 0.0% and 1.1% for both 
genders in all three age groups. Rohypnol was dropped from the study after 2009 because 
of the low numbers of users (between 0.0% and 0.3%), at which point no gender difference 
remained in any of the three age groups (in earlier years use by men had tended to exceed 
use by women). GHB was dropped from the study after 2015 (when prevalence was 
between 0.0% and 1.1% for both genders in all age groups). 
 
 For alcohol, 30-day prevalence levels (Figure 82 in Occasional Paper 93) exhibited a 
gradual, parallel decline from 1981 through 1992 for both genders in the 19-22 year old 
age group. Thirty-day prevalence fell from 83% to 72% among men and from 75% to 62% 
among women by 1992. There has been a convergence since then, beginning in the late 
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1990s, because use by men has declined slightly while use by women increased slightly 
through 2008. The increasing proportion of women attending college may help to explain 
this convergence, at least in part. The gender difference was virtually eliminated in this 
age group by 2004 and use remained quite level since then for both genders through 2017; 
however, in 2018, it decreased a significant 6.3 percentage points for men to 54.9% (an 
all-time low), and decreased nonsignificantly 2.6 percentage points for women to 57.1% 
(also an all-time low). In the two older age bands, there was a more modest, parallel 
decline for both genders, from 1985 through 1992 in the case of 23-26 year olds, and at 
least from 1988 (when data were first available) to 1991 or 1992 in the case of 27-30 year 
olds. From 1992 through 2004, use among men in the older two age bands showed fairly 
level rates of use; but use among women rose gradually, narrowing the gender difference 
among 23-26 year olds (78% vs. 71% in 2018) and among 27-30 year olds (74% vs. 69% 
in 2018).  
 
Gender differences in daily drinking (Figure 83 in Occasional Paper 93) have been 
somewhat consistent over the years in each of the three age groups, with men always 
higher than women but gender differences decreasing gradually in the two younger age 
groups. Among 19-22 year olds daily drinking showed a general long-term decline from 
about 1981 or 1982 through about 1992, with daily use falling more among men, 
considerably reducing but far from eliminating what had been a large gender difference. 
To illustrate, in 1981, 11.8% of men reported daily use versus 4.0% of women; the 
comparable 1992 statistics were 5.3% and 2.7%. After 1995, daily drinking began to 
increase among 19-22 year olds for both genders, but leveled a few years later. From 2002 
to 2005 their daily use was rising among men and falling among women, increasing their 
differences, but since 2005 there has been a considerable convergence with daily use 
among men falling and use among women increasing modestly through 2014. Men 
showed an increase in 2016, widening the gap, but then decreased significantly in 2018, 
decreasing the gap; in 2018 a slight gender difference remained for daily drinking in the 
19-22 year old age group—3.7% for men versus 1.6% for women— considerably smaller 
than it was in 1981 (11.8% vs. 4.0%, respectively). The gender differences have been 
larger and longer lasting for the two older age groups. Although the gap diminished in 
2014 for the 23-26 year olds, it widened somewhat through 2017 and then decreased again 
in 2018 (7.0% for men vs. 4.4% for women). Among the 27-30 year olds the gender 
difference increased from 2000 to 2017, with use rising for both genders, to a slightly 
greater extent among men; however, in 2018 daily drinking dropped for men, narrowing 
the difference (8.1% for men vs. 4.6% for women).  
 
There are also long-established and large gender differences in all three age groups in the 
prevalence of binge drinking (Figure 84 in Occasional Paper 93). Men in the 19-22 year 
old band have shown some longer-term decline in this statistic, from 54% in 1986 to 45% 
in 1995 to 29% in 2018 (a significant decline of 7.4 percentage points from 2017, reaching 
an all-time low). Use by women declined less, from 33% in 1981 to 28% in 1995 before 
rising some to 34% in 2006, and then back to 26% in 2018. Thus, the gender gap has 
narrowed considerably (from 24 percentage points in 1986 to 17 percentage points in 1995 
to just 3 percentage points by 2018). In the two older age bands (23-26 year olds and 27-
30 year olds), the sizable gender differences remained mostly stable as the binge drinking 
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rates drifted steadily upward in both genders since the early 1990s, at least until 2009 or 
2010. These rates have leveled or even declined a bit in both genders among 23-26 year 
olds over the past seven years (to 41% vs. 31% in 2018), and among the 27-30 year olds 
in the past five years (to 39% vs. 26% in 2018), suggesting a cohort effect. Overall, the 
gender differences for all three age groups have narrowed over the longer term. (Figure 
85 in Occasional Paper 93 shows gender differences by college student status for those 
aged 19-22; substance use by college student status is covered in this volume in Chapters 
8 and 9.)  
 
 Most striking for cigarette smoking by young adults are the similarities between the 
genders in both absolute levels and trends. All three age groups showed a long-term 
decline in 30-day smoking rates for both men and women (Figure 91 in Occasional Paper 
93). For 19-22 year olds, declines occurred from 1980 through 1991 and again since 1999; 
for 23-26 year olds, declines occurred from 1984 to 1995 and again since 2001; for the 
27-30 year olds, declines occurred from 1988 through 2001 and again since about 2006. 
These staggered patterns again reflect a cohort effect moving up the age scale. Among 
those aged 19–22 years, women had slightly higher rates of 30-day smoking until 1992; 
but there was a crossover and since 1994 men have had a higher 30-day prevalence of 
smoking. Since 1998, men 23–26 years old have had a higher 30-day prevalence of 
smoking than women. Among those 27–30 years old, men have generally had a higher 
30-day prevalence, with the gender gap increasing some in recent years. Overall, from 
about 2007 through 2017, gender differences widened a bit in all three age groups because 
women showed a more consistent decline than men over the years; however, in 2018, 
gender differences narrowed again due to greater declines for men. Among the two 
younger age groups in 2017, there was some evidence of leveling among men and women, 
but in 2018, the continuing decline resumed especially for men, with the decline being 
significant for men in the 23-26 year old group. In 2018, prevalence reached all-time lows 
for 19-22 year old men and women (13.1% and 9.2%. respectively) and 23-26 year old 
men and women (16.6% and 11.8%, respectively). Among 27-30 year olds, the decline 
has continued for men, reaching a new low of 13.6% in 2018, whereas use appears to have 
leveled for women the past few years (it was 13.5% in 2018). (Regarding vaping nicotine, 
the one-year changes in prevalence from 2017 to 2018 for men and women are presented 
in Chapter 4.) 
 
Male and female trends in daily smoking (Figure 92 in Occasional Paper 93) levels have 
also been quite parallel over most of the time for which data are available, particularly in 
the two younger age groups. Among 19-22 year olds there was a crossover after 1993—
before that point, women had slightly higher daily smoking rates, whereas men generally 
did from 1994 onward, primarily because use was rising faster among men through 1999. 
Both genders in this age group have shown parallel declines from 1999 through 2016; use 
rose nonsignificantly for both men and women in 2017 (to 8.0% and 6.1%, respectively), 
and then declined nonsignificantly for both in 2018 to all-time lows (5.6% and 4.9%). 
Among 23-26 year olds, the genders had very similar smoking rates until men started 
reporting higher daily smoking rates from 1996 on. Men declined less after 1998, opening 
up a modest gap; however, this gap has narrowed some in recent years as smoking has 
declined a bit more among men. However, in 2017, use increased nonsignificantly to 
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12.9% for men, and continued to decline for women to 7.1% (all-time low); in 2018, it 
declined significantly for men to 7.5% (all-time low), and increased slightly for women 
to 8.1%. In the oldest age band, the two genders were quite close until men opened a gap 
in 2002, and their rate generally remained somewhat higher through 2015. Between 2016 
and 2018, use slightly declined for men (to 9.3% in 2018, an all-time low) and leveled for 
women (9.8% in 2018).  
 
Smoking half-pack-a-day shows similar trends to daily smoking, though the gender 
differences are a little larger, with men showing higher rates than women since 1993 in 
the youngest age band, since 1989 in the middle age band, and since 1988 in the oldest 
age band, when use data for this group were first available (Figure 93 in Occasional Paper 
93). However, all three age groups have shown a convergence by 2018, with most groups 
reaching all-time lows; in 2018, for men and women, it was 2.4% and 2.1% respectively 
among 19-22 year olds, 3.4% and 4.9% respectively among 23-26 year olds, and 5.4% 
and 5.9% among 27-30 year olds. We note that smoking a half pack a day increased 
nonsignificantly to 7.8% in 2017 among 23-26 year old men, and then declined 
significantly in 2018 to 3.4% (an all-time low), a pattern consistent with increases and 
decreases in 30-day and daily smoking among men in this age group as noted above. 
 
 Hookah smoking generally has been slightly higher among men than women in all three 
age bands, but especially in the two older age bands; however, use has been declining and 
with that a convergence has taken place (Figure 98 in Occasional Paper 93). 
 
 There has been a large and fairly consistent gender difference in the use of small cigars, 
dissolvable tobacco, and snus, specifically, with men having higher prevalence levels in 
all three age groups (Figures 101, 104, and 107 in Occasional Paper 93).  
 
Regional Differences in Trends 
The respondent’s current state of residence was first asked in the 1987 follow-up surveys; thus 
trend data by region exist only for the interval since then. In this case, changes have been examined 
for all 19-28 year olds combined to increase estimate reliability. Because gender, for example, 
crosscuts all regions, it has less sampling error than when the sample is divided into four separate 
regions. (Each region is represented by between 800 and 2,200 weighted cases in all years. Actual 
case counts are somewhat higher.) By combining across all ages, we lose the ability to see the 
cohort effects that have occurred with many drugs, but we are able to see whether overall trends 
are similar across regions. Note that the charts showing regional differences in Occasional Paper 
93 differ from those just discussed for gender differences. There are no longer three age bands 
depicted: the freed space on each page is used to add additional prevalence periods (i.e., lifetime, 
annual, and 30-day). But for the most part we continue to concentrate on annual prevalence.  
 
In general, the changes that have occurred since 1987 have been fairly consistent across regions, 
particularly in terms of the direction of change. The four regions of the country—Northeast, 
Midwest, South, and West—have generally moved in parallel. Rather than include the large 
number of tables or figures necessary to show regional trends, we provide a verbal synopsis 
instead. The detailed information on subgroup trends through 2018 are available in graphic and 
tabular forms in MTF Occasional Paper 93. 
173
Monitoring the Future Occasional Paper No. 93 
 There were substantial drops among young adults 19-28 year olds in all four regions 
between 1987 (the initial measurement point) and 1991 for any illicit drug (Figure 2 in 
Occasional Paper 93). After 1991, most or all regions showed some increase and then a 
leveling for a number of years, followed by more recent increases through 2018. The 
proportions of 19-28 year olds using any illicit drug have been consistently lowest in the 
South and highest in the West and Northeast; but the regional differences have been fairly 
modest. In 2018 the West and Northeast had the highest annual prevalence at 48% and 
46% respectively, and the Midwest and South were lower at 41% and 39% respectively. 
The West has shown greater relative increases in the past few years.   
 
 For marijuana use (Figure 10 in Occasional Paper 93), the South has consistently been 
lowest, and the Midwest consistently has been second lowest. Generally, the other two 
regions have been fairly close to one another. However, the differences have generally not 
been great. The 2018 annual prevalence ranged from 34% (South) to 44% (Northeast and 
West). Regional differences in daily marijuana use have been relatively low over the 
years. The South has generally had the lowest levels of daily use. In 2018, daily use ranged 
from 6.9% (South) to 9.0% (Northeast), with none of the one-year changes being 
significant. (Regarding vaping marijuana, the one-year changes in prevalence from 2017 
to 2018 by region are presented in Chapter 4.) 
 
 For the use of any illicit drug other than marijuana (Figure 5 in Occasional Paper 93), 
the regional differences are not large and the regions have moved in parallel. The West 
stood out as consistently highest in annual use until 2000, with the other three regions 
being very similar; since 2001, use in the Northeast generally has been about as high as in 
the West. In 2018, use was 22% in the West, 20% in the Northeast, 19% in the Midwest, 
and 17% in the South. 
 
 Data on use of synthetic marijuana have been gathered since 2011 (Figure 15 in 
Occasional Paper 93). These data show a considerable decline between 2011 (when 
annual prevalence ranged from 5.5% in the Northeast to 9.7% in the Midwest) and 2018 
in all four regions. There remains little difference among the regions in annual prevalence, 
which ranges from 1.2% to 2.3% in 2018. 
 
 From 1987 (when data were first available) through 1994, rates of inhalant use remained 
relatively stable, quite low, and about equal in all four regions among 19-28 year olds. 
Annual use then rose in the Northeast in 1995 and 1996 and remained higher than in the 
other regions through 2000, before dropping back to rates comparable to the other three 
regions (Figure 18 in Occasional Paper 93). Except for that divergence, the regions have 
moved very much in parallel for this class of drugs. Annual prevalence in 2018 was at low 
levels among all young adults, ranging between 0.6% in the Midwest and South and 1.4% 
in the Northeast. 
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 From 1987 (when data were first available) through 2001, the West had the highest level
of lifetime prevalence for LSD (Figure 23 in Occasional Paper 93). From 1991 through
1995, the West had slightly higher annual prevalence levels of LSD than the other three
regions among young adults. Otherwise the lifetime and annual prevalence has been quite
similar in all four regions; all showed sharp declines in LSD use after 2001, though use
had been declining some in all regions for several years prior to that. From about 2009
through 2018, all four regions have shown some modest increase in annual prevalence of
LSD, with the Northeast typically having slightly higher annual prevalence through 2014,
and the West generally having the highest levels since then through 2018. In 2018,
prevalence of annual use was 5.7% in the West, 3.6% in the Midwest, 3.4% in the South,
and 3.1% in the Northeast.
 Salvia, which was first measured with a tripwire question in 2009, showed a continuous
decline from 2009 through 2013 in the West (which started out highest) and the South
(Figure 32 in Occasional Paper 93). Use began to decline in the Midwest after 2010 and
in the Northeast after 2011. Use was very low in all regions by 2018 at 0.9% or less annual
prevalence, compared to 2.5% to 5.4% in the four regions in 2009.
 Questions about MDMA (ecstasy and more recently Molly) were added to the follow-up
surveys of young adults in 1989 (Figure 29 in Occasional Paper 93). Through 1993, rates
were highest in the West and South and a little lower in the Northeast and Midwest
regions. Subsequently, use in the Northeast began to increase (as was true among 12th
graders), exceeding levels of use found in the South and West from 1999 to 2001. The
Midwest has quite consistently had a much lower level of MDMA use than the other three
regions, although it was joined by the South in recent years. In 2000 all four regions
showed a sharp and fairly parallel increase in MDMA use; the rise decelerated in 2001
and use began to decline thereafter in all regions. As discussed elsewhere, we believe that
this decrease may have been caused by growing concern about the hazards of MDMA use.
By 2003, little regional difference remained in annual prevalence, largely because the
declines in use were most pronounced in the Northeast and West. By 2007, use was down
a little more in all regions; but after 2007 MDMA use generally was increasing in the
West until it leveled after 2012, before increasing again in 2016, thereby reopening
regional differences that remained through 2018. In 2018 annual MDMA prevalence
levels among young adults were 6.4% in the West, 3.4% in the Midwest, 2.9% in the
South, and 2.5% in the Northeast.
 The considerable declines in cocaine use, observed in all regions between 1987 and 1991,
were greatest in the two regions that had attained the highest levels of use by the mid-
1980s—the West and Northeast (Figure 35 in Occasional Paper 93). These regional
differences had diminished considerably by 1992 after a large overall decline in use had
taken place. Similar to the finding for 12th graders, in 1992 the decline in annual
prevalence stalled in all regions except the Northeast. A gradual further decline then
occurred in all regions through 1996 (1997 for the West) before a slight rise began to
occur, likely reflecting the effects of young adults forgetting of the hazards of cocaine use
as a result of generational replacement. Regional variability in annual cocaine prevalence
was minimal for some years after the mid-1990s, but between 2005 and 2013, use in the
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Midwest and South declined more than in the West and Northeast, creating some regional 
difference; for the past few years, use has been increasing unevenly for the West and has 
been fairly level for the other three regions. Annual prevalence for the young adult age 
band in 2018 was 8.4% in the West, 6.7% in the Northeast, 5.2% in the Midwest, and 
4.6% in the South.  
 
 Through about 2011, lifetime prevalence of crack use generally has been highest in the 
West since crack use was first measured in 1987, as has been true for cocaine in general 
(Figure 38 in Occasional Paper 93). All four regions exhibited an appreciable drop in 
crack use between 1987 and 1991, again with the greatest declines in the West and 
Northeast, where prevalence had been the highest. Use then generally leveled in all 
regions except the South, where it continued a gradual decline through 1997. As was true 
for cocaine generally, annual prevalence for crack use among the regions have converged 
and are at very low levels, ranging from 0.2% to 0.5% in 2018.  
 
 The regions have trended fairly similarly in their prevalence of amphetamine use by 
young adults (Figure 53 in Occasional Paper 93). The only modest exception was that 
use declined more in the Northeast (which started out lowest) in the period 1987 to 1992, 
giving it a substantially lower rate than the other three regions; it remained lowest until 
1998. The West fairly consistently had the highest rate through about 2000, although not 
by much. By the late 1990s, the Northeast had caught up to the Midwest and South, 
making the regional differences very small; there have been no consistent regional 
differences since 2000 (annual prevalence ranged from 5.0% to 5.9%), with all regions 
showing uneven increases. In 2018 the annual prevalence levels ranged between 6.7% in 
the South and 8.3% in the West.   
 
 Methamphetamine use (Figure 60 in Occasional Paper 93) has been measured only since 
1999 (though crystal methamphetamine, discussed next, has been in the study for a longer 
interval). It shows some differences in rates among the regions and some differential 
trending, with a gradual decline for some years in annual prevalence in the Northeast 
(where use generally was lowest) and a gradual increase in the West (where use had 
usually been highest) from 2000–2004, after which use declined in the West. Use in the 
other two regions remained fairly flat until 2006, when both showed some decline. Use in 
the West fell after 2006, leaving very little variability among regions by 2012. (Lifetime 
prevalence reached particularly high levels in the West, starting at 16% in 1999, and 
declining fairly steadily to 3% in 2018.) Annual prevalence in 2018 ranged from 0.7% in 
the South to 1.9% in the West. 
 
 The West consistently has had the highest rates for crystal methamphetamine (ice) use, 
and until recently the regional differences were very substantial, particularly in terms of 
lifetime use (Figure 63 in Occasional Paper 93). The Northeast has generally had the 
lowest prevalence. When data were first available on crystal methamphetamine in 1990, 
the West had a lifetime prevalence of 5.1% versus a range of 1.7% to 2.3% in the other 
three regions. By 2006, the lifetime prevalence level in the West had increased to 8.8%, 
and lifetime prevalence in the Midwest and South grew quite steadily over that interval. 
This strongly suggests that crystal methamphetamine use among young adults diffused 
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from the West primarily to the South and Midwest regions, but diffused much less to the 
Northeast, which has had the lowest prevalence since 1998. The annual prevalence figures 
tell a similar story, but also show that there was a spike in past-year use in the West from 
1991 to 1995 before use there declined and then stabilized at around 2% from 1997 
through 2001. Rates then rose again in the West between 2001 and 2003 and stabilized at 
a slightly higher level around 2.7%. Since 2006, use in the West declined, narrowing the 
differences among regions. In 2018, annual use of crystal methamphetamine stood 
between 0.7% and 1.7% across all regions. 
 
 Bath salts (synthetic stimulants sold over the counter) were first included in the study in 
2012 and showed some regional variation, though all regions had an annual prevalence of 
use below 1.7% (Figure 66 in Occasional Paper 93). Use by young adults was highest in 
the Northeast at 1.6% in 2012, but use in all regions has fallen from the 2012 levels, and 
the differences among regions are now minor, ranging from 0.0% in the West to 0.6% in 
the Midwest in 2018. 
 
 The annual prevalence for sedatives (barbiturates) remained flat, and at about equivalent 
levels, in all four regions of the country from 1987, when first measured, through 1994 
(Figure 69 in Occasional Paper 93). Rates then rose gradually and in parallel in all regions 
for a number of years until about 2004, followed by some leveling and then some decline 
after 2008, followed by a leveling since 2011; regional differences have been consistently 
small. In 2018 annual prevalence ranged from 2.0% in the Northeast to 2.7% in the West. 
 
 The picture for tranquilizers (Figure 72 in Occasional Paper 93) is similar to that for 
sedatives (barbiturates). Annual prevalence generally held fairly steady in all regions from 
1987 through 1993, even though lifetime use was declining steadily in all regions through 
1997. After 1993 there was some increase in all regions in lifetime and annual use, again 
with the South experiencing the most increase through 2004, after which all regions 
showed a leveling in use, followed by gradual uneven declines in use for the four regions 
since about 2007 through 2018. The regional differences have been small, though they 
grew a bit larger during the period of increasing use in the late 1990s, primarily because 
the South showed a greater increases in lifetime and annual use than the other regions and 
had the highest prevalence through about 2008; since then, there have been few consistent 
regional differences. Annual prevalence in 2018 ranged from 2.8% in the Midwest to 4.9% 
in the South. 
 
 Levels and trends in heroin use were quite comparable across the four regions from 1987 
through 2006 (Figure 41 in Occasional Paper 93). All regions had low and stable rates 
through the early 1990s. A gradual increase was observed from about 1993 through 2000, 
during the relapse phase in the overall drug epidemic, and annual prevalence was fairly 
stable in all regions through roughly 2004. After that, there was a steady increase in heroin 
use in the Northeast from 0.4% in 2004 to 1.1% in 2009, and also an increase in the West, 
from 0.3% in 2004 to 0.8% in 2009. After 2009 young adults in these two regions 
continued to have the highest prevalence of heroin use through 2012. In 2013, use 
continued to rise in the Northeast bringing its annual prevalence up to 1.8%, compared to 
0.2% to 0.5% in the other three regions. This rise in the Northeast is consistent with 
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statements by governors in the Northeast that they were facing a rising level of heroin use. 
The rate in the West fell back to 0.5% in 2013. In 2014 there was a significant decline in 
annual prevalence in the Northeast, leaving it only slightly higher than the other regions 
(at 0.6% vs. 0.3%–0.4%). In 2015 the Northeast showed a small and nonsignificant rise 
back to 1.1% while the other regions remained level at 0.3% to 0.4%. In 2018, annual use 
dropped back to 0.3% in the Northeast, closing the gap (it ranged from 0.1% to 0.4% 
across all regions in 2018). 
 
 Trends in annual prevalence of the use of narcotics other than heroin without medical 
supervision have been quite parallel for the four regions (Figure 44 in Occasional Paper 
93). After a period of slight decline between 1987 and 1993 in all regions, a gradual, long-
term, and substantial increase occurred from the mid-1990s through 2003 or 2004, 
depending on the region, with little systematic change through 2010, at which point use 
began to decline gradually in all regions—a decline that for the most part continued up 
through 2018. The South tended to have the lowest prevalence of use from 2003 through 
2013, with the other three regions being tightly grouped; however, all regions were about 
the same in 2018, with annual prevalence ranging from 2.8% to 4.3%. It is noteworthy 
that trends in lifetime prevalence have been consistent with annual trends noted above, 
including the recent declines and lack of regional differences (11.6% to 12.7% in 2018). 
 
 The annual prevalence of OxyContin use without medical supervision was highest in the 
Northeast and lowest in the West in 2002, when it was first measured (Figure 47 in 
Occasional Paper 93). Use rose some in all regions through about 2009, and it has shown 
a substantial decline in all regions since then. The Midwest had the lowest prevalence 
level from 2010 through 2018 (except for 2013). The four regions were fairly tightly 
grouped in 2018, with annual prevalence ranging from 1.5% to 2.6%. In general, regional 
differences have not appeared very consistent due to the limited sample sizes.  
 
 Annual prevalence of use for Vicodin without medical supervision showed considerable 
variation among the regions between 2002, when it was first measured, and 2010 (Figure 
50 in Occasional Paper 93). The West and Midwest generally had the highest rates, with 
the South the lowest and the Northeast in between. However, the West and Midwest have 
shown declines in use since 2005 and 2006, respectively, narrowing the differences; use 
has since declined for all regions since 2010 with the South generally continuing to have 
the lowest prevalence. Annual prevalence levels in 2018 were 1.6% in the Northeast, 1.9% 
in the South, 2.9% in the West, and 3.3% in the Midwest. (It should be noted that the 
sample sizes are more limited than usual for Vicodin and OxyContin, because questions 
about their use are contained on only two of the six questionnaire forms. Consequently, 
the trends are less smooth.) 
 
 When two club drugs, GHB and ketamine, were first measured in 2002, the Northeast 
stood out as having a higher rate of annual use (especially so for ketamine); but use in the 
Northeast dropped over the next two years, bringing that region’s usage rates down to the 
same very low levels as the other three regions (Figures 77 and 80 in Occasional Paper 
93). There appears to have been a little resurgence of ketamine use between 2008 and 
2010 in all regions except the Midwest, followed by a decline in all regions in 2011. In 
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2012 through 2018 ketamine use stood slightly higher in the Northeast than in the other 
regions. In 2018, annual use ranged from 0.5% in the South to 1.3% in the Northeast. 
GHB use also appeared to rise in the Northeast in 2012, but use then fell back in 2013. 
Because of consistent very low levels of GHB (annual use ranging from 0.0% to 0.3% in 
2015), it was dropped from the surveys to make room for items on other drugs.  
 
 Questions about the use of Rohypnol, another so-called club drug, were discontinued in 
2010. Rohypnol use (Figure 75 in Occasional Paper 93) remained very low in all four 
regions from 2002, when it was first measured, through 2009, not reaching 1% in any 
region. For this reason, questions about its use were dropped from the surveys in 2010 to 
make room for other drugs.   
 
 With respect to alcohol use (Figure 86 in Occasional Paper 93), there were modest 
declines in 30-day prevalence in all four regions between 1987 (when the first 
measurement was available for 19-28 year olds) and 1992. The rates for 30-day prevalence 
among young adults then leveled in all regions. The West and South have consistently had 
lower rates of 30-day use than the Northeast and Midwest (as has generally been true 
among 12th graders). In 2018, 30-day use ranged from 62% in the South to 72% in the 
Northeast. 
 
Current daily use of alcohol also showed a decline from the first (1987) data collection 
through about 1994 or 1995 in all regions. The proportional declines were substantial—
on the order of 40–50%. (This decline corresponds to a period of appreciable decline in 
daily drinking among 12th graders, though we can tell from their longer-term data that 
their decline started in 1980; thus the decline may well have begun earlier among 19-28 
year olds as well.) After the mid-1990s there was some upward trending in daily 
prevalence in all regions through about 2007 or 2008, followed by a leveling. Across the 
years, there have not been consistent regional differences. In 2018 the four regions had 
rates of daily alcohol use between 3.4% (South) and 5.9% (Midwest). 
 
Binge drinking was fairly level in all regions between 1987 and the late 1990s or early 
2000s (bottom panel of Figure 86 in Occasional Paper 93.) There were then some modest 
increases through about 2006, followed by a leveling and even a slight decline, 
particularly in the West. Throughout the years, prevalence has been consistently higher in 
the Midwest and Northeast. Declines since 2011 have been greater for the Midwest and 
Northeast, with smaller declines in the West and South, narrowing the regional differences 
somewhat. In 2018, prevalence of binge drinking was 28% in the South, 30% in the West, 
34% in the Midwest, and 36% in the Northeast. 
 
 There have been highly consistent regional differences among young adults in cigarette 
smoking since data were first available in 1987—these differences exist for monthly, 
daily, and half-pack-daily prevalence levels (Figure 94 in Occasional Paper 93). The 
West has consistently had the lowest rates all three measures of cigarette use across the 
years. The other three regions have tended to cluster fairly closely, but usually with the 
Midwest highest and the Northeast a little lower. However, as prevalence levels have 
fallen in recent years, the rates have converged, with rather little regional difference 
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remaining in 2018. In general, all of the smoking measures have shown parallel 
movements across regions, suggesting that the forces accounting for changes have been 
nationwide in scope. (It should be remembered that, as illustrated earlier in this chapter, 
there are strong cohort effects in smoking that are obscured to a considerable degree when 
we combine age groups across a 10-year age span, as we have done in the present 
analyses.)  
 
As noted above, 2017 was the first year in many that did not show continued declines in 
30-day and daily cigarette smoking, with some nonsignificant increases suggesting a 
leveling in cigarette smoking among young adults. This pattern of leveling or even 
nonsignificant increases in 2017 held for all regions except the Northeast. However, in 
2018, the overall trend of continuing declines resumed, with the declines for both 30-day 
and daily cigarette smoking being significant for the Midwest and South. In 2018, 30-day 
use ranged from 12.9% in the Midwest to 10.8% in the South, with 2018 levels begin at 
all- time lows for all four regions. Likewise, daily use levels were at all-time lows in 2018 
for all four regions in 2018, ranging from 7.6% in the Northeast and South to 5.4% in the 
West. (Regarding vaping nicotine, the one-year changes in prevalence from 2017 to 2018 
by region are presented in Chapter 4.) 
 
 Smoking using a hookah (Figure 99 in Occasional Paper 93) has not shown important 
regional differences, with annual prevalence generally declining for all regions from 2014 
through 2017; in 2018, there was a significant increase in the Midwest to 15.3%, with use 
being 12.2 to 12.7% in the other three regions. Annual use of small cigars and snus 
(Figures 102 and 108, respectively in Occasional Paper 93) have shown some modest 
decreases or leveling in all regions from 2011 (when first asked) to 2018, with use of both 
consistently highest in the Midwest; the South has shown some recent modest increases 
in small cigar use. In 2018, small cigar use ranged from 20% in the South and 19% in the 
Midwest to 12% in the West; snus annual prevalence ranged from 6.1% in the Midwest 
to 1.5% in the West. Annual use of dissolvable tobacco (Figure 105 in Occasional Paper 
93) has generally been below 1% in all regions since 2011 (when first asked) through 
2018. 
 
Population Density Differences in Trends 
The analyses presented here for population density return to the use of three four-year age groups 
of young adults (19-22, 23-26, and 27-30); these age groupings allow a longer time interval to be 
examined for the younger strata and for cross-age comparisons of the trends. Among young adults, 
five levels of population density are distinguished based on the respondent’s answer to the 
question, “During March of this year did you live mostly . . .”; answer alternatives were “in a very 
large city (over 500,000 people), in a large city (100,000 to 500,000), in a medium-sized city 
(50,000 to 100,000), in a small city or town (under 50,000), or on a farm/in the country.” Data on 
the suburbs of cities of each size were combined with the corresponding city. These various 
subgroup data are not presented in tables or figures here because of the substantial amount of space 
they would require. Rather, a verbal synopsis of what they contain is presented. More detailed 
information on subgroup trends will soon be available in both graphic and tabular form in MTF 
Occasional Paper 93. 
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 Annual use of any illicit drug among young adults generally has moved in parallel among 
the various community-size strata. The farm/country stratum has tended to have the lowest 
use. The other four community-size strata have differed little from one another, though 
the very large cities have generally ranked at the top in all three age bands and have shown 
more of a recent increase in annual prevalence than the other strata among 23-30 year olds 
but not among 19-22 year olds (Figure 3 in Occasional Paper 93). Across the years among 
the 19-22 year olds, annual prevalence has been similarly high among the cities of all sizes 
and lowest among the farm/country stratum; in 2018, annual prevalence was: 33% for the 
farm/country stratum, 43% for small towns, 49% for medium-sized cities, 45% for large-
sized cities, and 50% for very large cities. Among 23-26 year olds and 27-30 year olds, 
population density differences in annual use have expanded in recent years, though still 
generally maintaining the positive relation with community size; in 2018, annual 
prevalence for the two age groups was 33% and 29% for farm/country, 42% and 35% for 
small towns, 41% and 33% for medium cities, 45% and 39% for large cities, and 53% and 
51% for very large cities.  
 
 Trends in the use of any illicit drug other than marijuana tell a similar story, with annual 
use generally highest in very large cities and lowest in farm/country communities across 
the age groups (Figure 6 in Occasional Paper 93). There was a long period of fairly 
parallel declines along with some convergence of usage rates among the community-size 
strata at all three age levels (among 19-22 year olds it was between 1981 and 1992), 
followed by an increase in use and more recently a leveling. In general, medium, large, 
and very large city strata have all tended to share about the same rates, while the 
farm/country stratum has tended to have the lowest rates, particularly prior to 1990; the 
differences by population density have been quite small since about 2000 through about 
2012 across the three age groups. After 2012 or 2013 the most noteworthy change has 
been increased prevalence in the very large cities among the two older age groups in the 
past few years.  
 
 Marijuana use (Figure 11 in Occasional Paper 93) has moved pretty much in parallel 
among the various community-size strata over the time intervals for which data exist. 
Among all three age strata annual prevalence of marijuana use tends to be ordinally related 
to population density, with the farm/country stratum having the lowest annual prevalence 
of marijuana use and the very large cities having the highest. Among 19-22 year olds, the 
annual prevalence levels have been quite close among communities of all sizes, except for 
the farm/country stratum. Use in the farm/country stratum fell less in the decline period 
during the ‘80s and rose more slowly in the subsequent increase than in the other 
community-size strata in the 90s, first narrowing and then increasing the gap; in 2018, 
annual prevalence was 27% for farm/country, 40% for small towns, and 44-47% among 
cities. In the past few years among 23-26 year olds and 27-30 year olds, the differences 
among the communities have widened some as use among the large and very large cities 
increased faster than among the other strata; however, in 2018, use in small towns 
increased more than most other strata (significantly so for the 23-26 year olds). In 2018, 
annual prevalence levels for the two older strata were 28% and 23% for farm country, 
39% and 30% for small towns, 36% and 27% for medium cities, 42% and 36% for large 
cities, and 50% and 46% for very large cities. (Regarding vaping marijuana, the one-year 
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changes in prevalence from 2017 to 2018 by population density are presented in Chapter 
4.) 
 
 Daily marijuana use (Figure 13 in Occasional Paper 93) has also moved largely in 
parallel among the five population-density strata within each age band, with few 
consistent differences among the strata over the years. The population-density strata all 
showed some decline in daily use from 1980 through about 1992, suggesting a period 
effect influencing all ages, and then more of a staggered increase from 1992 through 2000 
among the 19-22  year olds, from roughly 1998 to 2003 among the 23-26 year olds, and 
from roughly 2004 to 2008 among the 27-30 year olds, indicative of a cohort effect. Over 
the past decade, there have been few systematic differences between the strata in the three 
age groups, with all showing uneven increases; however, daily use among 23-30 year olds 
in the farm/country stratum has shown a consistent increase in the past few years. In 2018, 
daily use for 19-22 year olds ranged from 6.8% for very large cities to 8.7% for small 
towns; for 23-26 year olds, it ranged from 6.7% among medium cities to 13.0% among 
farm/country; and for 27-30 year olds, it ranged from 6.4% in farm/country to 9.8% in 
very large cities.  
 
 Synthetic marijuana, such as “K-2” and “Spice,” was added to the study in 2011; data 
covering only a six-year interval exist so far (Figure 16 in Occasional Paper 93). The 
farm-country stratum had the highest annual prevalence initially among 19-22 year olds 
(17.3% in 2011), but their use fell sharply and significantly in the years since then to 4.4% 
in 2018. In 2018 the annual prevalence among 19-22 year olds ranged from 1.3% to 2.1% 
among the other four strata. In the older age groups, use started from a lower level and 
generally has fallen in all community size strata as well, such that in 2018 annual 
prevalence ranged from 0.0% to 1.8% among 23-26 year olds and 27-30 year olds.  
 
 In general, there have not been large differences in LSD use among young adults as a 
function of community size since 1983 (Figure 24 in Occasional Paper 93). Among 19-
22 year olds (the young adult age group with by far the highest rates of LSD use prior to 
2003), use in communities of all sizes declined appreciably in the early to mid-1980s, 
particularly in the urban strata, eliminating modest prior differences by 1984. From around 
1989 through 1996, there was some increase in LSD use in all population-density strata 
among 19-22 year olds, with the most rural areas generally continuing to have the lowest 
prevalence of use. After 1997, there was some decline in LSD use in all community-size 
strata among 19-22 year olds, followed by a sharp decline occurring from 2001 to 2003, 
with all strata moving in concert. Since 2011, among 19-22 year olds, there have been 
uneven increases in annual use among all strata; in 2018, prevalence ranged from 3.6% in 
large cities to 6.0% in very large cities. The 23-26 year old respondents had some modest 
increases after 1989 in all community-size strata, though the increases had virtually ended 
by 1995. From about 1999 through about 2011, there were declines in all strata, with the 
largest decline occurring from 2001–2003 in most strata. (In Volume I in this series, we 
discussed how a sharp decline in supply may be responsible for the sizable decline in use 
among all ages after 2001.) Since about 2011, however, annual use has shown some 
unsteady increase through 2018, with annual prevalence in 2018 ranging from 1.9% in 
medium cities to 4.1% in very large cities. In the oldest age group, LSD use has remained 
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very low and for the most part quite stable through about 2013, with very little difference 
among the community size strata. Since about 2013 through 2018, annual use increased 
unevenly for all strata, with the 2018 increases being significant in medium and very large 
cities; in 2018 the annual prevalence of LSD ranged from 2.1% in farm/country to 5.0% 
in very large cities. 
 The use of hallucinogens other than LSD (Figure 27 in Occasional Paper 93), taken as
a class, has also shown considerably higher rates in the youngest age band compared to
the two older ones, suggesting a consistent sharp falloff in use with age—an age effect.
(The drug most often reported in this general class has been psilocybin or shrooms, as is
true among 12th graders as well.) Use of this general class of drugs has tended to be highest
in very large cities and lowest in farm/country communities across the years in the three
age groups. Use fell in communities of all sizes among young adults between 1980 and
about 1988. Among 19-22 year olds, there was then a leveling of use for a few years,
followed by an extended increase in use among all community-size strata. By 2003 the
rates attained by each stratum exceeded those originally observed in 1980; there have been
some declines and leveling since then in most strata (in 2018, it ranged from 4.6% in
farm/country to 2.2% in small towns). The 23-26 year old group showed slightly rising
rates of use between 1998 and 2004, followed by some uneven leveling through 2018.
Sharp increases occurred in the very large cities in 1999, 2000, 2010, and 2017; in 2018,
annual use was 4.6% in very large cities and 2.8% to 3.3% in the other four strata. The
27-30 year olds have generally had low rates of use, and the trend lines were very flat with
only minor community-size stratum differences until 2001, when all strata, especially the
very large cities, began to increase before showing some uneven leveling after 2005
through 2011. However, since 2012 and through 2018, there has been an uneven increase
in annual use in the very large city stratum, reaching 6.5% in 2018 (and ranging between
0.8% and 2.7% in the other four strata). Thus, both LSD and hallucinogens other than
LSD have been showing a particular increase in use in the very large cities among young
adults generally.
 Salvia (or salvia divinorum) use was first measured in 2009 and has shown somewhat
irregular trend lines since then (Figure 33 in Occasional Paper 93). The overall picture is
clearly one of decreasing use since 2009 in the youngest age-group and since 2010 in the
middle age-group. Annual prevalence levels started out highest in the farm/country
stratum among the two younger age groups; but use fell sharply in all strata and in both
age groups by about 2012 and annual prevalence is now very low for this drug across all
population density strata and age groups; in 2018, it ranged from 0.0% to 1.2% among 19-
22 year olds, it was less than 0.9% across all strata among the 23-26 year olds, and it
ranged from 0.0% to 2.3% among the 27-30 year olds.
 MDMA (ecstasy and more recently Molly) use was first measured in 1989, and since then
has shown some of the largest short-term changes of any drug among young adults (Figure
30 in Occasional Paper 93). Among 19-22 year olds annual use in 1989 was highest in
the very large cities (5% annual prevalence), but declined in all population-density strata
between 1989 and 1994 (to 1.6% or less). By 1998, use had begun to increase in all
community-size strata within this age band, except in the farm/country stratum. The
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farm/country stratum moved up sharply in 1999, but then the three most urban strata 
jumped sharply in 2000, opening a fair gap in use with large and very large cities having 
rates nearly twice as high as any of the other strata in 2002. All community-size strata 
showed large declines in MDMA use after 2000 or 2001, which lasted through 2004, 
narrowing the differences among them. In 2011, MDMA use in the very large cities rose 
sharply and has stayed highest there in the years since, with the other strata showing some 
leveling or uneven decline; in 2018, annual use was lowest in the small town stratum at 
2.5% and highest in the farm/country stratum at 5.4%. Among the 23-26 year olds, all 
population-density strata increased from about 1994 through 2000 (with a large increase 
among very large cities to 15%), then declined, or at least remained level, through 2003, 
and then stayed level through 2008 when differences by community size were negligible 
(ranging between 2.2% and 3.5%). After 2008 through 2018, annual use began to diverge 
among the communities, with use rising for very large cities and leveling or declining 
unevenly for the other strata; in 2018, annual prevalence among 23-26  year olds was 7.4% 
for very large cities and 0.5% to 3.8% for the other four strata. Considerably less increase 
in MDMA use occurred among 27-30 year olds, though there was some increase in the 
largest cities starting after 1996 and in the large and medium-sized cities after 1999. From 
1997 through 2005 the very large cities stood out as having the highest rates of MDMA 
use, but the differences were modest through 2012. Between 2012 and 2018, annual 
prevalence again started to rise among very large cities but tended to level or decline for 
the other four strata; in 2018, use was 9.9% in very large cities and 0.5% to 3.8% in the 
other four strata. It thus appears that over the past several years, MDMA use has made 
somewhat of a comeback among young adults in the country’s very large cities. 
MDMA use trends tell an interesting story. In very large cities use peaked in all three age 
bands in 2000 and then began to decline. The medium-sized cities were beginning to level 
or decline by 2001 in the two younger age bands. The small town and farm/country strata 
peaked in 2001 in all age groups. These data support our belief, based on school-level 
analyses of secondary schools, that the presence of this drug was still diffusing 
geographically—in this case, from more urban to more rural areas—and, were it not for 
this continued diffusion, MDMA use would actually have begun to decline nationally a 
year earlier. The data from 12th graders on perceived risk provide the clue as to the most 
likely cause of this turnaround; they showed a large jump in the level of perceived risk 
associated with MDMA use from 2000 through 2003. Unlike most other drugs discussed 
here, the pattern of change since the mid-1990s appears to reflect secular trends rather 
than cohort effects, with all age groups moving largely in parallel—that is, until the recent 
resurgence of use in the very large cities which has been staggered across the age bands 
largely consistent with a cohort effect.  
 In the early 1980s, cocaine use was positively correlated with population density, with the
highest use in the very large cities and the lowest use in the farm/country stratum (Figure
36 in Occasional Paper 93). The important drop in cocaine use that began after 1986
slowed considerably after 1992 or 1993 in all three age strata and in communities of all
sizes, by which time the positive association with population density had been virtually
eliminated. Among 19-22 year olds there was a slow sustained increase in cocaine use
among all community-size strata after about 1993 or 1994, and among 23-26 year olds
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after about 1998. There was some decline in the mid-2000s in all strata except large cities, 
which showed a decline in subsequent years. As just stated, usage rates among the 
population-density strata tended to converge considerably during the period of decline; 
this convergence remains, except for the very large cities, which since 2007 have shown 
rates of cocaine use somewhat higher than the less densely populated areas in all three age 
bands. In the 27-30 year old age group, a gradual increase in use emerged in nearly all 
population-density strata after 2000, no doubt reflecting a cohort effect working its way 
up the age spectrum. By 2004, all of the strata in the oldest age band leveled or declined 
from their peak rates; the single exception was very large cities, where use remained 
relatively high and even increased through 2018. In 2018, annual prevalence among 19-
22 year olds was 7.6% in very large cities and 3.0% to 5.1% in the other strata; among 23-
26 year olds, it was 13.7% in very large cities and 3.5% to 8.3% in the other strata; and 
among 27-30 year olds, it was 9.4% in very large cities and 2.3% to 5.6% in the other 
strata. 
 
 Crack use among all age groups peaked in 1987 or 1988 (strongly suggesting a secular 
trend at work at that time) and then, after declining appreciably, bottomed out in most all 
population-density strata for several years through 2018 (Figure 39 in Occasional Paper 
93). Use reported in these young adult samples at all three age levels has borne practically 
no systematic association with community size, and for the most part the strata have all 
tended to move in parallel, with the youngest age band tending to be highest in the 
farm/country stratum in many of the years. In 2018, annual prevalence was at or below 
0.9% across all strata in the older two age bands, and among 19-22 year olds use was at 
or below 1.7% in all strata. Clearly, as we have indicated in other chapters in this volume, 
crack cocaine may have become all but forgotten among young adults who are high school 
graduates. 
 
 Amphetamine use showed virtually no differences associated with urbanicity in any of 
the three age groups through about 2008; some differences occurred since then through 
2018, with annual use generally lowest in the farm/country stratum and highest in very 
large cities (Figure 54 in Occasional Paper 93). Among 19-22 year olds, trend lines began 
to diverge among the five strata in 2008, with differences becoming most prominent in 
2013 through 2015 especially between very large cities (12.0% in 2015) and farm/country 
(4.4% in 2015). Between 2016 and 2018, trends have converged again, with 2018 
prevalence ranging from 5.6% for large cities to 9.0% in medium cities. A similar pattern 
occurred for the 23-26 year olds beginning in 2010, with use tending to increase among 
very large cities and large cities and declining or leveling for the other three strata; in 2018 
use ranged from 4.2% in the farm/country stratum to 11.4% in very large cities. For 27-
30 year olds, trends have diverged among the strata since 2013, with use being generally 
level for farm/country and small town strata and increased unevenly for the city strata; in 
2018, use ranged from 4.2% for farm/country to 11.4% for very large cities. 
 
 Due to limited sample sizes, estimates of the use of crystal methamphetamine (ice) as a 
function of population density have been quite erratic across time in all three age groups, 
particularly in the earlier years of collecting such data (Figure 64 in Occasional Paper 
93). Since 2007, annual use has been relatively low in all strata and age bands and in 2018, 
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very low use was found across all strata in the three age groups (between 0.0% and 1.2%). 
Since the late 1990s, through about 2013 to 2015, the farm/country and small town 
segments have tended to show the highest rates of crystal methamphetamine use in the 
two older age bands. 
 
 The use of methamphetamine in any form has been measured only since 1999 (Figure 61 
in Occasional Paper 93). In general, the farm/country stratum has shown higher than 
average rates of use in the two youngest age groups, with higher rates in particular from 
2001 to 2005 among 19-22 year olds and from 2004 to 2007 among the 23-26 year olds. 
Among the 27-30 year olds the farm/country stratum was highest from 2009 to 2013, 
suggesting a cohort effect at work. Otherwise there has been little systematic difference. 
Among 19-22 year olds, all community-size strata have shown substantial declines in 
annual use since 2003 or 2004, reaching very low levels by 2007 through 2018 at 2.5% or 
lower; the exception is that use increased to 4.4% in the farm/country stratum in in 2017 
and held in 2018 (versus 0.0% to 0.4% in the other four strata in 2018). Annual use has 
declined some over the same interval among 23-26 year olds (2018 prevalence ranged 
from 0.0% to 1.9%). Among 27-30 year olds annual use generally declined from 2002 to 
2006 in all population-density strata; after 2009, this group showed a slight rebound in 
use, particularly in the farm-country stratum already mentioned; 2018 prevalence ranged 
from 0.6% to 2.5%.  
 
 Bath salts were added to the study in 2012, so trends are available only since then (Figure 
67 in Occasional Paper 93). They showed a high prevalence of annual use (6.5% annual 
prevalence) in 2012 in the farm/country stratum among 19-22 year olds, but a significant 
decline in 2013 such that there have been practically no differences among the different 
levels of population density in the years since; the exception is that use increased to 4.5% 
in the farm/country stratum in 2017 (versus 0.0% to 0.8% in the other four strata); in 2018, 
use dropped back among the farm/country stratum, and use was 1.0% or lower in all strata. 
Among 23-26 year olds, annual use started highest in 2012 in small towns and 
farm/country areas, but dropped there the next year; in 2018, annual prevalence was 
essentially 0.0% in all strata. Use among 27-30 year olds has been negligible all along, 
with annual prevalence ranging between 0.0% and 0.9% across all strata since 2012. These 
findings suggest that this type of drug use tended to be concentrated among younger 
people and in more rural areas; otherwise the use of bath salts is almost nonexistent.  
 
 Sedatives (barbiturates) have never shown much variation by population density, at least 
as far back as 1980, with trends showing gradual declines (through about 1992, 1995, and 
2000 for the three age groups, respectively), then increases (through about 2002, 2004, 
and 2007 for the three age groups, respectively), and more recently gradual declines or 
leveling. (Figure 70 in Occasional Paper 93). This remained true in all three age bands 
through 2018; one exception was that among 19-22 year olds use in the farm country areas 
emerged as highest between 2011 and 2014, and another exception is that use has 
increased somewhat in the past few years for those in very large cities among the two 
older age groups. Otherwise the trends have been similar within each age band. In 2018, 
annual use across all strata in the three age groups was below 6%.  
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 Tranquilizer use among young adults has also had little or no association with population 
density over the time interval under study (Figure 73 in Occasional Paper 93). Like 
sedatives (barbiturates), there was an earlier period of decline, staggered inflection points, 
a long period of gradual increase, and then a leveling staggered up the age band from 
about 2003–2005 through 2018. In recent years, tranquilizer use has tended to be 
somewhat lower in the farm/country stratum in the three age groups, but otherwise, there 
have been few consistent differences among the strata. In 2018, annual use across all strata 
in the three age groups ranged between 2% and 7%. 
 
 From 1980 to 1995, annual heroin prevalence was less than 1.0%—usually much less—
in all population-density strata for all three age bands (Figure 42 in Occasional Paper 93). 
After 1994, use among 19-22 year olds in all community-size strata rose and reached 1.0% 
in the three most urban strata by 1998. In fact, in the very large cities, it reached 2.1% in 
2000 (vs. 0.3–0.6% in the other strata). Use levels have been lower among 23-26 year olds 
and lower still among 27-30 year olds, making it difficult to discern systematic differences 
among the population-density strata in those age bands. In 2018 the annual prevalence of 
heroin was 0.6% or lower in all community-size strata for all three young adult age bands 
and near 0.0% in most.  
 
 The annual use of narcotics other than heroin (Figure 45 in Occasional Paper 93) had 
some positive association with population density among 19-22 year olds through the 
early 1990s; however, it has shown rather little systematic association since then. Use of 
narcotics other than heroin increased substantially in all community-size strata after 1993 
in the case of 19-22 year olds, after about 1996 in the case of 23-26 year olds, and after 
about 1998 in the case of 27-30 year olds; however, no systematic differentiation by 
community size was evident during those periods of increasing use. Clearly a cohort effect 
was at work, and the increasing use of these drugs was quite widespread. Use leveled off 
since about 2004 in the youngest age band, 2006 in the middle age band, and 2007 in the 
oldest age band. In the past few years, annual use continued to decline for most strata 
across the age groups, with the exception of some nonsignificant increase among the two 
older age bands in very large cities to 8.1% and 6.9%, respectively, in 2016 (levels for 
others ranged from 4% to 6%). In 2018, use continued to decline or level in all age groups 
in all population density strata, with annual prevalence ranging between 2.1% and 6.5%. 
Still, use remains at considerably higher levels, particularly in the two older age bands, 
than was true back in the 1980s and early 1990s. 
 
 Sample sizes for two of the narcotic drugs of particular interest, OxyContin and Vicodin, 
are not sufficient to estimate population-density differences or trends with a reasonable 
degree of accuracy (Figures 48 and 51 in Occasional Paper 93). It is clear, however, that 
Vicodin use has been in decline in all strata in all age bands since around 2008.  
 
 The absolute levels of inhalant use have remained low in these age groups, particularly 
above age 22 (Figure 19 in Occasional Paper 93). However, during the mid- to late 1980s, 
there was a gradual increase in use among 19-22 year olds in all community-size strata. 
No strong or consistent association with population density has appeared, though the very 
large cities have not infrequently had higher rates than the other areas among 19-22 year 
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olds, particularly in the period 1998 through 2000. Among both the 19-22 year olds and 
the 23-26 year olds, there has been some falloff in inhalant use since the late 1990s through 
2018 in all population-density levels, although the farm/country stratum in the two 
younger age groups showed a nonsignificant increase in 2018. In 2018, annual use was 
between 0.0% and 3.7% in all strata across the age groups. 
 
 Limitations in sample sizes make estimation of differences and trends as a function of 
population density difficult for the club drugs GHB (Figure 78 in Occasional Paper 93) 
and Ketamine (Figure 81 in Occasional Paper 93). 
 
 There have been few differences as a function of population density in the annual and 30-
day prevalence of drinking alcohol among 19-22 year olds since data were first available 
in 1980, except that the farm/country stratum has tended to have slightly lower-than-
average use across the years (Figures 87 and 88 in Occasional Paper 93); in 2018, 30-day 
use was 45% for the farm/country stratum and 53% to 63% in the other strata. In the two 
older age bands, however, there has been a fairly consistent positive correlation between 
population density and use of alcohol in the past 30 days—though not always a very strong 
one. In 2018, 30-day use ranged from 64% in the farm/country stratum to 83% in very 
large cities among 23-26 year olds; and among 27-30 year olds, it ranged from 55% in the 
farm/country stratum to 83% in very large cities. Trends have been fairly parallel for all 
strata in all age bands. There have also been no consistent trend differences in current 
daily drinking associated with population density in any of the three age bands, though 
since the early 2000s the very large cities tended to have the highest rates among the two 
older age groups (Figure 89 in Occasional Paper 93).  
 
 For binge drinking (Figure 90 in Occasional Paper 93), all community-size strata have 
been fairly close across time, with few consistent population density differences at all 
three age levels (exceptions noted below). Among 19-22 year olds, the farm/country 
stratum has fairly consistently shown a lower prevalence of binge drinking across the 
years. Binge drinking has declined for all groups since about 2007, with prevalence in 
2018 ranging from 25% in the farm/country stratum to 29% in large cities. Among 23-26 
year olds, the farm/country stratum has also tended to have the lowest binge drinking 
across the years, and very large cities having the highest, particularly since about 2002. 
Differences among the strata started to expand in 2007 and converged again in 2014, with 
the differences in binge drinking ordinal across the five strata. Between 2014 and 2018, 
binge drinking increased considerably in very large cities, and leveled or declined for the 
other strata; prevalence in 2018 ranged from 28% for the farm/country stratum to 46% for 
very large cities, with the other strata ranging from 31% to 39%. Among the 27-30 year 
olds, binge drinking has tended to be highest in very large cities across the years, 
particularly since about 2002. Differences among the strata began to emerge in 2006, with 
binge drinking rising in very large and large cities through 2013/2014, and leveling or 
declining for the other strata. Prevalence in 2018 ranged from 20% in small towns to 37% 
in very large cities. To summarize, binge drinking has tended to be lowest in the 
farm/country stratum in all three age bands, and has risen among very large cities in the 
two older age bands since the early 2000s, with greater differences emerging as a function 
of population density. 
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 Cigarette smoking has generally been negatively associated with population density in all 
three age strata, without much evidence of differential trends related to population density 
(Figures 95, 96, and 97 in Occasional Paper 93). There is one exception: Among 19-22 
year olds, all smoking prevalence measures rose from 1997 through 1999 in the 
farm/country and small town strata, while in most other strata they remained level. The 
differences in 1999 were most striking for half-pack-a-day smoking among the 19-22 year 
olds—24% for farm/country, 19% for small town, 15% for both medium-sized and large 
cities, and 10% for very large cities. Compare this with 1985, when there was virtually no 
difference in half-pack-a-day smoking rates among these strata (all were at 18% or 19%). 
Thus, smoking among those in their early 20s became more concentrated in the nonurban 
populations. In fact, among 19-22 year olds, the farm/country stratum has usually had the 
highest rate of daily smoking since 1986, and the small town stratum has generally ranked 
second since then. As smoking has declined in all strata in the youngest group, this 
difference has diminished, though not so much in the older two age bands. Among the 
two older age groups, the farm/country stratum has been highest more often than not. 
Among 19-22 year olds, there has been a decline in 30-day prevalence in most population 
density strata since about 2000 or 2001, down in 2016 to 10% in very large cities and 18% 
in farm/country communities, and among 23-26 year olds since 2005, down in 2016 to 
10% in large cities and 19% in farm/country communities; prevalence has been declining 
among 27-30 year olds since about 2009, down in 2016 to 12% in very large cities and 
17% in farm/country communities. These staggered recent declines across communities 
are consistent with cohort effects. Note also that differentiation among the different 
population density strata is greatest for half-pack-a-day smoking, particularly among the 
oldest age stratum. 
 
As noted above, the 2017 evidence suggested that cigarette smoking was leveling for 
young adults. With regard to population density, there was some evidence to support this 
particularly among the farm/country and small town strata in the two younger age bands. 
However, in 2018, the trend of continuing decline resumed for all measures of cigarette 
use among these strata in the two younger age groups. For example, for daily cigarette 
use, 2018 prevalence was at or near all-time lows for all strata in the two younger age 
groups, ranging from 4.8% in the farm/country stratum to 0.0% in very large cities among 
19-22 year olds, and from 7.8% in the farm/country stratum to 2.4% in large cities among 
23-26 year olds. Daily use either leveled or dropped somewhat for all strata among 27-30 
year olds in 2018, with prevalence ranging from 8.2% for the farm/country stratum to 
3.4% in large cities. (Regarding vaping nicotine, the one-year changes in prevalence from 
2017 to 2018 by population density are presented in Chapter 4.) 
 
 Smoking using a hookah has been measured since 2011 (Figure 100 in Occasional Paper 
93), and its use has tended to be positively correlated with population density for all age 
groups. Annual use has been declining among 19-22 year olds, and this decline generally 
continued in 2018. For the two older age groups, use either leveled or increased 
nonsignificantly in 2018. 
 
 Use of small cigars has not differed much as a function of population density, and use has 
been fairly flat in all strata since first measured in 2011, though recent years have shown 
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a positive correlation with population density, being higher in very large cities and lower 
in the farm/country stratum (Figure 103 in Occasional Paper 93). 
 
 Use of dissolvable tobacco (Figure 106 in Occasional Paper 93) has tended to be very 
low in all strata, with little consistent differences among the strata in any age group. 
 
 Use of snus, specifically, has also tended to be quite low, but with the farm/country 
stratum tending to be highest, particularly in the youngest age group, though their usage 
level has been falling fast (Figure 109 in Occasional Paper 93).  
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Any Illicit Drug a 70.5 69.9 67.9 66.4 64.5 62.2 60.2 59.6 57.5 57.4 56.4 56.7 57.0 57.4 58.2 58.1 59.0 60.2 60.5 60.4 59.7 59.8 59.3 59.3 58.4 59.1 58.9 60.0 62.2 62.9 62.8 64.0 63.8 -0.2 +3.8 sss
Any Illicit Drug
  other than Marijuana a 48.4 47.0 44.6 42.7 40.8 37.8 37.0 34.6 33.4 32.8 31.0 30.5 29.9 30.2 31.3 31.6 32.8 33.9 35.2 34.0 34.8 34.2 34.7 32.8 33.3 33.2 32.8 34.0 37.3 36.8 36.2 36.8 36.3 -0.5 +2.2 s
Marijuana 66.5 66.0 63.8 62.8 60.2 58.6 56.4 55.9 53.7 53.6 53.5 53.8 54.4 54.6 55.1 55.7 56.8 57.2 57.4 57.0 56.7 56.7 55.9 56.0 55.9 56.3 56.5 57.1 57.5 58.5 58.7 60.1 60.1 0.0 +3.0 ss
Inhalants b 12.3 12.7 12.6 13.2 12.5 13.4 13.5 14.1 13.2 14.5 14.1 14.1 14.2 14.2 14.3 12.8 12.4 12.2 11.6 10.3 10.9 9.1 9.5 8.9 7.9 7.2 7.2 6.5 6.7 6.4 6.3 5.2 5.6 +0.4 -1.0
  Nitrites c 2.6 6.9 6.2   — 1.9 1.4 1.2 1.3 1.0   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — — —
Hallucinogens d,y 18.5 17.1 17.0 15.9 16.1 15.7 15.7 15.4 15.4 16.1 16.4 16.7 17.4 18.0 18.4 18.3 19.6 19.7 19.3 17.6 17.2 16.0 14.8 14.2 13.9 13.0 12.2 12.4 11.9 11.7 12.2 12.9 14.3 +1.4 +1.8 s
  LSD y 14.6 13.7 13.8 12.7 13.5 13.5 13.8 13.6 13.8 14.5 15.0 15.0 15.7 16.2 16.4 16.0 15.1 14.6 13.4 11.2 10.1 9.6 8.1 7.3 7.2 6.1 6.2 6.3 6.6 7.0 8.0 8.8 10.3 +1.5 s +4.0 sss
  Hallucinogens
    other than LSD d,y 12.6 11.4 10.6 9.4 9.1 8.4 8.0 7.6 7.4 7.8 7.9 8.4 9.4 9.3 9.9 12.0 15.0 16.4 15.6 15.4 14.9 14.1 13.0 13.0 12.6 12.1 11.1 11.4 10.8 10.4 10.6 10.6 11.1 +0.5 -0.3
  PCP e 8.4 4.8 5.0   — 2.5 3.1 2.0 1.9 2.0 2.2 1.9 2.4 2.7 2.3 2.3 3.1 2.5 3.0 2.7 2.0 2.4 2.1 2.2 1.6 1.6 1.7 1.1 1.4 0.6 1.2 1.9 0.3 1.3 +1.0 -0.1
  MDMA (Ecstasy, Molly) z, original   —   —   — 3.3 3.7 3.2 3.9 3.8 3.8 4.5 5.2 5.1 7.2 7.1 11.6 13.0 14.6 15.3 16.0 14.9 14.4 13.1 13.1 11.5 12.3 11.3 11.4 11.6 11.4   —   —   —   —   —  —
Revised   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 12.5 12.9 12.5 12.6 12.2 -0.4 —
Cocaine 32.0 29.3 28.2 25.8 23.7 21.0 19.5 16.9 15.2 13.7 12.9 12.0 12.3 12.8 12.7 13.1 13.5 14.7 15.2 14.3 15.2 14.7 14.8 13.9 13.6 12.5 11.9 12.2 11.7 12.1 10.4 11.2 11.4 +0.2 -0.8
  Crack g   — 6.3 6.9 6.1 5.1 4.8 5.1 4.3 4.4 3.8 3.9 3.6 3.8 4.3 4.6 4.7 4.3 4.7 4.2 4.1 4.4 3.9 4.3 3.3 3.6 2.9 2.7 2.6 2.1 1.8 1.2 1.2 1.5 +0.3 -1.1 ss
  Other Cocaine h   — 28.2 25.2 25.4 22.1 19.8 18.4 15.1 13.9 12.4 11.9 11.3 11.5 11.8 11.7 12.1 12.8 13.5 14.4 13.3 14.4 14.0 13.9 13.5 13.1 12.2 11.8 11.8 11.6 11.8 11.9 12.6 12.2 -0.4 +0.4
Heroin 1.3 1.3 1.1 1.0 0.9 0.9 0.9 0.9 0.8 1.1 1.3 1.3 1.6 1.7 1.8 2.0 1.8 1.9 1.9 1.7 1.9 1.6 1.9 1.6 1.8 1.7 1.6 1.6 1.4 1.6 1.6 1.4 1.4 0.0 -0.2
  With a Needle i   —   —   —   —   —   —   —   —   — 0.4 0.4 0.3 0.4 0.6 0.4 0.6 0.4 0.5 0.4 0.6 0.6 0.5 0.5 0.5 0.8 0.7 0.5 1.0 0.7 0.7 0.7 0.8 0.4 -0.4 -0.6
  Without a Needle i   —   —   —   —   —   —   —   —   — 1.0 1.4 1.5 1.7 1.9 2.1 2.1 1.8 2.2 2.1 1.8 2.4 1.9 2.1 1.9 1.8 1.6 1.7 1.8 1.2 1.8 1.5 1.5 1.3 -0.1 -0.5
  Narcotics other than Heroin j,k,bb 10.7 10.6 9.8 9.6 9.4 9.3 8.9 8.1 8.2 9.0 8.3 9.2 9.1 9.5 10.0 11.5 13.9 16.8 17.6 17.8 18.7 18.8 19.5 18.5 19.0 18.2 17.6 17.4 16.3 15.0 14.3 13.4 12.3 -1.2 -5.1 sss
Amphetamines, Adjusted j,l 32.3 30.8 28.8 25.3 24.4 22.4 20.2 18.7 17.1 16.6 15.3 14.6 14.3 14.1 15.0 15.0 14.8 15.2 15.9 14.6 15.6 15.3 14.6 14.9 16.1 16.5 17.4 18.8 18.7 18.8 18.7 18.2 18.4 +0.3 -0.3
  Methamphetamine i   —   —   —   —   —   —   —   —   —   —   —   —   — 8.8 9.3 9.0 9.1 8.9 9.0 8.3 7.3 6.7 6.3 4.7 4.3 3.2 3.5 3.1 2.3 2.4 2.2 2.6 2.7 +0.1 -0.5
  Crystal Methamphetamine (Ice) i   —   —   —   — 2.5 2.9 2.2 2.7 2.5 2.1 3.1 2.5 3.4 3.3 3.9 4.0 4.1 4.7 4.7 4.4 4.7 3.7 3.6 3.4 2.8 3.1 2.6 2.8 1.7 2.2 1.8 1.8 1.3 -0.5 -1.5 ss
↓
TABLE 5-1
Trends in Lifetime Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
(Table continued on next page.)
2017– 
2018 
change
2013– 
2018 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Sedatives (Barbiturates) j,u 11.1 9.7 8.9 7.9 8.7 8.2 7.4 6.5 6.4 6.7 6.6 6.5 6.9 7.4 8.1 7.8 8.0 8.7 9.7 10.0 9.5 9.8 10.6 9.5 8.6 7.9 7.2 9.5 9.0 8.3 7.4 6.4 7.3 +0.8 -2.2 sss
  Sedatives, Adjusted j,m 16.7 15.0 13.2 12.1   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
  Methaqualone j 13.1 11.6 9.7 8.7   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Tranquilizers d,j 17.6 16.5 15.1 13.5 12.9 11.8 11.3 10.5 9.9 9.7 9.3 8.6 9.6 9.6 10.5 11.9 13.4 13.8 14.9 14.5 15.0 14.5 15.8 13.8 14.3 13.8 13.3 13.2 12.5 12.8 12.4 12.4 11.4 -1.0 -1.8 ss
Alcohol n 94.8 94.9 94.8 94.5 94.3 94.1 93.4 92.1 91.2 91.6 91.2 90.7 90.6 90.2 90.7 89.9 90.2 89.3 89.4 89.1 88.9 87.9 88.4 87.9 87.5 87.4 86.5 86.2 86.3 85.7 85.9 85.2 85.0 -0.2 -1.1
  Been Drunk o   —   —   —   —   — 82.9 81.1 81.4 80.7 82.1 80.7 81.4 79.8 81.6 80.4 81.1 81.2 80.9 80.1 79.9 80.9 80.1 80.1 78.2 79.0 78.9 78.9 77.4 78.3 76.4 75.2 75.4 76.2 +0.8 -1.2
  Flavored Alcoholic Beverages p,cc   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 83.2 84.6 84.4 84.0 82.6 83.5 81.4 82.2 82.4 80.9 80.6 81.0 79.9 79.2 80.9 +1.7 +0.1
Cigarettes   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Any Vaping i,aa,dd   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 30.3 26.9 34.3 37.0 +2.7   —
  Vaping Marijuana i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 17.2 21.6 +4.4 ss   —
  Vaping Nicotine I,ee   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 24.8 27.5 +2.7   —
  Vaping Just Flavoring I,ff   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 21.4 22.1 +0.7   —
Steroids q   —   —   — 1.1 1.2 1.7 1.9 1.5 1.3 1.5 1.5 1.4 1.4 1.9 1.4 1.4 1.6 1.8 1.9 1.8 1.8 1.7 1.8 1.8 1.7 1.3 1.7 1.2 1.7 1.6 1.4 1.4 1.0 -0.4 -0.2
Source. The Monitoring the Future study, the University of Michigan.
See footnotes following Table 5-4.
TABLE 5-1 (cont.)
2017– 
2018 
change
2013– 
2018 
change
Trends in Lifetime Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
  Crystal Methamphetamine (Ice) i
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Any Illicit Drug a 41.9 39.3 36.3 32.8 30.7 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 32.1 32.5 33.8 33.3 33.2 34.7 34.0 36.7 37.5 39.2 39.7 41.2 42.8 +1.6 +6.2 sss
Any Illicit Drug
  other than Marijuana a 27.0 23.9 21.3 18.3 16.7 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 18.4 18.1 18.9 17.4 18.5 17.6 17.2 18.1 21.2 19.5 19.9 20.1 19.0 -1.1 +0.9
Marijuana 36.5 34.8 31.8 29.0 26.1 23.8 25.2 25.1 25.5 26.5 27.0 26.8 27.4 27.6 27.9 29.2 29.3 29.0 29.2 28.2 27.7 28.5 28.6 29.3 28.7 31.0 30.2 32.2 31.6 34.0 35.3 37.5 39.1 +1.6 +7.0 sss
Synthetic Marijuana v   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 7.4 5.3 3.2 1.3 1.5 1.0 0.9 1.6 +0.6 -1.6 ss
Inhalants b 1.9 2.1 1.8 1.9 1.9 2.0 1.9 2.1 2.1 2.4 2.2 2.3 2.1 2.3 2.1 1.7 1.6 1.4 1.7 1.3 1.3 0.8 1.4 0.9 1.2 0.8 1.1 0.5 1.1 0.9 0.9 0.7 0.8 0.0 +0.3
  Nitrites c 2.0 1.3 1.0   — 0.4 0.2 0.1 0.4 0.3   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — —
Hallucinogens d,y 4.5 4.0 3.9 3.6 4.1 4.5 5.0 4.5 4.8 5.6 5.6 5.8 5.2 5.4 5.4 5.4 4.7 5.2 4.7 4.5 4.1 3.8 3.8 3.9 4.2 3.7 3.6 3.9 4.1 4.2 4.6 4.8 5.6 +0.8 +1.7 sss
  LSD y 3.0 2.9 2.9 2.7 3.3 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 1.2 0.9 0.8 1.2 1.1 1.4 1.7 1.5 1.7 1.6 2.0 2.2 2.6 3.1 3.4 3.9 +0.6 +1.9 sss
  Hallucinogens
    other than LSD d,y 2.5 2.1 1.9 1.8 1.7 1.7 1.9 1.9 2.0 2.5 2.8 3.1 3.0 3.0 3.4 3.5 4.0 4.9 4.5 4.2 3.8 3.6 3.4 3.3 3.7 3.2 2.9 3.2 3.1 3.0 3.0 3.0 3.3 +0.3 0.1
  PCP e 0.8 0.4 0.4   — 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.5 0.6 0.6 0.3 0.6 0.3 0.3 0.1 0.6 0.2 0.3 0.4 0.1 0.2 0.3 0.0 0.2 0.1 0.0 0.4 0.1 0.7 +0.6 0.5
  MDMA (Ecstasy, Molly) z, original   —   —   — 1.4 1.5 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 4.5 3.5 3.0 3.0 2.5 3.3 3.1 3.5 3.6 4.1 4.2 4.8   —   —   —   —   —   —
Revised   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 5.1 4.4 5.1 3.6 3.9 +0.3   —
  Salvia w   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 3.5 3.6 2.2 1.4 0.9 1.2 0.6 0.8 0.5 0.7 +0.1 -0.2
Cocaine 19.7 15.7 13.8 10.8 8.6 6.2 5.7 4.7 4.3 4.4 4.1 4.6 4.9 5.4 5.4 5.8 5.8 6.6 7.1 6.9 6.6 6.2 6.0 5.2 4.7 4.7 4.1 3.9 5.0 5.7 4.9 5.3 6.0 +0.8 +2.1 sss
  Crack g 3.2 3.1 3.1 2.5 1.6 1.2 1.4 1.3 1.1 1.1 1.1 1.0 1.1 1.4 1.2 1.3 1.0 1.0 1.3 1.2 1.1 1.0 0.9 0.7 0.5 0.6 0.5 0.3 0.4 0.4 0.0 0.2 0.2 0.0 -0.1
  Other Cocaine h   — 13.6 11.9 10.3 8.1 5.4 5.1 3.9 3.6 3.9 3.8 4.3 4.5 4.8 4.8 5.3 5.6 6.1 6.4 6.3 5.9 5.6 5.5 5.0 4.8 4.3 4.0 1.0 4.8 5.4 5.9 5.9 6.2 +0.3 +2.5 sss
Heroin 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.3 0.4 0.4 0.3 0.5 0.6 0.5 0.5 0.5 0.6 0.4 0.5 0.4 0.4 0.3 -0.1 -0.4 s
  With a Needle i   —   —   —   —   —   —   —   —   — 0.1 0.1 0.1 0.1 0.1 * 0.3 * * 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.4 0.3 0.3 0.2 0.2 0.3 0.2 0.1 -0.2 -0.3
  Without a Needle i   —   —   —   —   —   —   —   —   — 0.3 0.4 0.4 0.6 0.6 0.5 0.9 0.2 0.4 0.3 0.4 0.5 0.3 0.4 0.6 0.4 0.2 0.4 0.7 0.3 0.5 0.4 0.3 0.1 -0.2 -0.6 s
Narcotics other than Heroin j,k 3.1 3.1 2.7 2.8 2.7 2.5 2.5 2.2 2.5 3.0 2.9 3.3 3.4 3.8 4.1 5.0 7.1 8.5 9.0 8.7 9.1 8.7 9.1 8.4 9.0 7.9 7.3 7.0 6.3 5.2 5.2 4.0 3.4 -0.7 -3.6 sss
  OxyContin j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 1.9 2.6 3.1 3.1 3.1 2.9 3.9 5.2 3.2 2.8 2.3 2.8 2.5 2.5 2.1 1.9 1.9 -0.1 -0.9 s
  Vicodin j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 8.2 8.6 8.9 9.3 9.1 8.9 9.1 8.9 7.8 7.1 6.3 6.2 4.8 3.8 2.7 2.7 2.4 -0.2 -3.7 sss
Amphetamines, Adjusted j,l 10.6 8.7 7.3 5.8 5.2 4.3 4.1 4.0 4.5 4.6 4.2 4.6 4.5 4.7 5.4 5.8 5.9 5.8 6.2 5.1 5.6 5.6 5.3 6.0 7.1 7.2 7.8 7.5 8.0 7.9 7.2 7.8 7.5 -0.3 -0.3
  Ritalin j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 2.9 2.9 2.7 2.5 2.6 2.4 2.4 1.7 1.7 1.5 1.6 2.0 1.6 1.8 1.2 1.2 1.5 +0.3 -0.5
  Adderall j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 5.8 7.0 6.6 7.4 7.0 7.8 7.7 7.2 8.3 9.1 +0.7 +2.1 s
  Provigil j,r   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.5 0.5 0.3   —   —   —   —   —   —   —   — —
  Methamphetamine i   —   —   —   —   —   —   —   —   —   —   —   —   — 2.8 2.5 2.8 2.5 2.7 2.8 2.4 1.9 1.5 1.0 0.9 0.7 0.5 1.0 0.6 0.5 0.7 0.4 0.6 1.2 +0.5 +0.5
  Crystal Methamphetamine (Ice) i   —   —   —   — 0.4 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 1.3 1.5 1.6 1.1 1.1 0.8 0.8 0.5 0.5 0.6 0.8 0.3 0.5 0.1 0.7 0.4 -0.3 -0.4
↓
(List of drugs continued.)
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change
TABLE 5-2
Trends in Annual Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
(Table continued on next page.)
2017– 
2018 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Bath Salts (synthetic stimulants) o,gg   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.5 0.4 0.4 0.3 0.3 0.4 0.3 -0.1 -0.1
Sedatives (Barbiturates) j,u 2.3 2.1 1.8 1.7 1.9 1.8 1.6 1.9 1.8 2.1 2.2 2.4 2.5 2.8 3.4 3.7 3.9 3.9 4.4 4.2 3.9 4.2 4.7 3.8 3.3 3.2 2.7 3.4 3.2 2.7 2.6 2.2 2.5 +0.3 -1.0 ss
  Sedatives, Adjusted j,m 3.0 2.5 2.1 1.8   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
  Methaqualone j 1.3 0.9 0.5 0.3   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Tranquilizers d,j 5.4 5.1 4.2 3.7 3.7 3.5 3.4 3.1 2.9 3.4 3.2 3.1 3.8 3.7 4.6 5.5 7.0 6.8 7.4 6.7 6.5 7.1 6.8 6.4 6.3 5.9 5.3 5.4 4.8 5.0 5.0 4.7 4.0 -0.7 -1.4 ss
Rohypnol i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.3 0.5 0.1 0.1 0.2 0.3 0.2 0.1   —   —   —   —   —   —   —   —   —   —   —
GHB x   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.8 0.6 0.5 0.3 0.2 0.4 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.2   —   —   —   —   —
Ketamine x,hh   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 1.2 0.9 0.6 0.5 0.5 0.3 0.4 0.5 0.8 0.5 0.8 0.5 0.4 0.7 0.7 0.5 0.9 +0.4 +0.4
Alcohol n 88.6 89.4 88.6 88.1 87.4 86.9 86.2 85.3 83.7 84.7 84.0 84.3 84.0 84.1 84.0 84.3 84.9 83.3 84.4 83.8 84.4 84.0 83.6 83.8 82.7 83.5 82.5 82.5 82.3 81.2 82.1 81.2 81.6 +0.4 -0.9
  Been Drunk o   —   —   —   —   — 62.0 60.9 61.1 58.8 61.6 59.9 63.2 59.6 63.2 60.6 63.1 61.8 62.9 63.8 63.5 65.7 65.8 66.0 65.5 64.8 64.0 64.6 63.1 63.5 61.2 61.0 60.9 62.6 +1.7 -0.5
   Flavored Alcoholic Beverages p   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 62.7 58.4 58.5 58.9 58.3 57.0 52.0 56.3 54.8 54.1 55.4 57.3 57.8 54.8 57.1 +2.3 +3.0
   Alcoholic Beverages 
      containing Caffeine I,t,jj   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 28.1 36.7 36.9 35.0 33.5 29.6 31.8 29.9 -1.9 -7.0 ss
Cigarettes 40.1 40.3 37.7 38.0 37.1 37.7 37.9 37.8 38.3 38.8 40.3 41.8 41.6 41.1 40.9 41.1 39.1 38.6 39.0 39.1 36.9 36.2 35.0 33.9 33.0 31.5 29.8 29.8 27.0 26.2 23.4 23.9 22.5 -1.4 -7.3 sss
   Small Cigars o   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 19.2 18.0 18.4 18.6 17.9 15.5 16.0 15.9 -0.1 -2.5
   Tobacco using a Hookah o,ii   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 20.1 19.1 20.4 23.3 19.2 14.8 12.2 13.3 +1.2 -7.1 sss
Any Vaping I,kk   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 23.0 27.3 +4.3 s   —
  Vaping Marijuana i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 12.6 15.6 +3.1 s   —
  Vaping Nicotine I,ll   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 14.4 18.2 +3.8 s   —
  Vaping Just Flavoring I,ff   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 9.9 9.9 0.0   —
Dissolvable Tobacco i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 0.3 0.6 0.3 0.5 0.4 0.5 0.8 0.4 -0.4 +0.1
Snus i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 6.1 5.7 4.8 4.8 4.8 3.6 4.6 3.8 -0.8 -1.0
Steroids q   —   —   — 0.5 0.3 0.5 0.4 0.3 0.4 0.5 0.3 0.5 0.4 0.6 0.4 0.4 0.4 0.5 0.5 0.5 0.3 0.7 0.4 0.7 0.8 0.2 0.4 0.5 0.7 0.5 0.4 0.3 0.4 +0.1 -0.1
Source. The Monitoring the Future study, the University of Michigan.
See footnotes following Table 5-4.
2013– 
2018 
change
TABLE 5-2 (cont.)
Trends in Annual Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
2017– 
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Any Illicit Drug a 25.8 23.4 20.5 17.7 15.9 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 18.5 18.9 19.3 19.8 18.9 20.6 19.9 21.6 22.3 23.2 23.5 24.7 25.9 +1.1 +4.3 sss
Any Illicit Drug
  other than Marijuana a 13.0 10.7 9.5 7.5 6.0 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8.3 8.5 8.2 8.1 8.6 8.9 8.5 8.6 8.4 7.8 8.3 9.9 8.7 9.2 8.7 8.0 -0.6 -0.3
Marijuana mm 22.0 20.7 17.9 15.5 13.9 13.5 13.3 13.4 14.1 14.0 15.1 15.0 14.9 15.6 16.1 16.7 16.9 17.3 16.5 15.8 15.7 16.0 16.0 17.0 16.1 18.3 17.7 19.0 19.2 20.1 21.6 23.0 24.1 +1.1 +5.1 sss
Inhalants b 0.4 0.6 0.6 0.5 0.6 0.5 0.6 0.7 0.5 0.7 0.5 0.5 0.7 0.8 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.4 0.2 0.1 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.3 -0.1 +0.1
  Nitrites c 0.5 0.5 0.4   — 0.1 * 0.1 0.2 0.1   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — —
Hallucinogens d,y 1.3 1.2 1.1 1.1 0.9 1.1 1.5 1.2 1.4 1.7 1.2 1.5 1.4 1.3 1.2 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 1.0 0.9 0.6 1.0 0.9 1.1 0.8 0.9 1.2 +0.3 +0.2
  LSD y 0.9 0.8 0.8 0.8 0.6 0.8 1.1 0.8 1.1 1.3 0.7 0.9 1.0 0.8 0.8 0.7 0.3 0.2 0.1 0.1 0.2 0.2 0.4 0.2 0.4 0.3 0.3 0.4 0.4 0.7 0.6 0.6 0.8 +0.2 +0.4 s
  Hallucinogens
    other than LSD d,y 0.6 0.6 0.4 0.5 0.4 0.3 0.5 0.6 0.6 0.6 0.6 0.7 0.5 0.6 0.7 0.6 0.8 1.2 0.9 0.8 0.6 0.8 0.7 0.7 0.8 0.6 0.4 0.7 0.6 0.5 0.3 0.6 0.6 +0.1 -0.1
  PCP e 0.2 0.1 0.3   — 0.2 0.1 0.2 0.2 0.1 * 0.1 0.1 0.2 0.2 * * 0.1 0.1 0.1 * * * 0.1 * * 0.1 * 0.2 0.1 * 0.1 0.1 0.4 +0.3 +0.2
  MDMA (Ecstasy, Molly) z, origina   —   —   — 0.4 0.2 0.1 0.3 0.3 0.2 0.4 0.3 0.6 0.8 1.3 1.9 1.8 1.3 0.8 0.6 0.6 0.7 0.5 0.6 0.6 0.8 0.7 1.0 1.1 1.3 —   —   —   —   — —
Revised   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 1.4 0.8 1.3 0.8 1.1 +0.3 —
Cocaine 8.2 6.0 5.7 3.8 2.4 2.0 1.8 1.4 1.3 1.5 1.2 1.5 1.7 1.9 1.7 2.2 2.2 2.4 2.2 2.2 2.3 2.1 1.9 1.8 1.4 1.5 1.3 1.5 1.8 1.7 1.8 1.9 2.1 +0.2 +0.6 s
  Crack g   — 1.0 1.2 0.7 0.4 0.4 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.1 * 0.1 0.2 +0.1 +0.1
  Other Cocaine h   — 4.8 4.8 3.4 2.1 1.8 1.7 1.1 1.0 1.3 1.1 1.5 1.5 1.6 1.5 1.8 2.0 2.1 2.1 1.9 1.9 2.0 1.7 1.6 1.5 1.4 1.3 1.3 1.8 1.6 2.0 1.9 2.3 +0.4 +1.0 ss
Heroin 0.1 0.1 0.1 0.1 0.1 * 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 * 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.3 0.3 0.2 0.2 -0.1 -0.2
Narcotics other than Heroin j,k 0.9 0.9 0.7 0.7 0.7 0.6 0.7 0.7 0.6 0.9 0.7 0.9 0.9 1.2 1.4 1.7 2.9 2.9 3.0 3.5 3.2 3.4 3.6 3.2 3.4 2.9 2.7 1.0 2.1 1.8 1.9 1.1 0.9 -0.2 -1.7 sss
Amphetamines, Adjusted j,l 4.0 3.2 2.7 2.1 1.9 1.5 1.5 1.5 1.7 1.7 1.5 1.7 1.7 1.9 2.3 2.4 2.5 2.5 2.4 2.1 2.2 2.3 2.2 2.5 2.9 3.0 3.2 3.0 3.5 3.1 2.9 3.1 2.7 -0.4 -0.5
  Methamphetamine i   —   —   —   —   —   —   —   —   —   —   —   —   — 0.8 0.7 1.0 1.0 0.7 0.6 0.7 0.5 0.6 0.3 0.3 0.2 0.3 0.4 0.2 0.3 0.3 0.2 0.2 0.4 +0.2 +0.2
  Crystal Methamphetamine (Ice) i   —   —   —   —   — * 0.1 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.3 0.3 0.3 0.2 0.2 0.2 0.3 0.4 0.1 0.3 0.1 0.4 0.3 -0.1 -0.1
↓
2017– 
2018 
change
2013– 
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change
TABLE 5-3
Trends in 30-Day Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
(Table continued on next page.)
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Sedatives (Barbiturates) j,u 0.7 0.7 0.7 0.5 0.6 0.5 0.5 0.6 0.6 0.8 0.8 0.9 0.9 1.1 1.3 1.7 1.5 1.5 1.8 1.7 1.5 1.6 1.9 1.2 1.1 1.1 1.1 1.2 1.0 0.9 1.1 0.6 0.9 +0.3 -0.3
  Sedatives, Adjusted j,m 0.9 0.8 0.7 0.5   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
  Methaqualone j 0.3 0.2 0.1 *   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —
Tranquilizers d,j 1.8 1.6 1.4 1.2 1.1 0.9 1.0 1.0 0.8 1.1 0.7 1.1 1.2 1.3 1.8 2.1 2.8 2.4 2.7 2.6 2.3 2.8 2.7 2.8 2.2 2.3 1.9 1.9 1.9 1.7 1.9 1.4 1.3 -0.1 -0.6 s
Alcohol n 75.1 75.4 74.0 72.4 71.2 70.6 69.0 68.3 67.7 68.1 66.7 67.5 66.9 68.2 66.8 67.2 68.3 67.0 68.4 68.6 68.7 69.5 68.9 69.4 68.4 68.8 69.5 68.7 68.4 66.9 68.4 67.1 66.0 -1.2 -2.7 s
  Been Drunk o,nn   —   —   —   —   — 35.4 35.6 34.2 34.3 33.0 33.2 35.6 34.2 37.7 35.7 36.8 37.1 37.8 39.0 39.0 42.1 41.4 40.7 40.5 39.4 39.5 39.1 37.7 39.3 34.2 36.6 36.1 35.9 -0.1 -1.7
  Flavored Alcoholic Beverage p   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 29.5 27.6 24.9 25.9 26.7 24.4 24.5 23.8 26.1 25.4 26.9 24.7 28.8 27.6 29.4 +1.8 +4.0
Cigarettes 31.1 30.9 28.9 28.6 27.7 28.2 28.3 28.0 28.0 29.2 30.1 29.9 30.9 30.3 30.1 30.2 29.2 28.4 29.2 28.6 27.0 26.2 24.6 23.3 22.4 21.3 19.7 20.0 17.5 16.6 14.2 15.3 12.3 -3.0 sss -7.7 sss
Any Vaping i,aa   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 9.2 6.0 11.9 17.1 +5.2 sss   —
  Vaping Marijuana i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 6.6 9.3 +2.7 s   —
  Vaping Nicotine i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 6.5 10.6 +4.0 sss   —
  Vaping Just Flavoring i   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 3.3 4.2 +0.9   —
Steroids q   —   —   — 0.2 0.1 0.2 0.1 * 0.1 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.3 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.3 +0.1 +0.2
Source. The Monitoring the Future study, the University of Michigan.
See footnotes following Table 5-4.
2013– 
2018 
change
TABLE 5-3 (cont.)
Trends in 30-Day Prevalence of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
2017– 
2018 
change
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
Marijuana s 4.1 4.2 3.3 3.2 2.5 2.3 2.3 2.4 2.8 3.3 3.3 3.8 3.7 4.4 4.2 5.0 4.5 5.3 5.0 4.9 5.0 5.0 5.1 5.4 5.3 6.1 5.6 6.2 6.9 6.8 7.6 7.8 8.0 +0.1 +1.7 ss
Cocaine 0.2 0.1 0.2 0.1   * 0.1   * 0.1   * 0.1   *   *   * 0.1 * 0.1 * * 0.1 0.1 0.1 * * 0.1 * * * * 0.1 * 0.1 * 0.1 +0.1 +0.1
Amphetamines 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0
Alcohol
  Daily n,s 6.1 6.6 6.1 5.5 4.7 4.9 4.5 4.5 3.9 3.9 4.0 4.6 4.0 4.8 4.1 4.4 4.7 5.1 4.5 5.2 5.4 5.6 5.3 5.3 4.6 5.2 5.5 5.1 5.0 4.7 5.4 5.0 4.3 -0.7 -0.9
  Been Drunk o,s   —   —   —   —   — 0.5 0.4 0.4 0.5 0.3 0.4 0.9 0.5 0.9 0.5 0.4 0.6 0.8 0.7 0.5 0.6 0.6 0.5 1.0 0.7 0.7 0.4 0.5 0.6 0.4 0.3 0.3 0.5 +0.1 0.0
  5+ Drinks in a Row in
     Last 2 Weeks 36.1 36.2 35.2 34.8 34.3 34.7 34.2 34.4 33.7 32.6 33.6 34.4 34.1 35.8 34.7 35.9 35.9 35.8 37.1 37.0 37.6 37.8 37.9 36.7 35.9 36.5 35.5 35.1 33.5 31.9 32.3 31.8 31.2 -0.6 -3.9 sss
  10+ Drinks in a Row in
     Last 2 Weeks e   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 11.7 11.9 12.3 12.7 12.8 12.1 11.9 10.8 9.8 10.5 9.6 7.3 11.2 8.1 -3.1 -1.7
  15+ Drinks in a Row in
     Last 2 Weeks e   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   —   — 5.3 4.8 5.3 4.8 4.7 4.5 4.2 4.5 3.7 3.7 2.8 2.4 3.5 3.5 0.0 -0.2
Cigarettes
  Daily 25.2 24.8 22.7 22.4 21.3 21.7 20.9 20.8 20.7 21.2 21.8 20.6 21.9 21.5 21.8 21.2 21.2 20.3 20.8 19.6 18.6 17.3 16.7 15.0 14.8 13.8 12.8 12.1 10.7 9.7 8.2 8.8 7.0 -1.8 ss -5.1 sss
  1/2 Pack+/Day 20.2 19.8 17.7 17.3 16.7 16.0 15.7 15.5 15.3 15.7 15.3 14.6 15.6 15.1 15.1 14.6 14.2 13.9 13.5 12.5 11.9 11.1 10.2 9.3 9.3 7.5 7.6 7.0 6.6 5.7 4.9 4.7 3.8 -0.9 -3.2 sss
Source. The Monitoring the Future study, the University of Michigan.
See footnotes on the following page.
2017– 
2018 
change
2013– 
2018 
change
TABLE 5-4
Trends in 30-Day Prevalence of Daily Use of Various Types of Drugs
among Respondents of Modal Ages 19–28
(Entries are percentages.)
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Any Illicit Drug
   Total 41.9 39.3 36.3 32.8 30.7 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 32.1 32.5 33.8 33.3 33.2 34.7 34.0 36.7 37.5 39.2 39.7 41.2 42.7 +1.4 +6.2 sss
   Males 45.3 42.6 39.5 35.7 33.6 30.0 31.4 31.1 32.3 32.1 31.6 31.9 33.6 33.9 34.4 34.9 35.6 36.0 37.0 35.3 35.9 35.4 37.4 35.3 38.1 38.3 37.7 38.4 40.6 42.9 43.0 43.8 44.2 +0.4 +5.8 ss
   Females 39.0 36.5 33.6 30.5 28.3 24.5 25.8 26.1 25.3 28.1 27.3 27.1 27.1 27.6 28.2 30.1 30.2 31.0 31.4 31.1 29.5 30.7 31.4 32.0 29.9 32.4 31.5 35.4 35.3 36.7 37.5 39.5 41.6 +2.1 +6.2 sss
Any Illicit Drug
 other than Marijuana
   Total 27.0 23.9 21.3 18.3 16.7 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 18.4 18.1 18.9 17.4 18.5 17.6 17.2 18.1 21.2 19.5 19.9 20.1 19.1 -1.1 +0.9
   Males 30.4 26.5 23.8 21.0 19.1 16.4 16.3 14.7 16.2 16.2 15.4 15.6 16.2 16.7 17.8 17.2 18.9 19.8 21.3 20.4 21.8 20.3 21.1 18.7 21.5 19.9 19.5 19.7 23.7 22.9 23.1 23.0 21.5 -1.4 +0.4
   Females 24.0 21.6 19.4 16.2 14.7 12.5 12.2 11.6 10.5 12.0 11.4 12.0 11.0 11.5 12.9 14.1 14.6 17.0 17.1 17.3 16.0 16.7 17.5 16.6 16.5 16.2 15.7 17.1 19.4 17.2 17.7 18.2 17.4 -0.8 +1.3
 
Any Illicit Drug
   Total 25.8 23.4 20.5 17.7 15.9 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 18.5 18.9 19.3 19.8 18.9 20.6 19.9 21.6 22.3 23.2 23.5 24.8 25.8 +1.1 +4.3 sss
   Males 29.9 27.1 23.7 21.1 18.8 18.3 17.9 17.4 19.5 18.6 19.0 19.8 20.1 20.0 21.5 21.9 22.8 22.4 23.1 22.0 22.5 22.7 22.8 22.4 23.9 24.5 23.8 25.4 24.7 26.9 26.6 28.9 27.1 -1.8 +1.7
   Females 22.2 20.2 17.8 15.0 13.5 12.5 12.4 12.9 12.1 13.5 13.3 13.8 13.2 15.0 15.6 16.6 16.3 18.3 16.3 16.4 15.7 16.4 16.9 18.0 15.5 18.2 17.3 18.9 20.6 20.8 21.5 22.0 25.0 +2.9 s +6.1 sss
Any Illicit Drug
 other than Marijuana
   Total 13.0 10.7 9.5 7.5 6.0 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8.3 8.5 8.2 8.1 8.6 8.9 8.5 8.6 8.4 7.8 8.3 9.9 8.7 9.2 8.7 8.1 -0.6 -0.2
   Males 15.2 12.3 10.6 9.1 6.8 6.6 6.5 5.9 7.1 6.8 5.7 6.8 7.1 7.3 7.8 8.1 8.5 9.2 10.6 9.2 10.2 10.0 10.0 8.5 10.0 10.0 9.0 9.4 11.4 10.7 10.8 10.2 9.2 -1.0 -0.4
   Females 11.0 9.4 8.7 6.2 5.3 4.4 4.7 4.0 3.9 4.8 4.0 4.5 4.4 5.1 5.4 6.3 7.1 7.7 7.1 7.6 6.8 7.7 8.1 8.5 7.6 7.5 7.0 7.5 9.0 7.3 8.1 7.7 7.4 -0.3 0.0
 
All Respondents
   Total 6,900 6,800 6,700 6,600 6,700 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400 5,100 4,800 4,900 4,900 4,900 4,600 4,600 4,400 4,200 4,000 3,700 3,600 3,600
   Males 3,200 3,100 3,000 2,900 3,000 3,000 3,000 3,000 2,900 2,800 2,700 2,800 2,700 2,600 2,400 2,400 2,200 2,200 2,300 2,200 2,100 1,900 2,000 2,000 2,000 1,800 1,900 900 1,700 1,600 1,500 1,500 1,500
   Females 3,700 3,700 3,700 3,700 3,700 3,600 3,700 3,700 3,600 3,600 3,600 3,600 3,500 3,400 3,300 3,400 3,100 3,100 3,400 3,200 3,000 2,900 2,900 2,900 2,900 2,800 2,700 1,300 2,500 2,400 2,200 2,100 2,100
Source. The Monitoring the Future study, the University of Michigan.
Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone (until 1990), or tranquilizers not under a doctor’s orders.
2013– 
2018 
change
TABLE 5-5
Trends in Annual and 30-Day Prevalence of an Illicit Drug Use Index a
among Respondents of Modal Ages 19–28
Total and by Gender
Approximate Weighted N
2017– 
2018 
change
Percentage who used in last 12 months
Percentage who used in past 30 days
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Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
The illicit drugs not listed here show a daily prevalence of 0.2% or less in all years.
' * ' indicates a prevalence rate of less than 0.05%.
' — ' indicates data not available.
aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone 
(until 1990), or tranquilizers not under a doctor’s orders.  
bThis drug was asked about in four of the five questionnaire forms in 1986–1989;  N  is four fifths of N  indicated. Data were based on five of the six questionnaire 
forms in 1990–1998;   N  is five sixths of N  indicated. Data were based on three of six questionnaire forms in 1999–2017;  N  is three sixths of N  indicated. 
cThis drug was asked about in one questionnaire form.  N  is one fifth of N  indicated in 1986–1988 and one sixth of  N  indicated in 1990–1994. 
dIn 2001 the question text was changed on three of the six questionnaire forms. Other psychedelics was changed to other hallucinogens, and shrooms was added 
to the list of examples. For tranquilizers, Miltown was replaced with Xanax. Beginning in 2002 the remaining forms were changed to the new wording. 
eThis drug was asked about in one of the five questionnaire forms in 1986–1988;  N  is one fifth of N  indicated. Data were based on one of six questionnaire 
forms in 1990–2017;   N  is one sixth of N  indicated. 
fThis drug was asked about in two of the five questionnnaire forms in 1989;  N  is two fifths of N  indicated. Data were based on two of the six questionnaire forms 
in 1990–2001;  N  is two sixths of N  indicated. Data were based on three of the six questionnaire forms in 2002–2017;  N  is three sixths of N  indicated. 
gThis drug was asked about in two of the five questionnaire forms in 1987–1989;  N  is two fifths of N  indicated. Data were based on all six questionnaire forms 
in 1990–2001. Data were based on five of six questionnaire forms in 2002–2017;  N  is five sixths of N  indicated. 
hThis drug was asked about in one of the five questionnaire forms in 1987–1989;  N  is one fifth of N  indicated. Data were based on four of the six questionnaire 
forms in 1990–2017;   N  is four sixths of N  indicated.
iThis drug was asked about in two of the six questionnaire forms;  N  is two sixths of N  indicated. 
jOnly drug use that was not under a doctor’s orders is included here. 
kIn 2002 the question text was changed in three of the six questionnaire forms. The list of examples of narcotics other than heroin was updated: Talwin, laudanum, 
and paregoric—all of which had negligible rates of use by 2001—were replaced by Vicodin, OxyContin, and Percocet. The 2002 data presented here are based 
on the changed forms only;  N  is three sixths of N  indicated. In 2003 the remaining forms were changed to the new wording. The data are based on all forms 
in 2003 and beyond. 
lBased on the data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.  
mSedatives, adjusted” data are a combination of barbiturate and methaqualone data. 
nIn 1993 and 1994, the question text was changed slightly in three of the six questionnaire forms to indicate that a drink meant more than just a few sips. Because 
this revision resulted in rather little change in reported prevalence in the surveys of high school graduates, the data for all forms combined are used in order to 
provide the most reliable estimate of change. After 1994 the new question text was used in all six of the questionnaire forms. 
oThis drug was asked about in three of the six questionnaire forms; N  is three sixths of N  indicated.  For small cigars only, beginning in 2014 question asked on 
two of the six questionnaire forms; N is two sixths of N indicated.
pThis drug was asked about in one of the six questionnaire forms; N  is one sixth of N  indicated. 
qThis drug was asked about in one of the five questionnaire forms in 1989; N  is one fifth of N  indicated. Data were based on two of the six questionnaire forms 
in 1990–2017; N is two sixths of N  indicated.
rThis drug was asked about in two of the six questionnaire forms in 2002 –2009; N  is two sixths of N indicated.  Data were based on three of the six 
questionnaire forms in 2010-2017.  N is three sixths of N indicated.
sDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, and 5+ drinks, measured as having 
five or more drinks in a row in the last two weeks.
tIn 2012 the alcoholic beverage containing caffeine question text was changed to alcoholic beverage mixed with an energy drink. The data in 2011 and 2012
are not comparable due to this question change.
uIn 2013 the question text was changed on all forms: Tuinal, Nembutal, and Seconal were replaced with Ambien, Lunesta, and Sonata.  The data in 2012 and
2013 are not comparable due to this question change.
vThis drug was asked about in two of the six questionnaire forms in 2011-2012; N is two sixths of N indicated.  Data were based on three of the six 
questionaire forms in 2013-2017; N is three sixths of N indicated.
wThis drug was asked about in one of the six questionnaire forms in 2009; N is one sixth of N indicated; Data were based on two of the six questionnaire
forms in 2010-2011; N is two sixths of N indicated.  Data were based on three of the six questionnaire forms in 2012-2017; N is three sixths of N indicated.
xThis drug was asked about in two of the six questionnaire forms in 2002-2009; N is two sixths of N indicated; Data were based on three of the six questionnaire
forms in 2010-2011; N is three sixths of N indicated.  Data were based on two of the six questionnaire forms in 2012-2017; N is two sixths of N indicated.
yThis drug was asked about in all available questionnaire forms until 2014.  Beginning in 2014, data are based on five of the six questionnaire forms; N is 
five sixths of N indicated.
Footnotes for Tables 5-1 through 5-4
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zThis drug was asked about in two of the five questionnnaire forms in 1989;  N  is two fifths of N  indicated. Data were based on two of the six questionnaire forms 
in 1990–2001;  N  is two sixths of N  indicated. Data were based on three of the six questionnaire forms in 2002–2013;  N  is three sixths of N  indicated.  In 2014,
a version of the question was added to an additional form that included "molly" in the description.  In 2015 the remaining forms were changed to this updated
wording.  Data for both versions of the question are included here.  Beginning in 2015, data based on four of th six questionnaire forms.  N  is four sixths of
N  indicated.
aaIn 2017, the surveys switched from asking about vaping in general to asking separately about vaping nicotine, marijuana, and just flavoring.  
Beginning in 2017, data presented for any vaping are based on these new questions.
bbFor the estimate of lifetime Narcotics other than Heroin in 2018, there was a significant difference (p<.01) between the typical mail condition (13.9%) and new
web-push condition (10.9%) of survey administration.
ccFor the estimate of lifetime Flavored Alcoholic Beverages in 2018, there was a significant difference (p<.01) between the typical mail condition (76.4%) and new
web-push condition (85.5%) of survey administration.
ddFor the estimate of lifetime Any Vaping in 2018, there was a significant difference (p<.05) between the typical mail condition (33.4%) and new
web-push condition (40.4%) of survey administration.
eeFor the estimate of lifetime Vaping Nicotine in 2018, there was a significant difference (p<.01) between the typical mail condition (23.8%) and new
web-push condition (30.9%) of survey administration.
ffFor the estimate of lifetime Vaping Just Flavoring in 2018, there was a significant difference (p<.05) between the typical mail condition (19.4%) and new
web-push condition (24.5%) of survey administration.
ggFor the estimate of annual Bath Salts in 2018, there was a significant difference (p<.05) between the typical mail condition (0.6%) and new
web-push condition (0.0%) of survey administration.
hhFor the estimate of annual Ketamine in 2018, there was a significant difference (p<.05) between the typical mail condition (1.6%) and new
web-push condition (0.4%) of survey administration.
iiFor the estimate of annual Tobacco with a Hookah in 2018, there was a significant difference (p<.05) between the typical mail condition (11.6%) and new
web-push condition (14.9%) of survey administration.
jjFor the estimate of annual Alcoholic Beverages containing Caffeine in 2018, there was a significant difference (p<.05) between the typical mail condition (34.6%) and 
new web-push condition (25.9%) of survey administration.
kkFor the estimate of annual Any Vaping in 2018, there was a significant difference (p<.05) between the typical mail condition (24.3%) and new
web-push condition (29.9%) of survey administration.
llFor the estimate of annual Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail condition (15.6%) and new
web-push condition (20.6%) of survey administration.
mmFor the estimate of 30-day Marijuana in 2018, there was a significant difference (p<.05) between the typical mail condition (22.5%) and new
web-push condition (25.5%) of survey administration.
nnFor the estimate of 30-day Been Drunk in 2018, there was a significant difference (p<.05) between the typical mail condition (38.8%) and new
web-push condition (33.5%) of survey administration.
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FIGURE 5-1
ANY ILLICIT DRUG
Trends in Annual Prevalence
 among Respondents of Modal Ages 18 through 60, by Age Group
(Figure continued on next page.)
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 48.1
1977 51.1
1978 53.8 55.8
1979 54.2 54.5
1980 53.1 54.5 55.3
1981 52.1 53.4 55.4
1982 49.4 50.2 51.2 51.7
1983 47.4 47.4 49.9 48.9
1984 45.8 45.9 47.3 44.0 44.0
1985 46.3 45.7 46.3 47.8 45.2
1986 44.3 42.6 45.8 42.8 39.3 38.4
1987 41.7 39.5 42.3 37.9 40.1 36.2
1988 38.5 39.4 38.2 36.6 34.4 32.5 30.5
1989 35.4 35.7 35.0 31.4 30.5 30.9 28.9
1990 32.5 32.3 32.7 30.7 29.6 27.4 23.0
1991 29.4 28.1 29.9 27.0 25.2 23.9 24.5
1992 27.1 29.7 30.0 29.2 26.4 25.3 23.1                                                         
1993 31.0 30.5 30.2 29.8 25.6 24.6 21.7
1994 35.8 32.2 31.6 27.3 25.5 23.6 22.4 19.5
1995 39.0 35.6 31.9 28.5 27.3 23.9 21.3 21.6
1996 40.2 36.1 33.0 27.6 23.4 23.7 22.7 21.2
1997 42.4 36.7 33.5 27.3 25.4 20.7 22.2 20.3
1998 41.4 40.6 34.1 27.4 23.9 22.0 19.6 18.1 20.3
1999 42.1 40.4 33.3 31.1 24.5 20.8 19.0 17.7 16.7
2000 40.9 39.3 36.9 29.6 25.5 21.4 20.3 19.1 17.2
2001 41.4 38.4 40.2 31.1 27.4 22.9 21.1 17.8 15.8
2002 41.0 39.4 36.7 35.2 27.6 22.9 20.9 18.1 18.2
2003 39.3 38.1 38.3 34.6 27.5 26.3 20.6 17.9 15.8 17.8
2004 38.8 38.0 36.5 34.5 31.6 26.8 22.0 18.5 17.5 15.8
2005 38.4 38.9 36.4 31.9 32.0 24.3 25.2 18.2 19.1 15.3
2006 36.5 36.3 36.0 32.7 28.6 25.7 25.9 17.5 16.2 17.2
2007 35.9 35.2 35.0 34.1 29.3 28.5 22.7 17.5 17.4 18.3
2008 36.6 35.5 36.7 34.4 31.8 30.1 28.2 22.1 17.5 17.3 17.9
2009 36.5 35.5 38.8 34.1 29.6 27.4 27.9 20.0 19.1 17.0 16.0
2010 38.3 32.5 38.1 36.3 31.6 27.1 26.2 20.2 16.7 19.1 18.3
2011 40.0 37.9 37.5 35.4 32.1 29.9 26.2 24.2 16.9 17.8 16.8
2012 39.7 36.2 36.8 35.3 29.7 31.6 25.1 21.1 17.6 18.6 18.6
2013 40.1 37.5 42.4 35.9 32.0 34.9 25.6 23.3 18.7 17.7 17.0 16.6
2014 38.7 40.8 40.6 37.2 36.3 32.5 31.7 26.6 17.5 17.1 17.1 15.8
2015 38.6 40.6 42.0 41.2 38.1 33.9 27.5 28.0 19.6 18.4 19.2 18.3
2016 38.3 43.9 44.4 40.0 34.0 36.6 30.6 27.3 23.1 17.6 17.8 19.0
2017 39.9 41.8 43.7 42.4 40.0 38.4 34.9 30.1 22.1 20.3 19.3 19.7
2018 38.8 43.1 47.2 47.0 40.2 36.9 39.2 30.4 26.5 23.5 18.8 20.9 20.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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(Figure continued on next page.)
FIGURE 5-2
ANY ILLICIT DRUG OTHER THAN MARIJUANA
Trends in Annual Prevalence
 among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 25.4
1977 26.0
1978 27.1 28.6
1979 28.2 30.2
1980 30.4 33.3 35.5
1981 34.0 34.2 37.0
1982 30.1 32.4 34.2 35.4
1983 28.4 29.8 33.7 33.2
1984 28.0 27.5 31.6 29.4 30.2
1985 27.4 26.9 29.5 33.4 30.3
1986 25.9 24.7 29.1 29.3 25.5 26.5
1987 24.1 22.2 25.6 22.6 25.7 23.3
1988 21.1 21.3 22.8 21.1 21.0 20.4 20.0
1989 20.0 17.6 19.4 18.8 17.6 18.2 17.4
1990 17.9 16.5 17.4 17.5 16.6 15.2 12.4
1991 16.2 13.8 14.9 14.6 14.4 13.6 13.2
1992 14.9 13.4 15.4 14.8 13.4 13.2 11.6                                                           
1993 17.1 13.5 13.5 12.9 13.0 11.5 9.9
1994 18.0 14.6 14.1 12.9 12.0 11.1 10.8 11.2
1995 19.4 18.6 15.2 11.5 11.6 10.9 11.0 10.4
1996 19.8 17.4 13.7 13.1 10.0 10.7 10.3 11.4
1997 20.7 17.6 17.7 12.1 10.7 8.4 11.0 10.0
1998 20.2 17.3 15.3 12.9 10.8 8.9 7.8 8.2 9.3
1999 20.7 18.7 14.1 14.8 11.6 8.6 8.1 9.3 7.9
2000 20.4 19.6 17.0 15.0 12.5 9.9 7.4 9.3 7.7
2001 21.6 18.0 20.0 14.1 13.3 11.4 9.9 8.8 7.3
2002 20.9 19.6 18.9 17.2 14.6 11.4 10.9 9.6 9.7
2003 19.8 19.9 20.7 20.1 14.5 15.1 11.6 9.5 6.7 8.9
2004 20.5 20.2 21.2 21.2 16.3 14.6 11.8 11.0 8.3 9.3
2005 19.7 20.2 20.5 18.0 19.7 14.2 15.8 10.5 9.4 8.4
2006 19.2 18.1 22.0 19.4 16.9 15.1 15.3 10.8 9.8 10.3
2007 18.5 17.8 19.7 19.1 17.0 16.9 13.0 11.0 11.3 10.7
2008 18.3 16.8 19.5 21.3 19.1 18.0 16.5 13.7 11.3 10.7 10.0
2009 17.0 14.6 22.9 17.6 17.8 14.1 17.2 13.3 10.4 9.6 10.3
2010 17.3 17.2 20.0 20.1 19.5 15.8 14.5 12.5 9.3 11.5 10.8
2011 17.6 17.4 18.2 19.3 17.3 15.8 13.7 13.6 9.6 9.8 9.4
2012 17.0 17.0 17.9 18.8 15.0 17.2 13.7 12.5 10.8 11.3 10.2
2013 17.8 16.7 23.4 18.3 15.1 16.8 14.4 13.0 9.6 9.5 8.6 7.0
2014 15.9 21.1 23.4 20.8 21.7 18.7 20.3 15.0 8.9 9.1 8.7 7.9
2015 15.2 15.6 21.6 22.5 19.7 18.2 15.5 16.3 10.6 9.9 10.5 9.0
2016 14.3 18.9 23.6 18.8 18.2 19.8 16.7 14.5 12.2 9.0 9.2 9.1
2017 13.3 17.1 19.1 22.9 22.3 19.0 17.3 15.0 11.2 9.5 9.3 8.6
2018 12.4 14.2 22.1 22.1 17.8 19.1 19.9 13.7 10.6 10.7 10.9 9.5 7.3
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-3a
MARIJUANA
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 44.5
1977 47.6
1978 50.2 52.8
1979 50.8 51.0
1980 48.8 49.7 50.1
1981 46.1 49.0 51.1
1982 44.3 44.9 45.8 46.0
1983 42.3 43.0 45.4 43.8
1984 40.0 41.4 42.1 38.6 38.3
1985 40.6 40.3 40.9 42.0 39.2
1986 38.8 39.1 39.6 36.6 34.1 32.5
1987 36.3 35.8 37.4 33.7 35.4 31.4
1988 33.1 36.2 33.7 32.0 29.7 26.7 25.4
1989 29.6 32.2 31.6 27.3 26.2 26.8 24.7
1990 27.0 28.4 28.2 26.6 24.1 22.6 20.0
1991 23.9 25.4 26.8 23.2 21.8 20.9 21.0
1992 21.9 26.9 26.9 26.6 23.5 21.2 20.1                                                           
1993 26.0 27.9 26.1 26.5 22.2 21.3 18.8
1994 30.7 29.3 29.2 24.6 22.6 20.1 19.0 14.5
1995 34.7 31.8 28.1 25.8 24.4 20.4 18.2 17.2
1996 35.8 34.2 30.6 25.8 21.7 20.6 19.5 16.3
1997 38.5 34.8 30.6 25.1 23.3 18.0 18.0 17.5
1998 37.5 37.2 31.9 25.5 21.2 19.9 16.9 14.9 17.1
1999 37.8 37.9 31.5 27.4 21.8 18.2 16.0 14.7 13.8
2000 36.5 37.0 33.2 26.9 22.7 18.8 18.4 13.8 13.7
2001 37.0 35.4 37.5 28.3 25.0 19.4 17.1 14.8 12.5
2002 36.2 36.4 34.3 31.8 24.5 19.4 17.5 13.7 14.6
2003 34.9 35.9 33.1 30.0 24.3 21.2 17.0 13.0 13.4 14.0
2004 34.3 34.5 32.5 27.7 27.6 22.4 16.4 13.0 13.9 11.9
2005 33.6 34.9 32.6 26.8 26.4 19.7 18.9 12.9 14.3 11.7
2006 31.5 33.2 31.1 28.5 24.0 20.9 19.9 11.4 11.0 11.6
2007 31.7 33.1 30.5 29.3 24.7 24.4 18.3 10.8 11.6 12.6
2008 32.4 32.1 33.3 27.4 25.9 23.6 22.3 14.2 10.7 11.1 11.7
2009 32.8 33.2 33.7 29.5 25.2 23.3 22.5 12.6 12.2 11.6 10.1
2010 34.8 30.6 34.0 30.5 25.5 22.3 21.5 14.6 12.0 12.7 11.4
2011 36.4 34.4 34.8 31.8 27.0 25.8 20.9 17.7 10.6 11.6 10.8
2012 36.4 34.0 34.0 30.3 25.6 26.5 19.8 14.4 12.5 12.3 12.2
2013 36.4 35.5 36.7 34.3 28.4 25.2 22.4 17.1 14.3 11.9 11.9 12.1
2014 35.1 38.0 34.7 30.5 28.8 25.6 24.1 20.0 12.6 11.7 12.6 11.5
2015 34.9 38.6 37.8 32.7 33.5 26.9 22.2 21.1 14.7 13.3 12.8 12.8
2016 35.6 41.4 40.7 36.4 29.0 30.1 26.0 19.7 16.7 11.8 11.7 12.8
2017 37.1 38.3 41.1 38.7 34.7 34.9 30.4 23.8 17.8 15.2 14.3 15.0
2018 35.9 40.5 44.3 43.0 36.4 32.0 34.3 24.7 22.0 19.2 12.9 16.2 16.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-3b
MARIJUANA
Trends in 30-Day Prevalence  
among Respondents of Modal Ages 18 through 60, by Age Group 
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 32.2
1977 35.4
1978 37.1 38.0
1979 36.5 37.5
1980 33.7 33.9 35.9
1981 31.6 34.2 35.3
1982 28.5 28.6 29.1 30.3
1983 27.0 25.7 29.3 29.7
1984 25.2 24.6 26.4 25.4 24.9
1985 25.7 22.8 25.2 26.8 24.8
1986 23.4 22.9 23.3 23.0 19.9 20.7
1987 21.0 20.4 21.8 19.6 21.5 20.3
1988 18.0 20.1 18.5 17.4 17.2 16.1 15.4
1989 16.7 16.3 15.9 15.6 14.7 14.7 15.0
1990 14.0 15.2 14.3 13.4 13.4 12.9 11.5
1991 13.8 13.2 14.7 13.0 13.0 13.5 12.7
1992 11.9 14.1 14.7 12.5 12.6 12.0 12.2                                                           
1993 15.5 14.6 13.8 13.6 12.4 12.3 11.2
1994 19.0 15.3 16.5 13.3 12.9 11.6 11.4 8.7
1995 21.2 18.7 15.4 12.2 11.7 10.4 10.8 11.1
1996 21.9 19.9 16.4 14.2 12.6 11.0 10.5 8.8
1997 23.7 19.9 18.9 14.0 10.5 10.1 9.4 10.7
1998 22.8 20.1 17.5 13.8 11.8 10.5 9.0 9.1 10.5
1999 23.1 23.1 17.8 15.3 12.0 8.9 9.3 8.8 8.3
2000 21.6 22.3 19.8 14.7 12.5 10.7 9.8 8.3 8.5
2001 22.4 21.0 22.9 14.9 14.5 10.3 8.3 8.8 8.3
2002 21.5 22.2 20.1 17.2 14.8 9.9 9.0 8.9 8.1
2003 21.2 22.5 18.2 18.9 14.5 12.2 8.9 7.1 8.2 8.4
2004 19.9 20.7 18.3 15.6 15.1 12.0 8.5 7.8 8.3 6.5
2005 19.8 18.9 17.9 14.1 15.9 11.9 11.9 7.0 8.1 7.2
2006 18.3 17.5 17.4 16.2 14.0 13.1 10.1 6.2 6.7 6.3
2007 18.8 18.4 18.0 16.2 13.6 13.5 10.4 5.8 6.7 6.9
2008 19.4 17.9 17.8 16.2 13.3 14.2 12.9 7.8 6.6 6.4 7.2
2009 20.6 19.5 20.0 16.0 15.3 13.3 12.1 5.9 6.8 7.3 5.9
2010 21.4 18.0 18.0 17.3 13.6 13.5 11.0 8.9 7.1 7.3 6.8
2011 22.6 20.4 21.9 18.1 15.5 15.0 10.9 10.1 6.5 7.3 5.9
2012 22.9 21.6 19.8 18.0 14.0 14.6 11.5 9.1 6.5 6.6 7.3
2013 22.7 21.8 23.0 20.0 15.8 13.9 13.7 10.4 8.2 5.7 7.5 7.6
2014 21.2 24.3 21.2 17.8 17.4 15.1 13.2 11.1 6.8 7.1 8.1 8.1
2015 21.3 22.6 22.5 19.0 20.7 15.4 12.8 13.2 8.8 7.8 8.0 8.6
2016 22.5 24.9 25.1 22.3 18.0 18.2 15.3 10.8 10.5 7.2 7.4 6.4
2017 22.9 22.0 25.7 24.6 21.8 21.1 17.8 13.9 10.8 8.2 9.4 9.6
2018 22.2 24.1 27.5 26.1 21.7 21.5 22.7 15.1 13.8 11.3 8.4 9.9 4.7
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-3c
MARIJUANA
Trends in 30-Day Prevalence of Daily Use
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 8.2
1977 9.1
1978 10.7 10.5
1979 10.3 10.9
1980 9.1 8.1 10.9
1981 7.0 7.9 9.4
1982 6.3 6.6 6.4 8.1
1983 5.5 5.2 6.2 6.7
1984 5.0 4.7 5.3 5.5 6.0
1985 4.9 4.6 4.5 5.8 6.1
1986 4.0 3.5 4.1 4.9 3.6 4.8
1987 3.3 3.4 3.9 4.3 5.0 4.6
1988 2.7 3.5 3.5 3.1 3.4 3.0 3.2
1989 2.9 2.8 3.1 3.0 3.3 4.1 3.2
1990 2.2 2.3 2.5 2.7 2.7 2.4 2.2
1991 2.0 2.1 2.4 2.1 2.5 2.6 2.6
1992 1.9 1.4 2.6 2.3 2.6 2.5 2.9                                                          
1993 2.4 2.3 2.3 2.7 2.5 2.3 2.7
1994 3.5 3.1 2.9 3.1 2.7 2.2 2.4 2.3
1995 4.6 4.7 3.4 3.3 2.3 2.5 2.5 2.6
1996 4.9 4.9 3.2 2.3 3.1 2.5 2.2 2.3
1997 5.8 5.4 5.3 2.6 2.5 2.7 2.3 3.5
1998 5.6 5.2 5.2 3.1 2.4 2.3 2.4 2.7 3.2
1999 6.0 6.2 4.6 5.1 3.1 2.8 2.5 1.9 2.1
2000 6.0 6.0 5.5 3.8 3.4 2.0 2.2 2.7 2.6
2001 5.8 6.1 7.0 4.7 4.6 2.3 2.6 2.3 1.8
2002 6.0 6.0 6.0 5.5 2.7 2.5 2.3 3.0 3.0
2003 6.0 6.5 6.0 6.6 3.5 4.0 1.9 2.1 2.4 2.6
2004 5.6 6.0 5.1 5.3 5.5 2.9 2.0 2.5 1.8 2.0
2005 5.0 6.4 4.6 4.5 5.9 3.0 3.9 2.1 1.9 2.1
2006 5.0 5.2 5.3 5.3 5.0 4.3 2.5 2.8 2.3 1.4
2007 5.1 5.1 4.9 5.2 4.1 5.7 3.2 1.9 2.3 2.7
2008 5.4 4.1 6.1 5.4 5.5 4.3 4.8 2.2 2.2 2.7 2.0
2009 5.2 5.8 6.3 5.8 5.1 3.7 5.4 1.7 2.1 2.2 2.0
2010 6.1 6.0 5.1 5.8 4.0 5.3 4.0 3.8 2.3 2.2 2.2
2011 6.6 6.6 6.3 6.9 5.8 4.6 3.7 2.7 2.7 2.7 2.3
2012 6.5 6.2 6.1 5.7 5.1 5.1 4.5 3.6 2.6 2.2 2.7
2013 6.5 6.2 7.8 6.2 5.8 5.1 2.9 3.3 2.3 2.4 2.1 2.7
2014 5.8 7.9 7.7 6.8 6.1 6.1 5.7 5.1 1.4 2.6 2.5 2.4
2015 6.0 7.9 6.3 7.0 7.0 5.5 4.7 5.3 4.1 2.5 2.9 2.8
2016 6.0 7.0 8.8 9.6 6.6 6.2 6.7 3.7 3.4 2.8 2.2 2.7
2017 5.9 6.2 9.0 9.2 8.0 6.6 6.9 5.1 4.5 2.7 2.6 3.2
2018 5.8 7.1 8.6 7.5 8.3 8.4 8.0 5.2 3.5 3.4 3.8 4.4 2.0
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.
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FIGURE 5-4
INHALANTS a  
Trends in Annual Prevalence 
among Respondents of Modal Ages 18 through 30, b by Age Group
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Age 18  Ages 
19–20 
Ages    
21–22
Ages    
23–24
Ages    
25–26
Ages    
27–28
Ages    
29–30
Year
1976 3.0
1977 3.7
1978 4.1 2.6
1979 5.4 2.4
1980 4.6 2.5 1.8
1981 4.1 2.2 2.0
1982 4.5 2.7 1.9 1.9
1983 4.3 3.0 2.0 1.4
1984 5.1 2.9 1.7 1.5 0.6
1985 5.7 3.4 1.8 2.1 0.8
1986 6.1 3.5 2.6 1.2 1.2 0.8
1987 6.9 4.2 3.0 1.4 0.9 0.7
1988 6.5 4.4 2.7 1.0 0.5 0.1 0.5
1989 5.9 3.7 2.1 1.9 0.5 0.8 0.4
1990 6.9 4.0 2.3 1.4 0.5 0.7 0.3
1991 6.6 4.0 2.3 1.0 1.2 0.6 0.6
1992 6.2 3.5 3.0 1.3 0.6 0.4 0.6
1993 7.0 3.6 2.8 1.9 0.7 0.8 0.4
1994 7.7 3.1 3.3 1.9 0.7 0.6 0.6
1995 8.0 5.0 2.1 2.1 1.7 0.7 0.8
1996 7.6 4.2 2.7 1.8 0.9 0.7 *
1997 6.7 4.7 2.8 1.6 1.0 0.5 1.0
1998 6.2 4.1 2.4 1.1 1.7 0.9 0.1
1999 5.6 3.1 3.3 3.0 0.4 1.2 0.5
2000 5.9 3.2 3.0 2.4 1.0 0.9 0.1
2001 4.5 3.4 2.4 0.9 0.8 1.0 0.7
2002 4.5 2.8 1.9 1.9 0.8 0.6 0.5
2003 3.9 2.2 1.4 0.9 1.3 1.0 0.5
2004 4.2 3.1 2.1 1.6 1.2 0.3 0.6
2005 5.0 1.5 2.2 1.0 0.4 1.2 1.4
2006 4.5 2.4 2.1 0.9 0.5 0.4 0.5
2007 3.7 1.8 1.0 0.4 0.4 0.5 0.5
2008 3.8 1.8 1.5 1.7 1.1 0.9 0.7
2009 3.4 1.5 1.2 0.8 0.5 0.3 0.3
2010 3.6 1.9 2.1 1.1 0.6 0.5 0.7
2011 3.2 1.1 1.2 0.5 0.7 0.6 0.7
2012 2.9 2.1 0.9 1.5 0.7 0.2 0.6
2013 2.5 0.4 0.9 0.8 0.2 0.2 0.3
2014 1.9 1.7 0.8 1.5 0.2 1.1 0.7
2015 1.9 1.7 0.8 1.5 0.2 1.1 0.7
2016 1.7 0.6 0.6 0.7 0.7 1.6 0.2
2017 1.5 1.7 1.0 0.4 * 0.6 0.8
2018 1.6 1.9 0.5 0.3 0.6 0.5 0.9
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.
aUnadjusted for the possible underreporting of amyl and butyl nitrites. Chapter 5, Volume I , shows that 
such an adjustment would flatten the trend for seniors considerably because the line was adjusted up more
in the earlier years, when nitrite use was more prevalent. Questions about nitrite use were dropped from the 
follow-up questionnaires beginning in 1995. 
bQuestions about the use of inhalants were not included in the questionnaires for 35-, 40-, 45-, and 50-year-olds.
by Age Group
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FIGURE 5-5
HALLUCINOGENS a   
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 50, c by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50
Year
1976 9.4
1977 8.8
1978 9.6 9.5
1979 9.9 10.9
1980 9.3 9.7 10.1
1981 9.0 8.6 10.9
1982 8.1 9.9 9.3 8.1
1983 7.3 7.2 7.4 7.4
1984 6.5 6.0 7.5 5.4 4.7
1985 6.3 5.1 5.7 4.9 4.7
1986 6.0 6.3 5.7 4.6 3.0 2.4
1987 6.4 5.9 5.2 3.7 2.4 2.7
1988 5.5 5.8 5.8 3.8 2.5 1.3 2.1
1989 5.6 5.8 4.3 3.8 2.0 1.7 1.4
1990 5.9 6.3 5.0 4.4 2.3 1.8 1.2
1991 5.8 6.2 5.7 4.4 3.2 2.4 1.5
1992 5.9 6.7 7.2 4.2 3.7 2.2 1.9                                                         
1993 7.4 6.9 5.0 4.7 3.0 2.1 1.3
1994 7.6 6.7 6.8 4.3 3.0 2.4 1.5 0.8
1995 9.3 9.6 6.6 4.9 3.7 2.3 1.9 0.7
1996 10.1 10.1 6.2 5.4 3.2 2.2 1.4 0.5
1997 9.8 9.6 8.0 5.0 3.7 1.8 1.6 1.0
1998 9.0 8.1 6.7 5.2 3.2 2.0 1.4 0.6 0.8
1999 9.4 9.4 6.8 5.9 2.7 1.7 1.4 0.8 0.5
2000 8.1 8.0 7.4 4.9 3.9 2.6 1.7 0.5 0.9
2001 9.1 9.0 8.1 4.6 3.1 1.8 1.7 0.8 0.2
2002 6.6 7.3 5.8 5.2 2.8 2.2 2.0 0.3 0.7
2003 5.9 7.7 7.1 5.8 2.8 2.5 1.5 0.6 0.5 0.6
2004 6.2 6.3 6.7 4.4 3.2 2.6 1.4 1.0 0.5 0.3
2005 5.5 6.4 5.3 4.0 4.3 2.1 2.1 0.3 0.4 0.1
2006 4.9 5.8 5.3 4.6 2.1 2.4 1.5 0.4 0.1 0.1
2007 5.4 5.4 4.8 3.5 2.7 2.6 1.3 0.4 0.4 0.2
2008 5.9 5.2 5.5 3.3 3.2 1.7 2.9 1.1 0.2 0.1 0.2
2009 4.7 4.7 5.8 3.7 2.8 2.4 2.2 0.8 0.5 0.3 0.3
2010 5.5 5.3 5.1 4.7 3.5 2.3 2.1 1.8 0.6 0.3 0.2
2011 5.2 4.6 5.3 3.2 3.0 2.4 1.7 1.4 0.8 0.7 0.1
2012 4.8 5.3 3.9 3.7 2.6 2.1 2.3 1.1 0.2 0.6 0.1
2013 4.5 5.0 4.7 4.1 2.7 2.7 2.6 1.2 0.5 0.3 0.1
2014 4.0 5.6 4.7 4.3 3.2 2.8 2.4 1.4 0.2 0.7 0.4
2015 4.2 4.6 5.6 3.4 4.6 2.9 2.7 2.8 0.8 0.1 0.4
2016 4.3 4.6 5.7 4.8 5.4 2.9 4.2 1.5 1.0 0.2 0.5
2017 4.4 4.6 4.9 5.8 5.0 3.6 2.2 1.7 1.4 0.9 0.5
2018 4.3 5.9 5.9 5.7 4.1 6.3 3.8 2.1 1.1 0.5 0.1
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens were not included in the questionnaires for 55-year-olds.
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FIGURE 5-6
LSD
Trends in Annual Prevalence  
among Respondents of Modal Ages 18 through 35,b by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 
b
Year
1976 6.4
1977 5.5
1978 6.3 6.2
1979 6.6 8.1
1980 6.5 7.2 7.9
1981 6.5 6.4 8.0
1982 6.1 7.7 6.9 6.0
1983 5.4 5.4 4.9 4.6
1984 4.7 4.3 5.1 3.1 2.7
1985 4.4 3.3 3.3 2.9 2.9
1986 4.5 4.5 4.4 2.7 1.5 1.6
1987 5.2 4.7 3.7 2.2 1.6 1.8
1988 4.8 4.9 4.2 2.9 1.6 0.8 1.5
1989 4.9 4.5 3.2 2.7 1.4 1.1 0.8
1990 5.4 5.3 4.0 3.5 1.8 1.5 0.8
1991 5.2 5.4 5.0 3.8 2.5 1.9 1.0
1992 5.6 6.3 6.0 3.5 3.2 1.6 1.4
1993 6.8 6.2 4.3 3.5 2.4 1.8 1.0
1994 6.9 6.2 5.7 3.2 2.4 1.6 1.0 0.6
1995 8.4 8.2 5.5 4.1 2.6 1.7 1.4 0.4
1996 8.8 8.7 4.9 4.6 2.0 1.6 1.0 0.5
1997 8.4 7.8 5.5 4.0 2.6 1.3 0.8 0.5
1998 7.6 5.9 4.4 3.5 2.1 1.0 1.0 0.3
1999 8.1 7.7 4.5 4.3 1.9 1.2 0.8 0.6
2000 6.6 6.3 4.9 2.6 2.5 1.6 1.0 0.3
2001 6.6 6.4 4.7 2.5 1.7 1.3 1.1 0.5
2002 3.5 3.3 1.8 2.2 1.0 0.7 0.9 *
2003 1.9 1.9 1.2 1.4 0.6 0.6 0.4 *
2004 2.2 1.5 1.4 0.7 0.5 0.3 0.2 0.4
2005 1.8 1.5 1.0 0.7 0.7 0.1 0.4 0.1
2006 1.7 2.1 1.4 1.1 0.6 0.7 0.2 0.1
2007 2.1 1.5 1.3 1.4 0.9 0.6 0.3   —
2008 2.7 2.0 2.7 0.9 0.8 0.4 0.5   —
2009 1.9 2.2 2.7 1.4 1.0 0.6 0.2   —
2010 2.6 2.4 1.5 1.7 1.1 0.6 0.2   —
2011 2.7 2.6 2.7 1.5 1.1 0.4 0.9   —
2012 2.4 2.5 1.6 1.6 1.3 0.7 0.3   —
2013 2.2 2.9 2.9 2.0 1.5 0.7 0.7   —
2014 2.5 3.5 2.7 2.2 1.5 1.1 0.7   —
2015 2.9 3.1 4.1 2.1 2.9 0.9 1.1   —
2016 3.0 3.9 3.5 3.3 3.5 1.6 2.2   —
2017 3.3 3.0 3.8 4.2 3.4 2.5 0.8   —
2018 3.2 5.1 4.6 3.2 2.4 4.2 2.4   —
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.  
aBeginning in 2002, respondents were followed through age 30 instead of age 32 as in past years.  
bQuestions about LSD use were not included in the questionnaires administered to the 40-, 45-, and 50-year-olds, or the 
35-year-olds after 2006.
among Respondents of Modal Ages 18 through 35, by Age Group
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FIGURE 5-7
HALLUCINOGENS OTHER THAN LSD a 
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 35, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30 Age 35 
b
Year
1976 7.0
1977 6.9
1978 7.3 7.1
1979 6.8 7.3
1980 6.2 5.4 5.8
1981 5.6 4.6 6.5
1982 4.7 6.1 5.2 4.0
1983 4.1 3.9 4.3 4.2
1984 3.8 3.2 4.1 3.5 3.0
1985 3.6 3.2 3.7 2.8 2.7
1986 3.0 3.6 2.6 2.7 2.0 1.4
1987 3.2 2.5 2.7 2.4 1.3 1.5
1988 2.1 2.4 3.2 1.8 1.2 0.7 0.9
1989 2.2 3.0 2.0 1.9 1.2 0.8 0.9
1990 2.1 2.6 2.4 1.6 1.0 0.7 0.6
1991 2.0 2.6 2.2 1.4 1.3 1.0 0.6
1992 1.7 1.9 3.1 1.9 1.5 0.8 0.8
1993 2.2 2.8 1.9 2.2 1.4 0.9 0.8
1994 3.1 2.2 3.1 2.0 1.3 1.2 0.9 0.5
1995 3.8 3.9 3.2 1.9 1.8 1.1 0.7 0.3
1996 4.4 4.4 3.5 2.8 1.6 0.9 0.7 0.1
1997 4.6 5.1 5.2 2.3 1.6 1.0 1.1 0.6
1998 4.6 4.8 3.7 3.1 1.8 1.4 0.7 0.5
1999 4.3 4.2 4.2 3.6 1.5 0.9 0.8 0.4
2000 4.4 4.6 4.7 3.7 2.1 1.6 1.1 0.3
2001 5.9 5.5 5.9 3.0 1.9 0.9 1.0 0.4
2002 5.4 6.5 5.2 4.1 2.5 1.7 1.6 0.3
2003 5.4 7.3 6.9 5.5 2.5 2.2 1.3 0.6
2004 5.6 6.0 6.3 4.0 3.1 2.4 1.4 0.8
2005 5.0 6.2 5.0 3.7 4.0 2.1 1.9 0.2
2006 4.6 5.3 4.9 4.2 2.0 2.1 1.4 0.4
2007 4.8 5.2 4.7 3.0 2.4 2.5 1.2   —
2008 5.0 4.7 4.5 3.0 2.8 1.6 2.6   —
2009 4.2 4.1 4.5 3.1 2.4 2.2 2.2   —
2010 4.8 4.9 4.6 3.9 3.0 2.1 2.0   —
2011 4.3 3.9 4.3 2.6 2.8 2.3 1.3   —
2012 4.0 4.4 3.3 3.0 1.9 1.9 2.1   —
2013 3.7 4.1 3.7 3.4 2.2 2.4 2.3   —
2014 3.0 4.2 3.5 3.0 2.5 2.3 2.0   —
2015 2.9 3.5 3.4 2.4 3.2 2.5 2.3   —
2016 2.7 2.9 4.2 3.4 2.8 1.8 3.5   —
2017 2.9 3.2 2.5 3.7 3.5 2.2 1.9   —
2018 2.7 2.9 3.5 4.0 2.8 3.5 2.9   —
Source. The Monitoring the Future study, the University of Michigan.
Notes.  '— ' indicates data not available.  
aUnadjusted for the possible underreporting of PCP.
bQuestions about the use of hallucinogens other than LSD were not included in the questionnaires administered to the 40-, 45-, 
and 50-year-olds, or the 35-year-olds after 2006.
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FIGURE 5-8
MDMA (Ecstasy, Molly)
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 30, a by Age Group
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Year Original Revised Original Revised Original Revised Original Revised Original Revised Original Revised Original Revised
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989 1.9 2.1 1.3 0.3 1.0 0.1
1990 2.2 2.0 1.5 1.0 0.7 0.3
1991 0.6 1.1 1.0 0.6 0.6 0.7
1992 1.8 1.7 0.4 0.8 0.4 *
1993 1.1 0.5 1.2 0.5 0.7 *
1994 0.6 1.4 0.9 0.2 0.4 0.3
1995 2.2 2.1 1.3 1.2 1.4 0.3
1996 4.6 3.7 1.9 1.1 1.1 0.7 0.5
1997 4.0 3.1 3.9 1.3 1.6 0.5 1.4
1998 3.6 4.0 3.7 2.3 1.8 2.3 *
1999 5.6 4.9 4.6 3.3 3.4 1.8 0.7
2000 8.2 9.1 9.8 7.0 6.9 2.6 2.4
2001 9.2 11.0 10.8 6.8 4.3 4.1 2.6
2002 7.4 6.3 9.3 8.3 4.4 2.6 2.4
2003 4.5 5.3 5.3 5.2 3.4 3.1 1.2
2004 4.0 4.2 2.4 3.2 4.0 3.7 0.9
2005 3.0 4.1 3.3 2.8 2.3 2.5 2.0
2006 4.1 3.8 3.4 3.6 2.0 2.1 2.2
2007 4.5 3.1 2.7 2.6 1.9 1.9 1.4
2008 4.3 4.7 4.7 2.0 2.7 2.1 2.0
2009 4.3 3.4 3.9 3.4 2.7 1.8 1.9
2010 4.5 5.0 4.8 4.4 1.6 1.8 1.0
2011 5.3 4.8 4.7 3.7 2.5 2.3 2.0
2012 3.8 5.8 5.5 4.2 2.6 2.1 2.2
2013 4.0 5.0 5.9 4.9 3.3 2.0 1.6
2014 3.6 5.0 5.2 5.4 5.9 5.4 4.8 2.2 4.4 7.9 3.3 3.8 1.8 4.9
2015   — 3.6   — 5.2   — 4.2   — 4.8   — 4.5   — 3.5   — 2.6
2016   — 2.7   — 5.1   — 6.9   — 4.2   — 4.3   — 4.8   — 3.3
2017   — 2.6   — 1.8   — 4.8   — 5.7   — 3.3   — 2.3   — 2.9
2018   — 2.2   — 3.1   — 4.5   — 4.5   — 3.9   — 3.8   — 4.1
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.
aQuestions about use of ecstasy (MDMA, Molly) were not included in the questionnaires administered to the 35-, 
40-, 45-, and 50-year-olds.
bIn 2014, a version of the question was added to an additional form that included "molly" in the description.  In 2015 the remaining forms 
changed to this updated wording.  Data for both versions of the question are included here.  
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FIGURE 5-9
COCAINE
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 6.0
1977 7.2
1978 9.0 11.8
1979 12.0 15.0
1980 12.3 16.3 19.8
1981 12.4 15.9 20.5
1982 11.5 16.9 21.6 22.9
1983 11.4 13.8 21.2 20.8
1984 11.6 14.6 20.6 20.2 21.1
1985 13.1 15.4 19.2 23.5 21.6
1986 12.7 15.9 20.4 22.8 19.7 19.9
1987 10.3 13.4 16.0 16.2 17.4 15.6
1988 7.9 10.6 14.1 15.1 15.2 14.2 14.0
1989 6.5 7.6 11.8 12.0 10.7 12.2 11.6
1990 5.3 5.6 8.7 9.5 9.9 9.9 8.1
1991 3.5 3.8 6.1 7.2 7.4 6.9 6.7
1992 3.1 3.7 5.1 6.5 6.6 7.2 6.7                                                          
1993 3.3 3.2 4.1 4.6 6.3 5.8 4.7
1994 3.6 3.2 3.9 4.8 4.2 5.4 6.0 4.7
1995 4.0 3.9 4.3 4.5 4.6 4.6 4.5 4.3
1996 4.9 3.7 4.2 4.8 3.8 4.3 4.3 5.1
1997 5.5 4.5 5.8 4.9 4.3 3.7 4.3 4.1
1998 5.7 5.3 6.0 5.2 3.7 3.9 3.7 4.4 4.5
1999 6.2 5.7 5.6 6.8 5.0 3.9 3.6 4.6 4.1
2000 5.0 5.8 6.3 6.3 4.8 3.6 2.7 3.9 3.5
2001 4.8 6.0 7.5 5.4 5.4 4.8 2.8 3.5 3.0
2002 5.0 6.5 7.0 6.0 5.6 4.0 4.4 3.6 3.7
2003 4.8 6.3 7.4 8.3 5.4 5.5 4.9 2.7 3.1 3.4
2004 5.3 6.3 8.6 8.4 6.7 5.2 3.6 3.3 3.3 3.9
2005 5.1 6.4 7.5 6.7 8.2 5.7 4.5 2.8 2.8 2.9
2006 5.7 5.7 8.4 6.9 6.6 5.2 4.7 2.5 3.0 3.4
2007 5.2 5.8 7.2 5.8 6.4 5.9 4.1 2.0 2.7 3.6
2008 4.4 5.0 7.3 5.8 6.5 5.3 5.2 3.3 2.0 2.7 2.0
2009 3.4 3.2 6.9 6.9 4.5 4.7 5.6 2.5 2.2 3.4 2.6
2010 2.9 3.4 4.9 5.9 4.8 4.7 4.0 2.6 2.0 2.4 1.8
2011 2.9 3.9 4.3 6.1 6.0 3.4 3.3 2.9 1.3 2.1 1.6
2012 2.7 3.4 3.5 5.4 3.8 4.2 3.3 2.3 1.5 1.5 1.8
2013 2.6 2.6 4.8 4.2 4.4 3.5 3.4 3.3 2.2 2.0 1.7 1.0
2014 2.6 4.6 4.7 4.7 5.9 5.2 4.6 3.1 1.8 1.5 1.7 1.3
2015 2.5 4.5 4.7 7.0 6.9 5.2 3.7 4.6 1.6 1.7 1.9 0.9
2016 2.3 3.0 6.6 6.0 4.2 4.7 4.2 3.0 2.3 1.4 2.1 1.4
2017 2.7 3.0 6.6 5.6 7.2 4.0 4.0 4.9 2.1 1.5 1.5 1.5
2018 2.3 3.9 5.9 9.2 6.0 5.2 5.5 3.1 2.9 2.9 1.3 1.5 1.5
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-10
CRACK COCAINE
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986 4.1
1987 3.9 2.7 4.1 3.4 2.4 3.0
1988 3.1 2.7 2.9 4.0 2.7 3.0 3.2
1989 3.1 1.8 3.6 3.1 1.9 2.0 2.8
1990 1.9 1.0 1.6 2.1 2.3 1.3 1.7
1991 1.5 0.6 1.3 1.4 1.5 1.6 1.1
1992 1.5 1.3 1.3 1.3 1.3 1.6 0.9                                                          
1993 1.5 1.2 1.1 1.2 1.3 1.7 1.0
1994 1.9 1.2 1.1 0.8 1.0 1.5 1.5 1.0
1995 2.1 1.0 1.3 1.0 1.1 0.9 1.5 1.0
1996 2.1 1.3 1.4 1.2 0.7 0.8 1.0 1.5
1997 2.4 1.3 1.2 1.0 0.7 0.6 1.5 0.8
1998 2.5 1.3 1.4 1.2 0.4 0.8 0.7 1.2 1.5
1999 2.7 2.4 1.2 1.5 0.9 0.8 1.3 1.1 1.0
2000 2.2 1.6 1.6 1.2 1.1 0.6 0.5 0.8 0.5
2001 2.1 1.7 1.4 1.1 1.0 1.3 0.7 0.7 0.6
2002 2.3 1.7 1.0 1.1 0.7 0.6 0.9 1.3 1.0
2003 2.2 1.8 1.2 1.1 0.5 0.6 0.8 0.7 0.8 1.1
2004 2.3 1.6 1.8 1.2 1.1 0.8 0.6 0.5 0.8 1.2
2005 1.9 1.3 1.8 1.1 0.8 1.0 1.2 0.7 0.8 0.6
2006 2.1 1.4 1.5 0.9 1.2 0.5 0.3 0.8 0.5 1.1
2007 1.9 0.8 0.8 1.0 1.5 1.0 0.3 0.5 0.3 0.7
2008 1.6 1.2 0.9 0.9 0.9 0.7 0.5 0.5 0.4 0.7 0.4
2009 1.3 0.8 0.7 0.9 0.6 0.6 0.7 0.8 0.4 1.0 0.7
2010 1.4 0.8 0.3 0.6 0.5 0.4 0.6 0.6 0.2 0.4 0.7
2011 1.0 0.6 0.5 0.6 0.5 0.7 0.6 0.1 0.2 0.6 0.5
2012 1.2 0.6 0.3 0.6 0.4 0.4 0.3 0.2 0.3 0.6 0.5
2013 1.1 0.3 0.7 0.2 0.5 * 0.3 0.2 0.1 0.5 0.4 0.3
2014 1.1 0.8 0.3 0.1 0.4 0.6 0.5 0.9 0.2 0.2 0.5 0.3
2015 1.1 0.4 0.4 0.5 0.6 0.3 0.5 0.5 0.5 0.3 0.3 0.2
2016 0.8 * * * * 0.1 0.2 0.1 0.3 0.2 0.5 0.3
2017 1.0 0.3 0.4 0.1 * 0.1 0.1 0.4 * 0.1 0.2 0.3
2018 0.9 0.2 0.2 0.2 * 0.4 0.2 0.8 0.4 0.4 0.2 0.4 0.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-11
HEROIN
Trends in Annual Prevalence  
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 0.8
1977 0.8
1978 0.8 0.4
1979 0.5 0.3
1980 0.5 0.2 0.6
1981 0.5 0.5 0.4
1982 0.6 0.2 0.4 0.2
1983 0.6 0.2 0.3 0.6
1984 0.5 0.2 0.3 0.2 0.2
1985 0.6 0.1 0.3 0.2 0.3
1986 0.5 0.1 0.2 0.1 0.2 0.3
1987 0.5 0.2 0.3 0.1 0.3 0.3
1988 0.5 0.1 0.2 0.1 0.1 0.3 0.2
1989 0.6 0.2 0.2 0.1 0.1 0.2 0.3
1990 0.5 * 0.1 0.1 0.1 * *
1991 0.4 0.1 0.2 0.2 0.1 0.1 0.2
1992 0.6 0.1 0.3 0.2 0.1 0.2 0.1                                                          
1993 0.5 0.1 0.2 0.2 0.1 0.2 *
1994 0.6 0.1 0.1 0.1 0.2 0.2 0.3 0.3
1995 1.1 0.5 0.4 0.6 0.1 0.1 0.4 0.2
1996 1.0 0.7 0.5 0.3 0.3 0.1 0.2 0.2
1997 1.2 0.4 0.7 0.1 0.3 0.2 0.3 0.1
1998 1.0 1.1 0.4 0.2 0.3 0.1 0.1 0.1 0.4
1999 1.1 0.6 0.4 0.5 0.2 0.3 0.1 0.4 *
2000 1.5 0.7 0.5 0.4 0.3 0.1 0.1 0.1 0.1
2001 0.9 1.0 0.5 0.5 0.3 0.3 0.2 0.1 0.1
2002 1.0 0.4 0.1 0.3 0.3 0.1 0.2 0.2 0.3
2003 0.8 0.4 0.4 0.5 0.1 0.6 0.2 0.3 0.2 0.2
2004 0.9 0.4 0.5 0.3 0.2 0.1 0.3 0.1 * 0.2
2005 0.8 0.6 0.7 0.3 0.2 0.4 0.5 * * *
2006 0.8 0.5 0.6 0.3 0.4 * 0.1 0.3 0.2 0.1
2007 0.9 0.3 0.5 0.3 0.2 0.2 0.2 0.1 0.1 0.1
2008 0.7 0.6 0.9 0.6 0.3 0.2 0.3 0.1 * * 0.2
2009 0.7 0.8 0.7 0.7 0.5 0.3 0.3 0.4 * 0.1 0.3
2010 0.9 0.4 0.3 0.8 0.6 0.3 0.2 0.3 0.1 * 0.2
2011 0.8 0.4 0.4 0.6 0.5 0.4 0.3 0.0 0.1 0.1 *
2012 0.6 0.4 0.6 0.3 0.7 0.3 0.4 0.1 0.1 0.1 0.1
2013 0.6 0.5 0.8 0.6 0.8 0.6 0.4 0.6 0.2 0.2 0.1 *
2014 0.6 0.2 0.3 0.4 0.7 0.4 0.2 0.6 * 0.1 0.3 0.2
2015 0.5 0.2 0.3 0.8 0.7 0.5 0.6 0.1 * * 0.3 *
2016 0.3 0.1 0.4 0.5 0.6 0.5 0.5 0.6 * 0.1 0.2 0.1
2017 0.4 * 0.2 0.5 0.4 0.7 0.5 0.1 0.1 0.3 * 0.1
2018 0.4 0.1 0.2 0.3 0.3 0.4 0.3 0.4 0.3 0.2 0.1 0.1 *
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not availa  
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FIGURE 5-12
NARCOTICS OTHER THAN HEROIN a 
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 5.7
1977 6.4
1978 6.0 4.7
1979 6.2 4.7
1980 6.3 5.6 4.9
1981 5.9 4.9 5.0
1982 5.3 4.4 3.5 4.4
1983 5.1 4.2 4.0 3.3
1984 5.2 3.9 3.3 3.5 2.7
1985 5.9 3.4 3.8 3.8 3.4
1986 5.2 4.2 3.8 2.7 2.0 2.7
1987 5.3 3.7 3.6 2.4 2.5 3.0
1988 4.6 3.1 3.6 2.3 2.5 1.6 2.2
1989 4.4 3.0 3.4 2.4 2.4 2.9 2.1
1990 4.5 3.9 2.7 2.7 2.3 1.5 1.5
1991 3.5 3.2 2.4 2.4 2.4 1.8 1.8
1992 3.3 2.2 3.4 2.2 2.6 1.7 1.9                                                          
1993 3.6 2.5 2.9 2.0 2.0 1.4 1.3
1994 3.8 2.7 2.9 2.6 1.8 2.1 1.7 1.7
1995 4.7 4.7 3.1 2.5 1.8 2.4 1.9 1.6
1996 5.4 4.7 2.6 2.9 2.1 2.0 2.1 1.8
1997 6.2 4.3 5.0 2.7 2.2 2.0 2.6 2.0
1998 6.3 4.3 4.3 3.5 3.0 1.9 1.5 1.2 1.7
1999 6.7 5.5 4.2 4.1 3.0 1.8 1.8 2.1 1.4
2000 7.0 6.2 5.0 4.2 2.9 2.1 2.5 2.1 1.7
2001 6.7 7.0 6.8 4.3 3.7 3.1 2.9 2.4 1.6
2002 9.4 8.3 8.9 8.2 6.0 4.3 4.2 4.4 3.4
2003 9.3 9.9 9.6 9.7 6.4 6.7 5.1 3.4 2.3 2.8
2004 9.5 10.4 9.2 9.5 7.9 7.5 5.4 4.8 2.9 3.4
2005 9.0 9.9 10.2 7.6 8.8 6.9 7.8 4.3 3.4 3.1
2006 9.0 8.6 11.5 9.5 8.5 7.0 7.7 5.6 4.5 3.5
2007 9.2 8.2 9.4 9.4 8.5 8.1 6.1 3.8 5.8 4.4
2008 9.1 8.6 8.4 10.5 9.4 8.6 7.1 7.4 4.7 3.2 3.3
2009 9.2 6.4 11.0 8.0 9.8 6.7 8.9 6.0 4.7 4.1 4.0
2010 8.7 8.1 9.2 10.0 10.1 7.8 6.9 6.7 4.0 5.0 4.7
2011 8.7 7.7 7.7 7.8 9.0 7.6 6.7 5.8 4.9 4.0 4.2
2012 7.9 6.5 7.0 7.9 7.1 8.2 6.0 6.3 4.7 4.6 4.4
2013 7.1 7.1 6.9 7.2 6.9 6.8 6.5 6.6 4.1 3.0 3.1 2.5
2014 6.1 5.3 6.5 5.9 7.6 6.2 6.1 6.2 3.6 4.2 3.5 3.0
2015 5.4 3.6 4.7 6.4 5.9 5.4 6.0 5.6 4.5 3.6 4.6 3.4
2016 4.8 3.7 5.8 4.7 5.9 5.9 4.9 7.0 5.6 4.5 3.6 3.9
2017 4.2 3.6 3.3 4.1 4.7 4.6 5.0 5.2 4.8 3.9 3.5 3.6
2018 3.4 2.2 3.6 3.6 3.1 4.3 4.5 5.5 4.1 3.9 4.2 3.5 2.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
aIn 2002 the question text was changed on half of the questionnaire forms for 18- to 30-year-olds. The list of examples of 
narcotics other than heroin was updated. Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—
were replaced by Vicodin, OxyContin, and Percocet. The 2001 data presented here are based on all forms. The 2002 data are 
based on the changed forms only. In 2003 the remaining forms were changed to the new wording. The data are 
based on all forms in 2003. Beginning in 2002 data were based on the changed question text for 35- and 40-year-olds. 
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FIGURE 5-13
AMPHETAMINES
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 15.8
1977 16.3
1978 17.1 18.2
1979 18.3 21.5
1980 20.8 23.8 25.5
1981 26.0 25.5 26.7
1982 20.3 23.9 22.4 21.8
1983 17.9 19.7 19.9 18.3
1984 17.7 15.8 17.4 14.0 14.9
1985 15.8 14.5 13.0 14.1 12.5
1986 13.4 11.0 13.0 11.4 8.6 9.1
1987 12.2 9.1 9.9 7.9 8.3 7.9
1988 10.9 9.2 8.1 7.6 6.4 5.0 5.5
1989 10.8 6.9 6.8 5.1 5.5 4.3 5.0
1990 9.1 6.6 5.5 5.3 4.0 4.3 2.7
1991 8.2 4.9 4.9 3.8 3.4 4.0 2.9
1992 7.1 5.6 4.3 4.0 2.7 3.5 3.3                                                          
1993 8.4 5.4 4.8 3.8 2.9 2.6 2.4
1994 9.4 5.4 5.3 4.5 3.9 2.9 2.6 2.4
1995 9.3 7.2 5.7 3.0 3.5 2.7 2.5 1.9
1996 9.5 6.5 4.9 4.1 2.5 2.5 2.6 1.9
1997 10.2 5.9 7.3 3.8 3.2 2.0 2.7 1.7
1998 10.1 7.5 5.0 4.3 2.9 2.3 1.8 1.7 1.7
1999 10.2 7.9 5.0 4.5 3.4 2.6 2.4 1.9 1.2
2000 10.5 9.3 6.0 4.8 3.6 2.7 1.4 1.8 1.4
2001 10.9 8.7 7.9 5.2 3.6 3.2 1.9 1.9 1.0
2002 11.1 9.1 7.1 5.8 3.9 3.3 2.1 1.2 1.4
2003 9.9 8.6 7.5 5.8 3.1 3.6 2.6 2.2 1.0 1.4
2004 10.0 8.5 6.7 7.1 4.6 3.9 2.2 1.5 1.1 0.9
2005 8.6 7.0 6.8 5.0 3.8 2.6 3.0 1.2 0.8 0.5
2006 8.1 6.5 7.6 6.1 4.4 3.3 2.9 1.4 1.6 1.4
2007 7.5 6.7 7.5 5.9 4.2 3.3 2.1 1.5 0.8 1.1
2008 6.8 5.9 6.7 5.7 4.0 4.1 2.6 0.7 1.1 0.9 0.6
2009 6.6 6.2 9.0 5.4 5.3 3.5 2.9 1.9 0.9 0.7 1.0
2010 7.4 8.3 9.0 7.7 5.9 4.3 3.2 1.3 0.7 0.8 0.8
2011 8.2 8.7 8.8 8.8 5.3 3.8 3.2 1.4 0.6 1.3 1.0
2012 7.9 9.3 9.4 8.4 5.8 5.5 4.3 1.4 1.0 1.0 0.4
2013 9.2 8.6 9.5 7.5 5.6 5.7 2.9 2.2 1.5 1.2 1.0 0.7
2014 8.1 9.9 9.6 6.9 7.7 5.9 5.3 2.5 1.5 0.9 0.9 0.2
2015 7.7 7.6 10.6 8.4 7.4 5.4 5.0 3.5 1.9 1.0 1.0 0.4
2016 6.7 9.1 9.4 6.3 5.8 5.7 5.1 3.3 2.9 0.9 1.1 0.7
2017 5.9 6.7 9.5 8.4 7.3 7.2 5.7 4.1 2.2 2.1 0.7 0.9
2018 5.5 5.5 8.8 10.1 6.6 6.6 7.5 2.5 2.1 1.2 1.9 1.0 0.7
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-14
CRYSTAL METHAMPHETAMINE (ICE)  
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Age 18  Ages 
19–20 
Ages    
21–22
Ages    
23–24
Ages    
25–26
Ages    
27–28
Ages    
29–30
Year
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990 1.3 0.3 0.7 0.4 0.3 0.5 0.3
1991 1.4 0.4 0.5 0.4 0.2 * 0.1
1992 1.3 0.3 0.1 0.7 0.8 0.3 0.4
1993 1.7 1.4 1.0 0.9 0.1 0.6 0.3
1994 1.8 1.3 0.4 1.7 0.6 0.3 0.7
1995 2.4 1.1 2.2 0.8 0.2 0.8 0.6
1996 2.8 1.5 0.7 1.4 0.1 0.5 0.2
1997 2.3 0.7 1.5 1.3 0.4 0.3 0.7
1998 3.0 2.0 1.1 1.4 0.6 * *
1999 1.9 1.4 0.6 1.5 0.8 0.4 *
2000 2.2 1.3 1.2 2.3 0.7 0.7 *
2001 2.5 1.9 0.9 0.6 1.1 0.8 0.3
2002 3.0 2.6 1.2 1.6 0.9 0.8 0.7
2003 3.0 2.6 1.2 1.6 0.9 0.8 0.7
2004 2.0 1.7 1.2 1.1 0.9 1.3 0.1
2005 2.3 2.4 1.7 1.0 1.7 1.3 1.7
2006 1.9 1.6 1.7 0.5 0.6 1.0 0.9
2007 1.6 0.9 0.9 1.8 1.2 0.6 0.7
2008 1.1 0.7 0.2 1.4 0.8 0.7 0.3
2009 0.9 0.5 0.5 1.3 0.8 0.7 0.3
2010 0.9 0.7 0.5 0.3 0.7 * 0.1
2011 1.2 0.4 0.5 0.3 0.3 0.9 0.1
2012 0.8 0.7 0.5 0.1 0.6 1.0 0.5
2013 1.1 0.3 0.2 1.2 1.2 1.0 1.2
2014 0.8 0.3 0.3 0.3 0.3 0.2 0.7
2015 0.5 * 0.4 0.4 1.2 0.3 0.6
2016 0.8 * 0.4 * 0.2 * *
2017 0.8 0.5 0.8 0.2 0.8 1.1 0.7
2018 0.6 0.2 0.2 0.6 0.6 0.4 0.2
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not available.
aQuestions about use of crystal methamphetamine were not included in the questionnaires administered 
to the 35-, 40-, 45-, and 50-year-olds.
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FIGURE 5-15
SEDATIVES (BARBITURATES)
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 9.6
1977 9.3
1978 8.1 6.4
1979 7.5 6.9
1980 6.8 4.5 5.7
1981 6.6 4.7 5.8
1982 5.5 4.4 4.1 4.1
1983 5.2 3.5 3.1 3.7
1984 4.9 3.5 2.5 2.6 3.3
1985 4.6 2.0 2.3 3.0 3.4
1986 4.2 2.2 2.9 2.3 1.8 2.4
1987 3.6 1.9 2.7 1.5 2.1 2.3
1988 3.2 2.2 1.9 2.1 1.7 1.2 2.1
1989 3.3 1.6 1.8 1.8 1.3 1.7 1.4
1990 3.4 1.7 1.7 2.3 2.2 1.8 1.6
1991 3.4 1.8 1.4 2.0 2.5 1.4 1.6
1992 2.8 1.7 1.8 1.7 1.5 1.4 2.0                                                          
1993 3.4 1.9 1.6 1.7 1.8 2.3 1.1
1994 4.1 2.3 2.2 1.7 1.1 1.6 1.4 1.9
1995 4.7 3.4 2.6 1.4 1.2 1.4 1.7 1.7
1996 4.9 3.3 2.4 2.2 1.0 1.7 1.6 1.6
1997 5.1 4.0 3.5 1.5 1.5 1.0 1.8 1.3
1998 5.5 3.8 3.1 2.4 1.7 1.5 1.0 1.1 0.9
1999 5.8 5.0 2.5 3.2 1.8 1.1 1.2 1.6 1.5
2000 6.2 4.9 3.9 4.3 2.2 1.4 0.9 0.9 1.6
2001 5.7 5.2 4.8 3.4 2.7 2.1 1.3 1.8 1.4
2002 6.7 5.8 3.8 4.4 2.9 2.3 1.7 1.4 1.0
2003 6.0 5.2 4.8 3.9 2.5 3.1 1.5 1.3 0.7 1.0
2004 6.5 6.0 4.4 5.0 3.3 2.8 1.9 1.2 1.0 1.0
2005 7.2 5.1 5.0 3.8 4.0 2.8 4.4 1.4 1.3 1.4
2006 6.6 4.3 4.8 4.7 3.3 2.3 3.7 1.0 1.2 1.5
2007 6.2 4.4 4.1 4.6 3.8 4.0 3.2 3.8 2.4 2.5
2008 5.8 5.4 4.9 5.0 4.0 4.1 2.9 3.5 3.7 3.5 3.2
2009 5.2 3.5 5.6 2.9 4.1 2.6 2.9 3.1 2.9 2.7 3.0
2010 4.8 3.0 3.8 3.5 2.6 3.5 2.5 3.0 1.9 3.2 3.0
2011 4.3 2.9 2.8 3.5 4.1 2.7 2.2 4.1 2.2 2.0 2.5
2012 4.5 2.6 2.8 3.1 1.9 2.9 2.2 3.1 2.8 2.3 2.3
2013 4.8 3.1 3.6 3.6 4.2 2.7 2.6 2.6 2.7 2.7 1.8 2.2
2014 4.3 3.4 3.9 3.1 2.8 2.6 3.5 3.7 2.6 2.3 2.1 1.6
2015 3.6 2.1 3.5 3.1 2.5 2.3 2.2 2.3 2.2 2.7 3.3 2.7
2016 3.0 2.5 3.1 2.8 2.0 2.9 2.4 2.2 1.9 2.1 1.6 2.5
2017 2.9 2.0 2.1 2.2 2.5 2.3 2.1 3.1 2.1 2.2 2.2 1.6
2018 2.7 2.1 2.2 3.1 2.3 2.8 2.8 2.5 2.3 1.9 2.8 1.9 1.7
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-16
TRANQUILIZERS
Trends in Annual Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 10.3
1977 10.8
1978 9.9 9.4
1979 9.6 9.8
1980 8.7 8.8 9.0
1981 8.0 7.4 7.3
1982 7.0 5.6 7.2 8.6
1983 6.9 5.1 5.8 6.6
1984 6.1 5.4 5.4 5.6 6.7
1985 6.1 4.4 4.5 6.2 7.1
1986 5.8 4.2 5.4 5.2 5.4 6.8
1987 5.5 4.0 5.5 4.1 5.8 6.2
1988 4.8 3.5 4.5 4.2 4.3 4.8 4.6
1989 3.8 3.4 3.5 3.8 2.9 4.6 4.1
1990 3.5 3.0 3.6 3.8 5.0 3.3 3.9
1991 3.6 2.7 3.2 4.0 3.9 3.8 4.2
1992 2.8 2.2 3.8 3.4 4.5 3.4 3.7                                                          
1993 3.5 2.1 3.1 3.2 3.7 3.8 2.7
1994 3.7 1.9 2.9 3.1 3.3 3.6 3.2 3.1
1995 4.4 3.7 3.5 3.0 3.1 3.4 3.5 3.6
1996 4.6 3.5 3.7 3.0 2.4 2.9 3.1 3.6
1997 4.7 4.7 3.6 2.9 1.9 2.0 4.1 3.0
1998 5.5 4.2 4.5 3.7 3.6 2.9 2.4 2.2 3.0
1999 5.8 4.1 4.2 4.2 3.5 2.6 2.1 3.4 2.0
2000 5.7 5.5 5.3 5.3 3.7 3.0 2.7 3.2 3.0
2001 6.9 6.1 7.1 5.4 5.3 3.9 4.2 4.3 3.7
2002 7.7 8.8 7.8 6.4 7.0 4.9 5.0 4.0 4.2
2003 6.7 8.0 7.0 7.2 6.3 5.2 4.3 3.8 2.2 2.9
2004 7.3 8.0 8.1 8.3 6.8 5.6 4.8 3.6 3.5 3.1
2005 6.8 6.5 8.5 6.3 7.7 4.3 7.4 4.4 3.8 2.9
2006 6.6 6.1 7.6 6.8 5.6 6.2 6.6 4.0 3.5 4.0
2007 6.2 5.7 7.6 7.5 7.4 7.6 5.0 3.5 4.5 3.9
2008 6.2 7.1 6.3 8.1 6.7 5.7 6.5 5.6 3.1 3.8 4.2
2009 6.3 4.3 7.7 7.1 7.4 5.7 7.2 5.0 4.1 2.5 2.9
2010 5.6 5.2 6.6 7.2 7.2 5.2 6.4 4.4 3.7 4.3 3.8
2011 5.6 5.3 5.2 6.6 7.2 5.2 5.1 6.2 3.0 3.8 2.7
2012 5.3 4.8 4.3 5.9 5.1 6.6 4.1 3.1 3.3 4.6 4.3
2013 4.6 4.8 4.8 6.8 4.6 6.1 5.5 4.7 3.8 3.3 4.1 2.6
2014 4.7 5.0 3.8 3.8 6.0 5.1 5.7 6.4 3.9 2.9 3.5 2.7
2015 4.7 4.7 4.9 5.6 5.2 4.8 6.1 5.6 4.0 3.8 3.1 3.9
2016 4.9 4.2 7.0 4.9 3.6 5.1 5.0 3.9 3.6 3.9 3.7 2.9
2017 4.7 3.8 4.2 4.9 5.4 5.0 4.6 4.5 4.0 1.9 3.9 3.3
2018 3.9 3.5 3.9 4.7 3.9 4.0 5.1 4.9 3.1 4.1 3.8 3.1 2.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-17
STEROIDS
Trends in Annual Prevalence  
among Respondents of Modal Ages 18 through 30, a by Age Group
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Age 18  Ages 
19–20 
Ages    
21–22
Ages    
23–24
Ages    
25–26
Ages    
27–28
Ages    
29–30
Year
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989 1.9
1990 1.7
1991 1.4 0.4 0.3 0.4 0.5 0.8 0.4
1992 1.1 0.5 0.1 0.7 0.4 * 0.2
1993 1.2 * 0.9 0.4 * 0.2 *
1994 1.3 0.5 0.6 * 0.2 0.5 *
1995 1.5 0.4 0.6 0.8 0.2 * *
1996 1.4 0.3 0.1 0.3 1.0 * *
1997 1.4 0.6 0.2 0.9 0.5 0.2 *
1998 1.7 0.8 0.2 0.2 0.3 0.4 *
1999 1.8 0.5 1.1 0.1 1.0 0.1 *
2000 1.7 0.1 0.4 0.3 0.2 0.9 *
2001 2.4 0.4 0.9 * * 0.6 0.3
2002 2.5 1.0 0.3 0.4 0.3 * 1.1
2003 2.1 0.5 0.8 0.2 0.5 0.3 1.1
2004 2.5 0.8 0.2 0.5 0.5 0.3 *
2005 1.5 0.6 0.4 0.6 0.6 0.3 *
2006 1.8 0.4 1.0 * * 0.1 *
2007 1.4 0.6 1.0 0.3 0.5 1.0 *
2008 1.5 0.9 0.1 0.3 0.3 0.3 0.3
2009 1.5 1.0 0.4 1.3 * 0.6 0.3
2010 1.5 0.4 1.9 0.3 0.6 0.7 *
2011 1.2 * 0.3 * 0.2 0.3 0.1
2012 1.3 0.3 0.5 0.9 0.1 0.1 0.8
2013 1.5 0.7 0.3 0.6 0.4 0.5 *
2014 1.5 0.9 0.5 0.3 1.2 0.5 0.3
2015 1.7 0.3 0.4 0.5 1.1 * *
2016 1.0 0.5 0.4 0.8 0.2 0.1 *
2017 1.1 1.0 0.2 0.4 * * *
2018 1.1 * 0.4 0.8 0.4 0.6 0.6
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' * ' indicates a percentage of less than 0.05%. ' — ' indicates data not availa  
aQuestions about the use of steroids were not included in the questionnaires administered to the 35-, 
40-, 45-, and 50-year-olds.
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FIGURE 5-18a
ALCOHOL
Trends in Annual Prevalence   
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 85.7
1977 87.0
1978 87.7 89.8
1979 88.1 90.6
1980 87.9 89.0 90.2
1981 87.0 90.6 91.6
1982 86.8 88.6 91.8 90.0
1983 87.3 88.5 91.8 91.7
1984 86.0 88.7 89.1 90.4 88.2
1985 85.6 88.5 89.8 91.6 89.9
1986 84.5 88.2 90.1 88.1 88.8 87.8
1987 85.7 88.2 90.8 89.7 90.5 87.8
1988 85.3 86.6 89.5 89.7 89.4 87.7 87.2
1989 82.7 87.5 89.1 88.7 87.5 88.0 86.0
1990 80.6 85.6 89.6 88.2 87.5 86.4 86.9
1991 77.7 84.6 89.0 88.1 87.7 85.3 85.0
1992 76.8 81.9 87.9 89.1 86.7 85.6 84.5                                                          
1993 76.0 80.6 85.9 87.8 87.8 85.7 83.2
1994 73.0 78.2 84.4 86.6 86.0 84.5 82.6 82.5
1995 73.7 78.3 85.7 87.8 86.7 85.7 83.3 82.1
1996 72.5 79.6 84.4 85.7 85.9 85.3 84.7 83.5
1997 74.8 79.2 85.1 85.4 86.4 85.9 83.7 82.3
1998 74.3 79.7 86.3 84.9 83.8 85.3 84.2 82.3 77.3
1999 73.8 79.6 85.5 85.2 85.0 85.4 85.4 81.0 80.0
2000 73.2 79.7 86.2 87.2 84.2 82.9 83.7 81.0 80.3
2001 73.3 77.6 87.0 86.7 86.3 84.2 84.3 82.7 81.5
2002 71.5 78.0 85.8 88.0 88.3 84.7 83.6 85.1 80.0
2003 70.1 75.0 84.3 87.6 86.4 83.6 83.9 82.6 81.6 78.9
2004 70.6 75.2 86.8 87.2 87.9 86.1 83.5 86.7 79.8 79.2
2005 68.6 77.3 84.4 86.6 85.6 85.3 84.8 85.8 81.6 80.3
2006 66.5 77.9 83.6 88.2 86.4 86.9 84.0 83.7 80.5 82.8
2007 66.4 72.9 87.8 87.8 86.1 85.8 85.9 84.0 85.2 80.7
2008 65.5 72.3 88.6 86.6 86.4 84.7 87.8 84.3 82.0 80.3 79.0
2009 66.2 71.4 85.2 89.3 88.2 87.2 84.8 83.5 86.6 81.3 79.7
2010 65.2 68.8 83.4 89.2 86.7 86.6 86.7 85.0 86.1 81.1 80.3
2011 63.5 71.5 82.1 88.3 90.6 86.4 85.1 89.0 84.4 80.6 82.1
2012 63.5 70.3 81.8 85.0 89.4 86.7 84.2 87.2 83.0 84.4 80.2
2013 62.0 68.4 82.8 84.7 87.9 89.6 86.6 86.7 83.5 81.5 79.7 76.9
2014 60.2 67.3 84.0 85.3 85.5 90.2 86.4 89.2 84.1 84.8 83.3 77.9
2015 58.2 67.9 84.3 85.0 83.7 85.8 88.4 85.9 81.9 85.3 80.6 78.4
2016 55.6 67.6 86.5 85.0 84.4 85.2 90.8 87.3 85.7 83.0 81.5 80.5
2017 55.7 63.9 83.8 87.6 84.3 84.4 85.7 87.9 83.5 84.6 83.2 81.2
2018 53.3 63.0 83.5 89.7 86.8 85.7 86.1 87.0 86.4 84.2 79.9 80.8 77.5
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-18b
ALCOHOL
Trends in 30-Day Prevalence
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 68.3
1977 71.2
1978 72.1 75.8
1979 71.8 76.5
1980 72.0 76.6 78.3
1981 70.7 77.0 80.5
1982 69.7 75.7 79.9 77.9
1983 69.4 73.9 79.3 78.9
1984 67.2 73.6 78.1 77.6 75.2
1985 65.9 73.3 75.9 79.7 76.8
1986 65.3 72.9 77.2 75.7 76.3 73.6
1987 66.4 72.5 77.2 74.9 77.7 75.0
1988 63.9 69.6 76.2 75.9 74.1 74.6 72.1
1989 60.0 69.8 73.8 72.2 72.5 73.9 72.3
1990 57.1 66.6 74.1 73.6 71.4 70.9 70.2
1991 54.0 64.5 75.3 72.4 71.6 69.8 69.6
1992 51.3 61.0 72.7 73.0 69.8 69.1 69.2                                                          
1993 51.0 60.5 71.6 73.1 69.9 68.3 66.2
1994 50.1 59.9 70.4 70.1 70.4 69.9 67.0 65.1
1995 51.3 59.2 70.4 72.3 71.8 68.0 67.0 66.8
1996 50.8 58.1 69.5 69.2 68.5 69.3 68.0 64.7
1997 52.7 59.0 69.1 69.3 70.9 70.4 65.8 65.3
1998 52.0 59.7 69.4 70.3 66.3 68.7 66.1 62.9 59.8
1999 51.0 62.0 69.2 70.2 70.0 70.2 67.4 64.2 64.2
2000 50.0 59.1 70.5 71.5 68.7 64.6 65.2 64.0 63.1
2001 49.8 59.0 71.8 70.6 68.7 66.5 66.2 63.7 65.6
2002 48.6 59.2 71.9 71.9 71.2 67.9 65.4 67.3 65.4
2003 47.5 56.7 69.5 72.7 69.1 67.2 66.5 63.7 66.2 62.2
2004 48.0 56.7 72.4 72.8 72.4 68.8 64.5 70.3 63.7 65.7
2005 47.0 59.0 70.1 71.2 73.0 70.3 65.7 68.5 65.1 65.4
2006 45.3 57.6 69.7 73.8 70.4 72.8 68.7 63.3 62.3 66.7
2007 44.4 54.7 74.5 73.1 73.8 71.9 69.8 67.5 66.9 64.1
2008 43.1 53.8 74.4 74.0 73.9 69.8 73.4 65.0 66.3 67.9 63.7
2009 43.5 52.9 72.9 78.4 75.1 70.7 71.5 65.6 71.0 66.5 64.5
2010 41.2 51.2 71.6 74.6 73.6 72.2 69.1 67.7 72.7 67.0 67.1
2011 40.0 52.3 69.3 75.7 76.4 71.8 69.6 71.1 68.6 65.2 68.3
2012 41.5 54.1 70.5 73.5 76.7 73.4 70.8 69.5 68.0 72.0 65.7
2013 39.2 51.5 70.5 72.7 75.9 73.9 71.1 70.0 69.0 67.2 66.7 61.9
2014 37.4 50.1 71.1 71.0 73.2 77.3 73.2 73.1 67.8 71.6 66.5 64.4
2015 35.3 47.9 70.1 73.1 70.0 74.2 74.7 72.5 68.1 69.7 67.8 65.9
2016 33.2 49.2 73.0 73.9 71.6 72.3 76.1 72.2 69.4 69.1 67.6 68.7
2017 33.2 46.0 72.7 74.1 71.7 68.9 71.5 72.5 71.5 69.7 70.8 66.3
2018 30.2 44.4 68.8 75.1 73.0 69.6 72.1 70.7 72.2 71.2 63.9 66.9 61.1
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-18c
ALCOHOL
Trends in 30-Day Prevalence of Daily Use
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 5.6
1977 6.1
1978 5.7 7.6
1979 6.9 7.7
1980 6.0 7.0 8.4
1981 6.0 7.2 7.7
1982 5.7 7.5 7.8 8.2
1983 5.5 5.3 8.0 8.5
1984 4.8 5.8 7.7 6.8 7.5
1985 5.0 5.6 6.4 7.3 7.5
1986 4.8 5.3 6.3 6.2 5.3 7.3
1987 4.8 5.7 7.0 6.1 6.9 7.2
1988 4.2 4.8 7.2 6.2 6.3 5.7 7.6
1989 4.2 4.7 5.0 5.1 6.0 6.9 5.6
1990 3.7 4.0 4.9 5.3 4.8 4.9 5.6
1991 3.6 3.7 4.9 5.4 4.9 6.2 5.9
1992 3.4 3.3 4.4 4.2 6.1 4.4 5.8                                                          
1993 2.5 3.2 5.1 4.9 5.1 4.7 4.6
1994 2.9 3.3 3.9 3.7 3.3 5.4 5.0 7.2
1995 3.5 3.1 3.5 4.1 4.4 4.7 4.1 5.5
1996 3.7 2.7 5.1 4.8 3.7 3.6 5.1 7.5
1997 3.9 4.8 4.6 4.5 5.1 4.2 5.9 4.8
1998 3.9 3.6 5.7 3.9 3.4 3.1 3.4 6.0 6.9
1999 3.4 4.1 5.9 4.7 5.1 4.3 5.2 5.2 7.5
2000 2.9 3.9 5.3 4.2 3.8 3.5 3.9 5.2 6.5
2001 3.6 3.6 6.2 4.6 5.0 2.7 4.3 5.8 7.5
2002 3.5 3.9 5.6 5.0 5.4 3.7 3.8 4.8 6.6
2003 3.2 3.6 5.7 6.5 4.6 5.1 3.5 3.9 7.8 7.8
2004 2.8 3.7 5.7 5.5 4.3 3.5 3.8 6.3 6.6 9.0
2005 3.1 3.6 6.0 5.8 6.0 4.6 5.8 6.1 7.2 8.5
2006 3.0 4.3 5.9 5.7 5.2 5.8 4.5 5.3 7.0 9.5
2007 3.1 3.4 6.1 6.0 6.5 6.2 5.1 8.1 6.1 8.8
2008 2.8 2.3 5.5 6.3 6.4 6.3 4.8 5.4 7.2 9.9 11.0
2009 2.5 2.5 5.7 6.5 5.9 6.5 7.1 6.9 8.5 9.3 9.2
2010 2.7 1.8 5.4 4.9 5.6 5.7 6.1 6.0 7.8 7.2 10.5
2011 2.1 2.4 6.1 5.2 5.7 7.0 5.3 7.6 7.4 7.7 11.3
2012 2.5 3.0 4.9 6.4 5.9 7.5 7.2 6.3 8.3 9.5 10.6
2013 2.2 2.7 4.9 4.9 6.9 6.5 5.8 6.7 8.7 8.4 10.8 10.5
2014 1.9 2.9 5.6 5.2 5.7 5.8 7.6 8.0 7.3 8.8 9.8 10.0
2015 1.9 1.6 3.9 5.2 5.6 7.5 7.8 9.8 8.6 10.0 9.6 11.2
2016 1.3 2.0 6.0 4.5 6.4 7.5 6.8 7.9 8.5 8.7 9.7 14.5
2017 1.6 1.1 4.4 6.4 5.5 6.9 6.4 8.7 8.0 10.0 10.0 11.1
2018 1.2 1.4 3.5 6.0 5.0 5.5 6.4 8.0 8.0 9.9 10.4 11.1 12.3
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-18d
ALCOHOL
Trends in 2-Week Prevalence of Having 5 or More Drinks in a Row
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 37.1
1977 39.4
1978 40.3 41.1
1979 41.2 42.1
1980 41.2 42.7 40.7
1981 41.4 43.1 43.6
1982 40.5 41.7 41.6 37.1
1983 40.8 40.9 42.3 39.3
1984 38.7 41.0 40.4 35.1 33.7
1985 36.7 41.2 40.4 37.3 33.3
1986 36.8 41.2 40.8 35.8 31.5 30.1   
1987 37.5 37.2 41.0 36.6 33.3 32.2
1988 34.7 37.3 42.0 37.0 30.7 28.0 26.7
1989 33.0 36.9 39.3 35.4 31.7 29.8 26.3
1990 32.2 36.0 38.1 35.5 32.0 28.9 25.2
1991 29.8 37.0 40.3 34.4 31.5 28.8 24.3
1992 27.9 34.0 39.9 34.9 31.8 29.2 25.7                           
1993 27.5 34.6 40.3 35.0 32.1 29.0 25.1
1994 28.2 34.5 40.5 32.9 30.9 28.5 27.5 21.1
1995 29.8 31.7 38.5 35.6 28.7 26.9 26.3 20.0
1996 30.2 32.7 38.2 36.3 30.0 29.7 24.9 21.9
1997 31.3 36.5 40.2 33.4 31.5 29.3 26.5 22.3
1998 31.5 34.5 39.7 35.3 31.3 28.9 26.6 20.4 19.7
1999 30.8 35.3 40.2 38.1 33.0 32.0 26.9 21.4 20.5
2000 30.0 35.3 40.6 37.0 31.5 29.1 24.0 22.2 18.3
2001 29.7 36.3 42.4 38.2 33.7 29.2 27.3 20.6 21.3
2002 28.6 36.0 40.7 39.4 34.9 28.9 25.8 22.9 20.8
2003 27.9 33.6 39.9 39.3 35.1 31.1 26.4 22.4 20.7 20.1
2004 29.2 35.5 41.7 40.4 36.4 31.3 26.9 21.6 20.2 19.2
2005 27.1 36.3 40.4 39.2 37.7 31.5 29.1 23.0 22.2 19.6
2006 25.4 33.9 42.2 43.2 36.0 32.5 29.1 22.5 20.0 19.8
2007 25.9 31.4 45.8 39.8 38.3 33.4 28.4 23.6 20.4 19.4
2008 24.6 30.7 42.1 42.2 40.0 35.0 31.9 24.4 21.9 20.9 20.0
2009 25.2 28.1 41.2 41.7 39.5 34.2 32.1 21.8 25.1 21.8 17.9
2010 23.2 28.2 39.3 40.1 36.6 35.6 32.6 23.0 21.6 22.1 17.8
2011 21.6 29.8 39.2 39.9 38.7 35.0 30.4 25.7 22.2 20.0 19.1
2012 23.7 29.5 39.1 37.5 36.3 35.1 32.8 24.3 22.2 21.0 19.0
2013 22.1 27.2 40.2 37.7 37.0 33.6 30.9 24.4 24.3 20.1 20.3 17.0
2014 19.4 28.2 38.4 33.6 32.2 35.5 31.0 24.0 22.3 23.4 21.9 17.7
2015 17.2 23.7 34.8 35.0 34.8 31.6 27.7 29.2 20.3 20.5 22.0 18.9
2016 15.5 23.1 38.2 34.7 34.7 30.3 29.8 25.3 22.6 24.2 21.7 19.1
2017 16.6 22.1 39.8 31.2 33.8 31.4 28.7 27.5 24.5 23.2 19.8 16.9
2018 13.8 20.5 34.3 37.0 33.5 31.4 30.6 27.3 23.0 24.1 19.3 18.7 16.0
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-19a
CIGARETTES
Trends in 30-Day Prevalence  
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 38.8
1977 38.4
1978 36.7 39.3
1979 34.4 39.3
1980 30.5 36.0 37.9
1981 29.4 34.9 37.5
1982 30.0 32.1 36.2 36.7
1983 30.3 32.5 33.5 36.5
1984 29.3 31.5 32.2 33.6 33.7
1985 30.1 30.9 32.4 31.9 35.3
1986 29.6 30.0 32.0 29.9 31.3 32.5
1987 29.4 30.1 32.4 31.7 28.2 32.3
1988 28.7 28.4 29.8 29.9 27.3 29.1 28.9
1989 28.6 27.7 29.4 29.4 29.5 27.2 30.2
1990 29.4 27.2 28.6 27.8 28.4 26.5 27.8
1991 28.3 27.6 28.3 28.5 28.3 28.2 24.4
1992 27.8 29.5 29.0 28.4 26.3 27.8 23.8                                                          
1993 29.9 29.0 29.2 28.1 27.7 25.4 25.8
1994 31.2 31.3 28.8 27.0 26.4 25.0 25.5 24.8
1995 33.5 33.4 31.8 28.0 25.7 26.8 25.2 26.1
1996 34.0 34.0 32.3 30.1 26.8 26.0 23.4 25.4
1997 36.5 34.0 32.3 29.1 27.6 24.9 24.6 22.3
1998 35.1 33.9 33.7 30.9 29.9 25.6 23.1 23.6 24.3
1999 34.6 36.1 33.4 32.4 25.6 22.9 22.7 22.6 23.5
2000 31.4 32.2 33.6 29.5 28.2 26.5 21.2 24.0 23.5
2001 29.5 32.8 34.0 31.1 28.6 24.2 20.4 20.4 22.9
2002 26.7 29.8 32.6 31.9 27.3 24.7 24.4 21.9 18.9
2003 24.4 27.0 30.5 31.0 27.0 26.3 22.0 20.1 21.9 20.7
2004 25.0 27.9 31.3 31.5 29.6 25.9 21.9 20.0 20.0 20.2
2005 23.2 27.5 29.2 29.3 30.7 26.3 23.5 19.1 21.4 22.1
2006 21.6 24.6 27.3 28.1 29.1 26.3 24.4 17.7 17.3 18.9
2007 21.6 22.6 27.8 26.7 27.5 26.6 22.9 17.8 18.3 17.6
2008 20.4 21.8 24.5 26.5 24.5 25.7 24.0 20.4 17.8 17.3 18.8
2009 20.1 21.2 25.2 24.1 22.6 23.9 24.0 17.3 16.2 17.8 17.0
2010 19.2 19.6 22.8 23.0 24.3 22.5 23.9 18.3 15.2 18.3 19.9
2011 18.7 18.5 23.3 22.0 23.4 19.6 20.5 19.7 15.1 15.3 16.0
2012 17.1 16.8 18.9 20.4 20.7 22.0 18.6 18.0 12.8 15.9 15.4
2013 16.3 18.4 20.8 21.4 19.5 20.0 16.5 17.8 16.6 13.4 15.3 14.0
2014 13.6 15.8 18.9 18.3 16.3 18.1 19.0 18.0 13.5 15.4 14.5 14.6
2015 11.4 14.8 17.0 18.1 18.0 15.2 15.5 18.4 13.8 10.3 16.7 15.3
2016 10.5 9.2 15.5 14.9 15.4 15.6 14.8 16.1 13.5 12.1 13.7 13.2
2017 9.7 9.6 17.3 16.9 17.6 14.8 12.0 15.1 14.3 10.3 12.9 12.9
2018 7.6 10.5 10.9 14.7 13.0 12.4 14.6 13.0 12.9 12.9 11.1 13.8 13.4
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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FIGURE 5-19b
CIGARETTES
Trends in 30-Day Prevalence of Daily Use 
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 28.8
1977 28.8
1978 27.5 31.0
1979 25.4 31.2
1980 21.3 29.3 31.1
1981 20.3 26.0 31.4
1982 21.1 23.9 28.6 30.1
1983 21.2 24.4 26.0 30.6
1984 18.7 24.1 25.3 27.8 28.7
1985 19.5 23.2 25.3 25.1 30.4
1986 18.7 21.9 24.4 25.2 27.3 27.6
1987 18.7 22.5 24.2 26.0 23.7 27.9
1988 18.1 19.5 22.3 24.0 22.9 25.0 25.4
1989 18.9 18.9 22.5 23.3 25.0 22.9 26.4
1990 19.1 19.2 20.2 22.2 23.3 22.2 24.2
1991 18.5 19.4 20.6 22.5 22.8 23.9 21.0
1992 17.2 20.5 21.2 20.9 20.3 21.8 20.3                                                          
1993 19.0 21.1 20.5 20.1 21.9 20.1 21.7
1994 19.4 21.9 21.1 19.9 19.8 20.5 20.9 22.5
1995 21.6 22.2 24.0 20.0 19.2 20.9 20.1 23.0
1996 22.2 22.5 22.8 22.8 21.1 19.4 18.6 22.1
1997 24.6 22.7 21.4 21.5 19.2 17.6 19.7 18.3
1998 22.4 23.8 22.8 21.2 21.9 19.5 17.2 20.4 21.7
1999 23.1 25.6 24.2 21.4 19.6 16.0 17.2 19.7 20.9
2000 20.6 22.7 25.1 21.2 20.1 19.7 15.8 20.1 20.8
2001 19.0 21.9 23.6 22.4 20.9 17.2 14.4 16.4 20.1
2002 16.9 20.6 23.9 23.5 19.8 18.1 17.4 18.2 16.7
2003 15.8 18.8 20.8 21.5 20.4 19.8 16.4 16.3 19.0 19.0
2004 15.6 18.2 21.5 23.3 22.7 18.2 16.7 14.8 16.6 17.8
2005 13.6 17.6 19.2 20.4 22.5 18.6 18.9 14.5 18.5 20.1
2006 12.2 14.4 17.7 19.5 22.0 20.2 18.3 13.5 14.6 16.7
2007 12.3 12.9 18.3 17.5 19.2 19.3 16.8 13.9 15.8 15.4
2008 11.4 14.3 16.1 17.9 17.4 18.3 17.4 16.5 14.7 14.6 16.8
2009 11.2 12.8 14.9 16.2 15.3 16.5 16.7 13.7 12.7 15.6 15.4
2010 10.7 11.1 15.5 15.3 16.2 16.2 17.3 14.3 12.3 16.4 18.0
2011 10.3 10.2 15.0 13.7 17.0 13.4 14.8 15.7 11.8 13.6 14.2
2012 9.3 9.5 11.5 13.1 14.1 16.0 14.3 13.4 10.5 13.8 13.5
2013 8.5 10.8 12.0 13.1 10.9 13.8 11.3 12.4 13.5 11.0 13.2 13.2
2014 6.7 8.1 10.8 11.1 11.6 12.1 13.5 13.4 9.7 12.0 13.0 12.9
2015 5.5 6.8 10.0 11.0 11.4 9.1 11.3 13.5 11.6 8.5 14.2 13.4
2016 4.8 3.5 8.3 8.6 9.7 10.4 10.9 11.3 9.9 9.9 11.3 11.6
2017 4.2 4.8 8.7 9.6 9.4 10.9 7.4 11.4 11.4 8.3 11.4 11.2
2018 3.6 5.9 4.4 8.2 7.6 8.9 10.3 9.5 9.9 10.3 9.2 12.2 12.4
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
FIGURE 5-19b (cont.)
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FIGURE 5-19c
CIGARETTES
Trends in 30-Day Prevalence of Smoking a Half Pack or More per Day
among Respondents of Modal Ages 18 through 60, by Age Group
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Age 18
 Ages 
19–20 
Ages 
21–22
Ages 
23–24
Ages 
25–26
Ages 
27–28
Ages 
29–30
Age 35 Age 40 Age 45 Age 50 Age 55 Age 60
Year
1976 19.2
1977 19.4
1978 18.8 23.8
1979 16.5 24.6
1980 14.3 21.9 25.2
1981 13.5 19.3 25.3
1982 14.2 18.0 23.0 24.6
1983 13.8 17.2 19.7 25.1
1984 12.3 17.2 21.2 22.8 24.1
1985 12.5 16.6 20.4 20.8 24.8
1986 11.4 16.2 19.3 21.1 22.0 23.2
1987 11.4 15.6 19.3 21.6 19.9 23.3
1988 10.6 13.8 17.3 18.4 18.6 20.6 22.3
1989 11.2 13.0 16.4 18.6 20.6 19.0 22.0
1990 11.3 14.3 15.0 17.4 19.6 18.2 20.5
1991 10.7 12.7 14.1 17.4 18.2 19.0 16.7
1992 10.0 14.5 15.1 15.5 15.8 17.9 17.0                                                          
1993 10.9 14.5 14.5 15.2 17.4 16.3 17.9
1994 11.2 15.0 15.6 15.0 15.0 15.9 16.8 19.1
1995 12.4 15.2 18.1 15.3 14.2 16.3 16.5 19.1
1996 13.0 14.7 15.7 16.1 15.0 14.8 15.2 18.5
1997 14.3 15.4 14.7 16.4 13.2 12.8 15.9 15.4
1998 12.6 16.9 16.2 14.5 15.5 14.8 12.2 16.3 18.7
1999 13.2 16.3 16.4 14.8 15.0 12.4 13.2 17.3 17.2
2000 11.3 14.6 17.2 14.1 14.8 14.7 12.5 15.7 17.2
2001 10.3 13.9 15.9 15.8 15.1 12.6 11.4 13.4 15.9
2002 9.1 12.8 14.4 15.9 14.1 13.9 14.0 13.0 13.6
2003 8.4 11.7 13.8 15.4 14.0 14.8 12.7 12.4 14.9 16.8
2004 8.0 11.6 12.7 15.2 15.6 12.8 12.5 10.9 14.2 15.4
2005 6.9 10.1 12.1 13.9 13.6 13.1 14.1 11.3 16.0 16.4
2006 5.9 8.8 10.9 12.8 14.0 13.6 13.5 10.7 12.2 14.2
2007 5.7 7.5 10.7 10.6 14.3 13.0 12.6 10.5 12.1 12.3
2008 5.4 7.3 9.8 11.5 10.9 12.0 12.3 12.4 11.6 12.2 13.9
2009 5.0 7.4 9.1 8.6 10.3 11.8 10.5 11.1 8.5 13.0 12.2
2010 4.7 6.7 9.3 9.6 11.3 10.1 10.7 10.8 9.1 13.3 14.4
2011 4.3 4.5 7.9 8.2 9.7 7.6 9.2 10.8 8.7 11.0 11.1
2012 4.0 4.6 7.3 8.2 7.7 10.4 7.8 10.8 7.7 10.6 11.2
2013 3.4 5.4 6.5 8.1 6.4 8.5 7.1 8.9 10.2 8.7 10.3 11.1
2014 2.6 4.3 6.4 7.1 7.5 7.5 8.0 8.7 7.0 9.1 10.5 10.8
2015 2.1 3.6 5.1 7.0 6.6 6.2 7.7 9.1 9.2 6.4 11.4 11.2
2016 1.8 1.8 4.4 5.4 5.7 6.8 6.9 8.3 7.4 7.7 8.9 9.0
2017 1.7 2.7 3.8 5.9 4.8 5.8 4.1 6.2 7.8 5.8 8.9 8.9
2018 1.5 2.3 2.3 4.3 4.2 5.7 5.7 6.2 6.7 7.3 6.4 9.3 9.7
Source. The Monitoring the Future study, the University of Michigan.
Notes. ' — ' indicates data not available.  
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Chapter 6 
 
ATTITUDES AND BELIEFS ABOUT DRUGS 
AMONG YOUNG ADULTS 
 
One of the most important theoretical contributions of MTF has been to demonstrate the extent to 
which attitudes and beliefs about drugs can help explain the use of drugs. Earlier volumes in this 
monograph series, as well as other publications from the study, have demonstrated that shifts in 
certain attitudes and beliefs—in particular the degree of risk of harm perceived to be associated 
with use of a particular drug—are important in explaining changes in actual drug-using behavior. 
Indeed, on a number of occasions in these volumes and elsewhere we have accurately predicted 
such changes in use by using perceived risk as a leading indicator of use.1 In this chapter, we 
review trends in these attitudes and beliefs held by young adults since 1980. 
 
PERCEIVED HARMFULNESS OF DRUGS 
Figures 6-1 through 6-32 present three separate trend lines for four-year age strata: Respondents 
who are one to four years beyond high school (modal ages 19-22), five to eight years beyond high 
school (modal ages 23-26), and nine to twelve years beyond high school (modal ages 27-30). For 
comparison purposes, data are also included for the high school senior classes, listed as modal age 
18. Figures 6-1 to 6-3 present trends in the percentages of young adults aged 18 to 30 who perceive 
a “great risk” of harm (physically or in other ways) associated with three different levels of 
marijuana use—trying it once or twice (experimental), using it occasionally, and using it 
regularly.2 Subsequent figures do the same for selected levels of use of various other licit and illicit 
drugs. Table 6-1 provides the tabular information underlying the figures.  
 
For most of the life of the study, these questions were contained in one questionnaire form only, 
limiting the numbers of follow-up cases. Accordingly, we have used the four-year age bands to 
increase the available sample sizes to about 250-600 weighted cases per year for each age band, 
thereby improving the reliability of the estimates. (The numbers of weighted cases are given at the 
end of Table 6-1. The actual numbers of respondents are somewhat larger.) Still, these are 
relatively small sample sizes for young adults compared to those available regarding attitudes for 
8th, 10th, and 12th graders, and thus the change estimates are relatively less stable.  
 
Beginning with 2012 we expanded the numbers of forms from which these data are drawn; this 
increased the sample sizes from that point forward, thus improving the reliability of both the point 
estimates and the trend estimates. Because the questions are contained in different numbers of 
                                                 
1 See also: Bachman, J. G., Johnston, L. D., O’Malley, P. M., & Humphrey, R. H. (1988). Explaining the recent decline in marijuana use: 
Differentiating the effects of perceived risks, disapproval, and general lifestyle factors. Journal of Health and Social Behavior, 29, 92–112; 
Bachman, J. G., Johnston, L. D., & O’Malley, P. M. (1990). Explaining the recent decline in cocaine use among young adults: Further evidence 
that perceived risks and disapproval lead to reduced drug use. Journal of Health and Social Behavior, 31, 173–184; Bachman, J. G., Johnston, L. 
D., & O’Malley, P. M. (1998). Explaining recent increases in students’ marijuana use: Impacts of perceived risks and disapproval, 1976 through 
1996. American Journal of Public Health, 88, 887–892; Johnston, L. D. (1981). Characteristics of the daily marijuana user. In R. de Silva, R. L. 
DuPont, & G. K. Russell (Eds.), Treating the marijuana-dependent person (pp. 12–15). New York: The American Council on Marijuana; Johnston, 
L. D. (1985). The etiology and prevention of substance use: What can we learn from recent historical changes? In C. L. Jones & R. J. Battjes (Eds.), 
Etiology of drug abuse: Implications for prevention (NIDA Research Monograph No. 56, DHHS Publication No. ADM 85 1335, pp. 155–177). 
Rockville, MD: National Institute on Drug Abuse; Keyes, K. M., Schulenberg, J. E., O’Malley, P. M., Johnston, L. D., Bachman, J. G., Li, G., & 
Hasin, D. (2011).The social norms of birth cohorts and adolescent marijuana use in the United States, 1976-2007. Addiction, 106(10), 1790-1800. 
2 Beginning in 2018, the wording of this question was changed such that “smoke marijuana” was changed to “use marijuana.” 
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forms for the different drugs, the sample sizes vary between drugs, as is noted in the tables. For 
each question, we include data from all available forms.  
 
Because of the nature of the MTF design, trend data are available for a longer period for 19-22 
year olds (since 1980) than for 23-26 year olds (since 1984) or 27-30 year olds (since 1988). Also 
displayed in Table 6-1 are comparison data for 12th graders, shown here as 18 year olds, from 1980 
onward. (See also Table 8-3 in Volume I for the longer-term trends in 12th graders’ levels of 
perceived risk.) Questions about these attitudes and beliefs are not included in the questionnaires 
for respondents over age 30 due to the length limitations imposed by using a single questionnaire 
form for respondents ages 35 and older.  
 
As noted earlier in this volume, for 2018 data collections of 19-30 year olds, MTF randomly 
assigned half to receive the typical mail survey protocol and half to be pushed to web-based 
surveys (see Chapter 3). In comparing the attitudes between the two conditions, there were very 
few significant differences (about 3% of the over 500 comparisons) and thus we combined 
estimates as a weighted average for 2018. Exceptions (i.e., when there are significant differences 
between the two conditions) are noted in Tables 6-1 and 6-2.  
 
 Table 6-1 and Figures 6-1 to 6-32 illustrate considerable differences in the degree of risk 
of harm young adults have associated with various drugs. In general, the results closely 
have paralleled the distinctions in degree of risk across various drugs made by 12th graders.  
 
 Marijuana was seen as the least risky of the illicit drugs, although sharp distinctions were 
made between different levels of marijuana use (Table 6-1, Figures 6-1 through 6-3). In 
2018, experimental use of marijuana (i.e., trying it once or twice) was perceived as being 
of great risk by only 6% to 8% of all high school graduates ages 19-30, whereas regular 
use was perceived to carry great risk by a considerably higher percentage (21-25%). Since 
2006, there have been very substantial declines in perceived risk of regular marijuana use; 
in 2006, 55-58% of all four age groups saw great risk, and by 2018, 21-25% did so. These 
substantial declines suggest a possible period effect that has affected all age groups, 
indicative of a wide-ranging cultural change towards marijuana use. This change likely 
instigated and was further reinforced by increasing discussion about marijuana and the 
enactment of legislation at the state level liberalizing marijuana laws, including for medical 
use and for recreational use by adults. While actual law changes are specific to individual 
states, the discussions are prominent nationwide, and we believe have a direct effect on 
perceived risk across the nation. Levels of perceived risk of regular marijuana use in 2017 
and 2018 were the lowest observed since each of the young adult age groups was included 
in the study, going back to 1980 in the case of 19-22 year olds. In 2018, the level 
significantly declined 5.2 percentage points to 22.1% for the 19-22 year olds; it declined 
nonsignificantly 2.2 percentage points to 21.1% for 23-26 year olds; for 27-30 year olds, it 
was level at 24.8%. And likely not coincidentally, prevalence of daily marijuana use in 
2018 was at a new high among young adults at 8.0% (as discussed in Chapter 5). 
 
 In the mid-1980s and early 1990s, fewer of the older age groups attached great risk to 
regular use of marijuana than did the younger respondents (Figure 6-3). Indeed, there was 
a regular negative ordinal relationship between age and perceived risk for some years after 
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1980, when the first such comparisons were available. Although at first this looked like an 
age effect, the MTF design allowed us to recognize it as a cohort effect; the younger cohorts 
initially perceived marijuana as more dangerous than the older cohorts did and persisted in 
such beliefs as they grew older. Newer cohorts, however, showed lower levels of perceived 
risk that they then carried up the age spectrum. As a result, in the past few years, age 
differences have been slight. 
The decline in perceived risk in regular use that began in the 1990s was greater in the 
younger age bands, including grades 8 and 10, and least among the 27-30 year olds. We 
believe that much of the eventual decline in perceived risk in the older age bands resulted 
directly from replacement of earlier cohorts by later, less concerned ones. The credibility 
of this view is strengthened by the 1993-1995 reversal of the relationship between age and 
perceived risk of regular use. This reversal is consistent with an underlying cohort effect 
and could not simply reflect an association between age and a regular change in these 
attitudes. The decline in perceived risk of regular marijuana use ended in a somewhat 
staggered fashion—among 12th graders in 1999, among 19-22 year olds in 2001, among 
23-26 year olds in 2002, and among 27-30 year olds in 2004. This was also indicative of a
cohort effect playing out in these attitudes. In 2007 all four age strata showed declines of
three to four percentage points in perceived risk of regular marijuana use; although no one
of these declines was statistically significant taken alone, the consistency across all four
groups suggests that the shift was real. Since then the declines have continued, though
somewhat erratically; but all four age groups showed substantial declines between 2006
and 2018 in perceived risk of regular marijuana use, suggesting a possible period effect.
Indeed, the age bands 18, 23-26, and 27-30 all showed significant one-year declines in
perceived risk of regular marijuana use from 2014 to 2015, with continuing (but
nonsignificant) declines for all age groups in 2016, and continuing significant declines in
the older two age groups and nonsignificant declines in the two younger age groups in
2017. In 2018, as mentioned above, there was a significant decline in the 19-22 age group,
a nonsignificant decline for the 23-26 age group, and essentially no change for the 27-30
age group. Thus, for the two younger age groups, the 2018 levels are at all-time lows, with
the level remaining at an all-time low from 2017 for the oldest age group.
 Young adults (ages 19-30) viewed experimental use of any of the other illicit drugs as
distinctly riskier than the experimental use of marijuana (which was at 6% to 8% in 2018).
About 30-37% of young adults thought trying sedatives (barbiturates) involved great risk;
the corresponding figures were 33-34% for amphetamines, 34-39% for LSD, 52-54% for
narcotics other than heroin, 44-47% for MDMA (ecstasy and Molly), 45-49% for cocaine
powder, and 73-78% for heroin. Note that two classes of prescription drugs, sedatives and
amphetamines, have among the lowest levels of perceived risk among this set. (Perceived
risk of tranquilizers is not asked, but likely would rank low as well.)
 Items about perceived risk of synthetic marijuana use were added to the questionnaires in
2012 (Figures 6-4 and 6-5). These drugs are sold over the counter in small packets
containing plant material that has been sprayed with any number of chemicals with
chemical structures similar to cannabinoids. The percent seeing great risk in trying
synthetic marijuana in the three young adult age bands were 29-31% in 2012 and 40-46%
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in 2018, reflecting a clear increase in perceived risk in all four age groups over that interval. 
Following increases of 3 to 8 percentage points in perceived risk for all three young adult 
age groups between 2015 and 2016, it leveled or changed nonsignificantly for each of these 
age groups between 2016 and 2018; thus, 2018 levels of perceived risk are at or near their 
highest for all three since 2012. Correspondingly, as discussed in Chapter 5, use of 
synthetic marijuana has fallen precipitously since 2012 as perceived risk has risen. 
 Perceived risk of experimental use of LSD continued a nonsignificant decline in 2018 for
all four age groups, except for the 23-26 age group, which showed a nonsignificant
increase; proportions seeing great risk of harm in experimental use were 29%, 34%, 36%,
and 39%, respectively. The older age groups have been more likely to see LSD as
dangerous (Figures 6-6 and 6-7). These age distinctions became sharper through about
2001 for experimental use, as perceived risk declined more in the younger age groups,
indicating some important cohort changes in these attitudes, quite likely as a result of
generational forgetting of the dangers of LSD. Generational forgetting is a phenomenon
wherein younger replacement cohorts no longer carried the beliefs—nor had the direct or
vicarious experience upon which those beliefs were based—that the older cohorts had at
that age. (The implications of generational forgetting for prevention are discussed in the
last section of this chapter.) The distinctions continued to grow for regular use of LSD
through 2015 as perceived risk at age 18 continued a long-term uneven decline. From 2015
through 2018, perceived risk started to decline for the older age group too, reducing the
age gap in perceived risk.
 Perceived risk of experimenting with MDMA (ecstasy and, more recently, Molly) increased
nonsignificantly in 2018 for 19-22 and 23-26 year olds, to 45% and 44%, respectively; it
declined nonsignificantly for 27-30 year olds to 47% (Figure 6-18). These questions were
introduced in the follow-up surveys in 1989, but were not asked of 12th graders until 1997
(due to concerns about introducing the secondary school students to a drug with such an
alluring name). At the beginning of the 1990s, all young adult age groups viewed ecstasy
as a fairly dangerous drug, even for experimentation. But, again, the different age bands
showed diverging trends during the 1990s, with the oldest two age bands continuing to see
ecstasy as quite dangerous, but the 19-22 year olds (and very likely the 12th graders, for
whom we did not have data until 1997) coming to see it as less so. In 2000, 38% of 12th
graders saw great risk in trying ecstasy versus 49% of 27-30 year olds; in 2001, the
corresponding figures were 46% and 54%. In fact, three of the four age groups showed
appreciable increases in perceived risk of ecstasy use in 2001, which led us to predict a
decline in use. The increase in perceived risk continued in 2002 in the two youngest age
strata, and their use of ecstasy did, indeed, begin to decline, and decline sharply (see chapter
5). Perceived risk of using once or twice continued to rise among those 18 years old, whose
levels exceeded the levels seen in the other age bands from 2004 through 2009. Since about
2010, perceived risk of trying ecstasy has generally converged among the age groups,
showing some uneven change for young adults and a leveling for 12th graders. In 2018,
perceived risk ranged from 44% to 48% for all four age groups (Figure 6-18).
 Perceived risk of salvia use (Table 6-1) was included for the first time in 2012 in the young
adult questionnaires; the percent seeing great risk in trying salvia ranged from 19% to 23%
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among the young adults in 2012 and from 19% to 27% in 2018. Among 12th graders, 
however, in the same period there was a decline in perceived risk from 14% in 2012 to 
10% in 2018 (see Volume I3). 
 
 Recent years showed little systematic change in perceived risk of cocaine use among young 
adults and not a great deal of difference in this belief among the different age groups 
(Figures 6-9 through 6-11). In 2018, perceived risk of experimental use declined 
nonsignificantly for all age groups except for a nonsignificant increase for 23-26 year olds; 
among the four groups in 2018, it ranged from 48% to 56%. Regarding previous trends, a 
decline in perceived risk of trying cocaine and occasional use began among 19-22 year olds 
after 1994, among 23-26 year olds after 1999, and among 27-30 year olds after 2001, 
suggesting a cohort effect in this belief (Figures 6-9 and 6-10). Young adults generally 
reported somewhat higher perceived risk with respect to regular cocaine use than did 12th 
graders (Figure 6-11). The age differences were smaller for occasional and experimental 
use. Since the early 1990s, perceived risk of regular use of cocaine gradually declined 
among 12th graders, likely due to generational forgetting of the dangers of this drug, and 
resulted in an increasing gap between them and the older age groups (Figure 9-10). 
 
To illustrate cohort effects in the trends, we note that between 1980 and 1986, among 12th 
graders and the young adult age groups, the danger associated with using cocaine on a 
regular basis grew considerably -- by 13 and 17 percentage points, respectively. 
Interestingly, these changed beliefs did not translate into changed behavior until the 
perceived risk associated with experimental and occasional use began to rise sharply after 
1986. When these two measures rose, a sharp decline in actual use occurred. We 
hypothesized that respondents saw only these lower levels of use as relevant to them and, 
therefore, saw themselves as vulnerable only to the dangers of such use. (No one starts out 
planning to be a heavy user; further, in the early 1980s, cocaine was not believed to be 
addictive among many.) Based on this hypothesis, we included the additional question 
about occasional use in 1986, just in time to capture a sharp increase in perceived risk later 
that year. This increase occurred largely in response to the growing media frenzy about 
cocaine—and crack cocaine, in particular—and to the widely publicized, cocaine-related 
deaths of several public figures (most notably Len Bias, a collegiate basketball star and a 
top National Basketball Association draft pick). After stabilizing for a few years, perceived 
risk began to fall off around 1992 among 12th graders, but not among the older age groups, 
again suggesting that lasting cohort differences were emerging. Now, over 30 years later, 
none of the young adult age groups has had much exposure to the cocaine epidemic of the 
mid-1980s, which likely explains why there no longer is much age-related difference in the 
level of perceived risk, except with regards to regular use, for which 12th graders have been 
showing a declining level of perceived risk, unlike any of the young adult strata (Figure 6-
11). This likely reflects a generational forgetting of the dangers of cocaine by cohorts that 
are further and further from the peak of the cocaine epidemic in the mid-1980s.  
 
 Perceived harmfulness of crack use has tended to be very high and was lowest among 12th 
graders for many years through 2012 (Figures 6-12 through 6-14); we no longer ask these 
                                                 
3 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
257
questions of young adults. High school seniors have been considerably less likely than any 
of the older age groups to view occasional and regular use of crack cocaine as dangerous. 
Trend data (available since 1987) on the risks perceived to be associated with crack use 
showed increases in 1987-1990 for all age groups, followed by relatively little change in 
the older age strata. During the 1990s, twelfth graders showed decreases in the perceived 
risk of experimental use of crack—perhaps reflecting the onset of generational forgetting 
of its dangers—leaving them as perceiving considerably less risk than the older groups. 
The young adult age groups showed a staggered decline in this measure, with 19-22 year 
olds showing a decline after 1994, 23-26 year olds since 1996, and 27-30 year olds after 
2001. As a result, the several ages differed more in their levels of perceived risk of crack 
use, until declines in the older age groups after about 2002. Given this lack of historical or 
age variation, questions about perceived risk of crack use were dropped from the young 
adult questionnaires in 2012 to make room for such questions about other drugs. 
 
 Perceived risk of trying amphetamines (Figure 6-23) continued to show uneven change 
across the four age groups in 2018, decreasing nonsignificantly for the two younger age 
groups, increasing significantly for the 23-26 year olds, and increasing nonsignificantly for 
27-30 year olds; perceived risk in 2018 was 30%, 33%, 34%, and 33%, respectively. 
Regarding earlier trends, perceived risk increased in all four age strata very gradually from 
1980, when first measured, through 2010, with little difference among them. In 2011 it 
dropped in all strata and then held level thereafter through 2016 when it ranged from 31% 
to 34% across the four age groups. (Note that in 2011, we changed examples of 
amphetamines from “uppers, pep pills, bennies, speed” to “uppers, speed, Adderall, Ritalin, 
etc.”, which appears to account for the change in 2011.) Across the years, there was more 
difference among the age groups with regard to the risk attached to regular amphetamine 
use (Figure 6-24), with the older two strata generally seeing greater risk than the younger 
two strata, and especially the 12th graders. The younger two strata showed an increase in 
perceived risk during the 1980s and then some fallback in the early 1990s, before 
stabilizing. The sharp decline observed for experimental use after 2010 was also seen for 
regular use from 2009 to 2011 among 12th graders and from 2011 through 2012 among all 
of the young adult strata; since then, change has been uneven for the four age groups. 
Across the past decade, perceived risk of regular use has shown decline, sometimes an 
uneven decline, for all four age groups through 2018. 
 
 Perceived risk questions for Adderall (Table 6-1) were added to the young adult 
questionnaires for the first time in 2012. They showed that perceived risk of using once or 
twice ranged from 29% to 30% in the three young adult age bands in 2012. Perceived risk 
decreased and showed an uneven modest change over the years, with few consistent 
differences across the range bands. It decreased nonsignificantly in 2018 for the 18 year 
olds and the two older age groups, and increased nonsignificantly for 19-22 year olds; the 
range in 2018 was 30% to 37%.   
 
 Measures of perceived risk of crystal methamphetamine (ice) use are no longer included 
for young adults (Table 6-1). These measures were introduced in 1990, and the results 
showed what might be an important reason for its lack of rapid spread. More than half of 
all 12th graders and young adults perceived it as quite dangerous even to try, perhaps 
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because it was likened to crack in many media accounts. (Both drugs come in crystal form, 
both are burned and the fumes inhaled, both are stimulants, and both can produce a strong 
dependence.) There was rather little age-related difference in perceived risk associated with 
use of crystal methamphetamine in 1990 and 1991, although the two youngest age groups 
were somewhat higher. But as perceived risk fell considerably among 12th graders (and 
eventually among 19-22 year olds) and held steady or rose in the oldest two age groups, an 
age-related difference emerged. Twelfth graders have fairly consistently had the lowest 
level of perceived risk since 2002. Since about 2003 or 2004, perceived risk has risen some 
among all of the age strata, narrowing the age-related differences that had emerged for a 
few years. In 2011 perceived risk of trying this drug stood at 67% among 12th graders and 
at 73-75% in all of the older strata. Given this lack of variation in recent years and low 
levels of actual use, these questions were discontinued in the young adult (but not in the 
secondary school) surveys in 2012 to make room for such questions about other drugs. 
 
 In 2012 perceived risk questions about the use of bath salts, over-the-counter synthetic 
stimulants, were added to the questionnaires (Table 6-1). That year fairly high proportions 
of the young adults saw great risk of harm in even trying bath salts (45-49%), but 
considerably fewer of the 18 year olds did (33%). Perceived risk has increased dramatically 
for bath salts in all four age strata, with increases ranging from 18 percentage points among 
12th graders to 19 to 28 percentage points in the three young adult age strata. In 2018 even 
trying bath salts once or twice was seen as dangerous by between 63% and 77% in the 
young adult age strata, very high levels. (Some of this shift occurred because fewer 
respondents chose the “Can’t say, drug unfamiliar” option, suggesting that more of them 
were familiar with the drug and the risks associated with it.) 
 
 Perceived risk of experimental use of heroin (Figure 6-22) has shown long-term gradual 
increases for all age groups, though it appears to have leveled in the past few years among 
12th graders, with 2018 percentages being 62%, 73%, 76%, and 78%, respectively. Across 
the years, young adults have consistently been more cautious than 12th graders about heroin 
use, suggesting some age effect (Figures 6-20 through 6-22). In general, there has been 
relatively little change over the years in the proportions of all age groups seeing regular 
heroin use as dangerous, with the great majority of each group (over 80%) consistently 
holding this viewpoint.4 However, with regard to perceived risk of experimental use of 
heroin, there was a long-term gradual rise in all age strata from the mid-1980s through 
2015, with it showing some leveling since (Figure 6-20). From 1980 to 1986 there was a 
downward shift among 12th graders in the proportion seeing great risk associated with 
trying heroin (a trend that began in 1975 noted in Volume I) and some decline among 19-
22 year olds. Following this decline, young adults showed a gradually increasing caution 
about heroin use in the latter half of the 1980s—possibly due to heroin injection being 
associated with the spread of HIV—followed by a leveling through most of the 1990s (note 
that young adult data does not extend back equally far for all young adult age groups). In 
2018, as in all previous years, more young adults than 12th graders saw experimental and 
occasional heroin use as risky (Figures 6-20 and 6-21); and this difference has grown some 
                                                 
4 As we note in Volume 1, in 2018, 81% of 12th grade students perceived great risk in regular heroin use, which is a lower bound for the range of 
80% to 90% where it has fluctuated throughout the study. 
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since the early 1990s with regard to regular use, suggesting some generational forgetting 
of the dangers by the 12th graders (Figure 6-22). 
 
It is noteworthy for public health purposes that in 1996 and 1997, young adults’ perceived 
risk of experimental use of heroin increased some, as happened among 12th graders (as well 
as among 8th and 10th graders). These various trends could reflect, in chronological order, 
(a) the lesser attention paid to heroin by the media during the late 1970s and early 1980s 
as cocaine took center stage; (b) the subsequent great increase in attention paid to 
intravenous heroin use in the latter half of the 1980s due to the recognition of its importance 
in the spread of HIV/AIDS; (c) the emergence in the 1990s of heroin so pure that people 
no longer needed to use a needle to administer it; and (d) the subsequent increased attention 
given to heroin by the media (partly as a result of some overdose deaths by public figures 
and partly prompted by the emergence of “heroin chic” in the design industry), as well as 
through an anti-heroin media campaign launched by the Partnership for a Drug-Free 
America in June 1996.  
 
 Perceived risk questions about narcotics other than heroin (without medical supervision) 
were first asked of the young adults in 2012; between 43% and 47% of the three age groups 
saw great risk of harm in experimenting with such drugs. They have shown little systematic 
change since then through 2017 (with none of the one-year changes being significant), and 
then increased nonsignificantly by 6 to 8 percentage points for the three young adult age 
groups in 2018 (ranging from 52% to 54%) (Table 6-1). Many more see regular use as 
having great risk of harm (between 78% and 80% in 2018) with rather little systematic 
change since 2012; all three young adult age groups showed nonsignificant increases in 
2018. As with heroin use discussed above, young adults have tended to see use of narcotics 
other than heroin as more risky than have 12th graders. It may seem surprising, given the 
heavy public attention paid to narcotic drugs in recent years that perceived risk has not 
risen. On the other hand, it is quite high relative to many of the controlled substances and 
perhaps there was a rise prior to 2012.  
 
 In 2018, a minority of young adults saw binge drinking (having 5 or more drinks in a row) 
on weekends as dangerous (39-40%), as did a slightly larger proportion of 12th graders 
(45%; Figure 6-30). None of the changes in 2018 were significant, which has been true for 
the past several years for one-year changes, and there have been few differences among the 
young adult age groups. Regarding earlier trends, the belief that binge drinking carries 
great risk increased over the 1980s in these age groups, rising among 12th graders from 
36% in 1980 to 49% in 1992. Among 19-22 year olds, it rose from a low of 30% in 1981 
to 42% in 1992; the increases among the older groups were smaller. The increase in this 
belief could well help to explain the important decline in actual binge drinking, and could 
in turn be explained by the media campaigns against drunk driving in the 1980s and the 
increase in the drinking age in a number of states.5 Following a staggered pattern, perceived 
risk of harmfulness reached a peak among 18 year olds in 1992, among 19-22 year olds in 
                                                 
5 See O’Malley, P. M., & Johnston, L. D. (1999). Drinking and driving among U.S. high school seniors: 1984–1997. American Journal of Public 
Health, 89, 678–684; O’Malley, P. M., & Johnston, L. D. (2003). Unsafe driving by high school seniors: National trends from 1976 to 2001 in 
tickets and accidents after use of alcohol, marijuana and other illegal drugs. Journal of Studies on Alcohol, 64, 305–312; and O’Malley, P. M., & 
Johnston, L. D. (2013). Driving after drug use or alcohol use by American high school seniors, 2001-2011. American Journal of Public Health, 
103(11), 2027-2034.  
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1993, among 23-26 year olds in 1994, and among 27-30 year olds in 1995, suggesting some 
cohort effect in this important belief. This staggered pattern of additional peaks occurred 
again in 1996 for 18 year olds, in 1998 for 19-22 year olds, and in 1999 for the two older 
groups. It also appears that this cohort effect followed a period effect of increased perceived 
risk that took place for all age groups earlier in the 1980s. From 1998 through 2018, 
perceived risk of binge drinking has not changed much among the 19-30 age groups but 
has risen slightly among the 18 year olds.  
 
 The perception that having one or two drinks per day is dangerous continues to be low for 
all four age groups, with 2018 percentages of 23%, 18%, 17%, and 17%, respectively 
(Figure 6-28); none of the changes in 2018 were significant. Regarding trends, between 
1980 and 1991, a very gradually increasing proportion of all four age groups viewed this 
as being risky, but then they all showed a parallel decrease in perceived risk of this behavior 
through at least 2000. It seems likely that the earlier increase was due to the general rising 
concern about the consequences of alcohol use, particularly drunk driving, and that the 
subsequent decline in perceived risk was due at least in part to increasing reports of 
cardiovascular health benefits of light-to-moderate daily alcohol consumption. From about 
2001 through 2018, there has been little systematic change in this belief in any of the age 
strata, and there has been little difference by age across the entire 35-plus-year interval. 
However, since 1980, 18 year olds have consistently seen the least risk from heavy daily 
drinking and the most risk from weekend binge drinking (Figures 6-29 and 6-30).  
 
 In 2018, more than four fifths (82-85%) of young adults perceived regular pack-a-day or 
more cigarette smoking as entailing high risk (Figure 6-31), with none of the changes in 
2018 being significant. In recent years, 18 year olds consistently showed lower perceived 
risk than young adults did (and as reported in Volume I, 10th graders were still lower and 
8th graders lowest). Clearly, there is an age effect in young people coming to understand 
the dangers of smoking. Unfortunately, it appears that much of the learning about the risks 
of smoking happens after smoking initiation has occurred and many young people have 
already become addicted. These beliefs about smoking risks have strengthened very 
gradually in all age groups from senior year forward during the years we have monitored 
them (see Table 6-1 and Figure 6-31). The parallel changes in these beliefs across the 
different age groups indicate a period effect, suggesting that all of the age groups responded 
to common influences in the larger culture. These influences are discussed at length in 
Volume I6 in chapter 8 on attitudes and beliefs. The rise in perceived risk slowed between 
2002 and 2011, with only slight increases, mainly in the two youngest age strata. Changes 
since 2011 have been minimal. 
 
 In 2014 items concerning perceived risk of using e-cigarettes regularly were added to the 
12th grade and young adult surveys. These levels contrast starkly with the 82%-85% seen 
for cigarette smoking. In 2014, regular e-cigarette use was seen as dangerous by 14% of 
the 12th graders and 17% to 22% of the young adults (Table 6-1). Perceived risk increased 
for all age groups in 2015 and again in 2016, with 18% of the 12th graders and 28% to 31% 
of the young adults reporting regular use as dangerous (2015 to 2016 increases were 
                                                 
6 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
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significant for 19-22 and 23-26 year olds); however, these increases appear to have stalled 
for all age groups in 2017 and 2018, with percentages of 18% for 12th graders and 25% to 
33% for three young adult strata in 2018.  
  
 The regular use of smokeless tobacco was seen as dangerous by 48-57% of young adults 
and 40% of 12th graders in 2018, revealing a strong ordinal association with age—the older 
the age, the higher the perceived risk. These beliefs gradually strengthened from 1986 
through about 2001 in all age groups covered (Figure 6-32 and Table 6-1), particularly 
among the two older age groups. As with cigarettes, the change appears to reflect a secular 
trend (period effect) because of its parallel occurrence in all age groups. Perceived risk has 
not changed among the young adults in any systematic fashion since 2001; these data are 
based on only one form, so year-to-year nonsignificant fluctuations can appear to be 
relatively large.  
 
PERSONAL DISAPPROVAL OF DRUG USE  
For most of the life of the study, follow-up respondents were asked the same questions asked of 
12th graders in one of the six questionnaire forms concerning the extent to which they personally 
disapprove of various drug-using behaviors among “people (who are 18 or older).” Trends in the 
answers of young adults in the three age bands of 19 to 22, 23 to 26, and 27 to 30 are contained in 
Table 6-2. Comparison data for 12th graders are also provided for 1980 onward. (See Table 8-6 in 
Volume I for the longer-term trends in 12th graders’ levels of disapproval associated with using the 
various drugs.) As with the perceived risk questions, starting in 2012 the estimates were based on 
all questionnaire forms on which each disapproval question was located in order to increase sample 
size and, therefore, reduce sampling error. Each question is footnoted in Table 6-2 to indicate on 
how many forms it was contained in 2012 and thereafter. All summaries below pertain to Table 6-
2. 
 
 In general, disapproval levels of adult use of the various drugs ranked similarly across 
substances for both 12th graders and young adults. The great majority of young adults 
disapproved of using, or even experimenting with, all of the illicit drugs other than 
marijuana. For example, 93% or more of young adults in 2018 disapproved of regular use 
of each of the following drugs: LSD, cocaine, heroin, and sedatives (barbiturates). Fully 
67% to 97% of young adults disapproved of even experimenting with each of these same 
drugs. Many of these attitudes differed rather little as a function of age group in 2018.   
 
 For marijuana, disapproval tends to be lower; nevertheless, the clear majority of young 
adults disapproved of regular marijuana use in 2018 (61% to 62%), as did the majority of 
12th graders (67%). Over a third of young adults (35% to 39%) and about half of 12th 
graders (49%) disapproved of occasional use of marijuana in 2018. Disapproval of 
experimental marijuana use in 2018 was 26% to 30% for young adults and 41% for 12th 
graders. These 2018 percentages in disapproval of marijuana represent declines for young 
adults regarding occasional and regular marijuana use (significant declines for 19-22 and 
23-26 year olds, see Table 6-2); they are all at all-time lows since 1980. For 12th graders, 
the 2018 percentages represent nonsignificant one-year increases, serving to widen the gap 
between 12th graders and young adults in disapproval of marijuana use. With the exception 
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of 2018, however, disapproval of marijuana use at any level has been in decline among 12th 
graders longer term. 
Among drugs measured, marijuana use has shown the widest fluctuations in disapproval 
over time, fluctuations that generally parallel the changes in perceived risk (though 
sometimes with a one-year lag, with the change in perceived risk coming first). The most 
fluctuation has occurred among the younger age groups (Table 6-2). Among 12th graders, 
disapproval of regular marijuana use increased substantially in the 1980s, peaked in the 
early 1990s, declined some in the 1990s, and then leveled around 1998 with little change 
for some years thereafter. Since 2009, however, 12th graders have shown a fair decline in 
disapproval, falling from 80% in 2009 to 67% in 2018. The 19-22 year olds had a quite 
similar pattern, with a recent decline from 81% in 2009 to 61% in 2018. Among 23-26 year 
olds, some declines started later in the 1990s but were modest until about 2007, when 
disapproval of regular marijuana use fell from 85% to 61% in 2018. Thus since 2007 there 
has been a considerable decline in disapproval of regular (and occasional) marijuana use 
in all four age groups; the pattern is consistent with a secular trend, which would alert us 
to a possible increase in marijuana use. Indeed, such an increase in use has been occurring 
among 19-28 year olds since 2010 through 2018 (see Table 5-2). 
 Disapproval of experimental use of LSD has been declining among 12th graders and young
adults in recent years, reaching all-time lows in 2016 and 2017. However, in 2018, it
rebounded nonsignificantly for 12th graders (81%), 19-22 year olds (79%), and 27-30 year
olds (72%); it declined nonsignificantly for 23-26 year olds (67%). Still, the majority
disapprove of such experimental use, which has been true since 1980, when these data were
first available. Beginning around 1990, all age groups decreased some in their disapproval
of trying LSD (starting from very high levels of disapproval at 90-91%). The decline was
steepest among 12th graders, but there was a reversal in this group’s disapproval in 1997,
and then an increase through 2006. Disapproval in the older age groups declined less and
in staggered fashion; this trend showed some evidence of a reversal among 19-22 year olds
and 23-26 year olds since 2001 and 2002, respectively. The pattern again suggested lasting
cohort differences in these attitudes. From about 2010 through 2017, disapproval levels
generally showed consistent declines, reaching the all-time lows in 2016 and 2017 (ranging
from 72% to 78%); the 2018 percentages suggest this decline has stalled for most age
groups. Disapproval of regular LSD use has been near the top of the scale for more than
three decades, ranging from 92% to 99%.
 In 2018, experimenting with MDMA (ecstasy, Molly) was disapproved of by 85% of 12th
graders and by 79% to 81% of the young adults; none of the changes in 2018 were
significant, as has been the case for one-year changes in the last few years (Table 6-2). First
measured among young adults in 2001, disapproval of MDMA use was positively
associated with age in the early 2000s. In 2001 disapproval of trying ecstasy was quite
high, and from 2001 to 2010, disapproval rose to even higher levels in all age groups, with
little systematic change since then. Due to the advent of Molly—reputedly a stronger form
of MDMA than ecstasy—the question for young adults was changed to MDMA in 2015
with both ecstasy and Molly given as examples (there was no evidence that the addition of
Molly as an example had the effect of raising the disapproval level, as might have been
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expected; indeed, there was a slight, nonsignificant decline in disapproval of occasional 
use in 2015).  
 
 Disapproval of all three levels of heroin use (experimental, occasional, and regular use) 
has remained very high and fairly stable since MTF began, though there was a very gradual 
increase in disapproval in all age strata from the mid-1980s through around 2005, followed 
by a leveling. In 2018, disapproval of occasional and regular use was 96% to 98% in all 
age groups; disapproval of trying heroin was 95% to 97% across the age groups. For public 
health purposes, a noteworthy minor exception to the general pattern of trends for 
disapproval of heroin use was a little slippage in disapproval of experimental use that 
occurred among 12th graders (but not young adults) from 1991 through 1996 (from 96% to 
92%)a period during which heroin usage rates were rising.  
 
 Disapproval of regular cocaine use rose gradually among 19-22 year olds, from 89% in 
1981 to 99% in 1990, with little change thereafter (97% in 2018), and the older young adult 
age groups had similar trends (Table 6-2). In fact, all three young adult age bands were 
97% in disapproving of regular use in 2018. Disapproval of even experimental cocaine use 
is also quite high, with 2018 percentages being 89%, 87%, 77%, and 79%, respectively 
across the four age groups, representing nonsignificant changes since 2017. Regarding 
long-term trends, disapproval of experimental use increased during the 1980s, peaking first 
among 12th graders at 94% in 1991. It then peaked in 1995 among 19-22 year olds (at 94%) 
and 23-26 year olds (at 92%). Finally, it peaked in 1999 at 90% among 27-30 year olds, 
suggesting both a period and a cohort effect at work. All age groups had some modest 
falloff in disapproval since those peak levels were attained. The last five years have shown 
uneven declines for the two older age groups. This recent decline in disapproval among 
older young adults could signal some future resurgence in cocaine use. 
 
 Disapproval of experimenting with amphetamines was at or near all-time lows in 2018 for 
the two older age groups (68% and 73%, respectively), representing nonsignificant declines 
from 2017. It also decreased nonsignificantly for 19-22 year olds (74%) and 12th graders 
(81%). Regarding long-term trends, disapproval of experimental use rose gradually in the 
1980s as use was falling; thereafter, disapproval leveled in the mid-80% range through 
2010, with almost no difference among the age strata. For example, trying amphetamines 
once or twice was disapproved of by 73-74% of 19-26 year olds in 1984, compared to 84% 
by 1990. After a long period of level disapproval, all strata showed a slight drop in 
disapproval in 2011, followed by another leveling for most age groups, followed by another 
sharp drop of 10 percentage points in 2014 among 19-22 year old age group (which 
contains most of the college students). In the past few years, there has been some further 
decline, with each young adult age group reaching lowest levels since the early 1980s in 
2016 or 2018; for 12th graders, the 2018 percentage was the lowest over the past two 
decades.  
 
Disapproval of regular use started out very high among all age strata in the early 1980s and 
rose even higher by the early 1990s, where it remained for all age strata until 2011; after 
that there was a slight decline, but a leveling by 2012 that has largely continued into 2018 
with disapproval above 90% for all age groups.  
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Some of the decline and age-group differences in disapproval of amphetamine use in all 
four age groups since 2010 is likely explained by a change in the question wording. 
Adderall and Ritalin were included in the question for the first time in 2011 as examples 
of amphetamines. There had been very little difference among the various age strata in 
either their levels or trends in disapproval until the significant decline in 2014, which 
brought the college-age group (19-22 year olds) considerably below the other age groups 
in their disapproval of experimenting with amphetamines. In 2018, disapproval was lowest 
among 23-26 year olds at 68%, similar among the other two young adult age groups (73% 
to 74%), and highest for 12th graders (81%).  
 
 Disapproval of experimental use of sedatives (barbiturates) was at 87%, 81%, 76%, and 
78% across the four age groups, respectively, in 2018, continuing its modest decline over 
the past five years for all age groups. The 2018 decline was significant for 19-22 year olds. 
Over the years, disapproval of sedatives has moved very much in parallel with that for 
amphetamines. Disapproval increased significantly during the 1980s, accompanied by 
declining use. Disapproval of trying sedatives was at 84-85% in 1984 compared to 89-91% 
by 1990. Disapproval of sedative use slipped some among 12th graders after 1992 and 
among 19-22 year olds after 1994, with the 23-26 year olds following suit after 1996, and 
the 27-30 year old stratum in 2004. This pattern of staggered change again suggests cohort 
effects, reflecting lasting cohort differences in these attitudes. In 2018, disapproval of 
experimental use of sedatives stood between 76% and 87%, while disapproval of regular 
use was close to 100%.  
 
 In the past several years, the trends for disapproval of alcohol use have shown little 
systematic change. However, the longer-term story for disapproval of alcohol use is quite 
an interesting one, in that changes in the minimum drinking age seem to have led to modest 
changes in norms for the affected cohorts. Between 1980 and 1992, an increasing 
proportion of 12th graders favored total abstention; the percent who disapproved of 
drinking even just one or two drinks rose from 16% in 1980 to 33% in 1992. This figure 
fell back slightly over the years and stood at 31% in 2018. Among 19-22 year olds there 
was a modest increase in disapproving of any use between 1985 and 1989 (from 15% to 
22%), where it held for some years; it remained at 18% in 2018. For the two oldest age 
groups, there has been rather little change in these attitudes so far, ranging from 12% to 
15% in 2018. These differing trends may reflect the fact that during the 1980s, the drinking 
age was raised in a number of states so that by 1987 it was 21 in all states; this change 
would have had the greatest effect on 12th graders, who may have incorporated the legal 
restrictions into their normative structure and, as they entered young adulthood, brought 
these new norms with them. But the changes may be exhibited only among respondents in 
the cohorts that were underage after the time that the new law raising the minimum drinking 
age went into effect.  
 
Disapproval of having one or two drinks nearly every day has not shown any such cohort 
effects, because all age groups have generally moved in parallel, at similar levels of 
disapproval through 2004. The three youngest age bands (which include 12th graders 
through 26 year olds) showed an increase in disapproval of having one to two drinks daily 
up until about 1990 suggesting some secular trending (little data were yet available on the 
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oldest age group), but disapproval has declined a fair amount in all of the age groups since 
then. Starting in 2004, a bit of a gap opened up between 12th graders and young adults that 
has remained through 2018, as 12th graders showed some increase and then leveling in 
disapproval of having one to two drinks daily and young adults, especially the oldest group, 
continued to show declines. In 2018, disapproval was 75% for 12th graders (representing a 
significant increase from 2017) and 62%, 57%, and 51% for the three older age groups, 
respectively (representing nonsignificant change from 2017).  
 
The pattern of cross-time changes in disapproval of light daily drinking (having one or two 
drinks nearly every day) for young adults closely parallels what was observed for the 
perceived risk associated with light daily drinking. This holds especially in terms of overall 
declines among the older group, though the level of disapproval was much higher for heavy 
than for light daily use, as would be expected (above 90% in 2018 for all age groups). 
Declines in both variables among the young adults may well be due to widely publicized 
reports that some cardiovascular benefits may result from having one or two drinks per 
day. 
 
 Disapproval of binge drinking on weekends has shown quite a bit of variation over the 
years as well as age differences. In 2018, disapproval was 76% for 12th graders 
(representing an all-time high and a significant increase from 2017) and 65% to 69% for 
the young adults (representing nonsignificant change from 2017). Trends have been uneven 
over the years, but in general, disapproval has slowly increased for 12th graders from the 
most recent low of 63% in 1999 to 76% in 2018, has slowly increased for 19-22 year olds 
from the most recent low of 58% in 2002 to 69% in 2018, has shown little systematic 
change for 23-26 year olds since 1984 (ranging between 56% and 71%), and has slowly 
decreased for 27-30 year olds from the most recent high of 74% in 2004 to 65% in 2018. 
Thus, age group differences have been widening in recent years.  
 
It is important to note that the age-based trends in disapproval often mirrored the 
corresponding trends in prevalence of heavy drinking. In particular, from the early 1980s 
for the two youngest age groups there was a considerable increase in disapproval that 
continued through 1992 for 12th graders (who then showed some drop-off) and through 
1996 among 19-22 year olds (who then also showed some drop-off). As Figure 5-18d 
illustrates, the prevalence of occasions of heavy drinking declined substantially among 12th 
graders and 19-22 year olds between 1981 and the early 1990s, as norms became more 
restrictive. There was little or no change in disapproval among the 27-30 year olds, either 
in their levels of disapproval or in their rates of occasions of heavy drinking, until the early 
2000s, when their disapproval began to drop and occasions of heavy drinking began to 
increase.  
 
 Disapproval of pack-or-more-a-day cigarette smoking was at or near all-time highs in 
2018, at 89%, 87%, 84%, and 83% across the four age groups, respectively. Notably, the 
increase in 2018 for 12th graders was significant. Regarding long-term trends, 12th graders 
showed some increase in disapproval of pack-or-more-a-day smoking between 1982 (69%) 
and 1992 (74%). Their disapproval fell through 1997 (to 67%) as their smoking increased; 
disapproval then increased for several years (to 82% in 2006) before leveling and then 
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increasing through 2018 (89%), as smoking declined. The 19-22 year olds showed a similar 
increase in disapproval from 66% in 1982 to 87% in 2018. All four age strata showed some 
upward drift in their level of disapproval of smoking since about 1999 (reaching 83-89% 
in 2018), suggesting a secular change in attitudes during this period.  
 
COHORT DIFFERENCES AND THEIR IMPLICATIONS FOR PREVENTION AND 
THEORY 
An important theoretical point to be made, based on the strong evidence reported here for cohort 
effects in perceived risk and disapproval of many of the drugs under study, is that among the causes 
of cohort differences in actual use are lasting cohort differences in these critical attitudes and 
beliefs. In other words, the attitudes and beliefs brought into adulthood from adolescence tend to 
persevere and continue to shape individual and population drug use over the life course. 
 
A second point has to do with the causes of these attitudinal cohort effects. We noted earlier that 
the older respondents are more likely than the younger ones to see as dangerous the use of LSD, 
heroin, narcotics other than heroin, amphetamines, cocaine, and sedatives (barbiturates). Some 
years ago, Lloyd Johnston proposed a framework for a theory of drug epidemics in which direct 
learning (from personal use) and vicarious learning (from observing use by others in both the 
immediate and mass media environments) play important roles in changing these key attitudes.7 
To the extent that the data on perceived risk represent cohort effects (enduring differences between 
class cohorts), these findings would be consistent with this theoretical perspective. Clearly, use of 
these particular drugs was greater when the older cohorts were growing up, and public attention 
and concern regarding the consequences of these drugs were greatest in the 1970s and early to 
mid-1980s. In the early 1970s, LSD was alleged to cause brain and chromosomal damage, as well 
as bad trips, flashbacks, and behavior that could prove dangerous. Methamphetamine use was 
discouraged with the slogan “speed kills.” In addition, there was an epidemic of heroin use in the 
early 1970s. In the early 1980s there was an epidemic of cocaine use, and it reached a pinnacle in 
1986 with the widely reported deaths of sports stars and others from cocaine. Later cohorts 
(through the mid-1990s, at least) were not exposed to those experiences while growing up, and 
thus did not see the risks in the same way as the older cohorts did. While there may have been a 
secular trend toward greater perceived risk for drugs in general, in the case of LSD there may have 
also been an operating cohort effect (with younger cohorts seeing less danger) offsetting the secular 
trend among 12th graders; the net effect was a decrease in 12th graders’ perceived risk of LSD use 
after 1980. 
 
This vicarious learning explanation has a very practical implication for national strategy for 
preventing future epidemics. Because fewer in their immediate social circles and fewer public role 
models may be using these drugs and exhibiting the adverse consequences of use during certain 
historical periods, future cohorts of youth may have less opportunity to learn about the adverse 
consequences of these drugs in the normal course of growing up. Unless those hazards are 
convincingly communicated to them in other ways—for example, through school prevention 
                                                 
7 Johnston, L. D. (1991). Toward a theory of drug epidemics. In L. Donohew, H. E. Sypher, & W. J. Bukoski (Eds.), Persuasive communication 
and drug abuse prevention (pp. 93–131). Hillsdale, NJ: Lawrence Erlbaum.  
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programs, by their parents, and through the mass media, including public service advertising—
they will become more susceptible to a new epidemic of use of the same or similar drugs. 
For example, in Volume I,8 we reported an increase in use of several drugs in 8th, 10th, and 12th 
grades in 1994 through 1997. This increase suggests that this form of generational forgetting may 
well have occurred during those years. For the cohorts that follow such a rise in use, there is once 
again an increased opportunity for vicarious learning from the adverse experiences of those around 
them, but by that time, members of affected cohorts have had to learn the hard way what 
consequences await those who become involved with the various drugs. In the early 2000s we saw 
drug use subside to some degree, which once again created the conditions for generational 
forgetting of the dangers of many of these drugs. Over the past few years, we have seen substantial 
softening of attitudes among teens and young adults regarding marijuana, and also some softening 
in attitudes toward occasional or regular use of MDMA (ecstasy, Molly), LSD, and cocaine, which 
suggests a real possibility of future increases in use among young adults. 
8 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Try marijuana 18 10.0 13.0 11.5 12.7 14.7 14.8 15.1 18.4 19.0 23.6 23.1 27.1 24.5 21.9 19.5 16.3 15.6 14.9 16.7
  once or twice f 19–22 8.3 7.8 9.7 9.7 12.8 11.2 13.0 12.9 16.8 16.9 17.8 19.1 19.7 19.4 18.8 13.3 16.9 14.8 13.4
23–26 — — — — 9.6 10.0 12.4 14.5 16.0 14.0 17.7 14.0 15.0 13.0 15.0 15.8 18.5 15.1 16.7
27–30 — — — — — — — — 14.6 16.0 17.0 15.7 15.1 14.0 14.8 16.1 16.2 16.1 16.4
Use marijuana  18 14.7 19.1 18.3 20.6 22.6 24.5 25.0 30.4 31.7 36.5 36.9 40.6 39.6 35.6 30.1 25.6 25.9 24.7 24.4
  occasionally f,n 19–22 13.9 14.2 16.9 16.7 21.7 20.6 22.4 23.0 28.7 29.1 30.1 30.2 29.5 30.3 31.3 25.5 25.6 22.0 22.0
23–26 — — — — 15.8 16.3 20.9 20.8 26.8 25.3 30.4 26.2 27.4 24.0 25.5 27.7 27.3 26.4 26.8
27–30 — — — — — — — — 24.2 25.7 28.7 27.4 27.5 26.8 28.1 28.3 28.1 26.0 25.8
Use marijuana  18 50.4 57.6 60.4 62.8 66.9 70.4 71.3 73.5 77.0 77.5 77.8 78.6 76.5 72.5 65.0 60.8 59.9 58.1 58.5
  regularly f 19–22 43.9 47.8 52.4 58.4 62.2 66.8 67.6 69.4 72.4 74.9 73.0 75.0 69.3 69.2 65.0 62.1 61.3 60.7 53.4
23–26 — — — — 52.9 57.5 59.4 65.3 68.3 72.1 71.0 70.9 67.3 64.1 63.2 64.2 62.7 64.1 62.7
27–30 — — — — — — — — 67.5 69.1 69.2 67.5 68.8 69.4 65.6 69.2 67.3 65.0 63.6
Try synthetic marijuana 18 — — — — — — — — — — — — — — — — — — —
  once or twice g 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take synthetic marijuana 18 — — — — — — — — — — — — — — — — — — —
  occasionally g  19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try LSD once or 18 43.9 45.5 44.9 44.7 45.4 43.5 42.0 44.9 45.7 46.0 44.7 46.6 42.3 39.5 38.8 36.4 36.2 34.7 37.4
  twice h  19–22 44.8 44.4 45.0 44.7 46.0 44.3 47.6 49.4 49.2 49.5 49.3 48.0 45.6 42.4 42.3 40.3 44.4 40.1 38.7
23–26 — — — — 48.3 46.9 47.9 51.5 53.7 50.7 52.0 50.1 49.7 49.0 46.8 45.8 46.1 46.6 45.7
27–30 — — — — — — — — 53.3 55.6 54.6 52.5 53.0 51.5 53.5 52.5 50.1 52.0 52.0
Take LSD 18 83.0 83.5 83.5 83.2 83.8 82.9 82.6 83.8 84.2 84.3 84.5 84.3 81.8 79.4 79.1 78.1 77.8 76.6 76.5
  regularly h 19–22 83.4 85.3 86.2 86.0 84.5 86.4 87.1 85.6 85.4 85.5 85.8 86.6 87.0 81.3 81.0 80.5 82.4 83.6 78.6
23–26 — — — — 89.0 86.6 88.7 90.0 89.2 89.0 88.2 89.1 87.3 85.3 87.5 86.3 84.7 85.6 82.1
27–30 — — — — — — — — 89.1 91.2 92.0 87.1 88.5 89.0 89.2 88.4 87.0 87.2 90.5
Try PCP once or 18 — — — — — — — 55.6 58.8 56.6 55.2 51.7 54.8 50.8 51.5 49.1 51.0 48.8 46.8
  twice h 19–22 — — — — — — — 63.6 63.8 — — — — — — — — — —
23–26 — — — — — — — 64.8 63.2 — — — — — — — — — —
27–30 — — — — — — — — 65.9 — — — — — — — — — —
Try ecstasy 18 — — — — — — — — — — — — — — — — — 33.8 34.5
  (MDMA, Molly) once 19–22 — — — — — — — — — 45.2 47.1 48.8 46.4 45.0 51.1 48.3 46.7 45.5 42.7
  or twice h 23–26 — — — — — — — — — 49.5 47.2 47.4 45.5 41.9 50.6 49.3 50.4 50.5 47.7
27–30 — — — — — — — — — 44.9 48.7 47.7 44.2 51.7 47.3 50.0 50.6 48.8 50.4
Take ecstasy 18 — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — — — — — — — — — — — — — — — — — —
  occasionally h  23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try salvia 18 — — — — — — — — — — — — — — — — — — —
  once or twice d,k 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take salvia 18 — — — — — — — — — — — — — — — — — — —
  occasionally k,y 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try cocaine 18 31.3 32.1 32.8 33.0 35.7 34.0 33.5 47.9 51.2 54.9 59.4 59.4 56.8 57.6 57.2 53.7 54.2 53.6 54.6
  once or twice h 19–22 31.4 30.4 33.3 28.7 33.1 33.2 35.5 45.9 51.9 51.5 58.1 58.7 56.1 60.5 63.8 57.7 61.9 55.5 55.4
23–26 — — — — 31.3 31.1 35.9 48.0 47.1 51.3 51.5 50.5 53.5 54.1 56.0 58.7 57.2 63.1 60.2
27–30 — — — — — — — — 45.3 53.0 51.6 52.6 51.8 54.7 53.5 56.4 53.6 54.6 60.5
Take cocaine 18 — — — — — — 54.2 66.8 69.2 71.8 73.9 75.5 75.1 73.3 73.7 70.8 72.1 72.4 70.1
  occasionally h,o 19–22 — — — — — — 53.8 61.3 67.1 72.6 74.6 72.6 74.9 75.4 78.0 73.4 76.6 76.1 71.2
23–26 — — — — — — 50.9 62.6 63.2 69.9 69.9 70.3 69.9 72.8 70.3 76.0 71.3 76.5 74.2
27–30 — — — — — — — — 62.6 66.6 66.6 69.1 69.9 69.1 69.9 70.0 67.8 73.8 73.2
Take cocaine 18 69.2 71.2 73.0 74.3 78.8 79.0 82.2 88.5 89.2 90.2 91.1 90.4 90.2 90.1 89.3 87.9 88.3 87.1 86.3
  regularly h  19–22 65.2 69.3 71.5 75.2 75.1 82.9 82.0 88.0 90.3 89.1 93.9 93.5 92.9 91.7 92.2 91.5 92.2 91.6 88.7
23–26 — — — — 75.6 76.9 83.0 88.9 90.9 91.2 91.2 92.7 89.9 91.9 92.6 93.3 90.6 93.2 92.9
27–30 — — — — — — — — 88.9 92.0 91.4 90.9 92.0 91.6 92.1 91.3 91.6 92.7 93.0
TABLE 6-1
Trends in Harmfulness as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
(Table continued on next page.)
Percentage saying “great risk” a
(Years 
Cont.)
Q. How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they . . .
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Age Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Try marijuana 18 15.7 13.7 15.3 16.1 16.1 15.9 16.1 17.8 18.6 17.4 18.5 17.1 15.6 14.8 14.5 12.5 12.3 12.9 11.9 12.1 +0.2
  once or twice f 19–22 12.5 14.3 11.9 13.3 17.1 15.3 15.6 14.4 10.8 17.4 13.2 16.8 13.4 12.9 11.8 9.3 10.6 9.4 9.8 8.3 -1.5
23–26 16.4 13.1 13.0 15.1 15.3 13.6 13.0 13.9 13.0 12.5 10.6 12.7 10.5 10.1 9.7 9.6 9.5 9.0 6.9 6.2 -0.6
27–30 16.1 14.4 17.3 16.2 18.0 13.8 14.5 14.5 16.6 11.4 12.3 11.5 12.4 12.5 10.2 8.8 7.9 7.3 6.9 8.1 +1.2
Use marijuana  18 23.9 23.4 23.5 23.2 26.6 25.4 25.8 25.9 27.1 25.8 27.4 24.5 22.7 20.6 19.5 16.4 15.8 17.1 14.1 14.3 +0.1
  occasionally f,n 19–22 19.8 25.8 18.0 21.0 24.1 23.2 24.3 22.1 22.3 23.6 23.1 19.9 19.6 20.6 19.1 15.4 15.6 13.0 13.3 11.1 -2.2
23–26 26.4 24.9 20.5 24.5 22.2 22.7 21.6 22.3 20.2 18.5 18.1 19.3 15.5 17.1 14.4 14.8 13.7 14.1 9.7 9.2 -0.5
27–30 25.3 25.8 25.0 30.2 27.9 25.1 24.8 21.8 25.6 21.6 21.7 18.6 19.3 19.7 16.0 14.8 12.1 11.1 9.9 10.8 +0.9
Use marijuana  18 57.4 58.3 57.4 53.0 54.9 54.6 58.0 57.9 54.8 51.7 52.4 46.8 45.7 44.1 39.5 36.1 31.9 31.1 29.0 26.7 -2.2
  regularly f 19–22 55.2 58.0 49.6 56.7 57.8 57.2 55.3 54.5 50.4 51.6 46.4 49.8 43.0 43.5 39.4 35.1 33.3 30.0 27.3 22.1 -5.2 ss
23–26 60.1 60.3 55.1 53.7 56.7 54.2 53.6 55.9 52.5 52.4 43.0 47.1 39.3 40.1 35.9 34.5 30.6 30.2 23.3 21.1 -2.2
27–30 66.1 64.0 61.7 63.5 64.7 59.3 57.0 54.9 51.5 51.2 47.4 48.5 42.2 43.5 40.3 35.3 30.6 29.4 24.7 24.8 +0.1
Try synthetic marijuana 18 — — — — — — — — — — — — — 23.5 25.9 32.5 33.0 35.6 33.0 30.4 -2.6
  once or twice g  19–22 — — — — — — — — — — — — — 30.6 33.1 36.1 39.3 42.6 42.7 40.4 -2.3
23–26 — — — — — — — — — — — — — 29.1 29.4 38.5 40.4 45.1 40.8 45.0 +4.2
27–30 — — — — — — — — — — — — — 28.9 32.7 35.1 37.3 45.4 41.7 45.8 +4.1
Take synthetic marijuana 18 — — — — — — — — — — — — — 32.7 36.2 39.4 40.9 43.9 40.0 37.1 -2.9
  occasionally g 19–22 — — — — — — — — — — — — — 38.5 40.1 44.5 47.6 53.9 52.6 50.0 -2.7
23–26 — — — — — — — — — — — — — 37.3 38.6 47.2 49.5 53.0 50.8 56.4 +5.6
27–30 — — — — — — — — — — — — — 36.3 41.0 43.1 46.6 53.2 52.2 54.4 +2.3
Try LSD once or 18 34.9 34.3 33.2 36.7 36.2 36.2 36.5 36.1 37.0 33.9 37.1 35.6 34.7 33.1 34.9 35.5 33.2 31.7 30.0 29.0 -1.0
  twice h  19–22 38.1 37.9 37.5 35.3 39.7 39.2 38.7 43.5 40.9 46.5 38.5 40.9 43.5 43.5 40.3 40.1 39.4 36.5 34.5 34.3 -0.2
23–26 49.3 44.9 48.5 45.7 43.8 40.7 39.9 38.1 42.8 43.8 43.0 48.7 44.1 47.2 43.0 42.4 38.0 42.5 32.1 36.4 +4.3
27–30 49.9 46.4 46.7 44.9 47.5 47.2 47.9 44.9 44.6 42.4 41.7 41.5 45.2 45.8 45.2 45.6 47.6 43.7 41.3 38.5 -2.8
Take LSD 18 76.1 75.9 74.1 73.9 72.3 70.2 69.9 69.3 67.3 63.6 67.8 65.3 65.5 66.8 66.8 62.7 60.7 58.2 56.1 55.2 -0.9
  regularly h 19–22 82.2 81.6 79.2 81.1 78.6 78.4 77.8 78.9 77.5 73.9 74.8 72.8 74.4 78.0 76.6 74.7 72.7 75.7 65.1 64.7 -0.3
23–26 85.4 84.1 86.0 85.3 84.3 83.5 80.8 82.0 80.3 80.2 82.0 83.1 81.4 78.9 79.0 76.0 71.7 73.9 68.7 70.1 +1.4
27–30 87.8 85.3 86.9 85.3 87.5 83.9 87.9 82.2 85.7 82.9 80.2 87.0 83.0 83.2 83.8 80.3 79.9 73.2 71.7 71.7 0.0
Try PCP once or 18 44.8 45.0 46.2 48.3 45.2 47.1 46.6 47.0 48.0 47.4 49.7 52.4 53.9 51.6 53.9 53.8 54.4 55.1 53.6 51.7 -1.9
  twice h 19–22 — — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — — —
Try ecstasy 18 35.0 37.9 45.7 52.2 56.3 57.7 60.1 59.3 58.1 57.0 53.3 50.6 49.0 49.4 47.5 47.8 49.5 48.8 49.1 48.2 -0.9
  (MDMA, Molly) once 19–22 37.6 37.9 40.5 46.8 50.1 52.3 53.8 51.0 50.3 51.4 51.4 50.7 49.9 45.9 52.4 50.7 47.7 51.2 43.9 45.2 +1.3
  or twice h,m 23–26 50.0 46.7 45.7 45.6 45.9 44.9 51.2 46.4 51.4 46.3 46.4 47.5 54.2 43.7 49.1 56.5 48.8 50.5 43.2 43.7 +0.5
27–30 50.9 48.9 53.6 52.0 58.8 49.1 50.2 46.5 51.9 43.5 43.5 52.0 51.3 44.3 51.4 52.0 54.5 52.1 51.3 46.6 -4.7
Take ecstasy 18 — — — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — 72.5 77.8 81.7 78.3 80.0 82.5 79.3 81.9 79.2 76.2 71.6 76.7 75.3 72.9 66.9 72.1 64.2 67.6 +3.4
  occasionally h,m 23–26 — — 72.5 71.9 73.6 77.4 77.2 77.0 78.7 78.6 76.2 79.1 76.9 76.6 69.8 77.6 69.1 69.1 69.8 62.5 -7.3
27–30 — — 75.2 76.5 79.9 76.9 74.7 70.4 72.0 71.3 71.4 69.7 77.8 75.0 76.8 71.6 73.1 69.0 71.0 64.7 -6.3
Try salvia 18 — — — — — — — — — — — 39.8 38.7 13.8 12.9 14.1 13.1 13.0 10.2 9.8 -0.5
  once or twice d,k 19–22 — — — — — — — — — — — — — 22.5 21.4 25.9 23.7 23.8 23.6 18.9 -4.7
23–26 — — — — — — — — — — — — — 18.6 19.6 24.5 23.5 30.9 21.0 26.5 +5.5
27–30 — — — — — — — — — — — — — 18.8 20.6 18.4 21.7 25.2 21.3 25.8 +4.4
Take salvia 18 — — — — — — — — — — — — — 23.1 21.3 20.0 17.6 16.3 13.8 12.0 -1.9
  occasionally k,y 19–22 — — — — — — — — — — — — — 29.2 30.6 32.6 32.6 28.3 29.8 23.5 -6.4
23–26 — — — — — — — — — — — — — 26.6 25.5 31.1 31.2 38.6 33.6 35.1 +1.5
27–30 — — — — — — — — — — — — — 24.7 25.7 25.4 28.8 32.3 29.2 35.7 +6.6
Try cocaine 18 52.1 51.1 50.7 51.2 51.0 50.7 50.5 52.5 51.3 50.3 53.1 52.8 54.0 51.6 54.4 53.7 51.1 52.7 49.5 47.9 -1.6
  once or twice h 19–22 52.8 56.7 48.9 55.5 55.0 55.5 55.6 54.0 55.8 56.7 54.9 56.8 56.2 57.0 56.3 56.3 57.4 55.8 51.2 50.2 -0.9
23–26 62.6 63.1 62.4 61.0 55.4 52.1 53.0 52.5 56.9 55.0 56.6 56.7 54.9 60.3 50.9 57.3 49.1 55.2 48.1 47.9 -0.3
27–30 61.7 59.9 60.9 58.8 56.4 61.4 56.5 58.1 54.8 56.1 52.0 51.6 54.7 51.8 53.8 50.1 53.1 53.2 50.1 56.4 +6.2
Take cocaine 18 70.1 69.5 69.9 68.3 69.1 67.2 66.7 69.8 68.8 67.1 71.4 67.8 69.7 69.0 70.2 68.1 66.3 68.6 64.6 62.1 -2.5
  occasionally h,o 19–22 68.0 72.4 70.0 69.9 70.3 70.2 72.1 71.0 71.5 72.4 67.2 72.9 70.3 78.0 76.5 74.9 76.4 71.5 73.3 70.2 -3.1
23–26 77.8 76.2 74.2 75.4 68.3 74.1 70.4 68.5 70.9 67.2 74.9 71.6 71.6 76.9 75.8 75.8 69.5 70.7 67.3 68.4 +1.2
27–30 75.4 76.5 78.1 74.3 72.6 75.3 76.2 74.6 72.1 73.9 65.4 71.5 71.0 73.2 77.9 70.7 71.5 69.6 71.9 71.2 -0.6
Take cocaine 18 85.8 86.2 84.1 84.5 83.0 82.2 82.8 84.6 83.3 80.7 84.4 81.7 83.8 82.6 83.3 80.6 79.1 78.3 74.9 75.2 +0.3
  regularly h 19–22 88.5 90.7 85.1 88.3 87.4 87.1 89.2 86.2 86.7 87.0 88.6 87.9 86.3 92.3 91.4 89.7 90.4 89.6 92.2 88.5 -3.6
23–26 92.7 92.9 91.1 91.5 88.5 91.5 88.0 90.9 88.0 86.5 89.2 90.9 88.0 91.2 91.2 92.4 86.4 92.0 85.5 87.1 +1.6
27–30 92.4 92.3 94.5 91.2 92.9 91.3 94.0 90.0 89.9 91.1 88.8 92.7 87.2 91.2 91.7 88.7 90.0 91.6 89.5 88.8 -0.7
↓
(List of drugs continued.)
TABLE 6-1 (cont.)
Trends in Harmfulness as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Q. How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they . . .
Percentage saying “great risk” a
2017– 2018 
change
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Try crack once 18 — — — — — — — 57.0 62.1 62.9 64.3 60.6 62.4 57.6 58.4 54.6 56.0 54.0 52.2
  or twice h 19–22 — — — — — — — 59.4 67.3 68.5 69.4 66.9 65.4 63.5 70.1 61.9 65.2 62.0 59.3
23–26 — — — — — — — 59.1 63.5 69.8 67.3 66.9 67.1 64.2 69.3 64.8 68.6 64.7 67.3
27–30 — — — — — — — — 66.5 64.9 68.7 66.8 64.3 68.8 65.6 66.4 66.7 68.5 66.5
Take crack 18 — — — — — — — 70.4 73.2 75.3 80.4 76.5 76.3 73.9 73.8 72.8 71.4 70.3 68.7
  occasionally h 19–22 — — — — — — — 75.0 77.3 81.8 82.3 82.7 81.9 83.6 84.3 78.8 83.5 79.1 79.1
23–26 — — — — — — — 70.3 74.0 79.9 81.1 83.9 84.4 81.6 83.2 81.4 85.9 80.8 84.2
27–30 — — — — — — — — 76.4 76.7 82.6 81.8 79.1 83.6 78.6 81.1 81.3 85.3 81.7
Take crack 18 — — — — — — — 84.6 84.8 85.6 91.6 90.1 89.3 87.5 89.6 88.6 88.0 86.2 85.3
  regularly h  19–22 — — — — — — — 89.6 91.1 94.1 94.9 95.6 93.4 96.2 96.0 94.2 94.7 93.3 92.8
23–26 — — — — — — — 88.0 89.2 91.5 94.2 95.4 94.1 93.4 94.9 95.5 96.1 91.4 95.6
27–30 — — — — — — — — 89.6 89.5 95.3 94.4 93.3 93.5 93.0 94.0 94.3 96.0 94.3
Try cocaine 18 — — — — — — — 45.3 51.7 53.8 53.9 53.6 57.1 53.2 55.4 52.0 53.2 51.4 48.5  
   powder once 19–22 — — — — — — — 44.0 48.6 51.1 54.5 52.7 56.2 49.7 62.0 55.8 57.1 53.8 53.0
   or twice i 23–26 — — — — — — — 41.0 43.6 48.4 48.9 47.4 45.9 45.6 52.5 48.9 57.2 53.6 54.1
27–30 — — — — — — — — 42.0 45.1 46.2 43.3 42.3 49.9 47.1 48.2 48.9 49.1 49.8
Take cocaine 18 — — — — — — — 56.8 61.9 65.8 71.1 69.8 70.8 68.6 70.6 69.1 68.8 67.7 65.4
  powder 19–22 — — — — — — — 58.0 59.0 63.2 70.0 69.9 72.6 70.6 75.4 73.0 77.4 70.7 73.0
  occasionally i 23–26 — — — — — — — 50.0 53.2 62.2 63.3 67.0 65.8 64.0 68.8 68.8 76.1 72.8 77.0
27–30 — — — — — — — — 53.6 52.7 60.9 59.2 61.2 64.3 61.0 65.9 68.2 69.7 68.5
Take cocaine 18 — — — — — — — 81.4 82.9 83.9 90.2 88.9 88.4 87.0 88.6 87.8 86.8 86.0 84.1
  powder 19–22 — — — — — — — 86.6 87.6 91.3 92.5 93.8 92.1 94.0 94.9 93.5 93.8 92.8 91.5
  regularly i 23–26 — — — — — — — 82.9 84.1 88.5 92.4 93.8 91.3 92.4 92.8 92.1 94.8 90.8 93.7
27–30 — — — — — — — — 85.1 86.7 92.7 91.1 91.5 92.5 90.7 92.7 91.7 93.0 92.3
Try heroin once 18 52.1 52.9 51.1 50.8 49.8 47.3 45.8 53.6 54.0 53.8 55.4 55.2 50.9 50.7 52.8 50.9 52.5 56.7 57.8
  or twice g,p  19–22 57.8 56.8 54.4 52.5 58.7 51.0 55.5 57.9 58.9 59.6 58.3 59.9 59.8 58.9 60.8 58.9 61.0 63.9 60.7
23–26 — — — — 58.2 59.2 60.8 66.6 65.4 62.3 64.1 62.4 63.7 65.0 63.3 64.1 63.5 67.3 67.3
27–30 — — — — — — — — 66.0 69.7 67.5 66.1 66.5 69.3 69.6 66.4 66.4 67.9 69.7
Take heroin 18 70.9 72.2 69.8 71.8 70.7 69.8 68.2 74.6 73.8 75.5 76.6 74.9 74.2 72.0 72.1 71.0 74.8 76.3 76.9
  occasionally g,q 19–22 77.5 77.8 73.6 74.5 74.9 73.6 77.2 77.6 77.5 79.8 80.8 80.2 81.6 78.8 79.0 77.9 82.1 84.7 80.4
23–26 — — — — 81.2 80.7 78.9 84.5 82.4 80.8 83.4 84.4 81.5 82.1 80.8 85.3 82.4 86.5 83.9
27–30 — — — — — — — — 86.0 86.8 85.3 84.3 84.9 86.2 86.8 83.1 83.8 85.8 86.6
Take heroin 18 86.2 87.5 86.0 86.1 87.2 86.0 87.1 88.7 88.8 89.5 90.2 89.6 89.2 88.3 88.0 87.2 89.5 88.9 89.1
  regularly g  19–22 87.2 89.9 87.5 88.6 86.8 90.2 90.7 90.2 89.6 90.8 91.2 91.5 92.2 89.2 91.2 89.9 94.0 93.7 92.4
23–26 — — — — 92.0 90.1 90.6 92.8 91.5 91.3 91.0 92.6 91.3 91.6 93.0 93.5 92.7 94.4 93.4
27–30 — — — — — — — — 92.7 93.5 93.0 90.7 91.3 92.6 93.8 92.4 92.1 93.8 95.0
Try narcotics other than 18 — — — — — — — — — — — — — — — — — — —
  heroin once 19–22 — — — — — — — — — — — — — — — — — — —
  or twice h,x 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take narcotics other than 18 — — — — — — — — — — — — — — — — — — —
  heroin regularly h 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try 18 29.7 26.4 25.3 24.7 25.4 25.2 25.1 29.1 29.6 32.8 32.2 36.3 32.6 31.3 31.4 28.8 30.8 31.0 35.3
  amphetamines  19–22 24.6 24.6 27.8 24.8 26.9 23.9 27.1 27.4 31.7 28.9 35.6 32.8 34.5 33.3 36.3 32.9 36.8 30.1 31.7
  once or twice b,h,r 23–26 — — — — 29.6 29.4 29.4 34.1 33.2 32.5 35.3 31.0 32.7 32.6 32.9 34.3 34.9 37.8 40.9
27–30 — — — — — — — — 35.2 37.5 36.9 36.5 36.2 34.0 37.5 36.0 36.2 34.5 37.6
Take 18 69.1 66.1 64.7 64.8 67.1 67.2 67.3 69.4 69.8 71.2 71.2 74.1 72.4 69.9 67.0 65.9 66.8 66.0 67.7
  amphetamines 19–22 71.9 69.9 68.3 69.9 68.4 68.5 72.3 72.0 73.9 71.3 74.0 77.1 73.5 73.5 71.6 72.2 75.8 72.3 71.9
  regularly b,h 23–26 — — — — 75.8 77.2 75.6 78.2 77.4 76.7 77.8 79.4 76.4 76.2 73.6 80.5 78.5 79.1 77.5
27–30 — — — — — — — — 80.6 82.9 83.3 79.4 80.3 79.8 78.4 77.7 75.6 77.4 81.1
Try crystal 18 — — — — — — — — — — — 61.6 61.9 57.5 58.3 54.4 55.3 54.4 52.7
  methamphetamine (ice) h 19-22 — — — — — — — — — — 57.8 58.6 57.7 57.5 61.4 58.9 61.1 56.4 55.8
23–26 — — — — — — — — — — 56.5 56.0 55.6 52.0 61.0 57.8 64.1 60.7 58.2
27–30 — — — — — — — — — — 59.6 57.2 52.7 60.3 57.9 58.5 59.1 59.8 59.9
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Age Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Try crack once 18 48.2 48.4 49.4 50.8 47.3 47.8 48.4 47.8 47.3 47.5 48.4 50.2 51.7 52.0 55.6 54.5 53.6 53.9 51.6 51.3 -0.2  
  or twice h 19–22 56.1 52.9 54.1 54.1 55.1 56.8 56.6 55.3 51.9 54.9 54.9 53.7 56.6 — — — — — — — —
23–26 64.6 63.2 59.8 60.9 58.5 56.4 60.6 54.7 58.4 50.5 50.6 58.4 61.6 — — — — — — — —
27–30 65.0 62.9 69.3 67.4 66.0 62.6 61.9 56.8 64.1 56.2 56.2 62.2 60.4 — — — — — — — —
Take crack 18 67.3 65.8 65.4 65.6 64.0 64.5 63.8 64.8 63.6 65.2 64.7 64.3 66.2 66.5 69.5 68.5 67.8 66.2 65.3 64.4 -0.9  
  occasionally h  19–22 75.5 74.9 72.3 75.3 75.3 76.0 75.0 72.8 77.7 75.7 75.7 73.6 74.8 — — — — — — — —
23–26 81.6 84.0 80.1 82.2 77.1 76.4 78.6 76.8 79.8 75.2 75.2 77.7 82.8 — — — — — — — —
27–30 79.8 81.6 84.4 81.5 81.9 82.1 79.5 82.8 79.1 77.3 77.3 80.1 79.6 — — — — — — — —
Take crack 18 85.4 85.3 85.8 84.1 83.2 83.5 83.3 82.8 82.6 83.4 84.0 83.8 83.9 84.0 85.4 82.0 81.2 81.9 79.8 79.8 0.0  
  regularly h  19–22 92.3 91.1 89.6 91.1 93.8 93.3 92.5 90.3 90.3 93.6 93.6 93.1 90.8 — — — — — — — —
23–26 94.4 95.6 93.4 94.7 92.2 92.5 93.1 93.3 93.1 91.8 91.8 93.7 94.1 — — — — — — — —
27–30 95.2 93.5 96.8 94.2 94.4 94.0 95.2 94.1 93.6 93.1 93.1 93.9 92.6 — — — — — — — —
Try cocaine 18 46.1 47.0 49.0 49.5 46.2 45.4 46.2 45.8 45.1 45.1 46.5 48.2 48.0 48.1 49.9 49.9 49.0 49.3 45.1 44.9 -0.2  
   powder once 19–22 47.9 48.0 47.1 47.9 49.4 48.7 50.2 48.7 46.8 48.3 48.3 44.4 51.3 52.2 51.3 52.8 52.9 52.6 50.4 49.2 -1.3
   or twice i 23–26 53.8 53.2 53.9 52.5 50.8 46.0 53.3 45.8 48.1 44.1 44.2 43.9 47.4 52.5 47.4 48.9 49.2 48.4 47.0 44.8 -2.2
27–30 49.7 52.2 53.3 54.4 56.6 52.5 52.9 49.0 53.6 47.2 47.2 52.1 48.3 53.5 48.3 51.2 49.8 48.5 45.5 47.2 +1.7
Take cocaine 18 64.2 64.7 63.2 64.4 61.4 61.6 60.8 61.9 59.9 61.6 62.6 62.6 64.2 62.6 65.4 64.8 62.8 62.9 60.1 59.8 -0.3  
  powder 19–22 69.3 69.3 64.4 68.9 69.3 68.6 68.1 66.4 67.1 68.5 68.5 63.7 64.5 69.4 64.5 69.7 70.3 68.2 67.8 67.6 -0.3
  occasionally i 23–26 70.8 76.0 70.5 73.7 67.9 64.6 69.9 66.7 69.9 64.5 64.5 65.5 68.2 73.0 68.2 65.9 66.6 64.1 63.9 63.4 -0.5
27–30 70.1 71.3 73.5 71.9 71.7 71.5 71.7 73.1 69.3 64.9 65.0 68.9 68.8 71.0 68.8 67.3 64.8 64.2 62.7 64.3 +1.5
Take cocaine 18 84.6 85.5 84.4 84.2 82.3 81.7 82.7 82.1 81.5 82.5 83.4 81.8 83.3 83.3 83.9 81.5 80.1 80.7 78.8 77.6 -1.2  
  powder 19–22 92.4 90.7 89.8 91.0 92.0 91.6 90.7 89.1 89.5 92.3 92.3 90.7 91.0 88.3 90.2 88.6 89.6 89.8 87.3 87.3 -0.1
  regularly i 23–26 93.6 94.2 92.2 93.4 89.1 89.4 91.2 92.9 92.3 90.5 90.5 91.0 93.8 90.6 88.7 86.1 88.1 87.3 88.4 87.6 -0.8
27–30 93.1 91.5 94.0 93.3 94.1 93.1 93.9 92.4 92.5 90.1 90.2 92.1 91.5 92.2 90.9 89.2 91.4 89.2 85.3 87.3 +2.1
Try heroin once 18 56.0 54.2 55.6 56.0 58.0 56.6 55.2 59.1 58.4 55.5 59.3 58.3 59.1 59.4 61.7 62.8 64.0 64.5 63.0 61.8 -1.2  
  or twice g,p  19–22 63.5 63.2 64.0 63.1 64.6 67.3 66.5 65.0 69.6 67.7 67.3 64.2 66.5 66.8 68.9 66.1 70.4 70.5 70.9 73.4 +2.5
23–26 68.0 70.7 71.9 69.8 70.6 67.5 69.2 67.0 68.3 70.1 69.2 75.6 71.3 74.8 69.2 70.8 72.0 74.2 73.7 76.2 +2.5
27–30 70.1 67.4 68.2 70.9 72.3 68.4 74.4 70.8 70.2 70.2 67.6 69.6 69.1 70.4 72.7 71.7 74.5 72.6 74.3 77.8 +3.5
Take heroin 18 77.3 74.6 75.9 76.6 78.5 75.7 76.0 79.1 76.2 75.3 79.7 74.8 77.2 78.0 78.2 77.9 78.0 78.7 74.6 75.0 +0.3  
  occasionally g,q  19–22 82.5 82.0 83.6 82.2 84.9 85.1 83.8 84.3 85.4 84.5 83.3 81.3 82.9 82.1 85.0 83.3 85.8 85.9 86.3 84.2 -2.0
23–26 88.5 86.6 88.4 90.0 88.3 86.7 87.5 85.2 86.5 88.0 87.8 90.0 88.6 84.2 85.1 85.9 86.0 87.4 87.1 87.6 +0.6
27–30 87.1 86.5 86.4 87.9 87.4 88.6 91.2 88.3 88.5 87.7 87.7 90.1 85.8 86.2 88.6 83.7 88.2 85.0 89.4 87.6 -1.8
Take heroin 18 89.9 89.2 88.3 88.5 89.3 86.8 87.5 89.7 87.8 86.4 89.9 85.5 87.9 88.6 87.6 85.7 84.8 85.4 83.3 81.4 -1.8  
  regularly g  19–22 92.8 94.0 91.3 92.6 93.9 94.3 94.9 94.2 93.6 92.3 92.6 90.8 91.8 93.8 93.5 94.0 93.3 93.2 94.9 93.5 -1.5
23–26 93.7 94.8 95.9 96.3 96.5 96.0 94.8 95.8 93.1 95.7 94.5 97.1 94.2 92.5 95.0 96.2 92.5 95.3 94.8 94.5 -0.2
27–30 93.7 94.2 94.5 95.9 94.9 95.0 97.3 95.3 94.8 95.4 93.9 97.2 94.7 93.6 96.2 96.1 95.6 94.5 95.9 94.1 -1.8
Try narcotics other than 18 — — — — — — — — — — — 40.4 39.9 38.4 43.1 42.7 44.1 43.6 42.0 43.2 +1.1  
  heroin once 19–22 — — — — — — — — — — — — — 47.3 46.1 49.8 50.6 49.9 47.8 54.0 +6.2
  or twice h,x 23–26 — — — — — — — — — — — — — 45.3 44.1 45.2 46.4 45.8 45.7 53.3 +7.6
27–30 — — — — — — — — — — — — — 43.0 47.3 48.5 45.6 45.8 43.7 52.0 +8.2
Take narcotics other than 18 — — — — — — — — — — — 74.9 75.5 73.9 75.8 72.7 73.9 72.4 70.8 71.6 +0.8  
  heroin regularly h 19–22 — — — — — — — — — — — — — 70.3 74.9 76.0 76.2 76.2 73.2 78.3 +5.2
23–26 — — — — — — — — — — — — — 78.2 75.6 75.8 75.6 76.3 77.8 80.4 +2.5
27–30 — — — — — — — — — — — — — 76.2 75.7 76.0 74.9 76.7 78.1 79.5 +1.4
Try 18 32.2 32.6 34.7 34.4 36.8 35.7 37.7 39.5 41.3 39.2 41.9 40.6 34.8 34.3 36.3 34.1 34.0 31.1 31.9 29.2 -2.7  
  amphetamines 19–22 33.7 35.0 34.2 38.1 40.2 36.8 38.3 40.0 38.4 42.1 39.3 40.8 34.7 31.9 33.8 32.8 34.5 32.2 36.8 33.0 -3.8
  once or twice b,h,r 23–26 41.8 39.9 41.6 38.0 38.3 33.2 39.1 37.0 38.0 40.8 40.7 42.2 31.4 37.8 31.4 37.4 33.5 34.0 26.1 34.2 +8.1 s
27–30 36.3 39.4 38.5 39.0 40.5 39.2 38.2 39.7 37.4 36.5 36.2 38.5 36.9 35.3 34.0 30.4 32.1 30.5 31.6 33.4 +1.8
Take 18 66.4 66.3 67.1 64.8 65.6 63.9 67.1 68.1 68.1 65.4 69.0 63.6 58.7 60.0 59.5 55.1 54.3 51.3 50.0 51.1 +1.1  
  amphetamines 19–22 72.4 73.4 71.1 72.7 75.0 72.4 74.1 72.1 73.8 74.2 74.7 76.9 66.1 69.8 63.9 65.3 63.8 61.5 60.4 58.0 -2.4
  regularly b,h 23–26 78.7 79.0 77.7 77.9 80.1 75.1 80.1 78.3 77.0 76.5 73.9 80.8 69.7 68.3 64.9 68.5 59.0 65.8 57.8 61.1 +3.3
27–30 82.6 80.8 79.9 79.8 81.5 77.6 78.9 78.9 77.6 78.9 80.1 81.3 75.1 73.5 67.8 65.6 65.1 62.6 64.9 66.0 +1.1
Try crystal 18 51.2 51.3 52.7 53.8 51.2 52.4 54.6 59.1 60.2 62.2 63.4 64.9 66.5 67.8 72.2 70.2 70.0 70.0 69.3 67.1 -2.2  
  methamphetamine (ice) h 19-22 50.6 49.2 52.5 56.5 60.0 60.3 63.1 63.5 65.0 70.0 70.0 70.7 74.2 — — — — — — — —
23–26 61.3 60.1 59.2 57.7 58.6 55.9 63.9 63.9 66.6 65.6 65.6 70.1 74.6 — — — — — — — —
27–30 61.0 59.7 66.4 62.5 66.6 62.8 62.6 64.9 67.9 62.0 62.0 70.2 72.9 — — — — — — — —
↓
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Try bath salts (synthetic 18 — — — — — — — — — — — — — — — — — — —
  stimulants) once   19–22 — — — — — — — — — — — — — — — — — — —
  or twice h,v  23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try bath salts (synthetic 18 — — — — — — — — — — — — — — — — — — —
  stimulants) 19–22 — — — — — — — — — — — — — — — — — — —
  occasionally h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try Adderall 18 — — — — — — — — — — — — — — — — — — —
  once or twice h,w   19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Take Adderall 18 — — — — — — — — — — — — — — — — — — —
  occasionally h 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Try sedatives/ 18 30.9 28.4 27.5 27.0 27.4 26.1 25.4 30.9 29.7 32.2 32.4 35.1 32.2 29.2 29.9 26.3 29.1 26.9 29.0
  barbiturates 19–22 27.6 26.4 30.5 25.4 29.9 25.0 30.7 29.6 32.7 30.5 36.4 33.5 33.5 33.4 35.0 30.5 34.1 31.4 27.7
  once or twice c,h,s,t 23–26 — — — — 32.2 29.9 30.2 35.5 35.8 32.9 37.9 31.8 33.5 32.8 34.0 34.8 35.8 37.3 40.3
27–30 — — — — — — — — 37.2 38.7 39.0 37.0 38.2 36.5 40.5 36.6 37.2 35.7 36.7
Take sedatives/ 18 72.2 69.9 67.6 67.7 68.5 68.3 67.2 69.4 69.6 70.5 70.2 70.5 70.2 66.1 63.3 61.6 60.4 56.8 56.3
  barbiturates 19–22 74.0 73.3 72.7 71.3 71.6 71.7 74.5 73.0 74.0 71.7 75.5 75.5 73.6 71.1 69.4 66.4 70.7 69.5 65.1
  regularly c,h,u 23–26 — — — — 77.4 77.0 74.9 79.9 79.8 76.6 80.5 77.7 76.3 75.0 74.3 77.6 77.1 75.2 73.9
27–30 — — — — — — — — 81.5 83.7 84.0 79.6 78.6 80.2 78.3 77.7 74.1 77.1 79.9
Try one or two drinks 18 3.8 4.6 3.5 4.2 4.6 5.0 4.6 6.2 6.0 6.0 8.3 9.1 8.6 8.2 7.6 5.9 7.3 6.7 8.0
  of an alcoholic 19–22 3.0 3.4 3.1 2.3 4.7 3.1 5.4 3.5 3.9 5.9 6.1 5.4 5.8 6.6 6.5 4.5 3.3 3.2 4.2
  beverage (beer, 23–26 — — — — 5.5 3.0 6.5 6.6 4.2 5.1 5.7 4.4 5.6 3.2 4.5 4.3 4.8 4.4 4.4
  wine, liquor) i 27–30 — — — — — — — — 5.0 6.3 4.4 6.6 5.6 4.7 4.1 6.7 4.7 4.0 6.2
Take one or two 18 20.3 21.6 21.6 21.6 23.0 24.4 25.1 26.2 27.3 28.5 31.3 32.7 30.6 28.2 27.0 24.8 25.1 24.8 24.3
  drinks nearly 19–22 22.7 22.9 23.2 23.2 25.0 26.3 27.3 26.1 26.5 28.1 30.1 29.1 30.2 28.0 27.5 24.0 23.0 24.2 22.1
  every day i 23–26 — — — — 27.8 27.4 26.9 30.2 29.1 27.8 31.1 30.4 31.6 25.9 26.2 26.1 22.0 20.2 21.0
27–30 — — — — — — — — 27.4 31.7 32.2 31.7 30.9 28.0 27.4 27.2 24.0 24.8 20.8
Take four or five 18 65.7 64.5 65.5 66.8 68.4 69.8 66.5 69.7 68.5 69.8 70.9 69.5 70.5 67.8 66.2 62.8 65.6 63.0 62.1
  drinks nearly 19–22 71.2 72.7 73.3 72.7 76.2 74.1 74.0 76.4 72.8 75.7 76.1 75.5 71.8 72.1 70.3 72.5 68.5 71.4 70.4
  every day i 23–26 — — — — 76.7 77.9 80.1 77.2 81.8 76.9 79.7 80.2 78.0 76.7 77.5 75.2 72.0 75.1 69.3
27–30 — — — — — — — — 79.3 81.7 84.7 79.1 79.9 79.1 76.6 82.2 76.1 79.3 75.7
Have five or more 18 35.9 36.3 36.0 38.6 41.7 43.0 39.1 41.9 42.6 44.0 47.1 48.6 49.0 48.3 46.5 45.2 49.5 43.0 42.8
  drinks once 19–22 34.2 30.1 33.5 36.6 37.9 40.2 34.6 36.7 36.9 42.4 40.6 40.8 41.8 42.4 41.9 39.9 40.7 36.6 42.0
  or twice each 23–26 — — — — 38.4 39.7 39.1 39.8 35.8 37.7 40.2 39.3 37.6 36.2 40.2 37.9 39.1 37.4 41.1
  weekend i 27–30 — — — — — — — — 41.0 42.3 44.1 42.2 45.1 42.9 43.2 44.6 41.5 40.0 40.2
Smoke one or 18 63.7 63.3 60.5 61.2 63.8 66.5 66.0 68.6 68.0 67.2 68.2 69.4 69.2 69.5 67.6 65.6 68.2 68.7 70.8
  more packs of 19–22 66.5 61.7 64.0 62.1 69.1 71.4 70.4 70.6 71.0 73.4 72.5 77.9 72.6 76.0 71.2 71.6 73.8 76.3 77.2
  cigarettes 23–26 — — — — 71.1 70.1 75.7 73.6 75.5 71.4 78.5 75.3 76.3 78.4 76.4 76.0 76.0 77.6 76.5
  per day f 27–30 — — — — — — — — 72.8 75.2 77.8 75.4 77.6 75.0 75.3 75.6 73.0 80.3 80.9
Use electronic cigarettes 18 — — — — — — — — — — — — — — — — — — —
  (e-cigarettes) regularly 19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Use smokeless 18 — — — — — — 25.8 30.0 33.2 32.9 34.2 37.4 35.5 38.9 36.6 33.2 37.4 38.6 40.9
  tobacco 19–22 — — — — — — 29.7 34.1 31.1 37.1 33.5 38.9 40.1 43.3 37.6 42.3 40.9 46.5 47.4
  regularly h 23–26 — — — — — — 37.0 38.5 35.8 37.9 40.1 38.9 41.6 44.6 42.9 46.6 47.2 46.2 48.4
27–30 — — — — — — — — 42.8 42.8 43.8 44.3 44.1 47.3 46.3 44.2 43.6 50.2 52.6
Approximate Weighted N 18 3,234 3,604 3,557 3,305 3,262 3,250 3,020 3,315 3,276 2,796 2,553 2,549 2,684 2,759 2,591 2,603 2,449 2,579 2,564
Per Form = 19–22 590 585 583 585 579 547 581 570 551 565 552 533 527 480 490 500 469 464 431
23–26 540 512 545 531 527 498 511 505 518 503 465 446 438 420 413
27–30 513 587 490 486 482 473 443 450 422 434 416
(Years 
Cont.)
(Table continued on next page.)
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people risk harming 
themselves (physically or in 
other ways), if they . . .
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Age Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Try bath salts (synthetic 18 — — — — — — — — — — — — — 33.2 59.5 59.2 57.5 54.9 51.3 50.7 -0.6  
  stimulants) once   19–22 — — — — — — — — — — — — — 44.5 62.7 68.8 65.2 69.6 68.4 63.3 -5.1
  or twice h,v 23–26 — — — — — — — — — — — — — 46.7 66.3 67.3 69.4 70.9 68.6 74.8 +6.2
27–30 — — — — — — — — — — — — — 48.7 64.5 73.7 72.4 73.3 72.1 77.0 +4.8
Take bath salts (synthetic 18 — — — — — — — — — — — — — 45.0 69.9 68.8 67.4 64.2 61.5 60.7 -0.9  
  stimulants) 19–22 — — — — — — — — — — — — — 52.6 70.1 76.1 75.3 78.8 78.6 72.5 -6.1
  occasionally h 23–26 — — — — — — — — — — — — — 54.0 75.3 76.7 77.7 78.7 78.8 81.8 +3.0
27–30 — — — — — — — — — — — — — 55.9 71.5 78.4 77.4 80.7 81.4 85.4 +4.0
Try Adderall 18 — — — — — — — — — — — 33.3 31.2 27.2 31.8 33.6 34.3 32.5 32.0 34.0 +2.0  
  once or twice h,w   19–22 — — — — — — — — — — — — — 30.0 27.7 31.5 27.5 30.6 32.9 32.0 -1.0
23–26 — — — — — — — — — — — — — 28.9 32.9 32.2 29.8 32.9 27.5 30.1 +2.6
27–30 — — — — — — — — — — — — — 29.4 32.7 35.9 33.2 37.0 32.4 36.8 +4.4
Take Adderall 18 — — — — — — — — — — — 41.6 40.8 35.3 38.8 41.5 41.6 40.9 40.6 40.1 -0.5  
  occasionally h 19–22 — — — — — — — — — — — — — 38.8 39.8 41.8 40.2 43.0 45.4 47.3 +1.8
23–26 — — — — — — — — — — — — — 39.7 44.8 44.9 41.3 42.5 37.1 42.6 +5.6
27–30 — — — — — — — — — — — — — 44.1 45.0 45.3 44.2 47.7 46.5 49.3 +2.7
Try sedatives/ 18 26.1 25.0 25.7 26.2 27.9 24.9 24.7 28.0 27.9 25.9 29.6 28.0 27.8 27.8 29.4 29.6 28.9 27.4 26.9 26.3 -0.6  
  barbiturates 19–22 28.5 30.3 30.0 30.7 32.7 26.7 26.9 28.9 28.1 31.9 26.2 28.7 30.1 32.8 30.5 32.7 32.1 33.5 37.1 30.6 -6.5
  once or twice c,h,s,t 23–26 39.4 37.0 38.5 34.7 36.5 22.2 29.8 26.3 25.9 28.4 31.1 36.2 28.8 35.9 31.8 34.8 33.9 31.3 30.6 29.7 -0.9
27–30 35.2 36.3 40.9 37.3 38.6 31.4 31.7 28.8 28.0 27.8 27.5 27.4 34.4 28.7 31.9 25.0 34.2 34.8 30.4 37.2 +6.8
Take sedatives/ 18 54.1 52.3 50.3 49.3 49.6 54.0 54.1 56.8 55.1 50.2 54.7 52.1 52.4 53.9 53.3 50.5 50.6 47.0 44.0 45.1 +1.1  
  barbiturates 19–22 64.7 64.6 61.8 64.5 63.8 60.2 64.4 61.3 63.2 64.0 59.4 64.6 63.6 68.2 64.7 66.9 63.0 63.8 64.6 59.6 -5.0
  regularly c,h,u 23–26 75.1 73.8 73.1 73.1 72.8 63.9 67.0 67.6 64.8 66.8 64.4 69.6 64.9 71.4 67.6 72.3 64.5 65.2 62.9 68.8 +5.9
27–30 80.7 75.5 78.2 75.4 79.0 70.1 75.2 68.0 70.0 70.4 69.0 71.1 71.4 70.7 72.6 64.2 67.0 66.6 64.4 71.6 +7.2
Try one or two drinks 18 8.3 6.4 8.7 7.6 8.4 8.6 8.5 9.3 10.5 10.0 9.4 10.8 9.4 8.7 9.9 8.6 10.3 9.5 9.3 10.2 +0.9  
  of an alcoholic 19–22 5.7 5.4 4.8 6.6 7.5 5.1 3.8 7.7 5.1 7.9 4.1 6.8 7.2 6.4 5.8 5.7 4.9 4.9 6.5 5.9 -0.6
  beverage (beer, 23–26 6.6 3.5 5.5 5.1 5.7 4.7 5.3 5.1 4.8 6.5 5.7 5.5 4.0 3.5 4.3 5.4 5.1 3.9 4.1 3.3 -0.9
  wine, liquor) i 27–30 5.9 4.7 5.5 3.1 6.9 4.6 7.3 4.2 6.2 3.4 4.1 4.7 6.6 4.8 4.0 3.8 3.5 3.4 3.3 3.8 +0.5
Take one or two 18 21.8 21.7 23.4 21.0 20.1 23.0 23.7 25.3 25.1 24.2 23.7 25.4 24.6 23.7 23.1 21.1 21.5 21.6 21.6 22.8 +1.2  
  drinks nearly 19–22 23.9 22.1 19.6 22.7 19.8 21.3 22.1 22.0 19.0 24.4 20.6 20.8 20.1 23.1 20.0 22.4 19.9 18.6 17.8 18.3 +0.5
  every day i 23–26 26.0 21.7 23.5 23.4 19.1 22.9 19.9 22.5 21.2 21.0 21.1 20.8 14.4 18.4 18.8 17.5 17.2 17.4 15.4 16.8 +1.5
27–30 25.3 22.0 22.7 21.7 21.4 21.8 23.7 20.2 21.5 21.5 20.6 18.2 16.9 19.8 17.4 16.5 15.9 15.9 15.4 17.1 +1.7
Take four or five 18 61.1 59.9 60.7 58.8 57.8 59.2 61.8 63.4 61.8 60.8 62.4 61.1 62.3 63.6 62.4 61.2 59.1 59.1 58.7 59.1 +0.4  
  drinks nearly 19–22 69.9 69.9 64.5 71.1 66.4 65.3 63.0 66.6 68.8 68.5 67.1 65.6 67.4 69.6 68.7 67.9 70.2 70.4 65.1 66.8 +1.8
  every day i 23–26 72.8 71.7 75.8 74.9 71.1 74.2 71.2 72.4 70.2 70.0 67.8 68.3 69.9 73.1 69.7 69.2 71.2 70.7 70.1 70.0 -0.1
27–30 75.1 77.4 72.8 76.2 70.6 72.1 77.5 73.0 76.5 77.1 71.6 71.6 73.8 71.2 68.3 72.6 69.4 71.1 70.0 70.5 +0.5
Have five or more 18 43.1 42.7 43.6 42.2 43.5 43.6 45.0 47.6 45.8 46.3 48.0 46.3 47.6 48.8 45.8 45.4 46.9 48.4 45.7 44.7 -0.9  
  drinks once 19–22 37.2 38.9 37.2 37.8 40.4 38.1 37.5 37.2 43.4 41.7 35.2 40.7 40.1 41.6 40.6 43.8 41.8 43.6 39.6 40.3 +0.7
  or twice each 23–26 40.2 34.9 39.0 36.8 36.3 37.9 36.8 38.4 39.7 37.0 36.2 35.8 33.6 39.5 40.2 38.7 40.8 39.7 37.8 38.6 +0.8
  weekend i 27–30 41.9 37.9 41.6 40.6 42.5 40.5 44.0 39.1 40.4 40.4 40.1 38.6 42.0 41.6 37.2 41.2 40.6 39.6 42.0 40.2 -1.8
Smoke one or 18 70.8 73.1 73.3 74.2 72.1 74.0 76.5 77.6 77.3 74.0 74.9 75.0 77.7 78.2 78.2 78.0 75.9 76.5 74.9 73.9 -1.1  
  more packs of 19–22 75.7 77.1 76.6 80.6 77.8 81.1 80.5 80.8 79.3 79.5 80.3 79.7 81.5 82.3 82.8 82.8 83.5 84.8 83.8 82.4 -1.3
  cigarettes 23–26 80.9 79.7 83.9 85.1 83.6 84.1 81.6 86.4 80.7 83.6 82.0 83.2 84.8 83.1 82.9 82.8 85.1 84.2 84.3 84.9 +0.6
  per day f 27–30 80.7 78.4 82.7 80.6 82.0 81.7 84.1 83.8 84.3 86.6 83.6 89.3 86.6 84.6 84.1 83.9 85.9 85.4 86.3 84.2 -2.1
Use electronic cigarettes 18 — — — — — — — — — — — — — — — 14.2 16.2 18.2 16.1 18.0 +2.0  
  (e-cigarettes) regularly l 19–22 — — — — — — — — — — — — — — — 16.8 21.6 27.7 26.6 25.4 -1.1
23–26 — — — — — — — — — — — — — — — 21.7 23.0 28.6 28.2 31.4 +3.2
27–30 — — — — — — — — — — — — — — — 19.0 27.6 30.8 32.3 33.0 +0.7
Use smokeless 18 41.1 42.2 45.4 42.6 43.3 45.0 43.6 45.9 44.0 42.9 40.8 41.2 42.6 44.3 41.6 40.7 38.5 38.1 38.4 40.2 +1.8  
  tobacco 19–22 47.0 52.0 48.4 53.6 50.8 49.9 47.6 46.4 48.9 48.7 44.6 45.8 46.0 56.7 52.8 47.8 47.8 48.7 51.4 47.8 -3.6
  regularly h 23–26 53.1 49.8 59.8 61.4 58.9 57.8 55.8 59.1 55.3 51.0 52.2 54.2 53.7 59.4 53.5 53.4 47.3 52.5 54.6 50.6 -4.0
27–30 53.6 49.9 53.2 56.7 58.2 55.7 58.9 57.5 61.4 61.7 53.6 59.2 62.5 59.6 58.5 51.6 57.1 59.8 55.8 57.3 +1.5
Approximate Weighted N  18 2,306 2,130 2,173 2,198 2,466 2,491 2,512 2,407 2,450 2,389 2,290 2,440 2,408 2,331 2,098 2,067 2,174 1,992 2,175 2,243
Per Form = 19–22 447 424 430 395 402 447 412 411 375 377 393 363 374 345 337 314 315 270 281 283
23–26 418 400 392 382 401 426 408 361 351 375 345 363 366 323 337 319 296 284 264 267
27–30 400 377 384 369 380 388 374 358 344 350 337 343 319 335 320 282 312 259 284 266
Source. The Monitoring the Future study, the University of Michigan.
2017– 2018 
change
Percentage saying “great risk” a
Q. How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they . . .
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
TABLE 6-1 (cont.)
Trends in Harmfulness as Perceived by
274
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Trying marijuana 18 39.0 40.0 45.5 46.3 49.3 51.4 54.6 56.6 60.8 64.6 67.8 68.7 69.9 63.3 57.6 56.7 52.5 51.0 51.6
  once or twice j,z 19–22 38.2 36.1 37.0 42.0 44.1 46.6 51.6 52.8 55.8 62.4 59.6 60.4 57.8 60.6 63.5 57.1 55.4 56.2 55.9
23–26 — — — — 41.2 38.6 42.6 49.1 48.7 52.5 57.5 58.8 55.0 54.6 52.3 51.9 56.3 54.5 55.3
27–30 — — — — — — — — 49.0 50.9 53.8 54.6 51.9 56.8 55.7 57.5 54.1 59.0 55.7
Using marijuana 18 49.7 52.6 59.1 60.7 63.5 65.8 69.0 71.6 74.0 77.2 80.5 79.4 79.7 75.5 68.9 66.7 62.9 63.2 64.4
  occasionally j 19–22 49.6 49.1 51.3 56.0 60.4 62.6 66.7 67.2 69.5 77.3 76.3 77.0 74.8 75.8 76.9 70.4 68.9 70.2 67.8
23–26 — — — — 54.8 52.8 57.0 64.9 63.4 69.4 73.7 73.3 74.0 71.9 70.9 68.1 72.5 69.2 70.4
27–30 — — — — — — — — 65.3 67.1 68.9 73.0 67.2 72.2 69.4 72.5 70.5 74.5 72.4
Using marijuana 18 74.6 77.4 80.6 82.5 84.7 85.5 86.6 89.2 89.3 89.8 91.0 89.3 90.1 87.6 82.3 81.9 80.0 78.8 81.2
  regularly j,aa 19–22 74.3 77.2 80.0 81.8 84.9 86.7 89.2 88.7 89.1 91.2 93.1 91.3 89.5 90.2 90.1 86.8 87.7 88.1 85.3
23–26 — — — — 80.6 81.3 83.3 87.4 86.9 90.4 91.0 89.6 90.2 92.1 90.3 90.1 88.9 88.1 87.5
27–30 — — — — — — — — 87.6 87.5 89.7 89.6 87.2 89.4 88.7 91.9 89.9 92.1 89.2
Trying LSD 18 87.3 86.4 88.8 89.1 88.9 89.5 89.2 91.6 89.8 89.7 89.8 90.1 88.1 85.9 82.5 81.1 79.6 80.5 82.1
  once or twice h 19–22 87.4 84.8 85.9 88.4 88.1 89.1 90.4 90.0 90.9 89.3 90.5 88.4 84.6 88.5 86.8 84.2 83.0 83.1 80.8
23–26 — — — — 87.3 87.1 88.0 89.9 91.4 91.0 90.7 89.1 88.8 86.9 87.3 87.1 86.7 87.9 84.1
27–30 — — — — — — — — 91.0 87.2 89.7 87.9 85.6 88.8 88.2 87.4 88.7 88.7 87.3
Taking LSD 18 96.7 96.8 96.7 97.0 96.8 97.0 96.6 97.8 96.4 96.4 96.3 96.4 95.5 95.8 94.3 92.5 93.2 92.9 93.5
  regularly h 19–22 98.2 97.4 97.7 97.6 97.6 98.8 98.5 98.0 98.1 97.5 99.1 97.5 97.0 97.8 97.7 96.8 97.0 97.4 96.3
23–26 — — — — 99.2 98.0 98.5 99.0 98.0 98.4 98.3 98.4 98.3 98.1 97.7 96.7 97.7 96.1 97.6
27–30 — — — — — — — — 98.8 97.1 98.9 98.9 97.5 98.5 98.7 98.6 98.1 97.5 97.4
Trying ecstasy 18 — — — — — — — — — — — — — — — — — 82.2 82.5
  (MDMA, Molly) 19–22 — — — — — — — — — — — — — — — — — — —
  once or twice h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Taking ecstasy 18 — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — — — — — — — — — — — — — — — — — —
  occasionally h 23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
Trying cocaine 18 76.3 74.6 76.6 77.0 79.7 79.3 80.2 87.3 89.1 90.5 91.5 93.6 93.0 92.7 91.6 90.3 90.0 88.0 89.5
  once or twice h 19–22 73.0 69.3 69.9 74.1 72.5 77.6 78.9 82.3 85.3 88.8 90.1 91.2 90.6 92.7 93.9 94.2 92.0 91.7 89.9
23–26 — — — — 70.2 70.5 72.1 80.0 82.9 85.5 88.3 88.0 87.3 89.2 89.2 91.8 90.7 91.5 89.0
27–30 — — — — — — — — 82.1 81.0 85.5 86.9 83.9 85.7 86.6 86.6 88.3 89.2 90.3
Taking cocaine 18 91.1 90.7 91.5 93.2 94.5 93.8 94.3 96.7 96.2 96.4 96.7 97.3 96.9 97.5 96.6 96.1 95.6 96.0 95.6
  regularly h 19–22 91.6 89.3 91.9 94.6 95.0 96.3 97.0 97.2 97.9 97.4 98.9 97.9 98.4 97.8 98.8 98.2 97.9 98.0 97.8
23–26 — — — — 95.7 95.3 97.3 98.1 97.6 98.3 98.4 98.5 98.7 98.4 98.8 97.7 97.8 96.9 98.5
27–30 — — — — — — — — 98.1 97.0 99.3 99.0 97.2 98.7 99.0 98.9 98.5 97.9 97.8
Trying heroin 18 93.5 93.5 94.6 94.3 94.0 94.0 93.3 96.2 95.0 95.4 95.1 96.0 94.9 94.4 93.2 92.8 92.1 92.3 93.7
  once or twice h 19–22 96.3 95.4 95.6 95.2 95.1 96.2 96.8 96.3 97.1 96.4 98.3 95.9 95.9 96.3 96.6 95.6 95.2 95.6 95.1
23–26 — — — — 96.7 94.9 96.4 97.1 97.4 96.7 96.8 96.9 96.3 95.4 96.5 95.9 96.1 95.2 94.6
27–30 — — — — — — — — 97.9 95.8 97.5 96.6 94.8 97.3 94.7 96.3 96.0 96.9 95.9
Taking heroin 18 96.7 97.2 96.9 96.9 97.1 96.8 96.6 97.9 96.9 97.2 96.7 97.3 96.8 97.0 96.2 95.7 95.0 95.4 96.1
  occasionally h 19–22 98.6 97.8 98.3 98.3 98.6 98.7 98.3 98.3 98.3 97.9 99.2 98.2 98.1 98.1 98.3 97.7 97.9 97.8 98.2
23–26 — — — — 99.2 98.2 98.8 99.1 98.4 98.3 98.1 99.0 98.7 98.4 98.6 97.7 98.7 97.4 97.5
27–30 — — — — — — — — 99.2 97.3 99.0 98.9 97.0 98.9 98.7 98.9 98.0 98.7 97.6
Taking heroin 18 97.6 97.8 97.5 97.7 98.0 97.6 97.6 98.1 97.2 97.4 97.5 97.8 97.2 97.5 97.1 96.4 96.3 96.4 96.6
  regularly h 19–22 99.2 98.5 98.6 98.7 98.7 99.1 98.9 98.6 98.4 98.3 99.5 98.5 98.3 98.4 98.8 98.4 98.3 98.1 98.3
23–26 — — — — 99.4 98.8 99.1 99.4 98.7 98.7 98.5 99.3 99.2 98.9 98.8 98.7 98.9 97.6 98.5
27–30 — — — — — — — — 99.4 97.6 99.4 99.0 97.8 99.0 99.4 99.1 98.6 98.4 98.1
TABLE 6-2
Trends in Proportions Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Q. Do you disapprove of
people (who are 18 or 
older) doing each of the 
following?
Percentage disapproving e
(Years 
Cont.)
(Table continued on next page.)
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Age 
Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Trying marijuana 18 48.8 52.5 49.1 51.6 53.4 52.7 55.0 55.6 58.6 55.5 54.8 51.6 51.3 48.8 49.1 48.0 45.5 43.1 39.0 41.1 +2.1
  once or twice j,z 19–22 54.0 55.2 49.3 48.7 54.2 48.3 50.3 51.2 47.6 52.7 46.7 50.5 49.0 46.0 44.2 39.7 37.4 36.7 33.6 29.7 -3.9
23–26 55.7 54.8 51.2 52.4 47.8 53.4 47.7 47.5 54.6 46.2 44.9 42.5 38.8 40.9 38.1 37.8 34.6 36.3 29.2 26.0 -3.2
27–30 52.6 58.0 54.4 56.9 54.9 55.4 52.1 52.0 50.9 49.3 49.3 48.5 46.5 42.7 38.7 35.1 33.0 31.5 27.8 30.0 +2.1
Using marijuana 18 62.5 65.8 63.2 63.4 64.2 65.4 67.8 69.3 70.2 67.3 65.6 62.0 60.9 59.1 58.9 56.7 52.9 50.5 46.7 49.2 +2.6
  occasionally j 19–22 66.4 70.7 64.6 62.3 68.0 64.3 67.9 62.6 64.1 63.3 59.8 61.3 61.7 58.2 54.9 50.7 50.0 45.9 42.7 38.1 -4.6 s
23–26 71.1 68.6 67.4 64.0 63.8 69.3 65.6 62.2 68.0 64.5 62.4 59.1 53.1 55.8 51.3 51.3 49.1 46.8 41.5 35.2 -6.3 ss
27–30 71.5 72.2 70.9 69.1 71.2 69.1 68.2 68.7 67.5 63.7 63.7 62.7 63.7 58.3 55.0 50.0 47.3 44.0 39.8 39.1 -0.7
Using marijuana 18 78.6 79.7 79.3 78.3 78.7 80.7 82.0 82.2 83.3 79.6 80.3 77.7 77.5 77.8 74.5 73.4 70.7 68.5 64.7 66.7 +2.1
  regularly j,aa 19–22 84.5 86.6 84.5 82.8 84.8 82.7 84.4 82.5 83.7 83.6 80.8 80.7 78.1 77.0 75.7 71.3 71.0 70.6 67.3 61.1 -6.2 ss
23–26 86.1 83.9 86.4 81.7 82.3 87.4 84.3 81.9 85.3 84.3 80.2 78.3 76.4 76.7 73.6 71.4 70.4 68.8 65.0 60.8 -4.2 s
27–30 90.0 89.5 89.3 88.8 87.7 88.6 86.3 86.4 86.8 86.0 84.4 81.7 83.2 77.8 75.9 75.0 71.8 69.0 63.5 61.9 -1.6
Trying LSD 18 83.0 82.4 81.8 84.6 85.5 87.9 87.9 88.0 87.8 85.5 88.2 86.5 86.3 87.2 86.6 85.0 81.7 82.4 78.0 80.5 +2.5
  once or twice h 19–22 83.2 82.3 81.4 83.7 86.2 85.0 87.6 85.4 88.5 86.5 83.0 86.7 83.3 84.0 83.5 77.8 75.5 70.3 72.5 78.5 +6.0
23–26 84.8 80.3 83.0 79.2 80.1 84.0 84.0 84.5 87.6 81.8 85.0 82.6 80.1 83.3 79.7 79.8 76.8 73.9 73.9 66.5 -7.4
27–30 86.6 87.2 85.7 82.7 85.6 82.5 82.2 82.0 84.1 82.7 84.5 85.1 85.1 82.4 81.4 82.2 77.9 80.0 71.8 72.2 +0.4
Taking LSD 18 94.3 94.2 94.0 94.0 94.4 94.6 95.6 95.9 94.9 93.5 95.3 94.3 94.9 95.2 95.3 94.7 92.5 92.4 92.7 93.4 +0.7
  regularly h 19–22 97.0 96.8 96.5 96.9 98.4 97.3 98.9 97.8 97.7 96.8 96.8 96.6 96.5 96.0 96.7 97.0 95.2 95.4 93.9 95.9 +2.0
23–26 98.0 97.0 97.1 97.9 96.9 97.1 98.7 97.0 98.4 97.4 98.2 96.5 95.9 97.4 96.1 95.8 96.6 93.1 95.9 95.5 -0.4
27–30 97.9 98.6 98.2 98.0 98.2 98.2 97.2 96.7 97.2 97.1 98.6 98.6 97.1 97.3 97.2 97.3 96.0 96.4 94.0 92.8 -1.1
Trying ecstasy 18 82.1 81.0 79.5 83.6 84.7 87.7 88.4 89.0 87.8 88.2 88.2 86.3 83.9 87.1 84.9 83.1 84.5 84.0 85.1 85.6 +0.4
  (MDMA, Molly) 19–22 — — 81.5 80.3 87.2 83.5 90.3 87.5 88.5 89.5 89.1 91.4 85.9 87.9 83.9 83.7 79.7 83.2 78.2 81.1 +2.8
  once or twice h,m 23–26 — — 80.6 80.6 80.2 83.1 83.9 83.9 87.4 83.9 85.0 86.9 85.1 85.2 79.9 83.6 79.1 82.8 79.9 80.5 +0.6
27–30 — — 84.2 84.0 86.3 83.2 82.4 82.2 81.8 82.7 83.0 81.9 86.6 83.7 84.5 81.9 84.6 81.5 78.6 79.2 +0.6
Taking ecstasy 18 — — — — — — — — — — — — — — — — — — — — —
  (MDMA, Molly) 19–22 — — 92.8 91.8 95.6 93.8 96.7 94.0 95.3 94.8 95.2 95.3 91.8 94.4 92.3 94.6 90.7 90.2 93.1 92.7 -0.4
  occasionally h,m 23–26 — — 90.5 91.8 92.1 93.3 94.4 93.7 94.3 94.0 95.4 94.3 92.5 93.3 92.1 93.5 90.7 91.6 91.7 88.4 -3.3
27–30 — — 91.7 93.0 94.3 91.0 92.1 93.4 92.8 94.1 93.6 92.6 94.5 93.5 93.0 93.9 93.2 92.0 88.1 88.7 +0.6
Trying cocaine 18 89.1 88.2 88.1 89.0 89.3 88.6 88.9 89.1 89.6 89.2 90.8 90.5 91.1 91.0 92.3 90.0 89.0 88.4 88.0 88.9 +0.9
  once or twice h 19–22 90.9 89.9 87.7 87.9 89.3 87.7 92.3 88.2 89.2 85.8 87.8 87.1 90.1 89.7 90.5 86.7 86.0 84.3 85.6 86.8 +1.2
23–26 91.3 87.1 90.1 85.8 86.4 87.4 88.3 84.4 87.6 84.5 86.2 86.0 82.7 86.0 85.7 84.8 82.9 77.5 80.8 77.4 -3.3
27–30 90.4 89.4 90.3 88.5 91.5 88.0 87.0 85.8 87.7 87.4 88.3 87.3 87.0 85.6 82.5 85.0 79.1 83.7 75.8 78.6 +2.8
Taking cocaine 18 94.9 95.5 94.9 95.0 95.8 95.4 96.0 96.1 96.2 94.8 96.5 96.0 96.0 96.8 96.7 96.3 95.2 94.8 94.8 95.8 +1.1
  regularly h 19–22 97.6 98.0 97.2 97.0 98.2 98.5 98.7 98.9 99.0 97.6 97.6 97.6 97.2 97.6 97.4 97.8 97.8 97.2 97.0 97.1 +0.1
23–26 98.3 97.8 97.5 97.5 97.6 98.1 98.9 97.3 98.1 98.0 98.7 97.6 97.3 98.8 97.8 97.7 97.5 94.5 97.0 96.7 -0.2
27–30 98.8 98.7 98.4 97.8 98.8 98.8 97.8 97.2 97.9 97.3 99.0 99.0 98.4 98.5 98.0 97.6 98.0 96.9 96.1 97.0 +0.9
Trying heroin 18 93.5 93.0 93.1 94.1 94.1 94.2 94.3 93.8 94.8 93.3 94.7 93.9 94.3 95.8 95.6 94.7 94.2 94.1 93.7 95.0 +1.2
  once or twice h 19–22 95.5 94.1 94.2 95.0 96.4 95.9 98.8 95.6 97.6 95.7 95.5 95.8 96.7 95.9 96.3 96.5 96.1 94.9 96.8 95.7 -1.1
23–26 96.3 93.1 95.0 94.8 95.0 95.0 96.1 93.7 97.2 95.6 94.9 94.5 95.5 95.7 94.7 97.2 96.5 93.4 96.6 96.9 +0.4
27–30 96.7 95.9 96.4 94.4 97.6 94.9 95.6 93.9 96.4 96.2 95.4 96.3 95.7 95.9 94.8 95.3 95.2 95.9 95.5 96.3 +0.8
Taking heroin 18 95.7 96.0 95.4 95.6 95.9 96.4 96.3 96.2 96.8 95.3 96.9 96.2 96.3 97.0 96.9 96.6 95.3 95.5 95.5 96.4 +0.8
  occasionally h 19–22 97.2 98.0 97.9 97.9 98.3 98.9 99.4 98.2 98.8 97.3 97.9 97.5 97.7 97.4 98.0 97.8 97.5 97.4 97.7 97.9 +0.2
23–26 98.5 98.2 97.8 97.5 97.2 98.5 98.3 97.7 98.8 98.3 98.5 97.1 99.0 99.0 98.1 98.1 98.1 96.6 97.7 97.7 0.0
27–30 98.8 98.6 98.4 98.6 98.7 98.1 97.7 97.1 98.1 98.2 98.6 99.3 98.1 97.9 97.7 97.3 98.0 98.3 97.4 98.2 +0.8
Taking heroin 18 96.4 96.6 96.2 96.2 97.1 97.1 96.7 96.9 97.1 95.9 97.4 96.4 96.7 97.4 97.4 97.1 96.4 95.7 95.9 96.8 +0.9
  regularly h 19–22 98.2 98.5 98.2 98.3 98.8 99.0 99.2 98.9 99.1 98.3 98.1 97.6 97.9 98.3 98.4 97.9 98.1 97.6 97.7 98.0 +0.4
23–26 98.7 98.8 98.4 98.3 98.6 98.9 98.9 98.0 99.0 99.1 99.2 97.6 99.3 99.1 98.3 98.9 98.1 97.0 98.4 97.9 -0.6
27–30 98.8 98.7 98.7 98.4 99.3 98.8 99.1 97.5 98.2 98.4 99.0 99.3 98.6 98.3 97.9 97.6 98.5 98.9 98.0 98.5 +0.6
↓
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Trying 18 75.4 71.1 72.6 72.3 72.8 74.9 76.5 80.7 82.5 83.3 85.3 86.5 86.9 84.2 81.3 82.2 79.9 81.3 82.5
  amphetamines  19–22 74.5 70.5 68.9 74.0 73.0 75.6 78.9 79.9 81.8 85.3 84.4 83.9 83.8 87.2 88.3 85.0 84.4 83.3 84.6
  once or twice b,h,bb 23–26 — — — — 74.2 74.2 74.6 80.3 83.5 83.3 84.1 84.8 83.4 84.8 82.7 86.0 86.4 85.7 83.5
27–30 — — — — — — — — 83.5 81.0 84.3 83.7 80.9 83.5 82.0 83.1 85.8 86.3 85.9
Taking 18 93.0 91.7 92.0 92.6 93.6 93.3 93.5 95.4 94.2 94.2 95.5 96.0 95.6 96.0 94.1 94.3 93.5 94.3 94.0
  amphetamines 19–22 94.8 93.3 94.3 93.4 94.9 96.6 96.9 95.1 97.5 96.8 97.5 97.7 96.7 97.3 97.9 96.8 97.2 97.8 96.7
  regularly b,h 23–26 — — — — 96.6 95.9 96.6 97.0 97.2 98.1 97.9 97.9 97.7 98.4 97.7 97.0 97.9 97.0 98.0
27–30 — — — — — — — — 98.1 96.5 98.6 97.8 96.8 97.7 99.0 98.9 98.2 98.1 97.7
Trying sedatives/ 18 83.9 82.4 84.4 83.1 84.1 84.9 86.8 89.6 89.4 89.3 90.5 90.6 90.3 89.7 87.5 87.3 84.9 86.4 86.0
   barbiturates 19–22 83.5 82.3 83.8 85.1 85.2 86.1 88.3 87.5 90.1 92.0 91.1 90.4 88.8 90.7 91.1 90.5 89.1 86.6 85.8
   once or twice c,h 23–26 — — — — 84.0 84.5 84.4 89.8 90.7 89.4 88.8 87.9 88.8 88.5 88.0 89.3 88.3 88.3 87.4
27–30 — — — — — — — — 90.5 88.3 88.4 88.8 86.6 88.9 87.6 88.0 89.4 88.8 88.4
18 95.4 94.2 94.4 95.1 95.1 95.5 94.9 96.4 95.3 95.3 96.4 97.1 96.5 97.0 96.1 95.2 94.8 95.3 94.6
   barbiturates 19–22 96.6 95.6 97.3 96.5 96.6 98.1 98.0 97.0 97.9 97.7 98.7 98.0 97.9 98.2 98.7 97.7 97.9 97.7 97.7
   regularly c,h,cc 23–26 — — — — 98.4 98.5 97.7 98.6 98.3 98.3 98.5 98.5 98.6 98.5 98.5 97.4 98.4 97.4 98.5
27–30 — — — — — — — — 98.4 97.1 99.1 98.5 97.7 98.4 99.1 99.0 98.5 97.9 97.7
Trying one or two 18 16.0 17.2 18.2 18.4 17.4 20.3 20.9 21.4 22.6 27.3 29.4 29.8 33.0 30.1 28.4 27.3 26.5 26.1 24.5
  drinks of an alcoholic 19–22 14.8 14.5 13.9 15.5 15.3 15.4 16.9 16.0 18.4 22.4 17.6 22.2 16.9 20.8 22.2 22.0 22.0 18.3 21.5
  beverage (beer, 23–26 — — — — 17.4 16.1 13.2 17.7 13.7 17.5 18.6 19.5 17.4 18.1 17.6 16.5 18.0 15.8 18.6
  wine, liquor) j,dd 27–30 — — — — — — — — 19.5 19.1 18.7 18.8 17.9 19.5 18.6 18.2 16.1 17.4 15.2
Taking one or two 18 69.0 69.1 69.9 68.9 72.9 70.9 72.8 74.2 75.0 76.5 77.9 76.5 75.9 77.8 73.1 73.3 70.8 70.0 69.4
  drinks nearly 19–22 67.8 69.7 71.3 73.3 74.3 71.3 77.4 75.3 76.5 80.0 79.7 77.1 76.0 75.0 78.0 74.7 73.5 73.2 70.3
  every day j 23–26 — — — — 71.4 73.7 71.6 72.7 74.6 74.4 77.6 76.9 75.5 74.2 73.3 69.7 70.6 68.4 70.2
27–30 — — — — — — — — 76.0 73.9 73.3 76.1 69.5 73.5 72.4 71.8 71.4 71.8 69.8
Taking four or five 18 90.8 91.8 90.9 90.0 91.0 92.0 91.4 92.2 92.8 91.6 91.9 90.6 90.8 90.6 89.8 88.8 89.4 88.6 86.7
  drinks nearly 19–22 95.2 93.4 94.6 94.6 94.6 94.8 94.9 95.7 94.8 96.1 95.8 96.4 95.5 95.1 96.2 95.5 94.2 93.9 92.4
  every day j 23–26 — — — — 96.2 95.0 95.5 96.9 94.3 95.9 96.9 96.1 95.7 95.7 95.7 95.2 96.5 93.8 96.1
27–30 — — — — — — — — 97.4 94.6 96.1 95.3 94.8 94.8 96.4 96.7 96.4 96.2 95.0
Having five or 18 55.6 55.5 58.8 56.6 59.6 60.4 62.4 62.0 65.3 66.5 68.9 67.4 70.7 70.1 65.1 66.7 64.7 65.0 63.8
  more drinks 19–22 57.1 56.1 58.2 61.0 59.7 59.4 60.3 61.6 64.1 66.3 67.1 62.4 65.6 63.5 68.1 66.0 69.2 66.5 63.2
  once or twice 23–26 — — — — 66.2 68.3 66.5 67.5 65.2 63.2 66.9 64.6 69.6 66.8 66.9 65.3 70.9 66.6 69.5
  each weekend j 27–30 — — — — — — — — 73.9 71.4 73.1 72.1 68.4 73.4 73.5 73.7 72.4 73.0 71.1
Smoking one or 18 70.8 69.9 69.4 70.8 73.0 72.3 75.4 74.3 73.1 72.4 72.8 71.4 73.5 70.6 69.8 68.2 67.2 67.1 68.8
  more packs of 19–22 68.7 68.1 66.3 71.6 69.0 70.5 71.4 72.7 73.8 75.6 73.7 73.2 72.6 72.8 75.3 69.8 72.2 74.3 72.3
  cigarettes 23–26 — — — — 69.9 68.7 67.5 69.7 66.4 71.1 71.5 77.2 73.6 72.9 70.3 72.2 73.0 71.7 73.9
  per day j 27–30 — — — — — — — — 72.8 69.4 73.5 71.2 70.7 73.8 72.3 73.9 72.7 74.3 71.7
Approximate Weighted N 18 3,261 3,610 3,651 3,341 3,254 3,265 3,113 3,302 3,311 2,799 2,566 2,547 2,645 2,723 2,588 2,603 2,399 2,601 2,545
Per Form = 19–22 588 573 605 579 586 551 605 587 560 567 569 533 530 489 474 465 480 470 446
23–26 542 535 560 532 538 516 524 495 538 514 475 466 449 423 401
27–30 526 509 513 485 512 462 442 450 430 453 449
Percentage disapproving e
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Age 
Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Trying 18 81.9 82.1 82.3 83.8 85.8 84.1 86.1 86.3 87.3 87.2 88.2 88.1 84.1 83.9 84.9 83.1 81.4 82.1 81.9 81.0 -0.8  
  amphetamines 19–22 84.9 83.8 82.1 81.4 86.3 82.1 88.2 84.9 84.8 86.7 85.4 86.9 80.5 81.3 83.7 73.6 76.4 70.9 80.0 74.3 -5.6
  once or twice b,h,bb 23–26 84.5 82.4 83.9 83.5 79.9 81.6 81.3 79.0 85.8 79.7 84.4 84.1 76.5 80.7 77.3 81.4 76.9 72.9 75.5 67.9 -7.6
27–30 86.4 84.5 86.0 86.4 84.9 82.4 81.3 81.1 84.5 83.7 82.9 84.3 81.1 81.9 81.5 80.8 74.6 78.6 73.8 73.4 -0.4
Taking 18 93.7 94.1 93.4 93.5 94.0 93.9 94.8 95.3 95.4 94.2 95.6 94.9 92.9 93.9 93.2 93.0 92.2 92.2 92.0 92.8 +0.8  
  amphetamines 19–22 97.5 96.1 97.3 96.4 97.1 97.1 98.4 97.5 98.6 96.2 96.8 96.2 92.1 94.1 94.4 92.8 94.0 93.3 93.6 92.3 -1.3
  regularly b,h 23–26 97.0 97.6 96.8 96.3 97.2 95.9 98.3 96.2 97.6 97.3 98.1 96.8 94.8 95.9 94.6 92.4 93.7 90.4 94.4 91.7 -2.7
27–30 98.2 98.5 97.6 97.4 98.1 98.0 97.6 96.4 98.4 97.2 98.1 98.0 97.5 95.8 96.8 96.3 94.8 94.6 94.6 95.4 +0.9
Trying sedatives/ 18 86.6 85.9 85.9 86.6 87.8 83.7 85.4 85.3 86.5 86.1 87.7 87.6 87.3 88.2 88.9 88.5 87.4 86.5 85.9 86.9 +0.9  
   barbiturates 19–22 86.6 84.2 85.2 84.2 87.7 81.8 86.6 83.4 82.7 82.1 84.7 85.2 85.4 88.0 88.6 86.3 87.1 80.3 87.6 81.0 -6.6 s
   once or twice c,h 23–26 87.3 85.2 86.9 86.8 81.8 80.3 81.6 80.5 84.3 77.7 83.3 80.9 80.6 83.8 84.4 84.4 84.5 82.1 80.9 75.9 -5.0
27–30 87.6 87.3 88.5 86.9 89.2 81.8 78.7 80.1 83.5 80.5 82.5 80.3 83.3 83.1 82.6 82.5 81.2 79.2 75.9 78.3 +2.4
Taking sedatives/ 18 94.7 95.2 94.5 94.7 94.4 94.2 95.2 95.1 94.6 94.3 95.8 94.7 95.1 96.1 95.8 95.0 94.7 94.8 94.4 95.3 +0.9  
   barbiturates 19–22 97.3 97.4 96.9 97.8 98.5 96.6 98.3 98.1 98.3 96.7 96.7 96.3 96.7 96.4 96.5 97.8 96.7 95.4 96.6 95.2 -1.4
   regularly c,h,cc 23–26 97.6 97.4 97.0 97.1 97.1 96.1 98.0 96.3 97.8 96.7 98.4 95.7 98.1 97.3 97.2 96.6 95.7 94.9 95.5 95.0 -0.5
27–30 98.5 98.1 98.4 97.2 98.4 98.1 96.5 95.6 97.4 97.4 98.4 98.6 97.0 97.7 97.1 97.4 97.7 98.0 95.9 96.4 +0.5
Trying one or two 18 24.6 25.2 26.6 26.3 27.2 26.0 26.4 29.0 31.0 29.8 30.6 30.7 28.7 25.4 27.3 29.2 28.9 28.8 27.2 31.3 +4.1  
  drinks of an alcoholic 19–22 18.3 18.4 16.3 18.3 20.1 20.7 22.3 17.8 17.3 20.5 19.1 23.7 21.6 21.4 19.6 17.9 17.5 18.3 17.7 17.8 +0.1
  beverage (beer, 23–26 19.1 19.9 15.9 18.1 13.0 16.3 13.5 14.7 14.9 12.5 16.0 15.4 10.9 14.1 13.5 14.2 12.8 15.5 14.7 11.6 -3.1
  wine, liquor) j,dd 27–30 15.9 14.8 15.9 18.4 15.4 18.8 16.1 15.0 14.2 11.9 11.5 13.3 11.8 14.7 13.2 11.7 12.1 11.4 11.5 14.6 +3.0
Taking one or two 18 67.2 70.0 69.2 69.1 68.9 69.5 70.8 72.8 73.3 74.5 70.5 71.5 72.8 70.8 71.9 71.7 71.1 71.8 70.8 74.7 +3.9 s
  drinks nearly 19–22 67.3 66.7 68.3 63.9 66.9 68.1 64.6 68.2 65.1 65.2 67.4 68.4 71.0 65.7 64.0 61.6 63.3 64.2 62.1 61.7 -0.4
  every day j 23–26 73.4 66.3 66.5 62.7 65.0 61.7 64.4 62.0 62.4 66.4 62.0 62.5 55.7 53.9 54.4 53.3 53.4 58.6 53.9 57.3 +3.4
27–30 67.9 65.9 68.9 70.9 63.1 66.7 60.5 62.0 65.8 59.5 63.7 61.4 61.7 55.6 51.3 52.0 54.8 50.0 50.0 50.8 +0.8
Taking four or five 18 86.9 88.4 86.4 87.5 86.3 87.8 89.4 90.6 90.5 89.8 89.7 88.8 90.8 90.1 90.6 91.9 89.7 91.1 90.7 91.7 +1.0  
  drinks nearly 19–22 92.4 92.8 94.2 92.6 92.5 92.2 93.2 92.9 92.9 94.0 93.6 92.2 93.9 91.9 92.1 91.1 92.1 92.0 92.6 92.9 +0.3
  every day j 23–26 95.1 94.3 93.5 93.7 92.6 93.1 94.8 92.9 95.6 94.9 94.6 93.9 94.7 92.8 91.8 91.4 92.4 93.6 91.4 93.0 +1.6
27–30 97.2 95.3 96.1 95.4 95.6 96.0 92.8 92.7 95.0 93.9 96.0 94.3 95.8 92.1 92.1 93.4 91.8 91.2 90.5 91.8 +1.4
Having five or 18 62.7 65.2 62.9 64.7 64.2 65.7 66.5 68.5 68.8 68.9 67.6 68.8 70.0 70.1 71.6 72.6 71.9 74.2 72.5 75.8 +3.3 s
  more drinks 19–22 63.5 65.1 58.3 57.5 61.9 59.4 60.1 59.3 59.1 63.4 62.3 62.7 65.4 64.7 66.3 64.7 66.6 68.6 65.4 68.6 +3.1
  once or twice 23–26 68.1 66.2 66.0 61.2 65.5 60.9 64.5 59.7 62.4 63.0 59.5 61.7 55.9 63.0 63.3 62.0 62.6 69.4 64.4 65.0 +0.6
  each weekend j 27–30 73.1 73.1 73.0 70.9 71.5 73.8 67.5 67.3 71.5 66.4 65.8 67.5 64.9 63.3 65.0 64.1 66.1 64.0 65.8 65.3 -0.5
Smoking one or 18 69.5 70.1 71.6 73.6 74.8 76.2 79.8 81.5 80.7 80.5 81.8 81.0 83.0 83.7 82.6 85.0 84.1 85.3 86.6 89.0 +2.4 s
  more packs of 19–22 70.1 73.1 73.2 73.4 73.4 74.8 81.5 77.2 81.0 80.4 81.8 82.9 83.8 79.5 81.0 80.6 82.7 85.7 85.4 86.8 +1.5
  cigarettes 23–26 73.8 72.7 77.3 74.8 75.7 76.2 74.8 74.1 76.2 77.9 77.3 77.9 80.3 78.2 77.8 80.0 80.3 83.5 85.0 84.0 -0.9
  per day j 27–30 71.0 78.6 75.2 78.8 76.2 77.6 77.3 73.9 81.1 74.5 80.9 79.6 79.5 79.1 79.9 79.9 82.2 82.2 81.1 82.6 +1.6
Approximate Weighted N 18 2,310 2,150 2,144 2,160 2,442 2,455 2,460 2,377 2,450 2,314 2,233 2,449 2,384 2,301 2,147 2,078 2,193 2,000 2,129 2,267
Per Form = 19–22 449 416 413 402 396 431 378 378 333 365 368 364 340 356 280 316 264 252 225 271
23–26 397 389 404 346 385 403 374 364 325 335 328 347 309 334 312 308 284 271 234 264
27–30 429 395 368 359 346 370 367 330 355 339 325 334 306 312 301 304 262 258 276 285
Source. The Monitoring the Future study, the University of Michigan.
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Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
The illicit drugs not listed here show a daily prevalence of 0.2% or less in all years.
' * ' indicates a prevalence rate of less than 0.05%.
' — ' indicates data not available.
aAnswer alternatives were: (1) No risk, (2) Slight risk, (3) Moderate risk, (4) Great risk, and (5) Can’t say, drug unfamiliar.
bIn 2011 the list of examples was changed from upper, pep pills, bennies, and speed to uppers, speed, Adderall, Ritalin, etc.  These changes likely explain the 
discontinuity in the 2011 results.
cIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, 
yellows, etc. to just downers. 
These changes likely explain the discontinuity in the 2003 and 2004 results. 
dFor 12th graders only: In 2011 the question on perceived risk of using salvia once or twice appeared at the end of a questionnaire form.  In 2012 the question was
moved to an earlier section of the same form.  A question on perceived risk of using salvia occasionally was also added following the question on perceived risk of 
trying salvia once or twice.  These changes likely explain the discontinuity in the 2012 result.
eAnswer alternatives were: (1) Don’t disapprove, (2) Disapprove, and (3) Strongly disapprove. Percentages are shown for categories (2) and (3) combined.
fAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.   In 2012 and following
data based on five questionnaire forms.
gAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.  In 2012 and following
data based on two questionnaire forms.
hData based on one questionnaire form.
iAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.   In 2012 and following
data based on three questionnaire forms.
jAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.  In 2012 and following
data based on four questionnaire forms.
kAge 18 data based on one questionnaire form for all years reported.    For ages 19-30 only: Prior to 2012, data based on one questionnaire form.  In 2012 and 2013
two questionnaire forms.  Data based on one questionnaire form in 2014 and following.
lData based on two questionnaire forms for all years reported.
mBeginning in 2014 for Age 18 and 2015 for the other age groups, "molly" was added to the questions on perceived risk of using MDMA.  The same change was 
made to the questions on disapproval of MDMA use for all age groups in 2015.   Data for the two versions of the questions are not comparable due to this
change in the question text.
nFor the estimate of Perceived Risk of Using Marijuana Occasionally in 2018, there was a significant difference (p<.05) among those age 27-30 between the 
typical mail condition (12.8%) and new web-push condition (8.9%) of survey administration.
oFor the estimate of Perceived Risk of Using Cocaine Occasionally in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (74.8%) and new web-push condition (62.8%) of survey administration.
pFor the estimate of Perceived Risk of Trying Heroin Once or Twice in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (71.4%) and new web-push condition (80.5%) of survey administration.
qFor the estimate of Perceived Risk of Using Heroin Occasionally in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (84.4%) and new web-push condition (90.5%) of survey administration.
rFor the estimate of Perceived Risk of Trying Amphetamines Once or Twice in 2018, there was a significant difference (p<.05) among those age 27-30 between the 
typical mail condition (27.1%) and new web-push condition (38.8%) of survey administration.
sFor the estimate of Perceived Risk of Trying Sedatives/Barbiturates Once or Twice in 2018, there was a significant difference (p<.05) among those age 19-22 between the 
typical mail condition (23.4%) and new web-push condition (36.4%) of survey administration.
tFor the estimate of Perceived Risk of Trying Sedatives/Barbiturates Once or Twice in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (22.4%) and new web-push condition (36.0%) of survey administration.
uFor the estimate of Perceived Risk of Using Sedatives/Barbiturates Regularly in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (62.4%) and new web-push condition (74.3%) of survey administration.
vFor the estimate of Perceived Risk of Trying Bath Salts Once or Twice in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (68.0%) and new web-push condition (80.6%) of survey administration.
wFor the estimate of Perceived Risk of Trying Adderall Once or Twice in 2018, there was a significant difference (p<.05) among those age 23-26 between the 
typical mail condition (22.7%) and new web-push condition (36.1%) of survey administration.
xFor the estimate of Perceived Risk of Trying Narcotics Other Than Heroin Once or Twice in 2018, there was a significant difference (p<.05) among those age 23-26 
between the typical mail condition (46.3%) and new web-push condition (59.2%) of survey administration.
yFor the estimate of Perceived Risk of Using Salvia Occasionally in 2018, there was a significant difference (p<.05) among those age 19-22 between the 
typical mail condition (17.3%) and new web-push condition (28.5%) of survey administration.
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zFor the estimate of Disapproval of Trying Marijuana Once or Twice in 2018, there was a significant difference (p<.05) among those age 27-30 between the 
typical mail condition (32.6%) and new web-push condition (27.4%) of survey administration.
aaFor the estimate of Disapproval of Using Marijuana Regularly in 2018, there was a significant difference (p<.05) among those age 19-22 between the 
typical mail condition (65.1%) and new web-push condition (57.8%) of survey administration.
bbFor the estimate of Disapproval of Trying Amphetamines Once or Twice in 2018, there was a significant difference (p<.01) among those age 19-22 between the 
typical mail condition (83.1%) and new web-push condition (67.9%) of survey administration.
ccFor the estimate of Disapproval of Using Sedatives/Barbiturates Regularly in 2018, there was a significant difference (p<.05) among those age 27-30 between the 
typical mail condition (98.7%) and new web-push condition (93.8%) of survey administration.
ddFor the estimate of Disapproval of Trying Alcohol Once or Twice in 2018, there was a significant difference (p<.01) among those age 27-30 between the 
typical mail condition (17.3%) and new web-push condition (12.0%) of survey administration.
Footnotes for Tables 6-1 through 6-2 (cont.)
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-1
Trends in Harmfulness of MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-2
Trends in Harmfulness of MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-3
Trends in Harmfulness of MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-4
Trends in Harmfulness of SYNTHETIC MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
Trends in Harmfulness of SYNTHETIC MARIJUANA Use as Perceived by
Respondents in Modal Age Groups of 19–22, 23–26, and 27–30
Occasional Use
FIGURE 6-5
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-6
Trends in Harmfulness of LSD Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-7
Trends in Harmfulness of LSD Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
Trying Once or Twice
FIGURE 6-8
Trends in Harmfulness of PCP Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-9
Trends in Harmfulness of COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-10
Trends in Harmfulness of COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-11
Trends in Harmfulness of COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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0
20
40
60
80
100
’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17 ’18
P
E
R
C
E
N
T
 S
A
Y
IN
G
 G
R
E
A
T
 R
IS
K
YEAR OF ADMINISTRATION
18 23-26
19-22 27-30
291
Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-12
Trends in Harmfulness of CRACK COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-13
Trends in Harmfulness of CRACK COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
Regular Use
FIGURE 6-14
Trends in Harmfulness of CRACK COCAINE Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-15
Trends in Harmfulness of COCAINE POWDER Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-16
Trends in Harmfulness of COCAINE POWDER Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-17
Trends in Harmfulness of COCAINE POWDER Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
a In 2014 in the Age 18 questionnaire, "molly" was added to the question text.  In 2015, the same change was made to the questionnaires for the other age groups.  This likely explains the discontinuity in results for the affected years.
FIGURE 6-18
Trends in Harmfulness of ECSTASY (MDMA, Molly)a Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
a In 2015, "molly" was added to the question text. This likely explains the discontinuity in results for the affected years.
FIGURE 6-19
Trends in Harmfulness of ECSTASY (MDMA, Molly)a Use as Perceived by
Respondents in Modal Age Groups of 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-20
Trends in Harmfulness of HEROIN Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-21
Trends in Harmfulness of HEROIN Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Occasional Use
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-22
Trends in Harmfulness of HEROIN Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
0
20
40
60
80
100
’80 ’81 ’82 ’83 ’84 ’85 ’86 ’87 ’88 ’89 ’90 ’91 ’92 ’93 ’94 ’95 ’96 ’97 ’98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17 ’18
P
E
R
C
E
N
T
 S
A
Y
IN
G
 G
R
E
A
T
 R
IS
K
YEAR OF ADMINISTRATION
18 23-26
19-22 27-30
302
Source. The Monitoring the Future study, the University of Michigan.
aIn 2011 the list of examples was changed from upper, pep pills, bennies, and speed to uppers, speed, Adderall, Ritalin, etc.  These changes likely explain the discontinuity in the 2011 results.   
FIGURE 6-23
Trends in Harmfulness of AMPHETAMINEa Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2011 the list of examples was changed from upper, pep pills, bennies, and speed to uppers, speed, Adderall, Ritalin, etc.  These changes likely explain the discontinuity in the 2011 results.   
Regular Use
FIGURE 6-24
Trends in Harmfulness of AMPHETAMINEa Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. 
These changes likely explain the discontinuity in the 2003 and 2004 results. 
FIGURE 6-25
Trends in Harmfulness of SEDATIVE (BARBITURATE)a Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
aIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. 
These changes likely explain the discontinuity in the 2003 and 2004 results. 
Regular Use
FIGURE 6-26
Trends in Harmfulness of SEDATIVE (BARBITURATE)a Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-27
Trends in Harmfulness of ALCOHOL Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trying Once or Twice
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-28
Trends in Harmfulness of ALCOHOL Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Having One or Two Drinks per Day
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Source. The Monitoring the Future study, the University of Michigan.
Having Four or Five Drinks per Day
FIGURE 6-29
Trends in Harmfulness of ALCOHOL Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
Having Five or More Drinks Once or Twice Each Weekend
FIGURE 6-30
Trends in Harmfulness of BINGE DRINKING as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source. The Monitoring the Future study, the University of Michigan.
FIGURE 6-31
Trends in Harmfulness of TOBACCO Use as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Smoking One or More Packs of Cigarettes per Day
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Source. The Monitoring the Future study, the University of Michigan.
Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Regular Use
FIGURE 6-32
Trends in Harmfulness of SMOKELESS TOBACCO Use as Perceived by
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Chapter 7 
 
THE SOCIAL CONTEXT 
 
The social contexts in which individuals place and otherwise find themselves can influence the 
likelihood of using drugs in a number of ways. The context can provide social modeling and social 
norms for either use or abstention from use. Through friends and friends’ contacts it can also 
influence the availability of drugs and bring about an awareness of new drugs, including 
knowledge of their existence and their potential for altering mood and consciousness. Since its 
inception, MTF has measured three important features of the social context: (1) peer groups’ norms 
about drug use, (2) amount of direct exposure to drug use by friends and others, and (3) perceived 
availability of drugs. All three factors are measured by self-reports and are therefore measures of 
the perceived context, though evidence suggests that they bear a strong correlation with the actual 
context (e.g., consistency between one’s own reported attitudes and behaviors regarding substance 
use and perceived peer attitudes and behaviors). We believe that these three factors exert important 
influences on substance use at both the individual (micro) and the aggregate (macro) level. 
 
In Volume I,1 we examined these factors among secondary school students. In this chapter, we do 
the same for the young adult population ages 19 to 30, whose social contexts typically differ 
considerably from what they were in high school. Most high school graduates today enter college, 
many get civilian jobs, and some enter military service. These transitions almost always change 
the institutional contexts experienced by young adults (e.g., colleges, work organizations, military 
services) and therefore the circles of people to whom they are exposed and with whom they 
develop friendships. Such transitions also alter the potential consequences of drug use if it is 
discovered by authorities in the relevant institution; for example, consequences today can be quite 
severe for those in military service, and we have shown that illicit drug use drops when young 
people enter the military.2  
 
Each of the question sets discussed here is contained in only one of the six questionnaire forms, so 
the case counts are lower than those presented in most chapters in this volume. Therefore, these 
prevalence and trend estimates are more subject to random fluctuation or “noise” compared to 
those based on more questionnaire forms in this volume as well as those covered in Volume I1 
(MTF’s cross-sectional secondary school samples are much larger than its young adult samples). 
As we did in Chapter 6, when examining age variation within those aged 19-30, we use four-year 
age bands (19-22, 23-26, 27-30) to increase the available sample sizes to about 250-600 weighted 
cases per year for each age band, thereby improving the reliability of the estimates. (The numbers 
of weighted cases are given at the end of Table 7-1. The actual numbers of respondents are 
somewhat larger.) 
 
In addition, we include consideration of norms, exposure, and availability where relevant among 
those age 35 through 60. In such cases, the data are based on larger numbers because just one form 
is used for all respondents at each particular age.  
                                                 
1 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, University of Michigan. 
2 Bachman, J. G., Freedman-Doan, P., O’Malley, P. M., Johnston, L. D., & Segal, D. R. (1999). Changing patterns of drug use among U.S. military 
recruits before and after enlistment. American Journal of Public Health, 89, 672-677. 
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PEER NORMS AMONG YOUNG ADULTS (AGES 18–30) 
Table 7-1 provides current levels and trends in perceived friends’ disapproval of experimental, 
occasional and regular use of marijuana, alcohol, and cigarettes as reported by 12th graders, 19-22 
year olds, 23-26 year olds, and 27-30 year olds. Trend data are available since 1980, 1984, and 
1988, respectively, for these three 4-year age groupings of young adults. The survey question 
reads, “How do you think your close friends feel (or would feel) about you… [trying marijuana 
once or twice]?” The answer categories are “don’t disapprove,” “disapprove,” and “strongly 
disapprove.” Percentages discussed below are for the last two categories combined. 
 
The results for perceived peer norms are generally quite consistent with those for personal 
disapproval in the aggregate. Exceptions are trying marijuana once or twice and smoking one or 
more packs of cigarettes per day, for which friends’ attitudes are consistently reported as more 
disapproving than respondents' own attitudes (especially in the oldest age band), and weekend 
binge drinking, for which friends’ attitudes are seen as less disapproving than their own. The 
question set regarding friends’ disapproval employs a shorter list of drug-using behaviors but 
includes the same answer scale, stated in terms of strength of disapproval associated with different 
use levels of the various drugs, as do the questions on the respondent’s own attitudes about those 
behaviors (discussed in Chapter 6). While peer disapproval and personal disapproval questions 
appear on different questionnaire forms and therefore have different sets of respondents, the forms 
are distributed randomly in respondents’ senior year of high school and should leave no systematic 
sample differences.  
 
Perceptions of Close Friends’ Attitudes (Ages 18 to 30) 
Table 7-1 provides trends for each age band in the proportions of respondents indicating how their 
close friends would feel about the respondent engaging in various drug-using behaviors. For 
purposes of simplification, we begin by addressing results across the entire 19- to 30-year age band 
(tabular data for the entire age band are not presented). Then we distinguish among the three young 
adult age bands: 19-22, 23-26, and 27-30, along with 18 year olds. In 2010 questions about friends’ 
disapproval were dropped from the young adult follow-up questionnaires for all drugs except 
marijuana, binge drinking, and cigarettes. The dropped questions had shown a high degree of 
redundancy with respondents’ reports of their own attitudes in the aggregate, and thus were deleted 
to make room for other items. 
 
 Generally, the peer norms reported by young adults one to 12 years past high school have 
been quite similar to those reported by 12th graders.  
 
 In 2018, with regard to marijuana, 35% to 40% of the young adults thought their close 
friends would disapprove of their trying it, 40% to 46% thought their close friends would 
disapprove of occasional use, and two-thirds (64% to 68%) thought close friends would 
disapprove of regular use. Clearly the norms differ as a function of level of marijuana use, 
with less than half believing occasional use and about two-thirds believing regular use 
would meet with disapproval from their close friends. In comparison, in 2018, 
corresponding rates for 12th graders were 46%, 53%, and 68%, showing somewhat less 
differentiation as a function of level of marijuana use than young adults show. 
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 For each of the illicit drugs other than marijuana, 2009 was the last year in which results 
on peer norms were available. At that time, the great majority of young adults, nearly 9-in-
10, said that their close friends would disapprove of their even trying such drugs once or 
twice; 89% indicated this for cocaine, 87% for LSD, and 87% for amphetamines. (We 
stopped asking these questions beginning in 2010 to make space for new items on the 
survey and because the data that they provided on peer norms so closely tracked what their 
own attitudes were in the aggregate; below we provide a quick summary of trends for these 
three measures up through 2009.)  
 
 In 2018, with regard to friends’ disapproval of binge drinking on weekends, about half 
(52% to 56%) of any of the young adult age groups thought that their close friends would 
disapprove of their having five or more drinks once or twice each weekend. These levels 
of disapproval are considerably lower than among those 18 years old (72%). These levels 
are also lower than perceived disapproval of daily drinking. In 2009 (when we last asked 
these questions), nearly two thirds (63%) of young adults said their close friends would 
disapprove if they were daily drinkers, and 9 out of 10 (91%) thought friends would 
disapprove if they had four or five drinks nearly every day.  
 
 Peer disapproval of cigarette smoking is very high in all four age bands: In 2018, 87% of 
12th graders said their friends would disapprove of pack-a-day smoking, as did 90% to 92% 
of 19-30 year olds. 
 
Trends in Peer Norms (Ages 18 to 30) 
Important changes in the social acceptability of drug-using behaviors among both 12th graders’ 
and young adults’ peers have occurred since MTF began (see Table 7-1). We present overviews 
of trends, summarizing previous years. 
 
 In 2018, perceived peer disapproval of experimental, occasional, and regular use of 
marijuana among young adults were at historic lows since the early 1980s. This follows a 
period of declines in perceived peer disapproval for nearly a decade, as summarized below. 
 
Among 12th graders, the proportion saying their close friends would disapprove of their 
trying marijuana rose from 41% in 1979 to 73% in 1992, a period of substantial decline in 
use. Friends’ disapproval also grew substantially stronger in all of the young adult age 
bands in the years for which data are available. For example, among 19-22 year olds, the 
proportion thinking their close friends would disapprove if they even tried marijuana rose 
from 41% in 1981 to 65% in 1992 (Table 7-1). A similar peak in disapproval occurred for 
23-26 year olds in 1992 and 1993, and among 27-30 year olds in 1994 and 1995, 66% for 
both age bands; these trends suggest some cohort effects as classes of higher disapproving 
12th graders grew older. In all age groups, peer disapproval subsequently declined, though 
the declines were earliest and greatest among 12th graders, again consistent with cohort 
effects. The decline ended in 1997 for 12th graders and began to reverse, but continued 
through 2002 among 19-26 year olds. There was little systematic change for several years 
among 19-26 year olds until about 2008 when friends’ disapproval began to decline again 
for all three levels of marijuana use. In 2013 all young adult age groups showed a further 
decline in disapproval of experimental marijuana use; indeed, the declines for the older two 
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age bands were large and statistically significant. For example, the percent of 23-26 year 
olds and 27-30 year olds saying that their close friends would disapprove of their trying 
marijuana fell by about 9 percentage points in that one year, possibly reflecting both cohort 
effects and a secular trend. In 2013, about half of each age group (48% to 52%) said that 
their close friends would disapprove of their trying marijuana, down from between 57-62% 
as recently as 2008. Since 2013, perceived peer disapproval has continued to decline, 
reaching 35% to 40% in 2018 among young adults; these are new historic lows since the 
early 1980s.    
 
Close friends’ disapproval of occasional and regular marijuana use also rose until the early 
1990s among respondents 18 years old, and then declined between 1992 and 1997. It 
declined through 1999 among 19-22 year olds and continued to decline among 23-30 year 
olds through 2003. Recent peak years of friends’ disapproval of trying marijuana were 
2006 for 12th graders, 2008 for 19-26 year olds, and 2010 for 27-30 year olds. In essence, 
peer norms have moved in a way consistent with the existence of some lasting cohort 
differences in these norms, as well as in use. A more formal analysis of age, period, and 
cohort effects in disapproval came to the same conclusion.3 In the past decade or so, there 
have been continuing declines in friends’ disapproval of occasional and regular use among 
all age groups, suggesting more of a secular trend effect. In 2018, less than half of young 
adults (40% to 46%) said that their close friends would disapprove of their using marijuana 
occasionally, and a majority still said they would disapprove regular use (63% to 68%). 
Thus, 2018 levels of close friends’ disapproval of occasional and regular marijuana use 
are at historic lows since the early 1980s. Clearly peer norms among young adults, as well 
as teens, have become more accepting of marijuana use in recent years, corresponding to 
their increased use.   
 
 There was a gradual increase in peer disapproval of trying an amphetamine for all age 
groups (18-30) through 1991, followed by a small decline evident among 12th graders 
through 1997. Between 1997 and 2009, the last year we asked this question of young adults 
and for which data are available, levels of disapproval among 18-30 year olds increased to 
some extent, though not dramatically. In 2009, disapproval levels for trying an 
amphetamine were at 87% for all four age groups. Based on the data available on trends in 
respondents’ own disapproval (see Chapter 6), it seems likely that peer disapproval among 
young adults has weakened modestly in recent years, as it has for 12th graders. 
 
 Perceived peer norms for LSD were measured from 1980 through 2009 among the follow-
up respondents. Through 1991, peer disapproval of trying LSD showed very little change 
in any of the age bands, but it fell some in the 1990s, especially among 18 year olds and 
subsequently among 19-22 year olds. These declines bottomed out in a staggered fashion, 
beginning with the 12th graders in 1997, which thereafter showed a seven-percentage-point 
increase in peer disapproval. There was a five-percentage-point increase among 19-22 year 
olds (after 2000), and a three-percentage-point increase among 23-26 year olds (after 
2001), again suggestive of a cohort effect in these norms. In 2009, the last year we asked, 
                                                 
3 Keyes, K. M., Schulenberg, J. E., O’Malley, P. M., Johnston, L. D., Bachman, J. G., Li, G., & Hasin, D. (2011). The social norms of birth cohorts 
and adolescent marijuana use in the United States, 1976-2007. Addiction, 106(10), 1790-1800. 
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there was almost no difference among the age groups, with 85% to 87% of respondents in 
each age group saying their friends would disapprove of their trying LSD.   
 
 Perceived peer norms regarding cocaine use were measured from 1986 through 2009, after 
which such questions were dropped. In the eight-year interval from 1986 to 1994, self-
reported cocaine use declined substantially as peer norms in all age bands shifted toward 
disapproval. For example, by 1994, 95% of the 19-22 year olds thought their close friends 
would disapprove of their even trying cocaine once or twice. After 1994, peer norms 
against use continued to strengthen a bit in the upper age bands, perhaps through 
generational replacement, but weakened slightly in the younger age bands, likely reflecting 
a new cohort effect combined with generational forgetting of the consequences of using 
cocaine. By 2009 (the last year we asked) there was little difference by age in peer norms 
against cocaine use, with 85% to 91% saying their friends would disapprove of their even 
trying it. By way of contrast, in 1986 that statistic ranged between 71% and 80% among 
18-26 year olds. 
 
 For most of the years under consideration, peer norms against binge drinking on weekends 
(five or more drinks once or twice each weekend) among the three young adult age groups 
have tended to be weakest for the 19-22 year old age group, in which such behavior is most 
common, and strongest for the 27-30 year old group. Since 2002, disapproval of such 
drinking has also been low for the 23-26 year old group relative to the other two age bands. 
Since about 2012, the differences among the three age groups have diminished (ranging 
from 52% to 56% in 2018). Among 12th graders, friends’ attitudes had become somewhat 
more restrictive between 1981 and 1992 (and respondents’ own occasions of binge 
drinking declined during that interval), but attitudes were fairly level for some years and 
then rose from 56% in 2002 to 72% by 2018). There was a similar upward trend in peer 
disapproval among the various young adult age bands that followed a staggered pattern, 
again likely reflecting a cohort effect in these norms. However, between 1997 and 2000 
the 19-22 year old age group became somewhat less disapproving of occasions of binge 
drinking on weekends; this was followed by a decline in perceived peer disapproval 
between 2001 and 2004 among 23-26 year olds, and a decline from 2004 to 2009 among 
27-30 year olds. The recent increase in peer disapproval among 12th graders was not 
mirrored among the older age strata; thus peer disapproval of binge drinking became 
highest among the 12th graders, contrary to the situation in the late 1990s when 12th graders 
were the lowest. Despite some increases in peer disapproval over the years, this risky and 
potentially health-compromising form of drinking has the least restrictive perceived peer 
norms of regular use of all of the substances measured in MTF (only experimental and 
occasional use of marijuana have lower norms in recent years), yet about half still report 
peer disapproval. In 2018 the proportions saying that their friends would disapprove of 
such weekend binge drinking was between 52% and 56% for the three young adult age 
bands compared to 72% among the 12th graders. 
 
 Peer norms against cigarette smoking one or more packs per day have strengthened in 
staggered fashion among those age 18 and the young adult age groups. Between 1998 and 
2008, the proportion saying that their close friends would disapprove of their smoking a 
pack or more of cigarettes per day rose substantially from 69% to 83% among 18 year olds 
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and from 69% to 86% among 19-22 year olds. In other words, the proportions not 
disapproving were cut in half. The two older strata did not see a comparable change until 
peer disapproval among 23-26 year olds rose from 77% in 2005 to 88% in 2009, at which 
time their disapproval leveled. The change did not manifest itself among the 27-30 year 
olds until 2010; their rates of peer disapproval of smoking, which for some years had the 
highest rates of disapproval for smoking among the four age groups, stayed fairly level 
after 2000, until there was a 4.4-percentage-point jump in 2010, followed by a leveling. 
This pattern again suggests some cohort effects in peer norms working their way up the 
age spectrum. In 2018, very large proportions across the age bands reported that their 
friends would disapprove of pack-a-day smoking, ranging from 87% at age 18 to 90-92% 
among the young adult age groups. 
 
In the early years of MTF, peer disapproval of smoking a pack or more of cigarettes per 
day rose among 12th graders from 64% (1975) to 73% (1979). There was little further net 
change for 13 years through 1992, when friends’ disapproval stood at 76%. During the 
relapse in the drug epidemic between 1992/1993 and 1997/1998, all age groups showed a 
decrease in perceived peer disapproval of smoking, consistent with a secular trend.  
 
 It is noteworthy that peer norms for so many drugs have shown cohort effects in their 
patterns of change across age bands. In addition to cohort effects, secular trend effects are 
evident, with the recent declines in peer disapproval of marijuana use in all four age groups, 
suggesting a secular trend. 
 
ADULTS’ EXPOSURE TO DRUG USE THROUGH FRIENDS AND OTHERS  
(AGES 18–60) 
Exposure to drug use is important because it provides both the modeling of the behavior by peers 
(possibly including direct encouragement to use) and immediate access. Exposure is measured by 
two sets of questions, each appearing on a (different) single questionnaire form. The first set asks 
the respondent to estimate what proportion of his or her friends use each drug (i.e., friends’ use), 
while the second set asks, “During the LAST TWELVE MONTHS how often were you around 
people who were using each of the following to get high?” (i.e., direct exposure). The same 
questions are asked of 12th graders (modal age 18), and their results are included here for 
comparison purposes in Tables 7-2 and 7-3 and Figures 7-1 through 7-24. (Questions about direct 
exposure to drug use were not included in the questionnaires for 35-60 year olds due to the space 
limitations imposed by the use of a single questionnaire form at each of these ages.)  
 
With regard to our measures of friends’ use, we continue to present four-year age bands for the 
young adult friends’ use measures in order to increase the reliability of the estimates. Questions 
about friends’ use were included at ages 35, 40, 45, 50, 55, and 60. They are shown as one-year 
age bands, with both half-samples from each of those cohorts being surveyed at those modal ages. 
Starting with age 35, each year has a larger number of cases than single years at the earlier ages 
because all respondents in a cohort at later ages complete the relevant questionnaire items, 
compared with only one sixth of those at younger ages. At the end of each table in this chapter is 
a summary of the weighted number of cases upon which each annual estimate is based. (The actual 
numbers of cases are somewhat higher.)  
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Exposure to Drug Use (Ages 18 to 60) 
 Relatively high proportions of young adults in all of these age bands have had at least some 
friends who use some illicit drug (including marijuana); that proportion varies considerably 
with age, with older respondents reporting that fewer of their friends use (Table 7-2). In 
2018, illicit drug use by at least some friends was reported by 78% at age 18, increasing to 
86% for 23-26 year olds, then decreasing to 42% at age 60. The 2018 levels are at or near 
all-time highs (largely due to continued increase in friends’ use of marijuana as discussed 
below).4  
 
Clearly, among adults, the older the respondent, the less likely he or she is to report having 
friends who use any illicit drugs. In 2018, the proportions who said that most or all of their 
friends use one or more of the illicit drugs were much lower (Table 7-2): 27% for 12th 
graders, between 14% and 27% for the 19-30 year olds, and between 2% and 9% for those 
35, 40, 45, 50, 55, and 60 years old, quite a dramatic difference across ages and one that is 
consistent with the large differences in their own self-reported current use. 
 
With regard to being around others in the past 12 months who used any illicit drug (direct 
exposure), it was highest among 19-22 year olds in 2018 (Table 7-3). The percent saying 
that they had any direct exposure to people using in 2018 was 73% for 12th graders, 76% 
for 19-22 year olds, 74% for 23-26 year olds, and 66% for 27-30 year olds. The percent 
indicating that they often had direct exposure followed a similar age-group pattern: 31%, 
36%, 25%, and 25%, respectively (direct exposure is not asked of those age 35 and above). 
Among young adults, but not among 12th graders, rates of direct exposure in 2018 were at 
or near historic highs for the past three decades (since about the mid- to-late 1980s), as 
discussed in the section below on trends. Note that rates of any direct exposure tend to be 
lower than rates for any friends’ use (as summarized above), a pattern that holds for most 
illicit and licit substances. 
 
 With regard to illicit drugs other than marijuana, taken as a whole, considerably fewer 
respondents reported that any of their friends use compared to what is true for marijuana 
use (see below): 41% for 12th graders, 52-54% for 19-30 year olds, and 18-28% for 35-60 
year olds in 2018 (Table 7-2).4 The proportions who said that most or all of their friends 
use illicit drugs other than marijuana in 2018 were 5%, 2-7%, and less than 1%, 
respectively. Thus, very low proportions of the older age groups appear to be deeply 
immersed in a drug culture involving illicit drugs beyond marijuana. 
 
Regarding direct exposure to others using illicit drugs other than marijuana in the past year, 
the percent indicating that they were around any people using was highest in 2018 among 
19-26 year olds (46-47%) and lower among 12th graders (40%) and 27-30 year olds (35%) 
(Table 7-3). The percent indicating that they often were directly exposed was quite low, 
and similar across the four age groups (7-8%). As discussed below when considering 
                                                 
4 Due to a printing error in the young adult questionnaire in 2015, data cannot be reported for friends’ use in the young adult age bands in that one 
year for this index as well as for some individual drugs that were directly affected. We believe that the 2014 data present a reasonable approximation 
of what the values likely would be in 2015. This applies to some but not all of the measures of the individual drugs. This situation was remedied in 
the 2016 surveys. 
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trends, the rates of direct exposure in 2018 were at or near historic highs over the past three 
decades among young adults, but not among 12th graders. 
 With respect to individual illicit drugs, exposure among all of the age groups was greatest
for marijuana. The percentages in 2018 saying they have any friends who use was 77%
for 12th graders, 79% for 19-22 year olds, 84% for 23-26 year olds, and 80% for 27-30
year olds; it declined by age for the older adults from 60% at age 35 to 36% at age 60
(Table 7-2). In regard to most or all friends using in 2018, percentages were highest for
12th graders and 19-22 year olds (26%) and declined with age from 17% for 23-26 year
olds to 2% at age 60. For the age groups 23-24 through 55, the 2018 levels were at or near
new historic highs as discussed further below.
Similarly, rates of direct exposure to people using marijuana in the past year among young 
adults in 2018 were at or near historic highs over the past three decades. For any direct 
exposure, they were 70% for 12th graders, 76% for 19-22 year olds, 72% for 23-26 year 
olds, and 65% for 27-30 year olds; rates for often having direct exposure were 28%, 34%, 
24%, and 22%, respectively (Table 7-3). 
 The next-highest exposures in 2018 were for amphetamines (22% among 12th graders,
31% among 19-22 year olds, 33% among 23-26 year olds, and 32% among 27-30 year
olds) and cocaine (18% among 12th graders, 30% among19-22 year olds, 35% among 23-
26 year olds, and 25% among 27-30 year olds), followed by MDMA (ecstasy, Molly),
hallucinogens other than LSD, and narcotics other than heroin. (Use of several illicit
drugs was not asked of the age groups above 30 due to space limitations in the single
questionnaire form used at each of those ages. See Table 7-2.)
 For the remaining illicit drugs, the proportion of young adults reporting in 2018 that some
friends use a given drug was 10% or higher in at least two of the four age strata for the
following drugs: LSD (16-28%), sedatives (barbiturates) (12-16%), and tranquilizers (9-
12%), and steroids (8-13%). See Table 7-2 for specifics.
 In the past few years, reported friends’ use of cocaine has been highest among young
adults, and this continued in 2018 with 18% for 12th graders, and 25% to 35% for 19-30
year olds (peaking at age 23-26 at 35%). Those 35, 40, 45, 50, and 55 years old are asked
separately about cocaine powder; in 2018 far fewer reported having friends who use
cocaine powder, 15% for age 35 and 4% to 9% for the five older groups.
 For use of crack specifically, 9% of 12th graders reported having any friends using crack,
versus 6% to 11% of 19-30 year olds in 2018 (use is no longer asked of those age 35 and
over, because by 2017, the rate was down to 0-2%).
 The proportions who report having any friends who take heroin are now level across young
adulthood. In 2018, these percentages were 5.8%, 3.3%, 3.3%, and 3.8% for the age groups
of 18, 19-22, 23-26, and 27-30, respectively. These age differences are much smaller than
in earlier years, due to greater declines with time among the younger age groups. (This
question is not asked of those age 35 and over.)
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 At present, the percentages reporting any friends who use narcotics other than heroin are 
higher among older respondents: in 2018, 15% of 18 year olds, 20% of the 19-22 year olds, 
22% of 23-26 year olds, and 26% of 27-30 year olds. This was not always the case. In the 
late 1990s and early 2000s perceptions of friends’ use were lower among older young 
adults (this question is not asked of those age 35 and older) (Table 7-2). 
 
 In general, it appears that some respondents who report that their friends use illicit drugs 
are themselves not directly exposed to that use by their friends, judging by the differences 
in proportions saying they have some friends who use (Table 7-2) and the proportions who 
say they have been around people who were using during the prior year (Table 7-3 and 
Figure 7-1). That is, as has been true all along, more respondents report use by friends than 
report being around others who were using. When considering trends in the next section, 
we give more attention to findings from the direct exposure measure concerning being 
around others who use. 
 
 With respect to alcohol use, the great majority of young adults have at least some friends 
who get drunk at least once a week, although this peaks in their mid-to late-20s and then 
drops off gradually with age: in 2018, 55% in 12th grade, 72% at ages 19-22, 79% at ages 
23-26, 79% at ages 27-30, 67% at age 35, 59% at age 40, 58% at age 45, 48% at age 50, 
40% at age, and 33% at age 60.5 Given the potential serious consequences of this behavior, 
these rates are troublingly high across a wide age range. The proportions who say most or 
all of their friends get drunk once a week differ more substantially by age, with a peak in 
the respondents’ early to mid-20s. In 2018, 12% of 12th graders, 23% of 19-22 year olds, 
24% of 23-26 year olds, 16% of 27-30 year olds, and 10% for 35 year olds to 2% of 60 
year olds responded that most or all of their friends get drunk once a week. Note in 
particular how high these rates are among the high school and college-age populations, 
most of whom are underage. In terms of having any direct exposure during the prior year 
to people who were drinking alcohol “to get high or for ‘kicks’,” having some such 
exposure was almost universal in the three age groups of young adults: 84%, 89%, and 
89%, respectively, as well as among 18 year olds (78%) (Table 7-3 and Figure 7-23). 
 
 From ages 19 through 30, 62% to 74% reported in 2018 having at least a few friends who 
smoke cigarettes, compared to 51% of the 12th graders; there is a falloff through middle 
adulthood, reaching 48% at age 60. Similarly, 4% to 6% of the 18-30 year olds state that 
most or all of their friends smoke. Above those ages, the proportions decline to 4% for 35 
year olds and 2-3% for those 40 years of age and older.  
 
Trends in Exposure to Drug Use (Ages 18 to 60)  
Tables 7-2 and 7-3 also provide trend data on the proportions of respondents’ friends using drugs 
and the proportion of respondents who say they have been directly exposed to drug use by others. 
Both of these measures of exposure to use will be discussed in this section. As noted previously, 
trends are available for 19-22 year olds since 1980, for 23-26 year olds since 1984, and for 27-30 
year olds since 1988. Data for those 35, 40, 45, 50, 55, and 60 years old are available on friends’ 
                                                 
5 Due to the previously mentioned printing error, data are not available for the three young adult age bands in 2015, though they are included for 
the other age bands in Table 7-2. This situation was remedied for 2016 data. 
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use since 1994, 1998, 2003, 2008, 2013, and 2018, respectively. (Questions about being around 
drug users – direct exposure – were not included in the questionnaires administered to respondents 
age 35 and older, so those age bands are not included in Table 7-3 or Figures 7-1 through 7-24. 
However, these respondents were asked about the proportions of their friends using as shown in 
Table 7-2.) Twelfth-grade data (i.e., age 18) have also been included in these tables for comparison 
purposes. 
 
Figures 7-1 through 7-24 provide graphic presentation of trends in direct exposure to use for 12th 
graders and young adults. 
 
 An examination of Table 7-3 and Figures 7-1 through 7-6 shows that direct exposure to 
illicit drug use (in the 12 months preceding the survey) generally declines across the age 
bands for any illicit drug, marijuana, and any illicit drug other than marijuana, as well 
as many of the specific other illicit drugs (Figures 7-7 through 7-24). Up until the past few 
years, this age-band ordering was consistent across different historical periods; however, 
as summarized below, the past few years have shown some compression of age differences 
and re ordering of age groups, with the 19-22 year olds having the highest direct exposure 
to many drugs in 2018. An important exception to the long-standing age group ordering of 
direct exposure is cocaine, which did not show a decline in exposure with increasing age 
until after 1996. (Prior to that it showed an increase with increasing age.) Thus, up until 
the past few years, with the exception of cocaine, the consistent ordering of declining 
exposure across the age groups reflect age effects (changes with age observed across 
multiple cohorts) in both exposure to use and in personal use of most drugs.   
 
 Until 1992, young adults’ trends in direct exposure to use tended to parallel those observed 
for 12th graders. From 1980 to 1992, that meant a decreasing number of respondents were 
directly exposed to any illicit drug use (Table 7-3 and Figure 7-1) or reported any such use 
in their own friendship circle (Table 7-2). After 1992, however, an important divergence 
in trends emerged: 12th graders showed a substantial increase in both friends’ use and direct 
exposure to use (as well as self-reported use); 19-22 year olds showed a similar rise, but 
lagged by a few years; 23-26 year olds subsequently showed some rise; while the 27-30 
year old age band did not show a rise until 2002. As discussed in earlier chapters, this 
pattern no doubt reflects the emergence of lasting cohort differences that emerged in 
secondary school and, driven by generational replacement, continued up the age spectrum 
as the secondary school students grew older. The age differentials expanded in the 1990s 
during the relapse phase in the drug epidemic; first observed among the 12th graders, the 
increases in use then occurred on a staggered basis. The age differentials have diminished 
considerably during the 2000s, and especially since 2009, as direct exposure to use 
generally leveled among the younger age groups but rose among the older ones (see Figure 
7-1).  
 
Over the past decade, trends in friends’ use of any illicit drug were fairly level for 12th 
graders, rose modestly among 19-22 year olds, and increased more for the older age groups 
(Table 7-2). The 2018 percentages were 78% for 12th graders and 81% for the 19-22 year 
olds; they were 86% for 23-26 year olds (a significant seven percentage point increase from 
2017), 82% for 27-30 year olds (a nonsignificant four percentage point increase from 
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2017), and ranged from 62% among those 35 to 42% among those 60 years old. These 
2018 percentages are at or near historic highs for those 23-26 through 55 years old. Recent 
trends in direct exposure to people using any illicit drug were mostly level between 2012 
and 2016, with some modest increase among those aged 19-22 and 23-26 (Figure 7-1). In 
2018, direct exposure decreased somewhat for 12th graders to 73%, the lowest level in the 
past decade (Table 7-3); and it increased four percentage points (nonsignificant) for 19-22 
year olds to 76%, with this age-group now having the highest direct exposure among the 
four age groups. In 2017, direct exposure increased five percentage points for 23-26 year 
olds (nonsignificant) and ten percentage points for 27-30 year olds (significant); direct 
exposure was fairly level for these two age groups in 2018 at 74% and 67%, respectively. 
Thus, in 2018, direct exposure to people using an illicit drug were at or near historic highs 
over the past three decades for the three young adult age groups, and at the lowest level for 
12th graders in the past decade (trends that are largely due to exposure to marijuana use as 
discussed next). 
 
 Marijuana showed a very similar pattern of change compared to any illicit drug. It is 
particularly noteworthy that, while 34% of 19-22 year olds in 1980 said most or all of their 
friends used marijuana, only 8% said the same in 1991 (Table 7-2). Clearly, the number of 
friendship groupings in which marijuana use was widespread dropped dramatically in the 
1980s. This measure of friends’ use for 19-22 year olds more than doubled to 19% by 1999 
during the relapse phase in the larger epidemic, where it remained for a couple of years 
before falling to 12% by 2008, then increasing to 26% by 2018. The percent indicting that 
most or all of their friends use marijuana increased as well for the other age bands of adults 
across the past decade, increasing by two or more times between 2008 and 2018, reaching 
17% for 23-26 year olds, 13% for 27-30 year olds, and 8% for 35 year olds; in 2018, it 
ranged from 2% and 5% for 40-60 year olds. The 2018 percentages were at historic highs 
since the mid-1980s for all age groups of adults.   
 
Similar trends occurred for being around those using (direct exposure) in the past year 
among young adults, as shown in Figures 7-5 and 7-6. In the past decade, the percentages 
of those who report often being around friends who used marijuana increased for each age 
group of young adults, with a fairly level trend for 12th graders. They increased between 
2008 and 2018 from 18% to 34% for 19-22 year olds, from 14% to 24% for 23-26 year 
olds, and from 9% to 22% for 27-30 year olds (Table 7-3); the 2018 percentages were at 
new historic highs for all young adults combined.  
 
 The proportion of respondents reporting having any friends who use any illicit drugs other 
than marijuana began to decline after 1982 in the two younger age groups spanning 18-
22 (for whom we had data at that time; see Table 7-2 regarding use by friends, and also 
Figure 7-3 regarding direct exposure to use). By 1991/1992 there had been a considerable 
drop in all four age groups (spanning 18-30). This drop appears to be due particularly to 
decreases in friends’ use of cocaine and amphetamines, although there were decreases for 
sedatives (barbiturates) and tranquilizers as well. The levels then began to rise among the 
18-22 year olds in the early 1990s, while at the same time declining further for the 23-30 
year olds, reflecting lasting cohort effects, opening up a large age-related difference in 
friends’ use in the 1990s and into the early 2000s. The 23-26 year olds showed a later 
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increase in friends’ use and the 27-30 year olds showed a still later increase. After 2001 
there was some decline in reported friends’ use in the two youngest age strata while 
reported friends’ use continued to climb in the older two strata. The net effect was to narrow 
the age differences among the young adult strata considerably.   
 
More recently, the gap among the four age bands covering ages 18-30 has narrowed for the 
proportions saying that they have any friends who use some illicit drug other than 
marijuana. Between 2003 and 2012, there was little change among 12th graders, followed 
by a fairly consistent decrease through 2018 (41%) (Table 7-2). For 19-22 year-olds, the 
trend has remained fairly level from 2003 through 2018 (54%). For 23-30 year-olds, there 
was an unsteady increase for the past decade through 2018 (52-54%). Among those aged 
35 and older, considerably fewer report having any friends who use, but the past few years 
have shown some uneven increases for 35- year-olds through 2018 (28%), with fairly level 
trends for those 40 and older through 2018 (18-22%) (see Table 7-2 for the specifics). The 
similar trends in direct exposure to use are shown in Figure 7-3, though it is noteworthy 
that exposure has been increasing unevenly for the young adults over the past decade 
reaching 35-47% in 2018 (Table 7-3). Also, the proportions indicating often being directly 
exposed to friends’ use of any illicit drugs other than marijuana (Figure 7-4) has increased 
unevenly over the past decade reaching 7-8% in 2018 (Table 7-3), also reflecting a lasting 
cohort effect. 
 
 Between 1986 and about 1992, all four age groups (covering 12th grade through age 30) 
showed a considerable drop in the proportion of respondents with friends who used cocaine 
(Table 7-2) and in direct exposure to cocaine use (Figure 7-11). (Self-reported use declined 
sharply in the same period.) After that decline, the rates of any friends’ use peaked in 1998 
among 12th graders (31%) and 19-22 year-olds (27%), remained fairly steady through 2007, 
and declined since for 12th graders through 2018 (18%) while decreasing and then 
increasing unevenly for 19-22 year olds through 2018 (30%). For 23-26 year-olds, friends’ 
use increased through 2004 (27%), declined unsteadily through 2016 (22%), and increased 
through 2018 (35%). For 27-30 year-olds, friends’ use peaked in 2009 (22%) and has 
remained fairly steady since then (25% in 2018). These changes, staggered somewhat by 
age since the mid-1990s, reflect cohort effects. For 35-55 year olds (who are asked about 
cocaine powder specifically), there have been some recent modest increases for the 35 and 
40 year olds, with the recent trends remaining fairly steady for the 45-55 year olds. 
Regarding recent trends in being around those who use cocaine (Figure 7-11 and Table 7-
3), any direct exposure has remained fairly steady for 18 year olds across the last decade 
(17% in 2018) and showed some uneven increases among the young adult age groups 
reaching 20-25% in 2018. The story for crack has been fairly similar to that for cocaine 
regarding friends’ use (Table 7-2).  
 
 There were substantial increases between the early 1990s and about 2000 in the proportion 
of 12th graders and 19-22 year olds reporting that they have any friends who use (Table 7-
2), and being directly exposed to use by others of (Table 7-3 and Figure 7-15), narcotics 
other than heroin without medical supervision; also, there were smaller increases among 
23-30 year olds, resulting in some considerable age-related differences. After 2002, the 
proportions of 18 year olds and 19-22 year olds declined some for both measures, while 
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the 23-30 year olds continued to increase in a classic cohort-effect pattern of change, thus 
narrowing the age differences by 2009. There was a wording change in 2010 that served to 
increase the rates considerably for both measures for all age groups. In 2010, the 
percentages of those reporting any friends using narcotics other than heroin were 36%, 
31%, 37%, and 28%, respectively across the four age groups; since 2010, all four of these 
age bands have shown a decline through 2018, reaching 15%, 20%, 22%, and 26% (Table 
7-2). In 2010, the percentages of those reporting any direct exposure to people using
narcotics other than heroin were 30%, 28%, 26%, and 23% across the four age groups
respectively (Table 7-3); since 2010, percentages decreased substantially for all four age
groups, reaching 18%, 17%, 16%, and 17%, respectively (Table 7-3 and Figure 7-15). The
proportional declines since 2010 for both measures of exposure have been largest in the
younger age bands.
 The proportions saying that any of their friends use MDMA (ecstasy, Molly) increased
sharply in all age groups between 1992 and 2001 or 2002, though in a staggered fashion
(Table 7-2). Twelfth graders showed the first sharp increase beginning after 1992, 19-22
year olds after 1994, 23-26 year olds after 1996 and 27-30 year olds after 1997. These sharp
increases ended among 12th graders in 2001 (42%) and among 19-30 year olds a year later
in 2002 (43%, 37%, and 21% for the three young adult age groups respectively). Since
those peak levels, the proportions saying that they had any friends using ecstasy have
generally declined through about 2012 and 2013 for all age groups. Since 2013, friends’
use continued to decline modestly for 12th graders through 2018 (19%), whereas it has
shown some uneven increases for the young adults (reaching 23%, 29%, and 26%,
respectively in 2018). The staggered nature of past increases in friends’ use suggests a
cohort effect at work, but the nearly simultaneous decline in the early 2000s strongly
suggests a secular trend, likely due to the heavy media coverage during that period of
adverse consequences associated with ecstasy use.
 For all four of the youngest age groups (spanning ages 18-30), the proportions saying that
they were often directly exposed to others drinking alcohol declined modestly between
1987 and 1992 (Figure 7-24, Table 7-3). The next decade or so saw rather little change in
the four youngest age bands. Direct exposure among 12th graders declined considerably
from 2002 (53%) through 2018 (34%). The recent trend for 19-22 year-olds peaked in 2007
(61%) and declined unevenly through 2018 (45%); it peaked in 2012 (56%) for 23-26 year-
olds and declined unevenly through 2018 (52%); and it peaked in 2012 (50%) for 27-30
year-olds and showed some modest decline through 2018 (45%). This is again indicative
of a cohort effect with staggered decreases radiating up the age spectrum as the cohorts
age. The greater proportional declines among the two younger age groups has served to
widen the age gap somewhat over the past decade.
 The age groups above age 30 have consistently been much less likely to report that any of
their friends get drunk at least once a week, compared with those ages 18 to 30 (Table 7-
2). These proportions increased starting at different times: after 1998 among those age 35,
after 2004 among those age 40, and after 2005 among those age 45, suggesting somewhat
enduring cohort differences. The net effect has been to reduce the differences separating
those in their 20s from those older in terms of the proportion having any friends who get
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drunk at least once a week. In the past decade, this trend toward smaller age differences 
among adults continued. Since 2008, 12th graders showed consistent declines from 78% in 
2008 to 55% in 2018, 19-22 year olds showed more modest declines from 81% in 2008 to 
72% in 2018, 23-26 year olds showed a fairly level trend from 80% in 2008 to 79% in 
2018, and those aged 27 to 50 showed modest increases from 40-72% in 2008 to 48-79% 
in 2018. In 2018, it remained the case that the majority of those aged 18 through 45 have 
any friends who get drunk at least once a week, with those aged 50, 55, and 60 at 48%, 
40%, and 33% respectively. On the other hand, the proportions saying that most or all of 
their friends get drunk often were considerably smaller and declined sharply with age 
(Table 7-2).  
 
 Among 12th graders, the proportion who said most or all of their friends smoked cigarettes 
declined appreciably between 1975 and 1981, the same period in which self-reported use 
declined (Table 7-2). After that, neither measure showed much change until about 1992. 
Thereafter, substantial increases in both measures occurred. By 1997, one-third (34%) of 
12th graders reported that most or all of their friends smoked cigarettes (up from 21% in 
1992); since then, that percentage declined (along with self-reported use) to 14% in 2008, 
where it leveled for a few years, and then declined again reaching 6% in 2018, an all-time 
low. Among 19-22 year olds, a decline in friends’ use occurred between 1980 (or possibly 
earlier) and 1985, followed by a leveling through 1994. The percentage saying most or all 
of their friends smoked increased from 22% in 1994 to 29% in 2000, before declining 
steadily and considerably to a new low of 4% in 2018. Among 23-26 year olds, a downturn 
was evident between 1984 (the first year for which data are available) and 1988, after which 
reported friends’ use leveled through 2005 (20%) and then declined through 2018, reaching 
a new low of 4% (representing a significant decline from 2017). After 2002, some slight 
increases occurred through 2005 (13%) among the 27-30 year olds, followed by an 
unsteady decline through 2016, reaching a new low of 6% in 2016 through 2018. These 
staggered changes, until about 1998, illustrate that cohort effects were moving up the age 
spectrum. Among those aged 35-55, the proportion of those responding that most or all of 
their friends smoked cigarettes have consistently declined over the years since they entered 
the study (except those 35 years old who showed some increase in the middle- to late-
1990s), reaching 2-4% in 2018. The 2018 rates for all age groups were at or near historic 
lows. Since 1998 (or the earliest year available for the age bands above age 30), the 
proportion saying that any of their friends smoked cigarettes showed consistent decline for 
all age groups through 2018, where they were at or near historic lows (Table 7-2).  
 
Implications for Validity  
Nearly all of these changes in friends’ use and direct exposure to drug use parallel changes in self-
reported use by these age groups. This pattern reinforces the validity of self-report data, because 
there would presumably be less motivation to distort answers about the proportion of an unnamed 
set of friends who use a drug than about one’s own use. The systematic nature of the patterns of 
change across age strata (whether in terms of parallel changes consistent with a secular trend, or 
systematically staggered ones consistent with a cohort-related trend) is also supportive of the data 
validity. 
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PERCEIVED AVAILABILITY OF DRUGS AMONG ADULTS (AGES 18–60) 
Adults participating in the follow-up surveys receive questions identical to those asked of 12th 
graders regarding how difficult they think it would be to get each of the various drugs if they 
wanted them. The questions are contained in only one of the six questionnaire forms used through 
modal age 30. Data for the young adult follow-up samples, which are grouped into the same four-
year age bands used above (19-22, 23-26, 27-30), are presented in Table 7-4, along with data for 
12th graders and those 35, 40, 45, 50, 55, and 60 years old. Sample sizes are presented at the bottom 
of the table. The availability question is not asked for all drugs in the adult samples, as may be 
seen in Table 7-4. 
 
Perceived Availability 
Much like 12th graders, substantial proportions of the American adult population have access to 
various illicit drugs. (We do not ask about access to alcohol and cigarettes because we assume 
these are readily available to all adults.) Table 7-4 presents trends in perceived availability for the 
various substances. 
 
 Marijuana was by far the most readily available of the illicit drugs in 2018 (and in all 
previous years) with 85-90% of the young adult age groups (19-30) saying it would be 
“fairly easy” or “very easy” to get if they wanted some. Perceived access decreased 
somewhat with age after age 30, but even at age 60, 71% of the respondents said they could 
get marijuana fairly or very easily (Table 7-4). That is, as of 2018, well over 80% of adults 
aged 19-45, and 71-79% of those aged 50, 55, and 60, reported marijuana being readily 
available if they wanted it. Continuing changes in the legal status of marijuana will likely 
increase perceived availability in the years ahead.  
 
 Though less available than marijuana, amphetamines were still fairly available, with 51-
55% of young adults and 32-41% of those 35, 40, 45, 50, 55, and 60 years old reporting 
that amphetamines would be fairly or very easy to get (Table 7-4). 
 
 Cocaine was reported as readily available in 2018 by a significant proportion of young 
adults, with 39-42% saying it would be easy to get, higher than the 28% observed among 
12th graders (Table 7-4). Powdered cocaine availability was highest among those ages 19 
to 40 at 35-38% in 2018. Crack was seen as available to smaller proportions than powdered 
cocaine in 2018, ranging from 21% to 23% among 18-30 year olds (availability is not asked 
for those age 35 and older).  
 
 In 2018, 18% of 12th graders, and 19-22% of 19-26 year-olds said that they could get heroin 
fairly or very easily, though far fewer report having used heroin (Table 7-4). Reported 
availability was higher for the 27-30 year olds (29%), showing that availability tended to 
rise with age. (The question is not asked of respondents above age 30.) 
 
 Perceived availability of narcotics other than heroin also rose with age. In 2018, the 
percentage of those who said that such drugs would be fairly or very easy to get was 33%, 
42%, 50%, and 53%, respectively across the four age groups (Table 7-4). (The question is 
not asked of respondents above age 30.) 
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 Perceived availability of sedatives (barbiturates) showed some increase with age in 2018:
23%, 28%, 30%, and 35% across the four age groups, respectively (Table 7-4). (The
question is not asked of respondents above age 30.)
 Tranquilizers were reported as available in 2018 by considerably fewer respondents (13-
17% across the four age groups), which historically was not always the case (Table 7-4).
(The question is not asked of respondents above age 30.)
 MDMA (ecstasy, Molly) was seen as readily available in 2018 to 28% of 12th graders, and
39%, 34%, and 32% of the three young adult age groups, showing a peak of availability
among 19-22 year olds (Table 7-4). (The question is not asked of respondents above age
30.)
 Hallucinogens other than LSD (such as psilocybin) were reported as fairly or very easy
to get in 2018 by 29% of 12th graders, and 34%, 32%, and 29% for the three young adult
age groups, respectively, again showing a peak of availability among 19-22 year olds
(Table 7-4). (The question is not asked of respondents above age 30.)
 Perceived availability of LSD was also highest for the 19-22 year olds at 33% in 2018; it
was 28% for 12th graders, 27% for 23-26 year olds, and 21-23% among those 27 to 50 years
old (Table 7-4). (The question is not asked of respondents above age 50.)
 Crystal methamphetamine (ice) was perceived to be fairly or very easy to get by 14% of
12th graders, and by 15%, 15%, and 17% of the young adult age groups, respectively (Table
7-4). (The question is not asked of respondents above age 30.)
 Anabolic steroids were perceived to be fairly or very easy to get by between 20% and 23%
of all four age strata (Table 7-4). (The question is not asked of respondents above age 30.)
Trends in Perceived Availability 
 Marijuana has been almost universally perceived to be available by older adolescents and
young and middle adults throughout the historical periods covered by the data. Overall,
perceived availability has risen in the six older age groups on whom trend data are available
during the 2000s—that is, from 27- through 55 year olds (reaching 75-90% in 2018)—but
has simultaneously declined among 12th graders (80% in 2018) and held relatively steady
among 19-22 year olds (85% in 2018). As a result, there is now less variability by age in
the reported availability of marijuana (Table 7-4). From the peak year in 1979, perceived
availability decreased slightly through 1991 among 12th graders and decreased slightly
more from 1980 through 1991 among 19-22 year olds. After the late 1990s, the trends in
availability across the 18 through 30 age bands had generally been quite parallel,
suggesting secular trends in prevailing conditions that affected availability. Perceived
availability has generally increased in the past several years through 2018 for those aged
35 to 55, resulting in it being only somewhat higher for those aged 18-30 (80-90%) than
for those aged 35 to 55 (75-84%), and with it now being at or near all-time highs for the
latter group, coinciding with the ongoing changes in the legal status of marijuana.
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 Historic highs in perceived availability of cocaine occurred in the 1980s among all three 
young adult age strata (ages 19-30), reaching highest proportions in 1988 and 1989, at 
which time the older young adult age strata had higher availability than the younger ages. 
(From a policy perspective, it is worth noting that in 1987 the perceived availability of 
cocaine increased while use actually dropped sharply.) In the early 1990s, all four groups 
reported decreased availability by 4-7 percentage points, quite parallel to the drop in 
numbers of those who had friends who were users and to the decline in personal use. Until 
about 2001, there was some falloff in perceived cocaine availability in all age strata through 
age 30—particularly among those ages 23 through 30—and an increasing convergence 
among the age groups (ranging from 45% to 50% in 2001); it then generally leveled 
through 2007. From about 2007 through 2012 and 2013, all four age strata showed 
considerable declines in reported cocaine availability, followed by a leveling through 2018 
for 12th graders (28%), 23-26 year olds (39%), and 27-30 year olds (42%); 19-22 year-olds 
showed an increase from 28% in 2013 to 41% in 2018. The question about availability of 
any type of cocaine is not asked of respondents above age 30, but a question about specific 
cocaine powder availability is asked of them. As shown in Table 7-4, there have been some 
uneven increases in perceived availability since about 2012 through 2018 for those aged 
35-55 (reaching 32-38% in 2018).   
 
 Crack availability peaked in 1988-1989 for all age groups (it was first assessed in 1987) 
and declined through 1992, with little further change until 1995. Since 1995 through 2018, 
crack availability has declined substantially in all of the lower four age strata (ages 18-30). 
Data on 35, 40, 45, and 50 year olds are available for shorter intervals (and only through 
2017), but also show appreciable declines from initial measurements. 
 
 In 2018, between 21% and 33% of age groups 18 through 50 said they could get LSD fairly 
easily, which contrasts quite dramatically with the mid-1990s, when over 50% of those in 
the younger age strata said they could get it. Across the decades measured, the trends in 
LSD availability among young adults have had some parallels to those among 12th graders. 
For 12th graders, there was a drop of about 10 percentage points in the mid-1970s, and a 
later drop from 1980 to 1986. The latter drop, at least, was paralleled in the data from 19-
22 year olds. After 1986, LSD availability increased considerably in all age bands, reaching 
its peak levels by 1995 during the relapse phase of the illicit drug epidemic. At that time a 
considerable age-related difference developed, with availability lower in the older age 
groups. Since 1995, availability has fallen substantially in all age bands but particularly in 
the youngest two age bands, narrowing the differences among the age groups. Indeed, the 
drop-off in availability of LSD to 12th graders and 19-22 year olds was quite sharp in 2002, 
probably contributing to the steep decline in use that year because changes in attitudes and 
beliefs about LSD cannot explain it. Over the past decade through 2018, availability has 
either remained largely steady (among 18 year olds, 23-30 year olds, and those 40 and 
older) or declined somewhat (among 35 year olds); in contrast, it has increased for those 
aged 19-22. Across all age bands in 2018, availability was the highest among 19-22 year 
olds (33%) and considerably lower among those ages 27 and above (21-23%). Fifty-five 
and 60 year olds are not asked the question. 
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 Since 2001 through 2018, the general pattern among 12th graders and young adults
regarding the availability of hallucinogens other than LSD has been one of decline, with
availability for the four age groups declining from 38-49% in 2001 to 29-34% in 2018.
(This question is not asked of respondents over age 30.) Levels of availability are now
more differentiated by age than in prior decades, with it being higher for younger
respondents, though these differences have diminished in recent years. In the early 1980s,
there was a fair decline among all age groups in the availability of hallucinogens other than
LSD. There was little additional change through 1992. From 1992 to 1995, the three
youngest age groups all showed an increase in availability, with 12th graders showing the
largest increase. From 1996 to 2000, availability was fairly steady. All age groups showed
substantial increases in 2001, undoubtedly due to the changed question wording which
added shrooms, among other substances, to the examples of hallucinogens. (Shrooms refer
primarily to psilocybin mushrooms.) It appears that the inclusion of shrooms as an example
introduced a greater variability with age in reported availability of hallucinogens other than
LSD taken as a class.
 MDMA (ecstasy, Molly) questions were first introduced in MTF surveys in 1989 and 1990
(and are not asked of those over age 30). Availability rose very substantially in all of these
age groups during the 1990s and early 2000s. Among 12th graders, reported availability
nearly tripled from 22% in 1989 to 62% in 2001, the peak year of use for 12th graders. All
four age groupings showed sharp increases in 2000 and 2001, with the older age groups
continuing to increase through 2002 (to 41-60%) , their peak year for use. The availability
of ecstasy showed considerable declines from about 2001 through about 2010 (reaching
36%, 30%, 35%, and 31%, respectively for the four age groups); it then continued to
decline for 12th graders through 2018 (28%), increased for 19-22 year olds through 2018
(39%), and remained fairly steady for 23-30 year olds through 2018 (32-34%).
 All four age groups have shown some gradual, modest decline in heroin availability since
about 1997 or 1998, during which interval there has been rather little variability in heroin
availability across the 18-to-30 age range. (The question is not asked of respondents over
age 30.) Heroin availability varied within a fairly narrow range from 1980 to 1985, then
increased in all age groups through 1990. For the younger ages (18-22) heroin availability
rose further through 1995 while in the older two age groups it increased some later in the
1990s. It is clear that heroin was much more available to all of these age groups in the
1990s than it was in the 1980s. This increase in the availability, and in the purity, of heroin
most likely led to the emergence of non-injection forms of heroin use observed during this
period. In the past decade from 2008 through 2018, heroin availability declined for 12th
graders from 25% to 18%, declined for 19-22 year olds from 24% to 19%, remained fairly
steady for 23-26 year olds (23% to 22%), and increased unevenly for 27-30 year olds from
26% to 29%.
 The availability of narcotics other than heroin rose slowly among all four age groups from
1980 through the early to mid-2000s, with the exception of a period of considerable
stability from 1989 through 1994. (Respondents over age 30 are not asked this question.)
After 1994, the modest increase in availability was accompanied by steadily rising use.
Reported availability jumped in 2010, when new drugs, including Vicodin and OxyContin,
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were added to the list of examples in the question (this jump suggests that our earlier 
measure was underestimating availability to some extent). In 2010, availability was 54%, 
55%, 56%, and 62%, respectively among the four age groups, revealing little age 
differentiation. Since 2011, availability declined steadily for 12th graders (to 33% in 2018) 
and 19-22 year olds (to 42% in 2018), and rose through 2013 for the two older age groups 
(62% and 64%, respectively) before declining unevenly through 2018 (50% and 53%, 
respectively); these different trends served to increase the age differences among the four 
groups. It seems clear that availability of these drugs has been going down since 2011-
2013, especially in the younger age strata, likely in response to state and federal efforts to 
reduce their abuse by reducing availability.  
 
 In general, availability of amphetamines has declined to some extent for all age groups 
since about the time they entered the study, and the age groups above age 30 have reported 
somewhat lower availability than the younger strata, but not dramatically lower. In 1982, 
availability peaked for both 12th graders and 19-22 year olds, after which it fell through 
1991 by 14-15 percentage points. Among 23-26 year olds, there was a decline of 14 
percentage points between 1984 (when data were first available) and 2005. For 27-30 year 
olds, reported availability decreased by nine percentage points between 1988 (the first 
measurement point) and 2005. Decreases also occurred among 35-45 year olds in the 2000s 
but some reversal has been evident in recent years in the older cohorts. In 2011 all age 
strata from age 18 through age 35 showed an increase in perceived availability for 
amphetamines, statistically significant for those 19-22 and 23-26 years old. (It should be 
noted that the examples of amphetamines used in the question text were updated in 2011 
to include Adderall and Ritalin, while “pep pills” and “bennies” were eliminated as 
outdated examples. Therefore, the sharp rise in reported availability of amphetamines in 
2011 among young adults likely was due to the revision of the examples provided). 
Between 2011 and 2018, availability declined unevenly for 18 year olds (from 47% to 
39%), was fairly level for 19-22 year olds (52% and 54%), decreased unevenly for 23-26 
year olds (from 56% to 51%), and increased unevenly for 27-30 year olds (from 50% to 
55%). For those aged 35-50, 2011 percentages were 40%, 34%, 37%, and 34%, 
respectively, and changes have been uneven since 2011, with most age groups showing a 
fairly level or declining trend through 2017 or 2018; however in 2018, 40 and 50 year olds 
showed a significant increase. In 2018, availability was 38%, 41%, 35%, and 38%, for 35-
50 year olds respectively; it was 35% and 32% for 55 and 60 year olds.  
 
 By way of contrast to amphetamines, crystal methamphetamine or “ice” exhibited an 
increase in availability in the 1990s, rising for all four age strata from 1991 to 1998/1999 
before stabilizing with similar rates of availability from ages 18 to 30. (This question was 
not asked of those over 30.) All four strata have shown some decline in recent years 
(reaching 14-17% in 2018), starting with the youngest three age strata after 2006 and the 
27-30 year olds after 2008. In recent years through 2018, availability has been lowest for 
the youngest three age bands, a reversal of the situation in the early 1990s (Table 7-4). 
 
 Sedatives (barbiturates) exhibited a long-term decline in availability over more than two 
decades from about 1981 or 1982 through 2003 in the two younger groups—a 20-
percentage-point drop among 12th graders and a 23-percentage-point drop among 19-22 
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year olds. All groups showed increased perceived availability in 2004—no doubt due 
primarily to an updating of the examples given in the question, followed by an overall 
decline. As of 2018, there was a decline of 23 percentage points among 12th graders since 
2004 (from 46% to 23%), of 20 percentage points among the 19-22 year olds since 2007 
(from 48% to 28%), of 21 percentage points among 23-26 year olds since 2006 (from 51% 
to 30%), and of 11 percentage points among 27-30 year olds since 2007 (from 46% to 
35%). In 2018, perceived availability was higher in the 27-30 year old group (35%) than 
in the 18 year old group (23%).  
 
 Tranquilizer availability has declined long-term by about four fifths among 12th graders, 
from 72% in 1975 to 13% in 2018. Since 1980, when data were first collected for 19-22 
year olds, tranquilizer availability has declined by over three fourths (from 67% in 1980 to 
15% in 2018), such that previous differences in availability between these two groups were 
eliminated by 1992. The older young adult age groups have also shown a considerable 
decline in the availability of tranquilizers through 2018, thus narrowing the differences 
among them. For the most part, trend lines for the different age groups have been quite 
parallel, as has been true for sedatives (barbiturates). Indeed, tranquilizers have shown the 
most consistent pattern of change in perceived availability since MTF began. By 2018 only 
13% at age 18 said that tranquilizers were fairly or very easy to get, and only 14% to 17% 
of the three young adult age bands said the same. 
 
 Data on steroid availability were first gathered in 1990 (Table 7-4). There has been some 
decline in availability in all age groups since about 2000, including a sharper rate of decline 
in the youngest three age strata after 2007. (This question was not asked of those over 30.) 
While younger respondents used to report higher levels of availability than those in the 
older strata, by 2018 there was not much difference among them, with all age groups being 
at or near their lowest point in 2018 (from 20% to 23%).  
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Q. How do you think your 
close friends feel (or would 
feel) about you. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Trying marijuana once  18 42.6 46.4 50.3 52.0 54.1 54.7 56.7 58.0 62.9 63.7 70.3 69.7 73.1 66.6 62.7 58.1 55.8 53.0 53.8
  or twice 19–22 41.0 40.6 46.9 47.1 51.6 54.5 55.2 54.7 58.7 63.0 63.6 64.7 64.7 63.4 63.7 58.5 64.3 58.4 57.0
23–26 — — — — 47.7 47.0 49.1 53.9 58.2 62.6 61.3 64.5 65.6 65.5 63.2 63.8 61.2 59.3 66.5
27–30 — — — — — — — — 58.6 58.7 61.4 64.6 63.5 64.4 66.3 66.1 65.8 65.0 65.4
Using marijuana  18 50.6 55.9 57.4 59.9 62.9 64.2 64.4 67.0 72.1 71.1 76.4 75.8 79.2 73.8 69.1 65.4 63.1 59.9 60.4
  occasionally 19–22 50.9 49.2 54.0 57.9 59.4 64.6 64.4 65.1 69.8 71.5 74.1 73.9 74.3 73.1 73.0 66.6 71.3 65.1 65.1
23–26 — — — — 54.3 56.4 57.1 63.1 68.1 73.2 71.8 72.5 75.3 73.5 72.2 70.7 70.8 68.5 73.6
27–30 — — — — — — — — 67.8 69.4 71.9 73.7 76.0 75.1 76.4 73.8 75.6 72.4 74.9
 
Using marijuana  18 72.0 75.0 74.7 77.6 79.2 81.0 82.3 82.9 85.5 84.9 86.7 85.9 88.0 83.5 80.6 78.9 76.1 74.1 74.7
  regularly 19–22 70.3 75.2 75.7 79.5 80.0 82.7 83.5 84.8 86.9 87.5 89.1 88.4 89.1 87.6 85.9 83.9 84.5 83.3 81.1
23–26 — — — — 77.8 78.4 80.9 82.0 85.8 89.2 88.1 87.9 90.3 89.1 88.8 84.9 89.5 85.6 87.1
27–30 — — — — — — — — 85.4 86.0 88.4 89.2 88.7 88.2 88.9 89.7 89.6 87.8 90.8
Trying LSD once or 18 87.4 86.5 87.8 87.8 87.6 88.6 89.0 87.9 89.5 88.4 87.9 87.9 87.3 83.5 83.4 82.6 80.8 79.3 81.7
  twice 19–22 87.4 90.5 88.0 89.3 89.3 91.1 90.5 91.8 90.8 91.2 89.1 89.9 87.2 87.7 87.9 84.6 85.3 83.6 81.7
23–26 — — — — 87.4 90.8 88.6 89.8 88.9 91.0 90.1 92.4 88.9 87.7 86.3 85.3 88.5 85.4 87.6
27–30 — — — — — — — — 88.8 89.7 92.3 91.1 91.4 89.9 91.2 89.7 89.3 88.5 88.7
Trying cocaine once or 18 — — — — — — 79.6 83.9 88.1 88.9 90.5 91.8 92.2 91.1 91.4 91.1 89.2 87.3 88.8
  twice 19–22 — — — — — — 76.4 — 84.8 87.7 89.2 92.3 91.9 92.4 94.7 91.7 91.5 91.8 90.0
23–26 — — — — — — 70.8 — 81.4 84.5 84.1 86.7 87.4 87.7 87.9 90.4 90.0 91.1 92.0
27–30 — — — — — — — — 81.8 81.1 83.7 83.5 84.4 86.1 87.8 87.5 88.7 89.4 89.3
Taking cocaine 18 — — — — — — 87.3 89.7 92.1 92.1 94.2 94.7 94.4 93.7 93.9 93.8 92.5 90.8 92.2
  occasionally 19–22 — — — — — — 84.9 — 91.0 93.8 94.2 95.6 95.9 95.6 97.5 95.6 95.7 96.6 93.1
23–26 — — — — — — 81.7 — 88.2 91.5 92.4 94.1 93.8 93.5 94.3 94.6 95.4 95.1 95.2
27–30 — — — — — — — — 87.7 89.5 90.0 92.2 92.3 92.8 94.6 94.1 94.6 94.2 96.1
Trying an amphetamine  18 78.9 74.4 75.7 76.8 77.0 77.0 79.4 80.0 82.3 84.1 84.2 85.3 85.7 83.2 84.5 81.9 80.6 80.4 82.6
  once or twice 19–22 75.8 76.7 75.3 74.3 77.0 79.7 81.5 81.3 83.0 83.5 84.5 86.5 83.8 85.0 87.2 83.1 86.0 84.5 84.0
23–26 — — — — 78.4 79.1 76.7 81.7 83.0 85.6 84.3 85.0 83.6 84.2 84.7 87.6 86.5 83.3 87.0
27–30 — — — — — — — — 82.7 84.1 84.9 84.6 84.7 84.1 85.9 85.5 85.6 85.9 85.8
Taking one or two 18 70.5 69.5 71.9 71.7 73.6 75.4 75.9 71.8 74.9 76.4 79.0 76.6 77.9 76.8 75.8 72.6 72.9 71.5 72.3
  drinks nearly 19–22 71.9 72.1 68.6 73.5 71.6 72.2 72.7 70.2 73.9 77.1 73.3 73.7 74.0 71.2 73.0 68.3 68.9 73.5 67.3
  every day 23–26 — — — — 63.6 66.8 67.7 68.3 69.2 70.8 72.7 72.5 72.1 67.6 71.5 68.2 72.8 68.1 66.9
27–30 — — — — — — — — 71.0 68.0 70.4 71.9 68.8 73.2 70.9 68.8 65.7 67.3 66.7
Taking four or five 18 87.9 86.4 86.6 86.0 86.1 88.2 87.4 85.6 87.1 87.2 88.2 86.4 87.4 87.2 85.2 84.1 82.6 82.5 82.8
  drinks nearly every 19–22 93.7 91.7 89.9 91.9 91.7 92.5 91.5 90.8 90.4 92.5 89.9 91.7 92.6 89.6 90.1 88.8 88.1 90.0 85.9
  day 23–26 — — — — 90.8 90.2 92.5 92.8 93.7 92.1 92.1 92.4 91.1 93.1 92.1 92.2 92.6 90.7 93.7
27–30 — — — — — — — — 92.8 92.0 92.9 92.7 92.7 93.9 94.0 92.9 91.9 93.8 92.1
Having five or more   18 50.6 50.3 51.2 50.6 51.3 55.9 54.9 52.4 54.0 56.4 59.0 58.1 60.8 58.5 59.1 58.0 57.8 56.4 55.5
  drinks once or twice 19–22 53.5 51.7 51.7 53.3 50.8 53.3 47.0 49.4 50.5 56.8 53.1 51.4 53.6 51.9 54.4 55.5 52.1 56.4 52.8
  each weekend 23–26 — — — — 53.8 57.3 61.0 57.2 58.8 57.5 55.1 56.8 58.4 57.6 61.4 58.9 58.4 55.6 60.0
27–30 — — — — — — — — 61.9 65.1 66.3 68.2 66.2 66.7 63.7 64.6 61.6 64.0 63.0
Smoking one or more 18 74.4 73.8 70.3 72.2 73.9 73.7 76.2 74.2 76.4 74.4 75.3 74.0 76.2 71.8 72.4 69.2 69.3 68.5 69.0
  packs of cigarettes 19–22 75.6 75.1 75.4 78.5 76.2 79.7 77.7 78.6 80.2 78.4 77.5 78.3 79.0 76.0 73.8 70.9 73.9 76.5 69.2
  per day 23–26 — — — — 73.9 77.3 80.3 80.5 79.5 80.5 78.5 83.3 82.3 77.4 80.1 78.8 78.3 75.8 76.5
27–30 — — — — — — — — 81.2 80.9 82.9 84.5 83.1 86.8 82.5 83.4 81.9 80.5 81.9
Approximate  18 2,766 3,120 3,024 2,722 2,721 2,688 2,639 2,815 2,778 2,400 2,184 2,160 2,229 2,220 2,149 2,177 2,030 2,095 2,037
Weighted  N = 19–22 569 597 580 577 582 556 577 595 584 555 559 537 520 510 470 480 471 466 436
23–26 510 548 549 540 510 513 516 516 507 481 463 445 436 419 425
27–30 483 518 479 480 451 451 457 439 439 422 440
(Table continued on next page.)
Age 
Group
TABLE 7-1
Trends in Proportions of Respondents Reporting Their Close Friends Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Percentage saying friends disapprove a
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Trying marijuana once  18 55.1 58.1 57.6 54.1 58.4 59.5 60.9 62.3 60.4 60.8 61.4 54.9 53.0 52.9 51.2 50.4 51.0 48.6 44.3 45.8 +1.5  
  or twice 19–22 56.5 56.0 54.2 53.4 56.5 61.0 57.9 60.5 58.4 62.4 57.0 57.4 52.4 54.6 52.2 50.7 46.7 40.5 41.1 34.9 -6.2
23–26 62.6 64.6 55.2 53.8 51.4 57.7 55.9 60.7 55.8 62.1 57.1 58.0 55.5 59.3 50.2 50.1 43.7 44.7 40.0 39.1 -0.9
27–30 61.8 63.9 64.9 67.1 61.9 67.2 61.2 64.1 58.2 57.1 55.6 60.5 57.1 56.8 48.2 49.5 45.5 42.1 41.6 39.5 -2.1
Using marijuana  18 61.6 63.9 64.3 60.3 64.2 65.0 67.6 68.1 65.8 66.3 68.5 61.8 59.4 59.5 57.6 56.2 58.1 54.9 51.4 53.2 +1.8  
  occasionally 19–22 64.6 61.8 61.0 62.6 63.3 70.1 67.2 68.8 70.6 67.5 65.9 67.1 60.6 60.9 59.0 59.5 54.1 48.0 48.4 40.0 -8.3
23–26 70.2 70.9 63.9 64.5 61.6 63.5 65.5 71.3 63.8 70.1 66.8 63.4 64.7 69.3 60.9 57.6 54.9 52.6 49.1 45.2 -3.9
27–30 74.5 75.0 74.2 72.9 71.4 76.9 70.4 74.9 66.4 67.0 64.6 68.3 64.9 67.1 59.7 60.1 57.8 51.5 48.4 45.8 -2.6
Using marijuana  18 74.5 76.1 77.8 75.3 77.0 77.3 79.5 79.8 78.3 78.0 79.1 73.8 73.3 72.7 71.2 70.1 70.9 68.4 65.2 67.9 +2.7  
  regularly 19–22 78.2 78.5 80.0 80.5 79.1 84.4 82.2 84.1 83.7 81.4 81.9 81.1 76.3 74.5 75.2 77.1 74.3 67.1 71.4 63.8 -7.6
23–26 86.8 86.9 83.7 82.8 80.0 79.2 82.7 83.7 81.9 87.1 81.9 83.5 82.7 83.8 77.7 76.7 71.6 71.3 68.4 68.4 0.0
27–30 89.2 91.6 90.1 87.9 87.2 88.0 87.7 88.2 84.3 84.5 83.4 87.5 83.4 86.1 80.8 81.5 76.2 74.8 68.1 66.1 -2.0
Trying LSD once or 18 83.2 84.7 85.5 84.9 87.5 87.3 88.4 89.5 88.4 86.3 87.2 84.5 85.6 85.0 84.9 84.6 81.9 83.3 81.3 82.7 +1.4  
  twice b 19–22 82.0 82.1 85.2 86.9 86.9 88.6 90.5 90.4 90.0 90.0 87.1 — — — — — — — — — —
23–26 84.5 85.3 82.8 83.6 79.3 82.4 85.6 89.3 90.4 88.4 88.3 — — — — — — — — — —
27–30 88.4 85.6 87.4 86.3 87.1 87.7 86.9 88.5 83.5 85.3 84.6 — — — — — — — — — —
Trying cocaine once or 18 88.7 90.2 89.3 89.1 91.2 87.9 89.0 88.7 89.6 88.7 90.2 89.7 89.7 89.2 89.2 88.6 87.0 89.1 88.5 88.7 +0.2  
  twice b 19–22 91.2 89.4 89.1 91.7 90.6 90.3 90.3 91.2 93.3 90.2 91.2 — — — — — — — — — —
23–26 89.6 90.5 88.0 88.5 83.6 84.2 84.6 88.7 91.7 91.0 91.0 — — — — — — — — — —
27–30 90.5 90.4 89.3 88.8 89.9 91.8 89.5 92.0 86.4 88.0 84.5 — — — — — — — — — —
Taking cocaine 18 91.8 92.8 92.2 92.2 93.0 91.0 92.3 92.4 93.1 92.0 92.7 91.8 92.9 92.8 92.5 91.4 90.6 91.5 91.7 93.1 +1.3  
  occasionally b 19–22 95.7 94.7 94.5 95.6 95.1 96.0 95.3 96.1 97.1 95.5 95.6 — — — — — — — — — —
23–26 95.2 96.7 94.7 93.2 91.2 90.1 93.0 94.9 95.9 96.6 95.6 — — — — — — — — — —
27–30 95.4 95.9 94.2 94.0 95.1 96.3 94.5 95.4 93.2 94.3 94.3 — — — — — — — — — —
Trying an amphetamine  18 83.0 84.1 83.8 83.3 85.9 84.7 86.1 86.7 87.3 87.1 87.0 85.8 84.6 83.7 83.5 83.2 83.2 83.2 83.7 84.5 +0.8  
  once or twice b 19–22 85.8 81.6 84.5 87.6 87.6 89.4 88.9 89.4 89.1 90.2 87.4 — — — — — — — — — —
23–26 85.9 85.1 83.1 83.9 81.5 82.7 86.2 89.9 89.3 89.6 87.2 — — — — — — — — — —
27–30 87.2 87.8 86.4 86.0 87.9 88.9 87.5 88.5 82.9 85.3 85.6 — — — — — — — — — —
Taking one or two 18 71.7 71.6 73.4 71.6 74.7 72.8 74.0 73.2 74.5 75.2 75.5 75.0 74.9 74.0 75.4 74.0 76.3 76.3 77.3 77.8 0.5  
  drinks nearly 19–22 68.6 66.6 64.9 68.5 64.4 72.4 68.3 68.7 68.4 69.5 68.8 — — — — — — — — — —
  every day b 23–26 66.1 65.4 64.4 61.6 62.1 61.8 62.3 66.1 62.5 63.4 59.4 — — — — — — — — — —
27–30 64.3 67.3 67.1 64.0 64.5 65.0 62.8 64.9 59.4 58.9 59.8 — — — — — — — — — —
Taking four or five 18 82.2 82.8 84.4 80.1 83.1 82.9 82.7 83.3 84.8 84.7 84.6 83.4 85.8 84.1 85.8 83.8 85.3 85.6 87.3 86.5 -0.8  
  drinks nearly every 19–22 87.9 86.6 84.6 87.7 86.8 89.8 86.8 89.0 90.7 88.8 89.9 — — — — — — — — — —
  day b 23–26 89.9 92.5 91.1 88.1 89.3 87.8 89.1 90.8 87.8 93.8 89.1 — — — — — — — — — —
27–30 95.3 92.4 91.2 92.7 92.6 92.5 93.4 92.3 91.3 89.0 93.1 — — — — — — — — — —
Having five or more   18 57.6 57.7 57.8 55.6 60.3 59.4 59.9 60.6 60.0 62.1 63.5 62.0 62.2 62.3 65.2 65.6 68.5 70.7 69.0 72.1 +3.1  
  drinks once or twice 19–22 51.8 45.2 47.4 50.4 47.9 52.4 53.2 54.8 54.4 55.2 54.6 47.7 48.7 53.9 53.0 54.5 50.4 51.9 54.7 55.5 +0.8
  each weekend 23–26 54.5 56.6 56.9 52.9 49.5 49.5 51.9 56.0 51.3 55.3 51.0 51.2 50.7 53.4 48.5 52.3 49.7 51.1 52.1 51.9 -0.2
27–30 57.7 65.8 58.8 63.3 59.6 64.6 56.9 62.7 56.3 57.3 52.7 52.9 50.6 53.7 52.7 57.1 52.8 54.1 56.4 53.7 -2.7
Smoking one or more 18 71.2 72.6 74.5 75.7 79.2 78.6 81.1 81.2 81.4 82.5 81.6 81.4 81.6 83.2 84.4 84.0 85.1 87.1 85.3 87.0 +1.7  
  packs of cigarettes 19–22 73.9 71.1 74.3 77.3 78.3 82.1 82.7 84.8 87.0 85.5 86.8 85.7 84.8 89.2 87.9 90.9 90.7 90.2 89.5 90.7 +1.2
  per day 23–26 78.0 79.9 77.0 75.4 78.3 77.6 77.4 84.4 82.6 88.2 88.1 88.0 88.2 90.6 85.5 89.6 88.5 90.0 90.5 92.1 +1.7
27–30 82.6 84.0 83.6 86.1 84.0 84.6 82.2 84.1 81.3 83.9 85.0 89.5 88.4 88.1 90.0 89.4 92.2 91.2 90.1 90.1 0.0
Approximate  18 1,945 1,775 1,862 1,820 2,133 2,208 2,183 2,183 2,161 2,090 2,033 2,101 2,132 2,126 1,916 1,863 1,992 1,763 1,922 1,972
Weighted  N = 19–22 430 379 402 361 399 427 395 395 361 370 389 347 364 337 309 289 263 246 255 272
23–26 394 398 378 366 363 377 361 344 349 336 322 355 320 329 327 284 299 238 244 249
27–30 397 394 374 364 346 408 362 327 330 318 333 322 321 285 303 288 265 272 279 258
Source.  The Monitoring the Future study, the University of Michigan.
Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the 
change estimate and the prevalence estimates for the two most recent years is due to rounding. ' — ' indicates data not available.
aAnswer alternatives were: (1) Don’t disapprove, (2) Disapprove, and (3) Strongly disapprove. Percentages are shown for categories (2) and (3) combined.
bThese questions were dropped from the questionnaires beginning in 2010.
Percentage saying friends disapprove a
TABLE 7-1 (cont.)
Trends in Proportions of Respondents Reporting Their Close Friends Disapproving of Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Age  
Group
2017– 
2018 
change
Q. How do you think your close 
friends feel (or would feel) 
about you. . .
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Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take any illicit drug b
   % saying any 18 87.5 85.4 86.3 82.6 81.0 82.4 82.2 81.7 79.1 76.9 71.0 69.1 67.3 71.0 78.3 78.6 80.6 83.4 84.6
19–22 90.2 88.0 86.8 85.0 82.3 82.9 80.5 76.7 77.2 78.4 72.7 71.5 66.8 71.7 71.6 71.6 76.2 77.2 79.8
23–26 — — — — 83.6 82.7 80.3 80.9 74.4 73.8 65.8 63.0 67.3 64.6 66.7 65.3 64.6 67.0 67.6
27–30 — — — — — — — — 74.8 72.9 69.6 67.1 61.5 60.2 57.1 58.5 59.1 60.9 58.3  
35 — — — — — — — — — — — — — — 38.1 37.4 39.7 39.2 38.4
40 — — — — — — — — — — — — — — — — — — 39.2
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 32.5 29.8 26.5 23.8 20.9 22.7 21.5 18.6 15.8 15.7 11.6 11.7 12.0 15.5 20.3 21.7 23.8 23.7 25.9
19–22 34.9 32.8 28.1 22.4 21.9 18.2 16.2 14.0 13.5 10.9 10.5 8.8 9.0 10.4 14.9 13.1 17.3 16.2 16.8
23–26 — — — — 19.6 15.4 16.2 11.7 9.5 9.7 9.5 7.4 6.2 6.4 8.7 7.6 8.8 10.5 9.6
27–30 — — — — — — — — 8.6 6.4 5.9 2.9 5.8 5.0 5.6 6.1 3.6 4.5 5.3
35 — — — — — — — — — — — — — — 2.1 1.9 2.0 3.0 3.1
40 — — — — — — — — — — — — — — — — — — 2.3
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Take any illicit drug 
 other than marijuana b 18 62.4 63.3 64.7 61.2 61.3 61.8 63.3 62.4 56.5 56.2 50.1 46.3 47.1 48.7 53.7 53.7 54.5 55.1 55.6
   % saying any 19–22 67.9 67.8 66.7 65.2 60.8 62.1 61.0 57.3 53.5 60.8 53.4 51.5 45.3 51.4 46.3 46.4 46.5 49.7 53.3
23–26 — — — — 63.7 64.0 59.0 61.1 55.1 54.2 47.8 41.8 46.1 42.3 39.4 40.3 32.8 35.1 35.4
27–30 — — — — — — — — 55.9 55.0 49.7 47.2 37.7 38.5 33.9 37.7 36.4 33.9 34.1
35 — — — — — — — — — — — — — — 21.4 21.6 22.1 19.2 19.3
40 — — — — — — — — — — — — — — — — — — 20.9
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 11.1 11.9 10.9 11.0 10.3 10.4 10.3 9.2 6.9 7.7 5.1 4.6 5.3 7.1 7.1 7.7 8.9 7.0 8.9
19–22 9.8 12.9 11.8 9.8 9.3 8.6 7.6 5.0 5.3 4.0 3.2 2.6 3.3 4.0 4.4 3.5 6.2 4.1 4.3
23–26 — — — — 10.6 6.6 8.6 5.2 3.9 4.2 3.4 1.6 1.8 2.8 2.5 1.9 1.9 2.6 2.8
27–30 — — — — — — — — 4.6 3.0 2.8 1.0 1.4 1.5 1.5 1.5 0.9 1.2 0.9
35 — — — — — — — — — — — — — — 0.8 0.5 0.7 0.5 0.7
40 — — — — — — — — — — — — — — — — — — 0.4
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Percentage saying friends use a
Age 
Group
TABLE 7-2
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Take any illicit drug b,g
   % saying any 18 82.0 82.0 82.8 81.8 80.7 81.2 79.8 78.8 77.7 80.1 79.2 80.4 81.7 78.9 80.8 80.8 78.2 79.9 79.6 78.1 -1.5  
19–22 77.3 83.1 81.1 78.3 79.4 78.1 78.6 74.7 79.8 77.4 80.3 78.6 78.1 78.8 78.3 79.4 — 83.5 83.8 81.2 -2.6
23–26 67.9 67.8 66.9 73.4 70.8 70.8 74.2 72.2 71.3 72.2 74.5 75.7 80.3 74.2 76.9 78.5 — 80.2 79.1 85.8 +6.8 s
27–30 59.6 55.6 57.2 61.8 58.6 63.1 63.7 62.3 62.7 66.7 70.0 66.9 69.2 72.3 72.9 73.6 — 74.5 78.0 82.3 +4.3
35 36.3 37.7 39.1 40.9 37.5 37.9 40.0 40.4 42.1 44.9 44.4 45.0 50.8 49.0 52.7 55.3 55.9 60.9 62.9 61.7 -1.2
40 38.2 38.0 38.4 36.2 36.5 34.6 36.2 35.4 34.6 35.9 39.0 37.3 36.6 40.3 42.1 42.0 44.0 48.0 49.0 52.0 +3.0
 45 — — — — 37.8 38.3 34.3 36.7 38.5 35.9 36.1 37.7 36.2 39.2 39.5 41.3 39.6 42.8 43.8 48.2 +4.3
50 — — — — — — — — — 39.3 37.0 36.5 36.0 38.4 39.1 39.8 41.1 40.4 44.0 44.3 +0.3
55 — — — — — — — — — — — — — — 36.2 36.2 38.0 38.7 41.7 41.2 -0.5
60 — — — — — — — — — — — — — — — — — — — 42.0 —
   % saying most or all 18 25.5 24.5 25.2 23.1 23.5 23.0 20.2 20.9 21.7 21.3 22.4 25.4 29.1 26.4 26.7 24.6 28.0 24.9 26.1 26.7 +0.6  
19–22 20.6 18.9 20.3 20.2 17.3 14.7 15.8 16.8 14.5 13.7 16.0 17.2 21.8 17.3 22.1 20.5 — 22.3 25.5 27.1 +1.6
23–26 8.4 9.7 10.4 10.3 10.3 11.7 9.7 11.1 8.1 8.9 12.7 13.9 10.5 9.1 13.6 15.3 — 14.0 18.3 19.5 +1.2
27–30 5.7 5.3 7.1 6.9 6.9 3.9 4.7 5.4 6.5 6.3 6.4 6.6 7.1 6.8 6.7 8.3 — 9.1 10.3 13.9 +3.6
35 2.8 3.1 3.2 2.9 3.2 2.8 2.5 2.1 2.2 2.2 2.5 3.7 4.5 3.3 4.7 5.1 6.4 6.3 6.5 8.9 +2.4
40 2.0 2.0 1.6 2.2 1.6 1.6 2.1 2.5 2.0 1.3 1.3 2.1 1.9 1.2 2.3 3.3 3.4 4.1 3.9 4.6 +0.6
45 — — — — 2.2 1.5 1.4 1.7 1.3 1.3 1.2 1.5 1.2 1.0 1.5 1.9 1.6 2.2 2.1 3.2 +1.1
50 — — — — — — — — — 1.4 1.4 1.4 1.8 1.8 1.0 1.4 1.9 2.0 1.4 2.2 +0.8
55 — — — — — — — — — — — — — — 2.0 0.9 2.2 1.3 2.0 2.3 +0.3
60 — — — — — — — — — — — — — — — — — — — 1.8 —
Take any illicit drug
 other than marijuana b 18 51.2 52.5 55.0 54.3 50.0 51.4 51.3 51.0 50.0 49.3 49.4 53.7 49.9 48.9 45.4 43.7 41.2 44.2 40.3 41.1 +0.8  
   % saying any 19–22 54.8 56.1 60.0 57.2 50.8 53.4 54.9 49.5 52.5 46.4 47.5 52.0 52.0 49.3 52.4 50.3 — 46.2 51.2 54.3 +3.1
23–26 41.1 42.5 42.6 49.4 42.3 47.1 46.6 45.6 42.6 45.9 44.4 52.4 50.5 46.6 45.3 53.3 — 50.3 49.6 54.3 +4.8
27–30 35.2 31.7 33.5 36.0 34.7 35.8 33.1 36.2 34.2 36.4 41.6 40.1 40.9 50.1 44.6 48.2 — 45.1 50.7 52.2 +1.5
35 19.0 17.9 18.7 20.4 18.5 20.2 18.5 18.1 20.7 23.7 20.2 23.9 26.4 25.7 25.2 26.5 27.2 28.3 29.3 27.8 -1.5
40 21.0 21.9 21.4 21.0 20.2 18.5 21.0 20.3 20.3 19.8 20.6 18.8 17.4 20.2 18.7 17.9 21.3 23.5 20.3 19.6 -0.7
45 — — — — 23.4 25.1 20.8 22.7 25.0 21.2 20.7 20.9 21.5 22.6 20.9 19.7 18.3 18.3 19.8 21.5 +1.7
50 — — — — — — — — — 24.5 24.8 21.7 22.8 22.2 20.1 21.3 20.5 18.9 20.7 20.3 -0.4
55 — — — — — — — — — — — — — — 19.9 19.0 21.0 20.1 18.8 18.6 -0.2
60 — — — — — — — — — — — — — — — — — — — 18.2 —
   % saying most or all 18 7.4 7.4 7.0 6.1 6.7 7.3 6.7 5.3 6.5 5.3 5.6 7.1 6.5 5.5 4.3 5.1 6.0 4.6 4.6 4.8 +0.2  
19–22 5.1 7.7 8.0 5.7 5.1 3.5 4.8 4.2 3.9 3.4 3.6 4.8 7.4 4.6 6.6 5.5 — 4.6 5.7 6.6 +0.9
23–26 2.2 3.8 3.7 2.8 3.7 3.1 3.2 3.2 1.0 1.5 2.9 3.2 3.1 3.2 3.3 5.3 — 3.5 4.6 2.7 -1.9
27–30 1.3 1.5 2.6 2.3 0.7 0.8 0.9 1.4 2.2 2.5 1.7 1.5 2.5 1.5 0.7 1.6 — 2.4 2.5 1.9 -0.6
35 0.9 1.0 0.9 0.6 0.6 0.4 0.5 0.5 0.6 0.5 0.5 1.0 0.7 0.8 1.3 0.9 1.2 0.9 0.7 0.7 -0.1
40 0.8 0.7 0.5 0.3 0.3 0.2 0.5 0.7 0.6 0.7 0.3 * 0.2 0.1 0.2 0.4 0.6 0.4 0.5 0.4 -0.1
45 — — — — 0.7 0.7 0.4 0.9 0.5 0.5 0.3 0.3 0.1 0.2 0.4 0.5 0.2 0.3 0.5 0.6 +0.1
50 — — — — — — — — — 0.5 0.4 0.3 0.8 0.4 0.2 0.3 0.3 0.5 0.2 0.2 +0.1
55 — — — — — — — — — — — — — — 0.4 0.4 0.4 0.3 0.2 0.2 0.0
60 — — — — — — — — — — — — — — — — — — — 0.1 —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Percentage saying friends use a
Age 
Group
Q.  How many of your friends 
would you estimate. . .
2017– 
2018 
change
(Table continued on next page.)
336
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Use marijuana  
   % saying any 18 86.4 83.0 84.4 80.3 77.7 79.5 79.2 78.4 75.3 72.5 68.3 65.8 63.1 67.4 75.6 76.1 78.0 81.4 83.2
19–22 88.8 86.4 85.2 83.8 81.6 81.1 78.5 75.3 75.1 73.8 67.6 68.0 63.5 67.6 67.4 68.8 74.9 74.7 77.2
23–26 — — — — 82.0 80.8 77.7 79.4 71.6 69.8 61.8 59.6 61.3 61.2 62.6 63.2 62.6 63.5 65.0
27–30 — — — — — — — — 71.8 68.2 65.1 62.6 58.0 57.4 52.3 55.7 55.1 58.3 55.5
35 — — — — — — — — — — — — — — 36.9 36.3 36.3 35.0 34.6
40 — — — — — — — — — — — — — — — — — — 34.6
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 31.3 27.7 23.8 21.7 18.3 19.8 18.2 15.8 13.6 13.4 10.1 10.0 10.3 13.9 18.9 20.7 22.2 22.5 23.8
19–22 34.1 30.6 25.6 20.6 19.4 16.0 13.3 12.5 12.2 9.0 9.2 8.3 8.2 8.5 13.0 12.5 16.3 16.2 16.4
23–26 — — — — 17.0 14.3 13.7 10.4 7.8 8.6 8.3 6.9 5.6 5.6 7.5 6.6 8.2 9.8 9.0
27–30 — — — — — — — — 6.8 4.4 4.0 2.8 5.1 5.2 5.0 5.6 3.5 3.9 4.8
35 — — — — — — — — — — — — — — 3.0 2.5 2.9 2.9 2.8
40 — — — — — — — — — — — — — — — — — — 2.1
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Use inhalants
   % saying any 18 17.8 16.5 18.4 16.1 19.3 21.2 22.4 24.7 20.8 22.1 20.0 19.2 22.2 23.7 26.5 27.5 27.2 27.4 25.9
19–22 11.9 13.2 13.8 12.3 11.7 9.6 10.9 12.7 10.9 11.7 13.0 12.2 12.6 13.8 14.0 14.2 16.2 13.7 16.2
23–26 — — — — 7.7 6.7 7.2 6.1 6.2 5.9 6.1 4.4 5.1 6.3 7.0 9.3 5.6 7.5 6.2
27–30 — — — — — — — — 4.6 3.5 2.9 2.5 3.3 2.9 3.5 4.0 4.1 3.6 3.8
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.2 0.9 1.3 1.1 1.1 1.5 2.0 1.9 1.2 1.9 1.0 0.7 1.8 1.8 2.0 2.0 2.4 1.9 2.7
19–22 0.5 0.4 0.7 0.3 0.5 0.6 0.7 0.7 0.7 0.4 0.6 0.2 0.8 0.7 0.7 0.6 1.1 0.7 1.3
23–26 — — — — 0.6 0.2 0.6 0.1 0.2 0.4 0.4 0.1 * 0.1 0.2 0.7 0.5 0.8 *
27–30 — — — — — — — — 0.3 * 0.2 0.2 * 0.2 * * * * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
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TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Age 
Group
Percentage saying friends use a
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Use marijuana  
   % saying any 18 80.7 80.5 81.2 79.4 78.9 79.5 77.4 76.4 74.8 78.2 77.2 79.7 80.6 77.7 80.2 79.3 76.9 78.9 78.2 76.5 -1.7  
19–22 73.9 81.2 78.4 77.2 76.5 75.6 75.8 72.0 76.6 74.7 77.7 75.6 74.7 76.8 76.2 77.5 78.4 82.9 82.8 79.4 -3.4 s
23–26 64.4 64.8 64.5 68.8 67.7 68.4 70.7 67.6 69.0 67.7 71.7 71.9 77.5 71.5 73.4 74.7 74.6 79.2 77.5 84.4 +7.0
27–30 57.0 51.7 56.5 59.0 55.8 60.4 60.8 61.0 60.2 64.2 65.2 62.3 65.9 66.6 69.2 69.4 76.2 72.2 76.2 80.0 3.8
35 33.3 34.9 35.6 37.4 32.9 34.7 37.2 37.3 38.6 42.1 40.6 41.3 47.4 45.1 48.8 54.0 53.4 57.0 60.7 60.1 -0.7
40 32.5 32.3 31.8 31.4 30.7 29.9 30.4 29.4 29.2 29.6 33.6 32.1 32.4 35.8 38.0 38.2 39.4 45.0 46.4 49.7 +3.3
45 — — — — 31.1 29.4 26.3 28.4 30.0 28.6 29.4 32.6 30.3 33.0 34.5 36.4 34.8 37.6 40.4 45.7 +5.3 s
50 — — — — — — — — — 30.1 26.9 28.0 27.9 31.3 33.0 34.0 36.2 36.1 39.4 40.5 +1.1
55 — — — — — — — — — — — — — — 29.5 28.9 31.6 31.9 37.0 36.6 -0.5
60 — — — — — — — — — — — — — — — — — — — 36.3 —
   % saying most or all 18 24.2 23.2 24.0 21.4 21.7 21.1 17.9 19.6 19.2 19.9 20.9 23.6 27.3 25.0 25.7 23.4 25.9 23.8 24.3 25.7 1.4  
19–22 19.4 16.6 18.5 18.6 16.0 15.0 13.4 15.7 13.4 11.5 14.5 15.4 19.1 16.2 19.7 18.3 23.1 20.5 23.9 26.3 2.4
23–26 8.5 8.2 9.0 8.7 9.3 9.8 8.0 10.1 7.9 8.5 12.2 12.3 9.6 8.3 12.8 13.7 17.1 12.8 15.2 17.1 +1.9
27–30 5.5 4.9 6.3 6.2 6.7 3.5 4.3 5.0 6.6 5.0 5.8 6.3 5.8 5.6 6.6 7.8 7.4 8.0 9.4 12.7 +3.3
35 2.6 2.8 2.6 2.7 3.1 2.7 2.3 2.0 2.1 1.9 2.3 3.4 4.2 2.9 4.3 4.9 6.2 6.1 6.1 8.4 +2.3
40 1.4 1.9 1.2 2.0 1.4 1.6 1.8 2.1 1.6 0.9 1.2 2.1 1.7 1.2 2.1 3.1 3.1 3.8 3.9 4.5 +0.6
45 — — — — 1.9 0.9 1.3 1.1 1.0 1.0 1.1 1.3 1.1 0.9 1.3 1.6 1.5 2.1 2.0 2.9 +0.9
50 — — — — — — — — — 1.2 1.2 1.2 1.3 1.5 1.0 1.2 1.6 1.6 1.4 2.2 +0.9
55 — — — — — — — — — — — — — — 1.8 0.7 1.9 1.1 1.9 2.2 0.3
60 — — — — — — — — — — — — — — — — — — — 1.6 —
↓
Use inhalants
   % saying any 18 21.6 23.5 22.2 21.0 17.5 17.9 18.1 18.9 17.9 18.0 18.0 19.0 16.4 12.3 12.1 9.4 8.7 8.8 7.2 9.0 +1.8  
19–22 16.3 13.7 13.7 10.4 10.0 9.5 11.1 11.0 9.6 7.4 6.6 8.3 11.9 8.2 7.3 5.5 7.5 3.5 5.4 6.6 1.2
23–26 7.9 6.9 7.5 7.4 7.9 6.2 5.8 5.2 3.7 6.1 6.5 6.0 4.8 5.4 4.1 4.4 2.7 4.1 5.3 3.7 -1.6
27–30 4.2 3.6 6.0 4.5 3.2 2.6 3.2 3.3 2.8 2.7 3.6 1.7 3.2 3.8 2.9 5.4 1.7 3.7 4.2 4.7 +0.5
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.8 1.4 1.4 1.2 1.1 1.2 2.0 1.2 1.6 1.1 0.9 1.8 1.4 0.9 1.1 0.7 0.8 0.8 0.7 1.1 +0.4  
19–22 0.8 0.6 1.2 0.4 0.6 * 0.1 0.5 0.3 0.6 * 0.6 0.6 0.1 0.9 * 0.5 * * 0.8 0.8
23–26 0.1 0.7 0.1 0.4 0.3 * 0.1 0.3 * * * 0.1 0.1 * 0.3 0.3 * * 0.4 * -0.4
27–30 * * 0.3 0.3 * * * * * 0.3 0.3 * 0.3 * 0.1 0.5 * * 0.4 * -0.4
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
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TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q.  How many of your friends 
would you estimate. . .
Age 
Group
Percentage saying friends use a
2017– 
2018 
change
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Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Use nitrites
   % saying any 18 19.0 17.4 17.5 14.5 15.0 15.6 18.0 18.3 13.6 13.3 10.4 8.9 9.0 10.7 10.0 10.7 11.2 11.9 12.9
19–22 18.4 16.0 14.2 13.8 8.9 9.9 11.7 13.2 10.2 — — — — — — — — — —
23–26 — — — — 10.8 7.8 8.0 7.9 5.2 — — — — — — — — — —
27–30 — — — — — — — — 6.6 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.3 1.2 0.9 0.7 1.2 1.0 1.2 1.3 0.7 0.9 0.6 0.4 0.7 0.7 0.8 0.8 0.8 0.7 1.0
19–22 0.3 0.4 0.9 0.6 0.6 0.6 0.4 0.4 0.2 — — — — — — — — — —
23–26 — — — — 0.8 0.3 0.4 0.3 0.1 — — — — — — — — — —
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55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.9 2.0 1.7 1.7 2.4 2.3 2.3 1.9 2.1 1.2 1.8 1.4 1.0 0.8 1.1 0.8 1.5 0.9 1.1 1.0 -0.2
19–22 1.1 1.0 1.8 1.0 1.4 0.7 2.1 1.0 1.1 1.3 0.5 0.2 0.5 0.3 0.9 0.6 1.1 0.8 2.6 1.9 -0.6
23–26 0.5 0.8 1.6 1.0 1.6 1.0 1.5 1.4 0.8 0.6 1.7 0.9 0.4 0.6 0.9 1.1 1.0 0.6 2.0 0.2 -1.9 s
27–30 0.4 0.4 0.5 0.6 0.3 0.3 * * 1.4 0.9 0.7 0.2 0.5 0.6 0.5 0.4 0.4 0.5 0.8 0.6 -0.2
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q. How many of your friends 
would you estimate. . .
Age 
Group
Percentage saying friends use a
2017– 
2018 
change
(Table continued on next page.)
344
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take crack
   % saying any 18 — — — — — — — 27.4 25.4 26.1 19.2 17.6 17.8 17.9 20.0 19.2 21.6 22.2 24.4
19–22 — — — — — — — 23.8 21.8 20.6 14.6 14.3 11.8 13.6 13.8 14.0 9.4 13.1 16.4
23–26 — — — — — — — 26.4 22.4 19.8 14.4 10.8 10.8 8.8 8.8 11.1 8.2 8.3 8.3
27–30 — — — — — — — — 22.1 18.4 16.6 11.6 10.3 10.2 10.4 10.3 8.6 6.3 6.4
35 — — — — — — — — — — — — — — 4.5 5.1 4.4 3.1 2.8
40 — — — — — — — — — — — — — — — — — — 3.8
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — 2.2 1.1 2.1 0.6 0.6 0.7 0.9 1.0 1.1 0.9 1.1 1.7
19–22 — — — — — — — 0.7 0.8 1.0 0.6 0.2 0.1 0.3 0.4 0.3 0.5 0.3 0.9
23–26 — — — — — — — 0.8 0.9 0.8 0.5 0.1 0.1 0.5 0.2 * 0.3 0.5 0.4
27–30 — — — — — — — — 1.2 0.9 0.9 0.3 * 0.6 0.3 0.1 0.2 0.2 0.1
35 — — — — — — — — — — — — — — 0.6 0.3 0.4 * 0.1
40 — — — — — — — — — — — — — — — — — — *
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Take cocaine powder
   % saying any 18 — — — — — — — — — 25.3 24.6 19.8 19.7 18.1 20.7 19.2 22.8 24.8 22.9
19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — 14.2 12.9 15.4 11.1 10.4
40 — — — — — — — — — — — — — — — — — — 10.8
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — — — 2.3 2.5 1.8 2.0 1.6 1.9 1.7 1.9 2.0 1.9
19–22 — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — 0.8 0.3 0.6 0.4 0.4
40 — — — — — — — — — — — — — — — — — — 0.2
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Age 
Group
Percentage saying friends use a
(Table continued on next page.)
345
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Take crack
   % saying any 18 19.0 21.4 23.4 21.5 18.7 22.5 22.9 22.3 21.8 19.1 18.8 15.2 12.1 10.4 10.3 9.0 10.1 8.0 8.0 8.6 0.6  
19–22 15.7 16.5 17.4 18.0 11.8 16.0 14.9 14.5 16.0 12.2 11.3 7.2 8.3 5.1 8.3 6.9 — 5.9 4.9 8.1 +3.2
23–26 8.8 7.9 8.6 10.1 10.4 10.8 10.8 10.0 8.7 9.8 8.5 7.0 6.7 6.5 7.5 5.0 — 5.4 8.4 10.8 +2.4
27–30 8.7 6.0 7.1 6.4 6.5 5.2 8.5 9.1 6.9 5.8 9.5 3.6 4.2 3.6 4.6 4.2 — 4.8 5.2 5.6 +0.4
35 3.2 3.9 2.8 3.2 2.8 3.1 2.6 2.8 3.0 2.8 2.5 3.4 2.1 1.3 2.9 3.5 3.4 2.6 2.1 — —
40 3.0 2.9 3.5 2.6 2.7 2.6 2.8 2.3 3.1 1.9 1.2 1.5 1.2 1.2 1.2 2.1 1.9 1.1 1.2 — —
45 — — — — 3.7 3.3 2.4 3.0 2.9 1.8 2.3 2.2 1.8 1.6 2.1 1.2 1.0 1.0 0.5 — —
50 — — — — — — — — — 2.0 1.6 1.8 1.4 1.1 1.2 1.9 1.3 0.9 0.9 — —
55 — — — — — — — — — — — — — — 2.1 1.2 1.1 0.9 0.8 — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.5 1.4 0.8 0.8 1.4 1.6 1.6 1.0 1.3 1.1 1.1 1.5 0.9 0.8 0.9 0.8 1.0 0.7 1.0 0.8 -0.2  
19–22 0.9 0.5 0.3 0.2 0.4 0.1 1.0 0.8 0.3 0.4 0.3 * 0.3 0.3 0.6 0.1 — 0.4 * 0.4 +0.4
23–26 * 0.5 0.3 * 0.3 0.5 0.2 0.7 0.1 0.3 * 0.4 0.1 * 0.3 0.1 — 1.2 0.9 * -0.9
27–30 * * * 0.3 0.1 * 0.1 * 0.3 0.6 0.3 * * * 0.5 * — 0.2 0.4 * -0.4
35 0.3 0.5 0.2 0.3 0.3 0.1 0.2 0.2 0.2 * 0.1 0.3 * 0.1 * * 0.3 0.2 0.1 — —
40 0.2 0.2 0.1 * * * 0.1 0.2 0.1 0.0 * * * * 0.1 * 0.3 * 0.1 — —
45 — — — — 0.4 0.3 0.2 0.2 * * 0.1 * * 0.1 0.1 0.2 * 0.1 * — —
50 — — — — — — — — — 0.2 0.1 0.2 0.1 0.0 0.2 0.1 * 0.2 0.1 — —
55 — — — — — — — — — — — — — — 0.2 0.0 0.2 0.0 0.1 — —
60 — — — — — — — — — — — — — — — — — — — — —
Take cocaine powder
   % saying any 18 22.0 21.3 20.1 22.4 23.2 25.4 23.2 22.8 22.3 22.6 19.1 17.6 15.9 17.4 15.6 15.4 14.7 16.0 17.1 15.8 -1.3  
19–22 — — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — — —
35 10.0 10.3 9.4 9.4 8.2 9.2 8.3 8.4 9.1 11.4 8.7 10.5 12.8 9.0 11.6 12.8 13.2 12.0 13.4 15.4 +2.0
40 8.9 8.8 8.8 8.5 7.6 7.6 8.9 7.3 6.7 6.2 6.5 4.9 4.8 5.2 6.6 6.6 6.2 8.1 7.3 8.5 +1.1
45 — — — — 8.3 8.0 7.0 7.4 8.0 6.7 6.4 5.9 5.8 6.0 6.0 5.2 4.6 4.8 4.8 8.1 +3.3 ss
50 — — — — — — — — — 6.0 5.4 5.3 4.9 4.9 4.4 4.6 5.1 4.3 4.5 5.8 +1.3
55 — — — — — — — — — — — — — — 4.1 3.0 3.8 3.5 3.9 4.9 1.0
60 — — — — — — — — — — — — — — — — — — — 4.1 —
   % saying most or all 18 1.9 1.8 1.5 1.9 1.9 3.3 1.7 1.7 1.8 1.5 1.5 1.0 1.6 1.5 1.2 1.8 1.2 2.2 2.2 2.1 -*  
19–22 — — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — — —
35 0.6 0.7 0.4 0.4 0.4 0.2 0.2 0.2 0.4 0.2 0.2 0.4 0.0 0.1 0.7 0.1 0.8 0.4 0.6 0.3 -0.3
40 0.2 * 0.2 0.1 0.1 0.1 0.2 0.5 0.2 0.2 0.1 * * * * * 0.3 * 0.2 0.1 -0.1
45 — — — — 0.5 0.5 0.2 0.4 0.1 0.1 * * * 0.1 0.3 0.2 * 0.1 0.3 0.3 +0.1
50 — — — — — — — — — 0.2 0.2 0.2 0.0 0.0 0.1 0.2 * 0.4 0.1 0.1 0.0
55 — — — — — — — — — — — — — — 0.2 0.1 0.2 0.1 0.1 0.1 0.0
60 — — — — — — — — — — — — — — — — — — — 0.1 —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q.  How many of your friends 
would you estimate. . .
Age 
Group
Percentage saying friends use a
2017– 
2018 
change
(Table continued on next page.)
346
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take heroin
   % saying any 18 13.0 12.5 13.2 12.0 13.0 14.5 15.3 13.9 12.4 14.0 11.4 11.4 13.2 13.3 14.3 14.5 15.6 15.6 16.5
19–22 11.0 8.1 9.4 7.5 7.1 6.5 8.5 8.5 7.8 6.8 6.5 6.1 4.7 7.0 8.1 10.4 6.7 7.4 9.4
23–26 — — — — 6.1 4.4 4.3 6.5 3.6 5.2 4.2 3.6 3.8 4.5 4.9 5.8 4.0 6.2 5.8
  27–30 — — — — — — — — 3.8 2.8 4.5 2.7 3.1 3.6 4.2 3.6 4.4 4.2 3.5
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.0 0.5 0.7 0.8 0.8 0.9 1.1 0.9 0.7 1.1 0.4 0.4 0.7 1.1 1.0 1.1 0.9 0.8 1.3
19–22 0.3 0.5 0.1 0.2 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.1 0.2 0.4 0.4 0.4 0.2 0.5
23–26 — — — — 0.4 0.2 0.2 * 0.2 0.4 0.2 0.3 0.4 0.1 0.2 0.2 * 0.7 *
27–30 — — — — — — — — 0.2 0.1 0.2 0.2 * 0.2 0.3 * * * 0.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Take other narcotics d
   % saying any 18 22.4 23.1 23.9 20.8 21.4 22.8 21.8 23.2 19.2 19.2 17.2 13.7 14.9 16.1 18.5 19.5 21.8 22.2 24.8
19–22 22.8 20.4 21.9 17.9 17.4 16.9 14.6 15.4 14.1 15.0 12.9 14.1 10.8 13.2 10.5 15.9 13.4 13.2 15.2
23–26 — — — — 16.0 14.9 14.0 13.0 10.6 10.8 10.5 8.5 8.4 8.7 8.0 10.5 8.9 9.9 9.4
27–30 — — — — — — — — 12.1 8.6 9.1 9.3 7.5 8.2 8.0 7.7 9.5 7.9 8.3
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.7 1.5 1.4 1.4 1.6 1.4 1.8 1.4 1.2 1.4 0.9 0.5 1.1 1.2 1.0 1.6 1.5 1.4 2.9
19–22 0.9 0.7 0.6 0.5 0.8 1.0 0.5 0.4 0.9 0.1 0.6 0.4 0.5 0.6 0.6 0.6 0.4 0.4 0.8
23–26 — — — — 0.4 0.3 0.7 * 0.3 0.2 0.2 * * * 0.3 0.2 * 0.6 0.3
27–30 — — — — — — — — 0.3 * 0.2 0.2 0.1 0.2 0.2 * 0.2 * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Age 
Group
Percentage saying friends use a
(Table continued on next page.)
347
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Take heroin
   % saying any 18 12.7 14.9 13.1 12.9 10.3 12.7 13.1 12.7 12.9 11.2 12.7 12.4 10.2 7.7 8.5 7.9 7.1 6.0 5.3 5.8 +0.5  
19–22 9.7 7.7 8.7 8.9 5.3 7.0 6.4 7.5 9.0 6.4 3.9 5.3 6.2 6.4 4.8 4.6 5.6 6.6 3.6 3.3 -0.3
23–26 4.8 4.7 5.0 5.2 6.1 2.9 5.1 3.5 4.3 3.1 5.9 6.9 3.9 5.9 4.6 3.9 3.0 4.4 7.0 3.3 -3.7 ~
  27–30 3.8 2.8 4.3 3.9 3.4 3.0 3.8 2.5 3.0 2.1 3.9 3.3 2.6 3.5 4.6 3.3 4.9 4.6 3.7 3.8 +0.1
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.0 1.1 0.9 0.7 0.9 0.9 1.1 0.8 1.4 0.7 0.9 1.3 0.6 0.6 0.6 0.5 0.7 0.7 0.9 0.3 -0.5  
19–22 0.1 0.3 0.6 * 0.3 * 0.3 0.4 0.3 0.6 * * 0.5 0.1 0.6 * 0.6 * * 0.4 +0.4
23–26 * 0.3 * 0.1 * * 0.3 0.3 * * 0.1 0.5 0.1 0.1 0.8 0.3 0.5 0.2 0.6 * -0.6
27–30 * * * 0.3 * * * * * * 0.3 * 0.3 * 0.1 0.1 * 0.2 0.4 * -0.4
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Take other narcotics d
   % saying any 18 22.9 23.1 24.0 27.5 21.6 24.6 21.4 23.0 20.7 20.6 21.5 36.3 31.0 28.5 25.8 22.0 20.0 20.5 18.4 14.7 -3.7 s
19–22 19.8 23.2 23.0 21.8 21.9 22.6 19.9 17.6 23.7 16.8 15.3 31.4 31.3 25.7 29.5 20.9 21.7 17.1 19.1 19.6 +0.5
23–26 10.4 11.2 13.5 14.6 18.4 16.8 18.3 17.6 14.2 16.0 19.3 36.7 30.4 27.9 25.6 29.2 24.4 24.2 18.8 21.8 +3.0
27–30 7.2 8.4 11.2 11.8 11.0 12.0 12.5 13.1 10.6 14.3 14.2 28.4 29.8 32.9 30.4 29.6 28.7 25.5 26.8 26.2 -0.7
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.8 2.0 2.0 2.1 2.4 2.4 1.9 1.8 2.6 1.3 1.9 3.8 2.6 1.8 1.9 1.8 1.5 1.7 1.7 1.3 -0.3  
19–22 0.4 1.2 1.8 1.3 1.0 0.5 1.0 0.9 0.3 1.3 0.4 1.8 2.1 1.4 2.7 0.5 1.1 0.5 0.3 1.0 +0.7
23–26 * 0.4 0.5 0.6 0.6 0.5 0.8 0.5 0.3 0.1 0.9 1.6 1.1 1.0 1.6 1.2 1.0 0.6 1.0 * -1.0
27–30 0.2 * * 0.3 0.1 * * 0.6 * 0.6 0.6 0.9 1.2 0.1 0.5 0.5 * 0.5 0.9 0.2 -0.7
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q.  How many of your friends 
would you estimate. . .
Age 
Group
Percentage saying friends use a
2017– 
2018 
change
(Table continued on next page.)
348
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take amphetamines e 
   % saying any 18 43.9 48.8 50.6 46.1 45.1 43.3 41.8 39.5 33.4 33.5 28.7 24.3 24.3 27.5 28.1 30.3 32.2 32.7 33.8
19–22 54.1 52.2 51.3 49.7 46.1 42.1 38.5 34.5 26.8 29.6 23.3 26.2 19.5 21.0 20.9 21.7 21.6 21.1 24.4
23–26 — — — — 45.6 40.1 33.5 32.1 28.4 23.1 20.6 17.1 15.1 16.8 16.2 18.2 12.5 14.4 14.1
27–30 — — — — — — — — 26.1 21.6 19.3 17.0 15.3 14.0 13.1 13.7 15.5 12.9 11.0
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 4.8 6.4 5.4 5.1 4.5 3.4 3.4 2.6 1.9 2.6 1.9 1.3 1.3 2.0 1.8 2.0 2.8 2.4 3.4
19–22 3.8 5.7 4.6 3.8 3.3 2.9 1.3 1.9 1.4 0.7 1.0 0.6 0.9 0.2 1.1 1.2 0.7 0.7 1.2
23–26 — — — — 1.9 1.8 1.7 1.2 0.3 0.6 0.7 0.8 0.4 1.5 0.9 0.5 0.2 0.8 0.5
27–30 — — — — — — — — 0.6 0.4 0.5 0.5 0.1 0.5 0.5 0.3 0.3 0.1 0.3
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Take sedatives/
   barbiturates f
   % saying any 18 30.5 31.1 31.3 28.3 26.6 27.1 25.6 24.3 19.7 20.3 17.4 14.8 16.4 17.8 18.2 17.8 21.6 20.4 22.8
19–22 33.2 27.9 27.7 23.6 22.0 17.2 18.8 15.5 14.0 14.1 11.9 12.8 10.7 11.7 9.7 13.3 11.6 12.1 14.8
23–26 — — — — 22.2 18.7 16.3 14.1 11.2 10.4 8.9 8.3 8.7 8.2 7.6 9.6 6.9 8.4 7.9
27–30 — — — — — — — — 12.0 8.5 8.8 7.1 6.6 6.7 7.4 7.2 6.7 6.5 6.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.6 2.1 1.8 1.7 1.7 1.6 1.4 1.1 1.1 1.4 0.6 0.5 0.6 1.0 1.1 1.4 1.6 1.1 2.5
19–22 1.1 1.3 1.0 0.8 0.8 0.5 0.3 0.4 0.8 0.1 0.2 0.3 0.1 0.1 0.3 0.8 0.2 0.7 0.4
23–26 — — — — 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.2 * * 0.8 *
27–30 — — — — — — — — 0.2 * 0.4 0.2 0.2 0.2 * * 0.3 * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Age 
Group
Percentage saying friends use a
349
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Take amphetamines e 
   % saying any 18 30.8 32.9 33.2 34.4 28.1 31.4 28.8 29.0 27.4 27.3 30.0 31.1 31.3 30.5 25.7 25.0 24.2 27.3 21.4 21.5 +0.2  
19–22 25.5 28.4 28.0 28.6 24.0 23.5 25.9 25.4 26.9 19.9 26.6 27.3 29.5 30.5 37.9 33.4 38.5 30.6 35.2 30.9 -4.3
23–26 14.2 14.5 17.5 18.4 18.0 18.8 18.4 19.7 17.6 17.9 21.3 23.8 27.7 26.1 27.0 31.5 28.5 30.5 32.4 33.1 +0.7
27–30 11.8 11.9 12.9 12.3 12.0 13.5 11.8 12.5 10.0 12.8 16.4 16.4 17.2 22.9 24.7 24.1 27.0 25.4 30.0 31.8 +1.8
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 2.8 3.1 2.2 2.4 2.1 2.9 2.2 2.0 2.4 1.8 2.0 2.9 2.2 2.4 2.2 2.9 2.5 2.4 1.7 1.7 0.0  
19–22 0.7 1.7 1.6 1.3 1.2 0.5 0.7 1.1 0.4 1.3 1.6 1.2 4.3 2.0 3.5 3.8 4.3 2.4 3.0 2.2 -0.8
23–26 0.6 0.3 0.5 0.3 0.7 0.1 0.3 0.7 * 0.1 0.3 0.8 1.3 1.5 1.9 2.2 1.3 1.9 2.4 1.6 -0.8
27–30 0.6 0.1 0.5 0.9 0.1 * 0.4 0.4 0.4 0.3 0.5 0.3 0.3 0.3 0.1 0.3 0.8 0.5 1.1 0.7 -0.4
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Take sedatives/
barbiturates f
   % saying any 18 20.9 21.6 22.1 25.3 18.1 25.2 22.3 22.5 20.8 19.8 21.0 23.5 21.1 17.3 15.5 14.2 14.5 15.1 12.9 11.9 -0.9  
19–22 16.0 15.2 18.6 17.1 14.4 18.8 19.6 18.7 20.1 17.8 16.4 19.1 14.5 13.7 19.0 13.6 18.2 12.0 14.9 13.2 -1.7
23–26 8.3 6.6 11.1 10.9 12.9 16.7 15.7 16.2 16.5 13.4 18.6 17.6 12.2 11.8 14.3 15.0 11.9 15.4 11.6 16.2 +4.6
27–30 5.7 6.4 7.9 7.4 7.3 11.5 10.5 13.5 12.5 15.2 12.7 15.3 13.7 14.5 16.5 13.0 13.1 13.0 14.8 14.5 -0.3
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.4 1.7 1.1 1.7 1.9 2.0 1.8 1.3 1.6 1.3 1.3 1.5 1.3 1.5 1.2 1.1 1.4 1.4 1.0 0.8 -0.2  
19–22 0.4 1.0 0.9 0.8 0.7 0.3 0.3 0.2 0.6 0.5 1.0 0.6 0.6 0.3 1.2 0.7 1.3 * 0.2 0.4 +0.2
23–26 * 0.4 0.4 * 0.2 0.4 0.2 0.5 * 0.4 0.4 0.5 0.3 0.4 0.7 0.4 0.7 0.8 1.0 * -1.0
27–30 0.2 * 0.3 0.6 0.1 * 0.5 0.4 0.6 0.1 0.9 0.4 0.2 * 0.1 0.1 0.4 0.6 0.4 0.2 -0.2
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q.  How many of your friends 
would you estimate. . .
Age 
Group
Percentage saying friends use a
2017– 
2018 
change
350
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Take quaaludes 
   % saying any 18 32.5 35.0 35.5 29.7 26.1 26.0 23.5 22.0 17.1 16.6 14.3 12.0 13.1 14.2 14.2 15.5 18.1 16.1 17.4
19–22 38.3 36.2 35.4 30.5 24.6 19.9 20.3 16.9 12.5 10.9 10.0 10.6 9.2 10.0 7.8 11.5 10.1 9.3 10.6
23–26 — — — — 25.7 21.0 17.4 15.0 12.1 10.3 8.6 5.9 6.4 7.6 7.7 9.0 6.3 6.5 6.6
27–30 — — — — — — — — 11.8 7.9 8.2 7.0 7.1 6.5 6.6 4.5 6.9 4.9 4.1
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 3.6 3.6 2.6 2.6 1.7 1.3 1.6 1.0 1.0 1.3 0.8 0.5 0.8 1.1 1.1 1.3 1.7 1.1 2.0
19–22 1.9 2.7 1.2 1.3 1.2 0.6 0.2 0.4 0.4 0.2 0.6 0.2 0.1 0.1 0.2 0.7 0.1 0.6 0.5
23–26 — — — — 0.6 0.3 0.7 0.2 0.2 0.4 0.2 0.1 0.2 0.6 0.2 0.2 * 0.8 *
27–30 — — — — — — — — 0.5 0.2 0.2 0.2 * 0.2 * * 0.2 * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Take tranquilizers 
   % saying any 18 29.7 29.5 29.9 26.7 26.6 25.8 24.2 23.3 19.9 18.0 14.9 13.5 14.6 15.5 16.5 15.8 18.1 17.9 19.7
19–22 37.5 33.9 28.7 22.9 22.0 19.7 20.6 18.0 16.4 14.8 13.4 13.0 11.3 11.9 9.5 13.6 10.5 11.7 13.7
23–26 — — — — 29.3 26.3 22.3 20.8 15.5 13.1 14.8 12.1 12.5 11.0 13.4 10.4 10.7 9.6 8.5
27–30 — — — — — — — — 20.1 16.6 16.9 14.9 12.0 12.5 13.9 11.9 11.0 10.8 12.6
35 — — — — — — — — — — — — — — 14.3 12.2 13.1 10.8 10.7
40 — — — — — — — — — — — — — — — — — — 13.7
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.9 1.4 1.1 1.2 1.5 1.2 1.3 1.0 0.7 1.5 0.5 0.4 0.7 0.9 0.9 1.1 1.4 0.8 2.3
19–22 0.7 0.9 0.5 0.8 0.3 0.7 0.3 0.6 0.4 0.1 0.4 0.5 0.1 0.1 0.2 0.7 0.7 0.8 0.6
23–26 — — — — 0.4 0.3 0.5 * 0.3 0.4 0.2 0.3 0.1 0.4 0.2 * * 1.1 0.1
27–30 — — — — — — — — 0.5 0.3 0.4 0.2 0.1 0.2 0.4 * 0.2 * *
35 — — — — — — — — — — — — — — 0.5 0.3 0.3 0.1 0.2
40 — — — — — — — — — — — — — — — — — — 0.0
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Age 
Group
Percentage saying friends use a
(Table continued on next page.)
351
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Take quaaludes 
   % saying any 18 15.5 16.2 17.8 18.0 14.2 16.6 13.6 13.4 13.6 11.2 14.3 — — — — — — — — — —
19–22 11.4 13.1 14.6 13.0 10.3 8.3 8.2 8.6 8.8 5.9 5.3 — — — — — — — — — —
23–26 6.4 4.9 7.7 8.5 8.9 6.5 7.7 5.6 5.6 4.1 8.0 — — — — — — — — — —
27–30 5.1 5.0 4.9 6.6 4.3 4.4 3.6 4.9 4.3 5.8 4.5 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 1.4 1.4 1.2 1.2 1.2 1.6 1.3 1.3 1.6 0.8 1.1 — — — — — — — — — —
19–22 0.4 0.9 0.8 0.1 0.4 * 0.4 0.2 * 0.2 * — — — — — — — — — —
23–26 0.2 0.3 0.3 0.1 0.2 0.1 0.2 0.3 0.3 * 0.1 — — — — — — — — — —
27–30 0.2 0.3 * 0.3 * * 0.3 0.7 * 0.3 0.5 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Take tranquilizers 
   % saying any 18 16.4 19.4 18.6 21.2 17.2 18.3 16.9 15.3 15.5 15.0 15.8 16.1 13.9 13.3 11.7 10.1 11.5 12.0 11.1 10.5 -0.6  
19–22 16.2 16.7 21.3 18.1 14.5 12.3 11.5 13.0 17.2 11.6 11.1 11.6 8.2 10.2 12.7 8.6 10.8 7.2 7.9 10.1 +2.3
23–26 9.8 11.2 12.4 14.9 12.9 15.1 13.1 10.7 12.3 12.6 15.5 13.4 9.9 7.3 9.3 8.9 7.5 7.9 8.0 12.2 +4.2
27–30 10.4 10.6 9.6 10.6 10.4 9.9 9.7 8.5 9.1 12.3 10.3 9.5 9.4 12.6 12.3 8.7 11.6 7.1 9.3 8.6 -0.7
35 11.4 10.8 12.2 12.5 11.4 12.7 12.4 12.2 14.7 16.1 14.8 17.6 17.7 17.9 17.3 17.7 19.2 19.5 18.7 16.0 -2.8
40 14.8 15.2 15.1 15.6 15.0 13.6 14.1 16.1 16.0 15.0 15.1 13.6 12.9 15.8 14.5 13.2 14.5 17.1 14.7 12.0 -2.7
45 — — — — 17.3 19.8 15.4 18.3 20.7 17.3 17.5 16.3 16.7 18.8 16.7 15.8 14.5 14.2 13.7 15.7 +2.1
50 — — — — — — — — — 19.7 21.0 17.8 19.1 18.1 16.7 17.9 15.7 15.0 16.3 15.6 -0.6
55 — — — — — — — — — — — — — — 17.0 16.6 17.0 16.8 15.8 15.4 -0.4
60 — — — — — — — — — — — — — — — — — — — 14.7 —
   % saying most or all 18 1.3 2.1 1.3 1.6 1.5 1.7 1.6 1.2 1.8 1.2 1.5 1.4 0.8 0.8 1.0 1.3 1.5 1.1 1.0 0.7 -0.3  
19–22 0.3 0.6 0.9 0.4 0.4 0.3 0.3 0.3 0.3 0.1 0.1 0.6 0.6 0.2 0.6 0.4 0.8 * 0.7 0.6 0.0
23–26 * 0.5 0.8 0.1 * 0.5 0.7 0.4 * 0.1 0.3 0.2 0.1 0.3 0.3 0.3 0.2 0.4 0.4 * -0.4
27–30 0.4 * 0.4 0.6 0.1 * 0.2 0.2 * 0.1 0.5 * * * 0.1 0.1 0.6 0.4 0.4 0.2 -0.2
35 0.6 0.6 0.2 0.1 0.2 0.3 0.5 0.3 0.5 0.3 0.4 0.6 0.3 0.4 0.4 0.5 0.4 0.4 0.1 0.3 +0.2
40 0.4 0.1 0.3 0.2 * 0.2 0.2 0.3 0.3 0.3 0.1 * * 0.1 * 0.2 * 0.1 0.4 0.1 -0.3
45 — — — — 0.3 0.2 0.2 0.1 0.3 * 0.2 0.1 0.1 * 0.2 0.2 0.1 0.1 0.1 * 0.0
50 — — — — — — — — — 0.3 0.1 0.1 0.4 0.2 0.1 0.2 0.2 0.2 0.2 * -0.2
55 — — — — — — — — — — — — — — 0.3 0.4 0.2 0.2 0.1 0.0 0.0
60 — — — — — — — — — — — — — — — — — — — 0.0 —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q.  How many of your friends 
would you estimate. . .
Age 
Group
Percentage saying friends use a
2017– 
2018 
change
(Table continued on next page.)
352
Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Drink alcoholic beverages
   % saying any 18 96.1 94.7 95.7 95.5 94.6 94.6 95.6 95.4 95.7 95.1 92.0 91.2 90.5 88.9 90.1 90.9 89.6 90.7 91.2
19–22 96.3 96.7 96.6 97.3 96.8 95.8 96.9 95.6 97.0 97.6 96.1 95.2 93.1 95.1 92.5 94.8 93.7 94.5 94.5
23–26 — — — — 96.8 96.8 96.2 95.9 95.3 95.4 94.7 93.9 95.1 94.4 94.0 94.1 92.7 95.4 95.5
27–30 — — — — — — — — 96.1 96.0 95.2 94.4 95.6 93.4 93.3 93.3 93.1 95.1 93.1
35 — — — — — — — — — — — — — — 89.6 89.9 90.3 89.5 88.1
40 — — — — — — — — — — — — — — — — — — 88.4
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 68.9 67.7 69.7 69.0 66.6 66.0 68.0 71.8 68.1 67.1 60.5 58.6 56.9 57.0 59.6 56.4 56.4 60.9 61.0
19–22 76.6 77.6 75.2 75.1 74.9 71.9 74.2 71.3 73.4 74.1 70.0 71.4 67.4 66.5 68.7 63.9 67.0 63.8 69.4
23–26 — — — — 73.2 74.4 69.5 74.9 68.9 69.8 67.1 69.3 68.8 68.7 70.7 67.0 68.9 66.6 67.4
27–30 — — — — — — — — 66.7 67.8 62.0 62.7 63.3 61.3 63.2 62.6 64.1 66.6 62.9
35 — — — — — — — — — — — — — — 43.8 45.1 49.5 46.6 47.1
40 — — — — — — — — — — — — — — — — — — 37.7
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Get drunk at least 
 once a week
   % saying any 18 83.1 81.8 83.1 83.9 81.5 82.5 84.7 85.6 84.4 82.8 79.2 79.8 79.9 79.2 81.4 78.9 78.5 82.4 81.1
19–22 80.9 79.9 80.0 80.4 79.8 76.7 82.0 81.1 80.6 80.4 80.1 80.8 76.5 81.1 79.6 83.2 80.9 79.2 82.3
23–26 — — — — 73.1 72.7 73.5 73.7 72.1 73.1 72.2 74.0 73.1 74.3 72.1 73.1 74.5 71.9 74.1
27–30 — — — — — — — — 66.3 61.8 65.4 65.2 65.5 64.5 62.7 67.1 66.7 65.4 65.5
35 — — — — — — — — — — — — — — 44.3 43.2 44.9 42.9 46.1
40 — — — — — — — — — — — — — — — — — — 41.6
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 30.1 29.4 29.9 31.0 29.6 29.9 31.8 31.3 29.6 31.1 27.5 29.7 28.6 27.6 28.4 27.4 29.0 30.9 31.7
19–22 21.9 23.3 22.0 20.2 22.7 21.7 20.8 21.3 24.0 22.6 23.6 24.9 22.6 28.8 26.3 28.2 26.0 26.6 29.8
23–26 — — — — 11.4 11.6 12.5 11.9 12.8 12.0 13.9 11.6 14.6 13.2 15.2 15.2 14.0 17.0 16.0
27–30 — — — — — — — — 5.2 6.3 6.7 6.6 5.9 6.7 6.4 7.9 8.6 7.7 9.3
35 — — — — — — — — — — — — — — 3.6 3.6 5.4 3.2 4.4
40 — — — — — — — — — — — — — — — — — — 2.8
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Age 
Group
Percentage saying friends use a
(Table continued on next page.)
353
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Drink alcoholic beverages
   % saying any 18 90.2 89.8 89.2 88.0 87.9 87.8 87.2 86.0 85.1 85.2 83.7 83.9 82.6 82.0 82.0 79.7 75.5 77.2 75.7 74.2 -1.5  
19–22 92.8 95.2 93.4 94.5 92.5 90.4 95.0 91.9 94.0 92.6 93.2 90.9 88.9 93.3 92.0 91.0 — 87.7 86.8 86.5 -0.3
23–26 93.3 94.5 93.1 95.3 92.8 94.9 91.6 93.6 94.7 93.3 95.0 95.3 95.3 92.3 92.5 94.1 — 91.6 91.9 90.8 -1.1
27–30 94.4 92.7 91.4 92.8 90.5 94.4 93.7 95.6 92.4 91.7 93.9 93.0 92.5 93.4 91.6 95.1 — 94.7 92.5 90.3 -2.2
35 88.7 89.6 89.3 90.1 87.4 93.4 91.3 90.6 90.5 91.0 90.4 93.3 93.0 92.7 93.2 92.6 92.6 94.3 93.2 92.4 -0.8
40 88.9 90.7 89.6 90.5 89.2 90.5 92.1 90.8 93.0 89.3 92.6 92.1 92.4 91.3 91.9 90.8 91.2 91.4 91.2 92.5 +1.3
45 — — — — 87.9 90.3 89.8 90.1 89.8 90.5 89.5 90.6 90.8 90.1 91.4 92.4 92.5 91.3 90.0 91.2 +1.3
50 — — — — — — — — — 88.9 90.2 89.9 90.4 90.1 89.2 92.0 90.3 91.4 91.2 90.9 -0.3
55 — — — — — — — — — — — — — — 87.6 89.3 89.5 88.3 89.9 90.7 +0.8
60 — — — — — — — — — — — — — — — — — — — 88.7 —
   % saying most or all 18 58.2 57.2 59.2 53.7 53.1 53.9 55.3 52.4 52.0 51.6 50.5 51.4 50.3 49.4 46.9 46.2 42.3 39.2 39.7 38.0 -1.7  
19–22 67.8 70.1 65.4 68.8 63.9 66.4 71.8 65.4 71.1 64.4 69.7 69.1 63.3 66.3 63.2 63.4 — 66.1 62.4 62.8 0.5
23–26 63.6 70.8 65.7 73.4 66.0 71.3 69.3 69.2 70.2 76.3 76.9 75.5 79.7 74.3 73.7 76.5 — 66.5 65.4 65.5 1.5
27–30 64.4 64.8 64.9 66.3 61.5 69.0 66.2 70.7 65.6 67.1 74.0 72.2 70.9 74.9 72.9 74.7 — 75.1 76.3 71.3 -5.0
35 46.0 49.1 48.4 52.9 51.6 53.7 55.5 55.2 56.1 55.7 53.2 56.9 61.9 58.7 62.1 66.1 64.2 66.5 65.4 65.5 +0.2
40 41.4 42.5 44.7 44.8 47.2 43.3 47.2 45.9 50.3 48.9 54.5 54.7 54.3 55.9 56.6 53.6 55.2 57.6 60.2 62.6 +2.3
45 — — — — 38.9 41.7 42.4 45.1 46.6 47.0 45.9 46.7 47.2 53.5 52.0 56.1 57.8 55.1 56.5 56.2 -0.2
50 — — — — — — — — — 37.7 39.3 41.9 43.5 45.8 48.2 48.6 48.8 50.0 50.7 50.2 -0.5
55 — — — — — — — — — — — — — — 39.1 41.0 42.4 46.9 47.7 47.4 -0.3
60 — — — — — — — — — — — — — — — — — — — 39.5 —
Get drunk at least 
 once a week
   % saying any 18 81.5 79.5 79.6 78.3 77.3 79.0 78.7 77.4 75.5 76.2 76.2 73.5 71.9 68.9 69.9 64.2 58.9 59.0 58.0 55.4 -2.6  
19–22 82.8 82.2 81.9 81.5 81.5 80.5 85.1 81.7 84.4 81.3 82.8 81.2 78.3 83.6 77.7 78.2 — 75.6 76.5 72.1 -4.4
23–26 71.0 76.5 74.7 81.0 76.4 75.8 80.7 80.9 80.4 79.5 83.0 83.7 83.9 79.7 83.1 85.6 — 81.2 76.1 79.0 2.9
27–30 65.9 64.3 64.7 68.9 66.5 73.8 72.4 74.6 72.0 71.7 78.7 78.2 78.3 80.1 74.4 77.2 — 77.9 79.2 78.9 -0.2
35 44.5 46.9 47.6 48.3 47.9 52.0 50.7 52.6 55.0 56.0 56.0 59.2 63.2 62.4 63.9 65.4 68.0 67.8 68.2 66.5 -1.6
40 40.6 42.2 41.3 42.6 42.9 43.2 48.4 47.2 46.3 48.2 53.7 49.6 48.5 54.9 54.7 53.4 58.0 57.4 58.9 58.7 -0.2
45 — — — — 41.6 42.2 41.6 40.0 42.7 45.7 45.4 49.1 45.9 50.0 50.5 52.1 52.8 52.3 54.3 57.6 +3.3
50 — — — — — — — — — 40.0 38.3 39.6 42.4 42.5 45.0 45.5 46.7 48.7 47.3 48.4 +1.1
55 — — — — — — — — — — — — — — 35.1 35.4 39.2 39.7 38.9 39.9 +1.0
60 — — — — — — — — — — — — — — — — — — — 33.4 —
   % saying most or all 18 30.1 32.4 32.7 28.3 27.1 27.6 28.5 27.7 27.0 25.2 24.4 23.7 23.8 21.2 20.7 18.5 15.5 11.5 12.4 11.6 -0.9  
19–22 29.3 28.1 30.2 31.0 29.6 29.0 31.2 32.9 32.0 28.9 31.4 27.7 27.6 27.2 28.1 28.7 — 21.6 25.8 23.0 -2.8
23–26 16.8 17.4 19.1 19.2 18.3 24.0 24.0 20.3 22.8 23.1 23.2 24.0 22.6 20.0 23.4 20.2 — 23.5 20.1 24.1 3.9
27–30 12.1 9.8 11.7 8.9 13.0 9.4 11.2 13.5 12.2 10.9 17.1 13.7 13.2 13.5 13.2 15.2 — 16.7 17.2 15.8 -1.4
35 4.9 4.6 4.8 4.5 5.2 5.3 5.3 5.6 6.1 7.3 5.9 7.4 8.4 6.8 8.3 10.7 10.8 8.6 10.2 9.7 -0.5
40 3.0 2.5 2.9 3.8 3.9 3.0 3.6 4.0 3.4 4.8 4.6 4.8 4.8 4.3 4.2 5.7 5.6 5.6 6.7 6.8 0.0
45 — — — — 3.6 2.7 2.7 3.1 3.7 4.1 3.2 3.2 3.5 4.3 5.1 5.1 5.5 4.2 3.5 5.5 +2.0
50 — — — — — — — — — 3.2 2.7 2.0 2.9 2.5 3.6 4.1 3.6 4.0 3.0 3.7 +0.7
55 — — — — — — — — — — — — — — 2.0 1.9 3.2 3.1 2.9 2.5 -0.4
60 — — — — — — — — — — — — — — — — — — — 1.6 —
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Q.  How many of your friends 
would you estimate. . . 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(Years 
Cont.)
Smoke cigarettes
   % saying any 18 90.6 88.5 88.3 87.0 86.0 87.0 87.8 88.3 87.7 86.5 84.9 85.7 84.4 84.8 88.1 87.9 88.3 89.9 89.5
19–22 94.4 94.3 93.4 93.1 91.9 91.6 91.1 90.3 89.3 90.0 86.1 86.1 86.7 86.7 86.1 88.8 89.2 91.3 92.6
23–26 — — — — 93.9 95.0 91.6 92.1 89.8 90.1 88.7 89.6 85.6 88.3 86.4 86.8 85.3 85.4 88.7
27–30 — — — — — — — — 92.6 89.8 90.7 90.4 88.0 85.8 84.8 84.9 85.4 84.1 81.1
35 — — — — — — — — — — — — — — 72.7 71.7 71.7 72.4 71.8
40 — — — — — — — — — — — — — — — — — — 70.2
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 23.3 22.4 24.1 22.4 19.2 22.8 21.5 21.0 20.2 23.1 21.4 21.8 21.4 25.0 25.3 27.5 30.4 34.4 33.9
19–22 31.8 27.6 25.6 25.2 25.6 22.7 21.9 22.5 19.3 19.9 19.2 20.2 20.3 22.2 21.7 28.4 24.0 25.1 28.8
23–26 — — — — 25.6 22.7 19.7 18.5 16.5 20.5 16.9 18.1 16.0 15.5 16.6 13.9 17.6 17.0 16.8
27–30 — — — — — — — — 15.8 14.2 11.6 12.9 11.9 14.3 10.9 12.3 10.4 12.1 12.3
35 — — — — — — — — — — — — — — 7.9 7.2 9.3 7.2 8.0
40 — — — — — — — — — — — — — — — — — — 8.1
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Take steroids
   % saying any 18 — — — — — — — — — — 25.9 24.7 21.5 19.0 18.1 19.5 17.9 18.9 18.3
19–22 — — — — — — — — — 23.4 21.5 22.2 19.7 20.7 16.8 16.6 16.1 16.8 20.0
23–26 — — — — — — — — — 15.3 15.0 12.3 14.5 11.1 10.5 12.4 7.3 13.0 9.2
27–30 — — — — — — — — — 9.9 10.5 7.5 8.0 8.0 8.0 8.0 10.2 9.1 7.0
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 — — — — — — — — — — 1.8 1.0 1.7 0.9 1.2 1.3 0.8 1.7 1.4
19–22 — — — — — — — — — 0.2 0.6 * 0.1 0.4 0.2 0.1 * 0.1 0.3
23–26 — — — — — — — — — 0.4 * * 0.2 0.1 0.1 * * 0.5 *
27–30 — — — — — — — — — 0.5 * * * 0.2 0.1 * * * *
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Smoke cigarettes
   % saying any 18 89.3 87.2 86.8 85.4 83.3 83.7 81.8 81.4 77.1 78.4 79.6 78.0 75.4 74.3 72.1 66.4 60.2 58.4 54.0 50.9 -3.1  
19–22 91.0 90.9 90.9 89.7 86.5 89.7 89.3 85.8 86.8 84.4 88.3 81.8 79.4 78.2 77.4 76.5 76.0 70.8 63.9 62.2 -1.7
23–26 84.1 86.5 86.7 86.4 86.5 87.0 87.3 85.4 84.1 86.8 85.3 87.7 86.5 83.1 80.3 82.2 79.8 77.5 72.9 74.4 1.5
27–30 86.3 85.1 84.9 87.0 82.8 83.5 81.0 84.4 81.7 82.1 84.1 84.6 83.8 85.2 81.6 84.4 78.6 74.5 77.5 73.8 -3.7
35 69.9 70.8 69.2 66.6 67.0 67.7 65.5 67.0 64.8 67.6 62.2 65.4 66.1 66.4 63.2 63.8 65.2 65.0 62.6 60.1 -2.4
40 70.0 67.8 64.3 65.5 65.1 62.4 63.8 64.6 59.2 59.7 60.5 57.4 57.4 56.7 59.1 56.2 54.5 54.8 52.4 48.9 -3.6
45 — — — — 66.1 67.0 62.9 60.9 58.5 56.1 57.7 60.6 58.0 57.4 54.3 56.0 49.7 52.1 50.4 52.5 +2.1
50 — — — — — — — — — 62.1 61.3 59.2 55.9 57.4 54.7 55.4 55.4 52.4 52.8 53.1 +0.3
55 — — — — — — — — — — — — — — 56.5 52.4 52.9 48.5 49.4 47.4 -2.0
60 — — — — — — — — — — — — — — — — — — — 47.9 —
   % saying most or all 18 31.1 28.2 25.0 23.0 19.6 20.6 16.7 15.8 16.4 13.9 14.1 14.9 14.1 12.2 11.0 8.1 6.5 5.9 6.6 6.1 -0.5  
19–22 26.8 29.4 27.0 25.7 20.2 20.7 20.4 15.2 17.9 12.9 15.3 16.7 13.7 13.6 10.8 9.4 8.9 5.4 5.0 3.8 -1.2
23–26 17.5 17.0 15.5 15.1 18.3 19.8 19.6 13.9 14.7 15.0 13.4 15.0 11.1 10.6 13.5 11.4 9.5 5.6 7.9 3.5 -4.5 s
27–30 13.4 11.7 10.2 12.9 12.2 9.2 12.6 12.6 12.7 10.8 12.4 7.9 7.4 10.0 6.8 7.7 5.9 5.8 6.3 6.3 0.0
35 9.0 6.7 8.8 6.6 6.3 6.9 6.0 6.8 5.7 5.9 6.4 6.8 6.2 5.5 4.9 5.8 6.0 4.0 4.5 3.7 -0.8
40 7.4 6.8 5.7 5.8 5.9 6.0 7.0 5.1 4.7 4.5 3.9 4.0 4.2 2.9 3.8 4.0 4.1 2.7 3.5 2.6 -0.9
45 — — — — 5.7 5.9 6.1 5.4 4.5 3.7 4.8 5.2 3.8 3.4 4.6 2.5 3.3 2.8 1.3 1.7 0.4
50 — — — — — — — — — 4.0 4.3 4.2 3.6 2.6 2.3 4.4 3.4 2.6 2.5 2.6 0.1
55 — — — — — — — — — — — — — — 3.3 2.2 2.7 1.9 1.7 1.9 0.2
60 — — — — — — — — — — — — — — — — — — — 2.0 —
Take steroids
   % saying any 18 20.0 19.8 21.7 21.6 21.1 22.8 19.1 19.8 20.1 19.4 19.3 16.4 16.0 18.7 17.4 15.7 12.8 15.5 13.7 13.0 -0.6  
19–22 20.6 18.9 20.0 19.3 17.1 21.4 20.1 21.0 18.3 14.8 16.8 13.8 15.3 12.6 11.1 16.4 12.7 8.6 9.6 8.4 -1.3
23–26 15.0 12.2 13.6 14.3 12.9 12.4 11.6 13.4 13.8 13.3 12.8 11.7 13.9 10.0 11.6 12.7 8.7 11.9 10.6 9.2 -1.4
27–30 11.2 9.3 10.7 6.4 11.6 10.1 7.4 7.5 6.7 6.6 12.0 9.2 8.5 11.6 10.0 9.1 11.0 9.4 10.9 11.2 +0.3
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
   % saying most or all 18 0.9 1.9 1.2 1.5 1.5 2.6 1.5 0.9 1.2 1.3 1.5 1.7 1.1 1.8 1.5 1.7 1.0 1.9 1.7 1.5 -0.1  
19–22 0.1 0.3 0.7 0.7 0.4 * 0.1 0.3 0.3 0.3 * 0.7 0.6 0.4 0.7 0.5 0.4 * * 0.8 0.8
23–26 0.1 0.3 0.2 0.1 * 0.1 0.3 0.3 * * 0.7 * 0.1 0.1 0.3 0.1 * 0.9 0.4 * -0.4
27–30 * * * 0.3 * * 0.1 * * * 0.3 * * * * * 0.2 * 0.4 * -0.4
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
TABLE 7-2 (cont.)
Trends in Friends’ Use of Drugs as Estimated by
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
(
Cont.)
Approximate 18 2,987 3,307 3,303 3,095 2,945 2,971 2,798 2,948 2,961 2,587 2,361 2,339 2,373 2,410 2,337 2,379 2,156 2,292 2,313
Weighted N = 19–22 576 592 564 579 543 554 579 572 562 579 556 526 510 468 435 470 469 467 437
23–26 527 534 546 528 528 506 510 507 516 495 449 456 416 419 394
27–30 516 507 499 476 478 461 419 450 464 454 428
35 1,200 1,187 1,187 1,209 1,067
40 1,098
45
50
55
60
(Table continued on next page.)
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate 18 2,060 1,838 1,923 1,968 2,233 2,271 2,266 2,266 2,253 2,125 2,110 2,195 2,208 2,144 1,973 1,920 2,055 1,795 1,955 2,028
Weighted N = 19–22 426 402 402 375 388 443 395 377 362 375 382 376 353 348 340 315 297 251 269 258
23–26 414 387 403 358 362 411 361 336 340 355 311 359 314 330 328 305 305 272 268 269
27–30 424 363 359 348 369 396 363 350 324 332 309 340 325 333 284 307 260 287 287 306
35 1,071 1,033 1,005 918 968 985 1,041 953 884 905 974 922 858 877 848 776 741 740 731 676
40 1,156 1,144 1,119 1,083 945 1,004 975 951 896 924 905 952 877 852 844 919 808 782 819 762
45 976 1,074 1,052 1,009 999 904 937 889 887 874 844 825 889 812 773 781
50 940 1,009 1,016 974 987 840 891 830 845 793 760
55 880 943 933 926 941 788
60 880 943 933 926 941 673
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001. Any apparent inconsistency between the change estimate and the 
prevalence estimates for the two most recent years is due to rounding.  ' — ' indicates data not available. ' * ' indicates a prevalence rate of less than 0.05%.
aAnswer alternatives were: (1) None, (2) A few, (3) Some, (4) Most, (5) All. The any percentage combines categories (2)–(5). The most or all percentage combines categories (4) and (5).
bFor the young adult sample, any illicit drug includes all of the drugs listed in this table except cigarettes and alcohol. For the 35-, 40-, 45-, and 50-year-olds, 
any illicit drug includes marijuana, tranquilizers, crack, cocaine powder, and other illicit drugs.
cIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples. These changes likely explain
the discontinuity in the 2001 results.
dIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc.  This change likely explains the 
discontinuity in the 2010 results.
eIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin.  This change likely explains the discontinuity in the 2011 results.
fIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc.
to just downers. These changes likely explain the discontinuity in the 2004 results.
gNo data reported in 2015 due to a printing error in the questionnaire in which this question is asked.
Q.  How many of your friends 
would you estimate. . .
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Group
Percentage saying friends use a
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Any illicit drug b  
  % saying any 18 84.3 82.7 81.4 79.4 77.9 77.7 75.5 73.9 71.3 68.6 67.6 64.2 61.3 66.1 70.8 75.3 78.0 78.8
19–22 80.6 81.0 81.5 76.5 76.3 77.4 74.6 72.7 69.5 61.5 60.8 58.9 58.6 58.4 60.7 66.4 67.2 65.3
23–26 — — — — 68.9 70.2 68.0 62.4 62.7 58.3 54.6 52.1 48.2 49.9 47.1 54.2 50.3 55.4
27–30 — — — — — — — — 52.4 50.2 47.0 39.6 41.7 38.9 45.6 42.4 44.9 41.6
  % saying often exposed 18 36.3 36.1 31.4 29.8 28.3 27.2 26.3 23.3 20.8 22.0 20.7 18.2 18.0 24.0 29.3 32.3 33.8 34.7
19–22 34.6 34.0 32.1 24.4 24.4 23.7 21.1 18.9 19.9 16.2 16.4 17.6 21.4 16.1 18.1 23.7 20.4 25.3
23–26 — — — — 20.7 23.3 18.5 17.4 18.2 13.8 13.7 13.3 12.2 11.1 11.1 12.5 12.8 14.3
27–30 — — — — — — — — 13.7 12.0 10.8 8.2 10.5 9.0 12.5 8.5 10.1 10.3
  % saying any 18 58.5 62.6 62.5 59.4 59.8 59.3 55.3 51.7 47.8 47.1 45.4 40.0 41.6 42.6 45.3 47.2 49.7 47.9
19–22 56.9 58.4 61.6 54.9 57.1 53.3 53.4 48.5 46.4 36.5 39.4 33.8 37.1 29.4 33.9 36.8 36.5 39.4
23–26 — — — — 51.5 51.9 51.5 43.6 42.9 36.8 34.0 30.0 27.3 27.8 24.9 26.8 23.2 25.6
27–30 — — — — — — — — 35.8 33.7 31.5 25.8 26.6 24.2 25.8 21.1 21.8 21.4
  % saying often exposed 18 14.1 17.1 16.6 14.2 14.6 12.9 12.1 10.2 9.6 10.7 9.2 7.9 7.5 9.6 9.4 11.1 12.1 11.7
19–22 11.8 15.6 13.5 11.1 10.7 10.2 8.2 8.1 7.5 6.7 4.5 4.4 5.5 4.1 5.1 7.7 3.9 7.6
23–26 — — — — 9.0 10.4 9.3 8.5 6.7 5.0 5.1 3.5 2.6 3.0 2.2 3.5 3.4 3.1
27–30 — — — — — — — — 6.0 4.7 4.1 3.2 3.7 2.4 3.4 2.9 3.4 3.2
Marijuana 
  % saying any 18 82.0 80.2 77.9 76.2 74.4 73.5 72.0 70.4 67.0 64.8 63.4 59.6 56.8 61.0 67.2 72.7 75.6 76.8
19–22 79.8 79.8 78.7 72.7 74.1 75.5 72.4 70.5 66.3 59.3 57.5 55.0 56.4 55.4 56.8 64.0 64.8 63.4
23–26 — — — — 65.3 66.0 64.1 59.0 57.6 55.0 50.6 47.9 44.6 45.9 44.4 51.0 47.8 53.1
27–30 — — — — — — — — 49.1 47.4 42.1 36.0 38.2 35.3 41.9 38.3 41.8 39.1
  % saying often exposed 18 33.8 33.1 28.0 26.1 24.8 24.2 24.0 20.6 17.9 19.5 17.8 16.0 15.6 20.9 27.6 30.7 31.8 32.9
19–22 32.6 30.5 30.3 21.1 21.9 20.3 18.6 16.4 18.3 14.2 14.7 15.9 19.9 14.7 17.0 22.1 20.3 23.7
23–26 — — — — 17.5 20.6 14.6 14.8 15.6 11.6 11.2 11.6 10.9 10.4 10.4 11.1 11.5 12.9
27–30 — — — — — — — — 10.9 9.8 8.5 6.7 8.9 7.6 10.7 7.4 9.1 8.9
LSD
  % saying any 18 17.2 17.4 16.1 13.8 12.5 13.2 13.1 12.9 13.4 15.0 14.9 15.7 17.8 21.0 24.2 26.1 27.6 25.9
19–22 17.4 15.8 16.0 13.5 12.8 12.7 10.8 10.9 12.0 12.0 12.1 13.1 19.3 13.4 16.5 18.6 20.7 22.3
23–26 — — — — 8.3 9.3 8.8 7.3 6.3 6.7 8.4 8.6 8.8 7.8 8.4 9.9 8.6 7.6
27–30 — — — — — — — — 3.6 3.2 3.3 3.6 3.9 4.9 5.3 5.5 4.3 3.9
  % saying often exposed 18 1.4 2.0 1.9 1.4 1.5 1.3 1.6 1.8 1.6 2.2 2.6 2.9 3.0 3.9 4.2 6.1 4.7 5.1
19–22 1.4 1.5 1.4 0.6 0.8 0.7 0.5 1.2 0.6 1.1 1.2 1.0 2.0 1.1 0.4 3.6 1.4 1.8
23–26 — — — — 0.3 0.4 0.4 0.7 0.6 0.3 0.5 0.2 0.8 0.3 0.5 0.5 0.4 0.2
27–30 — — — — — — — — 0.3 0.2 0.5 0.2 0.2 0.5 0.5 0.2 0.2 *
Other hallucinogens c
  % saying any 18 20.4 17.6 16.8 13.1 12.7 12.5 11.8 10.0 9.0 8.8 9.4 9.4 9.7 12.1 14.0 15.8 16.6 17.8
19–22 18.3 16.3 16.3 12.5 10.5 11.0 9.2 9.1 7.7 8.4 8.3 8.9 10.6 6.7 8.3 12.8 13.1 15.0
23–26 — — — — 8.4 8.9 9.1 6.0 5.1 4.8 5.7 5.5 5.1 5.7 5.2 5.5 6.9 5.6
27–30 — — — — — — — — 5.0 3.4 3.4 3.4 2.1 3.7 3.4 4.2 3.2 2.9
  % saying often exposed 18 2.2 2.0 2.6 1.1 1.7 1.4 1.5 1.2 1.1 1.3 1.2 1.3 1.1 1.9 2.3 2.5 2.7 2.8
19–22 1.1 0.9 0.9 0.7 0.8 0.8 0.2 0.8 0.3 0.4 0.4 0.5 0.7 0.4 0.2 1.6 0.7 0.7
23–26 — — — — 0.1 0.3 0.5 0.6 0.8 0.1 0.4 0.4 * 0.2 0.4 0.3 0.3 0.2
27–30 — — — — — — — — 0.2 0.4 0.5 0.3 0.1 0.5 0.2 0.3 0.2 0.5
TABLE 7-3
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trends in Direct Exposure to Drug Use
you been around people 
who were taking each of the 
following to get high or for 
“kicks”?
Q. During the LAST 12 
MONTHS how often have Percentage saying exposed to drug a
Age 
Group
(Years 
Cont.)
(Table continued on next page.)
Any illicit drug other than 
marijuana b
359
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Any illicit drug b  
  % saying any 18 77.2 77.9 76.0 76.5 76.5 73.6 74.3 73.0 73.7 70.8 71.9 74.1 76.0 76.6 76.4 75.4 75.2 75.4 75.1 74.8 72.7 -2.2
19–22 69.1 65.8 64.7 69.7 65.7 68.0 67.6 68.8 67.1 67.4 66.2 69.8 66.0 68.3 70.4 72.1 73.6 72.5 73.1 72.3 76.4 +4.1
23–26 50.6 50.5 55.1 56.4 56.5 57.0 53.5 53.9 56.7 58.3 56.3 57.7 56.3 62.6 67.0 65.2 65.1 68.2 68.9 73.9 74.2 +0.3
27–30 37.5 41.1 40.8 42.2 47.0 46.7 43.3 45.7 48.4 44.1 48.7 42.5 49.3 51.6 58.9 57.2 57.1 56.7 58.6 69.0 66.5 -2.4
  % saying often exposed 18 33.2 35.6 32.6 33.6 32.6 31.8 30.4 29.9 29.7 27.8 28.6 31.4 33.2 34.6 34.9 32.3 31.3 32.5 33.1 32.8 30.8 -2.0
19–22 24.2 24.0 21.3 26.1 25.2 26.5 26.8 25.2 24.2 22.8 20.1 23.7 26.5 24.8 27.3 24.6 29.8 26.2 32.1 28.0 35.5 +7.6
23–26 14.2 15.0 15.9 16.4 15.9 17.8 15.1 18.7 14.9 18.9 15.4 14.9 18.8 19.4 21.2 20.8 20.1 23.2 23.3 22.9 25.4 +2.5
27–30 8.5 9.6 9.4 10.4 13.8 13.9 10.3 14.5 13.2 9.7 9.7 12.1 13.2 13.6 15.7 18.5 16.1 18.9 19.8 21.1 24.7 +3.6
  % saying any 18 47.3 46.5 47.2 49.9 49.3 46.3 48.3 45.9 45.4 45.4 43.8 44.3 47.2 46.6 45.0 44.2 41.0 44.3 43.8 41.7 40.1 -1.6
19–22 40.0 36.4 38.1 39.2 38.0 40.2 40.9 41.1 38.5 42.7 38.2 37.1 38.5 38.5 41.8 38.9 44.0 42.3 49.3 44.2 46.6 +2.4
23–26 27.1 28.0 31.0 31.4 31.5 32.2 32.6 32.3 34.5 33.1 31.3 33.0 34.8 39.9 37.8 37.4 33.9 38.6 38.5 39.4 46.4 +7.0
27–30 15.4 19.5 17.2 22.2 23.1 26.1 23.2 27.1 27.4 24.8 27.7 22.8 29.3 33.4 35.2 34.4 30.1 35.9 31.6 37.1 35.3 -1.8
  % saying often exposed 18 9.9 11.7 10.5 11.9 12.6 10.8 11.4 10.6 11.4 10.8 8.2 9.4 10.2 11.5 11.6 9.3 9.7 9.2 10.3 10.7 7.5 -3.3
19–22 7.0 4.8 6.4 7.8 8.6 5.2 7.9 8.0 6.7 6.9 6.6 6.8 6.6 6.9 10.1 8.1 9.4 7.0 9.6 7.5 8.0 +0.5
23–26 3.1 4.3 3.5 3.4 5.0 5.4 5.4 4.0 5.4 6.7 5.4 3.8 6.4 6.3 7.6 5.8 7.0 5.8 8.1 6.6 7.5 +0.9
27–30 1.0 2.5 1.6 3.7 4.7 4.9 2.4 5.6 4.0 3.4 2.3 3.0 4.8 4.2 4.5 4.8 4.9 6.6 6.0 4.4 6.6 +2.2
Marijuana 
  % saying any 18 75.5 75.8 73.8 74.9 74.2 71.4 72.2 70.8 71.4 68.4 69.8 71.8 74.2 74.6 75.1 73.7 73.4 73.2 73.1 73.5 70.1 -3.4
19–22 67.1 63.5 63.9 68.0 64.6 64.8 65.1 66.8 65.4 66.3 64.3 67.5 64.9 65.7 67.6 69.0 71.1 70.3 71.9 70.6 76.1 +5.6
23–26 48.8 48.1 51.8 54.2 53.5 54.4 50.6 49.7 51.9 53.3 54.0 55.5 54.0 57.9 63.9 63.4 61.1 63.6 66.7 70.9 71.8 +1.0
27–30 35.7 38.7 38.8 37.0 44.6 44.1 40.4 42.4 44.1 40.7 44.8 39.8 43.5 46.1 56.0 52.3 54.4 53.3 58.1 67.4 65.1 -2.3
  % saying often exposed 18 31.4 34.4 30.3 30.8 30.7 30.4 28.0 27.0 27.8 25.1 27.0 29.3 31.3 32.3 32.2 30.6 29.2 30.5 31.2 30.4 28.0 -2.3
19–22 22.8 23.0 20.4 24.5 24.8 24.2 24.5 23.6 23.1 20.1 18.3 22.6 25.2 22.9 24.2 22.6 28.2 25.7 30.1 26.7 34.3 +7.6
23–26 13.6 13.2 15.2 15.6 14.9 16.2 13.7 17.8 12.5 16.2 13.7 13.5 17.0 18.0 19.7 18.3 18.8 21.2 21.5 21.0 23.6 +2.6
27–30 8.1 8.8 8.6 8.4 11.7 11.7 9.6 12.2 11.5 8.2 8.5 12.3 10.8 10.9 13.9 16.0 14.7 16.5 17.7 20.4 22.3 +2.0
LSD
  % saying any 18 23.1 23.6 22.0 21.6 17.2 14.2 12.4 10.8 11.6 12.4 12.1 11.9 14.1 13.5 13.0 13.8 12.9 15.7 15.5 17.4 15.4 -2.0
19–22 21.0 20.1 15.9 15.2 13.6 10.0 8.5 7.2 10.4 6.3 9.2 9.1 9.7 10.1 12.2 10.0 13.1 13.4 19.3 15.5 14.3 -1.2
23–26 9.8 9.4 9.8 11.1 9.3 5.5 4.4 4.7 5.6 4.5 4.8 3.7 5.7 8.9 9.6 8.3 7.6 6.1 10.3 11.4 10.8 -0.7
27–30 3.2 3.7 3.2 4.3 4.8 3.0 4.7 4.0 3.4 3.9 1.7 3.8 4.2 4.1 4.2 4.7 4.6 7.7 6.2 9.8 7.6 -2.1
  % saying often exposed 18 3.2 4.1 3.3 2.8 2.6 1.8 1.6 1.5 1.9 1.7 0.8 1.3 1.4 1.4 1.6 1.5 1.5 1.9 2.1 2.4 2.0 -0.5
19–22 2.0 1.7 1.4 2.4 0.9 0.2 0.1 0.7 0.7 0.3 0.7 0.3 0.1 0.2 0.6 0.9 0.4 0.9 1.0 0.7 1.0 +0.3
23–26 0.1 0.3 0.2 * 0.3 0.3 * 0.3 * 0.5 0.6 * 0.6 0.3 1.4 0.1 0.8 0.1 0.8 0.2 0.9 +0.8
27–30 * 0.1 * * * 0.3 0.3 0.6 * 0.1 * 0.3 0.5 0.5 0.6 1.0 0.3 0.9 0.2 0.6 0.2 -0.4
Other hallucinogens c
  % saying any 18 15.9 17.7 16.3 28.1 26.4 25.8 24.8 24.3 23.8 23.5 23.6 22.0 25.0 23.8 22.7 22.3 19.8 20.4 18.6 17.5 15.5 -2.0
19–22 15.0 12.4 11.8 22.8 23.4 18.9 18.7 19.5 17.8 20.2 17.5 17.5 19.6 17.5 17.0 14.6 19.1 17.1 18.7 13.1 17.2 +4.1
23–26 8.7 5.8 8.9 14.8 14.7 11.9 10.1 11.3 10.3 9.8 9.8 9.9 12.5 13.8 13.6 14.6 10.3 11.8 11.4 12.2 14.7 +2.4
27–30 2.6 3.0 3.0 6.4 7.7 6.3 7.9 8.8 7.8 6.8 5.2 7.5 5.0 8.1 7.8 7.2 8.3 12.0 5.9 13.4 10.5 -3.0
  % saying often exposed 18 1.7 2.7 2.1 3.6 4.5 3.2 3.2 2.6 4.1 3.0 1.9 2.7 2.2 2.5 2.7 2.4 1.9 1.9 2.4 2.5 1.8 -0.7
19–22 0.5 0.6 0.8 2.6 2.4 0.4 0.7 1.2 0.7 0.7 0.9 0.9 1.1 1.3 0.8 * 0.9 0.6 0.6 1.1 1.3 +0.2
23–26 * * 0.4 0.2 0.4 * * 0.5 * 0.6 0.7 0.1 0.7 0.3 1.1 0.3 1.1 * 0.8 0.2 0.9 +0.8
27–30 * 0.1 * 0.4 * * 0.3 0.6 * 0.4 0.3 0.3 0.7 0.5 0.8 0.9 0.9 1.2 0.2 0.6 0.2 -0.4
↓
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Q. During the LAST 12 
MONTHS how often have 
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TABLE 7-3 (cont.)
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
you been around people 
who were taking each of the 
following to get high or for 
“kicks”?
2017– 
2018 
change
Percentage saying exposed to drug a
Any illicit drug other than 
marijuana b
360
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Cocaine
  % saying any 18 37.7 36.3 34.9 33.3 35.6 38.3 37.4 34.9 30.2 30.2 27.7 21.3 19.8 19.2 18.8 21.6 25.0 25.6
19–22 37.6 42.3 43.6 36.6 38.9 39.4 41.5 37.0 36.2 26.6 24.0 18.5 19.8 13.5 14.7 14.1 19.3 18.8
23–26 — — — — 38.5 40.6 42.0 34.5 35.9 28.0 24.0 19.9 16.7 14.6 14.3 14.1 12.5 14.0
27–30 — — — — — — — — 28.9 28.3 24.2 18.6 19.4 16.6 14.3 11.4 12.1 11.4
  % saying often exposed 18 5.9 6.6 6.6 5.2 6.7 7.1 7.8 5.9 5.1 5.4 4.7 3.4 2.7 2.9 2.5 3.2 4.0 4.2
19–22 5.8 7.6 6.5 4.3 6.5 7.0 5.4 5.2 4.8 4.3 2.2 1.6 1.7 1.7 1.8 1.7 1.2 2.4
23–26 — — — — 5.3 8.5 7.0 6.0 5.4 3.5 2.5 1.7 1.4 1.7 1.0 1.7 1.3 1.8
27–30 — — — — — — — — 4.4 3.9 2.9 2.2 2.0 1.2 1.5 1.4 1.9 1.6
Heroin
  % saying any 18 7.4 6.6 7.1 5.1 6.0 5.5 6.0 5.8 5.7 6.5 5.4 5.1 5.4 5.7 7.3 7.9 8.6 9.1
19–22 4.4 3.3 4.1 2.9 3.1 4.8 2.9 2.9 2.9 2.9 2.5 3.0 2.7 2.0 3.7 3.8 3.6 3.7
23–26 — — — — 2.3 3.3 3.2 2.9 1.7 2.3 2.3 1.8 1.7 1.5 1.9 2.8 2.9 2.7
27–30 — — — — — — — — 2.1 1.4 1.5 0.9 1.0 2.0 2.0 1.7 1.5 1.3
  % saying often exposed 18 0.4 0.6 1.0 0.7 1.1 0.5 1.0 0.9 0.8 1.0 0.5 0.9 0.7 1.1 0.7 1.2 1.6 1.2
19–22 0.2 0.3 0.3 0.1 0.2 0.5 0.2 0.1 0.2 0.1 0.2 0.4 0.6 0.4 0.6 1.2 0.2 0.4
23–26 — — — — * 0.7 0.3 0.6 0.4 0.3 0.6 0.3 * * * 0.2 0.2 0.3
27–30 — — — — — — — — 0.3 0.3 0.5 0.2 0.2 0.9 0.3 0.6 0.6 *
Other narcotics d
  % saying any 18 19.6 17.5 18.5 17.3 18.0 18.4 15.6 14.4 14.8 13.8 14.2 11.3 11.1 12.4 14.9 15.5 18.5 20.4
19–22 14.4 14.4 15.2 10.9 12.4 13.7 9.8 12.2 11.2 9.0 9.4 9.2 8.5 6.8 10.1 12.1 11.5 14.5
23–26 — — — — 9.0 12.3 9.2 9.7 7.4 8.0 5.9 8.3 7.0 4.6 6.9 7.8 7.4 6.5
27–30 — — — — — — — — 6.5 6.5 5.8 5.5 3.7 5.6 5.9 5.7 4.7 4.9
  % saying often exposed 18 1.7 1.7 2.4 2.2 2.0 1.8 2.1 1.7 1.7 1.7 1.6 1.4 1.3 1.7 1.7 2.1 3.4 2.5
19–22 0.7 0.5 0.5 0.9 0.7 1.0 0.5 0.4 0.9 0.3 0.2 1.0 0.9 0.6 0.8 1.4 0.7 1.5
23–26 — — — — 0.4 0.5 1.3 0.8 0.8 0.5 1.6 0.7 0.1 0.3 0.1 0.1 0.3 0.7
27–30 — — — — — — — — 0.7 0.5 1.0 0.3 0.8 1.2 0.8 0.8 0.7 0.5
Amphetamines
  % saying any 18 40.8 49.5 50.2 46.1 45.0 41.0 36.5 31.7 27.9 27.4 28.3 23.6 24.5 24.7 28.2 28.1 31.5 31.0
19–22 42.3 48.6 48.4 39.7 41.3 35.9 31.3 26.7 21.2 18.5 19.5 17.4 21.3 15.1 20.3 21.0 22.3 24.6
23–26 — — — — 32.3 30.5 29.1 20.9 18.8 14.0 16.8 14.6 11.8 13.2 11.2 13.0 11.1 11.7
27–30 — — — — — — — — 15.6 14.3 13.5 10.7 11.4 11.3 11.0 10.6 7.6 9.1
  % saying often exposed 18 8.3 12.1 12.3 10.1 9.0 6.5 5.8 4.5 4.1 4.7 4.1 3.1 3.0 3.9 4.1 4.5 5.6 5.2
19–22 7.4 9.9 7.7 6.9 5.4 4.4 3.1 3.3 2.2 1.5 1.1 1.9 2.6 1.5 3.3 5.0 1.3 4.1
23–26 — — — — 3.9 3.2 2.2 3.3 1.9 0.7 2.0 1.3 0.2 0.8 0.9 1.6 1.3 1.4
27–30 — — — — — — — — 2.0 2.0 1.2 0.8 0.8 1.3 0.7 1.6 1.8 1.0
(Table continued on next page.)
you been around people 
who were taking each of the 
following to get high or for 
“kicks”?
Percentage saying exposed to drug a
Q. During the LAST 12 
MONTHS how often have 
(Years 
Cont.)
Trends in Direct Exposure to Drug Use
TABLE 7-3 (cont.)
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
361
Age 
Group 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Cocaine
  % saying any 18 26.6 25.8 24.2 24.5 24.9 24.8 24.4 25.7 28.2 25.2 24.1 20.0 20.0 19.3 17.4 16.7 17.6 18.0 18.2 17.6 17.1 -0.5
19–22 21.6 18.5 19.1 20.6 22.5 18.4 23.6 22.7 22.9 22.5 22.7 18.6 17.8 15.5 18.9 11.5 17.6 18.0 28.7 18.6 25.4 +6.8
23–26 16.0 18.2 16.4 16.9 18.3 17.4 18.7 19.2 19.3 19.0 18.2 15.3 14.7 20.5 17.2 14.4 15.6 15.7 20.0 20.0 24.0 +4.1
27–30 8.6 11.6 10.2 11.6 12.2 12.6 13.0 15.8 16.0 14.1 14.8 13.2 11.4 13.1 14.2 15.0 12.1 17.8 15.4 19.3 20.3 +1.0
  % saying often exposed 18 3.7 4.6 4.6 4.5 5.3 5.0 4.7 4.2 5.3 4.6 3.6 2.6 2.1 2.3 2.8 2.1 2.2 2.3 3.0 3.0 1.7 -1.2
19–22 3.2 1.4 3.8 3.0 4.1 1.6 2.6 4.0 2.6 1.8 2.6 2.6 0.7 1.2 3.2 1.7 2.4 1.2 1.8 1.5 4.1 +2.6
23–26 1.5 2.2 1.8 1.0 2.5 1.9 2.9 1.8 2.0 3.2 1.0 1.0 1.2 1.4 2.0 1.0 2.1 0.8 3.4 3.2 3.3 0.0
27–30 0.8 1.5 0.3 1.6 2.4 1.7 0.7 2.4 0.8 0.7 1.4 0.8 0.1 1.4 0.8 1.6 1.8 2.0 2.2 1.9 1.7 -0.2
Heroin
  % saying any 18 8.7 8.1 9.1 8.7 8.3 7.3 6.6 7.3 9.0 8.6 6.8 7.3 8.3 6.4 6.0 6.6 5.2 5.6 5.3 6.4 5.2 -1.1
19–22 6.4 3.2 5.2 3.2 5.3 3.4 3.0 3.2 3.7 3.3 4.8 4.3 3.2 4.0 3.6 3.4 3.6 3.2 2.9 4.4 3.4 -1.0
23–26 3.1 2.9 2.6 2.4 3.8 2.0 3.1 2.6 3.5 3.6 1.8 1.8 4.1 4.8 2.4 2.3 2.4 3.9 5.1 5.2 4.7 -0.5
27–30 1.4 1.9 1.9 2.3 2.7 1.3 3.2 2.9 2.3 3.0 2.2 1.9 1.5 3.5 3.0 3.9 5.3 2.6 3.4 5.5 3.4 -2.1
  % saying often exposed 18 0.9 1.3 1.5 0.7 1.3 1.2 1.2 0.8 1.7 1.1 0.8 0.8 1.0 1.1 1.3 0.7 0.7 1.2 0.9 1.1 0.6 -0.5
19–22 0.7 0.8 0.7 0.8 0.6 0.2 * 0.8 0.1 * 0.6 * 0.4 0.7 1.0 1.0 0.9 * * 0.5 0.6 +0.1
23–26 0.5 1.0 * * 0.8 0.5 0.5 0.3 0.6 0.3 * * 1.2 0.3 0.2 * 0.3 1.1 0.8 0.6 0.8 +0.2
27–30 * 0.2 * * 0.7 0.3 * 0.4 0.3 0.4 0.3 0.6 * 1.2 0.7 1.3 0.5 1.0 0.9 1.0 0.7 -0.2
Other narcotics d
  % saying any 18 20.7 21.9 21.1 21.6 22.5 21.8 20.3 19.0 18.9 18.9 16.3 16.3 30.3 27.5 27.1 22.9 20.9 21.0 21.0 19.9 18.1 -1.8
19–22 15.3 13.9 17.0 18.3 18.7 13.6 14.5 16.8 15.3 12.5 13.2 14.2 27.5 23.7 25.2 19.5 21.3 17.8 19.9 15.3 16.9 +1.6
23–26 8.1 9.4 10.9 12.2 12.0 12.6 12.6 12.4 13.0 14.4 11.2 13.2 25.9 25.3 24.1 22.5 17.8 19.6 20.4 16.7 15.6 -1.1
27–30 3.6 5.2 6.5 9.0 7.9 9.5 8.8 11.6 10.6 9.2 9.1 9.7 23.4 22.7 23.6 24.5 19.4 19.1 14.8 22.8 16.5 -6.2
  % saying often exposed 18 2.8 3.9 2.9 3.0 3.8 3.0 3.3 2.6 3.4 3.4 2.1 2.7 5.3 5.6 5.7 3.8 3.6 2.8 3.8 3.4 1.8 -1.6
19–22 1.7 1.1 2.4 1.6 3.0 1.2 0.8 2.4 1.9 1.7 1.9 1.6 3.3 2.1 1.6 2.2 2.0 1.7 0.4 0.7 1.5 +0.8
23–26 0.5 1.1 0.7 1.0 0.9 1.6 1.4 1.3 1.1 1.8 1.0 1.3 4.4 2.5 3.6 1.5 2.3 2.0 4.0 1.6 1.4 -0.2
27–30 * 0.2 1.1 1.0 0.7 1.2 0.1 1.7 0.7 0.8 0.4 1.4 3.0 3.1 2.3 3.1 2.6 2.3 2.6 1.4 0.9 -0.5
Amphetamines e
  % saying any 18 29.9 30.1 29.5 31.5 30.6 27.4 27.2 26.4 26.6 23.8 23.3 23.8 23.6 28.0 26.2 25.4 23.7 25.7 24.3 22.4 21.9 -0.6
19–22 24.8 21.2 24.8 23.3 25.5 21.6 23.7 22.2 22.7 22.8 17.6 18.0 19.4 26.0 27.4 26.2 30.4 30.3 34.2 26.3 31.4 +5.1
23–26 14.6 12.3 18.5 18.2 17.9 15.4 18.8 15.6 18.7 16.6 13.7 15.3 15.8 24.2 23.1 21.4 22.0 23.5 25.8 23.0 32.2 +9.3 s
27–30 6.6 10.4 7.4 11.1 11.5 12.2 11.4 12.2 14.1 10.0 10.3 10.3 12.6 16.4 19.0 19.1 17.7 23.1 19.9 20.3 19.1 -1.1
  % saying often exposed 18 4.7 6.3 4.4 6.0 6.4 4.9 5.3 4.1 5.6 4.3 3.0 4.3 3.3 6.1 5.7 5.3 5.7 5.2 5.0 5.0 3.3 -1.7
19–22 2.9 2.2 2.4 2.6 5.6 1.7 4.1 3.1 2.9 2.3 2.1 3.0 3.9 3.3 5.5 3.7 6.8 5.4 8.2 4.9 4.3 -0.6
23–26 2.2 1.7 1.4 2.2 0.7 1.3 1.7 1.6 2.6 1.6 1.8 1.1 1.6 3.1 4.1 3.2 3.6 2.3 3.6 3.0 4.6 +1.6
27–30 0.2 1.1 0.4 0.6 1.5 1.0 1.2 1.0 0.8 1.1 0.3 0.7 0.6 1.7 3.0 2.7 2.0 3.5 2.7 1.8 3.1 +1.4
↓
(List of drugs continued.)
2017– 
2018 
change
you been around people 
who were taking each of the 
following to get high or for 
“kicks”?
Percentage saying exposed to drug a
Q. During the LAST 12 
MONTHS how often have 
Trends in Direct Exposure to Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
TABLE 7-3 (cont.)
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Sedatives/barbiturates e
  % saying any 18 25.2 25.9 25.7 22.5 21.2 18.9 15.8 13.1 12.4 11.8 13.3 10.0 10.2 11.9 13.0 14.5 15.5 16.1
19–22 25.6 23.1 21.8 18.3 15.7 14.7 12.8 12.0 8.2 8.3 6.5 7.9 7.3 7.2 7.4 10.1 8.8 11.7
23–26 — — — — 16.1 13.1 11.0 7.1 7.1 6.6 6.9 5.9 6.5 3.8 4.2 5.7 6.6 4.9
27–30 — — — — — — — — 8.0 6.8 5.9 5.4 5.2 5.7 4.5 5.2 3.5 3.8
  % saying often exposed 18 3.4 4.0 4.3 3.0 2.7 1.7 2.1 1.5 1.4 1.7 1.7 1.2 1.1 1.6 1.7 2.0 2.9 2.5
19–22 2.5 2.8 1.1 1.4 0.7 1.3 0.5 0.7 0.7 0.3 0.7 0.4 0.7 0.7 1.3 1.3 0.4 0.9
23–26 — — — — 0.7 0.9 1.7 0.8 0.6 0.3 1.1 0.3 0.3 * * 0.2 0.3 0.8
27–30 — — — — — — — — 0.7 0.4 0.6 0.2 0.4 1.2 0.2 0.6 0.5 0.2
Tranquilizers f
  % saying any 18 29.1 29.0 26.6 23.5 23.1 23.4 19.6 18.4 18.2 15.1 16.3 14.2 12.7 13.8 16.5 15.7 17.9 18.9
19–22 29.6 26.9 28.5 19.5 21.2 19.5 16.4 18.5 13.8 12.0 12.7 12.6 11.0 10.0 12.0 11.8 10.7 15.6
23–26 — — — — 23.1 21.0 16.9 15.9 13.4 12.9 12.0 10.4 9.7 10.9 9.8 10.3 10.1 9.4
27–30 — — — — — — — — 15.0 11.6 11.1 9.7 10.3 10.4 9.0 11.2 9.6 9.6
  % saying often exposed 18 3.2 4.2 3.5 2.9 2.9 2.2 2.5 2.6 2.2 2.1 1.9 1.4 1.9 1.7 1.8 2.3 3.5 3.2
19–22 3.2 2.6 1.8 2.1 1.5 1.7 0.9 1.1 1.8 1.0 1.1 1.1 1.5 1.1 1.3 1.5 0.5 1.3
23–26 — — — — 2.0 1.6 2.6 1.8 1.2 0.8 0.5 1.0 0.6 0.7 0.1 1.1 1.5 0.7
27–30 — — — — — — — — 1.4 0.3 1.7 0.8 1.3 1.3 1.0 1.1 0.8 1.2
Alcoholic beverages
  % saying any 18 94.7 94.0 94.0 94.0 94.0 94.0 94.1 93.9 93.1 92.3 93.6 91.7 90.6 91.8 90.0 91.2 91.5 91.4
19–22 94.3 93.8 94.5 93.4 94.2 92.7 93.6 94.4 92.5 91.8 92.4 94.0 93.3 92.9 93.7 93.1 93.7 93.1
23–26 — — — — 90.3 92.7 91.4 90.6 91.1 92.9 91.3 91.0 91.4 90.3 89.5 91.9 89.6 93.1
27–30 — — — — — — — — 87.1 88.4 86.2 87.7 87.3 86.6 86.2 89.3 89.2 86.4
  % saying often exposed 18 60.2 61.0 59.3 60.2 58.7 59.5 58.0 58.7 56.4 55.5 56.1 54.5 53.1 51.9 54.0 54.0 54.5 53.9
19–22 59.6 61.2 62.5 56.6 59.3 61.8 59.9 61.4 55.4 53.8 56.0 53.9 56.1 56.8 57.0 56.3 52.3 54.2
23–26 — — — — 52.1 54.8 51.4 53.0 48.1 50.9 49.7 48.4 45.4 45.4 43.3 47.5 44.8 49.8
27–30 — — — — — — — — 39.9 39.5 38.7 38.0 39.9 38.1 39.3 38.0 34.7 37.1
Approximate 18 3,259 3,608 3,645 3,334 3,238 3,252 3,078 3,296 3,300 2,795 2,556 2,525 2,630 2,730 2,581 2,608 2,407 2,595
Weighted  N = 19–22 582 574 601 569 578 549 591 582 556 567 567 532 528 489 460 464 485 471
23–26 533 532 557 529 531 514 523 494 532 513 471 467 447 424
27–30 522 507 506 478 502 457 425 452 432 455
Percentage saying exposed to drug a
(Years 
Cont.)
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Trends in Direct Exposure to Drug Use
TABLE 7-3 (cont.)
Age 
Group
(Table continued on next page.)
Q. During the LAST 12 
MONTHS how often have 
you been around people 
who were taking each of the 
following to get high or for 
“kicks”?
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1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Sedatives/barbiturates f
  % saying any 18 16.1 17.1 16.3 17.1 17.7 14.8 21.5 20.4 21.3 18.8 16.7 17.6 18.8 16.2 16.0 15.0 13.4 13.5 12.8 11.2 11.4 +0.2
19–22 13.4 11.6 13.1 13.1 16.0 11.9 17.2 17.8 16.0 16.1 15.2 17.3 16.1 12.2 14.8 10.7 14.2 13.1 16.9 9.3 12.9 +3.5
23–26 8.5 7.1 9.3 9.0 9.8 7.9 15.9 12.5 14.8 13.1 12.4 12.7 13.4 15.2 14.9 10.6 11.9 11.5 13.3 12.1 12.2 +0.1
27–30 2.7 4.1 2.9 5.3 6.0 6.1 9.2 12.4 11.9 10.3 10.1 9.9 11.6 10.4 11.7 10.1 11.8 12.1 10.5 13.1 11.7 -1.4
  % saying often exposed 18 2.7 3.8 2.7 2.7 4.6 2.8 4.1 3.7 3.9 3.9 2.1 3.4 2.5 3.1 2.9 2.5 2.3 1.8 2.5 2.3 1.9 -0.4
19–22 1.4 0.9 1.6 1.2 1.8 0.8 1.7 2.1 2.5 1.4 2.2 1.9 0.9 1.2 1.7 1.0 1.5 1.9 1.5 0.9 1.0 +0.1
23–26 0.5 0.9 0.7 0.2 0.3 0.4 0.7 1.1 1.1 1.6 1.7 0.7 1.0 1.0 1.5 0.8 1.3 0.5 1.4 0.8 0.8 +0.1
27–30 * 0.6 0.2 0.9 0.4 0.6 0.4 1.7 0.7 1.3 0.4 1.7 0.9 1.3 1.1 2.0 0.6 1.4 0.2 1.4 1.0 -0.4
Tranquilizers g
  % saying any 18 17.3 18.2 17.7 23.8 22.7 21.0 22.1 20.9 21.8 19.3 19.9 20.0 18.2 17.0 17.6 16.4 16.0 19.7 22.2 22.6 20.5 -2.1
19–22 16.9 14.3 18.5 21.3 23.6 20.0 21.9 20.6 23.1 21.4 20.0 19.6 18.1 16.6 19.0 13.3 18.3 16.8 24.4 18.1 20.6 +2.5
23–26 10.9 10.8 12.3 16.4 20.1 18.7 19.9 20.1 19.9 18.8 18.4 17.5 21.4 19.6 21.0 19.5 15.5 17.9 19.3 18.0 16.0 -2.1
27–30 6.1 8.8 7.6 12.6 13.6 15.3 14.6 18.1 19.2 16.7 16.8 13.5 18.6 16.5 19.5 17.5 16.3 17.4 13.8 23.5 17.5 -6.0
  % saying often exposed 18 2.8 3.7 3.5 4.9 5.8 4.2 4.1 4.5 5.4 4.9 3.7 3.9 2.8 3.4 3.3 3.4 3.4 2.6 4.6 4.7 3.1 -1.7
19–22 1.6 1.5 1.7 3.1 3.6 2.3 2.7 2.7 3.2 3.0 3.2 2.1 1.7 2.9 2.0 1.7 2.3 2.0 2.7 1.8 1.9 +0.1
23–26 1.1 1.5 1.7 1.3 2.1 1.6 2.0 1.3 2.6 2.4 3.6 1.5 3.2 2.6 2.5 1.6 1.8 1.2 1.9 3.1 1.1 -2.0
27–30 0.2 0.9 0.4 1.6 1.6 1.9 0.8 3.5 2.9 2.6 1.0 2.0 1.7 2.0 2.3 1.8 1.9 3.6 2.0 1.9 1.8 -0.1
Alcoholic beverages
  % saying any 18 92.2 91.8 90.7 90.8 89.5 88.3 87.6 87.4 87.6 86.5 85.7 86.5 85.2 85.0 85.3 84.8 82.1 80.5 80.4 78.9 78.3 -0.6
19–22 91.8 91.0 93.3 94.3 93.7 93.6 92.5 92.7 92.0 91.8 90.5 91.2 86.5 87.5 85.8 82.8 89.7 85.5 86.9 81.6 83.6 +2.0
23–26 89.1 91.5 92.1 90.1 91.9 91.8 92.2 90.0 94.0 94.5 92.0 93.0 91.1 94.2 88.7 88.7 82.7 87.2 86.9 90.2 89.2 -1.0
27–30 88.4 88.7 89.8 91.2 89.0 90.0 85.3 92.2 91.8 89.6 94.4 91.0 91.2 92.5 90.5 88.8 85.6 89.3 85.3 83.6 89.4 +5.8 s
  % saying often exposed 18 54.5 53.5 50.2 52.7 50.8 49.0 48.2 49.1 47.8 46.4 45.4 46.3 45.8 40.7 43.0 41.7 40.3 38.0 37.4 35.4 33.6 -1.7
19–22 57.9 54.7 54.3 53.4 54.9 55.7 54.3 58.9 55.0 60.7 53.9 53.4 48.5 46.0 50.6 45.3 49.5 51.1 53.2 43.2 45.1 +1.8
23–26 44.6 45.7 49.6 48.8 46.3 50.5 48.3 46.4 57.1 54.2 49.6 53.8 51.3 52.5 55.6 49.3 44.4 49.3 47.6 52.3 51.1 -1.2
27–30 36.6 38.3 34.4 40.0 39.6 40.6 36.8 43.6 47.3 44.3 47.8 45.2 43.0 49.3 50.4 48.1 47.7 47.4 48.7 46.5 44.5 -2.0
Approximate 18 2,541 2,312 2,153 2,147 2,162 2,454 2,456 2,469 2,469 2,448 2,332 2,274 2,434 2,372 2,299 2,150 2,075 2,177 2,018 2,086 2,200
Weighted  N = 19–22 445 450 415 412 403 396 432 377 378 333 365 368 364 340 356 281 316 264 251 228 271
23–26 400 398 389 406 345 385 404 374 363 327 333 328 347 308 334 311 308 286 271 237 264
27–30 449 430 395 369 359 347 370 370 330 356 339 324 336 306 312 301 303 263 259 276 285
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  Any apparent inconsistency between 
the change estimate and the prevalence estimates for the two most recent years is due to rounding. ' — ' indicates data not available.
' * ' indicates a prevalence rate of less than 0.05%.
aAnswer alternatives were: (1) Not at all, (2) Once or twice, (3) Occasionally, (4) Often. The “any” percentage combines categories (2)–(4).
bThese estimates were derived from responses to the question for the following drugs: marijuana, LSD, other hallucinogens, cocaine, heroin or other narcotics, amphetamines,
sedatives (barbiturates), and tranquilizers.
cIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the 
discontinuity in the 2001 results. 
dIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc. This change likely explains the discontinuity
in the 2010 results.
eIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin. This change likely explains the discontinuity in the 2011 results.
fIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just
downers. These changes likely explain the discontinuity in the 2004 results.
gIn 2001 Xanax was added to the list of examples. This change likely explains the discontinuity in the 2001 results. 
TABLE 7-3 (cont.)
Trends in Direct Exposure to Drug Use
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
Age 
Group
2017– 
2018 
change
you been around people 
who were taking each of the 
following to get high or for 
“kicks”?
Q. During the LAST 12 
MONTHS how often have Percentage saying exposed to drug a
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Marijuana 18 89.0 89.2 88.5 86.2 84.6 85.5 85.2 84.8 85.0 84.3 84.4 83.3 82.7 83.0 85.5 88.5 88.7 89.6 90.4
19–22 95.6 91.1 92.4 89.7 88.3 89.5 87.2 85.9 87.1 87.1 86.2 86.0 87.8 85.6 87.2 87.9 89.3 90.6 89.9
23–26 — — — — 92.5 88.8 88.8 90.3 86.9 88.7 83.3 82.5 83.8 84.6 87.1 86.2 85.3 84.4 87.5
27–30 — — — — — — — — 89.3 86.0 83.1 83.8 80.7 82.8 80.3 83.3 82.6 84.5 82.1
35 — — — — — — — — — — — — — — 75.7 75.6 73.0 77.1 76.0
40 — — — — — — — — — — — — — — — — — — 73.4
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Amyl & butyl nitrites 18 — — — — — — — 23.9 25.9 26.8 24.4 22.7 25.9 25.9 26.7 26.0 23.9 23.8 25.1
19–22 — — — — — — — 22.8 26.0 — — — — — — — — — —
23–26 — — — — — — — 23.1 28.0 — — — — — — — — — —
27–30 — — — — — — — — 26.7 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
LSD 18 35.3 35.0 34.2 30.9 30.6 30.5 28.5 31.4 33.3 38.3 40.7 39.5 44.5 49.2 50.8 53.8 51.3 50.7 48.8
19–22 39.6 38.4 35.1 31.8 32.7 29.6 30.5 29.9 33.9 36.4 36.6 37.8 42.5 44.9 43.7 50.5 50.8 47.7 51.1
23–26 — — — — 32.7 29.1 30.0 27.5 32.7 32.6 30.2 32.8 33.5 33.4 40.1 41.0 43.6 39.2 40.4
27–30 — — — — — — — — 29.4 29.9 32.3 27.0 30.9 30.5 27.2 35.6 33.6 35.2 32.9
35 — — — — — — — — — — — — — — 33.8 32.4 28.4 32.9 31.2
40 — — — — — — — — — — — — — — — — — — 31.1
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Other 18 35.0 32.7 30.6 26.6 26.6 26.1 24.9 25.0 26.2 28.2 28.3 28.0 29.9 33.5 33.8 35.8 33.9 33.9 35.1
  hallucinogens b 19–22 42.1 37.7 33.5 31.0 28.9 28.7 26.3 27.5 28.7 28.1 28.9 26.6 28.3 29.5 28.6 31.5 31.5 33.4 34.1
23–26 — — — — 31.8 29.6 26.4 25.6 29.6 28.7 27.0 25.7 27.7 25.3 28.3 29.2 32.6 31.0 32.4
27–30 — — — — — — — — 28.6 29.6 30.8 24.9 24.8 25.4 24.7 29.3 25.9 28.0 25.2
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
PCP 18 — — — — — — — 22.8 24.9 28.9 27.7 27.6 31.7 31.7 31.4 31.0 30.5 30.0 30.7
19–22 — — — — — — — 21.7 24.6 — — — — — — — — — —
23–26 — — — — — — — 21.2 27.6 — — — — — — — — — —
27–30 — — — — — — — — 24.3 — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Ecstasy (MDMA) 18 — — — — — — — — — 21.7 22.0 22.1 24.2 28.1 31.2 34.2 36.9 38.8 38.2
19–22 — — — — — — — — — — 26.6 24.9 27.1 23.9 27.0 29.3 33.4 35.6 39.4
23–26 — — — — — — — — — — 21.4 23.1 26.4 24.0 26.0 27.8 28.7 31.1 30.1
27–30 — — — — — — — — — — 27.1 20.8 22.2 22.8 21.9 27.1 29.3 24.3 26.4
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
(Table continued on next page.)
Age 
Group
(Years 
Cont.)
TABLE 7-4
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Q. How difficult do you 
think it would be for you 
to get each of the 
following types of drugs,
if you wanted some?
Percentage saying fairly easy or very easy to get a
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1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Marijuana 18 88.9 88.5 88.5 87.2 87.1 85.8 85.6 84.9 83.9 83.9 81.1 82.1 82.2 81.6 81.4 81.3 79.5 81.0 79.8 79.7 -0.1
19–22 87.4 89.6 91.7 88.1 87.7 87.3 88.0 86.8 88.4 87.5 83.0 84.2 82.9 85.4 83.9 85.7 88.7 86.5 90.1 84.6 -5.5
23–26 85.9 88.4 87.0 89.1 87.2 88.8 87.0 86.8 87.6 85.3 89.4 83.3 88.3 87.0 87.4 87.7 87.4 88.5 88.8 88.1 -0.6
27–30 83.0 81.5 84.8 83.6 81.8 86.0 84.6 87.6 87.8 86.4 88.9 84.6 85.6 85.1 86.8 86.4 91.5 86.8 87.0 89.9 +2.9
35 74.9 77.1 75.3 76.5 75.1 75.6 73.8 75.1 75.5 76.4 75.7 75.6 80.4 80.5 80.2 84.4 85.5 84.7 84.9 83.5 -1.4
40 71.7 73.1 70.4 72.1 72.3 68.9 73.6 69.7 71.2 72.5 72.9 73.6 74.6 74.6 78.8 76.0 77.3 80.7 82.3 84.3 +2.0
45 — — — — 68.5 69.9 70.1 67.9 70.1 68.1 67.9 73.4 69.8 71.8 73.6 76.9 77.2 81.1 82.6 83.5 +0.9
50 — — — — — — — — — 64.4 65.8 67.9 65.8 68.9 70.1 71.9 75.8 74.5 76.6 78.7 +2.1
55 — — — — — — — — — — — — — — 68.8 72.1 71.7 72.8 76.7 74.6 -2.1
60 — — — — — — — — — — — — — — — — — — — 71.3 —
Amyl & butyl nitrites 18 21.4 23.3 22.5 22.3 19.7 20.0 19.7 18.4 18.1 16.9 15.7 — — — — — — — — — —
19–22 — — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
LSD 18 44.7 46.9 44.7 39.6 33.6 33.1 28.6 29.0 28.7 28.5 26.3 25.1 25.1 27.6 24.5 25.9 26.5 28.0 26.3 28.0 +1.7
19–22 43.8 47.1 42.5 37.9 34.1 30.3 27.7 29.0 23.0 19.7 24.2 26.1 24.8 23.2 26.2 22.3 25.8 24.6 33.3 33.3 0.0
23–26 41.2 40.4 38.3 37.2 34.1 38.5 26.5 30.3 25.2 24.1 26.1 24.2 21.4 19.3 22.8 17.2 20.5 17.7 23.0 27.2 +4.3
27–30 35.7 35.6 38.3 32.3 33.5 30.0 29.3 29.7 26.8 28.1 22.5 25.2 26.6 19.1 21.7 21.1 15.5 20.4 17.9 22.1 +4.2
35 27.7 32.2 28.7 29.1 29.8 25.6 24.0 28.7 26.6 26.4 26.9 25.5 24.0 23.0 24.1 22.2 19.3 20.8 18.5 21.4 +2.9
40 31.0 28.5 25.7 27.4 25.0 24.4 24.3 23.9 21.5 25.1 22.2 23.3 22.6 21.6 20.1 23.0 20.6 21.4 18.8 22.3 +3.5
45 — — — — 24.2 27.0 25.4 23.7 23.6 21.1 19.4 23.6 21.3 18.9 23.4 21.2 17.9 19.7 21.6 21.8 +0.2
50 — — — — — — — — — 19.0 21.9 18.6 20.3 18.1 17.1 17.7 19.7 19.5 17.3 22.6 +5.3 s
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Other 18 29.5 34.5 48.5 47.7 47.2 49.4 45.0 43.9 43.7 42.8 40.5 39.5 38.3 37.8 36.6 33.6 31.4 32.5 28.4 28.6 +0.2
hallucinogens b 19–22 31.1 33.4 45.9 48.8 45.1 46.9 48.5 41.9 39.3 34.7 38.1 39.1 37.5 36.4 34.1 31.2 35.4 30.6 32.4 34.2 +1.9
23–26 31.5 28.5 38.3 39.7 39.2 44.4 39.2 41.5 36.8 39.3 39.2 32.3 35.0 32.7 31.8 27.5 31.1 29.6 30.1 32.1 +2.0
27–30 30.3 25.0 38.6 33.3 35.6 31.2 30.8 32.1 30.0 36.2 32.0 34.7 33.4 31.4 33.3 31.0 27.3 24.3 27.2 29.4 +2.2
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
PCP 18 26.7 28.8 27.2 25.8 21.9 24.2 23.2 23.1 21.0 20.6 19.2 18.5 17.2 14.2 15.3 11.0 13.8 12.6 10.6 10.8 +0.2
19–22 — — — — — — — — — — — — — — — — — — — — —
23–26 — — — — — — — — — — — — — — — — — — — — —
27–30 — — — — — — — — — — — — — — — — — — — — —
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Ecstasy (MDMA) 18 40.1 51.4 61.5 59.1 57.5 47.9 40.3 40.3 40.9 41.9 35.1 36.4 37.1 35.9 35.1 36.1 37.1 32.5 29.3 27.7 -1.6
19–22 43.2 49.9 55.5 59.7 52.1 45.8 43.5 41.2 38.4 34.7 37.1 30.4 37.9 28.3 33.9 32.9 38.6 33.4 32.0 38.7 +6.8
23–26 34.9 41.8 51.5 52.9 49.3 51.3 46.4 44.6 42.2 41.5 36.8 35.2 34.0 32.2 35.7 30.9 36.3 30.8 35.0 33.6 -1.3
27–30 30.0 35.5 40.6 41.2 41.0 41.1 38.0 40.5 40.7 42.2 38.0 31.2 33.8 32.8 28.6 29.7 33.2 35.8 33.1 31.7 -1.4
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
↓
(List of drugs continued.)
Age 
Group
2017– 
2018 
change
TABLE 7-4 (cont.)
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
Trends in Availability of Drugs as Perceived by
Percentage saying fairly easy or very easy to get aQ. How difficult do you 
think it would be for you to 
get each of the following 
types of drugs, if you 
wanted some?
366
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Cocaine 18 47.9 47.5 47.4 43.1 45.0 48.9 51.5 54.2 55.0 58.7 54.5 51.0 52.7 48.5 46.6 47.7 48.1 48.5 51.3
19–22 56.2 57.1 55.2 56.2 56.9 60.4 65.0 64.9 66.8 61.7 54.3 54.5 49.2 49.9 49.4 44.4 49.7 47.7
23–26 — — — — 63.7 67.2 65.8 69.0 71.7 70.0 65.6 58.0 61.1 53.8 54.4 54.7 50.2 46.9 51.8
27–30 — — — — — — — — 68.6 68.2 64.0 60.0 63.1 56.8 53.1 57.0 53.0 50.4 46.9
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Crack 18 — — — — — — — 41.1 42.1 47.0 42.4 39.9 43.5 43.6 40.5 41.9 40.7 40.6 43.8
19–22 — — — — — — — 41.9 47.3 47.2 46.9 42.1 42.1 38.4 41.6 40.7 32.9 39.9 40.0
23–26 — — — — — — — 44.5 53.0 49.9 46.9 42.0 42.6 42.5 42.4 42.3 37.9 37.2 38.4
27–30 — — — — — — — — 46.5 46.8 46.8 43.1 45.2 45.8 41.1 44.7 39.9 36.5 33.3
35 — — — — — — — — — — — — — — 49.6 48.2 43.1 44.3 45.0
40 — — — — — — — — — — — — — — — — — — 43.3
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Cocaine powder 18 — — — — — — — 52.9 50.3 53.7 49.0 46.0 48.0 45.4 43.7 43.8 44.4 43.3 45.7
19–22 — — — — — — — 58.7 60.2 61.7 56.5 52.5 48.9 45.7 47.8 45.5 41.3 46.0 47.1
23–26 — — — — — — — 64.9 69.1 60.1 58.6 53.2 56.4 50.5 49.7 49.6 45.9 43.6 44.4
27–30 — — — — — — — — 63.5 62.8 57.9 55.8 56.8 55.0 48.9 52.9 48.4 45.1 43.9
35 — — — — — — — — — — — — — — 53.9 52.1 46.7 48.3 47.0
40 — — — — — — — — — — — — — — — — — — 46.0
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Heroin 18 21.2 19.2 20.8 19.3 19.9 21.0 22.0 23.7 28.0 31.4 31.9 30.6 34.9 33.7 34.1 35.1 32.2 33.8 35.6
19–22 18.9 19.4 19.3 16.4 17.2 20.8 21.2 24.4 28.5 31.6 30.7 25.3 30.2 30.0 33.2 35.2 29.1 31.4 32.1
23–26 — — — — 18.6 18.1 21.0 22.3 28.4 31.2 28.1 25.6 25.7 25.7 29.2 29.3 32.3 30.5 35.1
27–30 — — — — — — — — 23.6 27.4 29.5 22.1 25.6 28.5 24.4 30.7 29.5 30.0 28.3
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Some other narcotic c 18 29.4 29.6 30.4 30.0 32.1 33.1 32.2 33.0 35.8 38.3 38.1 34.6 37.1 37.5 38.0 39.8 40.0 38.9 42.8
19–22 32.7 32.4 30.8 31.0 28.7 34.3 32.6 33.8 37.9 37.9 35.6 35.4 35.2 33.5 35.1 38.7 37.3 38.3 38.9
23–26 — — — — 32.8 32.1 33.6 32.2 35.9 36.4 34.7 33.2 33.9 33.1 35.8 32.6 36.7 35.7 39.9
27–30 — — — — — — — — 31.6 36.2 36.1 29.0 31.8 33.0 34.8 36.9 37.2 35.2 32.2
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Amphetamines 18 61.3 69.5 70.8 68.5 68.2 66.4 64.3 64.5 63.9 64.3 59.7 57.3 58.8 61.5 62.0 62.8 59.4 59.8 60.8
19–22 71.7 72.6 73.5 69.7 69.1 69.1 63.1 61.8 61.3 62.2 57.7 58.3 56.3 56.0 56.6 60.3 56.9 55.5 56.3
23–26 — — — — 65.8 66.0 64.5 65.3 62.2 60.1 55.8 54.8 54.5 52.6 52.9 56.0 52.8 51.2 53.2
27–30 — — — — — — — — 54.3 58.6 55.3 54.4 50.4 52.9 48.3 53.7 51.7 48.1 41.4
35 — — — — — — — — — — — — — — 45.6 43.5 39.1 40.9 39.4
40 — — — — — — — — — — — — — — — — — — 41.0
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
TABLE 7-4 (cont.)
(Table continued on next page.)
Q. How difficult do you 
think it would be for you 
to get each of the 
following types of drugs, 
if you wanted some?
(Years 
Cont.)
Percentage saying fairly easy or very easy to get a
367
Age 
Group 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Cocaine 18 47.6 47.8 46.2 44.6 43.3 47.8 44.7 46.5 47.1 42.4 39.4 35.5 30.5 29.8 30.5 29.2 29.1 28.6 27.3 28.1 +0.9
19–22 52.6 52.1 49.6 47.6 46.7 47.0 50.0 47.4 47.3 44.0 38.5 37.2 39.2 32.9 28.1 34.4 33.3 37.3 37.0 40.5 +3.5
23–26 45.7 45.0 44.6 47.8 40.8 50.7 48.4 51.2 47.4 45.5 44.0 41.1 37.8 37.4 36.8 36.8 36.2 36.8 38.0 38.6 +0.6
27–30 50.0 44.6 45.5 46.3 42.9 38.0 43.1 43.2 45.8 50.6 43.6 40.8 44.2 42.3 35.0 41.6 39.4 39.7 40.1 41.8 +1.6
35 — — — — — — — — — — — — — — — — — — — — —
 40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Crack 18 41.1 42.6 40.2 38.5 35.3 39.2 39.3 38.8 37.5 35.2 31.9 26.1 24.0 22.0 24.6 20.1 22.0 19.8 18.1 20.8 +2.7
19–22 40.8 40.2 37.3 35.7 37.5 33.7 34.0 35.2 35.7 31.4 27.3 27.2 27.3 20.6 20.8 23.3 21.0 20.0 18.3 22.1 +3.8
23–26 35.0 31.9 37.1 33.9 32.8 36.5 35.1 34.0 31.4 33.1 27.4 27.1 25.3 27.6 24.2 26.7 21.9 19.4 23.6 21.2 -2.4
27–30 38.8 35.9 36.9 33.4 33.7 28.0 34.4 29.6 36.4 36.1 33.1 27.5 28.9 25.2 24.6 26.5 26.5 28.4 22.6 22.8 +0.2
35 41.6 45.0 41.2 38.9 40.5 36.1 34.2 37.1 35.1 33.2 31.6 30.0 30.4 27.3 28.7 25.7 26.1 26.3 24.3 — —
40 44.3 42.0 38.7 39.5 39.0 35.8 38.6 37.1 32.7 35.2 33.2 30.9 30.1 27.9 25.5 28.1 24.7 25.0 22.7 — —
45 — — — — 37.0 40.0 40.6 36.2 37.0 34.2 31.7 36.2 32.3 28.2 32.3 27.3 24.7 28.8 26.5 — —
50 — — — — — — — — — 32.8 36.3 32.4 29.5 30.5 30.0 27.2 29.9 28.6 24.2 — —
55 — — — — — — — — — — — — — — 30.2 34.6 28.7 28.0 28.6 — —
60 — — — — — — — — — — — — — — — — — — — — —
Cocaine powder 18 43.7 44.6 40.7 40.2 37.4 41.7 41.6 42.5 41.2 38.9 33.9 29.0 26.4 25.1 28.4 22.3 25.8 22.9 21.3 23.0 +1.7
19–22 45.2 45.2 43.3 43.9 45.5 43.2 44.3 44.2 44.5 39.0 36.1 35.6 35.4 26.0 25.1 31.8 33.0 29.2 29.2 36.0 +6.8
23–26 44.3 41.8 44.4 40.7 43.4 48.5 45.1 46.4 45.0 41.4 41.6 40.3 37.5 37.0 35.1 34.0 34.3 32.4 34.5 35.5 +1.0
27–30 46.5 43.9 42.7 42.4 39.7 37.9 40.2 42.7 43.0 47.5 41.3 38.2 38.4 37.0 35.4 36.9 40.7 38.1 36.1 37.2 +1.1
35 43.4 47.9 43.1 41.7 42.0 39.6 35.8 39.5 37.4 38.6 34.9 35.5 35.3 31.4 35.2 31.9 34.2 35.3 33.7 38.4 +4.7
40 46.7 44.7 41.5 41.5 40.7 38.5 40.3 37.8 35.2 36.5 33.9 33.5 31.8 29.5 29.8 31.6 28.6 30.2 27.7 35.2 +7.5 ss
45 — — — — 39.0 40.2 40.6 37.3 38.2 34.1 31.5 37.2 33.2 28.7 34.0 29.9 26.6 29.6 29.6 31.7 +2.1
50 — — — — — — — — — 32.6 35.9 32.8 31.0 30.8 30.3 27.8 30.7 29.3 27.0 33.2 +6.2 ss
55 — — — — — — — — — — — — — — 30.6 35.3 30.4 29.8 30.9 32.3 +1.4
60 — — — — — — — — — — — — — — — — — — — 29.9 —
Heroin 18 32.1 33.5 32.3 29.0 27.9 29.6 27.3 27.4 29.7 25.4 27.4 24.1 20.8 19.9 22.1 20.2 20.4 20.0 19.1 18.4 -0.8
19–22 32.7 29.4 30.2 26.4 26.9 22.6 25.4 25.3 26.5 24.2 19.4 22.0 21.2 19.3 16.0 20.2 21.1 24.5 20.0 19.2 -0.8
23–26 31.9 25.7 26.6 27.2 25.5 30.9 22.5 28.1 22.2 23.4 23.4 23.1 21.1 22.7 23.1 21.1 21.2 24.9 22.1 22.3 +0.2
27–30 33.0 29.3 29.9 27.0 27.5 22.0 27.8 25.4 27.5 26.3 25.2 25.2 28.0 23.3 20.9 25.5 26.9 28.7 28.9 29.2 +0.3
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Some other narcotic c 18 40.8 43.9 40.5 44.0 39.3 40.2 39.2 39.6 37.3 34.9 36.1 54.2 50.7 50.4 46.5 42.2 39.0 39.3 35.8 32.5 -3.3
19–22 39.5 41.1 44.1 40.4 40.6 39.4 41.4 38.5 38.3 38.0 35.3 55.2 53.8 52.2 53.5 49.7 47.5 46.8 40.1 42.4 +2.3
23–26 38.2 38.1 35.8 40.0 40.3 47.7 44.7 45.5 41.7 41.2 42.5 56.2 59.6 58.6 62.1 52.1 52.6 55.0 48.3 49.6 +1.2
27–30 36.9 32.4 39.4 38.5 38.9 35.8 37.7 39.8 41.3 39.4 43.5 62.3 65.2 59.8 64.4 56.2 60.9 55.2 57.6 52.9 -4.7
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Amphetamines d 18 58.1 57.1 57.1 57.4 55.0 55.4 51.2 52.9 49.6 47.9 47.1 44.1 47.0 45.4 42.7 44.5 41.9 41.1 38.0 39.3 +1.3
19–22 57.6 60.2 56.5 53.7 55.1 53.9 56.9 52.3 55.8 49.5 49.8 43.6 52.3 54.4 54.0 55.3 57.4 54.8 57.9 53.8 -4.2
23–26 49.1 51.1 49.4 48.2 50.3 51.8 51.9 58.0 53.7 46.9 51.0 45.5 55.5 55.6 59.4 54.3 54.7 52.5 52.7 51.3 -1.3
27–30 48.2 47.6 49.3 45.6 48.7 43.9 45.3 49.2 48.1 45.0 51.1 46.4 49.9 54.6 54.2 55.5 56.6 49.2 58.0 54.6 -3.4
35 38.5 42.2 39.6 39.2 39.2 35.4 35.4 40.3 40.4 40.6 39.2 37.1 40.4 37.5 40.7 38.9 37.3 38.9 36.2 38.2 +2.0
40 41.9 39.4 37.5 39.4 38.7 37.9 41.1 38.4 37.6 39.2 37.2 37.0 34.3 35.8 34.6 35.6 34.0 36.7 34.8 40.6 +5.8 s
45 — — — — 35.8 39.8 39.3 37.1 38.3 36.8 33.0 39.8 37.0 34.5 39.3 35.2 32.4 35.2 34.9 34.8 -0.1
50 — — — — — — — — — 32.8 38.0 34.4 33.9 32.3 33.0 31.1 33.5 34.9 32.7 37.9 +5.2 s
55 — — — — — — — — — — — — — — 36.8 39.6 35.3 35.2 34.8 35.4 +0.6
60 — — — — — — — — — — — — — — — — — — — 32.3 —
↓
(List of drugs continued.)
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
TABLE 7-4 (cont.)
2017– 
2018 
change
Percentage saying fairly easy or very easy to get aQ. How difficult do you 
think it would be for you to 
get each of the following 
types of drugs, if you 
wanted some?
368
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Crystal 18 — — — — — — — — — — 24.0 24.3 26.0 26.6 25.6 27.0 26.9 27.6 29.8
  methamphetamine 19–22 — — — — — — — — — — 24.0 21.8 22.5 20.9 24.7 25.5 25.4 29.3 31.0
  (ice) 23–26 — — — — — — — — — — 22.3 20.0 21.3 22.9 24.5 24.7 24.7 25.8 30.2
27–30 — — — — — — — — — — 27.3 19.7 22.0 21.2 21.7 25.8 26.1 25.1 22.6
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Sedatives/ 18 49.1 54.9 55.2 52.5 51.9 51.3 48.3 48.2 47.8 48.4 45.9 42.4 44.0 44.5 43.3 42.3 41.4 40.0 40.7
  barbiturates d 19–22 59.5 61.1 56.8 54.2 48.1 52.7 46.8 44.6 45.5 47.7 44.2 41.7 43.4 41.9 40.6 42.9 41.1 39.8 39.2
23–26 — — — — 52.7 47.7 46.4 45.9 47.4 44.8 41.6 39.6 42.0 38.8 40.3 42.1 40.6 39.1 42.6
27–30 — — — — — — — — 43.2 44.5 44.2 38.5 37.8 39.7 37.4 39.9 41.2 39.1 33.9
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
Tranquilizers 18 59.1 60.8 58.9 55.3 54.5 54.7 51.2 48.6 49.1 45.3 44.7 40.8 40.9 41.1 39.2 37.8 36.0 35.4 36.2
19–22 67.4 62.8 62.0 62.3 52.5 55.6 52.9 50.3 50.0 49.4 45.4 44.8 40.7 40.9 41.0 40.2 37.6 37.8 36.8
23–26 — — — — 60.2 54.3 54.1 56.3 52.8 51.4 47.8 45.1 48.1 43.2 45.9 44.3 42.3 36.4 39.4
27–30 — — — — — — — — 55.3 54.4 54.9 47.5 47.8 47.4 44.4 44.8 46.2 41.9 39.9
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Steroids 18 — — — — — — — — — — — 46.7 46.8 44.8 42.9 45.5 40.3 41.7 44.5
19–22 — — — — — — — — — — 44.1 44.8 46.3 41.7 40.9 41.8 40.8 39.2 39.2
23–26 — — — — — — — — — — 37.6 35.8 39.3 35.8 37.0 37.4 33.9 35.5 34.9
27–30 — — — — — — — — — — 36.4 30.6 35.0 31.6 30.5 33.1 35.6 32.5 30.5
35 — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — —
Approximate 18 3,240 3,578 3,602 3,385 3,269 3,274 3,077 3,271 3,231 2,806 2,549 2,476 2,586 2,670 2,526 2,552 2,340 2,517 2,520
Weighted N = 19–22 582 601 582 588 559 571 592 581 568 572 571 534 512 480 459 470 467 463 433
23–26 540 541 548 539 526 514 532 511 523 500 463 449 418 419 395
27–30 519 513 510 487 475 473 437 446 468 459 425
35 1,142 1,141 1,146 1,150 1,032
40 1,029
45
50
55
60
Age 
Group
(Table continued on next page.)
Q. How difficult do you 
think it would be for you 
to get each of the 
following types of drugs, 
if you wanted some?
(Years 
Cont.)
Percentage saying “fairly easy” or “very easy” to get a
TABLE 7-4 (cont.)
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
369
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Crystal 18 27.6 27.8 28.3 28.3 26.1 26.7 27.2 26.7 25.1 23.3 22.3 18.3 17.1 14.5 17.2 13.7 15.3 14.5 13.6 13.6 -0.0
  methamphetamine 19–22 31.8 27.4 28.4 31.2 26.5 27.1 28.9 29.1 27.7 24.1 19.2 19.3 19.4 13.5 15.3 15.3 15.0 15.7 10.9 15.0 +4.1
  (ice) 23–26 28.5 25.8 26.4 25.1 26.4 32.3 27.8 32.3 27.8 27.7 23.1 26.1 18.2 23.5 16.3 16.0 15.1 14.0 16.2 15.1 -1.1
27–30 29.1 25.3 27.6 29.5 30.9 25.5 27.4 31.8 29.7 31.4 27.7 27.6 26.2 24.2 22.3 22.0 20.3 22.6 17.9 16.7 -1.2
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Sedatives/ 18 37.9 37.4 35.7 36.6 35.3 46.3 44.4 43.8 41.7 38.8 37.9 36.8 32.4 28.7 27.9 26.3 25.0 25.7 23.4 23.0 -0.4
  barbiturates e 19–22 42.3 40.6 39.3 40.8 38.4 43.8 47.8 42.6 47.5 43.2 42.6 39.6 38.1 31.6 32.1 32.6 35.3 31.1 30.3 28.2 -2.1
23–26 39.7 37.6 36.1 36.4 37.8 49.4 48.4 51.4 46.5 43.3 47.7 40.4 41.3 40.1 42.2 33.2 35.1 32.0 28.2 29.7 +1.5
27–30 38.4 36.1 38.1 34.8 35.6 40.5 42.9 43.3 46.4 44.7 48.5 43.1 42.9 42.3 44.8 39.9 42.9 35.9 36.5 35.1 -1.4
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Tranquilizers 18 32.7 33.8 33.1 32.9 29.8 30.1 25.7 24.4 23.6 22.4 21.2 18.4 16.8 14.9 15.0 14.4 14.9 15.2 14.9 13.0 -1.9
19–22 37.1 36.5 34.9 34.6 34.2 29.7 30.1 22.8 28.5 23.3 18.3 20.2 18.6 17.3 17.4 16.8 19.7 17.8 15.0 15.0 +0.1
23–26 38.3 37.6 38.7 33.7 32.5 36.6 32.9 33.0 31.7 30.3 27.7 21.8 23.0 22.1 18.5 17.5 16.6 13.3 15.9 14.4 -1.5
27–30 41.5 36.7 42.9 38.1 35.9 30.6 33.5 32.1 32.4 33.1 30.1 30.6 27.1 25.7 28.1 21.2 22.1 20.3 18.1 17.4 -0.7
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Steroids 18 44.6 44.8 44.4 45.5 40.7 42.6 39.7 41.1 40.1 35.2 30.3 27.3 26.1 25.0 28.5 22.0 23.7 21.3 20.1 21.1 +1.0
19–22 40.5 40.3 38.1 41.4 39.4 37.8 37.6 37.1 37.9 33.5 28.7 25.1 24.3 21.2 20.6 25.7 25.1 24.8 19.8 22.3 +2.4
23–26 37.1 34.0 34.7 33.1 31.1 34.7 31.2 34.2 33.3 30.2 28.6 22.2 29.2 25.6 23.6 24.1 18.3 18.7 18.5 23.0 +4.5
27–30 34.5 36.2 34.6 33.0 32.6 30.6 32.4 29.7 30.9 31.0 31.9 27.6 27.0 23.9 22.3 22.6 23.9 22.5 23.5 19.9 -3.6
35 — — — — — — — — — — — — — — — — — — — — —
40 — — — — — — — — — — — — — — — — — — — — —
45 — — — — — — — — — — — — — — — — — — — — —
50 — — — — — — — — — — — — — — — — — — — — —
55 — — — — — — — — — — — — — — — — — — — — —
60 — — — — — — — — — — — — — — — — — — — — —
Approximate 18 2,215 2,095 1,850 2,138 2,391 2,169 2,161 2,161 2,420 2,276 2,243 2,395 2,337 2,280 2,092 2,066 2,181 1,966 1,882 1,931
Weighted N = 19–22 425 400 398 375 386 441 392 376 362 380 377 377 355 341 342 313 294 252 266 261
23–26 415 388 401 362 356 411 359 335 338 355 312 358 313 332 325 309 305 271 267 269
27–30 424 365 357 349 368 393 359 347 324 334 305 340 325 334 281 310 258 284 291 303
35 1,022 981 977 890 934 963 1,009 925 863 898 952 895 852 875 844 769 726 732 727 675
40 1,093 1,096 1,065 1,037 898 967 928 919 868 881 870 911 850 823 820 883 787 765 796 746
45 911 1,026 1,005 972 954 851 888 846 852 842 806 785 839 783 738 753
50 902 975 989 939 958 819 868 802 827 776 738
55 832 903 907 909 920 766
60
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001.  
Any apparent inconsistency between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
' — ' indicates data not available.
aAnswer alternatives were: (1) Probably impossible, (2) Very difficult, (3) Fairly difficult, (4) Fairly easy, and (5) Very easy.
bIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the discontinuity 
in the 2001 results.
cIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin,OxyContin, Percocet, etc.  This change likely explains the discontinuity  
in the 2010 results.
dIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin.  This change likely explains the discontinuity in the 2011 results.
eIn 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers.
These changes likely explain the discontinuity in the 2004 results.
Age 
Group
Percentage saying “fairly easy” or “very easy” to get a
2017– 
2018 
change
Q. How difficult do you 
think it would be for you to 
get each of the following 
types of drugs, if you 
wanted some?
TABLE 7-4 (cont.)
Trends in Availability of Drugs as Perceived by
Respondents in Modal Age Groups of 18, 19–22, 23–26, 27–30, 35, 40, 45, 50, 55, and 60
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Source.  The Monitoring the Future study, the University of Michigan.
FIGURE 7-1
Trends in Direct Exposure to Use of ANY ILLICIT DRUGS
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Often Exposed
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
FIGURE 7-2
Trends in Direct Exposure to Use of ANY ILLICIT DRUGS
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Source.  The Monitoring the Future study, the University of Michigan.
aThese estimates were derived from responses to the question for the following drugs: marijuana, LSD, other hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), and tranquilizers.
FIGURE 7-3
Trends in Direct Exposure to Use of ANY ILLICIT DRUG OTHER THAN MARIJUANAa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source.  The Monitoring the Future study, the University of Michigan.
aThese estimates were derived from responses to the question for the following drugs: marijuana, LSD, other hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), and tranquilizers.
% Saying Often Exposed
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
FIGURE 7-4
Trends in Direct Exposure to Use of ANY ILLICIT DRUG OTHER THAN MARIJUANAa
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 Source. The Monitoring the Future study, the University of Michigan.
FIGURE 7-5
Trends in Direct Exposure to Use of MARIJUANA
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.  
% Saying Often Exposed
FIGURE 7-6
Trends in Direct Exposure to Use of MARIJUANA
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
FIGURE 7-7
Trends in Direct Exposure to Use of LSD
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
FIGURE 7-8
% Saying Often Exposed
Trends in Direct Exposure to Use of LSD
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the discontinuity in the 2001 results. 
% Saying Any Exposure
FIGURE 7-9
Trends in Direct Exposure to Use of HALLUCINOGENS OTHER THAN LSDa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2001 the question text was changed from other psychedelics to other hallucinogens, and shrooms was added to the list of examples.  These changes likely explain the discontinuity in the 2001 results. 
% Saying Often Exposed
FIGURE 7-10
Trends in Direct Exposure to Use of HALLUCINOGENS OTHER THAN LSDa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Any Exposure
FIGURE 7-11
Trends in Direct Exposure to Use of COCAINE
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Often Exposed
FIGURE 7-12
Trends in Direct Exposure to Use of COCAINE
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Any Exposure
FIGURE 7-13
Trends in Direct Exposure to Use of HEROIN
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Often Exposed
FIGURE 7-14
Trends in Direct Exposure to Use of HEROIN
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc. This change likely explains the discontinuity in the 2010 results.
% Saying Any Exposure
FIGURE 7-15
Trends in Direct Exposure to Use of NARCOTICS OTHER THAN HEROINa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source.  The Monitoring the Future study, the University of Michigan.
aIn 2010 the list of examples for narcotics other than heroin was changed from methadone, opium to Vicodin, OxyContin, Percocet, etc. This change likely explains the discontinuity in the 2010 results.
% Saying Often Exposed
FIGURE 7-16
Trends in Direct Exposure to Use of NARCOTICS OTHER THAN HEROINa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin. This change likely explains the discontinuity in the 2011 results.
% Saying Any Exposure
FIGURE 7-17
Trends in Direct Exposure to Use of AMPHETAMINESa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2011 pep pills and bennies were replaced in the list of examples by Adderall and Ritalin. This change likely explains the discontinuity in the 2011 results.
% Saying Often Exposed
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
FIGURE 7-18
Trends in Direct Exposure to Use of AMPHETAMINESa
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Source.  The Monitoring the Future study, the University of Michigan.
a  In 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. These changes likely explain the 
discontinuity in the 2004 results.
% Saying Any Exposure
FIGURE 7-19
Trends in Direct Exposure to Use of SEDATIVES (BARBITURATES)a
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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 Source.  The Monitoring the Future study, the University of Michigan.
a  In 2004 the question text was changed from barbiturates to sedatives/barbiturates and the list of examples was changed from downers, goofballs, reds, yellows, etc. to just downers. These changes likely explain the 
discontinuity in the 2004 results.
% Saying Often Exposed
FIGURE 7-20
Trends in Direct Exposure to Use of SEDATIVES (BARBITURATES)a
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
aIn 2001 Xanax was added to the list of examples. This change likely explains the discontinuity in the 2001 results. 
% Saying Any Exposure
FIGURE 7-21
Trends in Direct Exposure to Use of TRANQUILIZERSa
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.  
aIn 2001 Xanax was added to the list of examples. This change likely explains the discontinuity in the 2001 results.  
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
% Saying Often Exposed
FIGURE 7-22
Trends in Direct Exposure to Use of TRANQUILIZERSa
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Source.  The Monitoring the Future study, the University of Michigan.
% Saying Any Exposure
FIGURE 7-23
Trends in Direct Exposure to Use of ALCOHOL
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
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Source.  The Monitoring the Future study, the University of Michigan.
among Respondents in Modal Age Groups of 18, 19–22, 23–26, and 27–30
% Saying Often Exposed
FIGURE 7-24
Trends in Direct Exposure to Use of ALCOHOL
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Chapter 8 
 
PREVALENCE OF DRUG USE AMONG COLLEGE STUDENTS AND 
THEIR NONCOLLEGE PEERS 
 
College students have often been the harbingers of social and political changes that eventually 
spread to other segments of the population up and down the age spectrum. The Monitoring the 
Future (MTF) study tracks multiple forms of substance use among U.S. college students and has 
done so for nearly four decades. In this process, MTF has documented the fluctuations in college 
substance use as well as some patterns of influence on or by other age groups. This chapter focuses 
on the prevalence of drug use in 2018 by college students and their age-peers who graduated from 
high school and are not in college; the next chapter (Chapter 9) focuses on historical trends in drug 
use in these two groups. 
 
Definition of College Students 
College students are defined in this volume as those follow-up respondents one to four years past 
high school who report that they were taking courses as full-time students in a two- or four-year 
undergraduate college at the beginning of March of the year in question. Note that full-time 
students at two-year colleges, such as community colleges, are included.  
The definition excludes those who are currently enrolled in college part-time and those who 
previously may have been college students or may have graduated from college by March one to 
four years after high school. MTF has been able to generate an unparalleled national sample of 
college students and peers not in college every year since 1980 by following representative 
samples of sequential high school classes after they graduate. The graduating class of 1976 was 
the first such class followed after high school graduation, and by 1980 the survey included college 
students one to four years past high school.  
The absence of dropouts in the original high school senior samples should have practically no 
effect on the representativeness of these college samples, because very few high school dropouts 
go on to college. One notable limitation of the present design for the purpose of characterizing 
college students is that it limits the age range of the college sample. For trend estimation purposes 
(covered primarily in Chapter 9), we decided to limit the age band to the most typical one for 
college attendance, that is, one to four years past high school, which corresponds to modal ages 19 
through 22. According to statistics available from the United States Census Bureau,1 this age band 
should encompass about 75% of all undergraduate college students enrolled full-time in 2014, 
down slightly from the 79% covered in 1989. Although expanding the age band to include an 
additional two years would cover 79% of all enrolled college students of any age, it would slightly 
reduce the homogeneity of the college experience by including older classmates, it would bring 
more four-year college graduates into the noncollege group, and it would limit historical 
comparability. Special analyses conducted in 2017, which updated similar analyses done in 2011, 
1997, and 1985, indicated extremely small differences in the estimates of drug use prevalence 
under the two definitions (four- vs six-year intervals) for college students. In all the years we 
evaluated this, the annual prevalence of all drugs shifted 0.5 percentage points or less, with few 
                                                 
1 U.S. Census Bureau, October 2014. Available at: http://www.census.gov/  
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exceptions; specifically, based on the 2017 analyses, the difference was 0.6 percentage points for 
hallucinogens other than LSD, and 0.7 percentage points for MDMA (ecstasy, Molly). Thus, for 
purposes of estimating prevalence, the four- and six-year intervals are nearly interchangeable, 
suggesting that this limitation is negligible for our purposes of estimating current prevalence and 
historical trends (in Chapter 9). 
The MTF panels also include high school graduates one to four years past high school who were 
not attending college full time during March in the year in question. Having data for both groups 
is a rare and valuable feature of the MTF follow-up design and makes it possible to compare 
differences and changes in the use of various substances after high school for each group. Full-
time college students as defined here now constitute almost two-thirds (63%) of the entire follow-
up sample one to four years past high school, which contributes to relatively smaller sample sizes 
for noncollege youth (and thus less precision in our estimates). If data from the missing high school 
dropout segment—which has declined from around 15% to roughly 6% of a class cohort as 
summarized in Chapter 1—were available for inclusion as part of the noncollege segment, any 
difference between the two groups in terms of their substance use would likely be enlarged; 
therefore, any difference observed here is only an indication of the direction and relative size of 
difference between the college and the entire noncollege population, not an absolute estimate of 
the difference. 
PREVALENCE OF DRUG USE AMONG COLLEGE STUDENTS VERSUS THEIR 
NONCOLLEGE PEERS  
As has been true in recent years, the prevalence of use for many illicit drugs among college students 
was similar to that of noncollege youth in 2018, but there were important exceptions we note 
below. Also, in 2018 college students tended to be higher on alcohol use and vaping but lower on 
cigarette use compared to noncollege youth. When there were differences between college and 
noncollege youth, the degree of differences varied considerably by type of drug and measure of 
prevalence (lifetime, annual, 30-day, and daily), as Tables 8-1 through 8-4 show. Important gender 
differences in the college vs. noncollege comparisons are shown in the tables and summarized in 
a subsection below. 
 In 2018, annual prevalence of use of any illicit drug was similar for college students (45%)
and for noncollege respondents (44%) (Table 8-2). The annual prevalence of using any
illicit drug other than marijuana2 was 18% among both college students and noncollege
respondents. Thirty-day prevalence was also similar among college and noncollege youth
for use of any illicit drug (27% vs. 28%, respectively) and use of any illicit other than
marijuana (7.7% vs. 7.9%, respectively) (Table 8-3).
 The annual prevalence of marijuana use was similar among college students and
noncollege respondents in 2018 (42% vs. 41%, respectively) (Table 8-2); the same was
true regarding 30-day marijuana prevalence (25% versus 27%, respectively) (Table 8-3).
2 For the non-college youth estimate for annual use of Any illicit Drug other than Marijuana in 2018, there was a significant difference (p<.05) 
between the typical mail condition (22.4%) and new web-push condition (14.1%) of survey administration. 
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 The prevalence of current daily marijuana use (using on 20 or more occasions in the past
30 days), however, was almost two times higher for the noncollege group (10.9%)
compared to the college students (5.9%) (Table 8-4).
 With regard to vaping marijuana (based on new questions added to two of the six young
adult survey forms beginning in 2017), prevalence in 2018 was higher among college
students than noncollege youth. For the two groups respectively, annual prevalence was
20%3 and 11% (Table 8-2); 30-day prevalence was 10.8%4 and 7.9%, respectively (Table
8-3).
 In 2018, 3.1% of the noncollege group and 2.7% of the college group reported annual use
of narcotics other than heroin without medical supervision (Table 8-2). With respect to
annual use of specific drugs in this class, Vicodin was used by 1.6% of the noncollege
group vs. 1.4% of college students; the corresponding numbers for OxyContin were 1.3%
and 1.6%. Thus, for this important class of illicit drugs, annual prevalence was relatively
low in 2018 and similar between college students and noncollege youth.
 Several of the less commonly used drugs showed annual use rates for noncollege
respondents in 2018 that were two or more times the college student rates, including
heroin, methamphetamine, crystal methamphetamine, bath salts (synthetic stimulants),
and sedatives (barbiturates).
 The use of hallucinogens was somewhat higher among noncollege youth in 2018. Among
noncollege youth and college students, respectively, annual use of hallucinogens was 6.8%
and 5.2%, annual use of LSD was 6.0% and 5.2%, and annual use of hallucinogens other
than LSD was 4.3% and 2.5% (Table 8-2). However, annual use of MDMA (ecstasy,
Molly) was higher among college students (4.4%) than noncollege youth (2.8%).
 Amphetamine use without a doctor’s prescription was higher among college students than
among their noncollege age-mates. Annual prevalence of amphetamine use among college
students was 8.5% in 2018, compared to 4.8% in the noncollege group (Table 8-2).
Specifically, annual prevalence of Adderall use without medical supervision was higher
for college students (11.1%) than for noncollege respondents (8.1%) in 2018, as has been
the case for the last several years. The higher use by college students is very likely because
this amphetamine drug, intended for the treatment of attention deficit hyperactivity
disorder (ADHD), is sometimes used by students to stay awake and alert in order to
complete course work and to study for exams. The nonmedical use of Ritalin, another but
now less common stimulant drug prescribed for ADHD, was similarly low in the college
and noncollege groups in 2018 (annual prevalence of 1.3% for both groups).
 In 2018, annual cocaine use somewhat higher among college students (5.3%) than
noncollege youth (4.2%) (Table 4-2).
3 For the college student estimate for annual Vaping Marijuana in 2018, there was a significant difference (p<.05) between the typical mail 
condition (15.2%) and new web-push condition (25.1%) of survey administration. 
4 For the college student estimate for 30-day Vaping Marijuana in 2018, there was a significant difference (p<.05) between the typical mail 
condition (7.3%) and new web-push condition (14.5%) of survey administration. 
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  In addition, for most all measures of annual and current alcohol use, 2018 prevalence was 
higher for the college group than the noncollege group. This was true for both annual 
prevalence (75% vs. 70%) (Table 8-2) and 30-day prevalence (60% vs. 50%) (Table 8-3). 
 College students also had a higher prevalence (29%) of binge drinking (five or more drinks 
in a row at least once in the past two weeks) than their noncollege peers (25%) in 2018 
(Table 8-4). Similarly, more college students (38%) reported having been drunk in the 
prior 30 days, compared to noncollege respondents (24%) (Table 8-3). Both groups had 
relatively low daily drinking prevalence, with it being similar in 2018 among college 
students (2.4%) and noncollege youth (2.6%) (Table 8-4). Back in high school, college-
bound students, especially in earlier grades, were far less likely to drink alcohol at any 
level compared to their noncollege-bound peers (see Volume I); thus, both relative and 
absolute increases in most indices of alcohol use among college students in the first few 
years following high school are quite striking and point to full-time college attendance as 
a risk factor for binge drinking.  
 Beginning in 2005, we have given explicit attention to the problem of extreme binge 
drinking (also referred to as high intensity drinking), introducing a set of questions on the 
subject into one of the six questionnaire forms used with young adults, including college 
students (they are included on a second form, but those data are not included in this volume 
due to inconsistent variations in responses between the two forms). The questions asked 
respondents about the frequency in the past two weeks of having 10 or more drinks in a 
row and of having 15 or more drinks in a row. The low numbers of cases that resulted from 
a single questionnaire form necessitate combining multiple years of data (2012–2018), 
making 1,162 weighted cases available from the college student segment and 662 for the 
noncollege segment of the same age. Across the 7 years from 2012 to 2018, about one in 
ten college students (9.5%) reported having 10 or more drinks in a row at least once in the 
prior two weeks, and 3.1% reported 15 or more drinks in a row at least once in the prior 
two weeks.5 The noncollege respondents had similar respective rates (10.2% and 5.2%). 
Clearly, this type of extreme binge drinking is worrisome among both college students and 
noncollege youth.6,7 Trends since 2005 are considered in Chapter 9 (Tables 9-4, 9-5, and 
9-6), where we document a general downward trend, especially for college students. As 
will be discussed below, there are dramatic gender differences in the prevalence of these 
behaviors. 
 In 2018, 58% of both college students and noncollege youth reported using flavored 
alcoholic beverages8 in the prior year (Table 8-2). 
                                                 
5 See Patrick & Terry-McElrath (2017) for differences in 5+, 10+, and 15+ drinking by non-attenders, part-time college attenders, 2-year college 
attenders, and 4-year college attenders. Patrick, M. E., & Terry-McElrath, Y. M. (2017). High-intensity drinking by underage young adults in the 
United States. Addiction, 112, 82-93. 
6 Patrick, M. E., Terry-McElrath, Y. M., Kloska, D. D., & Schulenberg, J. E. (2016). High-intensity drinking among young adults in the United 
States: Prevalence, frequency, and developmental change. Alcoholism: Clinical and Experimental Research, 40, 1905-1912.  
7 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O’Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence of 
binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41, 
1319-1328. 
8 For the non-college youth estimate for annual use of Flavored Alcoholic Beverages in 2018, there was a significant difference (p<.05) between 
the typical mail condition (48.1%) and new web-push condition (71.3%) of survey administration. 
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 In 2018, prevalence of alcoholic beverages mixed with energy drinks was slightly higher
for the college than the noncollege group (27% versus 24% respectively) (Table 8-2).
 Among all substances studied, the largest differences for annual, 30-day, and daily
prevalence levels between college and noncollege groups occur for cigarette smoking. For
example, the prevalence of daily smoking for college students was 1.9% versus 10.1% for
noncollege respondents in 2018 (Table 8-4). Smoking at the rate of a half pack or more per
day stood at 0.5% versus 4.6% for these two groups, respectively. The 12th grade data show
the college-bound to have much lower smoking rates in high school than the noncollege-
bound; thus, in contrast to what was true for alcohol use, these substantial differences
observed at college age actually largely preceded college attendance.9 The smoking
differences would be even greater if dropouts were included in the noncollege group,
because dropouts have consistently shown an exceptionally high rate of smoking.10
 In 2017, we expanded the vaping questions on two of the six young adult survey forms to
get at specific substances being vaped including nicotine, marijuana, and just flavoring. In
2018, annual prevalence of vaping nicotine was higher for college youth (26%)11 than
noncollege youth (21%) (Table 8-2); this was also true regarding 30-day prevalence (16%
versus 13%, respectively) (Table 8-3). Prevalence of vaping just flavoring, however, was
lower for college students than noncollege youth; for the two groups, respectively, annual
prevalence was 14% and 18% (Table 8-2) and 30-day prevalence was 4.6% and 8.5%
(Table 8-3).
In sum, as has been true in recent years, prevalence of illicit drug use tended to be similar among 
19-22 year old college students and noncollege youth in 2018. This was true for annual prevalence
of marijuana (42% and 41%, respectively) and of any illicit drug other than marijuana (18% for
both); it was also true for 30-day prevalence of marijuana (25% and 27%, respectively) and of any
illicit drug other than marijuana (27% and 28%, respectively). However, noncollege youth had
much higher prevalence of near-daily marijuana use than college students (10.9% vs. 5.9%,
respectively). Annual prevalence of hallucinogens, including LSD, was somewhat higher among
noncollege youth in 2018, whereas MDMA (ecstasy, Molly) was somewhat higher among college
students than noncollege youth, which was also true for cocaine in 2018. As has been true for
many years, the only substances that college students were appreciably more likely to use than
their noncollege peers were amphetamines (including Adderall in particular) and alcohol
(particularly getting drunk and binge drinking). The higher rates of alcohol use among college
students emerged only after high school; during high school alcohol use was lower among those
who would later go on to college. As has been true all along, cigarette use is much more common
among noncollege youth than college students. Finally, based on new vaping questions added to
two of the six young adult survey forms, 30-day and annual prevalence of vaping marijuana and
vaping nicotine were higher among college students than noncollege youth (as we consider in
9 See also Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in 
young adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
10 For an analysis showing much higher smoking rates among 8th graders who later dropped out before completing high school, see Bachman, J. G., 
O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use connection: How 
successes and failures in school relate to adolescent smoking, drug use, and delinquency. New York: Lawrence Erlbaum Associates/Taylor & 
Francis. 
11 For the college student estimate for annual Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail 
condition (19.0%) and new web-push condition (32.0%) of survey administration. 
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 Chapter 9 when examining historical trends, this pattern was reversed in 2017, with prevalence 
being higher among noncollege youth than college students). Also in Chapter 9, we consider 
historical shifts in college vs. noncollege differences in prevalence of substance use. 
 
As discussed above and in Chapter 3, in 2018 we began our transition to web-based surveys among 
young adults, with half being randomly assigned to our typical mail-based condition and half to 
the new web-push condition in order to gauge any impact of survey condition on the prevalence 
estimates. As indicated above and in footnotes to Tables 8-1 through 8-4, there were very few 
significant differences in prevalence estimates between the two conditions, and thus we combined 
estimates across the two conditions into an average (weighted for sample size per condition) for 
college students and for noncollege youth. About 4% of the comparisons reported in this chapter 
for college students and for noncollege youth across all drugs and intensities of use yielded 
significant differences (and all were at p<.05 level, indicating that on average, about 5% would be 
significant by chance). Except for the vaping questions, there was little consistency in the 
significant differences across substances and drug use intensities. To summarize, significant 
differences (p<.05) were found for the following in 2018: lifetime prevalence of narcotics other 
than heroin for noncollege youth (11% for typical mail condition, 6% for web-push condition) and 
of flavored alcoholic beverages for noncollege youth (63% for mail and 85% for web-push); 
annual prevalence of any illicit drug other than marijuana among noncollege youth (22% for mail 
and 14 % for web-push) and of flavored alcoholic beverages among noncollege youth (48% for 
mail, 71% for web-push). For the vaping items, significant differences were found for five of the 
24 comparisons including for prevalence of lifetime marijuana vaping among noncollege youth 
(26% for mail and 13% for web-push), of annual any vaping among college students (27% for mail 
and 38% for web-push), of annual nicotine vaping among college students (19% for mail and 32% 
for web-push), of annual marijuana vaping among college students (15% and 25%), and of 30-day 
marijuana vaping among college students (7% for mail and 15% for web-push). We note that the 
vaping items are included on only two of the six young adult survey forms, meaning relatively 
small sample sizes for these comparisons (which argue against more finer-grained condition 
comparisons by sociodemographic characteristics). In general, the 2018 findings regarding typical 
mail-condition vs. new web-push condition of survey administration indicate that there are very 
few systematic differences between the two in terms of prevalence of numerous substances for 
college students and noncollege youth, providing a strong rationale for combining estimates across 
the two survey administration conditions. We are repeating this condition comparison in 2019 for 
young adults (which is an independent sample from 2018 given the biennial assessments for young 
adults), and will consider the extent to which significant differences between conditions hold in 
2019. For additional information, see our published articles for earlier experiments on mail and 
web conditions among young adults.12 
 
GENDER DIFFERENCES IN PREVALENCE OF USE AMONG COLLEGE STUDENTS 
AND THEIR NONCOLLEGE PEERS 
Data stratified by gender (and college student status) are provided in Tables 8-1 to 8-4. 
 
                                                 
12 Patrick, M. E., Couper, M. P., Laetz, V. B., Schulenberg, J. E., O'Malley, P. M., Johnston, L. D., & Miech, R. A. (2018). A sequential mixed 
mode experiment in the U.S. National Monitoring the Future study. Journal of Survey Statistics and Methodology, 6(1), 72-97. doi: 
10.1093/jssam/smx011. Patrick, M. E., Couper, M. P., Jang, B., Laetz, V. B., Schulenberg, J., Johnston, L. D., Bachman, J., O’Malley, P. M. 
(2019). Two-year follow-up of the sequential mixed-mode experiment in the U.S. National monitoring the future study. Survey Practice, 12(1). 
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 Most gender differences, especially among college students, replicated those discussed in
Chapter 4 for all young adults one to 12 years past high school, which in turn replicated
gender differences among secondary school students. Thus among college students men
tended to have similar or higher annual, 30-day, and daily prevalence than women;
however among noncollege youth, gender differences in prevalence are more mixed as
summarized below.
 Among college students in 2018, annual prevalence of use of any illicit drug was similar
for men and women (45% for each) (Table 8-2); and the same was true for 30-day use
(26% and 27%, respectively) (Table 8-3). For noncollege youth, annual prevalence was
higher for women than for men (46% and 41%, respectively); and the same was true for
30-day use (31% and 24%, respectively).
 Among college students in 2018, annual prevalence of any illicit drug other than
marijuana was higher for men (21%) than women (16%) (Table 8-2); and the same was
true for 30-day use (9.2% and 6.7%, respectively) (Table 8-3). Among noncollege youth,
annual prevalence was somewhat higher for women (19%) than men (17%); and the same
was true for 30-day use (9.3% and 6.1%, respectively).
 Annual marijuana use was similar among college men (43%) and women (42%) in 2018
(Table 8-2); and the same was true for 30-day marijuana use (24% and 25%, respectively)
(Table 8-3). Among noncollege youth, annual use was higher for women (44%) than men
(39%); and the same was true for 30-day use (30% and 23%, respectively)). In contrast,
daily marijuana use was about twice as high among college men (8.4%) compared to
college women (4.3%) and also higher for noncollege men (12.4%) than women (9.7%),
although the prevalence of daily use for both genders was much higher for the noncollege
than college group (Table 8-4).
 With regard to vaping marijuana, based on new questions added to two of the young adult
survey forms in 2017, annual prevalence in 2018 was somewhat higher among college men
than women (23% vs. 18%), as well as among noncollege men than women (13% vs. 10%)
(Table 8-2). Among college students, 30-day prevalence of vaping marijuana in 2018 was
higher among men than women (13.1% vs. 9.3%); however, among noncollege youth, men
and women were similar (8.1%% vs. 7.8%) (Table 8-3). Thus, in 2018, vaping marijuana
was highest among college men.
 Among college students, annual prevalence of any hallucinogens in 2018 was more than
twice as high for men than for women (8.2% vs. 3.4%), and the same was true for LSD
specifically (6.8% vs. 2.6%); corresponding prevalence for hallucinogens other than LSD
was 4.3% and 1.3%, and for MDMA (ecstasy and Molly) it was 7.2% and 2.7% (Table 8-
2). Among noncollege respondents, the gender gap was narrower; annual prevalence was
similar or slightly higher for men than for women for use of any hallucinogens (7.2% vs.
6.5%), for use of LSD specifically (6.3% vs. 5.8%), and for use of hallucinogens other than
LSD (5.3% vs. 3.6%); however, annual prevalence was lower for men than for women for
MDMA (ecstasy and Molly) (1.7% vs. 3.6%) (Table 8-2).
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  Among college students, annual prevalence of narcotics other than heroin without 
medical supervision was slightly higher for men (3.3%) than for women (2.3%) in 2018, 
whereas in the noncollege group annual prevalence was similar for men (3.2%) and women 
(3.1%) (Table 8-2). For the specific narcotic Vicodin, annual prevalence was low; it was 
slightly higher for college men (2.3%) than women (0.8%) and slightly higher for 
noncollege women (2.0%) than men (1.1%). For OxyContin annual use, which was also 
low, college men and women were similar (1.9% vs. 1.4%); it was slightly higher for 
noncollege women (2.0%) than men (0.4%).   
 
 Annual cocaine use in 2018 was higher among college men (7.0%) than women (4.3%); it 
was similar among noncollege men (4.5%) and women (4.0%) (Table 8-2). 
 Annual amphetamine use in 2018 was higher among college men (9.5%) than women 
(7.8%); in contrast, it was higher among noncollege women (6.6%) than men (2.5%) (Table 
8-2).  
 Annual Ritalin use without medical supervision in 2018 was similar among college men 
(1.4%) and women (1.5%), and the same was true for noncollege men (1.1%) and women 
(1.4%) (Table 8-2). 
 The annual prevalence of Adderall use outside of medical supervision in 2018 was higher 
for college men (14.6%) than women (8.8%), whereas use was higher among noncollege 
women (10.1%) than men (5.3%) (Table 8-2). Again, the higher use of amphetamines 
among male and female college students compared with male and female noncollege 
respondents suggests that some college students of both genders could be using these drugs 
to try to enhance their academic performance.  
 Among college students in 2018, 30-day alcohol use was slightly higher for women (61%) 
than men (58%); for noncollege youth, prevalence was similar for women (51%) and men 
(50%). Binge drinking (5+ drinks in a row at least once in the past two weeks) was higher 
for college men (32%) than women (27%); for noncollege youth it was similar for men and 
women (25% for each) (Table 8-4). Among college students, women were more likely than 
men to report being drunk in the past 30 days (40% vs. 36%) in 2018, and the same was 
true for noncollege women and men (26% vs. 23%) (Table 8-3).  
 Extreme binge drinking (also known as high intensity drinking; 10+ or 15+ drinks in a 
row in the past two weeks) showed a large gender difference in both groups. For the years 
2012–2018 combined (as discussed above), the prevalence of having 10 or more drinks in 
a row in the prior two weeks was over two times higher among college men (15.1%) than 
among college women (6.1%), and similarly higher among noncollege men (16.1%) than 
noncollege women (5.4%). Prevalence of 10+ drinks in a row were similar for college and 
noncollege men, and similar for college and noncollege women. Regarding the prevalence 
of having 15 or more drinks in a row, gender differences were similar across college and 
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 noncollege respondents: it was 6.0% and 8.7% for college and noncollege men, 
respectively, and 1.4% and 2.3% for college and noncollege women, respectively.13 
 Flavored alcoholic beverages were more likely to be consumed by college women than 
college men (60% vs. 55% reporting past-year use), and there was a considerably larger 
difference for the noncollege group (75% of women vs. 32% of men) in 2018 (Table 8-2).  
 Annual prevalence of alcoholic beverages mixed with energy drinks in 2018 was similar 
among college men and women (27% for both); among noncollege youth, it was higher 
among men (28%) than women (20%) (Table 8-2).  
 Among college students, 30-day prevalence of cigarette smoking was higher for men 
(10%) than for women (5%) in 2018, and that was true to a much lesser extent for the 
noncollege segment (18% and 16%, respectively) (Table 8-3); rates for both genders were 
much higher in the noncollege group. Daily smoking was slightly higher for men than 
women in the college segment (2.4% and 1.6%, respectively); the rates again were much 
higher in the noncollege segment (10% for both men and women) (Table 8-4). Put another 
way, daily smoking was four times as high among noncollege men than college men (10% 
vs. 2.4%), and six times as high among noncollege women than college women (10% vs. 
1.6%). Rates of smoking a half pack or more per day among college students were 0.8% 
for men and 0.3% for women, compared with 4.1% and 5.0% for the noncollege segment, 
respectively. 
 Prevalence of most other types of tobacco use was typically higher among men than women 
in both the college and noncollege groups in 2018, as shown in Tables 8-2 and 8-3.  
 With regard to vaping nicotine, annual prevalence was considerably higher among college 
men (34%) than women (21%); among noncollege youth, it was slightly higher among men 
than women (22% versus 19%) (Table 8-2). Thirty-day prevalence was much higher for 
college men than women (22% versus 12%); among noncollege youth it was similar for 
men and women (12% versus 13%) (Table 8-3). Thus, based on 2018 data, college men 
were at particularly high risk for this rapidly increasing health risk behavior. 
In sum, many licit and illicit drugs were used by a higher proportion of college men than college 
women in 2018, with the largest proportional differences occurring for daily marijuana use, 
extreme binge drinking, 30-day vaping of nicotine, and annual hallucinogen use. However, for 
prevalence of annual and 30-day marijuana use in 2018, college men and women were similar. 
Gender differences for the noncollege segment were more mixed, with noncollege women having 
higher annual and 30-day prevalence of using marijuana and any illicit drug other than 
marijuana, as well as higher annual prevalence of amphetamine and MDMA (ecstasy, Molly) 
use; but noncollege men had higher prevalence of daily marijuana use, extreme binge drinking, 
annual marijuana vaping, and annual hallucinogen use. We consider recent historical shifts in 
gender differences in substance use in Chapter 9. Compared with noncollege men, college men 
were more frequent users of alcohol and amphetamines (particularly Adderall outside of medical 
                                                 
13 For additional information on 10+ drinking by gender and college attendance, see Patrick, M. E., Terry-McElrath, Y. M., Kloska, D. D., & 
Schulenberg, J. E. (2016). High-intensity drinking among young adults in the United States: Prevalence, frequency, and developmental change. 
Alcoholism: Clinical and Experimental Research, 40, 1905-1912.  
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 supervision) and more likely to vape marijuana and nicotine, but considerably less likely to use 
marijuana daily; this same pattern generally held for noncollege versus college women. The most 
striking difference between the college and noncollege segments remains for cigarette smoking, 
with noncollege men and women showing much higher use than college men and women. 
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Any Illicit Drug a 55.1 59.0 57.7 56.5 53.5 61.0
Any Illicit Drug other than Marijuana a 27.3 30.3 32.5 30.0 24.0 30.5
Marijuana 52.0 55.2 55.5 51.5 49.8 58.3
Inhalants b 3.1 6.8 3.6 6.4 2.7 7.1
Hallucinogens c 8.6 13.7 13.2 14.7 5.9 12.8
     LSD c 7.0 11.8 11.4 12.9 4.4 10.9
     Hallucinogens other than LSD c   5.1 8.9 8.3 11.3 3.1 7.1
     MDMA (ecstasy, molly) d 7.8 8.2 10.7 6.9 5.9 9.3
Cocaine 7.6 7.1 9.1 6.6 6.7 7.6
     Crack c 0.6 1.1 0.4 0.3 0.7 1.7
     Other Cocaine d 6.8 7.8 7.0 6.9 6.7 8.4
Heroin 0.1 1.2 0.1 1.5 0.1 0.9
     With a Needle e 0.2 0.6 * * 0.3 1.1
     Without a Needle e 0.2 0.6 0.4 1.3 * *
Narcotics other than Heroin f,k 6.6 8.0 8.4 8.2 5.4 7.8
Amphetamines, Adjusted f,g 13.3 12.3 16.7 11.0 11.3 13.3
     Methamphetamine e 1.0 1.4 1.5 0.6 0.6 2.2
     Crystal Methamphetamine (Ice) e 0.8 0.5 1.3 0.5 0.6 0.6
Sedatives (Barbiturates) f 3.3 6.0 5.4 5.6 2.0 6.3
Tranquilizers f 7.3 9.5 7.7 7.1 7.0 11.5
Alcohol 77.5 72.9 75.5 65.8 78.7 78.6
     Been Drunk b 66.9 60.2 65.9 53.1 67.5 66.2
     Flavored Alcoholic Beverages h,l 70.8 72.9 71.7 55.3 70.4 83.7
Cigarettes — — — — — —
Any Vaping e 39.5 42.2 46.5 40.1 35.0 44.0
     Vaping Marijuana e,m 23.6 18.0 27.1 23.3 21.4 13.8
     Vaping Nicotine e 32.9 28.0 38.3 29.2 29.4 27.0
     Vaping Just Flavoring e 26.6 33.3 30.7 29.0 24.0 36.8
Steroids e 0.3 0.6 0.8 1.2 * *
Approximate Weighted N = 880 520 340 230 540 280
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
' — ' indicates data not available. 
See footnotes following Table 8-4.
TABLE 8-1
Lifetime Prevalence of Use for Various Types of Drugs, 2018:
Full-Time College Students vs. Others
by Gender
College Others
Full-Time
College
(Entries are percentages.)
among Respondents 1 to 4 Years beyond High School
Full-Time
College
Total
Others
Men Women
Others
Full-Time
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Any Illicit Drug a 44.9 44.1 44.8 41.2 45.0 46.4
Any Illicit Drug other than Marijuana a,n 18.2 17.8 21.1 17.0 16.4 18.5
Marijuana 42.3 41.4 42.5 38.6 42.2 43.8
Synthetic Marijuana b 1.6 2.3 1.8 3.5 1.5 1.4
Inhalants b 1.3 1.1 2.5 1.3 0.5 0.9
Hallucinogens c 5.2 6.8 8.2 7.2 3.4 6.5
     LSD c 4.2 6.0 6.8 6.3 2.6 5.8
     Hallucinogens other than LSD c 2.5 4.3 4.3 5.3 1.3 3.6
     MDMA (ecstasy, molly) d 4.4 2.8 7.2 1.7 2.7 3.6
     Salvia b 0.9 0.3 0.4 0.6 1.3 *
Cocaine 5.3 4.2 7.0 4.5 4.3 4.0
     Crack c 0.4 * * * 0.6 *
     Other Cocaine d 4.7 5.2 4.6 4.7 4.7 5.5
Heroin * 0.5 * 0.8 * 0.2
     With a Needle e * * * * * *
     Without a Needle e * * * * * *
Narcotics other than Heroin f 2.7 3.1 3.3 3.2 2.3 3.1
     OxyContin b,f 1.6 1.3 1.9 0.4 1.4 2.0
     Vicodin b,f 1.4 1.6 2.3 1.1 0.8 2.0
Amphetamines, Adjusted f,g 8.5 4.8 9.5 2.5 7.8 6.6
     Ritalin b,f 1.3 1.3 1.8 1.1 1.0 1.4
     Adderall b,f 11.1 8.1 14.6 5.3 8.8 10.1
     Methamphetamine e 0.4 1.2 * 0.6 0.6 1.7
     Crystal Methamphetamine (Ice) e * 0.5 * 0.5 * 0.6
     Bath Salts (synthetic stimulants) b * 0.3 * 0.7 * *
Sedatives (Barbiturates) f 1.5 3.1 2.7 2.8 0.7 3.4
Tranquilizers f 3.5 3.7 3.8 2.2 3.3 4.8
GHB e * * * * * *
Ketamine e 0.9 0.8 * * 1.6 1.5
Alcohol 74.6 70.1 73.7 64.6 75.1 74.7
     Been Drunk b 59.8 50.1 58.6 46.2 60.6 53.3
     Flavored Alcoholic Beverages h,o 58.1 58.4 54.5 32.3 60.1 74.9
     Alcoholic Beverages containing Caffeine e,j 27.0 23.7 27.3 27.8 26.7 20.0
TABLE 8-2
Annual Prevalence of Use for Various Types of Drugs, 2018:
Full-Time College Students vs. Others
by Gender
OthersOthers
Full-Time
College Others
(Entries are percentages.)
Total Men Women
Full-Time
among Respondents 1 to 4 Years beyond High School
College
Full-Time
College
(Table continued on next page.)
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Cigarettes 15.3 27.0 20.3 27.8 12.2 26.4
     Tobacco using a Hookah b 11.2 16.2 16.5 13.1 7.9 18.5
     Small Cigars e 15.4 13.5 23.1 22.5 10.1 6.1
     Dissolvable Tobacco e * * * * * *
     Snus e * 2.0 * 4.4 * *
Any Vaping e,p 32.2 31.6 39.5 29.8 27.5 33.1
     Vaping Marijuana e,r 19.8 11.2 23.0 13.2 17.8 9.6
     Vaping Nicotine e,q 25.9 20.6 33.7 22.1 21.0 19.4
     Vaping Just Flavoring e 13.6 18.1 13.0 16.0 14.0 19.7
Steroids e * 0.6 * 1.2 * *
Approximate Weighted N = 880 520 340 230 540 280
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 8-4.
Men Women
TABLE 8-2 (cont.)
Annual Prevalence of Use for Various Types of Drugs, 2018:
Others
Full-Time Full-Time Full-Time
College Others College Others College
Full-Time College Students vs. Others
among Respondents 1 to 4 Years beyond High School
by Gender
(Entries are percentages.)
Total
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Any Illicit Drug a 26.7 27.7 26.2 24.0 27.1 30.5
Any Illicit Drug other than Marijuana a 7.7 7.9 9.2 6.1 6.7 9.3
Marijuana 25.0 26.8 24.4 23.4 25.4 29.6
Inhalantsb 0.2 0.8 0.2 1.0 0.1 0.6
Hallucinogens c 1.1 2.1 1.8 2.0 0.7 2.2
     LSD c 1.0 1.3 1.5 0.7 0.7 1.8
     Hallucinogens other than LSD c 0.4 1.2 1.2 1.3 * 1.0
     MDMA (ecstasy, molly) d 1.3 0.9 2.7 * 0.4 1.6
Cocaine 2.3 1.4 3.6 1.0 1.5 1.7
     Crack c 0.2 * * * 0.3 *
     Other Cocaine d 1.9 1.5 2.6 1.5 1.5 1.5
Heroin * 0.1 * 0.2 * *
Narcotics other than Heroin f 1.0 0.5 0.5 0.2 1.3 0.8
Amphetamines, Adjusted f,g 2.9 1.8 3.9 0.9 2.3 2.5
     Crystal Methamphetamine (Ice) e * * * * * *
Sedatives (Barbiturates) f 0.5 1.3 0.4 0.6 0.5 1.8
Tranquilizers f 1.1 1.2 1.2 1.0 1.0 1.3
Alcohol 59.9 50.2 57.9 49.8 61.2 50.5
     Been Drunk b 38.4 24.3 35.5 22.7 40.2 25.6
     Flavored Alcoholic Beverages h 31.1 30.1 29.7 14.7 31.9 39.9
Cigarettes 6.8 16.8 9.6 17.9 5.0 16.0
Any Vaping e 21.2 20.8 27.7 18.5 17.1 22.7
     Vaping Marijuana e,s 10.8 7.9 13.1 8.1 9.3 7.8
     Vaping Nicotine e 15.7 12.5 22.3 12.4 11.5 12.6
     Vaping Just Flavoring e 4.6 8.5 6.1 8.2 3.6 8.7
Large Cigars h 3.8 1.9 9.9 4.6 * *
Flavored Little Cigars h 5.6 6.7 10.9 2.9 2.6 9.2
Regular Little Cigars h 1.4 6.6 3.8 9.4 * 4.6
Steroids e * 0.6 * 1.2 * *
Approximate Weighted N = 880 520 340 230 540 280
Source. The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 8-4.
Total Men Women
Full-Time Full-Time Full-Time
TABLE 8-3
Thirty-Day Prevalence of Use for Various Types of Drugs, 2018:
Full-Time College Students vs. Others
among Respondents 1 to 4 Years beyond High School
(Entries are percentages.)
by Gender
CollegeOthers Others OthersCollege College
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`Marijuana 5.9 10.9 8.4 12.4 4.3 9.7
Cocaine * * * * * *
Amphetamines, Adjusted f,g * * * * 0.1 *
Alcohol
     Daily 2.4 2.6 3.4 3.9 1.7 1.6
     5+ Drinks in a Row in Last 2 Weeks 28.8 25.0 31.8 25.0 26.8 25.0
Cigarettes
     Daily 1.9 10.1 2.4 9.7 1.6 10.3
     1/2 Pack+/Day 0.5 4.6 0.8 4.1 0.3 5.0
Approximate Weighted N = 880 520 340 230 540 280
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes on the following page.
College Others College Others College Others
Total Men Women
Full-Time Full-Time Full-Time
(Entries are percentages.)
TABLE 8-4
Thirty-Day Prevalence of Daily i Use for Various Types of Drugs, 2018:
 Full-Time College Students vs. Others 
among Respondents 1 to 4 Years beyond High School
by Gender
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aUse of any illicit drug includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, 
amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor’s orders. 
bThis drug was asked about in three of the six questionnaire forms. Total N  in 2018 for college students 
is approximately 440. 
cThis drug was asked about in five of the six questionnaire forms. Total N  in 2018 for college students 
is approximately 730. 
dThis drug was asked about in four of the six questionnaire forms. Total N  in 2018 for college students 
is approximately 590. 
eThis drug was asked about in two of the six questionnaire forms. Total N  in 2018 for college students 
is approximately 290. 
fOnly drug use that was not under a doctor’s orders is included here. 
gBased on the data from the revised question, which attempts to exclude inappropriate reporting of  
nonprescription amphetamines. 
hThis drug was asked about in one of the six questionnaire forms. Total N  in 2018 for college students 
is approximately 150. 
iDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured
as actual daily use, and 5+ drinks, measured as having five or more drinks in a row in the last two weeks.
jIn 2012 the alcoholic beverage containing caffeine question text was changed to alcoholic beverage mixed with energy  
kFor the non-college youth estimate for lifetime use of Narcotics other than Heroin in 2018, there was a 
significant difference (p<.05) between the typical mail condition (10.8%) and new web-push condition (5.8%) of survey administration.
lFor the non-college youth estimate for lifetime use of Flavored Alcoholic Beverages in 2018, there was a 
significant difference (p<.05) between the typical mail condition (62.9%)  and new web-push condition (84.7%) of survey administration.
mFor the non-college youth estimate for lifetime Vaping Marijuana in 2018, there was a significant difference (p<.05) between 
the typical mail condition (26.1%) and new web-push condition (12.9%) of survey administration.
nFor the non-college youth estimate for annual use of Any illicit Drug other than Marijuana in 2018, there was
 a significant difference (p<.05) between the typical mail condition (22.4%) and new web-push condition (14.1%) of survey administration.
oFor the non-college youth estimate for annual use of Flavored Alcoholic Beverages in 2018, there was a significant 
difference (p<.05) between the typical mail condition (48.1%) and new web-push condition (71.3%) of survey administration.
pFor the college student estimate for annual Any Vaping in 2018, there was a significant difference (p<.05) between 
the typical mail condition (26.9%) and new web-push condition (37.8%) of survey administration.
qFor the college student estimate for annual Vaping Nicotine in 2018, there was a significant difference (p<.05) between 
the typical mail condition (19.0%) and new web-push condition (32.0%) of survey administration.
rFor the college student estimate for annual Vaping Marijuana in 2018, there was a significant difference (p<.05) between 
the typical mail condition (15.2%) and new web-push condition (25.1%) of survey administration.
sFor the college student estimate for 30-day Vaping Marijuana in 2018, there was a significant difference (p<.05) between 
the typical mail condition (7.3%) and new web-push condition (14.5%) of survey administration.
drink.  The data for 2011 and 2012 are not comparable due to this question change.
Footnotes for Tables 8-1 through 8-4
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Chapter 9 
 
TRENDS IN DRUG USE AMONG COLLEGE STUDENTS AND THEIR 
NONCOLLEGE PEERS 
 
In this chapter we consider current trends and longer-term trends of substance use among college 
students and their noncollege peers. In the 1970s through 1990s changes in drug use tended to 
move up or down the age spectrum, reflecting cohort effects. During the 1960–70s drug epidemic, 
illicit drug use increased dramatically among U.S. college students, then spread quickly to their 
noncollege peers and eventually down the age spectrum to high school and even middle school 
students. The diffusion process reversed during the epidemic relapse in the 1990s when drug use 
increased first among those in early adolescence and then radiated up the age spectrum as those 
cohorts grew older (reflecting a cohort effect). The cohort effect continued as use subsequently 
declined among adolescents and this decline moved up the age spectrum. In the early 2000s, 
college students and high school seniors showed simultaneous decreases and then increases in 
marijuana use as well as in the index of any illicit drug use (a secular trend, reflecting similar 
changes regardless of age/cohort). 
 
More recently some evidence of a cohort effect has emerged particularly regarding marijuana. 
Annual marijuana use rose among high school seniors, particularly from 2009 through 2012; it 
rose among college students and their noncollege peers starting in 2011, continuing into 2016. Use 
leveled among high school seniors from 2013 through 2015 and, in 2017, leveled among both 
college students and noncollege youth. High school senior use then saw nonsignificant increases 
in 2016 and 2017 (and a leveling in 2018); as discussed below, the 2018 data showed a significant 
increase for college students and a nonsignificant increase for noncollege youth (Figure 9-3a). 
 
Again, we define college students as follow-up respondents (i.e., high school graduates) one to 
four years past high school who report that they were taking courses as full-time students in a two- 
or four-year undergraduate college at the beginning of March in the year in question. For more 
information, see the “Definition of College Students” subsection in Chapter 8. 
 
Trend data are also provided here on the other high school graduates, those follow-up respondents 
who are one to four years past high school but do not meet our definition of full-time college 
students (Figures 9-1 through 9-16c). These young people may be working full- or part-time, not 
working at all, and/or attending a two- or four-year college part-time. This is an important group 
by itself, given less is known about their substance use, as well as an important comparison group 
for the college students. 
 
The proportion of young adult high school graduates one to four years beyond high school who 
attend college full-time has increased considerably since the MTF follow-ups began. In 2018, 
about 63% of the weighted number of follow-up respondents one to four years past high school 
met our definition of college students, compared with only 38% in the 1980 survey, the first survey 
to provide the full sampling of college students. This means, of course, that the proportion of our 
annual follow-up samples that is in the noncollege group of the same age has diminished 
considerably. 
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The difference between the college group and the noncollege group provides an estimate of the 
degree to which college students’ usage levels for various substances are above or below other 
high school graduates in this age band. If we were able to include the high school dropout segment 
in the calculations for the noncollege group, many of the differences with the college-enrolled 
would be accentuated.1   
 
For each year, approximately 900–1,500 weighted respondents constitute the college student 
sample (see Table 9-7 for numbers [Ns] per year) and roughly 500–1,700 respondents constitute 
the noncollege group one to four years beyond high school. Trend comparisons for these two 
groups are provided in this chapter. The reported results begin with 1980, the first year that enough 
follow-up surveys had accrued to characterize young high school graduates one to four years past 
high school. The 2018 survey is thus the 39th in the annual series on college students and 
noncollege-attending youth 1 to 4 years out of high school. Methods, sampling, and procedures 
are summarized in Chapter 3. As we discuss in that chapter, for 2018 data collections of 19-30 
year olds, we randomly assigned half to receive typical mail surveys and half to a web-push 
condition (in which they were encouraged to complete a web-based survey). As we show in 
Chapter 8 when discussing 2018 prevalence estimates for college and noncollege youth, very few 
prevalence estimates varied significantly between the two conditions for either college or 
noncollege respondents; thus the two conditions were combined in a weighted average in that 
chapter and exceptions (i.e., when estimates between the two conditions differ significantly) are 
noted. In this current chapter on trends, we combine the 2018 estimates from the two conditions 
and we note the very few significant differences between conditions in Tables 9-1 through 9-4. 
 
Throughout much of the chapter, trends for the 12th grade samples are included for comparison 
purposes. It is important to keep in mind that the total 12th grade samples are shown and that there 
are substantial differences in rates of substance use within those samples between the college-
bound and those who do not plan to complete a four-year college. As shown extensively in Volume 
I2 and in Occasional Paper 92,3 12th grade students expecting to complete college are far less likely 
to smoke cigarettes and also less likely to use most other substances. So when considering figures 
that show higher rates of use among all 12th graders (regardless of college expectations) than 
among college students, it should not be concluded that usage declined after college entrance; the 
college-bound were already lower in usage rates than other 12th graders for almost all substances. 
 
One additional point is relevant to interpreting differences over time for those attending college 
and those not attending college, both in terms of the differences between them and trends over 
time for either taken separately: the proportion of college students who are female has risen 
                                                 
1 Panel analyses of samples from the high school classes of 1995–1997, followed for an eight-year period beginning when they were in 8th grade, 
clearly show that those who dropped out of high school had distinctly higher rates of substance use both before and after they left school. See 
Bachman, J. G., O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Freedman-Doan, P., & Messersmith, E. E. (2008). The education–drug use 
connection: How successes and failures in school relate to adolescent smoking, drinking, drug use, and delinquency. New York: Lawrence Erlbaum 
Associates/Taylor & Francis. 
2 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, secondary school students. Ann Arbor, MI: Institute for Social Research, The University of 
Michigan. 
3 Johnston, L. D., Schulenberg, J. E., O'Malley, P. M., Miech, R. A., Bachman, J. G. , & Patrick, M. E. (2019). Demographic subgroup trends 
among adolescents in the use of various licit and illicit drugs, 1975-2018 (Monitoring the Future Occasional Paper No. 92). Ann Arbor, MI: Institute 
for Social Research, University of Michigan. 
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substantially since 1980. In 1980, females constituted about 50% of the college respondents, but 
by 2018 they constituted 64%4. As will be discussed below, we have charted the trends separately 
for male and female college students to permit an assessment of what effect these changing 
proportions may have on the overall rates observed for college students.  
 
TRENDS IN PREVALENCE, 1980–2018: COLLEGE STUDENTS VERSUS THOSE 
NOT ENROLLED IN COLLEGE AND 12TH GRADERS 
 Regarding recent trends among college students, the annual prevalence of using any illicit 
drug rose gradually from a recent low of 34% in 2006 to 45% in 2018, the highest it had 
been for over three decades, since 1986 (Table 9-2 and Figure 9-1). The 2.7 percentage 
point increase over 2017 was not statistically significant. The five-year trend (from 2013 
to 2018) showed a 4.7 percentage point increase, which was statistically significant. This 
short-term (since 2013) and the longer-term (since 2006) increase through 2018 was driven 
primarily by an increase in marijuana use, as summarized below.  
 
Back during the first decade of MTF college student data, between 1980 and 1991, college 
student annual use of any illicit drug dropped fairly steadily, from 56% to 29%, a decrease 
of nearly half. After 1991, annual prevalence held fairly steady for a couple of years before 
rising gradually, reaching 38% in 1998 and again in 2001 before leveling at between 34% 
and 37% through 2012; since 2013 it increased to 2018 prevalence of 45%, the highest 
level for the past three decades (but still well below the 1980 peak of 56%). Annual use of 
any illicit drug among noncollege respondents moved similarly until 2000, when their 
annual use exhibited a four-percentage-point increase due largely to their sharper increases 
in marijuana, amphetamine, and tranquilizer use. Their use then declined unevenly until 
2007, and has since increased unevenly through 2018. In recent years the noncollege annual 
prevalence has not differed much from that for college students, though in some of the past 
few years, it was higher for noncollege youth, reaching a recent high of 47% in 2016. In 
2018, it was 45% (same as college students). Similar to college students, the five-year trend 
(from 2013 to 2018) for the noncollege respondents showed a 4.5 percentage point 
increase, but was not significant. (We should mention that because of the diminishing 
sample sizes for the noncollege group, their estimates have become less stable in recent 
years, as is illustrated in Figure 9-1.)  
 
Twelfth-graders’ annual use of any illicit drug showed a declining trajectory parallel to the 
other two groups from 1980 through 1991, but then followed with a much steeper increase 
through 1997 (in what we have called the “relapse phase” of the drug epidemic), leaving 
their prevalence considerably above the two older groups. Their use leveled after 1998 and 
then declined some after 1999 (by about six percentage points), whereas among college 
students there was a continued increase through 2001, followed by a leveling as use among 
12th graders continued to decline. As a result, all three groups had quite similar prevalence 
rates by 2007. After 2009, use increased among the high school seniors but did so 
somewhat later among the college students, creating some new divergence before they 
                                                 
4 As discussed in Chapter 3 on methods, panel data for this volume are weighted to help account for attrition through a post-stratification strategy. 
One result of that strategy is that the differential attrition with respect to gender (i.e., as is common in longitudinal research, we are more likely to 
lose men than women to follow-up) is accounted for to some extent. 
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converged in 2013. Between 2013 and 2017, annual prevalence remained fairly steady for 
12th graders and increased for both the college and noncollege groups; between 2017 and 
2018, there was a nonsignificant decrease for 12th graders and nonsignificant increases for 
college students and noncollege respondents. 
 
The divergences and convergences over the years among the three groups likely reflect 
cohort effects. After 2007 (2006 for college students), all three groups showed some 
increase in the annual prevalence of any illicit drug use—due largely to a turnaround in 
their use of marijuana, as described below—but the increase was greater and longer from 
2007 to 2011 among the 12th graders, compared to college students, likely once again 
reflecting a cohort effect. The divergence we are now seeing between 12th graders and 
college students may reflect another emerging cohort effect.  
 
 Regarding recent trends, annual prevalence of any illicit drug other than marijuana 
(Figure 9-2) has diverged among the three groups since 2012 (when it was 17% to 18% for 
all three groups), declining considerably for 12th graders (12% in 2018) and remaining 
fairly steady for college students (20% in 2016 and 18% in 2017). In 2018, the annual 
prevalence for college students was 18% (the five-year trend from 2013 was not 
significant). For noncollege respondents, it showed some uneven increase through 2016 
(24%), and then decreased significantly in 2017 to 18%, where it remained in 2018. Figure 
9-2 shows that since 1980, of the three groups the noncollege segment has usually had the 
highest levels of use of any illicit drug other than marijuana, although that was not the case 
in 2017 and 2018. An exception was during most of the 1990s (the relapse phase in the 
epidemic), when use among 12th graders rose sharply and exceeded use in the noncollege 
segment. The noncollege group also showed an increase during that phase, though slightly 
lagged, and passed the 12th graders in the early 2000s.  
 
An increase in use of any illicit drug other than marijuana among college students also 
occurred after around 1994, but it lagged considerably behind the upturn among 12th 
graders, reflecting a cohort effect. From 1986 through 2009, college students exhibited the 
lowest rates of use. In the earlier period from 1980 to 1994, use of any illicit drug other 
than marijuana declined appreciably among college students, with their annual prevalence 
dropping by nearly two thirds from 32% to 12% (Table 9-2). This generally paralleled the 
trends for the noncollege group and the 12th graders, indicating a secular trend during that 
period. All three groups showed some increase in use during the early 1990s; however, the 
rise in use of illicit drugs other than marijuana was again not as sharp among college 
students as it was in the other two groups, and it began two years later than among the 12th 
graders and one year later than among the noncollege group (Figure 9-2). This pattern is 
more consistent with a cohort effect.  
 
After 1999, use among 12th graders leveled off, whereas the college students and 
noncollege segment showed a continuing increase. In fact, the college students and 
noncollege respondents continued to show an increase in their annual prevalence rate from 
1998 through 2004, before declining from 2005 through 2007 among the noncollege group 
and through 2008 among the college students. From 2008 to 2012 the rate increased among 
the college students and declined steadily among those in the noncollege group, closing the 
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considerable gap between the noncollege group and both college students and 12th graders. 
Between 2009 and 2012, annual prevalence for college students and 12th graders 
converged. In 2012 all three groups had comparable annual prevalence rates at 17-18%.  
 
As summarized above, starting in 2013, the three groups began diverging again (Figure 9-
2). In 2013 and 2014, college students and their noncollege peers showed increases in 
annual use while use among 12th graders remained unchanged in 2013 and declined after 
2014. The increase in use of any illicit drug other than marijuana among college students, 
from 15% in 2008 to 21% in 2014, was significant (Table 9-2). Thus by 2014 annual use 
of any illicit drug other than marijuana by college students exceeded that by 12th graders, 
approached that of the noncollege segment, and reached a new recent peak rate. This 
increase appeared attributable mostly to college students’ increased use of amphetamines 
(without a doctor’s orders) and of MDMA (ecstasy, Molly). However, in 2015 all three 
groups showed a decline in their annual use of any illicit drug other than marijuana: the 
noncollege group declined by a significant 5.3 percentage points and the college students 
by a nonsignificant 2.4 percentage points. The net effect was to essentially eliminate the 
difference between those two groups; but their use remained above that of 12th graders and 
has in the years since then. In 2016, annual prevalence showed a rebound, with increases 
for college and noncollege youth and continued decline for 12th graders. In 2017, there was 
again a decline for college and noncollege respondents (with the decline for noncollege 
group being significant), resulting in similar prevalence across these two groups. In 2018, 
annual prevalence remained at 18% for college and noncollege respondents, and continued 
its gradual decline for 12th graders. 
 
 Regarding recent trends, annual prevalence of marijuana use among college students and 
noncollege respondents rose from recent lows in 2006 (for college students at 30%) and 
2007 (for noncollege youth at 32%) through 2016, reaching 39% and 41% respectively, 
both increasing about 5 percentage points from 2014 to and 2016 (Figure 9-3a); however, 
in 2017, both groups showed nonsignificant declines or leveling to 38% and 41%, 
respectively. In 2018, annual prevalence of marijuana for college students was 43%, 
increasing nonsignificantly 4.3 percentage points from 2017; the 5-year trend showed a 
significant increase of 7.1 percentage points from 2013 to 2018. In 2018, it was also 43% 
for noncollege students, a nonsignificant increase of 2 percentage points from 2017 (the 
five-year trend showed a nonsignificant increase of 2 percentage points). For both college 
students and noncollege respondents, the 2018 prevalence of annual marijuana use (43%) 
was at the highest level in three and a half decades, since 1983 for both groups. In contrast, 
prevalence for 12th graders increased from a recent low of 32% in 2007 through 2011 (to 
36%) and has remained fairly level since (36% in 2018). Whereas there was little 
distinction among the three groups for most of the past decade, annual prevalence began to 
show some divergence in the past few years with use becoming higher for the young adult 
groups than for 12th graders.  
 
Looking back to an earlier period, from 1981 through 1991, annual prevalence of marijuana 
use dropped by nearly half from 51% to 27% among college students (Figure 9-3a). The 
noncollege group showed a comparable decline over the same time interval, as did the 12th 
graders; trends in annual prevalence for all three groups were fairly comparable across that 
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interval, reflecting a secular trend. Use among 12th graders rose sharply after 1992, while 
use among college students and noncollege respondents rose more gradually. From 1991 
through 1998, annual prevalence rose by 14 percentage points among 12th graders, 
compared to 10 percentage points among college students and 7 percentage points among 
the noncollege group. As a result, the 12th graders came to exhibit the highest rate of 
marijuana use in the last half of the 1990s, but they were the first to show a leveling off in 
marijuana use (in 1998), followed by the college students in 1999 and the noncollege group 
in 2002. This suggests that a cohort effect was present during this period. All three groups 
had very similar rates of use by 2005 after use showed some decline, particularly among 
the 12th graders. The college students and 12th graders both showed some continuing 
decline in 2006, but they then both showed a gradual increase in their marijuana use from 
2006 through 2011, with the sharpest increase occurring among the 12th graders, indicating 
in both cases the end of the gradual decline in marijuana use seen earlier in the decade.  
 
 New questions about vaping marijuana were added to two forms of the young adult 
surveys in 2017 and 2018. Annual prevalence of vaping marijuana among college students 
in 2017 and 2018 was 10.7% and 20.2%, respectively (Table 9-2), showing a significant 
9.4 percentage point increase, among the greatest one-year increases for any substance 
since MTF began over 40 years ago. For noncollege respondents in 2017 and 2018, annual 
prevalence was 13.7% and 11.2%, respectively, showing a nonsignificant decline of 1.5 
percentage points. 
 
Thirty-day prevalence of vaping marijuana in 2017 and 2018 among college students was 
5.2% and 10.9%, respectively (Table 9-3), showing a significant 5.7 percentage point 
increase. This doubling of the 30-day prevalence of vaping marijuana for college students 
from 2017 to 2018 is among the largest one-year proportional increases for any substance 
for over 40 years. Among noncollege respondents 30-day prevalence was level at 7.8% in 
2017 and 7.9% in 2018.  
 
 Regarding recent trends, daily marijuana use among college students rose from 3.5% in 
2007 to 5.9% in 2014, which was the highest rate observed since 1980 (Figure 9-3b). In 
2015 trends showed a nonsignificant decline to 4.6%, and that was the year after 12th 
graders showed some decline in daily use to 5.9%. Between 2015 and 2017, daily use was 
fairly level (4.4% in 2017). In 2018, daily use among college students increased a 
nonsignificant 1.4 percentage points to 5.8%, just shy of the historic high of 5.9% in 2014. 
For 12th graders, daily use has leveled since 2014 (5.8% in 2018). In a rather dramatic 
contrast, daily marijuana use rose for noncollege respondents from 2012 through 2016 
(12.8%) and 2017 (13.0%), reaching a historic high for that population. In 2018, it declined 
for noncollege youth a nonsignificant 1.9 percentage points to 11.1%. After this dramatic 
increase in daily use of marijuana, as of 2018, daily marijuana use is nearly twice as high 
among noncollege respondents as among college students and 12th graders. 
 
Across the years, noncollege respondents have generally had the highest prevalence of 
daily marijuana use and college students have had the lowest (with college students and 
12th graders showing convergence in 2014 and 2018). The differences have been greatest 
in periods of relatively high use and diminished considerably when use was at its nadir at 
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the beginning of the 1990s. Daily marijuana use has varied widely in all three groups since 
1980. The period from 1980 through 1992 saw a large proportional decline in daily use in 
all three groups, with rates falling by half or more. Since 1992, the rates have climbed 
substantially in all three groups, though there were periods of leveling: for example, among 
high school seniors from 1999 through 2009, among college students from roughly 2003 
through 2006, and among the noncollege group from 2003 through 2010.  
 
 Synthetic marijuana (Figure 9-4) was first included in the study in 2011 and had an annual 
prevalence among college students of 8.5% at that time. Since then, annual use declined 
precipitously, to 0.9% in 2014, followed by some modest increase to 1.6% in 2018. Annual 
use among the noncollege and 12th grade respondents also has declined sharply since 2011, 
reaching 2.3% and 3.5%, respectively, in 2018, still higher than among college students. 
Since 2012 the 12th graders have shown the highest annual prevalence and college students 
the lowest.  
 
 Use of salvia, another fairly recent arrival to the drug scene, was added to the MTF 
questionnaires in 2009. It has seen a sharp decline in popularity among college students. 
Annual prevalence was 5.8% in 2009 but was 0.9% in 2018 (Table 9-2). Annual prevalence 
was 0.3% in the noncollege group in 2018 (Table 8-2 in Chapter 8). 
 
 Bath salts—containing cathinones, a synthetic stimulant—the use of which was first 
measured in 2012, have shown only trace levels of use among college students in the years 
since then (0.3% or less, and <.05% in 2018; Table 9-2). Among the noncollege group, use 
in 2018 was at 0.3% (Table 8.2). 
 
 In the past decade, annual amphetamine use without medical supervision rose substantially 
among college students (Figure 9-12), roughly doubling from 2008 (5.7%) through 2012 
(11.1%); but has since declined to 8.3% in 2018 (one-year and five-year trends are 
nonsignificant). Similarly, there has been a recent decline among 12th graders since 2013, 
and among noncollege youth since 2014, both reaching 5% in 2018 (the five-year decline 
for noncollege respondents was significant). The 1980s saw a dramatic decline of annual 
prevalence among college students, from 22% in 1981 to 4% in 1991. Proportionately, this 
was a larger drop than that among 12th graders, who also showed a considerable decline, 
but fairly parallel to the overall change among the noncollege group. These large declines 
in all three groups suggest a secular trend in that period. Amphetamine use among college 
students and their noncollege peers began to increase during the relapse phase in the drug 
epidemic after 1992 and 1993, respectively, through 2001, with a leveling in 2002. Still, 
during the 1990s and early 2000s, the prevalence rates for amphetamine use in all three 
groups remained well below the rates observed in the early 1980s. Since 2002, there have 
been some divergence among the three groups, with amphetamine use among college 
students (who consistently had the lowest rate of use from the mid-1980s through the mid-
2000s) holding steady through 2008, while use among 12th graders and the noncollege 
group declined, nearly closing the gaps among the three groups. In 2009, prevalence rates 
were similar for the college and noncollege groups (7.5% and 7.7%), and slightly lower 
among 12th graders (6.6%). Despite the recent declines for college students, their annual 
prevalence has remained the highest among the three groups since 2010. It seems very 
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likely that this is due to their higher interest in using these drugs to improve academic 
performance.5 Regarding college students’ nonmedical use of Adderall, annual prevalence 
has been between 9% and 11% since 2009 (when it was first included in the surveys); 
Ritalin use was between 1.3% and 2.4% during the past five years.  
 
 Use of inhalants has been very low among both college and noncollege respondents since 
1980, when rates were first measured (Figure 9-5). Although it dropped for college students 
from a peak of 4.1% in 1997 to a low of 0.2% in 2016, it increased significantly in 2017 to 
1.7%, the highest it has been since 2004; in 2018, it dropped nonsignificantly to 1.3%. For 
noncollege respondents, 2018 annual prevalence was 1.2%, down from its peak of 3.5% in 
2006. Twelfth graders have typically had considerably higher rates of inhalant use than 
either of these segments of the young adult population; and as is documented in Volume I,6 
the 8th and 10th graders have had still higher levels of use. With the one exception of 2017, 
there has been a consistent age effect, with use of inhalants declining considerably with 
increasing age. The college, noncollege, and 12th grade groups have trended largely in 
parallel across the years, but the increase through the mid-1990s and subsequent decline 
were substantially more pronounced among 12th graders, opening and then shrinking the 
gap between them and the two young adult groups. 
 
 Annual prevalence of LSD remains relatively low for all three groups, but has been 
showing some modest uneven increases for college and especially for noncollege youth 
over the past few years (Figure 9-7). Annual prevalence for the three groups was similar in 
2012 (at about 2%), and since then it increased unevenly to 4.1% for college students and 
6.1% for noncollege respondents in 2018 (the one-year increases were not significant; the 
five year increase for college students was not significant, but it was for noncollege 
respondents); it has remained fairly level for 12th graders (3.2% in 2018). The annual 
prevalence of hallucinogens overall, of which LSD is one component (Figure 9-6), has 
also been relatively low, though there has been little evidence of recent increases, as 
summarized below. During the early 1980s, one of the largest proportional declines 
observed among college students occurred with LSD: annual prevalence fell from 6.3% in 
1982 to 2.2% in 1985. After 1989, use in all three groups increased, with the prevalence 
among college students reaching 6.9% by 1995. After 1995, use fell gradually among 
college students, their noncollege peers, and 12th graders until 2001, followed in 2002 by 
a particularly sharp decrease in all groups. As a result, there was a considerable 
convergence in usage rates, which remained for some years. College students maintained 
lower levels of use than the other two groups for most of the life of the study until 2007. 
Use rose some in all three groups between 2007 and 2012, with little consistent difference 
among them suggesting a secular trend. Beginning in 2013, noncollege use increased 
unevenly through 2018, increased somewhat for college students, and remained fairly level 
for 12th graders. 
                                                 
5 Data from high school seniors in 2012 on their reasons for using amphetamines showed “To help me study” was the most frequently chosen reason 
among 17 reasons, and was mentioned by 59% of the college-bound vs. by only 18% of those not college bound. Bachman, J. G., Johnston, L. D., 
& O’Malley, P. M. (2014). Monitoring the Future: Questionnaire responses from the nation’s high school seniors, 2012. Ann Arbor, MI: Institute 
for Social Research, University of Michigan. 
6 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, secondary school students. Ann Arbor, MI: Institute for Social Research, The University of 
Michigan. 
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 Among college students the annual prevalence for hallucinogens other than LSD (Figure 
9-8).was 2.4% in 2018, a new low for the study; it increased nonsignificantly for the 
noncollege group, while remaining steady for 12th graders. The three groups converged in 
2012 at about 3.9%, after which use showed a slow decline for 12th graders (to 2.7% in 
2018) and an uneven change for noncollege respondents (to 4.1% in 2018). Use of 
hallucinogens other than LSD (which primarily involves the use of psilocybin known as 
mushrooms or “shrooms”) followed a track somewhat parallel to LSD use, at least up until 
about 2000. Other hallucinogen use declined in all three groups from the early 1980s 
through the early 1990s, followed by rising use during the relapse in drug use in the 1990s, 
and then some leveling. But the secular trends for these other hallucinogens diverged from 
those for LSD after about 2000, with an increase in their use, including among college 
students, just before and after the drop off in LSD use in 2002. While overall annual 
prevalence of LSD across the three groups was higher than that of the other hallucinogens 
in the first two decades of the study, overall annual prevalence is now about the same for 
these two classes of drugs.  
 
 The annual use of MDMA (ecstasy and, more recently, Molly) by college students 
increased nonsignificantly to 4.3% in 2018, and decreased nonsignificantly to 2.8% for 
noncollege respondents. This follows significant declines for both groups in 2017 (2.5% 
and 4.7%, respectively), and before that, a leveling in 2016 for college students (4.7%) and 
an increase for noncollege respondents (8.6%). In contrast, use among 12th graders has 
continued to decline in the past five years (Figure 9-9). Use by college students and their 
noncollege peers began to rise after 1994 and their rates tracked closely through about 2000 
(Figure 9-9). Questions about MDMA use were added to the 12th grade survey in 1996 and 
usage rates tracked similarly with those of the other two groups through about 2000. After 
1997 there was a sharp increase in use in all three groups. The annual prevalence for college 
students, for example, rose from 2.4% in 1997 to 9.2% in 2001 and rose considerably more 
among the noncollege group. Use in all three groups declined sharply from 2001 to 2004, 
when annual rates were back to 2.2% for college students, 2.7% for 12th graders, and 4.0% 
for the noncollege segment. Both the college and noncollege groups showed some increase 
in use by 2012, after which use by college students began a decline while use in the 
noncollege group began an uneven increase. It is worth noting that “Molly”—which is a 
purer form of MDMA than MDMA and has its own street name—was added as an example 
of MDMA in half of the questionnaires in 2014 and in all of them a year later. Figure 9-9 
shows in 2014 the prevalence reported by respondents with and without Molly included. 
There was rather little difference in the level for the two older groups, but the 12th graders 
showed a fair difference, with the inclusion of Molly leading to a higher prevalence. In 
2015, even with Molly included, all three groups showed a decline in annual prevalence, a 
decline that continued into 2018 for 12th graders. In 2016, the college group and especially 
the noncollege group showed an increase, reaching levels that constituted a doubling of 
prevalence since 2007; 2017 saw significant declines for all three groups, with 
nonsignificant declines continuing in 2018 for noncollege respondents and 12th graders and 
the college students showing a nonsignificant uptick.  
 
 Annual prevalence of nonmedical sedative (barbiturate) use has remained relatively low 
in recent years and has been declining in all three groups. It continued to decline 
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nonsignificantly in 2018 among college students (to 1.5%) and 12th graders (to 2.7%) and 
increased nonsignificantly for noncollege respondents (3.1 Figure 9-13). Throughout the 
time data have been available in this study (1980 through 2018), college students have had 
the lowest prevalence of use among the three groups. At that early date, sedative 
(barbiturate) use was already quite low among college students (at 2.9%), but it still fell by 
more than half to 1.3% by 1985. This proportional decline was sharper than among 12th 
graders and less sharp than among the noncollege respondents: both groups started at 
considerably higher levels of use than college students. Annual prevalence remained 
essentially unchanged between 1985 and 1993 for all three groups. A gradual increase in 
use occurred between 1994 and 2004 for college students and between 1993 and 2005 for 
the other two groups. After 2005, declines in use appeared in all three groups through 2011 
(2012 for the noncollege group), before showing a rise in use through 2013 and 2014. In 
fact, among college students sedative (barbiturate) use rose from 1.7% in 2011 to 3.1% in 
2014, before nonsignificant declines in use in the past four years; 12th graders have shown 
a similar recent trend, whereas noncollege respondents have shown an uneven decline since 
2014, likely due in part to their smaller numbers of cases.  
 
 Similar to what was found for sedatives (barbiturates), annual prevalence of nonmedical 
tranquilizer use also remains relatively low. It was level for college students in 2018 
(3.5%) and declined nonsignificantly for noncollege respondents (to 3.7%) and for 12th 
graders (to 3.9%) (Figure 9-14). For a few years prior to 2017, the annual prevalence of 
nonmedical tranquilizer use increased slightly among college students and noncollege 
respondents, reaching 4.9% and 7.1% respectively in 2016, while 12th grade prevalence 
remained level. For college and noncollege respondents, the increases through 2016 
reflected a reversal of a longer term downward trend that began in the early 2000s; 12th 
graders have also shown a long-term decrease since early 2000s. In general, tranquilizer 
annual prevalence trends have been similar to those for sedatives (barbiturates). Between 
1980 and 1994, annual tranquilizer use among college students dropped by nearly three 
fourths from 6.9% to 1.8%, a period in which use declined in the other two groups as well. 
After this long period of decline, tranquilizer use by college students increased gradually, 
returning to 6.9% by 2003. Use by the noncollege segment and by 12th graders dropped 
more sharply from 1980 through 1992, eliminating the differences among the three groups. 
Use rose after 1992 for all, but the noncollege group showed the largest gain after 1999, 
again creating some differences. By 2002, tranquilizer use was once again at or near its 
recent high in all three groups, followed by a period of decline, until 2014, after which 
there was some slight increase in use through 2016, and then decreases through 2018 for 
all three groups, especially the noncollege group.  
 
The nonmedical use of narcotics other than heroin7 (Figure 9-11a) has been declining for 
all three groups in the past decade, dropping from peak levels in the mid-2000s. These 
declines continued into 2018. Annual use declined nonsignificantly for college students 
(2.7%) in 2018, with the five-year trend (2013-2018) showing a significant decline of 2.7 
percentage points; for noncollege respondents, use declined nonsignificantly in 2018 
(3.2%), with the five-year trend showing a significant decline of 5.8 percentage points; and 
                                                 
7 As discussed in Chapters 4 and 5, because the questions about narcotics other than heroin were changed in 2002, the prevalence figures are 
adjusted estimates. See the earlier discussion for details. 
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for 12th graders, use declined significantly in 2018 (3.4%), with the five-year trend showing 
a significant decline of 3.7 percentage points (see Volume I8). These declines resulted in 
the lowest levels for all three groups since the late 1990s. 
 
The long-term trends in use have been quite parallel to those for sedatives (barbiturates) 
and tranquilizers. From 1980 through the mid-1990s, there was a slight decline for all 
groups, with little distinctions among the groups. Annual prevalence then rose considerably 
after about the mid-1990s in all three groups. Prior to then, the use of narcotics other than 
heroin by college students was down to about half by 1994 from what it was in 1980 (2.4% 
in 1994 vs. 5.1% in 1980) as a result of a fairly gradual decline over that 14-year interval. 
This trend closely paralleled use among participants’ noncollege counterparts and 12th 
graders. As with a number of other drugs, use among 12th graders began to rise after 1992, 
but use among college students did not begin to increase until after 1994, likely due to a 
cohort effect. In 2003, annual prevalence among college students reached a historic high 
point of 8.7% before leveling for three years. It then declined from 8.8% in 2006 to a two-
decade low of 2.7% by 2018. For the past decade, college students have shown the lowest 
prevalence among the three groups. Use among 12th graders leveled after reaching a 
historic high of 9.5% in 2004, but it then declined fairly steadily to a recent low of 3.4% in 
2018. The noncollege group emerged after 2000 as the most heavily using group for the 
first time, supplanting the high school seniors, as their use kept increasing through 2005, 
reaching an all-time high of 13%. After that, use in the noncollege group declined to a two-
decade low of 3.2% in 2018. It thus appears that all three groups have shown fairly steady 
and parallel declines in the use of these dangerous drugs since the early to mid-2000s, 
following a substantial increase in use by all three in the 1990s and into the early 2000s. 
Although there was a nonsignificant increase in 2016 for college and noncollege 
respondents, the 2018 results suggest that the overall declines for these two groups over 
the past decade are continuing. 
 
 Data on the nonmedical use of the specific narcotic drugs, OxyContin and Vicodin, were 
first collected in 2002 (Figures 9-11b and 9-11c and Table 8-2). The noncollege group had 
annual prevalence rates up to twice that for college students in the use of both drugs when 
their use was first measured in 2002, but the differences among the three groups have 
changed since then. 
 
Annual prevalence of nonmedical OxyContin use among college students rose fairly 
steadily, from 1.5% in 2002 to 5.0% in 2009, before dropping significantly to 1.2% in 
2012; it has since shown a modest uneven increase to 1.6% in 2018 (Figure 9-11c). Use in 
the noncollege segment rose from 2002 (3.3%) to 2005 (6.2%) and then declined to 4% by 
2010 and remained fairly level through 2015; in 2016 it declined to 2.1% and then to 1.6% 
in 2018. The trend line has been quite uneven, likely due to the limited numbers of cases 
in this segment. (Questions about OxyContin and Vicodin are in only three of the six 
questionnaire forms.) Among 12th graders, OxyContin use rose from 4.0% in 2002 to 5.1% 
in 2010 and then leveled for several years, before declining to 2.3% by 2018. It is clear that 
                                                 
8 Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the Future national 
survey results on drug use, 1975-2018: Volume I, secondary school students. Ann Arbor, MI: Institute for Social Research, The University of 
Michigan. 
421
OxyContin use increased among college students between 2002 and 2009, closing the 
previously existing gaps among the three groups; however, use has declined sharply among 
the college students since then, again opening a sizeable gap between them and the other 
two groups through 2015, after which the three groups have converged again at relatively 
low levels.  
 
Vicodin use without medical supervision (Figure 9-11b) showed a somewhat different 
pattern of change, with annual prevalence among all three groups remaining fairly level, 
and substantially higher than use of OxyContin, from 2002 through about 2008. Since then, 
annual prevalence for all three groups declined sharply, reaching its lowest point in 2017 
for college students (1.1%) and noncollege respondents (1.8%). Annual prevalence leveled 
for all three groups in 2018 (1.5%, 1.9%, and 1.7%, respectively). As with OxyContin, the 
noncollege group has consistently had higher Vicodin use than the college students. 
Twelfth-grade levels of Vicodin use have fallen in between. The 2017 and 2018 data show 
a convergence among the three groups at or near historical lows. Because of the limited 
numbers of cases, as with OxyContin, trend data for use of Vicodin have generally been 
uneven in the young adult groups.  
 
 Beginning in the mid- to late-2000s, the annual prevalence of cocaine use among college 
students, noncollege peers, and 12th graders (Figure 9-10) began to decline to levels below 
those in the 1990s and far below those in the 1980s. The trend line for college students 
continued to decline until 2013, and then increased a significant 1.7 percentage points to 
4.4% in 2014; it was level through 2016 and increased nonsignificantly the past two years 
to 5.2% in 2018 (the five-year trend from 2013 to 2018 showed a significant increase of 
2.5 percentage points). Although annual cocaine use remains relatively low among college 
students, the 2018 prevalence is the highest over the past decade. In the noncollege group 
there was also a bump up in cocaine use in 2013, which held for a few years and then 
increased to 6.5% in 2016; it has declined nonsignificantly the past two years to 4.2% in 
2018. For 12th graders, annual cocaine use has been level for the past decade (2.3% in 
2018).  
 
Regarding longer-term trends, the early to mid-1980s saw a level period during which 
cocaine use was considerably greater among college students and their noncollege peers 
than among 12th graders. It was followed by a dramatic drop in annual prevalence among 
college students (nearly nine tenths, from 17.1% in 1986 to 2.0% by 1994) and noncollege 
counterparts (from 18.9% in 1986 to 5.1% in 1994). A cohort effect emerged as cocaine 
use began to rise among 12th graders after 1992, among the college segment after 1994, 
and among the noncollege segment after 1995. Since 2000 the 12th graders and college 
students have had similar rates of use and parallel trends, while use in the noncollege 
stratum has been considerably higher. After around 2006 all three groups showed declines 
in use until 2012 among the noncollege group and 2013 among college students, with 12th 
graders continuing to decline. These patterns of change suggest that a secular trend was 
underway through most of the 1980s, combined with a considerable age effect. After 1992 
a cohort effect emerged through most of the 1990s, and since 2000 or so through 2012 a 
secular trend re-emerged with all three groups moving in parallel for the most part. After 
2012 the three groups diverged. 
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 Despite different trend patterns among the three groups, college students have exhibited 
the highest levels and greatest constancy in binge drinking (defined as having five or more 
drinks in a row at least once in the past two weeks) since the first measurement in the MTF 
surveys in 1980 (Figure 9-15d; note that 30-day alcohol use shows very similar patterns as 
shown in Figure 9-15b). From 1980 through 2018, college students’ prevalence of binge 
drinking declined 16 percentage points (from 44% to 28%); the 2018 prevalence was a 
significant decline from 2017, and represents the first time that prevalence was below 30%. 
For noncollege respondents and 12th graders, prevalence has also declined considerably 
since 1980 through 2018; noncollege respondents’ prevalence declined 16 percentage 
points (41% to 25%) and 12th graders’ prevalence declined 27 percentage points (41% to 
14%). 
 
As can be seen in Figure 9-15d, both the noncollege segment and 12th graders showed fairly 
substantial declines in the prevalence of binge drinking from 1981 through 1990. In 
contrast, college students showed no decline from 1981 to 1986 and then only a modest 
decline of five percentage points from 1986 through 1993. Between 1981 (when all three 
populations were very close in use) and 1992, this measure of binge drinking dropped by 
14 percentage points among 12th graders, by 11 percentage points among the noncollege 
respondents, but by only two percentage points among college students. After 1992, binge 
drinking began to rise among 12th graders while still declining some among college 
students, narrowing the gap somewhat and likely reflecting a cohort effect emerging during 
this period, similar to that observed for a number of illicit drugs. Binge drinking 
subsequently began to increase among the noncollege segment after 1995, and by less 
among college students after 1996, modest increases that continued into 2001. Between 
2001 and 2008, college students held fairly steady in their rates before showing some 
decline through 2015, followed by some leveling and then the significant decline in 2018; 
the noncollege segment held steady from roughly 2003 to 2007, followed by some uneven 
decline through 2018. Meanwhile, among 12th graders, binge drinking started a gradual 
decline after 1998 that continued into 2018, enlarging the difference between them and the 
two older groups. Once again there is evidence of cohort effects since the early 1990s, with 
the inflection points occurring later for the older strata.  
 
Why did college students’ binge drinking decline so little for a decade (1981–1991) 
compared to their noncollege peers and 12th graders? One possibility is that campuses 
provided some insulation from the effects of changes in the drinking age laws that took 
place in many states during that interval. Similarly, entrenched in many college campuses 
is a culture of binge drinking that had proven to be impervious to many societal trends and 
intervention attempts.9 Also, individuals who are under the legal drinking age in college 
are mixed in with peers who are of legal age to purchase alcohol; this was no longer true 
in high schools by the mid-1980s and was less true, perhaps, for many of those ages 19 to 
22 who were not in college. Finally, much alcohol advertising and promotion was and is 
directed specifically at the college student population. As summarized above, binge 
drinking has decreased for all three groups over the past decade reflecting a secular trend.  
 
                                                 
9 Schulenberg, J. E., & Maggs, J. L. (2002). A developmental perspective on alcohol use and heavy drinking during adolescence and the transition 
to young adulthood. Journal of Studies on Alcohol, Supplement 14, 54–70. 
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Starting in 2005, we included a set of questions concerning extreme binge drinking, also 
known as high-intensity drinking, in one of the six questionnaire forms used with young 
adults, including college students. The questions asked respondents about the frequency in 
the past two weeks of having 10 or more drinks in a row and also of having 15 or more 
drinks in a row. The low numbers of cases that result from a single questionnaire form 
necessitate combining multiple years of data (this item is included on a second form, but 
those data are not included in this volume due to inconsistent variations in responses 
between the two forms). By combining data across 2005 through 2011 and across 2012 
through 2018, we find that extreme binge drinking has declined for college students and 
noncollege respondents. As shown in Table 9-5, prevalence of 10 or more drinks in a row 
at least once in the prior two weeks decreased for college students from 13.6% in 2005-
2011 to 10.2% in 2012-2018; corresponding prevalence for noncollege respondents 
declined from 11.8% to 10.2%. Prevalence of 15 or more drinks in a row at least once in 
the prior two weeks decreased for college students from 5.0% in 2005-2011 to 3.1% in 
2012-2018; corresponding prevalence for noncollege respondents was level at 5.2% (Table 
9-6). In table 9-4, extreme binge drinking prevalence levels (for both 10 or more and 15 or 
more drinks) are shown for college students each year from 2005 through 2018. These 
levels are based on small sample sizes and thus show uneven trend lines from year to year. 
Nonetheless, the overall downward trends are evident, with notable recent declines in 10 
or more drinks after 2012, and notable recent declines in 15 or more drinks after 2014. 
These recent declines in prevalence of extreme binge drinking are consistent with declines 
in binge drinking (at the 5+ drinks level) for college students and noncollege respondents.10 
As we summarize below (and also discuss in Chapter 8), extreme binge drinking is much 
higher among males than females in both college and noncollege groups. 
 
College students’ daily drinking estimates (Figure 9-15c) showed a significant decline in 
2017 to 2.2%, dropping by half (from 4.3% in 2016) and reaching a historic low; it was 
level in 2018 (2.3%). For noncollege respondents it declined nonsignificantly in 2018 
(2.5%), and for 12th graders it continued on a long-term decline to 1.2%, reaching a historic 
low. Earlier trend data for college students appeared a little less stable, perhaps due to 
smaller sample sizes at those times, going from around 6.5% in the early 1980s to a 
considerable decline from 1984 through 1995 (to 3.0%), followed by a period of some 
increase during and after the relapse phase in the drug epidemic in the 1990s, reaching 
5.0% in 2002. From 2002 through 2016, daily drinking among college students fluctuated 
at about 4% without a clear downward trend; however, 2017 showed a clear and significant 
downward trend, and then leveled in 2018. Twelfth graders showed a somewhat similar 
pattern of daily drinking with a long period of decline, followed by an earlier reversal 
beginning in 1994. After 1998, 12th grade daily drinking resumed its decline, reaching its 
lowest level of 1.2% in 2018. Of the three groups, 12th graders have typically had the lowest 
rates of daily drinking. The noncollege respondents have generally had the highest rate of 
current daily drinking and have shown the most change in daily drinking trends. After a 
2008 decline in daily use among noncollege respondents, daily drinking levels have been 
fairly comparable between the college students and their noncollege peers; and both of 
                                                 
10 Patrick, M. E., Terry-McElrath, Y. M., Miech, R. A., Schulenberg, J. E., O’Malley, P. M., & Johnston, L. D. (2017). Age-specific prevalence 
of binge and high-intensity drinking among U.S. young adults: Changes from 2005 to 2015. Alcoholism: Clinical and Experimental Research, 41, 
1319-1328. 
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them showed some decline in daily use in 2015 and then uneven change through 2018, 
reaching levels that were at or near historic lows in 2018.  
 
 The 30-day prevalence of cigarette smoking (Figure 9-16a) among college students has 
declined dramatically for the past decade and a half, with any smoking in the past 30 days 
falling by more than three-fourths from a recent high of 31% in 1999 to an all-time low of 
7% in 2018; daily smoking has fallen by about nine-tenths over the same interval, from 
19% to 2% (also to an all-time low in 2018) (Figure 9-16b). In the early 1980s, cigarette 
smoking among U.S. college students declined modestly, and by less than the decline 
among their noncollege peers. Thirty-day prevalence for college students fell from 26% to 
22% between 1980 and 1984, remained fairly stable through 1990 (22%), then increased 
gradually but substantially, reaching 31% by 1999. In 2000 the first evidence of a new 
decline in smoking among college students began to appear, two years after smoking had 
begun to decline among 12th graders, this lag reflects a cohort effect. The noncollege group, 
which has consistently had the highest smoking rate of the three groups, showed a fairly 
consistent decline in 30-day prevalence from 1980 through 1990, an offsetting increase 
from 1990 through 2001 (44%), and a considerable decline since then to an all-time low of 
17% in 2018, showing a significant decline of 5.1 percentage points from 2017 (22%). 
Over the past decade and a half, 30-day use has declined in parallel form for noncollege 
and college respondents, with smoking being about twice as high among noncollege as 
among college respondents across the past seven years. Across the same period, prevalence 
of daily smoking also decreased in parallel form; it was three to four times as high among 
noncollege as among college respondents in recent years (Figure 9-16b and Table 9-4).  
 
While smoking rates have consistently been lower among college students than the 
noncollege segment, the trend lines for these two groups converged some after 1984, as 
smoking rates more or less stabilized among college students but continued to decline 
among young adults not in college (Figure 9-16a). In fact, between 1989 and 1991, use 
began to rise among college students while continuing to decline among noncollege 
respondents. Both groups showed fairly parallel increases in smoking between about 1991 
and 1999, after which use continued to increase among the noncollege segment but began 
to decline among college students, opening up a large difference between them. (Twelfth 
graders exhibited an increase from 1992 to 1997— peaking two to three years prior to the 
older groups—reflecting a cohort effect, and their use has declined significantly since 
then.) All three groups have seen very substantial declines since those peaks, and the rates 
for college students and 12th graders have largely converged, but use among the noncollege 
group remains far higher than the other two groups.  
 
The popularity of Camel cigarettes among the college-bound may have helped to explain 
some of the narrowing of the gap between college students and their noncollege-attending 
peers in the 1990s. The Joe Camel advertising and promotion campaign, which commenced 
in the late 1980s and ended in the late 1990s, may have succeeded in initiating more college 
and college-bound students (particularly males) to smoking than had been the case 
previously or has been the case since.11 
                                                 
11 Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (1999). Cigarette brand preferences among adolescents (Monitoring the 
Future Occasional Paper No. 45). Ann Arbor, MI: Institute for Social Research, University of Michigan. 
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 New questions about vaping nicotine were added to two forms of the young adult surveys 
in 2017 and 2018. Annual prevalence of vaping nicotine among college students in 2017 
and 2018 was 13.0% and 25.6%, respectively (Table 9-2), showing a significant 12.6 
percentage point increase, among the greatest one-year increases for any substance since 
MTF began over 40 years ago. For noncollege respondents, annual prevalence of vaping 
nicotine was 21% in both 2017 and 2018. 
 
Thirty-day prevalence of vaping nicotine in 2017 and 2018 among college students was 
6.1% and 15.5%, respectively (Table 9-3), showing a significant 9.4 percentage point 
increase. This increase of two-and-one-half times in the 30-day prevalence of vaping 
nicotine for college students from 2017 to 2018 is among the largest one-year proportional 
increases for any substance for over 40 years. Among noncollege respondents 30-day 
prevalence in 2017 and 2018 was 7.9% and 12.5%, respectively, showing a nonsignificant 
4.6 percentage point increase.  
 
Selective Summary of Recent Trends  
 
The main story for recent trends among college students is the continued increase in annual 
prevalence of marijuana use, which reached 43% in 2018, a historic high over the past three-and-
a-half decades; notably, the five-year trend from 2013 to 2018 showed a significant 7.1 percentage 
point increase. Likewise, for noncollege youth, annual marijuana use has continued to increase, 
also reaching 43% in 2018 and constituting a historic high over the past three-and-a-half decades. 
Meanwhile, among 12th graders, annual prevalence of marijuana use remained fairly steady from 
2011 through 2018 (36% in 2018), resulting in a continued divergence between them and both the 
college and noncollege groups. Daily marijuana use increased for college students in 2018 to 
5.8%, nearly the all-time high level of 5.9% reached in 2014; for noncollege respondents, daily 
marijuana use reached an all-time high of 13% in 2017 and dropped to 11% in 2018. Meanwhile, 
daily use among 12th graders has remained steady the past few years (5.7% in 2018). Thus, as of 
2018, more than one-in-ten noncollege respondents aged 19-22, and about one-in-twenty college 
students and 12th graders, use marijuana on a daily or near daily basis.   
 
Regarding annual prevalence of illicit drugs other than marijuana, recent trends have been level 
for college and noncollege respondents; it continued to decline for 12th graders. Two illicit drugs 
in particular have shown recent increases among college students, though prevalence for both 
drugs remains relatively low. The five-year trend in annual prevalence of cocaine use increased 
significantly from 2.7% in 2013 to 5.2% in 2018, the highest it has been over the past decade; for 
both noncollege respondents and 12th graders, annual cocaine use has declined somewhat or 
remained steady in the past few years (4.2% and 2.3% in 2018, respectively). Annual prevalence 
of LSD has shown some uneven increases in the past few years for college students (4.1% in 2018) 
and especially noncollege respondents (6.1% in 2018), with it remaining fairly level for 12th 
graders (3.2% in 2018).   
 
The use of two illicit drugs in particular has continued to decline for college students and 
noncollege respondents. Annual prevalence of the nonmedical use of narcotic drugs other than 
heroin continued to decline for college students, with a significant five-year decline from 5.4% in 
2013 to 2.7% in 2018; similarly, for noncollege respondents, there was a significant five-year 
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decline from 9.0% in 2013 to 3.2% in 2018 (use also declined significantly for 12th graders in the 
past five years to 3.4% in 2018). The 2018 prevalence in all three groups was at the lowest levels 
since the late 1990s. The annual use of amphetamines also continued to decline modestly for 
college students (to 8.3% in 2018), and more so for noncollege respondents and 12th graders (both 
at 5% in 2018). It is noteworthy that three newer drugs – synthetic marijuana, salvia, and bath 
salts – have also continued to decline among all three groups to very low levels. 
 
Several illicit drugs with relatively low use have shown some leveling or uneven change in recent 
years among college students and noncollege respondents, including MDMA (ecstasy, Molly) 
(annual prevalence of 4.3% and 2.8%, respectively in 2018) and nonmedical use of sedatives 
(barbiturates) (1.5% and 3.1%), and tranquilizers (3.5% and 3.7%). The trend in the use of 
inhalants has also been fairly level (1.3% and 1.2%). 
 
Binge drinking continued to decline among college students and noncollege youth (as well as 12th 
graders). In 2018 for college students, it declined significantly in 2018 to 28%, representing the 
first time that it was below 30%; it declined to 25% for noncollege respondents and to 14% for 
12th graders in 2018. And cigarette use continues to decline, with 30-day smoking reaching new 
lows in 2018 for college students (7%), noncollege respondents (22%), and 12th graders (8%).  
 
Based on new vaping questions in 2017 and 2018, vaping marijuana and nicotine was found to 
dramatically increase among college students over the one-year period. Among college students, 
30-day prevalence of vaping marijuana doubled between 2017 and 2018, from 5.2% to 10.9% (a 
significant increase), one of the largest one-year proportional increases for any substance since 
MTF began over 40 years ago. Among noncollege respondents, it was 8% in both 2017 and 2018. 
Among college students, 30-day prevalence of vaping nicotine more than doubled between 2017 
and 2018, from 6.1% to 15.5% (a significant increase), also one of the largest proportional one-
year increases for any substance over the past 40 years. It increased nonsignificantly for noncollege 
respondents, from 7.9% in 2017 to 12.5% in 2018. Beginning in 2019, the vaping items will be on 
four of the six young adult survey forms (they were on two forms in 2017 and 2018), providing 
more precise estimates on this rapidly growing phenomenon. 
 
Finally, regarding long-term trends, the findings over the years concerning divergences and 
convergences among the three groups highlight the importance of cohort effects in determining 
the source of changes. The overall drug use trends among college students parallel the trends 
among 12th graders, though after the early 1990s they were generally lagged by a few years; still, 
declines in many drugs from 1980 to 1990 were proportionately larger among 19-22 year olds 
(both college and noncollege) than among 12th graders. Despite parallel trends in the early 1990s, 
12th graders showed larger, and usually earlier, increases in the use of a number of drugs in the 
years since; as indicated in Volume I, 8th and 10th graders showed increases a year earlier than 12th 
graders. Clearly the upsurge, or what we have called a “relapse phase” in the illicit drug epidemic 
during the 1990s, did not originate on the nation’s college campuses, as did the earlier epidemic. 
The relapse originated among secondary school students, and the younger ones at that, and was 
carried up the age spectrum through generational replacement. In other words, it exhibited a cohort 
effect. 
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GENDER DIFFERENCES IN TRENDS AMONG COLLEGE STUDENTS 
As mentioned earlier, recent decades have seen a gradual rise in the proportion of college students 
who are female. Females constituted 50% of the 1980 sample of college students compared to 63% 
of our 2018 sample. Given that substantial gender differences exist in the use of some drugs, we 
have been concerned that apparent long-term trends in the levels of drug use among college 
students might actually be attributable to changes in the gender composition of each population. 
For this reason, in particular, we present separate trend lines for college men and women in the 
lower panels of Figures 9-1 through 9-16c. We do not focus on noncollege respondents in these 
figures or this subsection in large part due to the limited numbers of cases for subgroups.  
 
In general, college student trends in use of the various drugs have been highly parallel for men and 
women, as an examination of the relevant figures will show. The most noteworthy exceptions are 
mentioned below.  
 
 Certain drug use measures showed a convergence between the genders as use rates declined 
to low levels in the early 1990s. This was true for annual use of any illicit drug and any 
illicit drug other than marijuana. After 1991 the genders diverged again, with a recent 
convergence especially for any illicit drug, due largely to a convergence for marijuana, 
discussed next. 
 
 Marijuana use has been consistently higher among college men than among college 
women. There was some gender convergence in annual prevalence of marijuana use 
between 1980 and 1991 as overall use declined, and then some gender divergence between 
1991 and 1999 as usage rates rose. After 2001, the two genders diverged further, with use 
among men remaining essentially unchanged through 2008 and use among women 
decreasing (Figure 9-3a). Since 2010, use among college men has remained fairly steady, 
whereas use among college women increased from 2010 through 2016, reaching a level 
not seen since the 1980s, narrowing the gap considerably; use decreased nonsignificantly 
for both genders in 2017, to 41% for men and 37% for women. In 2018, annual use 
increased nonsignificantly for college men and women to 43% and 42%, respectively, 
essentially closing the gender gap; the five-year trend from 2013 to 2018 showed a 
nonsignificant increase of 2 percentage points for men, and a significant increase of 8 
percentage points for women.  
 
 Among college students, 30-day prevalence of vaping marijuana increased from 2017 to 
2018 nonsignificantly for men (8.7% to 13.1%) and significantly for women (2.9% to 
9.3%), showing a gender gap that appears to be decreasing. Among noncollege 
respondents, it was fairly level between 2017 and 2018 for both men (6.6% to 8.1%) and 
women (8.6% to 7.8%), showing little difference between men and women.  
 
 Daily marijuana use (Figure 9-3b) has generally been about twice as high among college 
men as among college women throughout the study; since the mid-1990s, such use has 
risen more among men, especially since 2007, opening a wide difference. Between 2014 
and 2017, daily use declined some for men and remained fairly level for women. In 2018, 
daily use increased nonsignificantly for both to 8.4% and 4.3%, respectively; neither of the 
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five-year trends were significant, but the 2018 level for women represents a new high since 
2003.  
 
 From 1999 to 2005, LSD use dropped more steeply among men than among women, 
offsetting sizeable previous differences in which men had higher use and bringing the 
genders close together at very low prevalence rates (Figure 9-7). The relatively small 
increases in use that have occurred since 2005 through 2018 have been greater among men, 
with a five-year nonsignificant increase of 2.7 percentage points for men and a five-year 
nonsignificant increase of 1.0 percentage points for women. 
 
 Use of hallucinogens other than LSD has dropped for both genders since 2002 or 2003, 
with percentages for men generally twice as high or more as those for women; in the past 
few years, it dropped more for men than for women, and there has been some convergence 
(Figure 9-8). 
 
 Until recently, annual prevalence of MDMA (ecstasy, Molly) use has been quite similar for 
college men and women since measures were first introduced in 1989, and changes in their 
usage levels have tracked closely (Figure 9-9). Between 2006-2007 and 2012-2013, men 
showed more increase than women; both showed some uneven declines from 2012-2013 
through 2017 (3.1% for college men and 2.2% for college women). In 2018, use increased 
significantly for college men to 7.2% and increased nonsignificantly for college women to 
2.7%. (Starting in 2014, Molly was included as an example of MDMA. See Figure 9-9.) 
From the first measurement in 1988 through 2005 the two genders tracked closely, 
including the period of rapid rise in use (1994-2001) and the subsequent period of rapid 
decline (2001-2004). 
 
 Trends in the nonmedical use of narcotics other than heroin have generally moved in 
parallel for both male and female college students, with men generally higher, except 
during the nadir in use at the beginning of the 1990s when their rates were equivalent. 
(Figure 9-11a). Both genders have shown considerable declines in their use since about 
2005 or 2006, with the past few years showing some convergence, dropping to 3.3% and 
2.3%, respectively in 2018; the five-year decline was significant for college men, but not 
for college women. 
 
 After 1986, cocaine use, which had been substantially higher among men until then, 
dropped more steeply for men than for women in general, and among male college students 
in particular, considerably narrowing the sizable gap between genders (Figure 9-10). Since 
1991, both genders have moved in parallel, with men reporting higher annual usage rates. 
Both genders showed small and nonsignificant upticks in use in 2014, which continued 
unevenly for college men (reaching 7.0% in 2018) and college women (reaching 4.3% in 
2018); the five-year increase was significant for women, but not for men.  
 
 Nonmedical amphetamine use (Figure 9-12) also showed some convergence in the 1980s 
due to a greater decline among men; the two genders showed virtually equivalent annual 
prevalence from 1986 through 1998. From 1998 through 2016 men had slightly higher 
annual prevalence rates generally, as use increased for both through 2012. Use continued 
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to increase for men through 2015 while it declined for women. These trends reversed in 
2016 and 2017, and as a result college women showed higher annual prevalence than 
college men in 2017 (9.2% and 7.7%, respectively); however, it decreased nonsignificantly 
for women in 2018 (7.8%) and increased nonsignificantly for men (9.5%). 
 
 The gender differences for nonmedical sedative (barbiturate) and tranquilizer use have 
been modest through most of the life of the study, with college men usually having slightly 
higher prevalence than college women (Figures 9-13 and 9-14). After 1995, a somewhat 
larger gap emerged for tranquilizers, again with men being higher. Tranquilizer use by 
college women peaked in 2003, briefly closing the gender gap, but use by men has 
consistently been slightly higher since then. Since 2003, both have shown uneven declines 
through 2018. Both genders have shown declines in annual use of sedatives from the early 
2000s through 2011 and converging during this period. Both then showed a slight rebound 
through 2014, followed by a leveling for men and decline for women, which has opened a 
gender gap. 
 
 Among college students, the annual prevalence of alcohol use has been virtually identical 
for the two genders since 1980, when use by college students was first reported (Figure 9-
15a). Both college men and women have shown a very gradual and modest decline over 
the past 35 years. Prior to 2000, 30-day alcohol prevalence showed modest differences, 
with men slightly higher (Figure 9-15b); however, that difference largely disappeared by 
2000. Since then, college men have had very slightly higher 30-day rates more years than 
not; but that difference disappeared after 2015.  
 
College men have consistently had considerably higher rates of daily drinking than college 
women (Figures 9-15c and 9-15d). But since about 2004 or 2005 the gender gap in daily 
drinking has narrowed, with little change among college women but an overall decrease 
among college men. Both showed declines in 2017 to historic low levels, and remained 
level in 2018. 
 
 Binge drinking (having one or more occasions of having five or more drinks in a row in 
the prior two weeks) has shown a considerable gender gap, but a gradual long-term decline 
among college men since about 1985 that continued into 2018, reduced the gap (Figure 9-
15d). Because there has been little change among college women, whose use has been 
consistently less than that of college men, the gender gap has narrowed. The gap in 2016 
was the lowest it had been, with men at 35% and women at 31%. In 2018, binge drinking 
declined nonsignificantly for both (32% and 27%, respectively), again narrowing the gap 
and representing new historic lows for both; the five-year decline was significant for men, 
but not for women.  
 
 The gender gap in extreme binge drinking also shows signs of decreasing, though two-
week prevalence remains much higher among men (Tables 9-5 and 9-6). Between 2005-
2011 and 2012-2018, having ten or more drinks in a row dropped from 24% to 15% for 
college men, whereas it declined somewhat for college women from 7% to 6%; 
corresponding prevalence for having 15 or more drinks in a row dropped for men from 
10.1% to 6.0%, and dropped from 1.8% to 1.4% for women. 
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  For the interval between 1980 and 1988, the 30-day prevalence of cigarette smoking was 
higher among college women than men (Figure 9-16a). However, the difference in 30-day 
prevalence narrowed because use by college women declined considerably between 1980 
and 1989, while use by college men did not decline. After 1989, as prevalence for both 
genders increased considerably, the difference remained quite small and the genders 
reversed position, with college men catching up to and passing women in their rate of 
smoking by 1994 and then generally remaining higher thereafter. (A similar reversal had 
occurred among 12th graders a few years earlier, so the reversal among college students 
probably reflected a cohort effect.) Both genders exhibited a considerable decrease in 30-
day smoking between 1999 and 2011, leaving only a modest difference between them 
(although the trend line for college men was irregular during this interval). Use then leveled 
for men through 2015 and continued to drop for women, widening the difference between 
them somewhat. In 2016 it dropped for men more than for women. Use leveled for men in 
2017 (11%) and continued to decline for women (6%). In 2018 the 30-day prevalence 
levels dropped nonsignificantly for both (to 10% and 5%, respectively), at new historic 
lows. Daily smoking and half-pack-a-day smoking (Figures 9-16b and c) also were initially 
higher among college women than among college men, this time up through 1994, after 
which the two genders have tracked rather closely, both reaching historic lows in 2017 or 
2018. It thus appears that college men in recent years have been more likely than college 
women to smoke at a less than daily rate but about equally likely as women to smoke at 
more frequent rates, though daily use is now very low for both.  
 
 Among college students, 30-day prevalence of vaping nicotine increased significantly 
from 2017 to 2018 for both men (10.6% to 22.3%) and women (3.2% to 11.5%), showing 
a considerable gender gap both years. Among noncollege respondents between 2017 and 
2018, it was level for men (12.4% both years) and increased significantly for women (from 
4.9% to 12.6%), with no gender gap in 2018. 
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Any Illicit Drug a 69.4 66.8 64.6 66.9 62.7 65.2 61.8 60.0 58.4 55.6 54.0 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2
Any Illicit Drug other than Marijuana a 42.2 41.3 39.6 41.7 38.6 40.0 37.5 35.7 33.4 30.5 28.4 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5
Marijuana 65.0 63.3 60.5 63.1 59.0 60.6 57.9 55.8 54.3 51.3 49.1 46.3 44.1 42.0 42.2 41.7 45.1 46.1 49.9 50.8
Inhalants b 10.2 8.8 10.6 11.0 10.4 10.6 11.0 13.2 12.6 15.0 13.9 14.4 14.2 14.8 12.0 13.8 11.4 12.4 12.8 12.4
Hallucinogens c,x 15.0 12.0 15.0 12.2 12.9 11.4 11.2 10.9 10.2 10.7 11.2 11.3 12.0 11.8 10.0 13.0 12.6 13.8 15.2 14.8
     LSD x 10.3 8.5 11.5 8.8 9.4 7.4 7.7 8.0 7.5 7.8 9.1 9.6 10.6 10.6 9.2 11.5 10.8 11.7 13.1 12.7
     Hallucinogens other than LSD c,x 11.6 9.0 10.6 8.3 9.2 8.1 7.8 6.8 6.2 6.2 6.0 6.0 5.7 5.4 4.4 6.5 6.5 7.5 8.7 8.8
     MDMA (ecstasy, molly), original d,z — — — — — — — — — 3.8 3.9 2.0 2.9 2.3 2.1 3.1 4.3 4.6 6.8 8.4
     MDMA (ecstasy, molly), revised d,z — — — — — — — — — — — — — — — — — — — —
Cocaine 22.0 21.5 22.4 23.1 21.7 22.9 23.3 20.6 15.8 14.6 11.4 9.4 7.9 6.3 5.0 5.5 5.0 5.6 8.1 8.4
     Crack e — — — — — — — 3.3 3.4 2.4 1.4 1.5 1.7 1.3 1.0 1.8 1.2 1.4 2.2 2.4
     Other Cocaine f — — — — — — — 18.1 14.2 16.0 10.2 9.0 7.6 6.3 4.6 5.2 4.6 5.0 7.4 7.8
Heroin 0.9 0.6 0.5 0.3 0.5 0.4 0.4 0.6 0.3 0.7 0.3 0.5 0.5 0.6 0.1 0.6 0.7 0.9 1.7 0.9
Narcotics other than Heroin g,h 8.9 8.3 8.1 8.4 8.9 6.3 8.8 7.6 6.3 7.6 6.8 7.3 7.3 6.2 5.1 7.2 5.7 8.2 8.7 8.7
Amphetamines g,i 29.5 29.4 30.1 27.8 27.8 25.4 22.3 19.8 17.7 14.6 13.2 13.0 10.5 10.1 9.2 10.7 9.5 10.6 10.6 11.9
     Methamphetamine j — — — — — — — — — — — — — — — — — — — 7.1
     Crystal Methamphetamine (Ice) j — — — — — — — — — — 1.0 1.3 0.6 1.6 1.3 1.0 0.8 1.6 2.2 2.8
Sedatives (Barbiturates) g,t 8.1 7.8 8.2 6.6 6.4 4.9 5.4 3.5 3.6 3.2 3.8 3.5 3.8 3.5 3.2 4.0 4.6 5.2 5.7 6.7
    Sedatives, Adjusted g,k 13.7 14.2 14.1 12.2 10.8 9.3 8.0 6.1 4.7 4.1 — — — — — — — — — —
    Methaqualone g 10.3 10.4 11.1 9.2 9.0 7.2 5.8 4.1 2.2 2.4 — — — — — — — — — —
Tranquilizers g,l 15.2 11.4 11.7 10.8 10.8 9.8 10.7 8.7 8.0 8.0 7.1 6.8 6.9 6.3 4.4 5.4 5.4 6.9 7.7 8.2
Alcohol m 94.3 95.2 95.2 95.0 94.2 95.3 94.9 94.1 94.9 93.7 93.1 93.6 91.8 89.3 88.2 88.5 88.4 87.3 88.5 88.0
     Been Drunk n — — — — — — — — — — — 79.6 76.8 76.4 74.4 76.6 76.2 77.0 76.8 75.1
     Flavored Alcoholic Beverages o — — — — — — — — — — — — — — — — — — — —
Cigarettes — — — — — — — — — — — — — — — — — — — —
Any Vaping j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — — — —
Steroids p — — — — — — — — — 0.4 1.5 1.4 1.7 1.9 0.5 0.8 0.6 1.6 0.9 1.3
(Table continued on next page.)
TABLE 9-1
Trends in Lifetime Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Years 
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880 900
Any Illicit Drug a 53.7 53.6 51.8 53.9 52.2 52.3 50.6 50.5 49.5 51.4 49.1 49.2 50.5 53.3 52.4 53.4 54.4 55.4 55.5 +0.1
Any Illicit Drug other than Marijuana a 25.8 26.3 26.9 27.6 28.0 26.5 26.3 25.3 22.6 25.6 24.8 24.3 23.8 28.3 29.0 26.4 26.5 26.1 27.1 +1.0
Marijuana 51.2 51.0 49.5 50.7 49.1 49.1 46.9 47.5 46.8 47.5 46.8 46.6 49.1 47.7 48.5 50.4 51.0 50.5 52.4 +1.9
Inhalants b 12.9 9.6 7.7 9.7 8.5 7.1 7.4 6.3 4.9 6.9 5.5 3.7 5.7 4.3 3.5 3.1 3.2 3.4 3.0 -0.4
Hallucinogens c,x 14.4 14.8 13.6 14.5 12.0 11.0 10.6 9.1 8.5 8.0 7.8 7.4 7.6 7.8 7.6 6.5 7.7 7.2 8.5 +1.3
     LSD x 11.8 12.2 8.6 8.7 5.6 3.7 3.5 3.3 4.3 3.3 4.0 3.7 3.1 4.4 4.5 4.8 5.1 5.3 6.9 +1.7
     Hallucinogens other than LSD c,x 8.2 10.7 11.0 12.8 10.1 10.6 10.1 8.5 8.2 7.8 7.1 6.9 7.2 6.8 6.8 5.1 6.6 5.0 5.0 0.0
     MDMA (ecstasy, molly), original d,z 13.1 14.7 12.7 12.9 10.2 8.3 6.9 5.4 6.2 6.5 6.2 6.8 8.7 8.1 8.2 — — — — —
     MDMA (ecstasy, molly), revised d,z — — — — — — — — — — — — — — 8.1 8.9 8.4 5.3 7.6 +2.3
Cocaine 9.1 8.6 8.2 9.2 9.5 8.8 7.7 8.5 7.2 8.1 6.6 5.5 5.2 5.1 6.2 6.1 5.3 6.5 7.5 +1.0
     Crack e 2.5 2.0 1.9 3.1 2.0 1.7 2.3 1.3 1.4 1.0 1.2 0.8 0.7 0.7 1.4 0.5 0.4 0.6 0.6 0.0
     Other Cocaine f 8.1 8.3 8.6 8.5 9.3 8.1 6.2 8.0 7.1 7.9 6.7 5.4 5.1 5.2 6.2 6.4 6.5 6.1 6.7 +0.6
Heroin 1.7 1.2 1.0 1.0 0.9 0.5 0.7 0.5 0.7 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.5 0.1 0.1 +0.1
Narcotics other than Heroin g,h 8.9 11.0 12.2 14.2 13.8 14.4 14.6 14.1 12.4 14.0 12.2 12.4 10.3 10.8 9.9 6.6 7.4 6.8 6.6 -0.2
Amphetamines g,i 12.3 12.4 11.9 12.3 12.7 12.3 10.7 11.2 9.1 11.8 12.1 13.4 14.4 16.1 15.0 13.9 13.6 12.6 13.2 +0.5
     Methamphetamine j 5.1 5.3 5.0 5.8 5.2 4.1 2.9 1.9 1.9 1.0 1.1 0.6 0.3 0.9 0.7 0.8 0.6 0.6 1.0 +0.4
     Crystal Methamphetamine (Ice) j 1.3 2.3 2.0 2.9 2.2 2.4 1.7 1.3 1.1 0.7 0.8 0.2 0.6 0.0 0.3 0.3 0.6 0.4 0.8 +0.4
Sedatives (Barbiturates) g,t 6.9 6.0 5.9 5.7 7.2 8.5 6.3 5.9 6.4 6.0 5.3 3.6 3.5 5.4 5.9 4.4 3.3 3.9 3.3 -0.6
    Sedatives, Adjusted g,k — — — — — — — — — — — — — — — — — — — —
    Methaqualone g — — — — — — — — — — — — — — — — — — — —
Tranquilizers g,l 8.8 9.7 10.7 11.0 10.6 11.9 10.0 9.1 8.6 9.2 8.1 7.1 6.4 7.8 6.9 7.8 6.5 6.7 7.4 +0.7
Alcohol m 86.6 86.1 86.0 86.2 84.6 86.6 84.7 83.1 85.3 82.6 82.3 80.5 81.0 78.0 79.4 81.4 81.3 79.1 77.4 -1.7
     Been Drunk n 74.7 76.1 75.1 74.9 73.4 72.9 73.1 71.6 72.5 69.1 70.5 67.9 70.0 66.5 68.8 68.6 66.7 64.8 66.8 +2.0
     Flavored Alcoholic Beverages o — — — — 79.0 84.5 80.9 80.6 78.6 78.1 77.4 76.7 76.6 67.5 72.7 74.8 76.1 72.4 71.0 -1.4
Cigarettes — — — — — — — — — — — — — — — — — — — —
Any Vaping j,aa — — — — — — — — — — — — — — — 26.0 26.8 36.0 39.9 +3.9
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — 14.4 23.8 +9.5 ss
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — 22.5 32.4 +9.9 ss
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — 26.7 27.1 +0.4
Steroids p 0.6 1.5 1.2 1.2 1.6 1.0 1.9 0.6 1.6 1.3 0.7 1.1 0.4 0.8 0.9 0.6 0.8 1.2 0.3 -0.9
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Any Illicit Drug a 56.2 55.0 49.5 49.8 45.1 46.3 45.0 40.1 37.4 36.7 33.3 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9
Any Illicit Drug other than Marijuana a 32.3 31.7 29.9 29.9 27.2 26.7 25.0 21.3 19.2 16.4 15.2 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4
Synthetic Marijuana u — — — — — — — — — — — — — — — — — — — —
Marijuana 51.2 51.3 44.7 45.2 40.7 41.7 40.9 37.0 34.6 33.6 29.4 26.5 27.7 27.9 29.3 31.2 33.1 31.6 35.9 35.2
Inhalants b 3.0 2.5 2.5 2.8 2.4 3.1 3.9 3.7 4.1 3.7 3.9 3.5 3.1 3.8 3.0 3.9 3.6 4.1 3.0 3.2
Hallucinogens c,x 8.5 7.0 8.7 6.5 6.2 5.0 6.0 5.9 5.3 5.1 5.4 6.3 6.8 6.0 6.2 8.2 6.9 7.7 7.2 7.8
     LSD x 6.0 4.6 6.3 4.3 3.7 2.2 3.9 4.0 3.6 3.4 4.3 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4
     Hallucinogens other than LSD c,x 5.2 4.7 5.4 3.9 4.1 3.9 3.8 3.1 3.4 3.1 3.0 3.1 2.6 2.7 2.8 4.0 4.1 4.9 4.4 4.5
     MDMA (ecstasy, molly), original d,z — — — — — — — — — 2.3 2.3 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5
     MDMA (ecstasy, molly), revised d,z — — — — — — — — — — — — — — — — — — — —
     Salvia v — — — — — — — — — — — — — — — — — — — —
Cocaine 16.8 16.0 17.2 17.3 16.3 17.3 17.1 13.7 10.0 8.2 5.6 3.6 3.0 2.7 2.0 3.6 2.9 3.4 4.6 4.6
     Crack e — — — — — — — 2.0 1.4 1.5 0.6 0.5 0.4 0.6 0.5 1.1 0.6 0.4 1.0 0.9
     Other Cocaine f — — — — — — — 10.7 10.6 9.3 5.1 3.2 2.4 2.5 1.8 3.3 2.3 3.0 4.2 4.2
Heroin 0.4 0.2 0.1 * 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.2
Narcotics other than Heroin g,h 5.1 4.3 3.8 3.8 3.8 2.4 4.0 3.1 3.1 3.2 2.9 2.7 2.7 2.5 2.4 3.8 3.1 4.2 4.2 4.3
     OxyContin g,j — — — — — — — — — — — — — — — — — — — —
     Vicodin g,j — — — — — — — — — — — — — — — — — — — —
Amphetamines g,i 22.4 22.2 21.1 17.3 15.7 11.9 10.3 7.2 6.2 4.6 4.5 3.9 3.6 4.2 4.2 5.4 4.2 5.7 5.1 5.8
     Ritalin g,j — — — — — — — — — — — — — — — — — — — —
     Adderall g,j — — — — — — — — — — — — — — — — — — — —
     Methamphetamine j — — — — — — — — — — — — — — — — — — — 3.3
      Crystal Methamphetamine (Ice) j — — — — — — — — — — 0.1 0.1 0.2 0.7 0.8 1.1 0.4 0.8 1.0 0.5
     Bath Salts (synthetic stimulants) n — — — — — — — — — — — — — — — — — — — —
Sedatives (Barbiturates) g,t 2.9 2.8 3.2 2.2 1.9 1.3 2.0 1.2 1.1 1.0 1.4 1.2 1.4 1.5 1.2 2.0 2.3 3.0 2.5 3.2
    Sedatives, Adjusted g,k 8.3 8.0 8.0 4.5 3.5 2.5 2.6 1.7 1.5 1.0 — — — — — — — — — —
    Methaqualone g 7.2 6.5 6.6 3.1 2.5 1.4 1.2 0.8 0.5 0.2 — — — — — — — — — —
Tranquilizers g,l 6.9 4.8 4.7 4.6 3.5 3.6 4.4 3.8 3.1 2.6 3.0 2.4 2.9 2.4 1.8 2.9 2.8 3.8 3.9 3.8
Rohypnol j — — — — — — — — — — — — — — — — — — — —
GHB w — — — — — — — — — — — — — — — — — — — —
Ketamine w — — — — — — — — — — — — — — — — — — — —
Alcohol m 90.5 92.5 92.2 91.6 90.0 92.0 91.5 90.9 89.6 89.6 89.0 88.3 86.9 85.1 82.7 83.2 83.0 82.4 84.6 83.6
     Been Drunk n — — — — — — — — — — — 69.1 67.3 65.6 63.1 62.1 64.2 66.8 67.0 65.4
     Flavored Alcoholic Beverages o — — — — — — — — — — — — — — — — — — — —
     Alcoholic Beverages 
          containing Caffeine j,s — — — — — — — — — — — — — — — — — — — —
Cigarettes 36.2 37.6 34.3 36.1 33.2 35.0 35.3 38.0 36.6 34.2 35.5 35.6 37.3 38.8 37.6 39.3 41.4 43.6 44.3 44.5
Any Vaping j,aa,bb — — — — — — — — — — — — — — — — — — — —
     Vaping Marijuana j,aa,cc — — — — — — — — — — — — — — — — — — — —
     Vaping Nicotine j,aa,dd — — — — — — — — — — — — — — — — — — — —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — — — —
Tobacco Using a Hookah j — — — — — — — — — — — — — — — — — — — —
Small Cigars y — — — — — — — — — — — — — — — — — — — —
Snus j — — — — — — — — — — — — — — — — — — — —
Dissolvable Tobacco j — — — — — — — — — — — — — — — — — — — —
Steroids p — — — — — — — — — 0.4 0.5 0.6 0.2 0.9 0.2 0.4 0.2 0.7 0.2 0.9
(Table continued on next page.)
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880 900
Any Illicit Drug a 36.1 37.9 37.0 36.5 36.2 36.6 33.9 35.0 35.2 36.0 35.0 36.3 37.3 40.5 38.6 41.4 42.8 42.4 45.2 +2.7
Any Illicit Drug other than Marijuana a 15.6 16.4 16.6 17.9 18.6 18.5 18.1 17.3 15.3 16.9 17.1 16.8 17.1 19.3 20.8 18.5 19.7 18.1 18.0 -0.1
Synthetic Marijuana u — — — — — — — — — — — 8.5 5.3 2.3 0.9 1.5 1.3 0.5 1.6 +1.1
Marijuana 34.0 35.6 34.7 33.7 33.3 33.3 30.2 31.8 32.3 32.8 32.7 33.2 34.9 35.5 34.4 37.9 39.3 38.3 42.6 +4.3
Inhalants b 2.9 2.8 2.0 1.8 2.7 1.8 1.5 1.5 1.1 1.2 1.7 0.9 1.5 0.5 1.3 0.6 0.2 1.7 1.3 -0.5
Hallucinogens c,x 6.7 7.5 6.3 7.4 5.9 5.0 5.6 4.9 5.1 4.7 4.9 4.1 4.5 4.5 4.0 4.3 4.5 4.1 5.1 +1.1
     LSD x 4.3 4.0 2.1 1.4 1.2 0.7 1.4 1.3 2.6 2.0 2.1 2.0 1.9 2.6 2.2 3.0 3.1 2.8 4.1 +1.3
     Hallucinogens other than LSD c,x 4.4 5.5 5.8 7.1 5.6 5.0 5.4 4.7 4.4 4.1 4.4 3.4 3.9 3.7 3.2 3.0 3.4 2.5 2.4 -0.1
     MDMA (ecstasy, molly), original d,z 9.1 9.2 6.8 4.4 2.2 2.9 2.6 2.2 3.7 3.1 4.3 4.2 5.8 5.3 5.0 — — — — —
     MDMA (ecstasy, molly), revised d,z — — — — — — — — — — — — — — 4.9 4.2 4.7 2.5 4.3 +1.8
     Salvia v — — — — — — — — — 5.8 3.5 3.1 1.5 1.0 1.1 0.4 0.7 0.3 0.9 +0.5
Cocaine 4.8 4.7 4.8 5.4 6.6 5.7 5.1 5.4 4.4 4.2 3.5 3.3 3.1 2.7 4.4 4.3 4.0 4.8 5.2 +0.5
     Crack e 0.9 0.9 0.4 1.3 1.3 0.8 1.0 0.6 0.5 0.3 0.4 0.3 0.3 0.3 0.8 0.2 0.0 0.2 0.4 +0.2
     Other Cocaine f 4.1 4.1 5.0 5.1 6.3 5.0 3.8 5.3 4.2 4.2 4.0 3.0 3.0 2.8 4.1 4.2 4.7 4.4 4.6 +0.2
Heroin 0.5 0.4 0.1 0.2 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.1 0.1 0.3 0.0 0.1 0.2 0.0 * 0.0  
Narcotics other than Heroin g,h 4.5 5.7 7.4 8.7 8.2 8.4 8.8 7.7 6.5 7.6 7.2 6.2 5.4 5.4 4.8 3.3 3.8 3.1 2.7 -0.4
     OxyContin g,q — — 1.5 2.2 2.5 2.1 3.0 2.8 3.6 5.0 2.3 2.4 1.2 2.3 1.3 1.5 1.9 1.7 1.6 -0.2
     Vicodin g,q — — 6.9 7.5 7.4 9.6 7.6 6.7 6.7 8.4 4.9 5.8 3.8 4.4 2.8 1.6 1.3 1.1 1.5 +0.4
Amphetamines g,i 6.6 7.2 7.0 7.1 7.0 6.7 6.0 6.9 5.7 7.5 9.0 9.3 11.1 9.6 10.1 9.7 9.8 8.6 8.3 -0.2
     Ritalin g,q — — 5.7 4.7 4.7 4.2 3.9 3.7 3.2 1.7 1.9 2.3 1.8 3.6 1.6 2.0 2.4 1.4 1.3 -0.2
     Adderall g,q — — — — — — — — — 10.2 9.0 9.8 9.0 10.7 9.6 10.7 9.9 9.4 11.0 +1.6
     Methamphetamine j 1.6 2.4 1.2 2.6 2.9 1.7 1.2 0.4 0.5 0.3 0.4 0.2 0.0 0.4 0.1 0.5 0.0 0.4 0.4 -0.1
     Crystal Methamphetamine (Ice) j 0.5 0.6 0.8 0.9 1.1 1.4 0.6 0.7 0.1 0.1 0.5 0.1 0.6 * * * * 0.4 * -0.4
     Bath Salts (synthetic stimulants) n — — — — — — — — — — — — 0.3 0.1 0.2 0.1 0.0 0.2 * -0.2
Sedatives (Barbiturates) g,t 3.7 3.8 3.7 4.1 4.2 3.9 3.4 3.6 3.7 3.1 2.5 1.7 2.2 2.7 3.1 2.3 2.1 1.9 1.5 -0.4
    Sedatives, Adjusted g,k — — — — — — — — — — — — — — — — — — — —
    Methaqualone g — — — — — — — — — — — — — — — — — — — —
Tranquilizers g,l 4.2 5.1 6.7 6.9 6.7 6.4 5.8 5.5 5.0 5.4 4.9 4.2 3.4 4.4 3.5 4.3 4.9 3.6 3.5 -0.1
Rohypnol j — — 0.7 0.4 0.3 0.1 0.2 0.1 0.3 * — — — — — — — — — —
GHB w — — 0.6 0.3 0.7 0.4 * 0.1 0.2 * 0.1 0.1 * 0.1 0.2 * — — — —
Ketamine w — — 1.3 1.0 1.5 0.5 0.9 0.2 0.4 0.1 0.7 0.6 0.4 0.9 0.1 0.6 0.5 0.3 0.9 +0.6
Alcohol m 83.2 83.0 82.9 81.7 81.2 83.0 82.1 80.9 82.1 79.4 78.6 77.4 79.2 75.6 76.1 79.0 78.9 75.8 74.6 -1.2
     Been Drunk n 64.7 68.8 66.0 64.7 67.1 64.2 66.2 64.8 66.8 61.5 63.8 60.1 61.5 57.9 60.5 61.6 60.7 58.0 59.2 +1.2
     Flavored Alcoholic Beverages o — — — — 63.2 67.0 63.5 62.6 65.0 66.1 60.3 63.0 58.1 57.6 64.2 64.5 68.5 60.3 58.4 -1.9
     Alcoholic Beverages 
          containing Caffeine j,s — — — — — — — — — — — 33.6 33.8 39.1 32.8 34.1 29.4 31.3 27.4 -3.9
Cigarettes 41.3 39.0 38.3 35.2 36.7 36.0 30.9 30.7 30.0 29.9 28.1 25.8 23.4 23.2 22.6 20.1 18.7 16.7 15.5 -1.3
Any Vaping j,aa,bb — — — — — — — — — — — — — — — — — 23.5 32.4 +8.9 s
     Vaping Marijuana j,aa,cc — — — — — — — — — — — — — — — — — 10.7 20.2 +9.4 ss
     Vaping Nicotine j,aa,dd — — — — — — — — — — — — — — — — — 13.0 25.6 +12.6 sss
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — 13.1 14.0 +0.9
Tobacco Using a Hookah j — — — — — — — — — — — 27.9 25.7 26.1 32.7 23.4 16.9 10.0 11.4 +1.4
Small Cigars y — — — — — — — — — — — 23.6 20.3 19.0 24.2 19.6 17.6 14.0 15.6 +1.6
Snus j — — — — — — — — — — — 6.5 4.7 4.8 5.0 5.8 3.3 4.3 1.0 -3.3
Dissolvable Tobacco j — — — — — — — — — — — * 0.3 0.2 0.5 1.1 0.3 0.7 0.0 -0.7
Steroids p 0.1 0.6 0.5 0.3 0.6 0.5 0.8 0.6 0.1 0.7 0.3 0.2 0.3 0.8 0.5 0.3 0.0 0.6 0.0 -0.6
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Any Illicit Drug a 38.4 37.6 31.3 29.3 27.0 26.1 25.9 22.4 18.5 18.2 15.2 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6
Any Illicit Drug other than Marijuana a 20.7 18.6 17.1 13.9 13.8 11.8 11.6 8.8 8.5 6.9 4.4 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4
Marijuana 34.0 33.2 26.8 26.2 23.0 23.6 22.3 20.3 16.8 16.3 14.0 14.1 14.6 14.2 15.1 18.6 17.5 17.7 18.6 20.7
Inhalants b 1.5 0.9 0.8 0.7 0.7 1.0 1.1 0.9 1.3 0.8 1.0 0.9 1.1 1.3 0.6 1.6 0.8 0.7 0.6 1.5
Hallucinogens c,x 2.7 2.3 2.6 1.8 1.8 1.3 2.2 2.0 1.7 2.3 1.4 1.2 2.3 2.5 2.1 3.3 1.9 2.1 2.1 2.0
     LSD x 1.4 1.4 1.7 0.9 0.8 0.7 1.4 1.4 1.1 1.4 1.1 0.8 1.8 1.6 1.8 2.5 0.9 1.1 1.5 1.2
     Hallucinogens other than LSD c,x 1.9 1.2 1.4 1.0 1.2 0.7 1.2 0.8 0.8 1.1 0.8 0.6 0.7 1.1 0.8 1.6 1.2 1.2 0.7 1.2
     MDMA (ecstasy, molly), original d,z — — — — — — — — — 0.3 0.6 0.2 0.4 0.3 0.2 0.7 0.7 0.8 0.8 2.1
     MDMA (ecstasy, molly), revised d,z — — — — — — — — — — — — — — — — — — — —
Cocaine 6.9 7.3 7.9 6.5 7.6 6.9 7.0 4.6 4.2 2.8 1.2 1.0 1.0 0.7 0.6 0.7 0.8 1.6 1.6 1.2
     Crack e — — — — — — 1.3 0.4 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3
     Other Cocaine f — — — — — — — 3.5 3.2 3.2 1.0 1.0 0.9 0.6 0.3 0.8 0.6 1.3 1.5 1.0
Heroin 0.3 * * * * * * 0.1 0.1 0.1 * 0.1 * * * 0.1 * 0.2 0.1 0.1
Narcotics other than Heroin g,h 1.8 1.1 0.9 1.1 1.4 0.7 0.6 0.8 0.8 0.7 0.5 0.6 1.0 0.7 0.4 1.2 0.7 1.3 1.1 1.0
Amphetamines g,i 13.4 12.3 9.9 7.0 5.5 4.2 3.7 2.3 1.8 1.3 1.4 1.0 1.1 1.5 1.5 2.2 0.9 2.1 1.7 2.3
     Methamphetamine j — — — — — — — — — — — — — — — — — — — 1.2
     Crystal Methamphetamine (Ice) j — — — — — — — — — — * * * 0.3 0.5 0.3 0.1 0.2 0.3 *
Sedatives (Barbiturates) g,t 0.9 0.8 1.0 0.5 0.7 0.4 0.6 0.5 0.5 0.2 0.2 0.3 0.7 0.4 0.4 0.5 0.8 1.2 1.1 1.1
    Sedatives, Adjusted g,k 3.8 3.4 2.5 1.1 1.0 0.7 0.6 0.6 0.6 0.2 — — — — — — — — — —
    Methaqualone g 3.1 3.0 1.9 0.7 0.5 0.3 0.1 0.2 0.1 0.0 — — — — — — — — — —
Tranquilizers g,l 2.0 1.4 1.4 1.2 1.1 1.4 1.9 1.0 1.1 0.8 0.5 0.6 0.6 0.4 0.4 0.5 0.7 1.2 1.3 1.1
Alcohol m 81.8 81.9 82.8 80.3 79.1 80.3 79.7 78.4 77.0 76.2 74.5 74.7 71.4 70.1 67.8 67.5 67.0 65.8 68.1 69.6
     Been Drunk n — — — — — — — — — — — 45.0 45.0 43.8 42.8 37.9 40.3 46.4 44.3 44.6
     Flavored Alcoholic Beverages o — — — — — — — — — — — — — — — — — — — —
Cigarettes 25.8 25.9 24.4 24.7 21.5 22.4 22.4 24.0 22.6 21.1 21.5 23.2 23.5 24.5 23.5 26.8 27.9 28.3 30.0 30.6
Any Vaping j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Marijuana j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — — — —
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — — — —
Large Cigars o — — — — — — — — — — — — — — — — — — — —
Flavored Little Cigars o — — — — — — — — — — — — — — — — — — — —
Regular Little Cigars o — — — — — — — — — — — — — — — — — — — —
Steroids p — — — — — — — — — * 0.2 0.3 0.2 0.2 0.2 0.1 * 0.2 0.2 0.4
TABLE 9-3
Trends in 30-Day Prevalence of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Years 
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880 900
Any Illicit Drug a 21.5 21.9 21.5 21.4 21.2 19.5 19.2 19.3 18.9 20.7 19.2 21.4 22.3 22.8 22.7 23.4 24.3 23.3 26.3 +3.0
Any Illicit Drug other than Marijuana a 6.9 7.5 7.8 8.2 9.1 8.2 8.2 8.1 7.3 8.4 8.1 8.2 7.8 8.8 10.0 9.2 8.4 7.0 7.6 +0.6
Marijuana 20.0 20.2 19.7 19.3 18.9 17.1 16.7 16.8 17.0 18.5 17.5 19.4 20.5 20.6 20.8 21.1 22.2 21.2 24.7 +3.5
Inhalants b 0.9 0.4 0.7 0.4 0.4 0.3 0.4 0.1 0.4 0.1 0.5 0.3 0.2 0.1 0.3 0.2 * 0.9 0.2 -0.7
Hallucinogens c,x 1.4 1.8 1.2 1.8 1.3 1.2 0.9 1.3 1.7 1.0 1.4 1.2 1.1 1.0 1.0 1.4 0.8 1.2 1.1 -0.1
     LSD x 0.9 1.0 0.2 0.2 0.2 0.1 0.3 0.3 0.8 0.3 0.7 0.5 0.4 0.4 0.5 0.7 0.4 0.8 1.0 +0.1
     Hallucinogens other than LSD c,x 0.8 0.8 1.1 1.7 1.2 1.1 0.7 1.1 1.3 0.8 1.2 0.8 0.7 0.8 0.7 0.9 0.5 0.6 0.4 -0.2
     MDMA (ecstasy, molly), original d,z 2.5 1.5 0.7 1.0 0.7 0.8 0.6 0.4 0.6 0.5 1.0 0.7 1.4 0.8 1.3 — — — — —
     MDMA (ecstasy, molly), revised d,z — — — — — — — — — — — — — — 1.0 0.7 1.0 0.5 1.3 +0.8
Cocaine 1.4 1.9 1.6 1.9 2.4 1.8 1.8 1.7 1.2 1.3 1.0 1.2 1.1 0.9 1.8 1.5 1.4 1.3 2.2 +0.9
     Crack e 0.3 0.1 0.3 0.4 0.4 0.1 * 0.1 0.1 0.1 0.1 0.1 * 0.3 0.1 * * * 0.2 +0.2
     Other Cocaine f 0.9 1.5 1.4 1.9 2.2 1.8 1.3 1.6 1.1 1.2 1.0 1.2 1.3 0.9 1.8 1.4 1.7 1.1 1.9 +0.9
Heroin 0.2 0.1 * * 0.1 0.1 0.2 0.1 * 0.1 * * 0.1 0.2 * * 0.2 * * 0.0
Narcotics other than Heroin g,h 1.7 1.7 3.2 2.3 3.0 3.1 3.1 2.2 2.3 2.7 2.3 2.1 2.2 1.5 1.2 1.3 1.1 0.7 1.0 +0.3
Amphetamines g,i 2.9 3.3 3.0 3.1 3.2 2.9 2.5 3.1 2.8 3.4 4.1 4.5 4.6 5.0 4.8 4.2 3.8 3.6 2.9 -0.8
     Methamphetamine j 0.2 0.5 0.2 0.6 0.2 0.1 0.2 0.1 * 0.1 * * * * 0.1 * * * * 0.0
     Crystal Methamphetamine (Ice) j * 0.1 * 0.3 0.1 0.2 * 0.1 * * 0.2 * 0.3 * * * * 0.4 * -0.4
Sedatives (Barbiturates) g,t 1.1 1.5 1.7 1.7 1.5 1.3 1.3 1.4 1.4 1.2 0.6 0.8 0.8 0.9 0.7 1.0 0.9 0.5 0.5 0.0
    Sedatives, Adjusted g,k — — — — — — — — — — — — — — — — — — — —
    Methaqualone g — — — — — — — — — — — — — — — — — — — —
Tranquilizers g,l 2.0 1.5 3.0 2.8 2.7 2.2 2.1 1.8 1.6 2.2 1.3 1.6 1.1 1.2 1.7 1.6 1.8 0.9 1.1 +0.2
Alcohol m 67.4 67.0 68.9 66.2 67.7 67.9 65.4 66.6 69.0 65.8 65.0 63.5 67.7 63.1 63.1 63.2 63.2 62.0 59.6 -2.4
     Been Drunk n 43.9 44.7 44.4 40.4 47.4 43.1 47.6 46.8 45.3 42.4 43.6 39.9 40.1 40.2 42.6 38.4 40.8 34.8 37.8 +3.0
     Flavored Alcoholic Beverages o — — — — 34.0 30.9 26.2 27.5 35.8 32.3 31.5 29.5 31.3 29.1 32.9 30.5 33.5 36.7 30.9 -5.8
Cigarettes 28.2 25.7 26.7 22.5 24.3 23.8 19.2 19.9 17.9 17.9 16.4 15.2 12.5 14.0 12.9 11.3 8.9 8.0 6.8 -1.2
Any Vaping j,aa — — — — — — — — — — — — — — — 8.8 6.9 11.3 21.3 +10.0 sss
     Vaping Marijuana j,aa,ee — — — — — — — — — — — — — — — — — 5.2 10.9 +5.7 s
     Vaping Nicotine j,aa — — — — — — — — — — — — — — — — — 6.1 15.5 +9.4 sss
     Vaping Just Flavoring j,aa — — — — — — — — — — — — — — — — — 4.3 4.8 +0.6
Large Cigars o — — — — — — — — — — — — — — 8.4 4.9 4.4 1.7 3.7 +2.1
Flavored Little Cigars o — — — — — — — — — — — — — — 9.8 5.6 5.6 4.9 5.6 +0.7
Regular Little Cigars o — — — — — — — — — — — — — — 8.6 4.1 3.6 1.7 1.4 -0.3
Steroids p * 0.3 * 0.1 * * * 0.1 * 0.2 * 0.2 * * * 0.3 * 0.3 * -0.3
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
TABLE 9-3 (cont.)
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1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Approximate Weighted N = 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
Marijuana 7.2 5.6 4.2 3.8 3.6 3.1 2.1 2.3 1.8 2.6 1.7 1.8 1.6 1.9 1.8 3.7 2.8 3.7 4.0 4.0
Cocaine 0.2 * 0.3 0.1 0.4 0.1 0.1 0.1 0.1  * *  * * * 0.1 * * * * *
Amphetamines g 0.5 0.4 — — — — — — — — — — — — — — — — — —
Amphetamines, Adjusted g,i — — 0.3 0.2 0.2  * 0.1 0.1  *  * * 0.1 * 0.1 0.1 0.1  * 0.2 0.1 0.1
Alcohol m
     Daily 6.5 5.5 6.1 6.1 6.6 5.0 4.6 6.0 4.9 4.0 3.8 4.1 3.7 3.9 3.7 3.0 3.2 4.5 3.9 4.5
     Been Drunk n — — — — — — — — — — — 0.5 0.2 0.3 0.8 0.5 0.1 1.3 0.8 1.0
     5+ Drinks in a Row in Last 2 Weeks 43.9 43.6 44.0 43.1 45.4 44.6 45.0 42.8 43.2 41.7 41.0 42.8 41.4 40.2 40.2 38.6 38.3 40.7 38.9 40.0
     10+ Drinks in a Row in Last 2 Weeks o — — — — — — — — — — — — — — — — — — — —
     15+ Drinks in a Row in Last 2 Weeks o — — — — — — — — — — — — — — — — — — — —
Cigarettes
     Daily 18.3 17.1 16.2 15.3 14.7 14.2 12.7 13.9 12.4 12.2 12.1 13.8 14.1 15.2 13.2 15.8 15.9 15.2 18.0 19.3
     1/2 Pack+/Day 12.7 11.9 10.5 9.6 10.2 9.4 8.3 8.2 7.3 6.7 8.2 8.0 8.9 8.9 8.0 10.2 8.5 9.1 11.3 11.0
TABLE 9-4
Trends in 30-Day Prevalence of Daily r Use of Various Types of Drugs
among College Students 1 to 4 Years beyond High School
(Entries are percentages.)
(Table continued on next page.)
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Approximate Weighted N = 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 880 900
Marijuana 4.6 4.5 4.1 4.7 4.5 4.0 4.3 3.5 3.9 4.9 4.4 4.7 4.8 5.1 5.9 4.6 4.9 4.4 5.8 +1.4
Cocaine * * * * * 0.1 0.1 * * * * * * * * * 0.1 * * 0.0
Amphetamines g — — — — — — — — — — — — — — — — — — — —
Amphetamines, Adjusted g,i 0.1 0.2 0.1 0.3 0.2 0.2 0.4 0.1 0.2 0.1 * 0.2 0.1 * 0.2 0.1 * 0.1 0.0 -0.1
Alcohol m
     Daily 3.6 4.7 5.0 4.3 3.7 4.6 4.8 4.3 4.0 4.3 3.6 3.8 3.9 3.6 4.3 3.1 4.3 2.2 2.3 +0.2
     Been Drunk n 0.7 0.5 0.8 1.1 0.8 0.5 0.6 0.7 0.5 0.7 0.3 1.3 0.4 0.5 0.4 0.7 0.4 0.0 0.6 +0.6
     5+ Drinks in a Row in Last 2 Weeks 39.3 40.9 40.1 38.5 41.7 40.1 40.2 41.1 40.0 36.9 37.0 36.1 37.4 35.2 35.4 31.9 32.4 32.7 28.4 -4.3 s
     10+ Drinks in a Row in Last 2 Weeks o — — — — — 12.5 13.7 13.9 13.0 15.8 11.6 14.6 13.7 10.4 9.1 7.3 9.0 10.5 5.1 -5.4
     15+ Drinks in a Row in Last 2 Weeks o — — — — — 5.1 4.2 5.1 4.7 6.4 4.0 5.4 4.7 3.6 5.1 1.2 2.1 1.3 3.4 +2.1
Cigarettes
     Daily 17.8 15.0 15.9 13.8 13.8 12.4 9.2 9.3 9.2 8.0 7.6 7.3 5.2 5.6 5.2 4.2 2.6 2.0 1.9 -0.1
     1/2 Pack+/Day 10.1 7.8 7.9 7.6 6.8 6.7 4.9 4.3 4.3 3.8 3.9 2.5 2.4 2.4 2.4 1.4 1.7 0.2 0.5 +0.3
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes following Table 9-7.
TABLE 9-4 (cont.)
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Total 2005-2011 2012-2018 Change
Full-Time College 13.6 9.5 -4.1
Weighted N 1296 1162
Others 11.8 10.2 -1.6
Weighted N 884 662
Males
Full-Time College 23.6 15.1 -8.5
Weighted N 584 430
Others 17.9 16.1 -1.8
Weighted N 373 298
Females
Full-Time College 7.2 6.1 -1.1
Weighted N 915 732
Others 7.4 5.4 -2.0
Weighted N 510 364
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 9-7.
TABLE 9-5
Trends in Having 10+ Drinks in a Row in the Last Two Weeks:
 Full-Time College Students vs. Others 
among Respondents 1 to 4 Years beyond High School
by Gender
(Entries are percentages.)
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Total 2005-2011 2012-2018 Change
Full-Time College 5.0 3.1 -1.9
Weighted N 1267 1162
Others 5.2 5.2 0.0
Weighted N 886 660
Males
Full-Time College 10.1 6.0 -4.1
Weighted N 585 430
Others 9.4 8.7 -0.7
Weighted N 373 296
Females
Full-Time College 1.8 1.4 -0.4
Weighted N 913 732
Others 2.1 2.3 +0.2
Weighted N 512 364
Source.  The Monitoring the Future study, the University of Michigan.
Notes.  ' * ' indicates a prevalence rate of less than 0.05%. 
See footnotes following Table 9-7.
TABLE 9-6
Trends in Having 15+ Drinks in a Row in the Last Two Weeks:
 Full-Time College Students vs. Others 
among Respondents 1 to 4 Years beyond High School
by Gender
(Entries are percentages.)
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1980 i 1981 i 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Any Illicit Drug
     Total 69.4 66.8 64.6 66.9 62.7 65.2 61.8 60.0 58.4 55.6 54.0 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2
     Males 71.0 67.5 68.1 71.3 66.4 69.8 64.7 63.5 56.0 56.5 52.5 51.3 50.8 45.7 49.5 47.3 50.3 52.1 54.4 58.4
     Females 67.5 66.3 61.5 63.0 59.2 61.6 59.4 57.4 60.2 54.9 55.1 49.7 47.1 46.0 42.6 44.3 45.6 46.7 52.0 49.6
Any Illicit Drug other than Marijuana
     Total 42.2 41.3 39.6 41.7 38.6 40.0 37.5 35.7 33.4 30.5 28.4 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5
     Males 42.8 39.8 45.1 44.6 40.9 42.1 38.2 37.2 31.8 30.6 26.2 27.6 26.3 24.3 24.6 26.6 25.0 27.3 27.3 29.4
     Females 41.6 42.6 34.7 39.2 36.4 38.3 37.0 34.6 34.6 30.4 30.1 24.3 26.1 24.3 20.1 22.9 21.2 22.2 23.3 22.8
Any Illicit Drug
     Total 56.2 55.0 49.5 49.8 45.1 46.3 45.0 40.1 37.4 36.7 33.3 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9
     Males 58.9 56.2 54.6 53.4 48.4 50.9 49.8 43.3 37.0 38.2 34.2 30.2 32.8 32.6 33.9 36.1 36.6 38.3 40.1 42.5
     Females 53.3 54.0 44.9 46.7 41.9 42.7 41.1 37.7 37.6 35.4 32.5 28.4 28.7 29.1 29.5 31.7 32.7 31.1 36.4 33.2
Any Illicit Drug other than Marijuana
     Total 32.3 31.7 29.9 29.9 27.2 26.7 25.0 21.3 19.2 16.4 15.2 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4
     Males 33.7 32.8 33.4 33.5 29.2 29.7 28.6 23.5 19.4 18.7 15.7 14.4 13.8 15.0 14.9 19.5 15.1 18.1 17.0 19.0
     Females 31.1 30.8 26.9 26.8 25.2 24.4 22.1 19.6 19.0 14.6 14.8 12.1 12.6 10.5 10.2 13.3 11.3 14.1 12.1 12.8
Any Illicit Drug
     Total 38.4 37.6 31.3 29.3 27.0 26.1 25.9 22.4 18.5 18.2 15.2 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6
     Males 42.9 40.6 37.7 33.8 30.4 29.9 31.0 24.0 18.8 20.0 18.2 16.0 18.0 16.0 20.5 23.7 20.6 23.4 23.1 26.7
     Females 34.0 34.8 25.6 25.5 23.7 23.2 21.7 21.1 18.3 16.7 12.7 14.6 14.5 14.5 12.7 15.7 15.8 16.2 17.6 18.1
Any Illicit Drug other than Marijuana
     Total 20.7 18.6 17.1 13.9 13.8 11.8 11.6 8.8 8.5 6.9 4.4 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4
     Males 22.8 18.6 20.2 16.0 16.1 12.6 14.4 9.0 8.2 8.0 4.9 4.8 5.1 7.3 6.2 8.8 6.1 7.8 8.6 7.5
     Females 18.7 18.5 14.2 12.1 11.5 11.2 9.3 8.5 8.8 6.0 4.0 3.9 4.2 3.8 3.4 4.5 3.4 6.1 4.6 5.6
All Respondents
     Total 1,040 1,130 1,150 1,170 1,110 1,080 1,190 1,220 1,310 1,300 1,400 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440
     Males 520 530 550 550 540 490 540 520 560 580 620 640 680 660 590 610 560 630 570 590
     Females 520 600 610 620 570 600 650 700 750 720 780 770 810 830 820 840 890 860 880 850
(Table continued on next page.)
Percentage who used in last 12 months
Percentage who used in last 30 days
Approximate Weighted N
Percentage who used in lifetime
TABLE 9-7
Trends in Lifetime, Annual, and 30-Day Prevalence of an Illicit Drug Use Index a
among College Students 1 to 4 Years beyond High School, by Gender
(Years 
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2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Any Illicit Drug
    Total 53.7 53.6 51.8 53.9 52.2 52.3 50.6 50.5 49.5 51.4 49.1 49.2 50.5 53.3 52.4 53.4 54.4 55.5 55.1 -0.4
     Males 54.4 53.9 54.3 54.1 54.9 54.2 55.0 52.3 50.7 53.2 53.5 52.3 52.4 53.7 54.5 55.1 54.5 57.8 57.7 -0.1
     Females 53.2 53.5 50.2 53.7 50.6 51.3 47.8 49.4 48.8 50.2 46.2 47.3 49.2 53.0 50.9 52.5 54.3 54.1 53.5 -0.5
Any Illicit Drug other than Marijuana
     Total 25.8 26.3 26.9 27.6 28.0 26.5 26.3 25.3 22.6 25.6 24.8 24.3 23.8 28.3 29.0 26.4 26.5 26.3 27.3 +1.0
     Males 28.9 27.0 30.4 27.6 31.1 29.0 29.2 26.5 25.2 29.9 27.8 27.8 26.0 30.4 29.8 31.0 28.1 27.0 32.5 +5.6
     Females 23.5 25.9 24.6 27.5 26.2 25.1 24.4 24.6 21.0 22.7 22.8 22.1 22.2 26.8 28.3 23.8 25.6 25.8 24.0 -1.8
Any Illicit Drug
     Total 36.1 37.9 37.0 36.5 36.2 36.6 33.9 35.0 35.2 36.0 35.0 36.3 37.3 40.5 38.6 41.4 42.8 42.5 44.9 +2.4
     Males 38.0 38.8 39.5 39.2 40.9 40.7 39.2 38.0 38.7 37.6 40.3 41.2 39.5 41.3 39.2 45.2 44.9 46.4 44.8 -1.7
     Females 34.7 37.3 35.4 34.8 33.4 34.2 30.6 33.1 32.9 35.0 31.6 33.2 35.7 40.0 38.2 39.2 41.5 40.0 45.0 +5.0
Any Illicit Drug other than Marijuana
     Total 15.6 16.4 16.6 17.9 18.6 18.5 18.1 17.3 15.3 16.9 17.1 16.8 17.1 19.3 20.8 18.5 19.7 18.2 18.2 0.0
     Males 18.6 17.2 19.2 19.3 22.1 21.1 22.6 19.0 17.8 19.7 20.3 20.1 19.6 22.0 21.8 24.6 22.7 19.8 21.1 +1.3
     Females 13.5 15.8 15.0 17.1 16.5 16.9 15.2 16.3 13.7 15.0 15.1 14.7 15.4 17.4 20.1 14.9 17.9 17.1 16.4 -0.7
Any Illicit Drug
     Total 21.5 21.9 21.5 21.4 21.2 19.5 19.2 19.3 18.9 20.7 19.2 21.4 22.3 22.8 22.7 23.4 24.3 23.5 26.7 +3.3
     Males 24.0 25.0 25.1 22.8 26.1 22.9 23.4 22.7 23.1 23.4 25.9 27.0 27.0 27.8 25.9 27.4 25.4 26.4 26.2 -0.3
     Females 19.6 19.8 19.3 20.5 18.4 17.5 16.6 17.1 16.2 19.0 15.0 17.9 19.1 19.3 20.2 21.1 23.6 21.5 27.1 +5.5 s
Any Illicit Drug other than Marijuana
     Total 6.9 7.5 7.8 8.2 8.2 8.2 8.1 7.3 8.4 8.1 8.2 7.8 8.8 10.0 9.2 8.4 7.0 7.7 +0.7
     Males 8.2 9.0 8.4 8.1 11.3 10.3 10.3 9.5 9.6 9.0 10.4 10.6 9.2 11.2 12.4 12.9 11.8 7.2 9.2 +2.0
     Females 6.0 6.4 7.4 8.3 7.8 7.0 6.9 7.2 5.8 8.0 6.7 6.7 6.8 7.2 8.3 7.1 6.4 6.9 6.7 -0.2
All Respondents
     Total 1,350 1,340 1,260 1,270 1,400 1,360 1,280 1,250 1,270 1,320 1,260 1,230 1,150 1,090 1,030 1,020 870 870 880
     Males 560 540 490 480 520 500 500 470 510 530 500 480 480 430 440 380 340 340 340
     Females 790 800 770 790 880 860 780 770 760 790 760 750 670 660 590 640 540 530 540
Source.  The Monitoring the Future study, the University of Michigan.
See footnotes on the following page.
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Notes. Level of significance of difference between the two most recent years: s = .05, ss = .01, sss = .001. Any apparent inconsistency between the change estimate and the 
prevalence estimates for the two most recent years is due to rounding. ' — ' indicates data not available. ' * ' indicates a prevalence rate of less than 0.05%.
aAny illicit drug includes use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone (until 1990), or tranquilizers not 
under a doctor ʾs orders.  
bThis drug was asked about in four of the five questionnaire forms in 1980–1989, in five of the six forms in 1990–1998, and in three of the six forms beginning in 1999.
cIn 2001 the question text was changed on three of the six questionnaire forms. Other psychedelics was changed to other hallucinogens, and shrooms was added to the list of examples. 
Beginning in 2002 the remaining forms were changed to the new wording.
dThis drug was asked about in two of the five questionnaire forms in 1989, in two of the six questionnaire forms in 1990–2001, in three of the six questionnaire forms in 2002–2015, and 
in four of six questionnaire forms beginning in 2015.  
eThis drug was asked about in one of the five questionnaire forms for annual use only in 1986, two of the five questionnaire forms in 1987–1989, in all six questionnaire forms in 1990–2001, and 
in five of the six questionnaire forms beginning in 2002.. 
fThis drug was asked about in one of the five questionnaire forms in 1987–1989 and in four of six questionnaire forms beginning in 1990.
gOnly drug use that was not under a doctor ʾs orders is included here.
hIn 2002 the question text was changed on three of the six questionnaire forms. The list of examples of narcotics other than heroin was updated: Talwin, laudanum, and paregoric—all 
of which had negligible rates of use by 2001—were replaced by Vicodin, OxyContin, and Percocet. The 2002 data presented here are based on the changed forms only; 
N  is three sixths of N  indicated. In 2003 the remaining forms were changed to the new wording. The data are based on all forms in 2003 and beyond.
iRevised questions about amphetamine use were introduced in 1982 to more completely exclude inappropriate reporting of nonprescription amphetamines.  In 2013 the question wording was changed 
slightly in thee of the six questionnaire forms.  2013 data are based on the changed forms only; N is one half of N indicated.
jThis drug was asked about in two of the six questionnaire forms.  Questions about Rohypnol use were dropped from the questionnaires beginning in 2010.
kSedatives, adjusted data are a combination of barbiturate and methaqualone data.
lIn 2001 the question text was changed on three of the six questionnaire forms. Miltown was replaced with Xanax in the list of examples. Beginning in 2002 the remaining forms 
were changed to the new wording.
mIn 1993 and 1994, the question text was changed slightly in three of the six questionnaire forms to indicate that a drink meant more than just a few sips. Because this revision resulted in rather 
little change in reported prevalence in the surveys of high school graduates, the data for all forms combined are used in order to provide the most reliable estimate of change. 
After 1994 the new question text was used in all six of the questionnaire forms.
nThis drug was asked about in three of the six questionnaire forms. 
oThis drug was asked about in one of the six questionnaire forms. 
pThis drug was asked about in one of the five questionnaire forms in 1989 and in two of the six questionnaire forms beginning in 1990.
qThis drug was asked about in two of the six questionnaire forms through 2010 and in three of the six questionnaire forms beginning in 2011. 
rDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes, measured as actual daily use, and 5+ drinks, 
measured as having five or more drinks in a row in the last two weeks.
sIn 2012 the alcoholic beverage containing caffeine question text was changed to alcoholic beverage mixed with an energy drink.  The data in 2011 and 2012
are not comparable due to this question change.
tIn 2013 the question text was changed on all forms: Tuinal, Nembutal, and Seconal were replaced with Ambien, Lunesta, and Sonata.  The data in 2012 and
2013 are not comparable due to this question change.
uThis drug was asked about in two of the six questionnaire forms in 2011-2012; N is two sixths of N indicated.  Data were based on three of the six 
questionaire forms beginning in 2013; N is three sixths of N indicated.
vThis drug was asked about in one of the six questionnaire forms in 2009; N is one sixth of N indicated; Data were based on two of the six questionnaire
forms in 2010-2011; N is two sixths of N indicated.  Data were based on three of the six questionnaire forms beginning in 2012; N is three sixths of N indicated.
wThis drug was asked about in two of the six questionnaire forms in 2002-2009; N is two sixths of N indicated; Data were based on three of the six questionnaire
forms in 2010-2011; N is three sixths of N indicated.  Data were based on two of the six questionnaire forms in 2012-2015; N is two sixths of N indicated.
xThis drug was asked about in all six questionaire forms from 1980-2013.  Data based on five of six forms beginning in 2014; N is five sixths of N indicated.
yThis drug asked about in three of six questionnaire forms from 2011-2013; N is one half of N indicated.  Beginning in 2014, data based on two of six questionnaire forms; N is two sixths of N indicated.
z  In 2014 a revised question on use of ecstasy (MDMA) including "Molly" was added to one form at each level. The 2013 and 2014 "Original wording" data reported here are for only the 
 questionnaires using the original question wording. The 2014 and 2015 "Revised wording" data reported here are for only the questionnaires using the version which includes "Molly."
aaIn 2017, the surveys switched from asking about vaping in general to asking separately about vaping nicotine, marijuana, and just flavoring.  
Beginning in 2017, data presented for any vaping are based on these new questions.
bbFor the estimate of annual Any Vaping in 2018, there was a significant difference (p<.05) between the typical mail condition (26.9%) and new web-push condition (37.8%) of survey administration.
ccFor the estimate of annual Vaping Marijuana in 2018, there was a significant difference (p<.05) between the typical mail condition (15.2%) and new web-push condition (25.1%) of survey administration.
Footnotes for Tables 9-1 through 9-7
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ddFor the estimate of annual Vaping Nicotine in 2018, there was a significant difference (p<.05) between the typical mail condition (19.0%) and new web-push condition (32.0%) of survey administration.
eeFor the estimate of 30-day Vaping Marijuana in 2018, there was a significant difference (p<.05) between the typical mail condition (7.3%) and new web-push condition (14.5%) of survey administration.
Footnotes for Tables 9-1 through 9-7 (continued)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
Trends in Annual Prevalence 
among Male vs. Female College Students 
FIGURE 9-2
ANY ILLICIT DRUG OTHER THAN MARIJUANA
Trends in Annual Prevalence among College Students vs. Others 
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
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 Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
MARIJUANA
Trends in Annual Prevalence 
among Male vs. Female College Students 
FIGURE 9-3a
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
MARIJUANA
Trends in 30-Day Prevalence of Daily Use
among Male vs. Female College Students 
FIGURE 9-3b
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-4
SYNTHETIC MARIJUANA
Trends in Annual Use among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aUnadjusted for the possible underreporting of amyl and butyl nitrites.
INHALANTS a 
among Male vs. Female College Students 
Trends in Annual Prevalence
FIGURE 9-5
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aUnadjusted for the possible underreporting of PCP.
HALLUCINOGENS a 
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-6
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
LSD
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-7
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
HALLUCINOGENS OTHER THAN LSD
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-8
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aIn 2014, a version of the question was added to an additional form that included "molly" in the description.  In 2015, the
remaining forms were changed to this updated wording.  Data for both versions of the question are included here. 
ECSTASY (MDMA, Molly) a
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-9
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
COCAINE
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-10
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
aIn 2002 the question text was changed on half of the questionnaire forms. The list of examples of narcotics other than heroin 
was updated: Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—were replaced by Vicodin,
OxyContin, and Percocet. The 2002 data presented here are based on the changed forms only. In 2003 the remaining forms
were changed to the new wording.  
NARCOTICS OTHER THAN HEROIN a 
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-11a
NARCOTICS OTHER THAN HEROIN a 
Trends in Annual Prevalence among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
0
5
10
15
’80’81’82’83’84’85’86’87’88’89’90’91’92’93’94’95’96’97’98’99’00’01’02’03’04’05’06’07’08’09’10’11’12’13’14’15’16’17’18
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
Full-Time College Students
Others
12th Graders
0
5
10
15
’80’81’82’83’84’85’86’87’88’89’90’91’92’93’94’95’96’97’98’99’00’01’02’03’04’05’06’07’08’09’10’11’12’13’14’15’16’17’18
P
E
R
C
E
N
T
YEAR OF ADMINISTRATION
Male College Students
Female College Students
457
Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
FIGURE 9-11b
VICODIN
Trends in Annual Prevalence among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
FIGURE 9-11c
OXYCONTIN
Trends in Annual Prevalence among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
AMPHETAMINES
Trends in Annual Prevalence 
among Male vs. Female College Students 
FIGURE 9-12
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 Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
SEDATIVES (BARBITURATES)
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-13
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
TRANQUILIZERS
Trends in Annual Prevalence 
among Male vs. Female College Students 
FIGURE 9-14
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Trends in Annual Prevalence among College Students vs. Others
1 to 4 Years beyond High School 
(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
ALCOHOL
Trends in Annual Prevalence
among Male vs. Female College Students 
FIGURE 9-15a
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
ALCOHOL
Trends in 30-Day Prevalence
among Male vs. Female College Students 
FIGURE 9-15b
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(Twelfth graders included for comparison.)
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
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Source. The Monitoring the Future study, the University of Michigan.
Note.     Others refers to high school graduates one to four years beyond high school not currently enrolled full-time in college.
(Twelfth graders included for comparison.)
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Chapter 10 
 
STUDY PUBLICATIONS 
 
MTF results are reported in a number of other types of publications, in particular peer-reviewed 
journals. Selected articles published by MTF Investigators since the last release of this Volume or 
are in press as of this writing are summarized below. These publications used MTF data from the 
8th, 10th, and 12th grade samples, and/or the panel data.  Further details, as well as more listings of 
publications from previous years, may be found on the Monitoring The Future website. 
 
Two-year follow-up of a sequential mixed-mode experiment in the U.S. national 
Monitoring the Future study1 
Introduction: This study examines the two-year follow up of an original mixed-mode longitudinal 
survey experiment, comparing participant retention in the experimental conditions to retention in 
the standard Monitoring the Future (MTF) control condition. 
Methods: Two-year MTF follow-up data were collected in 2016 at modal age 21/22 based on 
original data collected in 2014 at modal age 19/20. The control group consisted of participants 
who completed an in-school baseline survey in 12th grade in 2012 or 2013 and were selected to 
participate in the first follow-up survey by mail in 2014 (N=2,451). A supplementary sample who 
completed the 12th grade baseline survey in 2012 or 2013 but were not selected to participate in 
the main MTF follow-up (N=4,950) were recruited and randomly assigned to one of three 
experimental conditions in 2014 and 2016: 1: Mail Push, 2: Web Push, 3: Web Push + Email.  
Results: The first experiment found Condition 3 (Web Push + Email) promising based on similar 
response rates and lower costs (Patrick et al. 2018). The current study examines associations 
between the experimental response in 2014 and 2016, change in response mode and device type 
from 2014 to 2016, and cumulative cost comparisons across conditions. Results indicated that 
responding via web in 2014 was associated with greater odds of participation again in 2016 
regardless of condition; respondents tended to respond in the same mode although the “push” 
condition did move respondents toward web over paper; device type varied between waves; and 
the cumulative cost savings of Web Push + Email grew larger compared to the MTF Control.  
Conclusion: The web push strategy in MTF is promising for maintaining respondent engagement 
while reducing cost. 
 
Historical trends in the grade of onset and sequence of cigarette, alcohol, and 
marijuana use among adolescents from 1976-2016: Implications for "Gateway" 
patterns in adolescence2 
Introduction: In the past decade, marijuana use prevalence among adolescents has remained 
relatively steady while cigarette and alcohol prevalence levels have declined. We examined 
historical trends in: average grade of onset of marijuana, alcohol, and cigarette use by 12thgrade; 
proportion who try alcohol/cigarettes before first marijuana use, among those who use by 
12th grade; and conditional probability of marijuana use by 12th grade after trying 
                                                 
1 Patrick, M. E., Couper, M. P., Jang, B., Laetz, V. B., Schulenberg, J., Johnston, L. D., Bachman, J., & M., O. M. P. (2019). Two-year follow-up 
of a sequential mixed-mode experiment in the U.S. national Monitoring the Future study. Survey Practice. 
2 Keyes, K. M., Rutherford, C., & Miech, R. (2018). Historical trends in the grade of onset and sequence of cigarette, alcohol, and marijuana use 
among adolescents from 1976-2016: Implications for "Gateway" patterns in adolescence. Drug and Alcohol Dependence, 194, 51-58. doi: 
10.1016/j.drugalcdep.2018.09.015. 
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alcohol/cigarettes.  
Methods: Data were drawn from 40 yearly, cross-sectional surveys of 12th grade US adolescents. 
A subset of students (N = 246,050) were asked when they first used each substance. We 
reconstructed cohorts of substance use from grade-of-onset to determine sequence of drug use, as 
well as probability of marijuana use in the same or later grade.  
Results: Average grade of first alcohol and cigarette use by 12th grade increased across time; e.g., 
first cigarette increased from grade 7.9 in 1986 to 9.0 by 2016 (β=0.04, SE = 0.001, p < 0.01). The 
proportion of 12th grade adolescents who smoke cigarettes before marijuana fell below 50% in 
2006. Each one-year increase was associated with 1.11 times increased odds of first cigarette in a 
grade after first marijuana (95% C.I. 1.11-1.12). Among those who initiate alcohol/cigarettes prior 
to marijuana by 12th grade, the probability of subsequent marijuana use is increasing.  
Conclusion: Marijuana is increasingly the first substance in the sequence of adolescent drug use. 
Reducing adolescent smoking has been a remarkable achievement of the past 20 years; those who 
continue to smoke are at higher risk for progression to marijuana use. 
 
College degree attainment by age of first marijuana use and parental education3 
Background: Age of first marijuana use is a key predictor of later educational outcomes, but 
limited work has identified demographic factors that impact this association across continuous 
ages of first use. The purpose of this study was threefold: (1) to identify the age-varying prevalence 
of later college degree attainment as a function of age of first marijuana use; (2) to examine the 
age-varying association of gender and college degree attainment as a function of age of first use; 
and (3) to examine the age-varying association of parent education and college degree attainment 
as a function of age of first use.  
Methods: Data were from the panel portion of the Monitoring the Future (MTF) study, an ongoing 
longitudinal study of adolescents and young adults. Those who used marijuana by age 22 were 
included in analyses. Among these participants (N = 2134), 47.0% were male, 67.5% were white, 
53.2% reported having at least one parent with a bachelor's degree or higher, and 44.1% attained 
a bachelor's degree or higher by age 25/26.  
Results: Intercept-only and logistic time-varying effect models (TVEMs) modeled prevalence 
levels and associations as functions of age of first marijuana use. Prevalence of college degree 
completion was relatively linear across age of first use; such that college degree attainment 
increased as age of first use increased. Results indicated that college degree attainment varied 
across age of first use similarly for men and women. Degree attainment differences existed based 
on parent education. Parental education and degree attainment were most strongly linked at an age 
of first use between 16 and 19 years.  
Conclusions: Findings suggest that age of first marijuana use has an association with academic 
achievement such that earlier ages of first use are associated with lower academic achievement 
later in adulthood. Parental education serves as a protective factor for college degree attainment in 
late adolescence. 
 
 
 
 
 
                                                 
3 Linden-Carmichael, A. N., Kloska, D. D., Evans-Polce, R., Lanza, S. T., & Patrick, M. E. (2018). College degree attainment by age of first 
marijuana use and parental education. Substance Abuse, 1-5. doi: 10.1080/08897077.2018.1521354 
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E-cigarette price sensitivity among middle and high school students: Evidence from 
Monitoring the Future4 
Aims: We estimated associations between e-cigarette prices (both disposable and refill) and e-
cigarette use among middle and high-school students in the United States. We also estimated 
associations between cigarette prices and e-cigarette use.  
Design: We used regression models to estimate the associations between e-cigarette and cigarette 
prices and e-cigarette use. In our regression models, we exploited changes in e-cigarette and 
cigarette prices across four periods of time and across 50 markets. We report the associations as 
price elasticities. In our primary model, we controlled for socio-demographic characteristics, 
cigarette prices, tobacco control policies, market fixed effects and year-quarter fixed effects. 
Setting: United States of America. Participants: A total of 24 370 middle- and high-school students 
participating in the Monitoring the Future Survey in years 2014 and 2015. Measurements: Self-
reported e-cigarette use over the last 30 days. Average quarterly cigarette prices, e-cigarette 
disposable prices and e-cigarette refill prices were constructed from Nielsen retail data (inclusive 
of excise taxes) for 50 US markets.  
Findings: In a model with market fixed effects, we estimated that a 10% increase in e-cigarette 
disposable prices is associated with a reduction in the number of days vaping among e-cigarette 
users by approximately 9.7% [95% confidence interval (CI) = -17.7 to 1.8%; P = 0.02] and is 
associated with a reduction in the number of days vaping by the full sample by approximately 
17.9% (95% CI = -31.5 to -4.2%; P = 0.01). Refill e-cigarette prices were not statistically 
significant predictors of vaping. Cigarette prices were not associated significantly with e-cigarette 
use regardless of the e-cigarette price used. However, in a model without market fixed effects, 
cigarette prices were a statistically significant positive predictor of total e-cigarette use. 
Conclusions: Higher e-cigarette disposable prices appear to be associated with reduced e-cigarette 
use among adolescents in the US. 
 
Recent rapid decrease in adolescents' perception that marijuana is harmful, but no 
concurrent increase in use5 
Background: National trends in adolescent's marijuana risk perceptions are traditionally used as 
a predictor of concurrent and future trends in adolescent marijuana use. We test the validity of this 
practice during a time of rapid marijuana policy change.  
Methods: Two repeated cross-sectional U.S. nationally-representative surveys of 8th, 10th, and 
12th-graders: Monitoring the Future (MTF) (1991-2015; N=1,181,692) and National Survey on 
Drug Use and Health (NSDUH) (2002-2014; N=113,317). We examined trends in the year-to-year 
prevalence of perceiving no risk of harm in using marijuana regularly, and prevalence of regular 
marijuana use within the previous month. A piecewise linear regression model tested for a change 
in the relationship between trends. Similar analyses examined any past-month use and controlled 
for demographic characteristics.  
Results: Among MTF 12th-graders, the prevalence of regular marijuana use and risk perceptions 
changed similarly between 1991 and 2006 but diverged sharply afterward. The prevalence of 
regular marijuana use increased by approximately 1 percentage point to 6.03% by 2015. In 
contrast, the proportion of 12th-graders that perceived marijuana as posing no risk increased over 
                                                 
4 Pesko, M. F., Huang, J., Johnston, L. D., & Chaloupka, F. J. (2018). E-cigarette price sensitivity among middle and high school students: Evidence 
from Monitoring the Future. Addiction, 113(5), 896-906. doi: 10.1111/add.14119 
5 Sarvet, A. L., Wall, M. M., Keyes, K. M., Cerda, M., Schulenberg, J. E., O'Malley, P. M., Johnston, L. D., & Hasin, D. S. (2018). Recent rapid 
decrease in adolescents' perception that marijuana is harmful, but no concurrent increase in use. Drug and Alcohol Dependence, 186, 68-74. doi: 
10.1016/j.drugalcdep.2017.12.041 
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11 percentage points to 21.39%. A similar divergence was found among NSDUH 12th-graders and 
other grades, for any past month marijuana use, and when controlling demographic characteristics. 
Conclusions: An increase in adolescent marijuana use has not accompanied recent rapid decreases 
in marijuana risk perceptions. Policy makers may consider broader prevention strategies in 
addition to targeting marijuana risk perceptions. Further monitoring of predictors of marijuana use 
trends is needed as states legalize recreational marijuana use. 
 
Simultaneous alcohol and marijuana use among young adult drinkers: Age-specific 
changes in prevalence from 1977-20166 
Background: The overall prevalence of U.S. young adult alcohol use has decreased, but little is 
known about historical change in related behaviors such as simultaneous alcohol and marijuana 
(SAM) use that may increase alcohol-related risks and societal costs. The purpose of this paper 
was to examine historical change in SAM use prevalence among U.S. young adult alcohol users 
from 1977 to 2016, and consider the extent to which observed historical change in SAM use among 
alcohol users reflects co-occurring change in marijuana use during these years. 
Methods: Data on past 12-month alcohol, marijuana, and SAM use at up to 6 modal ages (19/20, 
21/22, 23/24, 25/26, 27/28, and 29/30) were collected from 11,789 individuals (45.0% men) 
participating in the Monitoring the Future panel study. Annual prevalence estimates within modal 
age group were obtained; historical SAM use trends among alcohol and marijuana users were 
estimated. 
Results: From 2014 to 2016, SAM use was reported by approximately 30% of alcohol users aged 
19/20 and 21/22, and 20 to 25% of alcohol users aged 23/24 through 29/30. Since the mid-1990s, 
age-specific historical trends in SAM use prevalence among alcohol users followed 1 of 4 patterns: 
significant increase followed by oscillating increases/decreases (at modal age 19/20), consistent 
and significant increases (at modal ages 21/22, 23/24, and 25/26), stability followed by increase 
(at modal ages 27/28), or stability (at modal ages 29/30). In contrast, SAM use trends among 
marijuana users primarily reflected stability, with some evidence of a decrease across time at 
modal ages 19/20 and 23/24. Historical change in SAM prevalence among alcohol users was 
strongly and positively correlated with changes in overall marijuana use prevalence.  
Conclusions: A growing proportion of early and mid-young adult alcohol users reported SAM 
use, with the highest risk among those in the early years of young adulthood. Young adult SAM 
use may continue to increase in proportion to the degree that young adult marijuana use continues 
to increase. 
 
The end of convergence in developmental patterns of frequent marijuana use from 
ages 18 to 30: An analysis of cohort change from 1976–20167 
Background: This study examines the extent to which the developmental pattern of frequent 
marijuana use prevalence from ages 18 to 30 (overall and by gender) has varied across historical 
time (cohort groups) using data from a national sample of US young adults.  
Methods: Self-reported data on frequent marijuana use (use on 20+ occasions in the past 30 days) 
from modal ages 18 to 30 were obtained from 58,059 individuals from 29 sequential cohorts 
(graduating high school classes of 1976-2004) participating in the Monitoring the Future study. 
                                                 
6 Terry-McEllrath, Y. M., & Patrick, M. E. (2018). Simultaneous alcohol and marijuana use among young adult drinkers: Age-specific changes in 
prevalence from 1977-2016. Alcoholism: Clinical and Experimental Research, 42(11), 2224-2233. doi: 10.1111/acer.13879 
7 Terry-McElrath, Y. M., Patrick, M. E., O'Malley, P. M., & Johnston, L. D. (2018). The end of convergence in developmental patterns of frequent 
marijuana use from ages 18 to 30: An analysis of cohort change from 1976–2016. Drug and Alcohol Dependence, 191, 203-209. doi: 
10.1016/j.drugalcdep.2018.07.002 
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Time-varying effect modeling was used to model cohort group differences in developmental 
patterns of frequent use overall and by gender.  
Results: Developmental patterns of frequent marijuana use prevalence varied meaningfully across 
cohort groups. Frequent use at age 18 differed significantly across cohort groups as expected based 
on national data. Among earlier cohort groups (reaching age 30 during 1987-2008), developmental 
patterns converged by age 30 to relatively low frequent marijuana use prevalence. In contrast, 
among cohort groups reaching age 30 during 2008-2016, frequent marijuana use at age 30 was 
significantly higher than all previous cohort groups. Observed cohort differences did not vary 
significantly by gender.  
Conclusions: Cross-cohort convergence in developmental patterns of frequent marijuana use 
prevalence by age 30 was not observed among recent cohort groups, among whom age 30 frequent 
marijuana use prevalence was at the highest levels observed since the study began. Higher frequent 
marijuana use prevalence in late young adulthood has meaningful health risk and service provision 
implications. 
 
Recent increases in depressive symptoms among US adolescents: trends from 1991 
to 20188  
Background: Mental health problems and mental health related mortality have increased among 
adolescents, particularly girls. These trends have implications for etiology and prevention and 
suggest new and emerging risk factors in need of attention. The present study estimated age, 
period, and cohort effects in depressive symptoms among US nationally representative samples of 
school attending adolescents from 1991 to 2018.  
Methods: Data are drawn from 1991 to 2018 Monitoring the Future yearly cross-sectional surveys 
of 8th, 10th, and 12th grade students (N = 1,260,159). Depressive symptoms measured with four 
questions that had consistent wording and data collection procedures across all 28 years. Age-
period-cohort effects estimated using the hierarchical age-period-cohort models.  
Results: Among girls, depressive symptoms decreased from 1991 to 2011, then reversed course, 
peaking in 2018; these increases reflected primarily period effects, which compared to the mean 
of all periods showed a gradual increase starting in 2012 and peaked in 2018 (estimate = 1.15, p < 
0.01). Cohort effects were minimal, indicating that increases are observed across all age groups. 
Among boys, trends were similar although the extent of the increase is less marked compared to 
girls; there was a declining cohort effect among recently born cohorts, suggesting that increases in 
depressive symptoms among boys are slower for younger boys compared to older boys in recent 
years. Trends were generally similar by race/ethnicity and parental education, with a positive 
cohort effect for Hispanic girls born 1999-2004.  
Conclusions: Depressive symptoms are increasing among teens, especially among girls, consistent 
with increases in depression and suicide. Population variation in psychiatric disorder symptoms 
highlight the importance of current environmental determinants of psychiatric disorder risk, and 
provide evidence of emerging risk factors that may be shaping a new and concerning trend in 
adolescent mental health. 
 
 
 
 
                                                 
8 Keyes, K. M., Gary, D., O'Malley, P. M., Hamilton, A., & Schulenberg, J. (2019). Recent increases in depressive symptoms among US 
adolescents: trends from 1991 to 2018. Social Psychiatry and Psychiatric Epidemiology. doi: 10.1007/s00127-019-01697-8 
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A prospective study of nonmedical use of prescription opioids during adolescence 
and subsequent substance use disorder symptoms in early midlife9 
Background: This longitudinal study assesses characteristics associated with adolescents' 
nonmedical use of prescription opioids (NMUPO) including: frequency, co-ingestion, motives, 
specific opioid type; sequence of initiation of medical use of prescription opioids and NMUPO in 
relationship to subsequent substance use disorder (SUD) symptoms.  
Methods: Twenty-one independent national cohorts of U.S. high school seniors (n = 8,373) were 
surveyed and followed 17 years from adolescence to age 35.  
Results: The majority of adolescents who engaged in NMUPO reported occasional/frequent 
NMUPO, non-pain relief motives for NMUPO, simultaneous co-ingestion involving NMUPO and 
other drugs, opioid analgesics with high misuse potential, and multiple types of opioid analgesics. 
Adolescents who reported NMUPO for pain relief, NMUPO involving opioid analgesics with high 
misuse potential, or multiple prescription opioids had significantly greater odds of SUD symptoms 
at age 35, relative to those who had no history of NMUPO during adolescence. In addition, medical 
use of prescription opioids after initiating NMUPO (or NMUPO only) during adolescence was 
associated with significantly greater odds of subsequent SUD symptoms at age 35 relative to those 
who reported the medical use of prescription opioids only or had no medical use or NMUPO during 
adolescence.  
Conclusions: This is the first U.S. national prospective study to examine the relationships between 
adolescents' NMUPO characteristics and later SUD symptoms in early midlife. Several 
characteristics (frequency, co-ingestion, motives, opioid type, and medical/NMUPO initiation 
history) were identified that could be used to screen and detect high-risk youth for indicated 
interventions to reduce prescription opioid misuse and SUDs. 
 
Adolescent vaping and nicotine use in 2017-2018 - U.S. national estimates10 
Background: Multiple media reports highlighted a surge in nicotine vaping among U.S. 
adolescents in 2018. This study is the first to use nationally representative data to assess the 
magnitude of increases in nicotine vaping from 2017 to 2018. 
Methods: Data for this study come from Monitoring the Future, which surveyed nationally 
representative, independent samples of 12th, 10th, and 8th grade students in 2017 and 2018. 
Analyses are based on a total of 13,850 completed survey responses. For a randomly selected 
subsample of the 12th grade respondents the surveys included a cluster of questions on both vaping 
and the six most common forms of tobacco use, thereby allowing examination of overall nicotine 
use with any nicotine product. 
Results: Nicotine vaping significantly increased by 9.9, 7.9, and 2.6 percentage points in 12th, 10th, 
and 8th grade, respectively. In 12th grade overall use of nicotine by any method measured in the 
survey increased by 5.2 percentage points. This increase in overall nicotine use was driven solely 
by nicotine vaping, which more than offset declines the prevalence of use of the six of the most 
commonly used tobacco products. 
Conclusions: Increases in vaping in 2018 are the largest ever seen for any of the 30-day prevalence 
outcomes monitored by Monitoring the Future in the 44 years it has continuously tracked 
                                                 
9 McCabe, S. E., Veliz, P. T., Boyd, C. J., Schepis, T. S., McCabe, V. V., & Schulenberg, J. E. (2019). A prospective study of nonmedical use of 
prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife. Drug and Alcohol Dependence, 194, 
377-385. doi: 10.1016/j.drugalcdep.2018.10.027 
10 Miech, R., Johnston, L., O'Malley, P. M., Bachman, J. G., & Patrick, M. E. (2019). Adolescent vaping and nicotine use in 2017-2018 - U.S. 
national estimates. New England Journal of Medicine. doi: 10.1056/NEJMc1814130 
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adolescent substance use. These results document a recent increase in adolescent nicotine use, due 
to an epidemic of nicotine vaping among U.S. adolescents in 2018. 
 
Increasing marijuana use for black adolescents in the United States: A test of 
competing explanations11 
Aims: In the last decade the relatively lower levels of marijuana use for black relative to non-black 
high school seniors has grown smaller and disappeared, drawing to a close a unique disparity that 
actually favored a disadvantaged group for at least thirty years. In this study we test trends in 
cigarette smoking and religiosity as possible explanations for this closing disparity. The study also 
examines whether increasing marijuana levels for black adolescents is better characterized as a 
cohort effect or an historical period effect.  
Design: Analyses use relative risk regression and focus on data from yearly, cross-sectional 
surveys from the time period 2008-2017. Data come from the nationally representative Monitoring 
the Future survey, which conducts in-school surveys of secondary school students. The analysis 
uses data from 114,552 high school seniors (in 12th grade), 123,594 in 10th grade, and 136,741 in 
8th grade.  
Findings: Past 12-month marijuana prevalence significantly increased for black as compared to 
non-black adolescents from 2008 to 2017 in 12th grade, 10th grade, and 8th grade. The increase 
attenuated by more than half and was not statistically significant after adjusting for cigarette 
smoking. In contrast, the increase was little changed after adjusting adolescent levels of religiosity. 
The increase is better characterized as a cohort effect than a period effect.  
Conclusions: These results support the increase in marijuana use for black relative to non-black 
adolescents as an unexpected consequence of the great decline in adolescent cigarette smoking, 
which has occurred more slowly for black adolescents. 
 
The national prevalence of adolescent nicotine use in 2017: Estimates taking into 
account student reports of substances vaped12 
Introduction: This study presents the first nationally-representative estimates of adolescent 
nicotine prevalence that take into account adolescent reports of substances vaped. These reports 
allow nicotine estimates that consider the impact of the newly-emerged group of adolescents who 
report vaping only non-nicotine substances such as flavoring and/or marijuana and do not use 
nicotine in any form – a group typically treated as nicotine users.  
Methods: Data come from Monitoring the Future and are a randomly-selected subsample of 2231 
U.S. 12th grade students who answered surveys with detailed questions on tobacco use and vaping 
in 2017.  
Results: Among 12th grade students 24.7% used nicotine in the last 30 days. This estimate does 
not include the 3.8% of students who vaped only non-nicotine substances and did not use nicotine 
in any other form. These students more closely resemble their peers who do not use nicotine than 
those who do, in terms of perceived risk and disapproval of cigarettes, as well as percentage of 
friends who use cigarettes.  
Conclusions: A decline in overall nicotine prevalence was statistically significant, but not 
strikingly large, after taking into account students who vape non-nicotine substances and do not 
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use nicotine in any form. These students are largely similar to their peers who do not use nicotine, 
which underscores the importance of efforts to alert youth that they may be vaping nicotine 
unknowingly, and prevent them from doing so. 
 
 “Flakka” use among high school seniors in the United States13  
Background: Use of synthetic cathinones, commonly referred to as "bath salts", has been 
associated with tens of thousands of emergency department visits in the US; however, few national 
studies have estimated prevalence of use and we know very little about use among adolescents. In 
this study we estimate prevalence and correlates of use of "Flakka" (alpha-PVP), a highly-potent 
"bath salt" associated with at least 80 deaths in the US.  
Methods: We analyzed data from the 2016/2017 Monitoring the Future study, which surveyed a 
nationally representative sample of high school seniors in the US (n = 3786). Bivariable and 
multivariable models were used to determine demographic and drug-related correlates of use.  
Results: Overall, 0.8% (95% CI: 0.5-1.2) of high school seniors in 2016/2017 are estimated to 
have used Flakka in the past year. Students whose parents have less than a high school education 
were at higher odds for use (aOR = 4.12, 95% CI: 1.00-16.94). Flakka users reported high 
prevalence of use of other drugs, particularly synthetic cannabinoids (85.6%), ketamine (72.3%), 
marijuana (59.1%), and GHB (47.5%). Flakka use was also associated with use of a higher number 
of other drugs and higher frequency of use of other drugs, with 51.7% using 4-12 other drugs and 
22.4% using 4-12 other drugs >6 times.  
Conclusions: Students who use multiple drugs are elevated risk for Flakka use, suggesting 
synthetic cathinone use alone is rare and the use of multiple substances may compound adverse 
effects of these drugs. Socio-economic disparities are concerning given reduced access to 
prevention and intervention. 
 
Faster escalation from first drink to first intoxication as a risk factor for binge and high-
intensity drinking among adolescents14 
Introduction: Age of first drink is a key risk factor for adolescent high-risk alcohol use. The 
current study examined whether speed of escalation from first drink to first intoxication is an 
additional risk factor, and whether these two factors are associated with binge and high-intensity 
drinking among adolescents.  
Methods: Data collected in 2005-2017 from a nationally-representative sample of 11,100 U.S. 
12th grade students participating in the Monitoring the Future study were coded to indicate grade 
of first drink, grade of first intoxication, and speed of escalation from first drink to first 
intoxication. Logistic regression models estimated bivariate and multivariable odds of past 2-week 
binge (5+ drinks in a row) and high-intensity (10+ drinks in a row) drinking in 12th grade.  
Results: Of those who reported intoxication by 12th grade, almost 60% reported first drunkenness 
in the same grade in which they first drank. The likelihoods of 12th grade binge and high-intensity 
drinking were significantly associated with both grade of first drink and speed of escalation to 
intoxication. Past two-week high-intensity drinking prevalence was 17.4% among those with 
immediate (same-grade) escalation from first drink to first intoxication; 15.8% among those with 
a 1-grade delay, and 12.6% among those with a 2+ grade delay to intoxication.  
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Conclusions: The majority of students escalate quickly from having their first drink to being 
intoxicated for the first time. Both earlier age of first drink and a faster escalation from first drink 
to first intoxication are important indicators of binge and high-intensity drinking risk among 
adolescents. 
 
Prevalence of high-intensity drinking from adolescence through young adulthood: 
National data from 2016-201715 
High-intensity drinking (HID; ie, having 10+ drinks in a row) is a recognized public health concern 
due to the individual and public risks (eg, alcohol-related injuries, alcohol poisoning, memory loss, 
sexual risk) associated with consumption of a large quantity of alcohol over a relatively short time 
period. Using nationally representative samples of US 8th, 10th, and 12th grade students, and 
follow-up of subsamples of 12th graders, we present overall and sex-specific prevalence estimates 
of past 2-week HID from 29 966 individuals at the modal ages of 14 to 30 in 2016-2017. Similar 
data for the more commonly studied measure of binge drinking (having 5+ drinks in a row) are 
provided for comparison. HID prevalence ranged from 1% to 11.5% and was significantly higher 
for males than females at all ages other than modal age 14 (8th grade). Binge drinking prevalence 
ranged from 3.5% to 32.5%; males reported a higher prevalence than females at approximately 
half of the ages examined. Peak binge drinking and HID age for males was earlier (modal age 
21/22) than that for females (modal age 21-24 for binge drinking and 25/26 for HID). The observed 
rapid increase in HID from adolescence through the early to mid-20s highlights the importance of 
prevention and intervention efforts targeted to these ages. 
 
Reasons high school students use marijuana: Prevalence and links with use across 
four decades16   
Objective: Changes in the legality and prevalence of marijuana raise questions about whether 
adolescents' reasons for using marijuana and associations between reasons for use and recent 
marijuana use have changed historically.  
Method: Using nationally representative data from Monitoring the Future for 1976-2016 (N = 
39,964; 47.6% female), we examined changes in self-reported reasons for marijuana use and in the 
associations between reasons for use and past-30-day marijuana use among 12th graders who used 
marijuana in the past 12 months.  
Results: Time-varying effect modeling showed variation in reasons for use among adolescent past-
year marijuana users from 1976 to 2016. Social/recreational reasons for marijuana use (i.e., 
Boredom, Feel Good/Get High, Experiment, Fit In) generally declined in prevalence; the exception 
was Good Time, which remained quite stable. Prevalence of coping with negative affect reasons 
(i.e., Anger/Frustration, Escape Problems, Relax, Get Through Day) approximately doubled across 
40 years. Over time, social/recreational reasons were consistently associated with greater odds 
(i.e., Boredom, Feel Good/Get High, Good Time) or lower odds (i.e., Experiment, Fit In) of recent 
marijuana use. Coping with negative affect reasons, drug effect reasons, and compulsive use were 
consistently associated with greater odds of recent use.  
Conclusions: The most common reasons for marijuana use among high school students have 
shifted markedly in 40 years, with particular increases for coping-related reasons. However, 
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reasons for use remain significant, stable predictors of use. This suggests a move toward riskier 
(coping-related) use but supports the continued salience of motivation-based approaches for 
prevention and intervention. 
 
Shifting age of peak binge drinking prevalence: Historical changes in normative 
trajectories among young adults aged 18 to 3017 
Background: This study examined the extent to which the developmental pattern of prevalence 
of binge drinking in the past 2 weeks from ages 18 through 30 has changed across 29 cohorts of 
U.S. young adults, and whether the changes differed by gender.  
Methods: Analyses used national longitudinal data from 58,019 12th-grade students (from 
graduating high school classes 1976 to 2004) participating in the Monitoring the Future study 
followed through modal age 30 (with age 29/30 data collected from 1987 to 2016). Weighted time-
varying effect modeling was used to model cohort group differences in age-related patterns of 
binge drinking.  
Results: The age of peak binge drinking prevalence increased across cohorts (from age 20 in 1976 
to 1985 to 22 in 1996 to 2004 for women, and from 21 in 1976 to 1985 to 23 in 1996 to 2004 for 
men). Historical change in the developmental pattern of binge drinking across all ages of young 
adulthood differed for men and women. Even after controlling for key covariates, women in the 
more recent cohort group reported significantly higher binge drinking prevalence than women in 
earlier cohorts from ages 21 through 30. Men in the more recent cohort group reported higher 
binge drinking prevalence at ages 25 to 26, but prevalence levels then converged to those seen in 
earlier cohort groups by age 30.  
Conclusions: An older age of peak binge drinking and a decreased rate of decline in the prevalence 
of binge drinking in later young adulthood among more recent cohorts have resulted in an 
extension of individual and societal risks associated with binge drinking, particularly for women, 
across young adulthood. High-risk alcohol use prevention efforts are needed throughout at least 
the third decade of life. 
 
Simultaneous alcohol and marijuana use among underage young adults in the United 
States18 
Objective: The current study examines the prevalence, stability, and correlates of simultaneous 
alcohol and marijuana (SAM) use among underage US young adults, a population at high risk for 
participating in this behavior.  
Method: Analyses used data from 1719 respondents (46.8% men) who participated in the 
nationally representative 12th-grade Monitoring the Future study and provided responses to SAM 
use items at longitudinal follow-up at modal ages 19/20 between 2007 and 2016. Prevalence 
estimates and covariate associations with SAM use were estimated.  
Results: SAM use prevalence at modal age 19/20 was 22.5%. Multivariable models indicated that 
odds of age 19/20 SAM use were significantly (p<.05) higher for men (vs. women) and for 
respondents who started alcohol use by age 18 (vs. those who delayed uptake until after high 
school). Odds of SAM use were especially high for individuals attending college full-time and not 
living with parents. Among those who reported SAM use at modal age 18, 56.2% continued to 
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report SAM use at modal age 19/20. Among those who did not report SAM use at modal age 18, 
only 14.2% reported SAM use at modal age 19/20.  
Conclusions: SAM use among young adults aged 19/20 in the US is relatively common, but 
especially so for those who began such use by age 18, highlighting the early onset and stability of 
this behavior. Among underage drinkers, SAM risk varies by sex, race/ethnicity, college status, 
and living arrangements. 
 
Young adult longitudinal patterns of marijuana use among US national samples of 12th 
grade frequent marijuana users: A repeated measures latent class analysis19 
Background and Aims: Long-term frequent marijuana use is associated with significant negative 
outcomes, yet little is known about the longitudinal course of marijuana use among those who start 
frequent use during adolescence. Objectives are (a) to identify latent patterns of within-person 
marijuana use from ages 19-30 among 12th graders reporting frequent marijuana use, (b) to 
examine if membership in identified patterns has changed across historical time, and (c) to examine 
if key covariates differentiate class membership.  
Design: Setting and participants: Longitudinal, national US panel data from 4,423 individuals 
(53.4% of the eligible sample; 2,744 [62%] males) who reported frequent marijuana use in 12th 
grade (modal age 18 years; senior year cohorts 1976-2006) followed biennially from age 19/20 
through 29/30. Measurements: Self-reported past 30-day marijuana use (frequent use defined as 
use on 20+ occasions), demographics, college graduation, marriage, and parenthood.  
Findings: Repeated measures latent class analysis (RMLCA) identified five latent classes of past 
30-day marijuana use from ages 19/20 through 29/30: Continued Frequent Users (estimated 
membership 23.4%); Frequent to Non-Frequent Users (15.5%); Consistent Non-Frequent Users 
(18.4%); Non-Frequent Users to Discontinuers (19.5%); and Discontinuers (23.2%). In 
multivariable models, membership in the highest-risk latent class (Continued Frequent Users) 
versus one or more of the lower-risk latent classes was more likely for recent cohorts (p=0.038 to 
<0.001), as well as those who did not marry (p=0.039 to <0.001) or become parents (p=0.001) by 
modal age 29/30.  
Conclusions: Nearly one in four 12th grade (modal age 18 years) frequent marijuana users in the 
US continues to report high frequency use through age 30; the proportion continuing high 
frequency use across young adulthood has increased among more recent cohorts. 
 
Lifetime prevalence of self-reported concussion among adolescents involved in 
competitive sports: A national U.S. study20 
Purpose: Examine lifetime prevalence of diagnosed concussion in US-national samples of 8th, 
10th, and 12th graders involved in 16 different competitive sports; examine associations between 
concussion and individual sports, controlling for demographic characteristics and multiple sports 
involvement.  
Methods: Analysis of nationally representative Monitoring the Future data from 2 cohorts (2016-
2017; n=25,408).  
Results: Adolescents who participated in baseball, basketball, football, gymnastics, ice hockey, 
lacrosse, soccer, track, weightlifting, and 'other sports' had greater odds of reporting multiple 
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diagnosed concussions compared with peers not participating in these sports. Adolescents who 
participated in tennis had lower odds of reporting any diagnosed concussion or multiple 
concussions. Females who participated in gymnastics, soccer, and swimming showed a stronger 
association in reporting a diagnosed concussion when compared with males who participated in 
these same types of sports.  
Conclusions: The study provides needed epidemiological information on prevalence of reported 
diagnosed concussion among teens participating in popular school and community sports. Certain 
high contact (e.g., football) and high volume (e.g., basketball) sports need increased efforts to 
manage adolescent athletes who already have a history of concussion or repeated concussions. 
 
OTHER DATA ON CORRELATES AND TRENDS 
Drug use correlates and trends not presented in this monograph or in the papers above can be 
calculated using the publicly available MTF data archive at the Inter-university Consortium of 
Political and Social Research (ICPSR). In addition, interested users can use the online interface at 
the National Addiction and HIV Data Archive Program (sponsored in part by the National Institute 
on Drug Abuse) to produce cross-tabulations for variables of interest, also available at the ICPSR 
website.  
 
These online resources allow users to calculate hundreds of correlates of drug use. For data 
previous to 2013, MTF published bivariate correlates without accompanying interpretation in a 
series of annual volumes entitled Monitoring the Future: Questionnaire Responses from the 
Nation’s High School Seniors. For each year between 1975 and 2012, a separate volume presents 
univariate and selected bivariate distributions on all questions asked of 12th graders. A host of 
variables dealing explicitly with drugs—many of them not covered here—are contained in that 
series. Bivariate tables are provided for all questions asked of high school seniors each year 
distributed against an index of lifetime illicit drug involvement, making it possible to examine the 
relationships between hundreds of potential risk factors and illicit drug use. These reference 
volumes are available on the MTF website and include MTF data up to 2012. They were 
discontinued thereafter as the online resources make it possible for interested readers to themselves 
calculate these statistics and any combination thereof, for 8th and 10th grade as well as for 12th 
grade respondents.  
 
An annual occasional paper on subgroups21 presents trends in both graphic and tabular form for 
the various subgroups of adolescents for each of the many drug classes. It covers all years for all 
three grades in which data have been collected. It is available on the MTF website. An additional 
occasional paper on subgroup trends among young adults22 is also available on the website. 
 
WEBSITE 
Any reader wishing to obtain more information on the study, or to check for recent findings and 
publications, may visit the MTF website. Prior to publication in this series of annual monographs, 
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many recent MTF findings on substance use trends and related attitudes and beliefs are posted on 
the website in two forms: (1) press releases issued in mid-December of the year in which the data 
were collected; and (2) an Overview of Key Findings monograph posted at the end of the following 
January. 
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